data_2fo8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fo8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.962 ' HB3' HG21 ' A' ' 22' ' ' VAL . 16.1 t60 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.072 -0.714 . . . . 1.1000000000000001 109.072 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.512 ' HB2' ' HZ2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -137.73 136.65 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.567 -0.288 . . . . 2.8500000000000001 110.972 -178.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.886 HG22 HG11 ' A' ' 105' ' ' VAL . 2.1 t -112.36 157.5 13.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.856 0.36 . . . . 1.23 111.03 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -151.76 170.64 19.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.421 1.089 . . . . 1.1000000000000001 108.113 -172.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 26.0 tptp -48.33 -37.06 15.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.561 0.949 . . . . 1.47 113.561 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.08 79.2 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.914 0.864 . . . . 1.05 110.742 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.734 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.6 m80 -65.32 -3.7 4.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.134 -0.939 . . . . 2.7000000000000002 111.346 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.703 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 26.0 t-20 -50.27 -18.92 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.679 0.612 . . . . 1.48 110.03 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.45 55.73 0.6 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.29999999999999999 111.285 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.66 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -113.79 156.1 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.041 0.756 . . . . 1.0800000000000001 113.041 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 m -139.39 112.69 8.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.185 -1.042 . . . . 1.3 108.185 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 23.1 tp -151.14 163.24 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 3.4700000000000002 111.74 -167.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.0 m -104.58 148.04 26.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.179 -0.674 . . . . 2.0800000000000001 109.179 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 108' ' ' LYS . 2.8 m -127.55 156.82 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.053 -0.659 . . . . 1.3600000000000001 112.429 -177.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.76 142.4 34.77 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.789 -1.189 . . . . 1.27 107.789 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 22' ' ' VAL . 10.7 m -119.8 -176.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.792 0.329 . . . . 1.8500000000000001 110.724 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.6 -59.52 0.69 Allowed Glycine 0 CA--C 1.505 -0.58 0 N-CA-C 111.224 -0.75 . . . . 0.70999999999999996 111.224 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -73.68 -68.22 0.53 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 2.3500000000000001 108.96 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -167.64 141.33 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.755 -1.111 . . . . 1.3600000000000001 110.283 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.962 HG21 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -113.68 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.494 -0.928 . . . . 1.1799999999999999 108.494 169.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.646 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -108.88 157.35 18.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.056 0.931 . . . . 1.74 112.524 -169.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.6 HD13 ' HB ' ' A' ' 5' ' ' VAL . 29.7 mm -134.28 103.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.579 -1.646 . . . . 1.1000000000000001 108.428 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -112.73 139.0 48.71 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.528 -0.733 . . . . 0.64000000000000001 112.194 -175.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -111.59 148.41 38.8 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.531 -0.759 . . . . 1.47 109.947 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 40.3 Cg_endo -87.09 11.84 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.229 2.619 . . . . 0.34999999999999998 111.976 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.502 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 21.5 t 69.3 -66.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.343 -0.844 . . . . 0.91000000000000003 110.83 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.23 64.05 2.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.438 -0.949 . . . . 1.3899999999999999 108.438 -170.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.41 117.76 2.5 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.88 3.053 . . . . 0.97999999999999998 113.272 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.482 HG23 ' CZ ' ' A' ' 89' ' ' TYR . 22.3 p -91.64 -89.1 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.212 -0.904 . . . . 2.0899999999999999 112.849 -170.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 t -163.26 22.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.007 0.908 . . . . 2.6800000000000002 110.141 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.26 -35.83 1.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.46 -0.791 . . . . 1.5800000000000001 111.377 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.566 ' HA ' ' C ' ' A' ' 90' ' ' MET . 2.2 m-85 -62.43 143.99 56.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.974 -0.613 . . . . 2.7200000000000002 111.189 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.483 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -139.53 156.04 47.15 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.387 -0.968 . . . . 1.1599999999999999 108.387 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.502 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -81.0 117.27 21.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.518 0.675 . . . . 0.42999999999999999 111.51 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.721 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 56.2 m-85 -127.46 175.78 7.97 Favored 'General case' 0 C--O 1.212 -0.882 0 N-CA-C 108.179 -1.045 . . . . 3.0299999999999998 108.179 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.698 ' HA ' HD21 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -67.2 -74.38 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.773 0.715 . . . . 0.53000000000000003 109.715 171.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -110.51 -8.16 14.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.048 -0.524 . . . . 2.3900000000000001 110.157 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.08 106.59 2.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.366 -0.921 . . . . 0.72999999999999998 112.047 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.25 -23.92 5.86 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.674 . . . . 0.85999999999999999 112.448 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 m -128.33 141.84 51.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.653 0.263 . . . . 1.53 110.41 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -136.97 134.85 37.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.682 -0.69 . . . . 3.0600000000000001 110.048 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -128.54 145.85 51.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.754 0.788 . . . . 2.2999999999999998 112.136 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.871 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 6.2 p -111.43 137.75 21.19 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.584 -0.895 . . . . 2.0 108.584 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 7.5 Cg_exo -74.42 137.16 22.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.434 2.089 . . . . 1.8899999999999999 111.431 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 69.18 34.46 3.0 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.902 0.751 . . . . 2.4300000000000002 110.949 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.04 137.93 34.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.787 0.803 . . . . 3.2599999999999998 110.945 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.7 t 177.56 -55.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.045 -1.434 . . . . 2.48 107.396 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -89.84 -32.41 16.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.015 -0.993 . . . . 1.5600000000000001 109.336 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.781 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.5 m-85 -119.46 160.36 22.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.463 -1.244 . . . . 0.95999999999999996 107.767 176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -165.74 169.44 15.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.651 0.66 . . . . 2.0099999999999998 112.131 -168.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.871 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.2 p -103.1 139.66 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.696 -0.684 . . . . 1.8400000000000001 111.952 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.807 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.38 142.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.893 -0.78 . . . . 2.4500000000000002 108.893 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -122.44 133.4 54.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.384 0.611 . . . . 2.3900000000000001 111.195 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.606 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -150.1 111.0 4.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.268 -0.878 . . . . 1.96 110.495 -176.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -123.92 127.02 47.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.671 -0.695 . . . . 1.8700000000000001 111.257 -174.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.3 -0.864 . . . . 2.73 111.003 -177.563 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 109.808 -1.317 . . . . 1.8 109.808 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.692 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -153.99 90.18 1.35 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 113.836 1.05 . . . . 1.3 113.836 -168.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.893 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.7 mt-10 -110.31 104.12 12.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.54 -0.754 . . . . 0.81000000000000005 109.083 175.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.692 ' HE2' ' HB ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -113.64 159.4 19.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.777 0.799 . . . . 0.65000000000000002 112.445 -171.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.721 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 44.9 m-85 -132.28 108.91 9.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.933 -1.485 . . . . 1.4299999999999999 109.4 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.807 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 26.0 m170 -108.61 107.46 17.96 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.203 -0.31 . . . . 0.56000000000000005 111.339 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.773 HG11 ' HE2' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -103.75 119.34 52.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.047 0.927 . . . . 1.49 110.419 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.781 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.8 m -102.85 105.75 16.2 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.979 -1.119 . . . . 1.1399999999999999 107.979 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.3 p -147.45 149.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 123.633 0.583 . . . . 1.6000000000000001 110.335 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -133.91 102.3 5.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.966 0.888 . . . . 2.1600000000000001 109.884 167.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -168.34 127.56 1.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.34 -0.845 . . . . 1.1000000000000001 109.887 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.32 101.42 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 O-C-N 123.648 0.592 . . . . 1.1100000000000001 111.916 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.87 167.57 36.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.349 -0.7 . . . . 0.33000000000000002 111.349 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.565 HG22 ' HD2' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -103.43 128.63 50.53 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.9 -0.765 . . . . 1.1499999999999999 109.883 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.773 ' HE2' HG11 ' A' ' 75' ' ' VAL . 1.8 t-80 -103.38 106.35 16.84 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.526 -0.546 . . . . 0.52000000000000002 109.526 -175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.38 109.34 21.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.497 -0.927 . . . . 1.1100000000000001 108.497 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.36 103.83 15.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.027 -0.533 . . . . 1.26 110.257 -169.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.8 OUTLIER -109.65 103.41 12.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.504 -0.771 . . . . 1.53 109.118 177.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.698 HD21 ' HA ' ' A' ' 38' ' ' PHE . 96.0 mt -104.72 125.56 50.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.763 -0.653 . . . . 1.0900000000000001 109.571 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.8 m -100.87 122.46 43.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.658 0.742 . . . . 1.1000000000000001 110.762 -169.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.483 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -92.8 87.18 5.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.686 -1.143 . . . . 1.6599999999999999 109.884 -174.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.566 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 1.4 mtm -134.1 165.94 23.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.203 0.525 . . . . 1.24 110.993 -173.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.521 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 77.2 mtt180 -64.86 111.28 5.45 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.971 -1.013 . . . . 3.1299999999999999 109.272 170.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.97 -26.25 24.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.288 2.658 . . . . 1.04 114.405 -171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.411 ' CD1' HG21 ' A' ' 94' ' ' THR . 42.9 p90 -90.11 -3.22 58.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.002 0.371 . . . . 1.1799999999999999 112.002 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 95' ' ' GLY . 6.8 t -169.25 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.462 -0.149 . . . . 1.3500000000000001 111.369 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.605 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.29 98.13 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 1.1599999999999999 111.838 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.685 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.7 Cg_exo -49.55 126.69 16.67 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.916 2.411 . . . . 1.6899999999999999 111.334 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -54.17 -29.75 46.79 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.503 0.927 . . . . 3.02 113.503 -168.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -129.43 14.78 6.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.147 -0.621 . . . . 4.9199999999999999 111.594 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 16.1 t0 -112.29 -1.82 15.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.857 0.837 . . . . 1.6699999999999999 109.528 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.7 m -95.0 136.98 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.765 -1.107 . . . . 1.74 110.13 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.688 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.9 tt0 -86.86 179.03 6.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 1.9099999999999999 108.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.688 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 46.7 ttt180 -158.09 145.05 17.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.903 0.859 . . . . 0.78000000000000003 110.071 174.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.796 ' CZ ' HG12 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -103.36 150.79 23.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.004 -1.453 . . . . 1.0700000000000001 109.124 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.4 m -153.41 102.78 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.862 -0.335 . . . . 1.03 110.862 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.886 HG11 HG22 ' A' ' 5' ' ' VAL . 12.6 p -104.86 136.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 119.663 -0.815 . . . . 1.5 109.395 167.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -104.4 103.49 13.21 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.271 -0.877 . . . . 1.0 108.703 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.643 HD13 HG12 ' A' ' 16' ' ' VAL . 3.1 pp -126.95 152.51 47.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.218 -0.447 . . . . 2.6499999999999999 109.95 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 16' ' ' VAL . 30.9 tptt -104.91 111.23 23.91 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.681 -0.407 . . . . 2.3500000000000001 110.099 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.448 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -103.47 122.8 45.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 123.409 0.443 . . . . 1.1499999999999999 110.139 -174.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.44 HD22 ' CG ' ' A' ' 108' ' ' LYS . 10.5 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.188 -0.91 . . . . 1.78 110.687 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.976 ' HB3' HG22 ' A' ' 22' ' ' VAL . 42.8 t60 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 1.1000000000000001 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 19.1 ptmt -143.92 142.3 30.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.684 0.278 . . . . 2.8500000000000001 110.83 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.836 HG12 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -107.41 138.97 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 1.23 111.458 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.532 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 0.8 OUTLIER -116.12 168.06 10.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.926 -1.034 . . . . 1.1000000000000001 110.335 171.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.7 tptp -37.5 -45.57 0.74 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.739 1.385 . . . . 1.47 114.739 -172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.96 62.52 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.61 0.719 . . . . 1.05 111.803 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.713 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.5 m80 -65.95 -1.79 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 2.7000000000000002 111.282 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.721 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 26.2 t-20 -47.38 -17.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.847 0.717 . . . . 1.48 110.089 170.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.93 55.9 0.61 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.7 -0.682 . . . . 0.29999999999999999 111.74 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -108.53 158.35 17.64 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.582 0.956 . . . . 1.0800000000000001 113.582 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.7 m -147.11 104.98 3.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.018 -0.992 . . . . 1.3 108.856 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 17.9 mt -146.29 167.28 23.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.855 0.687 . . . . 3.4700000000000002 112.855 -170.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.4 m -103.54 136.0 44.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.714 -0.676 . . . . 2.0800000000000001 110.139 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 3' ' ' HIS . 30.9 m -126.2 154.04 35.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 1.3600000000000001 112.11 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.55 143.17 33.42 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.83 -0.804 . . . . 1.27 108.83 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 110' ' ' ASN . 23.7 m -121.48 -179.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.952 0.406 . . . . 1.8500000000000001 111.747 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.97 -60.61 0.67 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.65 -0.704 . . . . 0.70999999999999996 111.403 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.58 -74.15 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.424 0.63 . . . . 2.3500000000000001 109.994 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.8 tp -165.61 136.03 3.65 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.977 -1.01 . . . . 1.3600000000000001 109.681 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.976 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.4 t -120.17 110.18 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.353 0.597 . . . . 1.1799999999999999 109.663 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 4.4 pt-20 -111.33 159.67 17.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.805 0.812 . . . . 1.74 111.901 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.615 HD13 HG11 ' A' ' 105' ' ' VAL . 29.9 mm -134.26 103.8 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.174 -1.376 . . . . 1.1000000000000001 108.527 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.504 HE21 ' C ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -108.11 141.44 39.81 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.299 0.571 . . . . 0.64000000000000001 111.55 -174.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -117.11 146.75 38.79 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.128 -0.942 . . . . 1.47 108.864 171.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 67.7 Cg_endo -83.98 9.62 4.04 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 122.685 2.257 . . . . 0.34999999999999998 111.804 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.603 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 69.53 -47.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.042 0.839 . . . . 0.91000000000000003 110.667 -174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 27' ' ' PRO . 0.9 OUTLIER 58.08 63.05 4.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.124 -1.065 . . . . 1.3899999999999999 108.124 -173.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.5 100.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.669 2.913 . . . . 0.97999999999999998 113.501 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.89 -36.67 6.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.091 -0.959 . . . . 2.0899999999999999 111.074 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 34' ' ' PHE . 11.6 t -176.47 -157.44 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.024 -0.732 . . . . 2.6800000000000002 109.024 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.41 -22.99 17.24 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.483 -0.389 . . . . 1.5800000000000001 113.16 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 90' ' ' MET . 15.4 m-30 -40.23 137.93 0.95 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.765 0.654 . . . . 2.7200000000000002 112.765 171.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.26 154.83 41.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.975 -1.011 . . . . 1.1599999999999999 109.021 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.603 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.3 m95 -85.12 124.29 31.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 0.42999999999999999 111.369 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.899 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -157.81 145.07 18.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 3.0299999999999998 109.733 175.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.571 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -48.77 -75.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.333 0.494 . . . . 0.53000000000000003 112.333 -173.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.21 -17.85 18.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.445 0.64 . . . . 2.3900000000000001 110.298 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.755 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 113.6 85.56 1.4 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.299 -0.953 . . . . 0.72999999999999998 111.525 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.29 70.07 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.535 -0.84 . . . . 0.85999999999999999 111.576 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.7 m -129.1 140.36 51.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 1.53 109.648 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -140.63 141.02 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.655 -0.498 . . . . 3.0600000000000001 109.655 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.04 161.66 37.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.171 0.51 . . . . 2.2999999999999998 111.832 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.736 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 20.6 t -115.03 130.88 23.85 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.928 -0.767 . . . . 2.0 108.928 170.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 14.8 Cg_exo -68.91 -4.29 13.12 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.569 2.179 . . . . 1.8899999999999999 112.064 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.19 4.65 10.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.947 -0.569 . . . . 2.4300000000000002 111.416 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.687 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.6 pt-20 -84.08 101.05 11.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.863 0.84 . . . . 3.2599999999999998 111.709 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -127.95 5.71 5.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 2.48 110.558 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -170.04 -36.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.214 1.007 . . . . 1.5600000000000001 108.579 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.823 ' HB3' ' O ' ' A' ' 76' ' ' THR . 4.1 m-85 -104.84 165.33 11.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.581 -1.645 . . . . 0.95999999999999996 107.424 172.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -157.46 172.04 19.28 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.764 0.711 . . . . 2.0099999999999998 112.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.736 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 21.8 t -99.57 134.17 39.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.535 -0.757 . . . . 1.8400000000000001 111.716 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -111.34 125.02 53.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.711 -0.677 . . . . 2.4500000000000002 109.194 170.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -103.9 152.28 22.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 2.3900000000000001 110.905 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.703 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -162.4 111.77 1.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.96 109.81 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.811 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.2 m-85 -111.39 118.73 36.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.446 -0.343 . . . . 1.8700000000000001 110.292 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.205 0.526 . . . . 2.73 110.658 176.382 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 110.449 -1.06 . . . . 1.8 110.449 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.25 87.82 1.34 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.638 0.732 . . . . 1.3 112.38 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.2 mt-10 -104.55 105.78 16.02 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.022 -0.99 . . . . 0.81000000000000005 108.481 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.703 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 7.5 m-70 -104.98 150.29 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.747 0.784 . . . . 0.65000000000000002 111.805 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.899 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.6 m-85 -122.82 104.89 9.57 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.303 -1.317 . . . . 1.4299999999999999 108.864 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.541 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -102.47 107.15 18.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.963 -0.384 . . . . 0.56000000000000005 109.963 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.4 m -102.62 116.53 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 122.706 1.241 . . . . 1.49 108.33 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.823 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.7 m -102.64 106.37 17.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.177 -1.416 . . . . 1.1399999999999999 107.177 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.652 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.0 p -154.58 149.81 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 123.692 0.62 . . . . 1.6000000000000001 111.13 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -131.18 103.5 6.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.523 -0.547 . . . . 2.1600000000000001 109.523 167.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.42 127.26 2.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.315 -0.402 . . . . 1.1000000000000001 110.672 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -60.54 100.53 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.787 0.679 . . . . 1.1100000000000001 111.089 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.49 169.58 40.0 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.474 -1.051 . . . . 0.33000000000000002 110.474 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -101.99 132.09 48.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.642 -0.917 . . . . 1.1499999999999999 109.698 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.727 ' HD1' HG23 ' A' ' 85' ' ' VAL . 40.1 t-80 -102.64 104.16 14.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.691 -0.485 . . . . 0.52000000000000002 109.691 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.53 111.99 24.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.417 -0.586 . . . . 1.1100000000000001 109.417 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.727 HG23 ' HD1' ' A' ' 83' ' ' HIS . 2.3 t -105.62 103.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.95 -0.568 . . . . 1.26 110.852 -171.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.15 102.87 11.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.88 -0.785 . . . . 1.53 108.88 176.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 85' ' ' VAL . 96.0 mt -108.09 127.41 53.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.773 -0.649 . . . . 1.0900000000000001 109.96 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.47 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.7 m -102.75 130.59 49.75 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.525 0.679 . . . . 1.1000000000000001 110.968 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.64 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 10.9 t80 -102.6 88.75 3.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.272 -0.877 . . . . 1.6599999999999999 109.633 -175.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.612 ' HE1' ' CE1' ' A' ' 37' ' ' TYR . 15.5 mtm -126.75 177.94 6.24 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.457 -0.571 . . . . 1.24 109.457 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.578 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 7.6 ttm180 -93.17 112.73 57.53 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.533 -0.914 . . . . 3.1299999999999999 108.533 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.558 ' HG2' ' CZ3' ' A' ' 93' ' ' TRP . 1.5 Cg_endo -44.74 -48.3 10.68 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.573 2.848 . . . . 1.04 114.293 -169.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.558 ' CZ3' ' HG2' ' A' ' 92' ' ' PRO . 39.5 p90 -80.34 0.39 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.566 . . . . 1.1799999999999999 112.527 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.799 HG22 ' H ' ' A' ' 95' ' ' GLY . 1.3 t -158.4 -79.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.57 -0.159 . . . . 1.3500000000000001 110.57 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.799 ' H ' HG22 ' A' ' 94' ' ' THR . . . 76.62 82.44 0.53 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 121.066 -0.587 . . . . 1.1599999999999999 112.013 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.753 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 1.5 Cg_endo -42.17 125.35 3.31 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.852 3.035 . . . . 1.6899999999999999 112.09 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.6 m -55.01 -39.35 69.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.921 -1.036 . . . . 3.02 112.969 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.76 1.61 19.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.825 -0.35 . . . . 4.9199999999999999 110.925 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.753 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.2 t0 -100.91 -16.29 17.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.518 0.675 . . . . 1.6699999999999999 109.427 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.3 p -73.79 133.75 43.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.051 -0.977 . . . . 1.74 111.486 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 8.3 tp10 -86.96 169.64 12.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.596 -0.89 . . . . 1.9099999999999999 108.596 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 22.0 ttt180 -155.82 142.41 18.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.843 0.83 . . . . 0.78000000000000003 110.648 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.836 ' HZ ' HG12 ' A' ' 5' ' ' VAL . 3.1 t80 -104.65 154.87 19.41 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.096 -1.411 . . . . 1.0700000000000001 109.378 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.717 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 52.4 m -158.8 101.95 1.66 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.043 0.449 . . . . 1.03 110.253 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 12' ' ' ALA . 11.0 p -104.87 132.0 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.079 -0.648 . . . . 1.5 109.602 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 13' ' ' THR . 69.5 m-85 -105.17 113.55 27.21 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.386 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.669 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -136.27 158.53 44.19 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.351 -0.611 . . . . 2.6499999999999999 109.351 178.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.472 ' O ' HG22 ' A' ' 16' ' ' VAL . 30.9 tttm -103.99 114.22 28.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.872 -0.418 . . . . 2.3500000000000001 109.872 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.474 ' HB2' HG11 ' A' ' 18' ' ' VAL . . . -101.18 125.42 47.81 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.402 0.438 . . . . 1.1499999999999999 109.851 -171.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.09 -0.957 . . . . 1.78 110.125 -171.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.839 ' HB3' HG23 ' A' ' 22' ' ' VAL . 5.3 t60 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.33 -0.989 . . . . 1.1000000000000001 108.33 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -135.41 134.26 39.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.853 0.359 . . . . 2.8500000000000001 111.402 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.811 HG13 ' HZ ' ' A' ' 103' ' ' PHE . 2.5 t -118.68 127.49 75.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 1.23 111.004 170.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.555 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 0.8 OUTLIER -114.14 169.58 8.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.529 -1.214 . . . . 1.1000000000000001 109.864 169.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 19.4 tptp -35.2 -44.92 0.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.451 1.278 . . . . 1.47 114.451 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.16 -31.63 53.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.546 0.688 . . . . 1.05 112.385 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.749 ' HB2' HG11 ' A' ' 5' ' ' VAL . 74.1 m80 -68.1 -1.46 5.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.735 -0.666 . . . . 2.7000000000000002 111.201 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.713 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.8 t-20 -45.94 -20.92 0.1 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.697 0.623 . . . . 1.48 109.765 168.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.84 58.03 0.62 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.371 -0.831 . . . . 0.29999999999999999 111.256 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.659 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -117.35 151.57 36.72 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.72 0.637 . . . . 1.0800000000000001 112.72 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 35.4 m -146.12 108.84 4.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.404 -0.817 . . . . 1.3 109.332 174.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -161.51 167.46 25.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.727 0.299 . . . . 3.4700000000000002 111.562 -172.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.649 HG21 ' HB3' ' A' ' 108' ' ' LYS . 87.2 m -102.84 144.16 31.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.669 -0.241 . . . . 2.0800000000000001 110.725 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.669 HG21 ' O ' ' A' ' 108' ' ' LYS . 2.9 m -124.96 151.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.058 0.456 . . . . 1.3600000000000001 111.533 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.63 132.3 51.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.346 -0.983 . . . . 1.27 108.346 167.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.481 HG13 HG22 ' A' ' 22' ' ' VAL . 1.4 t -109.96 -141.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.375 -0.53 . . . . 1.8500000000000001 109.895 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' H ' HG11 ' A' ' 18' ' ' VAL . . . 111.38 -50.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.70999999999999996 110.906 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.82 -71.06 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.437 -0.579 . . . . 2.3500000000000001 109.437 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.77 136.84 8.36 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.182 -0.917 . . . . 1.3600000000000001 109.47 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.839 HG23 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -108.64 117.18 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.123 -0.695 . . . . 1.1799999999999999 109.123 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.34 140.3 38.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.397 0.618 . . . . 1.74 112.284 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HB ' ' A' ' 5' ' ' VAL . 40.2 mm -129.21 101.61 6.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.621 -1.172 . . . . 1.1000000000000001 107.907 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -113.89 138.24 50.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.42 0.628 . . . . 0.64000000000000001 111.4 -173.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.73 148.25 39.97 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.523 -0.762 . . . . 1.47 109.315 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 16.1 Cg_endo -88.34 13.3 2.59 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 122.74 2.293 . . . . 0.34999999999999998 110.849 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 1.024 ' HG ' ' HG3' ' A' ' 71' ' ' GLU . 2.4 m 71.23 -49.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.885 -1.052 . . . . 0.91000000000000003 111.92 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.42 63.09 5.96 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.491 -0.929 . . . . 1.3899999999999999 108.491 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.83 104.22 0.1 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 123.728 2.952 . . . . 0.97999999999999998 113.424 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.452 HG23 ' CE2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -100.88 -49.99 3.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.003 -0.999 . . . . 2.0899999999999999 111.044 178.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 34' ' ' PHE . 12.4 t -164.75 -147.88 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.364 -0.606 . . . . 2.6800000000000002 109.364 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.21 -22.64 37.38 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.61 -0.329 . . . . 1.5800000000000001 112.633 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 100' ' ' SER . 4.1 m-30 -35.74 138.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.621 0.971 . . . . 2.7200000000000002 113.621 169.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.476 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -148.19 148.86 31.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.318 -1.31 . . . . 1.1599999999999999 108.568 172.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.586 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.3 m95 -80.08 112.73 17.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.039 0.447 . . . . 0.42999999999999999 110.778 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.705 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 58.1 m-85 -118.99 179.79 4.05 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.477 -0.934 . . . . 3.0299999999999998 108.477 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.628 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -70.24 -78.89 0.07 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.26 -0.576 . . . . 0.53000000000000003 109.659 170.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -106.16 3.91 28.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.16 0.505 . . . . 2.3900000000000001 109.815 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.483 ' HA3' ' HE1' ' A' ' 90' ' ' MET . . . 90.18 112.16 1.49 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.5 -0.773 . . . . 0.72999999999999998 111.458 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 -19.16 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.85999999999999999 112.227 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -128.55 142.18 51.14 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.081 0.467 . . . . 1.53 111.834 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.746 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -142.01 127.8 19.3 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.853 -1.067 . . . . 3.0600000000000001 109.487 168.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.05 155.44 46.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.208 0.528 . . . . 2.2999999999999998 111.423 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.57 ' OG ' ' HB ' ' A' ' 53' ' ' VAL . 11.1 p -115.42 127.59 26.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.764 -0.653 . . . . 2.0 109.644 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 44.9 Cg_exo -58.21 124.97 17.11 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.695 2.263 . . . . 1.8899999999999999 112.249 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 91.7 m-20 77.63 30.04 0.5 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.189 0.931 . . . . 2.4300000000000002 111.981 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB3' ' HG ' ' A' ' 45' ' ' SER . 11.9 pt-20 -79.18 48.79 0.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 3.2599999999999998 111.769 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.6 m -85.96 -34.49 20.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.372 -0.376 . . . . 2.48 111.415 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -125.54 -31.35 3.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.793 0.806 . . . . 1.5600000000000001 109.523 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 2.3 m-85 -103.44 167.23 9.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.414 -1.266 . . . . 0.95999999999999996 107.834 176.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -148.4 165.08 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.046 -0.662 . . . . 2.0099999999999998 111.198 -160.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.57 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 4.0 p -109.34 150.9 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.408 0.623 . . . . 1.8400000000000001 111.446 -175.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -124.59 144.67 50.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.264 -0.88 . . . . 2.4500000000000002 109.817 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 8.6 p30 -123.96 133.82 53.62 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.877 -0.601 . . . . 2.3900000000000001 109.556 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -154.53 105.24 2.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.771 -0.649 . . . . 1.96 110.738 -175.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.889 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -120.25 142.9 48.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.532 -0.758 . . . . 1.8700000000000001 110.774 -176.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--N 1.321 -0.669 0 CA-C-O 121.118 0.485 . . . . 2.73 110.127 173.22 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.253 0 CA-C-O 121.249 0.36 . . . . 1.8 113.708 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.544 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -157.1 86.99 0.97 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.406 0.521 . . . . 1.3 112.406 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 1.024 ' HG3' ' HG ' ' A' ' 28' ' ' SER . 40.9 mt-10 -102.14 106.92 17.85 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.57 . . . . 0.81000000000000005 109.821 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.544 ' HE2' ' HB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -112.52 152.6 28.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.628 -0.829 . . . . 0.65000000000000002 111.669 -174.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.746 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 39.4 m-85 -115.36 119.02 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.912 -1.495 . . . . 1.4299999999999999 109.08 172.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -113.86 103.72 11.46 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.961 -0.296 . . . . 0.56000000000000005 110.794 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.758 HG12 ' HE2' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -105.2 117.9 51.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.104 0.954 . . . . 1.49 110.127 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 10.5 m -103.65 103.81 13.78 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.77 -1.105 . . . . 1.1399999999999999 108.428 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 10.3 p -151.36 144.61 16.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 123.563 0.54 . . . . 1.6000000000000001 110.341 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -129.29 103.65 7.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.771 0.796 . . . . 2.1600000000000001 109.742 169.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.98 145.06 6.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.141 -0.936 . . . . 1.1000000000000001 109.208 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.33 94.07 2.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.141 0.496 . . . . 1.1100000000000001 111.329 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.89 168.17 31.17 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.33000000000000002 111.041 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 108' ' ' LYS . 3.1 m -101.35 128.59 47.44 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.837 -0.802 . . . . 1.1499999999999999 109.566 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.758 ' HE2' HG12 ' A' ' 75' ' ' VAL . 19.2 t-80 -104.29 103.83 13.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.52000000000000002 109.827 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.75 122.2 42.97 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.325 -0.991 . . . . 1.1100000000000001 108.325 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.68 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -114.86 102.07 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.482 -0.487 . . . . 1.26 110.702 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.7 OUTLIER -108.75 103.37 12.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.323 -0.991 . . . . 1.53 108.323 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.628 HD22 ' HA ' ' A' ' 38' ' ' PHE . 78.5 mt -105.07 124.84 50.22 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.734 -0.666 . . . . 1.0900000000000001 109.698 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 5.6 m -101.74 116.81 33.55 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.958 0.885 . . . . 1.1000000000000001 110.742 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.476 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 2.5 t80 -84.81 96.73 9.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.321 -1.309 . . . . 1.6599999999999999 109.574 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.483 ' HE1' ' HA3' ' A' ' 40' ' ' GLY . 7.2 mtm -137.77 167.29 22.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.833 0.349 . . . . 1.24 110.214 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -70.21 103.87 0.7 Allowed Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.659 -0.867 . . . . 3.1299999999999999 108.659 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.23 -37.88 14.07 Favored 'Trans proline' 0 N--CA 1.477 0.522 0 C-N-CA 123.871 3.047 . . . . 1.04 114.851 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 94' ' ' THR . 43.1 p90 -80.8 -2.14 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 1.1799999999999999 112.457 -175.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.685 HG21 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -162.47 -65.03 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.338 0.113 . . . . 1.3500000000000001 110.844 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.685 ' H ' HG21 ' A' ' 94' ' ' THR . . . 72.44 85.53 0.21 Allowed Glycine 0 CA--C 1.505 -0.533 0 C-N-CA 121.237 -0.506 . . . . 1.1599999999999999 111.935 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.77 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 72.2 Cg_exo -44.09 113.59 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.41 2.74 . . . . 1.6899999999999999 112.246 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.5 m -74.24 53.99 0.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.73 -0.668 . . . . 3.02 111.112 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -175.69 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.083 -0.962 . . . . 4.9199999999999999 109.052 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.77 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 34.0 t70 -106.87 -17.61 14.16 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.609 -0.723 . . . . 1.6699999999999999 109.497 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.601 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 10.0 p -72.96 143.02 47.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.057 -0.974 . . . . 1.74 112.457 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -103.62 171.33 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.193 -1.039 . . . . 1.9099999999999999 108.193 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 45.1 ttt180 -153.56 140.36 19.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.804 0.812 . . . . 0.78000000000000003 110.675 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.811 ' HZ ' HG13 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -102.9 155.3 18.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.209 -1.359 . . . . 1.0700000000000001 108.615 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.6 m -158.23 102.25 1.76 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.58 -0.448 . . . . 1.03 111.28 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 5' ' ' VAL . 12.9 p -104.78 133.79 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.911 -0.716 . . . . 1.5 109.439 166.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' THR . 73.9 m-85 -104.25 104.44 14.35 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.062 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.744 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 1.5 pp -128.28 154.08 46.29 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.707 -0.397 . . . . 2.6499999999999999 110.602 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.669 ' O ' HG21 ' A' ' 16' ' ' VAL . 22.0 tptm -104.5 115.51 30.49 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.1 -0.704 . . . . 2.3500000000000001 109.1 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.13 127.09 49.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.852 0.358 . . . . 1.1499999999999999 110.75 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.19 -0.91 . . . . 1.78 110.553 -177.632 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.963 ' HB3' HG23 ' A' ' 22' ' ' VAL . 35.8 t60 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.462 -0.94 . . . . 1.1000000000000001 108.462 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 17.6 ptpt -146.01 153.35 40.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.801 0.334 . . . . 2.8500000000000001 110.672 172.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.825 HG22 HG12 ' A' ' 105' ' ' VAL . 2.1 t -115.05 135.01 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.158 0.504 . . . . 1.23 111.089 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.582 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -115.92 170.76 8.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 1.1000000000000001 110.003 171.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 24.5 tptp -35.72 -49.26 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.75 1.389 . . . . 1.47 114.75 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.13 63.03 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.387 0.613 . . . . 1.05 112.124 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.739 ' HB2' HG11 ' A' ' 5' ' ' VAL . 69.9 m80 -64.91 -2.95 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.556 . . . . 2.7000000000000002 111.177 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.626 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 21.2 t-20 -44.99 -22.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.214 0 O-C-N 123.694 0.621 . . . . 1.48 110.392 170.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.39 55.1 0.68 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.566 -0.743 . . . . 0.29999999999999999 111.277 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.663 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -119.06 156.59 29.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.238 0.829 . . . . 1.0800000000000001 113.238 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 87.6 m -145.93 111.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.004 -0.998 . . . . 1.3 108.927 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 3.8 pp -152.8 167.31 29.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 3.4700000000000002 111.766 -170.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -103.44 147.21 27.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 2.0800000000000001 110.414 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 108' ' ' LYS . 1.9 m -128.55 162.67 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.128 -0.487 . . . . 1.3600000000000001 110.96 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 110' ' ' ASN . . . -109.0 125.96 52.61 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.252 -1.018 . . . . 1.27 108.252 167.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.621 HG23 ' C ' ' A' ' 110' ' ' ASN . 23.2 m -105.28 -168.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.382 -0.527 . . . . 1.8500000000000001 111.121 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 113.95 -53.09 0.61 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.415 -0.674 . . . . 0.70999999999999996 111.415 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.45 -73.3 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.169 0.509 . . . . 2.3500000000000001 109.813 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 tp -166.12 137.19 3.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 1.3600000000000001 109.588 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.963 HG23 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -117.19 113.97 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.828 0.823 . . . . 1.1799999999999999 109.63 173.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 40.6 mt-10 -102.91 156.99 17.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.115 0.959 . . . . 1.74 112.267 -171.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.619 HD11 ' HB ' ' A' ' 5' ' ' VAL . 40.2 mm -133.66 133.75 56.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.232 -1.766 . . . . 1.1000000000000001 106.232 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.92 135.65 23.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.601 0.715 . . . . 0.64000000000000001 111.564 178.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -109.41 153.41 42.8 Favored Pre-proline 0 N--CA 1.431 -1.375 0 CA-C-N 114.818 -1.083 . . . . 1.47 108.977 174.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.571 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 41.7 Cg_endo -90.81 11.35 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.935 2.423 . . . . 0.34999999999999998 111.457 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.641 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 27.8 t 69.58 -59.6 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 0.91000000000000003 111.198 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.571 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.6 OUTLIER 52.73 56.89 15.06 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.097 -0.705 . . . . 1.3899999999999999 109.097 -173.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 81.6 Cg_exo -49.61 111.1 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.832 3.022 . . . . 0.97999999999999998 113.579 -168.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.584 HG21 ' CE2' ' A' ' 89' ' ' TYR . 6.0 p -87.45 -38.93 15.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 2.0899999999999999 109.417 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t 175.91 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.794 -1.094 . . . . 2.6800000000000002 108.375 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.04 -33.03 67.93 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 118.23 0.468 . . . . 1.5800000000000001 113.589 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 52.7 m-85 -52.09 148.71 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.916 0.389 . . . . 2.7200000000000002 111.897 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.03 161.42 41.95 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.648 -0.705 . . . . 1.1599999999999999 109.764 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.627 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -82.76 120.61 25.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.15 0.5 . . . . 0.42999999999999999 112.012 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.819 ' HE1' ' HE3' ' A' ' 90' ' ' MET . 0.4 OUTLIER -156.15 147.69 22.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.101 -0.703 . . . . 3.0299999999999998 109.101 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -40.93 -68.76 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.61 0.596 . . . . 0.53000000000000003 112.61 -171.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.15 17.69 2.44 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.568 -0.453 . . . . 2.3900000000000001 111.828 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 125.0 85.88 0.64 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 119.778 -1.201 . . . . 0.72999999999999998 113.075 170.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.82 12.25 10.06 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.843 -0.694 . . . . 0.85999999999999999 112.242 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -135.16 139.26 44.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.469 -0.937 . . . . 1.53 108.469 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.63 142.19 33.42 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.376 0.423 . . . . 3.0600000000000001 110.546 -173.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.56 153.12 47.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.06 0.457 . . . . 2.2999999999999998 111.505 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.827 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 18.0 t -104.77 132.87 20.51 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.8 -0.815 . . . . 2.0 108.8 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 84' ' ' ALA . 9.9 Cg_exo -72.86 25.21 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.304 2.669 . . . . 1.8899999999999999 113.426 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' SER . 60.4 t30 -178.49 48.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.297 0.57 . . . . 2.4300000000000002 109.486 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.827 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 8.8 pt-20 -114.64 122.6 46.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.742 0.782 . . . . 3.2599999999999998 111.147 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -141.99 -39.72 0.37 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.806 -1.088 . . . . 2.48 108.819 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.855 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.77 -35.41 6.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.629 -0.714 . . . . 1.5600000000000001 110.516 176.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.855 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 9.3 m-85 -108.9 164.46 12.38 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.497 -0.927 . . . . 0.95999999999999996 108.497 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -161.84 172.08 16.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.411 0.624 . . . . 2.0099999999999998 112.598 -164.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.698 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 20.3 t -99.73 143.99 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.411 -0.813 . . . . 1.8400000000000001 111.472 -174.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.587 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 7.5 pt-20 -109.33 132.22 54.33 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.644 -0.873 . . . . 2.4500000000000002 108.644 169.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.61 131.87 53.9 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.537 -0.865 . . . . 2.3900000000000001 110.986 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.464 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.78 104.89 2.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.098 -0.955 . . . . 1.96 110.34 -172.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.583 ' CB ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 p90 -131.2 131.59 44.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.448 0.642 . . . . 1.8700000000000001 112.153 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 2.73 110.507 -175.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.748 0 N-CA-C 110.302 -1.119 . . . . 1.8 110.302 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.402 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -155.79 86.01 1.05 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 117.902 0.851 . . . . 1.3 112.571 -175.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.641 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 37.6 mt-10 -104.36 104.37 14.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.81000000000000005 109.716 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -114.12 163.71 14.83 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.22 1.009 . . . . 0.65000000000000002 112.577 -171.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.674 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 42.0 m-85 -140.13 104.08 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.173 -1.831 . . . . 1.4299999999999999 108.769 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.587 ' HB2' ' CG ' ' A' ' 54' ' ' GLU . 55.6 m170 -103.35 123.45 46.83 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.824 -0.548 . . . . 0.56000000000000005 110.034 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.594 HG12 HG12 ' A' ' 53' ' ' VAL . 3.4 m -105.77 123.4 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 122.23 1.014 . . . . 1.49 109.918 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.72 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 8.5 m -102.64 104.78 15.17 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.806 -1.183 . . . . 1.1399999999999999 107.806 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.6 p -150.46 142.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.118 -0.492 . . . . 1.6000000000000001 110.694 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.533 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.55 101.59 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.265 0.555 . . . . 2.1600000000000001 109.713 167.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' HE2' ' A' ' 50' ' ' MET . . . -167.5 145.78 4.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.406 -0.816 . . . . 1.1000000000000001 109.602 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.24 89.89 2.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 1.1100000000000001 110.81 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.12 166.93 31.69 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 110.717 -0.953 . . . . 0.33000000000000002 110.717 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.5 132.25 48.67 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.692 0.746 . . . . 1.1499999999999999 109.811 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.599 ' HD1' HG21 ' A' ' 85' ' ' VAL . 45.1 t-80 -104.42 106.14 16.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.173 -0.467 . . . . 0.52000000000000002 110.527 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.445 ' H ' ' HG2' ' A' ' 46' ' ' PRO . . . -101.2 115.23 30.02 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.325 -0.62 . . . . 1.1100000000000001 109.325 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.5 t -106.3 105.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.848 -0.615 . . . . 1.26 111.331 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 7.5 m120 -112.96 102.89 10.86 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.47 -0.567 . . . . 1.53 109.47 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 98.8 mt -107.33 123.4 48.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.674 -0.694 . . . . 1.0900000000000001 109.453 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 5.4 m -103.45 130.73 50.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.4 0.619 . . . . 1.1000000000000001 111.405 -170.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.584 ' CE2' HG21 ' A' ' 31' ' ' THR . 43.7 t80 -95.76 84.91 3.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.399 -0.819 . . . . 1.6599999999999999 109.776 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.819 ' HE3' ' HE1' ' A' ' 37' ' ' TYR . 17.4 mtm -121.53 173.7 7.24 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.905 0.383 . . . . 1.24 109.981 -175.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.551 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 3.2 ttm-85 -86.71 114.06 56.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 108.861 -0.792 . . . . 3.1299999999999999 108.861 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.8 Cg_endo -49.86 -27.33 15.64 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.976 3.118 . . . . 1.04 115.88 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 42.7 p90 -104.03 10.77 35.95 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.945 -0.472 . . . . 1.1799999999999999 111.996 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.8 t -166.05 -62.0 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.26 -0.176 . . . . 1.3500000000000001 111.034 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.585 ' H ' HG23 ' A' ' 94' ' ' THR . . . 61.86 79.24 0.14 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 112.13 -0.388 . . . . 1.1599999999999999 112.13 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.715 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 50.6 Cg_exo -36.08 128.21 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.839 3.026 . . . . 1.6899999999999999 112.562 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 p -35.01 -64.23 0.28 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 124.663 1.227 . . . . 3.02 114.059 -170.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -124.0 33.8 5.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.333 -0.547 . . . . 4.9199999999999999 110.685 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 29.1 t0 -106.82 -4.66 19.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.98 0.895 . . . . 1.6699999999999999 108.905 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.9 m -89.0 142.41 27.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.346 -1.297 . . . . 1.74 110.252 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.644 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 29.1 tt0 -92.49 179.31 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.01 -0.737 . . . . 1.9099999999999999 109.01 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.644 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 29.7 ttt180 -161.65 142.51 10.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.719 0.771 . . . . 0.78000000000000003 111.408 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.734 ' HZ ' HG13 ' A' ' 5' ' ' VAL . 1.2 t80 -105.22 154.39 20.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.237 -1.347 . . . . 1.0700000000000001 109.341 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 45.1 m -158.45 102.43 1.73 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.871 0.367 . . . . 1.03 110.97 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.825 HG12 HG22 ' A' ' 5' ' ' VAL . 12.6 p -107.21 136.62 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 120.027 -0.669 . . . . 1.5 109.53 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' THR . 78.4 m-85 -104.62 104.08 13.85 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 174.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.611 HD12 HG11 ' A' ' 16' ' ' VAL . 3.3 pp -122.67 145.46 48.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.947 -0.76 . . . . 2.6499999999999999 108.947 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.783 ' O ' HG23 ' A' ' 16' ' ' VAL . 71.7 tttt -103.27 124.52 48.8 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.105 -0.638 . . . . 2.3500000000000001 109.704 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.521 ' HB3' HG11 ' A' ' 18' ' ' VAL . . . -100.98 129.34 46.81 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.456 0.473 . . . . 1.1499999999999999 110.31 -170.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.621 ' C ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.747 0 CA-C-O 118.314 -0.85 . . . . 1.78 109.816 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.948 ' HB3' HG21 ' A' ' 22' ' ' VAL . 23.6 t60 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.001 -0.74 . . . . 1.1000000000000001 109.001 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -138.7 148.17 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.014 0.435 . . . . 2.8500000000000001 110.765 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 9' ' ' HIS . 1.9 t -112.41 138.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 1.23 110.928 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.543 ' H ' ' ND1' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -116.96 169.07 9.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.4 -0.818 . . . . 1.1000000000000001 110.322 170.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.3 tptp -39.72 -43.72 1.44 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.01 1.115 . . . . 1.47 114.01 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.96 -35.45 33.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.645 0.736 . . . . 1.05 111.862 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.746 ' HB2' HG11 ' A' ' 5' ' ' VAL . 76.0 m80 -66.26 -1.96 3.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.496 -0.775 . . . . 2.7000000000000002 111.654 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.711 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.9 t-20 -46.01 -21.54 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.414 0.626 . . . . 1.48 109.586 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.08 57.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.29999999999999999 111.376 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 105' ' ' VAL . . . -117.23 160.53 20.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.257 0.836 . . . . 1.0800000000000001 113.257 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 14.2 m -151.48 114.59 4.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.016 -0.993 . . . . 1.3 109.116 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.6 pt? -158.26 166.73 31.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.172 0.51 . . . . 3.4700000000000002 111.606 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -104.04 141.5 36.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 2.0800000000000001 110.523 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.7 m -126.75 152.1 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.417 -0.356 . . . . 1.3600000000000001 111.196 -175.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.54 118.26 36.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.838 -0.801 . . . . 1.27 108.838 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 22' ' ' VAL . 27.3 m -100.01 -170.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.252 0.548 . . . . 1.8500000000000001 111.584 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.631 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 128.38 -46.02 1.11 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.214 -0.754 . . . . 0.70999999999999996 111.214 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -89.48 -69.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.64 -0.504 . . . . 2.3500000000000001 109.64 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.2 tp -166.46 126.06 1.57 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.59 -0.732 . . . . 1.3600000000000001 111.177 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.948 HG21 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -107.85 114.32 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.819 0.818 . . . . 1.1799999999999999 110.05 174.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.01 153.48 20.2 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.884 0.849 . . . . 1.74 112.1 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.603 HD12 ' HB ' ' A' ' 5' ' ' VAL . 49.1 mm -133.21 102.48 4.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 113.758 -1.564 . . . . 1.1000000000000001 107.467 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -114.16 132.84 55.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.057 0.932 . . . . 0.64000000000000001 111.752 -172.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 3.9 mm? -109.27 154.54 42.09 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.584 -1.189 . . . . 1.47 108.924 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 65.3 Cg_endo -88.99 9.53 3.56 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 122.741 2.294 . . . . 0.34999999999999998 111.394 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.657 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 19.9 t 69.47 -57.21 0.54 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.219 -0.901 . . . . 0.91000000000000003 110.474 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.7 OUTLIER 54.35 62.98 7.91 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.984 -1.117 . . . . 1.3899999999999999 107.984 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.46 112.9 1.14 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.528 2.819 . . . . 0.97999999999999998 113.209 -165.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' CE2' ' A' ' 89' ' ' TYR . 8.3 p -92.5 -43.67 9.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.459 -0.791 . . . . 2.0899999999999999 110.086 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.665 HG23 ' HD1' ' A' ' 34' ' ' PHE . 5.1 t 175.79 -136.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.571 -0.9 . . . . 2.6800000000000002 108.571 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.44 -17.13 46.41 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 118.024 0.375 . . . . 1.5800000000000001 113.551 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.665 ' HD1' HG23 ' A' ' 32' ' ' THR . 2.4 m-85 -68.86 142.74 54.73 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.987 0.515 . . . . 2.7200000000000002 110.584 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.485 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -149.13 159.06 44.58 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.27 -0.641 . . . . 1.1599999999999999 109.27 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.575 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 98.2 m95 -73.48 119.32 17.55 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.361 0.601 . . . . 0.42999999999999999 111.474 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.688 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 41.6 m-85 -128.46 -177.09 4.03 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 115.425 -0.807 . . . . 3.0299999999999998 108.862 170.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.5 m-85 -78.15 -77.71 0.15 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.49 0.586 . . . . 0.53000000000000003 109.93 168.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.25 -0.54 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 2.3900000000000001 110.532 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 108.23 102.87 2.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.748 . . . . 0.72999999999999998 112.28 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.13 2.79 67.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.848 -0.692 . . . . 0.85999999999999999 111.662 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.562 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -132.33 144.56 50.65 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.834 0.453 . . . . 1.53 111.783 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.58 132.2 27.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.444 -0.798 . . . . 3.0600000000000001 110.582 167.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.47 152.57 50.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.023 -0.535 . . . . 2.2999999999999998 110.786 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.593 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 17.3 t -119.76 135.17 24.03 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.033 -0.729 . . . . 2.0 109.033 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 12.2 Cg_exo -70.7 -8.08 22.79 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.802 2.335 . . . . 1.8899999999999999 113.07 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.432 HD22 ' HA3' ' A' ' 81' ' ' GLY . 5.0 m-20 -125.72 26.23 6.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 2.4300000000000002 111.075 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 45' ' ' SER . 15.3 pt-20 -95.23 77.27 3.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.341 1.067 . . . . 3.2599999999999998 111.693 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -95.3 -56.79 2.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.858 -1.064 . . . . 2.48 110.203 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.775 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 18.1 ptt? -108.25 -31.28 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.742 -1.117 . . . . 1.5600000000000001 109.243 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.775 ' HD1' ' HG3' ' A' ' 50' ' ' MET . 12.3 m-85 -103.8 167.97 9.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.743 -1.571 . . . . 0.95999999999999996 108.009 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 14.7 t -158.63 168.75 26.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.709 0.686 . . . . 2.0099999999999998 112.427 -169.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.8 p -101.2 136.77 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.311 -0.859 . . . . 1.8400000000000001 110.988 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -127.99 141.97 51.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.43 -0.804 . . . . 2.4500000000000002 109.619 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -108.21 140.34 41.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 2.3900000000000001 111.739 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.79 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.23 104.24 3.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.103 -0.953 . . . . 1.96 109.39 171.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.6 p90 -124.63 150.26 46.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.563 -0.744 . . . . 1.8700000000000001 110.853 -172.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.256 0.551 . . . . 2.73 112.197 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' C ' ' HG1' ' A' ' 70' ' ' THR . . . . . . . . 0 CA--C 1.508 -0.375 0 N-CA-C 110.978 -0.849 . . . . 1.8 110.978 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.611 HG22 ' NE2' ' A' ' 72' ' ' HIS . 31.8 m 137.14 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.227 1.411 . . . . 1.3 108.733 150.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 39.4 mt-10 -103.51 115.63 30.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.671 -1.149 . . . . 0.81000000000000005 110.167 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.79 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 1.7 m170 -108.53 144.98 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.678 0.751 . . . . 0.65000000000000002 111.775 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.688 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 14.2 m-85 -116.77 112.38 21.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.513 -1.221 . . . . 1.4299999999999999 109.058 170.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -104.45 113.99 27.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.059 -0.519 . . . . 0.56000000000000005 110.764 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.3 m -104.54 118.53 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 122.252 1.025 . . . . 1.49 108.501 171.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.743 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.1 m -102.26 103.74 14.24 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.48 -1.304 . . . . 1.1399999999999999 107.48 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.615 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 4.7 p -155.94 142.01 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 123.651 0.594 . . . . 1.6000000000000001 111.158 -173.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.917 ' HZ3' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -127.14 101.78 6.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.057 -0.72 . . . . 2.1600000000000001 109.057 165.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.62 138.19 4.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 1.1000000000000001 109.92 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.65 99.48 3.11 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.746 0.654 . . . . 1.1100000000000001 111.854 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA3' HD22 ' A' ' 47' ' ' ASN . . . -165.71 166.46 38.55 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.429 -1.068 . . . . 0.33000000000000002 110.429 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 5.5 m -100.83 130.78 46.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.138 0.969 . . . . 1.1499999999999999 109.957 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.691 ' HD1' HG21 ' A' ' 85' ' ' VAL . 36.5 t-80 -102.97 105.47 15.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.211 -0.904 . . . . 0.52000000000000002 109.854 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.52 24.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.121 -0.696 . . . . 1.1100000000000001 109.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.45 103.08 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.604 -0.726 . . . . 1.26 110.928 -170.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -109.12 103.26 12.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.148 -0.686 . . . . 1.53 109.148 176.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 38' ' ' PHE . 88.1 mt -105.78 126.04 51.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.691 -0.686 . . . . 1.0900000000000001 110.507 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' MET . 6.0 m -102.55 121.2 41.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.339 0.59 . . . . 1.1000000000000001 110.98 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.621 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 54.1 t80 -86.52 97.79 10.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 1.6599999999999999 109.284 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.665 ' HG3' HG23 ' A' ' 88' ' ' THR . 27.6 mtm -134.39 159.48 40.92 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.275 -0.42 . . . . 1.24 111.83 -172.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.459 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 48.3 mtt180 -64.2 105.55 0.73 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 108.227 -1.027 . . . . 3.1299999999999999 108.227 163.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -46.63 -32.16 11.34 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.633 2.888 . . . . 1.04 114.765 -167.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 37.7 p90 -88.12 -2.82 58.84 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.133 0.42 . . . . 1.1799999999999999 112.133 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.673 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -162.23 -68.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.493 -0.129 . . . . 1.3500000000000001 111.338 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.673 ' H ' HG23 ' A' ' 94' ' ' THR . . . 73.41 78.38 0.56 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.789 -0.719 . . . . 1.1599999999999999 111.533 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 13.0 Cg_exo -32.84 114.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.103 3.202 . . . . 1.6899999999999999 113.066 172.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 p -41.27 -55.66 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.801 -1.091 . . . . 3.02 113.361 -171.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -100.11 20.07 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.626 -0.43 . . . . 4.9199999999999999 111.636 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 14.0 t0 -124.34 6.17 8.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 1.6699999999999999 110.308 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 32.8 m -98.61 147.86 24.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.454 -0.794 . . . . 1.74 111.149 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 4.7 tp10 -100.52 166.69 10.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.067 -0.716 . . . . 1.9099999999999999 109.067 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 46.8 ttt180 -153.51 140.14 18.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.77 0.795 . . . . 0.78000000000000003 111.232 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.74 ' CZ ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -104.4 157.4 17.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.116 -1.402 . . . . 1.0700000000000001 109.07 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 53.5 m -159.55 102.4 1.54 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.839 0.352 . . . . 1.03 110.977 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.733 HG13 HG22 ' A' ' 5' ' ' VAL . 14.6 p -105.55 138.91 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.033 -0.667 . . . . 1.5 110.1 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.4 m-85 -104.52 104.2 14.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.034 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.9 pp -126.0 148.53 49.26 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.213 -0.662 . . . . 2.6499999999999999 109.213 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.704 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.4 ttmm -104.59 122.71 46.16 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.198 -0.601 . . . . 2.3500000000000001 110.165 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 18' ' ' VAL . . . -101.74 128.9 47.87 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.414 0.446 . . . . 1.1499999999999999 110.134 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.6 ' C ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.52 -0.752 . . . . 1.78 110.34 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.942 ' HB3' HG23 ' A' ' 22' ' ' VAL . 26.8 t60 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 108.932 -0.766 . . . . 1.1000000000000001 108.932 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -132.28 144.65 50.74 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.938 -0.305 . . . . 2.8500000000000001 110.254 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.747 HG22 HG13 ' A' ' 105' ' ' VAL . 2.3 t -112.64 133.48 58.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 1.23 111.134 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.487 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 2.0 p -117.46 170.29 8.85 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.974 -1.012 . . . . 1.1000000000000001 109.462 170.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.727 ' HD3' HD22 ' A' ' 29' ' ' ASN . 8.6 tptm -34.82 -49.04 0.42 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.973 1.471 . . . . 1.47 114.973 -170.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.06 63.81 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.326 0.584 . . . . 1.05 112.537 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.733 ' HB2' HG12 ' A' ' 5' ' ' VAL . 75.3 m80 -64.49 -2.86 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 2.7000000000000002 110.903 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.621 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 21.7 t-20 -45.53 -19.63 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.975 0.797 . . . . 1.48 110.484 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.32 59.27 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.97 -0.852 . . . . 0.29999999999999999 110.97 175.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.67 ' HB1' HG23 ' A' ' 105' ' ' VAL . . . -120.35 148.21 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.903 0.705 . . . . 1.0800000000000001 112.903 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 85.5 m -134.73 119.08 17.8 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.42 -0.809 . . . . 1.3 109.163 168.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pt? -159.69 166.27 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 3.4700000000000002 111.036 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.0 m -103.29 148.1 26.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.255 -0.43 . . . . 2.0800000000000001 110.437 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.3 m -126.41 155.41 36.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 1.3600000000000001 111.441 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.52 111.49 22.54 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.945 -0.761 . . . . 1.27 108.945 171.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.798 HG21 ' HA ' ' A' ' 78' ' ' LYS . 12.9 m -89.84 -167.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.946 0.403 . . . . 1.8500000000000001 111.078 -173.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.0 -54.49 0.73 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.238 -0.745 . . . . 0.70999999999999996 111.238 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.2 -63.2 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.722 -0.844 . . . . 2.3500000000000001 108.722 171.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 22' ' ' VAL . 54.9 tp -165.5 163.61 19.52 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.495 -1.229 . . . . 1.3600000000000001 109.944 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.942 HG23 ' HB3' ' A' ' 3' ' ' HIS . 1.3 t -140.46 106.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.449 -0.945 . . . . 1.1799999999999999 108.449 164.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.0 pt-20 -112.25 158.36 19.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 122.222 1.011 . . . . 1.74 112.579 -172.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.591 HD12 HG13 ' A' ' 105' ' ' VAL . 46.0 mm -132.9 103.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.451 -1.704 . . . . 1.1000000000000001 108.5 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -113.27 133.5 55.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.819 0.819 . . . . 0.64000000000000001 111.535 -176.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -108.88 144.27 29.29 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.062 -0.972 . . . . 1.47 108.997 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.495 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 67.4 Cg_endo -81.09 10.1 3.55 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 122.499 2.132 . . . . 0.34999999999999998 111.264 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.692 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 19.4 t 69.37 -61.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.997 -1.001 . . . . 0.91000000000000003 111.191 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.727 HD22 ' HD3' ' A' ' 7' ' ' LYS . 1.7 m-80 56.6 62.01 6.64 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.942 -0.762 . . . . 1.3899999999999999 108.942 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 74.8 Cg_exo -52.12 103.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.369 2.712 . . . . 0.97999999999999998 113.105 -168.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.501 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.5 p -83.15 -37.27 23.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.347 -0.842 . . . . 2.0899999999999999 110.027 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.438 HG23 ' CD1' ' A' ' 34' ' ' PHE . 7.7 t 179.11 -144.53 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.402 -0.962 . . . . 2.6800000000000002 108.402 -177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.74 -11.33 29.41 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 118.093 0.406 . . . . 1.5800000000000001 113.242 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.716 ' CD2' ' HA ' ' A' ' 90' ' ' MET . 1.4 m-85 -71.78 151.71 43.29 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.003 0.521 . . . . 2.7200000000000002 111.469 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -152.15 161.67 42.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.801 -0.636 . . . . 1.1599999999999999 109.663 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.692 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -79.53 117.18 20.24 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.402 0.62 . . . . 0.42999999999999999 111.437 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 70.7 m-85 -125.17 -178.41 4.19 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 108.083 -1.08 . . . . 3.0299999999999998 108.083 168.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.642 ' HA ' HD21 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.85 -80.36 0.06 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.029 -0.669 . . . . 0.53000000000000003 109.556 169.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -104.08 -0.31 28.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.246 0.546 . . . . 2.3900000000000001 110.168 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.555 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 102.22 104.73 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.72999999999999998 111.826 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.88 -0.69 71.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.742 -0.742 . . . . 0.85999999999999999 111.955 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -129.71 141.56 50.87 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.843 0.354 . . . . 1.53 111.493 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.592 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.12 129.54 17.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.375 -0.83 . . . . 3.0600000000000001 110.334 167.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.09 153.79 51.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.082 0.467 . . . . 2.2999999999999998 111.257 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 18.1 t -104.71 129.2 25.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 2.0 108.712 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 10.9 Cg_endo -96.22 161.54 1.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.205 3.27 . . . . 1.8899999999999999 112.573 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 70.92 8.5 6.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.264 -0.88 . . . . 2.4300000000000002 111.176 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 51' ' ' PHE . 5.5 tp10 -158.27 134.04 9.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.514 0.673 . . . . 3.2599999999999998 112.091 -171.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 p -130.09 28.36 5.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.799 -1.091 . . . . 2.48 109.521 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.529 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 21.5 ptt? -138.0 -40.96 0.53 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.486 -0.931 . . . . 1.5600000000000001 108.486 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.826 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.6 m-85 -103.05 149.75 24.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.72 -1.585 . . . . 0.95999999999999996 106.72 165.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 171.61 18.93 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.834 -0.746 . . . . 2.0099999999999998 111.536 -161.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.596 ' HB ' HG13 ' A' ' 75' ' ' VAL . 6.1 p -100.34 139.98 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.404 0.621 . . . . 1.8400000000000001 112.248 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 11.2 pt-20 -109.34 152.28 25.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.571 -0.9 . . . . 2.4500000000000002 108.571 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.464 ' ND2' ' HZ1' ' A' ' 43' ' ' LYS . 7.4 p30 -128.2 140.06 52.12 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.75 -0.38 . . . . 2.3900000000000001 111.289 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.852 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.34 114.5 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.332 0.587 . . . . 1.96 110.273 173.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 8.2 m-85 -109.7 105.11 14.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.796 -0.638 . . . . 1.8700000000000001 110.057 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.988 -0.551 . . . . 2.73 111.297 -177.454 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 111.065 -0.814 . . . . 1.8 111.065 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -156.89 92.44 1.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.711 0.634 . . . . 1.3 112.711 -174.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 37.1 mt-10 -104.09 109.11 20.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.572 -0.899 . . . . 0.81000000000000005 108.572 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.852 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.7 m170 -108.19 145.97 33.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.551 0.691 . . . . 0.65000000000000002 112.056 -170.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.604 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.5 m-85 -121.24 104.54 9.81 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.057 -1.429 . . . . 1.4299999999999999 108.596 170.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.623 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 19.6 m170 -104.24 107.87 18.99 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 122.234 -0.291 . . . . 0.56000000000000005 110.284 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.596 HG13 ' HB ' ' A' ' 53' ' ' VAL . 3.8 m -101.56 118.87 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 122.349 1.071 . . . . 1.49 108.294 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.826 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.6 m -101.74 103.98 14.76 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.702 -1.592 . . . . 1.1399999999999999 106.702 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.648 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -151.26 147.41 15.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.133 0.896 . . . . 1.6000000000000001 110.874 -170.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.798 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.61 102.07 4.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.217 0.532 . . . . 2.1600000000000001 109.988 170.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -163.23 137.1 5.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 1.1000000000000001 110.137 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.44 77.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.264 0.554 . . . . 1.1100000000000001 111.651 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.47 166.76 29.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.798 -0.921 . . . . 0.33000000000000002 110.798 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -99.98 133.08 44.87 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.519 -0.872 . . . . 1.1499999999999999 109.047 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.648 ' HB3' ' HG ' ' A' ' 107' ' ' LEU . 12.5 t-80 -103.45 103.64 13.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.184 -0.673 . . . . 0.52000000000000002 109.184 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.33 109.11 20.68 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.877 -0.786 . . . . 1.1100000000000001 108.877 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.39 106.87 21.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.166 -0.47 . . . . 1.26 111.146 -170.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 5.0 m-80 -109.42 103.8 12.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.498 -0.774 . . . . 1.53 109.232 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 38' ' ' PHE . 84.9 mt -105.23 123.6 48.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.461 -0.791 . . . . 1.0900000000000001 109.744 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.442 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.4 m -102.5 120.09 39.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 1.1000000000000001 110.933 -172.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.868 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 50.1 t80 -88.23 98.22 11.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 1.6599999999999999 109.732 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.716 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 10.2 mtm -136.3 163.98 29.15 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 110.277 -0.268 . . . . 1.24 110.277 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.453 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 12.8 ttt180 -65.41 110.59 4.56 Favored Pre-proline 0 C--O 1.221 -0.405 0 N-CA-C 107.673 -1.232 . . . . 3.1299999999999999 107.673 168.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.549 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 1.7 Cg_endo -43.98 -33.96 5.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.231 3.288 . . . . 1.04 115.42 -169.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.549 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 48.9 p90 -102.24 8.03 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.859 0.689 . . . . 1.1799999999999999 112.859 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.497 HG23 ' N ' ' A' ' 95' ' ' GLY . 12.8 t -167.8 -55.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.789 -0.364 . . . . 1.3500000000000001 111.602 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 58.1 78.75 0.12 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-O 119.703 -0.498 . . . . 1.1599999999999999 113.377 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HB2' ' HZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -29.08 115.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.236 3.291 . . . . 1.6899999999999999 113.439 170.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 m -73.42 67.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.301 -0.863 . . . . 3.02 111.261 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 t60 176.35 -30.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.18 -0.918 . . . . 4.9199999999999999 109.078 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.486 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -91.81 -7.18 50.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.6699999999999999 110.018 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -68.3 122.3 18.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.008 -0.996 . . . . 1.74 112.404 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.868 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.6 tp10 -91.05 165.33 13.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.023 -1.103 . . . . 1.9099999999999999 108.023 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 39.2 ttt180 -159.2 136.98 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.711 0.767 . . . . 0.78000000000000003 111.094 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.717 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -104.3 154.37 19.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.438 -1.256 . . . . 1.0700000000000001 109.162 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.1 m -154.87 103.25 2.41 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.866 -0.333 . . . . 1.03 110.783 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.747 HG13 HG22 ' A' ' 5' ' ' VAL . 10.6 p -104.96 136.12 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 119.676 -0.81 . . . . 1.5 109.682 168.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' THR . 74.4 m-85 -103.9 104.15 14.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.467 -0.938 . . . . 1.0 108.467 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.4 pp -122.68 146.17 47.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.269 -0.641 . . . . 2.6499999999999999 109.269 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.769 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.7 ttmm -103.48 116.71 32.91 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.559 -0.456 . . . . 2.3500000000000001 111.0 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.65 151.3 21.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.896 -0.779 . . . . 1.1499999999999999 108.896 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.574 ' O ' HG23 ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.804 -0.617 . . . . 1.78 111.631 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.995 ' HB3' HG21 ' A' ' 22' ' ' VAL . 43.8 t60 . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.23 -0.656 . . . . 1.1000000000000001 109.23 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -142.65 130.84 22.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.283 -0.417 . . . . 2.8500000000000001 110.499 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.781 HG13 ' CZ ' ' A' ' 103' ' ' PHE . 2.3 t -106.58 137.05 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.399 -0.52 . . . . 1.23 111.702 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.508 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 2.6 p -119.01 168.75 10.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 1.1000000000000001 109.412 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -40.11 -39.46 0.9 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.47 1.285 . . . . 1.47 114.47 -170.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.81 -36.45 62.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.558 0.694 . . . . 1.05 111.83 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.721 ' HB2' HG11 ' A' ' 5' ' ' VAL . 77.6 m80 -65.66 -1.59 2.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.649 -0.705 . . . . 2.7000000000000002 111.41 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.739 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.9 t-20 -46.01 -19.36 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.316 0.646 . . . . 1.48 110.161 169.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -142.12 55.33 0.59 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.427 -0.669 . . . . 0.29999999999999999 111.427 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.667 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -112.45 160.22 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.97 0.73 . . . . 1.0800000000000001 112.97 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 34.1 m -152.25 110.37 3.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.158 -0.928 . . . . 1.3 109.336 173.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.697 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.5 pt? -158.13 166.58 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 3.4700000000000002 111.195 -172.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 108' ' ' LYS . 94.5 m -104.2 148.61 26.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.945 0.403 . . . . 2.0800000000000001 110.715 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.792 HG21 ' O ' ' A' ' 108' ' ' LYS . 2.2 m -125.53 157.65 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.042 -0.526 . . . . 1.3600000000000001 110.035 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.34 104.2 12.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.65 -0.5 . . . . 1.27 109.65 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.506 HG13 HG22 ' A' ' 22' ' ' VAL . 33.2 m -84.09 175.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.234 0.54 . . . . 1.8500000000000001 112.072 -172.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.77 -32.15 3.38 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 111.211 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.74 -76.22 0.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.664 -0.495 . . . . 2.3500000000000001 109.664 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.2 tp -166.05 123.39 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.462 -0.79 . . . . 1.3600000000000001 110.66 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -107.78 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.598 0.713 . . . . 1.1799999999999999 109.645 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.557 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -113.0 159.25 19.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.869 0.842 . . . . 1.74 112.44 -172.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.696 HD12 HG11 ' A' ' 105' ' ' VAL . 47.2 mm -134.43 102.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.111 -1.404 . . . . 1.1000000000000001 108.722 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -106.03 141.57 37.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.368 0.604 . . . . 0.64000000000000001 111.334 -175.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 3.1 mt -125.93 142.65 42.94 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.562 -0.744 . . . . 1.47 110.284 172.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 43.3 Cg_endo -84.2 16.29 1.96 Allowed 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.787 2.325 . . . . 0.34999999999999998 112.427 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 8.0 t 65.8 -61.25 0.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.657 0.783 . . . . 0.91000000000000003 111.219 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.463 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 58.8 83.44 0.22 Allowed Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.292 -1.003 . . . . 1.3899999999999999 108.292 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.88 98.36 0.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.388 2.725 . . . . 0.97999999999999998 113.416 -166.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.521 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.4 p -83.13 -45.29 14.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.034 -0.728 . . . . 2.0899999999999999 109.034 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.668 HG22 ' HD1' ' A' ' 34' ' ' PHE . 8.9 t 173.91 -140.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.024 -0.989 . . . . 2.6800000000000002 108.503 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.24 -27.78 47.74 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 118.043 0.383 . . . . 1.5800000000000001 113.853 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.668 ' HD1' HG22 ' A' ' 32' ' ' THR . 41.6 m-85 -56.56 147.79 21.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.058 0.543 . . . . 2.7200000000000002 111.67 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.525 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -152.37 157.8 41.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.067 0.547 . . . . 1.1599999999999999 109.637 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.693 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 92.9 m95 -78.29 119.74 22.07 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.415 0.626 . . . . 0.42999999999999999 111.688 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 85.0 m-85 -126.55 -177.79 4.12 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.012 -1.107 . . . . 3.0299999999999998 108.012 168.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.642 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -72.88 -76.61 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.934 -0.707 . . . . 0.53000000000000003 109.576 165.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.5 3.09 8.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.77 -0.65 . . . . 2.3900000000000001 111.009 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.0 100.38 1.11 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.03 -1.081 . . . . 0.72999999999999998 113.327 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.13 22.38 60.55 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.847 -0.692 . . . . 0.85999999999999999 111.916 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -140.35 142.38 35.58 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 122.754 0.422 . . . . 1.53 111.209 -174.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.73 140.51 31.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.99 -0.55 . . . . 3.0600000000000001 110.035 164.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.76 145.44 46.6 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.915 -0.584 . . . . 2.2999999999999998 110.271 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.499 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 2.9 p -104.17 128.48 27.03 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.536 -0.913 . . . . 2.0 108.536 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.7 Cg_exo -77.83 39.83 0.8 Allowed 'Trans proline' 0 C--N 1.335 -0.166 0 C-N-CA 123.492 2.795 . . . . 1.8899999999999999 112.835 -170.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -173.99 32.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.485 -0.561 . . . . 2.4300000000000002 109.485 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 10.9 pt-20 -94.85 109.17 21.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.712 0.768 . . . . 3.2599999999999998 111.585 -173.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.2 m -145.92 10.46 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.464 -0.789 . . . . 2.48 110.118 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -178.12 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 1.5600000000000001 109.122 -172.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.5 m-85 -123.58 157.25 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.17 -1.377 . . . . 0.95999999999999996 107.835 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -152.57 166.46 31.98 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.662 0.616 . . . . 2.0099999999999998 112.662 -162.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 p -109.27 136.11 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.607 -0.724 . . . . 1.8400000000000001 111.818 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.92 137.79 51.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.59 -0.732 . . . . 2.4500000000000002 109.628 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.86 142.74 34.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.236 -0.586 . . . . 2.3900000000000001 110.784 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.42 104.92 3.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.432 -0.804 . . . . 1.96 109.861 -177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.923 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -116.62 132.39 56.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.367 0.603 . . . . 1.8700000000000001 112.189 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 2.73 109.723 172.735 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.0 0 N-CA-C 111.72 -0.552 . . . . 1.8 111.72 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.38 81.47 1.12 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.617 0.723 . . . . 1.3 110.757 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.923 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 20.9 mt-10 -104.05 102.44 12.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.949 -1.023 . . . . 0.81000000000000005 108.405 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -113.81 151.3 32.26 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.411 -0.916 . . . . 0.65000000000000002 111.324 -174.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.577 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 39.6 m-85 -118.83 104.45 10.56 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.97 -1.468 . . . . 1.4299999999999999 109.332 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 17.9 m170 -104.64 104.86 14.75 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.252 -0.431 . . . . 0.56000000000000005 110.883 -171.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.98 120.82 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 122.424 1.107 . . . . 1.49 109.785 177.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.757 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.6 m -102.92 104.43 14.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.508 -1.223 . . . . 1.1399999999999999 107.839 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.62 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.2 p -147.29 147.35 17.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.808 0.693 . . . . 1.6000000000000001 110.672 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -130.45 103.48 6.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.993 0.902 . . . . 2.1600000000000001 108.664 166.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.84 166.15 15.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.257 -0.883 . . . . 1.1000000000000001 109.189 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.91 102.74 14.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 1.1100000000000001 110.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.51 167.18 37.6 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.726 -0.67 . . . . 0.33000000000000002 111.449 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -103.31 139.71 38.38 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.909 -0.76 . . . . 1.1499999999999999 109.648 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.766 ' HB3' ' HG ' ' A' ' 107' ' ' LEU . 7.2 t-80 -113.62 104.54 12.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.847 -0.615 . . . . 0.52000000000000002 110.418 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.42 109.44 21.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.177 -0.675 . . . . 1.1100000000000001 109.177 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.41 104.35 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.123 -0.49 . . . . 1.26 111.12 -171.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -106.19 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.018 -0.734 . . . . 1.53 109.018 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 38' ' ' PHE . 85.6 mt -106.4 124.85 50.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.663 -0.699 . . . . 1.0900000000000001 110.127 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.2 m -103.54 118.31 36.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.529 0.681 . . . . 1.1000000000000001 111.381 -171.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.525 ' CE1' ' HA ' ' A' ' 35' ' ' ALA . 53.4 t80 -82.6 90.2 6.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.6599999999999999 109.408 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.518 ' HA ' ' HD2' ' A' ' 34' ' ' PHE . 25.9 mtm -120.86 158.66 27.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.984 -0.553 . . . . 1.24 111.434 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -70.48 105.45 1.22 Allowed Pre-proline 0 C--O 1.219 -0.503 0 N-CA-C 108.034 -1.099 . . . . 3.1299999999999999 108.034 167.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.569 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 10.0 Cg_endo -51.83 -27.49 27.46 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.373 2.715 . . . . 1.04 114.789 -169.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.569 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 44.2 p90 -94.58 4.59 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 1.1799999999999999 111.774 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.808 HG21 ' H ' ' A' ' 95' ' ' GLY . 1.5 t -167.99 -74.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.521 -0.309 . . . . 1.3500000000000001 110.317 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.808 ' H ' HG21 ' A' ' 94' ' ' THR . . . 68.19 75.95 0.46 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.422 -0.418 . . . . 1.1599999999999999 112.944 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.489 ' HG2' ' HZ ' ' A' ' 34' ' ' PHE . 1.8 Cg_endo -45.23 117.4 1.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.885 2.39 . . . . 1.6899999999999999 111.081 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -55.23 -39.18 69.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.404 -0.816 . . . . 3.02 112.521 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -83.78 -19.19 35.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.616 0.246 . . . . 4.9199999999999999 111.219 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -93.38 -5.96 48.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.688 0.756 . . . . 1.6699999999999999 109.343 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.9 m -90.75 145.97 24.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 1.74 110.643 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -98.43 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.332 -0.988 . . . . 1.9099999999999999 108.332 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.451 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 26.9 ttt180 -146.74 141.66 26.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.907 0.861 . . . . 0.78000000000000003 110.968 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.781 ' CZ ' HG13 ' A' ' 5' ' ' VAL . 1.3 t80 -102.75 154.94 18.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.208 -1.36 . . . . 1.0700000000000001 108.468 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 90.8 m -156.61 102.14 2.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.645 -0.422 . . . . 1.03 111.179 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.696 HG11 HD12 ' A' ' 24' ' ' ILE . 14.9 p -104.74 135.96 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 119.913 -0.715 . . . . 1.5 109.984 168.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 13' ' ' THR . 94.3 m-85 -104.57 107.59 18.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.289 -0.869 . . . . 1.0 109.036 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.766 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 1.7 pp -128.86 152.76 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.223 -0.658 . . . . 2.6499999999999999 109.223 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.792 ' O ' HG21 ' A' ' 16' ' ' VAL . 18.6 ttmm -105.17 117.56 34.31 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.334 -0.617 . . . . 2.3500000000000001 109.334 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.03 110.39 22.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.951 -0.388 . . . . 1.1499999999999999 109.951 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.359 -0.837 . . . . 1.78 110.139 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.844 ' HB3' HG23 ' A' ' 22' ' ' VAL . 70.2 t60 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.844 -0.798 . . . . 1.1000000000000001 108.844 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -140.7 140.54 34.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.847 0.356 . . . . 2.8500000000000001 110.585 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.786 HG13 ' CZ ' ' A' ' 103' ' ' PHE . 2.3 t -106.09 132.26 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.397 -0.521 . . . . 1.23 110.959 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.689 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 2.8 p -113.74 169.78 8.73 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.091 -0.959 . . . . 1.1000000000000001 110.155 169.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -41.01 -40.63 1.47 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.86 1.059 . . . . 1.47 113.86 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.88 61.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.672 0.749 . . . . 1.05 111.598 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.709 ' HB2' HG11 ' A' ' 5' ' ' VAL . 52.1 m80 -67.56 -1.74 5.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 2.7000000000000002 111.583 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.679 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 22.7 t-20 -48.33 -17.93 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.517 0.511 . . . . 1.48 109.674 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.88 56.74 0.64 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.507 -0.769 . . . . 0.29999999999999999 111.716 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.666 ' HB1' HG23 ' A' ' 105' ' ' VAL . . . -106.54 157.83 17.38 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.662 0.986 . . . . 1.0800000000000001 113.662 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 29.4 m -153.77 103.59 2.62 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.332 -0.849 . . . . 1.3 109.282 168.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.3 pt? -164.12 169.79 17.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 3.4700000000000002 111.761 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 108' ' ' LYS . 88.9 m -100.7 145.95 27.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 2.0800000000000001 111.054 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.687 HG21 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -119.74 152.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.478 -0.783 . . . . 1.3600000000000001 110.701 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.36 108.02 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.551 -0.537 . . . . 1.27 109.551 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG12 HG21 ' A' ' 22' ' ' VAL . 34.4 m -86.63 -169.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.017 0.437 . . . . 1.8500000000000001 111.99 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 116.31 -50.51 0.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.70999999999999996 111.296 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.18 -77.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.286 0.565 . . . . 2.3500000000000001 110.082 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -166.89 120.51 1.02 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.348 -0.842 . . . . 1.3600000000000001 110.261 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 3' ' ' HIS . 6.9 t -111.63 104.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 1.1799999999999999 110.06 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.75 160.94 15.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.005 0.907 . . . . 1.74 112.183 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.692 HG22 HG13 ' A' ' 85' ' ' VAL . 17.7 mm -130.37 101.58 5.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.647 -1.615 . . . . 1.1000000000000001 107.828 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -108.46 143.31 37.6 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.299 0.571 . . . . 0.64000000000000001 110.923 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -128.34 142.08 43.5 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.839 -0.619 . . . . 1.47 110.619 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 73.1 Cg_endo -77.41 6.14 4.62 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.34999999999999998 111.671 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.731 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 11.2 t 68.39 -55.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.249 0.968 . . . . 0.91000000000000003 110.129 -172.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.4 m-80 54.7 57.82 11.69 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.339 -1.356 . . . . 1.3899999999999999 107.339 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 51.7 Cg_exo -53.56 108.12 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.326 2.684 . . . . 0.97999999999999998 113.139 -161.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.469 ' H ' ' HH ' ' A' ' 89' ' ' TYR . 3.5 t -132.54 104.29 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.285 -1.325 . . . . 2.0899999999999999 110.023 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.45 HG21 ' H ' ' A' ' 33' ' ' GLY . 3.8 m 72.15 -177.13 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.6 -0.727 . . . . 2.6800000000000002 110.075 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' H ' HG21 ' A' ' 32' ' ' THR . . . -61.49 -15.98 48.41 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 118.505 0.593 . . . . 1.5800000000000001 114.332 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.813 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 1.2 m-85 -62.26 155.41 24.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.545 0.572 . . . . 2.7200000000000002 112.545 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.51 160.4 43.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.116 -0.947 . . . . 1.1599999999999999 108.832 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.19 117.5 20.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.635 0.731 . . . . 0.42999999999999999 111.537 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.624 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 66.2 m-85 -125.61 -176.68 3.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.955 -1.128 . . . . 3.0299999999999998 107.955 168.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.61 ' HA ' HD21 ' A' ' 87' ' ' LEU . 1.3 m-85 -74.12 -77.95 0.11 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.794 -0.762 . . . . 0.53000000000000003 109.178 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -114.3 10.56 17.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.699 -0.682 . . . . 2.3900000000000001 110.46 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 96.57 106.11 2.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.72999999999999998 112.351 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.08 -3.46 51.81 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.85999999999999999 112.414 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -128.69 142.94 50.86 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.806 0.336 . . . . 1.53 111.869 -178.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.06 132.96 27.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.316 -0.856 . . . . 3.0600000000000001 110.532 164.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.98 154.05 51.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.234 0.54 . . . . 2.2999999999999998 111.114 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.809 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 41.0 t -104.92 131.2 22.01 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.638 -0.875 . . . . 2.0 108.638 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.65 -25.67 20.76 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.487 2.791 . . . . 1.8899999999999999 113.286 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.515 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 46.8 m-20 -139.7 81.7 1.84 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 2.4300000000000002 109.957 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.0 pt-20 -117.61 58.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.599 0.714 . . . . 3.2599999999999998 110.854 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -80.94 -60.04 2.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.559 -0.746 . . . . 2.48 111.246 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.79 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.96 -29.21 8.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.589 0.709 . . . . 1.5600000000000001 109.961 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.79 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 6.3 m-85 -105.64 165.01 11.46 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.908 -1.042 . . . . 0.95999999999999996 108.795 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -153.84 167.54 29.34 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.942 -0.703 . . . . 2.0099999999999998 112.587 -163.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.99 134.0 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.383 -0.826 . . . . 1.8400000000000001 111.547 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.25 155.35 18.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.986 -1.006 . . . . 2.4500000000000002 109.294 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 4.6 p-10 -125.13 146.58 49.41 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.937 -0.574 . . . . 2.3900000000000001 110.878 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HD2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -164.84 103.91 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.96 110.049 178.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.863 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -118.87 128.56 54.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.701 0.762 . . . . 1.8700000000000001 111.699 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 C--O 1.211 -0.952 0 CA-C-N 114.531 -1.213 . . . . 2.73 107.755 174.268 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.172 0 N-CA-C 112.725 -0.15 . . . . 1.8 112.725 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.49 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -161.47 83.77 0.62 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.777 0.658 . . . . 1.3 112.777 -175.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.863 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 30.3 mt-10 -104.79 104.83 14.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.447 -0.946 . . . . 0.81000000000000005 108.447 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -115.43 149.28 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.394 -0.922 . . . . 0.65000000000000002 112.157 -173.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.624 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 41.4 m-85 -109.13 114.64 28.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.484 -1.689 . . . . 1.4299999999999999 108.476 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.536 ' CD2' ' HD2' ' A' ' 56' ' ' LYS . 5.5 m170 -104.27 109.36 21.17 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.86 -0.525 . . . . 0.56000000000000005 111.11 -173.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG23 ' HE2' ' A' ' 83' ' ' HIS . 64.3 t -103.04 110.35 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.633 0.73 . . . . 1.49 110.071 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 23.2 m -101.99 105.31 16.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.93 -1.137 . . . . 1.1399999999999999 107.93 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.626 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 7.3 p -150.89 151.68 12.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.804 -0.634 . . . . 1.6000000000000001 110.669 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -135.31 103.61 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.838 0.828 . . . . 2.1600000000000001 109.422 166.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.3 158.06 13.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.596 -0.729 . . . . 1.1000000000000001 109.307 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 110' ' ' ASN . . . -84.39 95.28 8.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.484 0.659 . . . . 1.1100000000000001 110.217 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.515 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -146.45 169.54 27.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.219 -0.9 . . . . 0.33000000000000002 111.679 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -107.38 130.0 54.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.296 -0.631 . . . . 1.1499999999999999 109.296 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.673 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 43.3 t-80 -104.11 102.51 12.25 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.28 -0.262 . . . . 0.52000000000000002 110.324 -172.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.16 128.67 50.03 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.322 -0.622 . . . . 1.1100000000000001 109.322 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 24' ' ' ILE . 2.1 t -128.66 103.88 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 120.801 -0.36 . . . . 1.26 111.656 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.507 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -109.03 103.26 12.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.481 -0.933 . . . . 1.53 108.481 171.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 38' ' ' PHE . 91.9 mt -103.83 122.34 44.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 1.0900000000000001 109.566 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.641 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.2 m -101.31 117.86 35.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.816 0.817 . . . . 1.1000000000000001 110.941 -171.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.813 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -84.43 92.43 8.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.629 -1.168 . . . . 1.6599999999999999 109.425 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.609 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 12.6 mtm -128.72 165.05 21.65 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.433 -0.349 . . . . 1.24 110.185 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' PHE . 9.3 ttm180 -67.02 106.47 1.19 Allowed Pre-proline 0 C--O 1.213 -0.819 0 N-CA-C 107.954 -1.128 . . . . 3.1299999999999999 107.954 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 4.4 Cg_endo -44.96 -30.92 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 124.067 3.178 . . . . 1.04 115.25 -168.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.528 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 36.9 p90 -95.24 5.67 51.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.395 0.517 . . . . 1.1799999999999999 112.395 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -164.99 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.568 0.21 . . . . 1.3500000000000001 111.568 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.609 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 63.86 86.95 0.05 OUTLIER Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.869 -0.492 . . . . 1.1599999999999999 111.869 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 1.017 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 29.1 Cg_exo -57.32 118.4 5.26 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.269 1.98 . . . . 1.6899999999999999 110.042 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.3 t -49.4 -53.38 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.726 0.641 . . . . 3.02 112.465 -167.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -92.19 5.51 50.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.951 0.405 . . . . 4.9199999999999999 110.645 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 1.017 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 27.2 t70 -112.99 1.24 15.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 1.6699999999999999 109.878 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -98.86 171.5 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.594 -0.73 . . . . 1.74 111.457 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.1 tp10 -115.39 170.88 8.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.831 -0.803 . . . . 1.9099999999999999 108.831 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.641 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 34.8 ttt180 -157.18 141.69 16.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.821 0.819 . . . . 0.78000000000000003 111.184 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.786 ' CZ ' HG13 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -104.36 157.74 16.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.313 -1.312 . . . . 1.0700000000000001 108.594 177.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.0 m -157.85 102.48 1.84 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.514 . . . . 1.03 111.306 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.724 HG11 HG22 ' A' ' 5' ' ' VAL . 14.2 p -103.66 134.48 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.482 -0.562 . . . . 1.5 109.482 169.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' THR . 72.0 m-85 -105.21 112.7 25.92 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 77.8 mt -127.85 164.9 21.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.011 -0.995 . . . . 2.6499999999999999 110.024 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.687 ' O ' HG21 ' A' ' 16' ' ' VAL . 58.4 tttm -119.99 113.85 21.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.385 -0.969 . . . . 2.3500000000000001 108.385 172.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 83' ' ' HIS . . . -101.14 106.83 18.11 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.908 -0.405 . . . . 1.1499999999999999 109.908 -171.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.135 -0.936 . . . . 1.78 110.437 -168.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.966 ' HB3' HG22 ' A' ' 22' ' ' VAL . 32.2 t60 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.798 -0.815 . . . . 1.1000000000000001 108.798 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 21.5 pttp -149.55 150.44 32.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.702 0.287 . . . . 2.8500000000000001 111.423 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 1.037 HG23 HG12 ' A' ' 105' ' ' VAL . 2.1 t -120.11 136.3 57.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.433 0.635 . . . . 1.23 111.961 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.539 ' H ' ' ND1' ' A' ' 9' ' ' HIS . 1.1 p -120.33 170.34 9.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.785 -1.098 . . . . 1.1000000000000001 110.473 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 16.7 tptm -35.62 -48.6 0.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.692 1.368 . . . . 1.47 114.692 -171.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.59 -33.32 60.19 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.601 0.715 . . . . 1.05 111.817 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.746 ' HB2' HG12 ' A' ' 5' ' ' VAL . 75.0 m80 -64.75 -2.32 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 2.7000000000000002 111.227 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 25.9 t-20 -45.57 -22.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.332 0.653 . . . . 1.48 109.995 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.42 54.0 0.66 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.5 -0.773 . . . . 0.29999999999999999 111.357 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.632 ' HB2' HG23 ' A' ' 105' ' ' VAL . . . -116.76 156.03 27.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.654 0.613 . . . . 1.0800000000000001 112.654 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 39.4 m -145.95 112.91 6.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.394 -0.821 . . . . 1.3 109.433 173.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -157.88 167.62 29.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 3.4700000000000002 111.347 -173.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 16' ' ' VAL . 85.8 m -101.52 146.59 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.724 0.297 . . . . 2.0800000000000001 111.107 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 108' ' ' LYS . 2.1 m -131.76 162.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 1.3600000000000001 110.936 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.78 137.88 51.89 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.66 -1.237 . . . . 1.27 107.66 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.795 HG11 ' H ' ' A' ' 19' ' ' GLY . 1.6 t -121.06 -164.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 119.892 -0.723 . . . . 1.8500000000000001 110.25 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.795 ' H ' HG11 ' A' ' 18' ' ' VAL . . . 124.31 -48.87 0.93 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.765 -0.934 . . . . 0.70999999999999996 110.765 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -84.43 -71.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.292 0.568 . . . . 2.3500000000000001 109.685 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -165.46 144.38 6.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.246 -0.888 . . . . 1.3600000000000001 110.096 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.966 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.1 t -123.14 120.11 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 109.341 -0.615 . . . . 1.1799999999999999 109.341 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 49.8 mt-10 -103.8 151.53 22.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.933 0.873 . . . . 1.74 112.442 -171.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.646 HD13 ' HB ' ' A' ' 5' ' ' VAL . 41.6 mm -133.88 137.74 51.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.227 -1.768 . . . . 1.1000000000000001 106.227 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.4 142.12 29.05 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.662 -0.649 . . . . 0.64000000000000001 111.217 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.412 HD11 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -117.25 144.72 34.37 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.28 -0.873 . . . . 1.47 109.181 169.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HG2' HD21 ' A' ' 29' ' ' ASN . 73.8 Cg_endo -82.63 12.52 2.87 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 C-N-CA 122.862 2.375 . . . . 0.34999999999999998 111.515 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.724 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.1 t 68.11 -44.99 0.5 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.982 0.913 . . . . 0.91000000000000003 112.257 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.623 ' O ' HG21 ' A' ' 31' ' ' THR . 1.1 p30 41.89 78.81 0.36 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.443 0.64 . . . . 1.3899999999999999 110.777 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 25.9 Cg_exo -63.97 109.98 1.22 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.357 2.705 . . . . 0.97999999999999998 112.111 -169.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 29' ' ' ASN . 1.3 t -142.46 117.15 9.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.724 -0.671 . . . . 2.0899999999999999 111.534 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.7 m 73.52 -42.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.478 0.656 . . . . 2.6800000000000002 112.314 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 31' ' ' THR . . . 162.72 -118.58 0.83 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 107.72 -2.152 . . . . 1.5800000000000001 107.72 -172.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.776 ' HA ' ' C ' ' A' ' 90' ' ' MET . 8.5 m-30 61.77 178.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.577 0.703 . . . . 2.7200000000000002 111.607 167.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.485 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -174.35 144.79 0.95 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.634 -1.247 . . . . 1.1599999999999999 107.634 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.724 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 94.8 m95 -76.97 99.07 5.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.359 0.6 . . . . 0.42999999999999999 110.848 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.47 179.76 4.18 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.736 -1.209 . . . . 3.0299999999999998 107.736 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -68.64 -69.03 0.35 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.628 -0.829 . . . . 0.53000000000000003 109.372 167.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.52 13.33 3.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 2.3900000000000001 110.44 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.21 112.05 3.3 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.613 -0.803 . . . . 0.72999999999999998 113.101 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 4.26 34.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.475 -0.393 . . . . 0.85999999999999999 113.03 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 p -139.94 144.63 37.18 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 112.425 0.528 . . . . 1.53 112.425 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.23 127.68 18.92 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.901 -1.045 . . . . 3.0600000000000001 110.122 167.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.92 145.0 51.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.071 0.463 . . . . 2.2999999999999998 110.781 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -111.86 135.89 21.2 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.073 -0.714 . . . . 2.0 109.073 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 36.9 Cg_exo -61.51 128.78 25.76 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.278 1.986 . . . . 1.8899999999999999 111.457 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 92.8 m-20 72.19 30.76 2.04 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.954 0.784 . . . . 2.4300000000000002 112.149 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.18 45.72 1.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.579 0.704 . . . . 3.2599999999999998 110.985 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -81.29 -19.56 42.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.541 -0.754 . . . . 2.48 111.339 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.418 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 17.5 ptt? -138.76 -35.82 0.57 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.748 0.785 . . . . 1.5600000000000001 109.964 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.851 ' HB3' ' O ' ' A' ' 76' ' ' THR . 8.4 m-85 -106.2 166.19 10.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.95999999999999996 108.443 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -153.03 167.11 30.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.767 0.712 . . . . 2.0099999999999998 112.623 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.9 p -103.34 141.57 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.252 -0.886 . . . . 1.8400000000000001 111.671 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -116.36 137.94 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 2.4500000000000002 109.614 173.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -110.64 159.17 17.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.753 0.311 . . . . 2.3900000000000001 111.386 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -158.24 117.22 3.13 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.264 -0.426 . . . . 1.96 109.977 175.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.727 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 2.6 m-85 -123.51 106.46 10.63 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.296 -0.562 . . . . 1.8700000000000001 109.794 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 . . . . . 0 N--CA 1.444 -0.774 0 CA-C-N 116.335 -0.393 . . . . 2.73 111.661 -175.886 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 N-CA-C 111.346 -0.701 . . . . 1.8 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.27 85.22 0.24 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.472 0.654 . . . . 1.3 110.344 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.727 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.0 mt-10 -113.58 104.66 12.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.534 -0.757 . . . . 0.81000000000000005 108.991 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.618 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -110.77 165.42 11.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.753 0.787 . . . . 0.65000000000000002 111.436 -170.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.473 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 60.0 m-85 -136.57 104.51 5.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.98 -1.464 . . . . 1.4299999999999999 109.128 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.599 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 40.1 m170 -102.79 113.84 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.958 -0.464 . . . . 0.56000000000000005 109.86 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 m -103.91 125.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 122.135 0.969 . . . . 1.49 110.079 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.851 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 3.7 m -103.82 103.54 13.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.101 -1.444 . . . . 1.1399999999999999 107.101 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.643 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.1 p -157.25 129.94 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 123.292 0.37 . . . . 1.6000000000000001 111.033 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -123.2 102.55 8.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.497 0.665 . . . . 2.1600000000000001 110.606 176.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.68 140.42 4.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.52 -0.764 . . . . 1.1000000000000001 109.757 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -64.61 87.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.61 0.569 . . . . 1.1100000000000001 111.484 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.87 166.48 32.96 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 110.693 -0.963 . . . . 0.33000000000000002 110.693 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.0 OUTLIER -101.0 136.01 41.53 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.773 -0.771 . . . . 1.1499999999999999 109.228 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.494 ' O ' HD12 ' A' ' 107' ' ' LEU . 55.8 t-80 -101.63 102.42 13.11 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.836 -0.802 . . . . 0.52000000000000002 108.836 -174.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.21 103.7 13.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.188 -0.671 . . . . 1.1100000000000001 109.188 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.1 p -106.52 109.36 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.662 -0.699 . . . . 1.26 111.291 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -107.21 103.76 13.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.863 -1.062 . . . . 1.53 108.932 176.055 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.56 HD21 ' HA ' ' A' ' 38' ' ' PHE . 76.3 mt -106.2 128.39 53.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.258 -0.428 . . . . 1.0900000000000001 110.142 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.452 ' HB ' ' SD ' ' A' ' 90' ' ' MET . 3.2 m -104.51 130.84 52.41 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.931 0.396 . . . . 1.1000000000000001 110.579 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 40.6 t80 -96.23 93.82 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.283 -0.636 . . . . 1.6599999999999999 109.283 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.776 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -131.16 158.43 40.5 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.506 -0.316 . . . . 1.24 110.623 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.65 ' N ' ' HA ' ' A' ' 34' ' ' PHE . 41.5 mtt180 -58.65 108.8 1.45 Allowed Pre-proline 0 CA--C 1.512 -0.51 0 O-C-N 124.083 0.864 . . . . 3.1299999999999999 110.083 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 7.0 Cg_exo -38.38 -37.97 0.79 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.903 3.735 . . . . 1.04 115.083 -174.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -91.92 1.27 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.131 0.789 . . . . 1.1799999999999999 113.131 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.65 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.8 t -158.52 -62.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.071 -0.393 . . . . 1.3500000000000001 111.43 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.65 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.34 93.56 0.23 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.958 -0.639 . . . . 1.1599999999999999 113.263 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.806 ' HB2' ' HB2' ' A' ' 99' ' ' ASP . 17.4 Cg_exo -69.22 97.54 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.587 2.192 . . . . 1.6899999999999999 110.008 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.6 m -62.52 -25.1 67.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.655 0.74 . . . . 3.02 109.095 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -59.24 -32.26 69.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.839 -1.073 . . . . 4.9199999999999999 110.618 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.806 ' HB2' ' HB2' ' A' ' 96' ' ' PRO . 1.5 m-20 -109.34 -105.45 0.36 Allowed 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.679 -0.237 . . . . 1.6699999999999999 110.598 -174.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 99' ' ' ASP . 86.9 p 49.28 -179.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.106 1.15 . . . . 1.74 114.106 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.28 137.89 30.96 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.748 -1.204 . . . . 1.9099999999999999 107.748 165.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -121.21 142.87 49.49 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.786 -0.765 . . . . 0.78000000000000003 111.565 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.648 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . 1.1 t80 -104.38 153.9 20.5 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.216 -1.357 . . . . 1.0700000000000001 108.989 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 54.2 m -161.03 103.84 1.3 Allowed 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.147 0.28 . . . . 1.03 110.317 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 1.037 HG12 HG23 ' A' ' 5' ' ' VAL . 7.5 p -110.08 136.6 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 118.15 -1.42 . . . . 1.5 109.877 168.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' THR . 79.4 m-85 -103.94 101.95 11.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.799 -1.092 . . . . 1.0 108.15 175.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.732 HD13 HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -124.49 142.62 51.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.438 -0.949 . . . . 2.6499999999999999 108.438 176.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 16' ' ' VAL . 78.3 tttt -101.89 122.77 44.64 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.369 -0.532 . . . . 2.3500000000000001 110.507 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.98 159.18 15.58 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.692 0.62 . . . . 1.1499999999999999 110.71 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 4.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.353 -0.832 . . . . 1.78 109.553 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.707 ' NE2' HD13 ' A' ' 107' ' ' LEU . 20.2 t60 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 121.487 0.66 . . . . 1.1000000000000001 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 20.1 pttp -149.71 141.14 23.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 2.8500000000000001 110.771 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.825 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -103.22 140.15 22.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-O 121.018 0.437 . . . . 1.23 110.562 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.572 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 7.2 p -121.71 169.05 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.503 -0.772 . . . . 1.1000000000000001 109.73 171.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -38.0 -47.01 1.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.335 1.235 . . . . 1.47 114.335 -171.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.55 61.83 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.47 0.652 . . . . 1.05 111.871 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.733 ' HB2' HG12 ' A' ' 5' ' ' VAL . 47.9 m80 -62.57 -3.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.629 . . . . 2.7000000000000002 111.672 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.63 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 3.7 t-20 -46.91 -19.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.145 0.578 . . . . 1.48 110.171 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.33 51.87 0.74 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.955 -0.641 . . . . 0.29999999999999999 112.078 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.624 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -106.03 162.3 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.513 0.931 . . . . 1.0800000000000001 113.513 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 85.7 m -153.74 103.76 2.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.336 -0.847 . . . . 1.3 109.134 170.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 6.5 tt -156.06 164.26 38.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 110.141 -0.318 . . . . 3.4700000000000002 110.141 -170.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 m -103.15 140.91 36.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 2.0800000000000001 111.414 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 108' ' ' LYS . 2.6 m -116.97 158.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 1.3600000000000001 111.372 -174.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.77 121.28 44.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 1.27 109.586 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.604 HG21 ' C ' ' A' ' 110' ' ' ASN . 17.6 m -108.26 -173.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.8500000000000001 111.271 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 130.11 -56.65 0.74 Allowed Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 111.244 -0.742 . . . . 0.70999999999999996 111.244 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.35 -68.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.333 0.587 . . . . 2.3500000000000001 109.654 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -165.99 141.38 4.8 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 114.863 -1.062 . . . . 1.3600000000000001 109.179 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -117.65 126.63 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 110.003 -0.369 . . . . 1.1799999999999999 110.003 173.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 21.2 mt-10 -103.34 142.83 33.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.882 0.849 . . . . 1.74 112.732 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.631 HG23 HG11 ' A' ' 85' ' ' VAL . 41.7 mm -124.45 101.06 8.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.321 -1.363 . . . . 1.1000000000000001 107.321 165.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -108.93 138.24 45.58 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.492 0.663 . . . . 0.64000000000000001 111.781 -169.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -119.58 144.77 37.54 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.517 -0.765 . . . . 1.47 109.441 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.523 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 36.7 Cg_endo -86.78 13.86 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.682 2.255 . . . . 0.34999999999999998 111.66 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.704 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 34.3 t 67.6 -49.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.314 -0.857 . . . . 0.91000000000000003 111.62 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER 50.45 57.05 17.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.185 -1.043 . . . . 1.3899999999999999 108.185 -172.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 83.2 Cg_exo -50.11 119.59 5.11 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.88 3.054 . . . . 0.97999999999999998 114.156 -163.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.645 HG22 ' CE2' ' A' ' 89' ' ' TYR . 10.8 p -98.35 -53.37 3.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.19 -0.914 . . . . 2.0899999999999999 110.138 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.633 HG23 ' HD1' ' A' ' 34' ' ' PHE . 2.7 t -171.18 -115.76 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.048 -0.524 . . . . 2.6800000000000002 109.976 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -14.95 79.58 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.211 -0.519 . . . . 1.5800000000000001 112.561 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.633 ' HD1' HG23 ' A' ' 32' ' ' THR . 3.7 m-85 -67.94 145.92 54.08 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.094 0.558 . . . . 2.7200000000000002 110.316 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.81 157.41 43.17 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.74 -0.467 . . . . 1.1599999999999999 109.74 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.6 m95 -77.26 113.31 14.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.413 0.625 . . . . 0.42999999999999999 111.017 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 46.5 m-85 -125.48 175.36 7.57 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.544 -1.28 . . . . 3.0299999999999998 107.544 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.607 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.4 m-85 -65.17 -65.69 0.64 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.465 -0.894 . . . . 0.53000000000000003 109.532 170.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.71 21.59 3.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.997 -0.547 . . . . 2.3900000000000001 110.59 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.79 92.64 1.58 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.466 -0.873 . . . . 0.72999999999999998 113.276 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.99 -8.92 76.56 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.764 -0.731 . . . . 0.85999999999999999 112.628 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -128.4 143.92 51.07 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 111.906 0.336 . . . . 1.53 111.906 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -140.99 139.43 34.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.254 -0.884 . . . . 3.0600000000000001 110.383 172.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.39 145.29 33.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.979 0.419 . . . . 2.2999999999999998 111.594 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.743 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 40.2 m -104.76 137.02 19.1 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 2.0 109.556 173.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 31.2 Cg_exo -60.35 -22.46 71.2 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.208 2.605 . . . . 1.8899999999999999 113.421 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.615 HD22 ' HA3' ' A' ' 81' ' ' GLY . 88.4 m-20 -119.72 24.66 10.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.436 0.16 . . . . 2.4300000000000002 111.408 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 6.5 pt-20 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.946 0.879 . . . . 3.2599999999999998 111.074 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 m -160.45 -49.62 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.469 -1.308 . . . . 2.48 107.469 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.505 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -103.46 -41.04 6.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.551 -1.204 . . . . 1.5600000000000001 109.233 173.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.674 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.9 m-85 -105.62 165.75 10.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.113 -0.949 . . . . 0.95999999999999996 108.535 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -163.7 170.32 17.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 2.0099999999999998 111.575 -168.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.2 p -102.11 135.0 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.61 -0.723 . . . . 1.8400000000000001 111.37 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 1.3 pm0 -120.1 136.31 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.55 -0.907 . . . . 2.4500000000000002 108.55 170.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.879 HD21 ' HH ' ' A' ' 57' ' ' TYR . 96.2 m-20 -103.23 153.82 19.98 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.845 -0.742 . . . . 2.3900000000000001 111.494 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 108.82 3.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.011 -0.995 . . . . 1.96 109.376 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.879 ' HH ' HD21 ' A' ' 55' ' ' ASN . 0.7 OUTLIER -114.75 135.1 54.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.782 -0.644 . . . . 1.8700000000000001 110.621 -174.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.559 -0.291 . . . . 2.73 110.307 169.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.849 0 N-CA-C 111.955 -0.458 . . . . 1.8 111.955 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.39 81.3 0.97 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.485 0.659 . . . . 1.3 110.98 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 31.4 mt-10 -104.27 104.04 13.88 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.576 -0.898 . . . . 0.81000000000000005 108.576 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -108.94 150.13 28.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.517 -0.873 . . . . 0.65000000000000002 110.837 -175.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.633 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 10.0 m-85 -109.56 115.08 29.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.167 -1.379 . . . . 1.4299999999999999 108.95 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 15.8 m170 -104.24 108.24 19.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.164 -0.471 . . . . 0.56000000000000005 110.341 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.677 HG21 HG11 ' A' ' 22' ' ' VAL . 4.2 m -103.45 117.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.175 0.988 . . . . 1.49 108.777 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.674 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 68.0 m -102.62 103.71 14.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.978 -1.119 . . . . 1.1399999999999999 107.978 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 2.9 p -154.76 144.57 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.515 -0.766 . . . . 1.6000000000000001 110.619 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.5 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.1 103.05 6.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.822 0.82 . . . . 2.1600000000000001 109.006 165.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.79 134.72 2.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.375 -0.83 . . . . 1.1000000000000001 110.522 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -65.14 102.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.757 0.66 . . . . 1.1100000000000001 111.367 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA3' HD22 ' A' ' 47' ' ' ASN . . . -165.49 167.2 38.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.152 -1.179 . . . . 0.33000000000000002 110.152 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.8 m -101.85 131.54 48.14 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 118.055 0.927 . . . . 1.1499999999999999 109.436 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.595 ' HD1' HG22 ' A' ' 85' ' ' VAL . 32.5 t-80 -103.96 102.96 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.948 -0.39 . . . . 0.52000000000000002 109.948 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.85 122.13 43.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.014 -0.735 . . . . 1.1100000000000001 109.014 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.0 t -113.97 109.87 30.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.134 -0.485 . . . . 1.26 111.696 -170.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.431 ' ND2' HG21 ' A' ' 104' ' ' THR . 8.0 m120 -109.68 104.09 13.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.223 -0.658 . . . . 1.53 109.223 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.572 HD21 ' CE2' ' A' ' 73' ' ' PHE . 82.5 mt -108.49 121.34 44.76 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 1.0900000000000001 110.004 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.436 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 2.6 m -102.35 118.9 37.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.397 0.617 . . . . 1.1000000000000001 110.657 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.645 ' CE2' HG22 ' A' ' 31' ' ' THR . 53.9 t80 -86.01 91.22 8.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.942 -1.026 . . . . 1.6599999999999999 109.606 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.684 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 3.2 mtm -131.7 165.13 24.42 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.506 -0.316 . . . . 1.24 110.473 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.421 ' HB2' ' H ' ' A' ' 95' ' ' GLY . 70.5 mtt180 -57.28 112.54 4.79 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.48 -0.933 . . . . 3.1299999999999999 108.48 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -52.06 -24.81 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.236 2.624 . . . . 1.04 114.504 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CD1' HG22 ' A' ' 94' ' ' THR . 47.6 p90 -96.94 2.77 52.01 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.881 0.326 . . . . 1.1799999999999999 111.881 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.691 HG21 ' H ' ' A' ' 95' ' ' GLY . 3.3 t -173.84 -67.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.483 -0.135 . . . . 1.3500000000000001 111.309 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.691 ' H ' HG21 ' A' ' 94' ' ' THR . . . 77.87 89.81 0.35 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.843 -0.694 . . . . 1.1599999999999999 112.065 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 11.0 Cg_exo -37.31 113.26 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.487 2.792 . . . . 1.6899999999999999 111.718 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 t -75.94 9.85 2.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 3.02 111.944 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -130.12 4.37 4.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.122 -0.325 . . . . 4.9199999999999999 110.122 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 22.8 t0 -127.05 0.82 6.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.203 0.525 . . . . 1.6699999999999999 110.916 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 m -87.91 148.27 24.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.045 -0.525 . . . . 1.74 111.084 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.5 tp10 -100.8 169.36 9.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 1.9099999999999999 108.812 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.436 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 33.5 ttt180 -153.8 140.01 18.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.806 0.812 . . . . 0.78000000000000003 110.703 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.825 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 2.5 t80 -104.13 156.87 17.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.278 -1.328 . . . . 1.0700000000000001 108.668 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.752 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 66.9 m -158.8 101.18 1.63 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 120.885 0.374 . . . . 1.03 110.121 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.635 HG12 HG21 ' A' ' 5' ' ' VAL . 9.3 p -104.65 134.7 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 119.793 -0.763 . . . . 1.5 109.73 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 13' ' ' THR . 91.1 m-85 -104.07 113.99 27.93 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 3' ' ' HIS . 17.3 mt -137.7 165.08 27.26 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.835 -0.62 . . . . 2.6499999999999999 109.753 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.748 ' O ' HG23 ' A' ' 16' ' ' VAL . 78.5 tttt -119.76 124.4 46.07 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.47 -0.492 . . . . 2.3500000000000001 110.237 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.436 ' HB1' HG12 ' A' ' 18' ' ' VAL . . . -101.62 127.24 48.44 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.397 0.436 . . . . 1.1499999999999999 110.066 -172.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.604 ' C ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.648 -0.705 . . . . 1.78 109.977 -174.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 1.024 ' HB3' HG21 ' A' ' 22' ' ' VAL . 28.4 t60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.415 -0.587 . . . . 1.1000000000000001 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -144.05 141.14 29.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.24 -0.436 . . . . 2.8500000000000001 110.606 177.567 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.845 HG23 HG11 ' A' ' 105' ' ' VAL . 2.1 t -106.25 134.12 48.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-O 121.166 0.508 . . . . 1.23 111.525 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.5 ' H ' ' ND1' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -113.76 168.47 9.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.136 -0.938 . . . . 1.1000000000000001 110.289 170.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.298 1.592 . . . . 1.47 115.298 -171.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.23 -30.87 60.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.77 0.714 . . . . 1.05 111.757 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.731 ' HB2' HG11 ' A' ' 5' ' ' VAL . 73.9 m80 -66.06 -2.26 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.659 -0.7 . . . . 2.7000000000000002 111.267 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.65 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -49.48 -17.24 0.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.165 -0.68 . . . . 1.48 109.165 171.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.93 50.08 0.68 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.96 -0.563 . . . . 0.29999999999999999 111.787 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.651 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -110.18 158.08 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.198 0.814 . . . . 1.0800000000000001 113.198 -173.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 91.7 m -148.8 107.74 3.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.144 -0.935 . . . . 1.3 109.738 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pp -153.76 168.26 26.89 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 3.4700000000000002 111.668 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.408 HG21 ' N ' ' A' ' 16' ' ' VAL . 55.0 m -101.16 146.62 27.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.423 -0.353 . . . . 2.0800000000000001 110.608 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 108' ' ' LYS . 6.0 m -129.45 160.78 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.105 0.478 . . . . 1.3600000000000001 111.477 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.65 124.12 51.55 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.54 -0.911 . . . . 1.27 108.54 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.64 HG22 ' C ' ' A' ' 110' ' ' ASN . 22.5 m -102.49 -165.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.509 -0.476 . . . . 1.8500000000000001 111.385 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 112.12 -50.38 0.77 Allowed Glycine 0 CA--C 1.504 -0.652 0 N-CA-C 111.041 -0.823 . . . . 0.70999999999999996 111.041 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -75.61 -75.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.795 0.807 . . . . 2.3500000000000001 109.132 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -166.64 140.48 3.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.521 -1.218 . . . . 1.3600000000000001 109.349 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 1.024 HG21 ' HB3' ' A' ' 3' ' ' HIS . 1.7 t -123.57 104.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.586 0.708 . . . . 1.1799999999999999 109.155 172.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.1 pt-20 -109.45 160.19 16.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.795 0.807 . . . . 1.74 111.568 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.614 HD12 ' HB ' ' A' ' 5' ' ' VAL . 22.6 mm -134.68 104.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.072 -1.422 . . . . 1.1000000000000001 108.624 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.612 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -110.04 139.26 45.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.533 0.682 . . . . 0.64000000000000001 111.904 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.84 139.99 26.35 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 114.985 -1.007 . . . . 1.47 108.955 171.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 85.1 Cg_endo -79.06 8.77 3.64 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 122.824 2.349 . . . . 0.34999999999999998 111.893 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.647 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 7.9 t 66.22 -63.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.03 0.831 . . . . 0.91000000000000003 110.291 -173.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 60.81 65.42 2.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.059 -1.089 . . . . 1.3899999999999999 108.059 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.66 112.86 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.875 3.05 . . . . 0.97999999999999998 113.57 -165.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.633 HG23 ' CE2' ' A' ' 89' ' ' TYR . 38.7 p -80.7 -73.98 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.167 -1.378 . . . . 2.0899999999999999 112.176 -174.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 t -171.19 -12.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.473 -0.785 . . . . 2.6800000000000002 110.359 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.44 -33.93 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.39 -0.684 . . . . 1.5800000000000001 111.39 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.556 ' HA ' ' C ' ' A' ' 90' ' ' MET . 45.7 m-85 -52.5 139.72 24.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.559 -0.32 . . . . 2.7200000000000002 111.284 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.629 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -137.72 151.44 48.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 1.1599999999999999 108.661 171.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.647 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.87 109.79 14.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.328 0.585 . . . . 0.42999999999999999 111.415 -174.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.432 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 51.2 m-85 -114.67 177.53 4.61 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 108.395 -0.965 . . . . 3.0299999999999998 108.395 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.741 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -70.02 -73.94 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.01 0.823 . . . . 0.53000000000000003 109.466 169.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.43 -11.86 14.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.709 -0.678 . . . . 2.3900000000000001 110.179 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.31 108.1 2.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.564 -0.827 . . . . 0.72999999999999998 112.099 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.06 -16.92 7.94 Favored Glycine 0 CA--C 1.516 0.145 0 C-N-CA 120.987 -0.625 . . . . 0.85999999999999999 112.648 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 m -128.97 142.09 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.886 -0.413 . . . . 1.53 109.886 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -139.91 141.56 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.522 -0.548 . . . . 3.0600000000000001 109.522 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.45 164.35 28.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.607 0.718 . . . . 2.2999999999999998 112.625 -172.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.841 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 15.9 p -135.23 128.41 18.39 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.315 -0.857 . . . . 2.0 108.996 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.9 150.36 86.49 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.635 2.223 . . . . 1.8899999999999999 112.138 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.426 ' HB2' HG21 ' A' ' 77' ' ' VAL . 94.6 m-20 66.35 42.78 2.88 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.573 0.546 . . . . 2.4300000000000002 110.574 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -88.72 31.15 0.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 3.2599999999999998 111.304 -173.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -88.09 12.11 14.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.392 -0.367 . . . . 2.48 111.266 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.453 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 20.5 ptt? -175.27 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.627 . . . . 1.5600000000000001 110.461 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.751 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.4 m-85 -122.5 162.87 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.121 -0.945 . . . . 0.95999999999999996 109.297 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -159.65 167.88 27.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.342 0.592 . . . . 2.0099999999999998 112.278 -164.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.841 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.5 p -103.09 139.34 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.311 -0.859 . . . . 1.8400000000000001 111.401 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.676 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -112.43 142.93 44.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.194 -0.669 . . . . 2.4500000000000002 109.194 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.16 161.32 16.08 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.959 -0.296 . . . . 2.3900000000000001 111.229 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.758 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -165.14 111.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.881 -0.785 . . . . 1.96 108.881 171.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 5.7 m-85 -111.18 112.83 24.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.173 -0.611 . . . . 1.8700000000000001 111.916 -173.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.219 -0.9 . . . . 2.73 109.417 172.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 111.805 -0.518 . . . . 1.8 111.805 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -156.24 86.96 1.03 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.64 0.733 . . . . 1.3 112.349 -173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 39.9 mt-10 -103.98 103.56 13.41 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.936 -1.135 . . . . 0.81000000000000005 107.936 174.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.758 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 11.0 m-70 -105.03 150.59 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.719 0.771 . . . . 0.65000000000000002 111.863 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.6 m-85 -125.2 104.5 8.54 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.912 -1.494 . . . . 1.4299999999999999 108.679 172.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.676 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 23.3 m170 -102.52 104.27 14.68 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.159 -0.312 . . . . 0.56000000000000005 110.159 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.816 HG11 ' HE2' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -101.9 114.57 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.609 1.195 . . . . 1.49 109.479 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.751 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 27.7 m -101.61 104.72 15.6 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.248 -1.342 . . . . 1.1399999999999999 107.904 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 6.1 p -149.04 148.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 124.206 0.941 . . . . 1.6000000000000001 110.043 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -130.99 102.77 6.18 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.845 0.831 . . . . 2.1600000000000001 108.854 164.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.21 160.94 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.271 -0.877 . . . . 1.1000000000000001 110.063 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.25 95.99 10.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.994 0.426 . . . . 1.1100000000000001 111.151 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.14 165.84 34.95 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.308 -0.717 . . . . 0.33000000000000002 111.308 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -102.44 131.73 48.92 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.062 -0.669 . . . . 1.1499999999999999 109.846 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.816 ' HE2' HG11 ' A' ' 75' ' ' VAL . 2.8 t-80 -104.13 104.46 14.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.728 -0.669 . . . . 0.52000000000000002 110.041 -173.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.89 109.69 21.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.319 -0.993 . . . . 1.1100000000000001 108.319 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.96 104.26 16.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 116.063 -0.517 . . . . 1.26 111.191 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -113.4 103.29 11.14 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.687 0.756 . . . . 1.53 110.121 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 38' ' ' PHE . 90.8 mt -105.89 129.62 54.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.761 -1.109 . . . . 1.0900000000000001 110.137 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.719 HG23 ' HG3' ' A' ' 90' ' ' MET . 5.9 m -101.31 118.93 37.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.588 0.709 . . . . 1.1000000000000001 110.747 -171.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.67 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 1.6 t80 -87.84 83.42 7.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.568 -1.197 . . . . 1.6599999999999999 109.467 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.719 ' HG3' HG23 ' A' ' 88' ' ' THR . 30.2 mtm -117.26 158.32 24.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.858 0.361 . . . . 1.24 111.833 -171.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -70.09 105.94 1.41 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.158 -1.053 . . . . 3.1299999999999999 108.158 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.476 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.7 Cg_endo -50.71 -26.79 18.19 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.49 2.793 . . . . 1.04 114.564 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.2 p90 -92.25 -4.5 53.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.196 0.443 . . . . 1.1799999999999999 112.196 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.633 HG21 ' H ' ' A' ' 95' ' ' GLY . 5.2 t -161.89 -62.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.365 -0.209 . . . . 1.3500000000000001 111.076 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.633 ' H ' HG21 ' A' ' 94' ' ' THR . . . 53.18 66.64 2.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.962 -0.355 . . . . 1.1599999999999999 112.967 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.5 128.7 24.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.671 2.247 . . . . 1.6899999999999999 112.269 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 98' ' ' HIS . 10.8 t -57.79 138.9 55.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.752 -0.658 . . . . 3.02 109.687 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 97' ' ' SER . 56.1 m80 77.96 -8.11 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.805 0.69 . . . . 4.9199999999999999 111.574 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -99.41 -25.66 14.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.83 0.824 . . . . 1.6699999999999999 108.925 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.456 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 6.2 p -81.26 163.33 23.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.72 -1.127 . . . . 1.74 110.9 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.67 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 10.8 tp10 -103.09 172.35 6.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.727 -0.842 . . . . 1.9099999999999999 108.727 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 48.8 ttt180 -156.04 139.9 16.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.797 0.808 . . . . 0.78000000000000003 110.909 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.653 ' CZ ' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.75 156.53 17.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.228 -1.351 . . . . 1.0700000000000001 109.052 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.823 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 93.5 m -160.22 103.5 1.45 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.788 -0.365 . . . . 1.03 111.105 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.845 HG11 HG23 ' A' ' 5' ' ' VAL . 11.1 p -103.72 137.47 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 120.308 -0.557 . . . . 1.5 110.31 170.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.5 m-85 -105.29 107.87 19.08 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.772 . . . . 1.0 109.127 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.704 HD22 ' HE2' ' A' ' 3' ' ' HIS . 2.6 pp -130.69 146.13 52.1 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.443 -0.577 . . . . 2.6499999999999999 109.443 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 16' ' ' VAL . 11.8 tttp -103.76 114.72 29.19 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.583 -0.447 . . . . 2.3500000000000001 110.722 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HB3' HG11 ' A' ' 18' ' ' VAL . . . -100.53 132.2 46.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.306 -0.406 . . . . 1.1499999999999999 110.382 -168.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.64 ' C ' HG22 ' A' ' 18' ' ' VAL . 7.7 p30 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.26 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.921 ' HB3' HG23 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.403 -0.962 . . . . 1.1000000000000001 108.403 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.49 134.55 25.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 2.8500000000000001 111.364 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.953 HG23 HG11 ' A' ' 105' ' ' VAL . 2.0 t -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.227 -0.442 . . . . 1.23 110.786 173.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.47 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -146.85 170.82 16.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.195 0.998 . . . . 1.1000000000000001 108.621 -172.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 23.2 tptp -48.17 -39.53 21.12 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.257 0.836 . . . . 1.47 113.257 -173.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.64 77.55 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.688 0.756 . . . . 1.05 110.856 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.744 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.7 m80 -64.4 -3.9 3.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.203 -0.908 . . . . 2.7000000000000002 111.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.709 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 17.7 t-20 -48.03 -21.44 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.378 0.671 . . . . 1.48 110.548 171.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.06 54.6 0.65 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.22 -0.752 . . . . 0.29999999999999999 111.22 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.05 160.58 20.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.961 0.726 . . . . 1.0800000000000001 112.961 -174.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.4 m -151.76 117.03 5.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.231 -0.895 . . . . 1.3 109.467 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.673 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.6 pp -164.29 168.29 18.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.534 0.207 . . . . 3.4700000000000002 111.367 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.0 m -102.97 145.9 29.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.885 0.374 . . . . 2.0800000000000001 111.077 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -123.5 162.26 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.74 -0.664 . . . . 1.3600000000000001 110.15 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HA ' ' OXT' ' A' ' 110' ' ' ASN . . . -115.16 117.01 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.733 -0.84 . . . . 1.27 108.733 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 22' ' ' VAL . 25.2 m -93.85 178.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.481 . . . . 1.8500000000000001 111.956 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.52 -52.86 0.76 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.70999999999999996 111.556 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -78.06 -72.52 0.36 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.558 -0.534 . . . . 2.3500000000000001 109.558 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -168.07 128.49 1.33 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.753 -0.658 . . . . 1.3600000000000001 110.931 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.921 HG23 ' HB3' ' A' ' 3' ' ' HIS . 1.9 t -104.41 114.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.703 0.763 . . . . 1.1799999999999999 109.725 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.6 145.07 30.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.464 -0.789 . . . . 1.74 111.854 -171.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 5' ' ' VAL . 38.5 mm -128.6 102.98 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.873 -1.158 . . . . 1.1000000000000001 107.873 169.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.523 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -114.91 138.48 50.76 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.304 -0.559 . . . . 0.64000000000000001 111.859 -173.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 26' ' ' LEU . 4.2 mm? -116.42 144.2 32.65 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.517 -0.765 . . . . 1.47 109.178 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 42.6 Cg_endo -85.73 13.26 2.8 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 122.992 2.462 . . . . 0.34999999999999998 111.858 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.537 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 12.2 t 69.34 -65.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.9 0.75 . . . . 0.91000000000000003 111.225 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.408 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.8 m-80 58.95 77.09 0.41 Allowed Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.285 0.634 . . . . 1.3899999999999999 109.832 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -52.91 105.03 0.11 Allowed 'Trans proline' 0 CA--C 1.517 -0.333 0 C-N-CA 123.495 2.797 . . . . 0.97999999999999998 113.741 -166.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.577 HG23 ' CE2' ' A' ' 89' ' ' TYR . 70.2 p -83.4 -53.49 5.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.083 . . . . 2.0899999999999999 109.667 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 t -179.52 -136.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.686 -1.227 . . . . 2.6800000000000002 107.686 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.48 -25.61 65.35 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.078 -0.582 . . . . 1.5800000000000001 113.176 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.6 m-30 -53.3 150.32 6.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.123 0.487 . . . . 2.7200000000000002 112.027 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.01 163.97 36.73 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.226 -0.897 . . . . 1.1599999999999999 109.093 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.537 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -83.6 123.44 29.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.216 0.532 . . . . 0.42999999999999999 111.505 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.834 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -158.32 147.58 19.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.459 -0.791 . . . . 3.0299999999999998 109.296 173.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.6 m-85 -45.31 -68.9 0.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.232 0.456 . . . . 0.53000000000000003 112.232 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.48 ' HG3' ' OG1' ' A' ' 42' ' ' THR . 7.1 pt-20 -130.34 18.84 5.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.082 0.468 . . . . 2.3900000000000001 110.79 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 100.27 91.64 2.08 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.561 -0.828 . . . . 0.72999999999999998 113.128 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 -3.35 80.22 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.804 -0.712 . . . . 0.85999999999999999 112.388 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -128.3 142.76 51.04 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.91 0.386 . . . . 1.53 111.663 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.738 ' H ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -144.22 133.9 23.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.237 -0.892 . . . . 3.0600000000000001 111.097 173.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.71 160.25 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 2.2999999999999998 110.086 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.919 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 31.0 t -125.73 138.54 32.16 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.323 -0.621 . . . . 2.0 109.323 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 32.1 Cg_exo -58.72 129.42 32.19 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.396 2.064 . . . . 1.8899999999999999 111.006 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 92.0 m-20 72.37 42.87 0.52 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.05 0.844 . . . . 2.4300000000000002 110.629 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.73 33.67 0.48 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.859 -0.609 . . . . 3.2599999999999998 111.602 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 m -67.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.264 0.554 . . . . 2.48 110.176 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.659 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -107.36 -33.43 7.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.583 -0.735 . . . . 1.5600000000000001 110.594 -177.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 5.0 m-85 -104.83 165.24 11.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.049 -0.978 . . . . 0.95999999999999996 108.729 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -159.35 170.29 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.066 -0.654 . . . . 2.0099999999999998 112.309 -166.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.919 ' HB ' ' HB2' ' A' ' 45' ' ' SER . 2.5 p -99.86 126.21 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.522 -0.763 . . . . 1.8400000000000001 110.319 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -111.26 125.06 53.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 2.4500000000000002 108.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.77 152.94 21.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.299 0.571 . . . . 2.3900000000000001 111.463 -172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.768 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -164.9 114.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.222 -0.899 . . . . 1.96 109.333 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 m-85 -120.88 156.37 32.15 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.168 -0.613 . . . . 1.8700000000000001 110.127 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.433 -1.308 0 CA-C-N 115.837 -0.62 . . . . 2.73 110.8 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.087 0 N-CA-C 110.829 -0.908 . . . . 1.8 110.829 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.426 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -161.64 84.82 0.62 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.406 0.521 . . . . 1.3 112.406 -172.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.4 mt-10 -104.15 109.44 21.25 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.285 -0.635 . . . . 0.81000000000000005 109.285 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.768 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 2.1 m170 -110.89 148.92 31.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.674 0.749 . . . . 0.65000000000000002 111.899 -171.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.834 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 27.0 m-85 -118.82 109.12 15.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.284 -1.325 . . . . 1.4299999999999999 108.864 171.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -103.53 107.33 18.13 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.893 -0.41 . . . . 0.56000000000000005 109.893 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 2.4 m -103.31 118.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 122.453 1.12 . . . . 1.49 109.19 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 20.8 m -102.75 104.26 14.55 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.807 -1.182 . . . . 1.1399999999999999 107.807 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.54 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -146.59 140.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 1.6000000000000001 110.262 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.522 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.23 102.22 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.821 0.82 . . . . 2.1600000000000001 109.868 171.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.83 167.27 17.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.93 -1.032 . . . . 1.1000000000000001 108.58 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -99.69 89.61 4.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.184 0.516 . . . . 1.1100000000000001 110.506 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.1 168.1 31.86 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.123 -0.791 . . . . 0.33000000000000002 111.123 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.2 m -101.89 134.17 45.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.594 0.697 . . . . 1.1499999999999999 109.609 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.766 ' HD1' HG22 ' A' ' 85' ' ' VAL . 30.1 t-80 -104.4 104.64 14.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.668 -0.696 . . . . 0.52000000000000002 109.684 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.76 109.7 21.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.562 -0.533 . . . . 1.1100000000000001 109.562 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.766 HG22 ' HD1' ' A' ' 83' ' ' HIS . 1.1 t -105.55 104.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.827 -0.624 . . . . 1.26 111.235 -170.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.28 103.51 12.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.084 -0.71 . . . . 1.53 109.084 174.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.61 128.44 52.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.269 -0.641 . . . . 1.0900000000000001 109.269 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.466 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 9.0 m -102.6 137.09 41.28 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.673 0.749 . . . . 1.1000000000000001 110.922 -170.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.577 ' CE2' HG23 ' A' ' 31' ' ' THR . 0.8 OUTLIER -103.78 90.05 3.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.919 -1.037 . . . . 1.6599999999999999 109.6 -175.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 5.0 mtm -132.62 173.46 11.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 110.024 -0.361 . . . . 1.24 110.024 -175.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 -82.07 114.01 47.63 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 3.1299999999999999 109.444 170.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.88 -35.15 39.26 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 123.537 2.825 . . . . 1.04 114.133 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -85.14 2.02 45.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.738 0.273 . . . . 1.1799999999999999 111.738 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -170.88 -74.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.583 -0.28 . . . . 1.3500000000000001 111.24 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.76 ' H ' HG23 ' A' ' 94' ' ' THR . . . 80.83 108.08 0.31 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.431 -1.068 . . . . 1.1599999999999999 110.431 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.808 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 10.3 Cg_exo -73.51 40.82 0.56 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.741 2.961 . . . . 1.6899999999999999 113.558 -172.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.7 t 44.22 -85.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.393 1.077 . . . . 3.02 112.625 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.7 -21.39 66.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.263 -0.426 . . . . 4.9199999999999999 110.748 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.808 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 21.7 t0 -92.62 3.92 54.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.542 0.687 . . . . 1.6699999999999999 110.211 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 7.1 m -95.52 144.92 25.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 1.74 110.626 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.91 178.19 5.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.7 -0.852 . . . . 1.9099999999999999 108.7 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 56.3 ttt180 -161.12 144.51 12.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.78000000000000003 110.625 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.721 ' CZ ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.45 156.29 18.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.709 -1.132 . . . . 1.0700000000000001 109.198 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 99.4 m -157.66 103.47 1.92 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.625 -0.43 . . . . 1.03 111.375 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 5' ' ' VAL . 11.7 p -108.63 136.84 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 119.617 -0.833 . . . . 1.5 109.993 168.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 13' ' ' THR . 97.6 m-85 -106.2 103.34 12.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.732 173.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.673 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.19 150.89 48.01 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.198 -0.667 . . . . 2.6499999999999999 109.198 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.815 ' O ' HG23 ' A' ' 16' ' ' VAL . 48.4 tttm -102.78 119.77 39.43 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.376 -0.601 . . . . 2.3500000000000001 109.376 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -99.94 115.68 30.24 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 123.928 0.768 . . . . 1.1499999999999999 109.725 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.767 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-N 114.718 -1.128 . . . . 1.78 110.569 -171.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.908 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.408 -0.96 . . . . 1.1000000000000001 108.408 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.5 pttt -135.67 151.47 50.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.884 0.373 . . . . 2.8500000000000001 111.021 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.819 HG22 HG11 ' A' ' 105' ' ' VAL . 2.1 t -122.43 155.22 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 1.23 111.046 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.441 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 7.2 p -143.67 170.55 15.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.922 -1.036 . . . . 1.1000000000000001 108.67 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 24.9 tptp -48.28 -38.16 18.12 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.573 0.582 . . . . 1.47 112.573 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.31 79.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.883 0.849 . . . . 1.05 111.073 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.747 ' HB2' HG12 ' A' ' 5' ' ' VAL . 32.9 m80 -63.9 -2.93 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 2.7000000000000002 111.346 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.719 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 15.5 t-20 -49.93 -19.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.257 0.623 . . . . 1.48 110.685 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.87 48.61 0.92 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.296 -0.722 . . . . 0.29999999999999999 111.296 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.729 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -112.54 154.92 25.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.875 0.694 . . . . 1.0800000000000001 112.875 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 41.3 m -147.9 104.38 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.271 -0.877 . . . . 1.3 109.062 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.729 HD13 ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -141.81 167.93 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.141 0.496 . . . . 3.4700000000000002 111.618 -171.254 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 m -101.59 139.03 37.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.599 -0.728 . . . . 2.0800000000000001 109.897 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -127.46 162.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.252 0.549 . . . . 1.3600000000000001 112.137 -175.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.19 120.64 38.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.452 -0.944 . . . . 1.27 108.452 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.805 HG11 ' H ' ' A' ' 19' ' ' GLY . 2.2 t -105.73 -156.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.166 -0.679 . . . . 1.8500000000000001 109.166 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.805 ' H ' HG11 ' A' ' 18' ' ' VAL . . . 108.67 -49.04 0.88 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.667 -0.973 . . . . 0.70999999999999996 110.667 -175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.62 -73.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.086 -0.709 . . . . 2.3500000000000001 109.086 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.8 tp -166.88 145.14 5.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.346 -0.843 . . . . 1.3600000000000001 109.367 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -122.63 111.71 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.568 0.699 . . . . 1.1799999999999999 109.641 171.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.669 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -104.83 139.73 39.16 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.55 0.69 . . . . 1.74 110.918 -173.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.617 HG23 HG12 ' A' ' 85' ' ' VAL . 47.1 mm -117.34 101.48 12.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.932 -1.136 . . . . 1.1000000000000001 107.932 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.61 142.95 34.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.243 0.544 . . . . 0.64000000000000001 111.211 -172.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 3.7 mt -128.44 138.15 32.44 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-O 121.546 0.689 . . . . 1.47 111.079 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.496 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 85.3 Cg_endo -78.78 8.66 3.61 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.035 2.49 . . . . 0.34999999999999998 112.068 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 13.7 t 69.37 -57.81 0.52 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.712 0.632 . . . . 0.91000000000000003 110.165 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.496 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 52.54 63.46 8.79 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.051 -1.092 . . . . 1.3899999999999999 108.051 -172.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 48.3 Cg_exo -44.94 125.67 6.87 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 124.136 3.224 . . . . 0.97999999999999998 114.486 -165.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.1 t -157.6 96.8 1.55 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.605 -1.179 . . . . 2.0899999999999999 110.433 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 m 73.22 176.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.746 -0.661 . . . . 2.6800000000000002 110.102 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 91' ' ' ARG . . . -59.05 -8.71 6.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.539 -0.362 . . . . 1.5800000000000001 113.926 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.635 ' HA ' ' C ' ' A' ' 90' ' ' MET . 6.3 m-85 -55.06 154.68 5.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 2.7200000000000002 111.779 176.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.83 154.21 32.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.489 -0.56 . . . . 1.1599999999999999 109.489 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 97.7 m95 -76.52 111.28 11.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.9 0.381 . . . . 0.42999999999999999 110.944 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.824 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 10.1 p90 -149.25 146.26 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 3.0299999999999998 109.575 170.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.7 m-85 -44.86 -78.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.947 1.092 . . . . 0.53000000000000003 113.947 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -118.22 -10.57 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.3 -0.56 . . . . 2.3900000000000001 111.621 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.773 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 138.87 92.37 0.25 Allowed Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 119.937 -1.125 . . . . 0.72999999999999998 113.039 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.07 15.51 65.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.843 -0.694 . . . . 0.85999999999999999 111.865 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -138.63 144.16 39.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.462 -0.369 . . . . 1.53 111.502 -176.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.28 131.34 26.3 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.55 -0.75 . . . . 3.0600000000000001 111.285 171.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.16 160.49 40.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.715 -0.675 . . . . 2.2999999999999998 110.324 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.616 ' HB2' HG22 ' A' ' 53' ' ' VAL . 13.3 t -104.54 134.89 19.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.48 -0.933 . . . . 2.0 108.48 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.53 41.59 0.26 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.433 2.755 . . . . 1.8899999999999999 113.262 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 45' ' ' SER . 21.2 t-20 177.33 41.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.84 -1.17 . . . . 2.4300000000000002 107.84 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -80.58 45.07 0.75 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.603 -0.726 . . . . 3.2599999999999998 111.714 -173.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -74.9 -41.06 60.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.013 0.435 . . . . 2.48 111.003 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.656 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -134.86 -21.3 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.329 0.585 . . . . 1.5600000000000001 110.668 -177.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.733 ' HB3' ' O ' ' A' ' 76' ' ' THR . 3.7 m-85 -124.24 162.47 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.223 -0.898 . . . . 0.95999999999999996 109.662 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -152.69 170.6 19.86 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.786 0.661 . . . . 2.0099999999999998 112.786 -160.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.672 HG13 HG12 ' A' ' 75' ' ' VAL . 46.5 t -99.84 123.85 52.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.542 -0.753 . . . . 1.8400000000000001 111.175 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.21 117.82 34.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.281 -0.872 . . . . 2.4500000000000002 108.71 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -104.2 150.19 24.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 2.3900000000000001 111.438 -171.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.19 116.0 3.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.945 -0.57 . . . . 1.96 109.837 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.777 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 9.6 m-85 -113.79 136.05 53.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.479 -0.328 . . . . 1.8700000000000001 111.258 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.32 -0.4 . . . . 2.73 109.969 171.845 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 110.987 -0.845 . . . . 1.8 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.407 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.4 OUTLIER -152.74 80.44 1.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.556 0.693 . . . . 1.3 112.58 179.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.777 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.9 mt-10 -105.45 103.59 13.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.458 -0.942 . . . . 0.81000000000000005 108.458 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -108.59 159.19 16.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.814 0.816 . . . . 0.65000000000000002 111.499 -171.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.824 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 28.4 m-85 -122.47 108.54 13.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.909 -1.496 . . . . 1.4299999999999999 109.018 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.669 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 31.9 m170 -102.31 110.74 22.78 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.515 -0.55 . . . . 0.56000000000000005 109.515 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.672 HG12 HG13 ' A' ' 53' ' ' VAL . 3.3 m -102.18 120.06 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.58 1.181 . . . . 1.49 109.219 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 13.9 m -103.09 103.61 13.7 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.318 -1.364 . . . . 1.1399999999999999 107.318 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.1 p -160.4 118.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.396 0.435 . . . . 1.6000000000000001 111.259 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.45 104.0 11.0 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.174 0.988 . . . . 2.1600000000000001 109.869 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.452 ' HB1' ' HE2' ' A' ' 50' ' ' MET . . . -165.65 143.26 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.653 -1.158 . . . . 1.1000000000000001 109.737 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 96.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 1.1100000000000001 111.107 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.32 166.16 38.19 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.33000000000000002 110.175 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -101.62 132.7 47.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.808 0.804 . . . . 1.1499999999999999 109.382 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.661 ' HD1' HG22 ' A' ' 85' ' ' VAL . 44.8 t-80 -103.84 104.95 15.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.494 -0.775 . . . . 0.52000000000000002 109.786 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.23 113.76 27.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.374 0.607 . . . . 1.1100000000000001 109.623 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.96 103.93 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 1.26 111.2 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -105.45 103.71 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.289 -0.634 . . . . 1.53 109.289 173.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.507 ' HG ' HG11 ' A' ' 85' ' ' VAL . 78.0 mt -107.01 123.82 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.51 -0.552 . . . . 1.0900000000000001 109.51 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.488 HG21 ' CG ' ' A' ' 90' ' ' MET . 3.3 m -105.86 119.96 40.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.24 0.543 . . . . 1.1000000000000001 112.002 -169.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 35' ' ' ALA . 28.0 t80 -88.05 85.31 6.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 1.6599999999999999 109.38 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.645 ' HE1' ' HE1' ' A' ' 37' ' ' TYR . 20.7 mtm -124.34 167.13 14.77 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.443 -0.344 . . . . 1.24 110.299 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.454 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.4 ttt180 -78.65 108.67 8.47 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.792 -0.818 . . . . 3.1299999999999999 108.792 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.59 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 5.8 Cg_endo -46.93 -32.24 12.42 Favored 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.546 2.831 . . . . 1.04 115.459 -167.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.59 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.3 p90 -96.92 11.73 34.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.684 0.624 . . . . 1.1799999999999999 112.684 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.3 t -168.63 -50.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 1.3500000000000001 111.87 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 51.48 80.56 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 O-C-N 123.303 0.377 . . . . 1.1599999999999999 112.361 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.845 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 92.4 Cg_exo -40.31 105.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.148 2.565 . . . . 1.6899999999999999 111.218 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.1 m -54.91 125.31 19.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 3.02 111.117 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 77.03 -2.27 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.406 -0.815 . . . . 4.9199999999999999 111.216 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.845 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 26.4 t0 -97.13 -27.34 14.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.941 0.877 . . . . 1.6699999999999999 108.668 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.508 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 12.4 m -68.24 157.08 36.29 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.071 -1.422 . . . . 1.74 110.846 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.1 tp10 -96.51 161.13 14.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.559 -0.904 . . . . 1.9099999999999999 108.559 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 31.5 ttt180 -148.83 139.96 23.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.432 0.634 . . . . 0.78000000000000003 110.315 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.765 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -104.22 155.86 18.38 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 1.0700000000000001 109.208 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 70.5 m -157.15 102.76 1.97 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.73 -0.388 . . . . 1.03 111.161 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.819 HG11 HG22 ' A' ' 5' ' ' VAL . 10.7 p -105.63 136.2 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.639 -0.824 . . . . 1.5 110.014 168.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 13' ' ' THR . 88.4 m-85 -104.71 104.64 14.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.047 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.656 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 pp -123.01 147.68 46.38 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.374 -0.602 . . . . 2.6499999999999999 109.374 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.733 ' O ' HG21 ' A' ' 16' ' ' VAL . 38.5 tttt -103.27 115.3 30.29 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.377 -0.529 . . . . 2.3500000000000001 110.557 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -101.19 153.56 19.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.952 -0.567 . . . . 1.1499999999999999 110.775 -169.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.7 p30 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.242 -0.89 . . . . 1.78 108.891 -178.066 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.934 ' HB3' HG22 ' A' ' 22' ' ' VAL . 6.8 t60 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.222 -0.659 . . . . 1.1000000000000001 109.222 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -141.82 130.05 22.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.283 0.364 . . . . 2.8500000000000001 111.286 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.73 HG13 ' CZ ' ' A' ' 103' ' ' PHE . 2.0 t -104.72 157.7 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.873 0.368 . . . . 1.23 110.462 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -144.81 170.2 16.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.171 0.989 . . . . 1.1000000000000001 108.904 -173.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.523 ' HZ1' ' ND2' ' A' ' 29' ' ' ASN . 16.5 tptm -46.9 -43.85 19.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.031 0.752 . . . . 1.47 113.031 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.2 70.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.941 0.877 . . . . 1.05 110.974 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.699 ' HB2' HG11 ' A' ' 5' ' ' VAL . 24.4 m80 -62.57 -4.02 1.76 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.928 . . . . 2.7000000000000002 111.438 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.675 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.7 t-20 -45.84 -22.29 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 1.48 110.422 172.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.65 54.95 0.73 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.904 -0.665 . . . . 0.29999999999999999 111.726 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . . . -117.38 146.26 43.54 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.157 0.799 . . . . 1.0800000000000001 113.157 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 36.9 m -141.24 111.19 6.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.433 -0.803 . . . . 1.3 109.779 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.0 pp -166.64 171.66 11.41 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.148 0.179 . . . . 3.4700000000000002 110.937 -173.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -99.17 143.65 29.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.106 0.479 . . . . 2.0800000000000001 111.674 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 108' ' ' LYS . 4.0 m -119.08 160.24 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.668 -0.697 . . . . 1.3600000000000001 111.624 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.49 135.99 44.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.213 -0.662 . . . . 1.27 109.213 172.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 77' ' ' VAL . 24.3 m -121.5 -166.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.962 0.411 . . . . 1.8500000000000001 111.773 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 108.95 -56.65 0.46 Allowed Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.29 -0.724 . . . . 0.70999999999999996 111.29 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -75.42 -71.99 0.33 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.955 -0.757 . . . . 2.3500000000000001 108.955 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -166.95 141.3 3.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.593 -0.73 . . . . 1.3600000000000001 110.184 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.4 t -120.57 116.7 50.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.526 -0.546 . . . . 1.1799999999999999 109.526 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.714 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -114.78 149.23 37.28 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.663 -0.815 . . . . 1.74 112.225 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 5' ' ' VAL . 44.3 mm -124.13 102.51 11.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.69 -1.141 . . . . 1.1000000000000001 108.681 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.96 141.82 36.7 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.561 -0.712 . . . . 0.64000000000000001 112.46 -172.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -116.73 147.48 39.99 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.25 -0.886 . . . . 1.47 109.403 171.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.422 ' CD ' ' HB2' ' A' ' 7' ' ' LYS . 43.1 Cg_endo -85.98 11.62 3.27 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.883 2.389 . . . . 0.34999999999999998 111.52 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.6 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 30.4 t 70.84 -51.45 0.68 Allowed 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.399 -0.818 . . . . 0.91000000000000003 111.118 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' ND2' ' HZ1' ' A' ' 7' ' ' LYS . 0.8 OUTLIER 58.4 67.36 2.18 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.008 -0.738 . . . . 1.3899999999999999 109.008 -173.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.18 97.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.439 2.759 . . . . 0.97999999999999998 112.618 -168.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' HH ' ' A' ' 89' ' ' TYR . 1.3 t -105.11 -39.44 6.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 2.0899999999999999 111.353 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -178.21 -150.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.951 -0.759 . . . . 2.6800000000000002 108.951 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.76 -23.36 55.66 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.71 -0.281 . . . . 1.5800000000000001 113.349 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HA ' ' C ' ' A' ' 90' ' ' MET . 14.3 m-30 -46.01 137.19 6.02 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.212 0.529 . . . . 2.7200000000000002 112.123 172.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.533 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -141.96 149.94 40.77 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.34 -0.985 . . . . 1.1599999999999999 108.34 171.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.575 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.2 m95 -77.04 117.81 18.98 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.568 0.699 . . . . 0.42999999999999999 111.141 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 47.0 m-85 -126.03 -179.59 4.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.186 -1.042 . . . . 3.0299999999999998 108.186 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.8 m-85 -73.2 -82.07 0.05 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.818 -0.753 . . . . 0.53000000000000003 109.505 167.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.76 10.09 24.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 2.3900000000000001 110.144 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.26 105.76 2.51 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.835 -0.698 . . . . 0.72999999999999998 112.225 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 3.3 59.98 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.892 -0.671 . . . . 0.85999999999999999 111.966 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -129.98 142.61 50.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.454 -0.373 . . . . 1.53 111.566 -177.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.828 ' HZ1' ' HH ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -142.61 129.15 20.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.938 -0.573 . . . . 3.0600000000000001 110.835 166.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.35 137.41 34.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.726 -0.67 . . . . 2.2999999999999998 110.14 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.837 ' HB2' HG21 ' A' ' 52' ' ' THR . 15.4 m -104.4 138.7 19.59 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 121.24 0.543 . . . . 2.0 110.714 171.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 48' ' ' GLU . 9.8 Cg_endo -93.66 170.05 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.719 3.613 . . . . 1.8899999999999999 113.493 -168.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.564 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 59.7 t30 74.67 -36.27 0.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.991 0.916 . . . . 2.4300000000000002 111.107 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.716 ' OE1' ' HG2' ' A' ' 50' ' ' MET . 4.9 mm-40 -109.99 148.34 31.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.201 1.001 . . . . 3.2599999999999998 113.561 -170.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.4 t -130.01 -11.85 4.21 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.624 -1.626 . . . . 2.48 109.089 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.716 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 19.0 ptt? -97.89 -37.24 9.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.494 -0.483 . . . . 1.5600000000000001 110.652 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.674 ' CE2' HG21 ' A' ' 76' ' ' THR . 0.2 OUTLIER -147.4 97.01 2.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.519 -0.753 . . . . 0.95999999999999996 110.474 -174.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.837 HG21 ' HB2' ' A' ' 45' ' ' SER . 11.0 t 177.78 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.627 0.649 . . . . 2.0099999999999998 111.446 160.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -174.73 142.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.953 0.501 . . . . 1.8400000000000001 111.235 162.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 7.9 tp10 -168.76 154.31 6.42 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.959 -0.756 . . . . 2.4500000000000002 108.959 167.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.7 139.68 25.37 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.171 0.51 . . . . 2.3900000000000001 111.858 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.659 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -163.02 103.87 1.0 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.581 -0.736 . . . . 1.96 110.474 175.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.828 ' HH ' ' HZ1' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -124.81 125.11 43.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 1.8700000000000001 111.495 -177.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.414 -0.812 . . . . 2.73 111.078 -176.084 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.982 0 N-CA-C 111.111 -0.796 . . . . 1.8 111.111 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.25 80.64 0.83 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.436 0.636 . . . . 1.3 111.265 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 40.4 mt-10 -104.44 103.23 12.9 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.457 -0.792 . . . . 0.81000000000000005 109.01 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.659 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -108.26 145.71 33.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.685 -0.806 . . . . 0.65000000000000002 110.973 -174.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 6.5 m-85 -117.47 109.64 17.01 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.619 -1.173 . . . . 1.4299999999999999 109.736 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.714 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -103.54 149.92 24.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.715 -0.476 . . . . 0.56000000000000005 109.715 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.577 HG12 ' HE2' ' A' ' 83' ' ' HIS . 3.5 m -132.95 126.93 54.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.882 0.848 . . . . 1.49 108.902 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.674 HG21 ' CE2' ' A' ' 51' ' ' PHE . 3.7 m -102.39 101.36 11.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 1.1399999999999999 108.452 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.634 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 3.8 p -144.14 145.88 21.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.503 -0.479 . . . . 1.6000000000000001 112.074 -167.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.694 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -138.91 103.48 4.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.55 -0.907 . . . . 2.1600000000000001 108.55 163.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.31 164.92 19.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 1.1000000000000001 109.597 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.58 86.95 2.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 1.1100000000000001 109.998 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -158.05 167.92 34.44 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.42 -0.809 . . . . 0.33000000000000002 111.184 -175.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.1 m -100.23 132.6 45.51 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.817 -0.753 . . . . 1.1499999999999999 109.908 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.85 ' HD1' HG21 ' A' ' 85' ' ' VAL . 48.2 t-80 -103.5 103.82 13.82 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.753 -0.658 . . . . 0.52000000000000002 109.586 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.17 110.97 23.06 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.957 -0.757 . . . . 1.1100000000000001 108.957 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.85 HG21 ' HD1' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -107.44 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.682 -0.69 . . . . 1.26 110.292 -171.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.507 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.22 103.6 12.82 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.917 -0.771 . . . . 1.53 108.917 176.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 38' ' ' PHE . 63.7 mt -107.35 123.99 49.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.641 -0.709 . . . . 1.0900000000000001 109.666 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.499 HG21 ' CG ' ' A' ' 90' ' ' MET . 4.4 m -102.15 119.8 39.4 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.871 0.844 . . . . 1.1000000000000001 110.688 -173.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.764 ' HH ' HG21 ' A' ' 31' ' ' THR . 7.4 t80 -89.3 88.37 7.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.503 -1.226 . . . . 1.6599999999999999 109.676 -175.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.575 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 14.1 mtm -129.22 166.43 19.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.245 0.545 . . . . 1.24 111.051 -172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.432 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.3 mtm180 -70.04 107.39 2.31 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.859 -1.064 . . . . 3.1299999999999999 108.786 168.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.5 Cg_endo -51.63 -27.0 24.38 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.335 2.69 . . . . 1.04 114.655 -169.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.457 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 45.7 p90 -93.46 3.89 54.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.0 0.37 . . . . 1.1799999999999999 112.0 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 95' ' ' GLY . 2.3 t -164.06 -66.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.834 -0.166 . . . . 1.3500000000000001 111.14 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.683 ' H ' HG22 ' A' ' 94' ' ' THR . . . 67.53 94.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.012 -0.435 . . . . 1.1599999999999999 112.012 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.941 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 15.8 Cg_exo -64.92 130.03 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.607 2.205 . . . . 1.6899999999999999 111.11 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.8 t -43.75 -50.32 7.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.955 0.902 . . . . 3.02 113.018 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -121.65 20.79 10.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.522 -0.471 . . . . 4.9199999999999999 111.029 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.941 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.7 t0 -103.99 -22.18 13.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.412 -0.958 . . . . 1.6699999999999999 108.412 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.3 m -80.0 148.22 31.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.614 -1.175 . . . . 1.74 110.561 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.84 172.87 7.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.096 -1.076 . . . . 1.9099999999999999 108.096 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 26.6 ttt180 -158.48 139.01 12.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.407 0.623 . . . . 0.78000000000000003 110.361 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.766 ' CZ ' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -103.76 155.88 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.875 -1.057 . . . . 1.0700000000000001 109.069 -178.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 24.3 m -157.36 104.56 2.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.881 0.372 . . . . 1.03 110.972 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.766 ' HB ' ' CZ ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -103.81 132.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 119.769 -0.772 . . . . 1.5 109.592 168.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.684 ' O ' HD12 ' A' ' 107' ' ' LEU . 73.1 m-85 -108.06 97.42 7.12 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.628 -1.249 . . . . 1.0 107.628 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 106' ' ' TYR . 8.9 mp -134.21 144.78 48.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.288 -0.634 . . . . 2.6499999999999999 109.288 -173.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 16' ' ' VAL . 35.5 ttpt -102.81 130.98 49.98 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.129 -0.628 . . . . 2.3500000000000001 110.946 -166.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.564 ' HB1' HG13 ' A' ' 18' ' ' VAL . . . -100.06 132.37 45.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.1499999999999999 109.566 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.588 ' C ' HG21 ' A' ' 18' ' ' VAL . 6.2 p30 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.386 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.973 ' HB3' HG21 ' A' ' 22' ' ' VAL . 33.3 t60 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.385 -0.598 . . . . 1.1000000000000001 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -138.91 134.15 32.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.266 -0.642 . . . . 2.8500000000000001 109.266 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.93 HG21 HG23 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -107.49 125.81 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 119.5 -0.88 . . . . 1.23 110.685 178.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.78 ' N ' ' HD1' ' A' ' 9' ' ' HIS . 0.7 OUTLIER -120.99 152.09 38.97 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.122 0.416 . . . . 1.1000000000000001 112.122 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 27.0 tptp -31.17 -45.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.252 1.945 . . . . 1.47 116.252 -153.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.61 -34.98 1.57 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.311 1.053 . . . . 1.05 111.731 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.925 ' ND1' HG11 ' A' ' 5' ' ' VAL . 2.4 p-80 -55.19 -9.36 0.4 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.126 -1.397 . . . . 2.7000000000000002 113.159 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -58.14 -15.32 9.24 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 107.633 -1.247 . . . . 1.48 107.633 -174.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.91 58.63 0.69 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.091 -1.413 . . . . 0.29999999999999999 110.169 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 9' ' ' HIS . . . -116.09 151.91 34.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.752 0.649 . . . . 1.0800000000000001 112.752 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 23.6 m -149.43 108.45 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.772 -0.649 . . . . 1.3 109.941 173.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.743 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.1 pt? -150.67 166.85 29.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 3.4700000000000002 111.25 -171.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -103.11 144.63 31.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.638 -0.256 . . . . 2.0800000000000001 110.424 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -128.41 156.27 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 1.3600000000000001 111.493 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.2 137.73 42.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.338 -0.986 . . . . 1.27 108.338 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG11 HG22 ' A' ' 22' ' ' VAL . 29.5 m -115.74 -178.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.664 -0.414 . . . . 1.8500000000000001 111.424 -177.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.4 -60.59 0.66 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.272 -0.731 . . . . 0.70999999999999996 111.272 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.2 -72.08 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.339 0.59 . . . . 2.3500000000000001 109.725 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.4 tp -165.69 133.36 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.984 . . . . 1.3600000000000001 110.45 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.973 HG21 ' HB3' ' A' ' 3' ' ' HIS . 2.2 t -119.95 113.0 39.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.368 -0.604 . . . . 1.1799999999999999 109.368 174.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.2 pt-20 -111.48 157.32 20.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.509 1.147 . . . . 1.74 112.985 -173.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.6 mm -126.62 102.69 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.889 -1.959 . . . . 1.1000000000000001 107.405 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.531 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -114.59 135.17 54.43 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.04 0.924 . . . . 0.64000000000000001 111.91 -173.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.33 145.32 32.63 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.735 -1.12 . . . . 1.47 108.855 174.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 71.4 Cg_endo -82.12 7.08 5.3 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.648 2.232 . . . . 0.34999999999999998 111.345 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.622 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 67.77 -64.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.91000000000000003 109.658 -172.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.71 67.98 1.23 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.285 -1.006 . . . . 1.3899999999999999 108.285 -171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.82 108.83 0.31 Allowed 'Trans proline' 0 CA--C 1.52 -0.177 0 C-N-CA 123.378 2.719 . . . . 0.97999999999999998 112.813 -169.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.87 -37.25 13.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.363 -0.835 . . . . 2.0899999999999999 111.482 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 t -178.22 -44.7 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 111.748 0.277 . . . . 2.6800000000000002 111.748 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.98 -32.97 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 111.436 -0.665 . . . . 1.5800000000000001 111.436 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HE1' ' HD2' ' A' ' 96' ' ' PRO . 31.2 m-85 -43.26 141.49 1.26 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.222 -0.489 . . . . 2.7200000000000002 111.778 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.502 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -140.17 150.22 43.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.847 -1.07 . . . . 1.1599999999999999 108.438 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.622 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.4 m95 -78.83 118.37 20.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.969 0.414 . . . . 0.42999999999999999 111.01 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.798 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -150.37 145.68 26.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 3.0299999999999998 109.789 172.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 1.1 m-85 -46.37 -76.19 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.879 0.696 . . . . 0.53000000000000003 112.879 -172.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.23 -8.84 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 2.3900000000000001 110.936 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.682 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 116.75 86.64 1.24 Allowed Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 119.72 -1.228 . . . . 0.72999999999999998 112.193 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.6 -4.34 74.15 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.149 -0.78 . . . . 0.85999999999999999 111.149 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.39 137.84 52.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.836 -0.431 . . . . 1.53 109.836 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -141.52 139.59 33.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.534 -0.543 . . . . 3.0600000000000001 109.534 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.3 165.37 27.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.23 0.538 . . . . 2.2999999999999998 111.487 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.49 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 2.6 p -114.26 140.05 24.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.603 -0.726 . . . . 2.0 109.247 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.6 Cg_exo -76.16 -5.59 16.42 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 1.8899999999999999 113.128 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.492 HD21 ' HB1' ' A' ' 79' ' ' ALA . 9.4 p-10 -151.17 67.64 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.496 0.665 . . . . 2.4300000000000002 110.663 -177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -109.45 -147.49 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 3.2599999999999998 111.518 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m 71.43 36.14 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.431 0.634 . . . . 2.48 110.894 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptt? 175.94 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.57 -1.195 . . . . 1.5600000000000001 107.879 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 11.6 m-85 -130.13 162.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.336 -1.756 . . . . 0.95999999999999996 106.291 173.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -152.46 166.13 32.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 119.48 1.036 . . . . 2.0099999999999998 112.953 -165.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.3 p -103.01 133.08 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.14 -0.936 . . . . 1.8400000000000001 110.966 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 28.9 tt0 -104.18 153.98 20.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.99 -1.004 . . . . 2.4500000000000002 108.779 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -133.47 122.73 24.09 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.094 -0.503 . . . . 2.3900000000000001 109.966 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.795 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -137.73 113.27 9.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.617 0.722 . . . . 1.96 110.07 176.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.789 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.4 m-85 -106.83 124.04 49.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.333 -0.848 . . . . 1.8700000000000001 110.49 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.456 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 96.7 m-85 . . . . . 0 C--N 1.32 -0.715 0 CA-C-O 121.284 0.564 . . . . 2.73 110.586 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 108.85 -1.7 . . . . 1.8 108.85 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.49 92.62 1.51 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.418 0.896 . . . . 1.3 113.418 -168.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.789 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 36.8 mt-10 -104.44 106.82 17.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.81000000000000005 108.741 174.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.795 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.6 m170 -107.4 152.78 23.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.413 0.625 . . . . 0.65000000000000002 111.825 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.798 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 30.8 m-85 -123.44 108.29 12.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.301 -1.318 . . . . 1.4299999999999999 108.6 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.608 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 21.0 m170 -103.6 107.65 18.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.194 -0.457 . . . . 0.56000000000000005 110.377 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.759 HG12 ' HE2' ' A' ' 83' ' ' HIS . 3.3 m -101.93 113.99 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-O 122.986 1.374 . . . . 1.49 108.463 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 16.9 m -101.52 103.23 14.08 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.723 -1.584 . . . . 1.1399999999999999 106.723 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.57 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.2 p -153.97 146.82 14.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 124.167 0.917 . . . . 1.6000000000000001 111.179 -173.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.59 102.5 6.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.561 0.696 . . . . 2.1600000000000001 109.533 166.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' A' ' 47' ' ' ASN . . . -165.83 140.29 4.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.69 -0.687 . . . . 1.1000000000000001 110.043 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.89 95.89 2.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.383 0.611 . . . . 1.1100000000000001 111.213 -177.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.75 34.03 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.201 -0.909 . . . . 0.33000000000000002 110.993 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.0 m -102.97 134.84 45.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.895 -0.78 . . . . 1.1499999999999999 108.895 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.884 ' HD1' HG22 ' A' ' 85' ' ' VAL . 31.0 t-80 -102.96 105.35 15.67 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.36 -0.607 . . . . 0.52000000000000002 109.36 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.11 106.63 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.808 -0.812 . . . . 1.1100000000000001 108.808 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.884 HG22 ' HD1' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -104.88 110.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 1.26 110.773 -170.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -114.39 104.28 11.89 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.962 0.789 . . . . 1.53 109.164 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.579 ' H ' ' HD1' ' A' ' 103' ' ' PHE . 76.6 mt -105.55 130.48 53.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.166 -0.679 . . . . 1.0900000000000001 109.166 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.525 HG21 ' CG ' ' A' ' 90' ' ' MET . 6.7 m -102.42 122.08 43.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.343 0.592 . . . . 1.1000000000000001 110.354 -172.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.502 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.2 t80 -91.18 85.54 5.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.308 -0.86 . . . . 1.6599999999999999 109.486 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.584 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . 7.9 mtm -128.94 172.35 11.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.177 0.513 . . . . 1.24 110.943 -175.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.501 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 5.4 mtm180 -84.23 109.84 22.19 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.485 -0.779 . . . . 3.1299999999999999 109.477 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 2.0 Cg_endo -41.63 -34.7 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.724 3.616 . . . . 1.04 115.51 -168.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -87.03 3.53 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.504 0.557 . . . . 1.1799999999999999 112.504 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 95' ' ' GLY . 6.2 t -169.22 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.409 -0.182 . . . . 1.3500000000000001 111.401 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.584 ' CA ' ' HB3' ' A' ' 90' ' ' MET . . . 66.12 78.74 0.22 Allowed Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.137 -0.554 . . . . 1.1599999999999999 111.784 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 1.019 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 71.6 Cg_exo -47.82 121.51 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.296 2.664 . . . . 1.6899999999999999 111.958 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -50.08 -39.52 42.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.969 -1.014 . . . . 3.02 113.25 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -112.79 17.53 18.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.32 -0.552 . . . . 4.9199999999999999 110.925 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 1.019 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 25.3 t0 -121.53 -0.29 9.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.737 0.78 . . . . 1.6699999999999999 109.57 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 p -97.9 156.22 16.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.104 -0.953 . . . . 1.74 110.96 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 40.6 tt0 -108.26 175.81 5.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.453 -0.943 . . . . 1.9099999999999999 108.453 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 47.8 ttt180 -158.7 142.81 15.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.685 0.755 . . . . 0.78000000000000003 110.483 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.718 ' CZ ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -104.16 162.81 12.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.428 -1.26 . . . . 1.0700000000000001 109.796 -177.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 38.2 m -164.67 104.82 0.82 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 123.407 0.442 . . . . 1.03 110.39 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.93 HG23 HG21 ' A' ' 5' ' ' VAL . 13.4 p -110.87 136.67 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 119.408 -0.917 . . . . 1.5 109.153 166.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' THR . 98.0 m-85 -103.5 103.44 13.41 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 174.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.743 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -127.26 147.24 50.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.653 -0.499 . . . . 2.6499999999999999 109.653 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.703 ' O ' HG22 ' A' ' 16' ' ' VAL . 20.1 tttm -102.38 117.02 33.82 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.78 -0.368 . . . . 2.3500000000000001 110.346 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.502 ' HB3' HG12 ' A' ' 18' ' ' VAL . . . -100.62 120.4 39.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.614 0.571 . . . . 1.1499999999999999 110.176 -170.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.513 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.516 -0.754 . . . . 1.78 110.422 -174.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.962 ' HB3' HG21 ' A' ' 22' ' ' VAL . 16.1 t60 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.072 -0.714 . . . . 1.1000000000000001 109.072 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' HB2' ' HZ2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -137.73 136.65 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.567 -0.288 . . . . 2.8500000000000001 110.972 -178.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.886 HG22 HG11 ' A' ' 105' ' ' VAL . 2.1 t -112.36 157.5 13.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.856 0.36 . . . . 1.23 111.03 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -151.76 170.64 19.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.421 1.089 . . . . 1.1000000000000001 108.113 -172.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 26.0 tptp -48.33 -37.06 15.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.561 0.949 . . . . 1.47 113.561 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.08 79.2 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.914 0.864 . . . . 1.05 110.742 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.734 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.6 m80 -65.32 -3.7 4.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.134 -0.939 . . . . 2.7000000000000002 111.346 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.703 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 26.0 t-20 -50.27 -18.92 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.679 0.612 . . . . 1.48 110.03 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.45 55.73 0.6 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.29999999999999999 111.285 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.66 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -113.79 156.1 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.041 0.756 . . . . 1.0800000000000001 113.041 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 m -139.39 112.69 8.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.185 -1.042 . . . . 1.3 108.185 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 23.1 tp -151.14 163.24 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 3.4700000000000002 111.74 -167.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.0 m -104.58 148.04 26.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.179 -0.674 . . . . 2.0800000000000001 109.179 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 108' ' ' LYS . 2.8 m -127.55 156.82 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.053 -0.659 . . . . 1.3600000000000001 112.429 -177.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.76 142.4 34.77 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.789 -1.189 . . . . 1.27 107.789 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 22' ' ' VAL . 10.7 m -119.8 -176.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.792 0.329 . . . . 1.8500000000000001 110.724 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.6 -59.52 0.69 Allowed Glycine 0 CA--C 1.505 -0.58 0 N-CA-C 111.224 -0.75 . . . . 0.70999999999999996 111.224 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -73.68 -68.22 0.53 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 2.3500000000000001 108.96 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -167.64 141.33 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.755 -1.111 . . . . 1.3600000000000001 110.283 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.962 HG21 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -113.68 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.494 -0.928 . . . . 1.1799999999999999 108.494 169.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.646 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -108.88 157.35 18.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.056 0.931 . . . . 1.74 112.524 -169.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.6 HD13 ' HB ' ' A' ' 5' ' ' VAL . 29.7 mm -134.28 103.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.579 -1.646 . . . . 1.1000000000000001 108.428 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -112.73 139.0 48.71 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.528 -0.733 . . . . 0.64000000000000001 112.194 -175.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -111.59 148.41 38.8 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.531 -0.759 . . . . 1.47 109.947 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.545 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 40.3 Cg_endo -87.09 11.84 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.229 2.619 . . . . 0.34999999999999998 111.976 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.502 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 21.5 t 69.3 -66.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.343 -0.844 . . . . 0.91000000000000003 110.83 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.23 64.05 2.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.438 -0.949 . . . . 1.3899999999999999 108.438 -170.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.41 117.76 2.5 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.88 3.053 . . . . 0.97999999999999998 113.272 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.482 HG23 ' CZ ' ' A' ' 89' ' ' TYR . 22.3 p -91.64 -89.1 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.212 -0.904 . . . . 2.0899999999999999 112.849 -170.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 t -163.26 22.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.007 0.908 . . . . 2.6800000000000002 110.141 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.26 -35.83 1.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.46 -0.791 . . . . 1.5800000000000001 111.377 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.566 ' HA ' ' C ' ' A' ' 90' ' ' MET . 2.2 m-85 -62.43 143.99 56.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.974 -0.613 . . . . 2.7200000000000002 111.189 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.483 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -139.53 156.04 47.15 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.387 -0.968 . . . . 1.1599999999999999 108.387 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.502 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -81.0 117.27 21.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.518 0.675 . . . . 0.42999999999999999 111.51 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.721 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 56.2 m-85 -127.46 175.78 7.97 Favored 'General case' 0 C--O 1.212 -0.882 0 N-CA-C 108.179 -1.045 . . . . 3.0299999999999998 108.179 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.698 ' HA ' HD21 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -67.2 -74.38 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.773 0.715 . . . . 0.53000000000000003 109.715 171.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -110.51 -8.16 14.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.048 -0.524 . . . . 2.3900000000000001 110.157 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.08 106.59 2.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.366 -0.921 . . . . 0.72999999999999998 112.047 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.25 -23.92 5.86 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.674 . . . . 0.85999999999999999 112.448 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 m -128.33 141.84 51.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.653 0.263 . . . . 1.53 110.41 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -136.97 134.85 37.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.682 -0.69 . . . . 3.0600000000000001 110.048 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -128.54 145.85 51.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.754 0.788 . . . . 2.2999999999999998 112.136 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.871 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 6.2 p -111.43 137.75 21.19 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.584 -0.895 . . . . 2.0 108.584 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 7.5 Cg_exo -74.42 137.16 22.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.434 2.089 . . . . 1.8899999999999999 111.431 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 69.18 34.46 3.0 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.902 0.751 . . . . 2.4300000000000002 110.949 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.04 137.93 34.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.787 0.803 . . . . 3.2599999999999998 110.945 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.7 t 177.56 -55.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.045 -1.434 . . . . 2.48 107.396 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -89.84 -32.41 16.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.015 -0.993 . . . . 1.5600000000000001 109.336 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.781 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.5 m-85 -119.46 160.36 22.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.463 -1.244 . . . . 0.95999999999999996 107.767 176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -165.74 169.44 15.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.651 0.66 . . . . 2.0099999999999998 112.131 -168.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.871 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.2 p -103.1 139.66 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.696 -0.684 . . . . 1.8400000000000001 111.952 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.807 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.38 142.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.893 -0.78 . . . . 2.4500000000000002 108.893 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -122.44 133.4 54.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.384 0.611 . . . . 2.3900000000000001 111.195 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.606 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -150.1 111.0 4.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.268 -0.878 . . . . 1.96 110.495 -176.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.893 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -123.92 127.02 47.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.671 -0.695 . . . . 1.8700000000000001 111.257 -174.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.454 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 93.1 m-85 -126.04 103.71 26.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.3 -0.864 . . . . 2.73 111.003 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -91.52 104.56 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.827 3.018 . . . . 1.9199999999999999 111.758 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 1.061 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 19.8 Cg_exo -72.64 -24.06 18.95 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 124.101 3.201 . . . . 2.6400000000000001 112.83 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.795 ' OD2' ' HD3' ' A' ' 63' ' ' LYS . 8.2 t70 -147.31 -174.55 4.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.735 -0.839 . . . . 5.7999999999999998 108.735 -171.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.6 t -153.9 4.95 0.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.806 0.669 . . . . 7.4299999999999997 112.806 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.795 ' HD3' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -135.97 -12.79 1.93 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.584 -0.446 . . . . 9.0800000000000001 110.845 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 46.6 tp -142.57 -80.55 0.21 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.069 -0.514 . . . . 8.4399999999999995 110.582 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 17.0 tp 169.81 124.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 4.8499999999999996 109.113 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 1.061 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -81.43 52.84 4.6 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 121.088 -0.577 . . . . 3.02 111.768 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.46 -71.37 0.11 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.119 0.568 . . . . 4.54 111.085 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -119.88 73.56 0.32 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.698 -0.763 . . . . 3.3599999999999999 112.578 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -56.48 134.23 51.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.808 -1.317 . . . . 1.8 109.808 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.692 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -153.99 90.18 1.35 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 113.836 1.05 . . . . 1.3 113.836 -168.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.893 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.7 mt-10 -110.31 104.12 12.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.54 -0.754 . . . . 0.81000000000000005 109.083 175.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.692 ' HE2' ' HB ' ' A' ' 70' ' ' THR . 0.1 OUTLIER -113.64 159.4 19.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.777 0.799 . . . . 0.65000000000000002 112.445 -171.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.721 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 44.9 m-85 -132.28 108.91 9.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.933 -1.485 . . . . 1.4299999999999999 109.4 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.807 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 26.0 m170 -108.61 107.46 17.96 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.203 -0.31 . . . . 0.56000000000000005 111.339 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.773 HG11 ' HE2' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -103.75 119.34 52.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.047 0.927 . . . . 1.49 110.419 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.781 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.8 m -102.85 105.75 16.2 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.979 -1.119 . . . . 1.1399999999999999 107.979 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.534 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.3 p -147.45 149.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 123.633 0.583 . . . . 1.6000000000000001 110.335 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -133.91 102.3 5.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.966 0.888 . . . . 2.1600000000000001 109.884 167.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -168.34 127.56 1.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.34 -0.845 . . . . 1.1000000000000001 109.887 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.32 101.42 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 O-C-N 123.648 0.592 . . . . 1.1100000000000001 111.916 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.87 167.57 36.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.349 -0.7 . . . . 0.33000000000000002 111.349 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.565 HG22 ' HD2' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -103.43 128.63 50.53 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.9 -0.765 . . . . 1.1499999999999999 109.883 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.773 ' HE2' HG11 ' A' ' 75' ' ' VAL . 1.8 t-80 -103.38 106.35 16.84 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.526 -0.546 . . . . 0.52000000000000002 109.526 -175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.38 109.34 21.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.497 -0.927 . . . . 1.1100000000000001 108.497 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.36 103.83 15.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.027 -0.533 . . . . 1.26 110.257 -169.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.8 OUTLIER -109.65 103.41 12.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.504 -0.771 . . . . 1.53 109.118 177.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.698 HD21 ' HA ' ' A' ' 38' ' ' PHE . 96.0 mt -104.72 125.56 50.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.763 -0.653 . . . . 1.0900000000000001 109.571 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.685 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.8 m -100.87 122.46 43.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.658 0.742 . . . . 1.1000000000000001 110.762 -169.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.483 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -92.8 87.18 5.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.686 -1.143 . . . . 1.6599999999999999 109.884 -174.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.566 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 1.4 mtm -134.1 165.94 23.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.203 0.525 . . . . 1.24 110.993 -173.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.521 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 77.2 mtt180 -64.86 111.28 5.45 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.971 -1.013 . . . . 3.1299999999999999 109.272 170.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.97 -26.25 24.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.288 2.658 . . . . 1.04 114.405 -171.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.411 ' CD1' HG21 ' A' ' 94' ' ' THR . 42.9 p90 -90.11 -3.22 58.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.002 0.371 . . . . 1.1799999999999999 112.002 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.605 HG23 ' H ' ' A' ' 95' ' ' GLY . 6.8 t -169.25 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.462 -0.149 . . . . 1.3500000000000001 111.369 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.605 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.29 98.13 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 1.1599999999999999 111.838 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.685 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.7 Cg_exo -49.55 126.69 16.67 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.916 2.411 . . . . 1.6899999999999999 111.334 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -54.17 -29.75 46.79 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.503 0.927 . . . . 3.02 113.503 -168.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -129.43 14.78 6.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.147 -0.621 . . . . 4.9199999999999999 111.594 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 16.1 t0 -112.29 -1.82 15.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.857 0.837 . . . . 1.6699999999999999 109.528 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.7 m -95.0 136.98 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.765 -1.107 . . . . 1.74 110.13 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.688 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.9 tt0 -86.86 179.03 6.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 1.9099999999999999 108.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.688 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 46.7 ttt180 -158.09 145.05 17.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.903 0.859 . . . . 0.78000000000000003 110.071 174.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.796 ' CZ ' HG12 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -103.36 150.79 23.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.004 -1.453 . . . . 1.0700000000000001 109.124 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.4 m -153.41 102.78 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.862 -0.335 . . . . 1.03 110.862 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.886 HG11 HG22 ' A' ' 5' ' ' VAL . 12.6 p -104.86 136.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 119.663 -0.815 . . . . 1.5 109.395 167.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -104.4 103.49 13.21 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.271 -0.877 . . . . 1.0 108.703 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.643 HD13 HG12 ' A' ' 16' ' ' VAL . 3.1 pp -126.95 152.51 47.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.218 -0.447 . . . . 2.6499999999999999 109.95 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.746 ' O ' HG23 ' A' ' 16' ' ' VAL . 30.9 tptt -104.91 111.23 23.91 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.681 -0.407 . . . . 2.3500000000000001 110.099 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.448 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -103.47 122.8 45.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 123.409 0.443 . . . . 1.1499999999999999 110.139 -174.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.44 HD22 ' CG ' ' A' ' 108' ' ' LYS . 10.5 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.188 -0.91 . . . . 1.78 110.687 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.976 ' HB3' HG22 ' A' ' 22' ' ' VAL . 42.8 t60 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 1.1000000000000001 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 19.1 ptmt -143.92 142.3 30.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.684 0.278 . . . . 2.8500000000000001 110.83 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.836 HG12 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -107.41 138.97 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 1.23 111.458 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.532 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 0.8 OUTLIER -116.12 168.06 10.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.926 -1.034 . . . . 1.1000000000000001 110.335 171.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.7 tptp -37.5 -45.57 0.74 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.739 1.385 . . . . 1.47 114.739 -172.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.96 62.52 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.61 0.719 . . . . 1.05 111.803 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.713 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.5 m80 -65.95 -1.79 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 2.7000000000000002 111.282 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.721 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 26.2 t-20 -47.38 -17.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.847 0.717 . . . . 1.48 110.089 170.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.93 55.9 0.61 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.7 -0.682 . . . . 0.29999999999999999 111.74 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.704 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -108.53 158.35 17.64 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.582 0.956 . . . . 1.0800000000000001 113.582 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.7 m -147.11 104.98 3.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.018 -0.992 . . . . 1.3 108.856 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 17.9 mt -146.29 167.28 23.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.855 0.687 . . . . 3.4700000000000002 112.855 -170.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.4 m -103.54 136.0 44.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.714 -0.676 . . . . 2.0800000000000001 110.139 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.559 HG12 ' CD2' ' A' ' 3' ' ' HIS . 30.9 m -126.2 154.04 35.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 1.3600000000000001 112.11 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.55 143.17 33.42 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.83 -0.804 . . . . 1.27 108.83 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 110' ' ' ASN . 23.7 m -121.48 -179.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.952 0.406 . . . . 1.8500000000000001 111.747 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.97 -60.61 0.67 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.65 -0.704 . . . . 0.70999999999999996 111.403 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.58 -74.15 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.424 0.63 . . . . 2.3500000000000001 109.994 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.8 tp -165.61 136.03 3.65 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.977 -1.01 . . . . 1.3600000000000001 109.681 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.976 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.4 t -120.17 110.18 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.353 0.597 . . . . 1.1799999999999999 109.663 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 4.4 pt-20 -111.33 159.67 17.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.805 0.812 . . . . 1.74 111.901 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.615 HD13 HG11 ' A' ' 105' ' ' VAL . 29.9 mm -134.26 103.8 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.174 -1.376 . . . . 1.1000000000000001 108.527 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.504 HE21 ' C ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -108.11 141.44 39.81 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.299 0.571 . . . . 0.64000000000000001 111.55 -174.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -117.11 146.75 38.79 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.128 -0.942 . . . . 1.47 108.864 171.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 67.7 Cg_endo -83.98 9.62 4.04 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 122.685 2.257 . . . . 0.34999999999999998 111.804 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.603 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 69.53 -47.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.042 0.839 . . . . 0.91000000000000003 110.667 -174.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 27' ' ' PRO . 0.9 OUTLIER 58.08 63.05 4.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.124 -1.065 . . . . 1.3899999999999999 108.124 -173.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.5 100.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.669 2.913 . . . . 0.97999999999999998 113.501 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.89 -36.67 6.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.091 -0.959 . . . . 2.0899999999999999 111.074 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.512 HG21 ' H ' ' A' ' 34' ' ' PHE . 11.6 t -176.47 -157.44 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.024 -0.732 . . . . 2.6800000000000002 109.024 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.41 -22.99 17.24 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.483 -0.389 . . . . 1.5800000000000001 113.16 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 90' ' ' MET . 15.4 m-30 -40.23 137.93 0.95 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.765 0.654 . . . . 2.7200000000000002 112.765 171.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.26 154.83 41.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.975 -1.011 . . . . 1.1599999999999999 109.021 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.603 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.3 m95 -85.12 124.29 31.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 0.42999999999999999 111.369 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.899 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -157.81 145.07 18.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 3.0299999999999998 109.733 175.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.571 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -48.77 -75.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.333 0.494 . . . . 0.53000000000000003 112.333 -173.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.21 -17.85 18.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.445 0.64 . . . . 2.3900000000000001 110.298 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.755 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 113.6 85.56 1.4 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.299 -0.953 . . . . 0.72999999999999998 111.525 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.29 70.07 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.535 -0.84 . . . . 0.85999999999999999 111.576 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.7 m -129.1 140.36 51.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 1.53 109.648 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -140.63 141.02 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.655 -0.498 . . . . 3.0600000000000001 109.655 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.04 161.66 37.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.171 0.51 . . . . 2.2999999999999998 111.832 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.736 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 20.6 t -115.03 130.88 23.85 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.928 -0.767 . . . . 2.0 108.928 170.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 14.8 Cg_exo -68.91 -4.29 13.12 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.569 2.179 . . . . 1.8899999999999999 112.064 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.19 4.65 10.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.947 -0.569 . . . . 2.4300000000000002 111.416 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.687 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.6 pt-20 -84.08 101.05 11.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.863 0.84 . . . . 3.2599999999999998 111.709 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -127.95 5.71 5.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 2.48 110.558 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -170.04 -36.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.214 1.007 . . . . 1.5600000000000001 108.579 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.823 ' HB3' ' O ' ' A' ' 76' ' ' THR . 4.1 m-85 -104.84 165.33 11.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.581 -1.645 . . . . 0.95999999999999996 107.424 172.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -157.46 172.04 19.28 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.764 0.711 . . . . 2.0099999999999998 112.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.736 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 21.8 t -99.57 134.17 39.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.535 -0.757 . . . . 1.8400000000000001 111.716 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -111.34 125.02 53.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.711 -0.677 . . . . 2.4500000000000002 109.194 170.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -103.9 152.28 22.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 2.3900000000000001 110.905 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.703 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -162.4 111.77 1.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.96 109.81 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.811 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.2 m-85 -111.39 118.73 36.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.446 -0.343 . . . . 1.8700000000000001 110.292 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.06 100.09 38.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.205 0.526 . . . . 2.73 110.658 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 3.5 Cg_exo -83.29 132.02 5.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.688 2.925 . . . . 1.9199999999999999 111.129 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.652 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 72.5 Cg_endo -90.9 -11.85 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.509 2.139 . . . . 2.6400000000000001 112.76 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.525 ' OD2' ' HD3' ' A' ' 63' ' ' LYS . 22.0 t70 -178.07 -57.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 5.7999999999999998 110.927 -173.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m 74.72 15.84 3.17 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.833 -1.076 . . . . 7.4299999999999997 113.633 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' HD3' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -145.25 21.97 1.54 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.954 0.883 . . . . 9.0800000000000001 108.92 166.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 22.8 tp -177.98 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.99 -1.459 . . . . 8.4399999999999995 108.647 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 168.72 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.533 0.733 . . . . 4.8499999999999996 109.174 175.113 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.652 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -88.84 -52.34 2.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.104 -0.57 . . . . 3.02 111.937 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.71 -68.51 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.327 0.584 . . . . 4.54 110.121 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.98 95.28 0.21 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.289 -0.869 . . . . 3.3599999999999999 111.443 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -62.89 139.22 44.73 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.449 -1.06 . . . . 1.8 110.449 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.25 87.82 1.34 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.638 0.732 . . . . 1.3 112.38 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.2 mt-10 -104.55 105.78 16.02 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.022 -0.99 . . . . 0.81000000000000005 108.481 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.703 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 7.5 m-70 -104.98 150.29 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.747 0.784 . . . . 0.65000000000000002 111.805 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.899 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.6 m-85 -122.82 104.89 9.57 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.303 -1.317 . . . . 1.4299999999999999 108.864 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.541 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -102.47 107.15 18.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.963 -0.384 . . . . 0.56000000000000005 109.963 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 22' ' ' VAL . 2.4 m -102.62 116.53 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 122.706 1.241 . . . . 1.49 108.33 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.823 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.7 m -102.64 106.37 17.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.177 -1.416 . . . . 1.1399999999999999 107.177 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.652 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.0 p -154.58 149.81 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 123.692 0.62 . . . . 1.6000000000000001 111.13 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -131.18 103.5 6.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.523 -0.547 . . . . 2.1600000000000001 109.523 167.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.42 127.26 2.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.315 -0.402 . . . . 1.1000000000000001 110.672 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -60.54 100.53 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.787 0.679 . . . . 1.1100000000000001 111.089 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.49 169.58 40.0 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.474 -1.051 . . . . 0.33000000000000002 110.474 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -101.99 132.09 48.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.642 -0.917 . . . . 1.1499999999999999 109.698 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.727 ' HD1' HG23 ' A' ' 85' ' ' VAL . 40.1 t-80 -102.64 104.16 14.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.691 -0.485 . . . . 0.52000000000000002 109.691 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.53 111.99 24.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.417 -0.586 . . . . 1.1100000000000001 109.417 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.727 HG23 ' HD1' ' A' ' 83' ' ' HIS . 2.3 t -105.62 103.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.95 -0.568 . . . . 1.26 110.852 -171.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.15 102.87 11.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.88 -0.785 . . . . 1.53 108.88 176.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 85' ' ' VAL . 96.0 mt -108.09 127.41 53.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.773 -0.649 . . . . 1.0900000000000001 109.96 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.47 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.7 m -102.75 130.59 49.75 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.525 0.679 . . . . 1.1000000000000001 110.968 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.64 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 10.9 t80 -102.6 88.75 3.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.272 -0.877 . . . . 1.6599999999999999 109.633 -175.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.612 ' HE1' ' CE1' ' A' ' 37' ' ' TYR . 15.5 mtm -126.75 177.94 6.24 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.457 -0.571 . . . . 1.24 109.457 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.578 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 7.6 ttm180 -93.17 112.73 57.53 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.533 -0.914 . . . . 3.1299999999999999 108.533 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.558 ' HG2' ' CZ3' ' A' ' 93' ' ' TRP . 1.5 Cg_endo -44.74 -48.3 10.68 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.573 2.848 . . . . 1.04 114.293 -169.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.558 ' CZ3' ' HG2' ' A' ' 92' ' ' PRO . 39.5 p90 -80.34 0.39 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.566 . . . . 1.1799999999999999 112.527 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.799 HG22 ' H ' ' A' ' 95' ' ' GLY . 1.3 t -158.4 -79.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.57 -0.159 . . . . 1.3500000000000001 110.57 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.799 ' H ' HG22 ' A' ' 94' ' ' THR . . . 76.62 82.44 0.53 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 121.066 -0.587 . . . . 1.1599999999999999 112.013 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.753 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 1.5 Cg_endo -42.17 125.35 3.31 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.852 3.035 . . . . 1.6899999999999999 112.09 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.6 m -55.01 -39.35 69.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.921 -1.036 . . . . 3.02 112.969 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.76 1.61 19.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.825 -0.35 . . . . 4.9199999999999999 110.925 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.753 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.2 t0 -100.91 -16.29 17.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.518 0.675 . . . . 1.6699999999999999 109.427 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.3 p -73.79 133.75 43.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.051 -0.977 . . . . 1.74 111.486 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.64 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 8.3 tp10 -86.96 169.64 12.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.596 -0.89 . . . . 1.9099999999999999 108.596 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 22.0 ttt180 -155.82 142.41 18.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.843 0.83 . . . . 0.78000000000000003 110.648 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.836 ' HZ ' HG12 ' A' ' 5' ' ' VAL . 3.1 t80 -104.65 154.87 19.41 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.096 -1.411 . . . . 1.0700000000000001 109.378 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.717 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 52.4 m -158.8 101.95 1.66 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.043 0.449 . . . . 1.03 110.253 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 12' ' ' ALA . 11.0 p -104.87 132.0 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.079 -0.648 . . . . 1.5 109.602 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 13' ' ' THR . 69.5 m-85 -105.17 113.55 27.21 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.697 -0.683 . . . . 1.0 109.386 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.669 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -136.27 158.53 44.19 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.351 -0.611 . . . . 2.6499999999999999 109.351 178.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.472 ' O ' HG22 ' A' ' 16' ' ' VAL . 30.9 tttm -103.99 114.22 28.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.872 -0.418 . . . . 2.3500000000000001 109.872 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.474 ' HB2' HG11 ' A' ' 18' ' ' VAL . . . -101.18 125.42 47.81 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.402 0.438 . . . . 1.1499999999999999 109.851 -171.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.09 -0.957 . . . . 1.78 110.125 -171.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.839 ' HB3' HG23 ' A' ' 22' ' ' VAL . 5.3 t60 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.33 -0.989 . . . . 1.1000000000000001 108.33 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -135.41 134.26 39.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.853 0.359 . . . . 2.8500000000000001 111.402 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.811 HG13 ' HZ ' ' A' ' 103' ' ' PHE . 2.5 t -118.68 127.49 75.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 1.23 111.004 170.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.555 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 0.8 OUTLIER -114.14 169.58 8.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.529 -1.214 . . . . 1.1000000000000001 109.864 169.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 19.4 tptp -35.2 -44.92 0.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.451 1.278 . . . . 1.47 114.451 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.16 -31.63 53.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.546 0.688 . . . . 1.05 112.385 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.749 ' HB2' HG11 ' A' ' 5' ' ' VAL . 74.1 m80 -68.1 -1.46 5.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.735 -0.666 . . . . 2.7000000000000002 111.201 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.713 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.8 t-20 -45.94 -20.92 0.1 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.697 0.623 . . . . 1.48 109.765 168.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.84 58.03 0.62 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.371 -0.831 . . . . 0.29999999999999999 111.256 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.659 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -117.35 151.57 36.72 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.72 0.637 . . . . 1.0800000000000001 112.72 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 35.4 m -146.12 108.84 4.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.404 -0.817 . . . . 1.3 109.332 174.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -161.51 167.46 25.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.727 0.299 . . . . 3.4700000000000002 111.562 -172.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.649 HG21 ' HB3' ' A' ' 108' ' ' LYS . 87.2 m -102.84 144.16 31.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.669 -0.241 . . . . 2.0800000000000001 110.725 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.669 HG21 ' O ' ' A' ' 108' ' ' LYS . 2.9 m -124.96 151.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.058 0.456 . . . . 1.3600000000000001 111.533 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.63 132.3 51.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.346 -0.983 . . . . 1.27 108.346 167.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.481 HG13 HG22 ' A' ' 22' ' ' VAL . 1.4 t -109.96 -141.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.375 -0.53 . . . . 1.8500000000000001 109.895 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' H ' HG11 ' A' ' 18' ' ' VAL . . . 111.38 -50.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.70999999999999996 110.906 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.82 -71.06 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.437 -0.579 . . . . 2.3500000000000001 109.437 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.77 136.84 8.36 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.182 -0.917 . . . . 1.3600000000000001 109.47 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.839 HG23 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -108.64 117.18 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.123 -0.695 . . . . 1.1799999999999999 109.123 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.34 140.3 38.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.397 0.618 . . . . 1.74 112.284 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.595 HD12 ' HB ' ' A' ' 5' ' ' VAL . 40.2 mm -129.21 101.61 6.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.621 -1.172 . . . . 1.1000000000000001 107.907 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -113.89 138.24 50.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.42 0.628 . . . . 0.64000000000000001 111.4 -173.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.73 148.25 39.97 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.523 -0.762 . . . . 1.47 109.315 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 16.1 Cg_endo -88.34 13.3 2.59 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 122.74 2.293 . . . . 0.34999999999999998 110.849 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 1.024 ' HG ' ' HG3' ' A' ' 71' ' ' GLU . 2.4 m 71.23 -49.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.885 -1.052 . . . . 0.91000000000000003 111.92 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.42 63.09 5.96 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.491 -0.929 . . . . 1.3899999999999999 108.491 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.538 ' HG2' ' HG2' ' A' ' 60' ' ' PRO . 72.9 Cg_exo -52.83 104.22 0.1 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 123.728 2.952 . . . . 0.97999999999999998 113.424 -168.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.452 HG23 ' CE2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -100.88 -49.99 3.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.003 -0.999 . . . . 2.0899999999999999 111.044 178.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 34' ' ' PHE . 12.4 t -164.75 -147.88 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.364 -0.606 . . . . 2.6800000000000002 109.364 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.21 -22.64 37.38 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.61 -0.329 . . . . 1.5800000000000001 112.633 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 100' ' ' SER . 4.1 m-30 -35.74 138.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.621 0.971 . . . . 2.7200000000000002 113.621 169.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.476 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -148.19 148.86 31.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.318 -1.31 . . . . 1.1599999999999999 108.568 172.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.586 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.3 m95 -80.08 112.73 17.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.039 0.447 . . . . 0.42999999999999999 110.778 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.705 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 58.1 m-85 -118.99 179.79 4.05 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.477 -0.934 . . . . 3.0299999999999998 108.477 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.628 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -70.24 -78.89 0.07 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.26 -0.576 . . . . 0.53000000000000003 109.659 170.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -106.16 3.91 28.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.16 0.505 . . . . 2.3900000000000001 109.815 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.483 ' HA3' ' HE1' ' A' ' 90' ' ' MET . . . 90.18 112.16 1.49 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.5 -0.773 . . . . 0.72999999999999998 111.458 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 -19.16 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.85999999999999999 112.227 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -128.55 142.18 51.14 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.081 0.467 . . . . 1.53 111.834 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.746 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -142.01 127.8 19.3 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.853 -1.067 . . . . 3.0600000000000001 109.487 168.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.05 155.44 46.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.208 0.528 . . . . 2.2999999999999998 111.423 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.57 ' OG ' ' HB ' ' A' ' 53' ' ' VAL . 11.1 p -115.42 127.59 26.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.764 -0.653 . . . . 2.0 109.644 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 44.9 Cg_exo -58.21 124.97 17.11 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.695 2.263 . . . . 1.8899999999999999 112.249 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 91.7 m-20 77.63 30.04 0.5 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.189 0.931 . . . . 2.4300000000000002 111.981 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' HB3' ' HG ' ' A' ' 45' ' ' SER . 11.9 pt-20 -79.18 48.79 0.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 3.2599999999999998 111.769 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.6 m -85.96 -34.49 20.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.372 -0.376 . . . . 2.48 111.415 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -125.54 -31.35 3.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.793 0.806 . . . . 1.5600000000000001 109.523 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 2.3 m-85 -103.44 167.23 9.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.414 -1.266 . . . . 0.95999999999999996 107.834 176.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -148.4 165.08 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.046 -0.662 . . . . 2.0099999999999998 111.198 -160.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.57 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 4.0 p -109.34 150.9 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.408 0.623 . . . . 1.8400000000000001 111.446 -175.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -124.59 144.67 50.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.264 -0.88 . . . . 2.4500000000000002 109.817 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 8.6 p30 -123.96 133.82 53.62 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.877 -0.601 . . . . 2.3900000000000001 109.556 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -154.53 105.24 2.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.771 -0.649 . . . . 1.96 110.738 -175.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.889 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -120.25 142.9 48.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.532 -0.758 . . . . 1.8700000000000001 110.774 -176.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -122.45 98.86 43.27 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.118 0.485 . . . . 2.73 110.127 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 3.1 Cg_exo -83.2 136.33 7.78 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.891 3.06 . . . . 1.9199999999999999 111.11 170.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.741 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 50.7 Cg_exo -63.64 -167.49 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.263 2.642 . . . . 2.6400000000000001 114.736 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -167.92 -65.17 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.471 -1.695 . . . . 5.7999999999999998 107.738 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.5 p -162.96 -75.51 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 113.678 -1.601 . . . . 7.4299999999999997 109.752 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.672 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -86.51 -12.48 48.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.55 -0.75 . . . . 9.0800000000000001 112.424 -177.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.672 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 66.4 mt -58.46 -56.22 24.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.334 0.588 . . . . 8.4399999999999995 110.524 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.57 ' CD2' ' HA2' ' A' ' 69' ' ' GLY . 1.5 tp -167.45 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.985 -1.007 . . . . 4.8499999999999996 109.172 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.741 ' HA2' ' HB3' ' A' ' 60' ' ' PRO . . . 78.73 -64.42 3.62 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.866 -1.061 . . . . 3.02 114.407 162.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.518 ' O ' ' HD2' ' A' ' 30' ' ' PRO . . . -61.91 -66.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.088 0.471 . . . . 4.54 111.455 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.48 ' O ' HD22 ' A' ' 65' ' ' LEU . . . -132.51 106.22 0.64 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.678 -0.772 . . . . 3.3599999999999999 111.259 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 65' ' ' LEU . . . -66.41 -151.32 0.15 Allowed Glycine 0 C--N 1.331 0.298 0 O-C-N 123.832 0.372 . . . . 1.8 113.708 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.544 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -157.1 86.99 0.97 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.406 0.521 . . . . 1.3 112.406 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 1.024 ' HG3' ' HG ' ' A' ' 28' ' ' SER . 40.9 mt-10 -102.14 106.92 17.85 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.57 . . . . 0.81000000000000005 109.821 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.544 ' HE2' ' HB ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -112.52 152.6 28.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.628 -0.829 . . . . 0.65000000000000002 111.669 -174.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.746 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 39.4 m-85 -115.36 119.02 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.912 -1.495 . . . . 1.4299999999999999 109.08 172.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -113.86 103.72 11.46 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.961 -0.296 . . . . 0.56000000000000005 110.794 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.758 HG12 ' HE2' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -105.2 117.9 51.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.104 0.954 . . . . 1.49 110.127 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 10.5 m -103.65 103.81 13.78 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.77 -1.105 . . . . 1.1399999999999999 108.428 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 10.3 p -151.36 144.61 16.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 123.563 0.54 . . . . 1.6000000000000001 110.341 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -129.29 103.65 7.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.771 0.796 . . . . 2.1600000000000001 109.742 169.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.98 145.06 6.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.141 -0.936 . . . . 1.1000000000000001 109.208 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.33 94.07 2.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.141 0.496 . . . . 1.1100000000000001 111.329 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.89 168.17 31.17 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.33000000000000002 111.041 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.433 ' HA ' ' HD2' ' A' ' 108' ' ' LYS . 3.1 m -101.35 128.59 47.44 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.837 -0.802 . . . . 1.1499999999999999 109.566 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.758 ' HE2' HG12 ' A' ' 75' ' ' VAL . 19.2 t-80 -104.29 103.83 13.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.52000000000000002 109.827 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.75 122.2 42.97 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.325 -0.991 . . . . 1.1100000000000001 108.325 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.68 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -114.86 102.07 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.482 -0.487 . . . . 1.26 110.702 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.7 OUTLIER -108.75 103.37 12.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.323 -0.991 . . . . 1.53 108.323 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.628 HD22 ' HA ' ' A' ' 38' ' ' PHE . 78.5 mt -105.07 124.84 50.22 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.734 -0.666 . . . . 1.0900000000000001 109.698 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 5.6 m -101.74 116.81 33.55 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.958 0.885 . . . . 1.1000000000000001 110.742 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.476 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 2.5 t80 -84.81 96.73 9.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.321 -1.309 . . . . 1.6599999999999999 109.574 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.483 ' HE1' ' HA3' ' A' ' 40' ' ' GLY . 7.2 mtm -137.77 167.29 22.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.833 0.349 . . . . 1.24 110.214 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.4 mtm180 -70.21 103.87 0.7 Allowed Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.659 -0.867 . . . . 3.1299999999999999 108.659 169.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -45.23 -37.88 14.07 Favored 'Trans proline' 0 N--CA 1.477 0.522 0 C-N-CA 123.871 3.047 . . . . 1.04 114.851 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 94' ' ' THR . 43.1 p90 -80.8 -2.14 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 1.1799999999999999 112.457 -175.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.685 HG21 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -162.47 -65.03 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.338 0.113 . . . . 1.3500000000000001 110.844 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.685 ' H ' HG21 ' A' ' 94' ' ' THR . . . 72.44 85.53 0.21 Allowed Glycine 0 CA--C 1.505 -0.533 0 C-N-CA 121.237 -0.506 . . . . 1.1599999999999999 111.935 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.77 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 72.2 Cg_exo -44.09 113.59 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.41 2.74 . . . . 1.6899999999999999 112.246 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.5 m -74.24 53.99 0.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.73 -0.668 . . . . 3.02 111.112 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -175.69 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.083 -0.962 . . . . 4.9199999999999999 109.052 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.77 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 34.0 t70 -106.87 -17.61 14.16 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.609 -0.723 . . . . 1.6699999999999999 109.497 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.601 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 10.0 p -72.96 143.02 47.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.057 -0.974 . . . . 1.74 112.457 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -103.62 171.33 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.193 -1.039 . . . . 1.9099999999999999 108.193 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 45.1 ttt180 -153.56 140.36 19.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.804 0.812 . . . . 0.78000000000000003 110.675 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.811 ' HZ ' HG13 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -102.9 155.3 18.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.209 -1.359 . . . . 1.0700000000000001 108.615 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.68 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.6 m -158.23 102.25 1.76 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.58 -0.448 . . . . 1.03 111.28 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.754 HG11 HG22 ' A' ' 5' ' ' VAL . 12.9 p -104.78 133.79 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.911 -0.716 . . . . 1.5 109.439 166.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 13' ' ' THR . 73.9 m-85 -104.25 104.44 14.35 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.062 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.744 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 1.5 pp -128.28 154.08 46.29 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.707 -0.397 . . . . 2.6499999999999999 110.602 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.669 ' O ' HG21 ' A' ' 16' ' ' VAL . 22.0 tptm -104.5 115.51 30.49 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.1 -0.704 . . . . 2.3500000000000001 109.1 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.13 127.09 49.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.852 0.358 . . . . 1.1499999999999999 110.75 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.19 -0.91 . . . . 1.78 110.553 -177.632 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.963 ' HB3' HG23 ' A' ' 22' ' ' VAL . 35.8 t60 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.462 -0.94 . . . . 1.1000000000000001 108.462 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 17.6 ptpt -146.01 153.35 40.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.801 0.334 . . . . 2.8500000000000001 110.672 172.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.825 HG22 HG12 ' A' ' 105' ' ' VAL . 2.1 t -115.05 135.01 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.158 0.504 . . . . 1.23 111.089 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.582 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -115.92 170.76 8.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 1.1000000000000001 110.003 171.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 24.5 tptp -35.72 -49.26 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.75 1.389 . . . . 1.47 114.75 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.13 63.03 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.387 0.613 . . . . 1.05 112.124 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.739 ' HB2' HG11 ' A' ' 5' ' ' VAL . 69.9 m80 -64.91 -2.95 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.556 . . . . 2.7000000000000002 111.177 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.626 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 21.2 t-20 -44.99 -22.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.214 0 O-C-N 123.694 0.621 . . . . 1.48 110.392 170.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.39 55.1 0.68 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.566 -0.743 . . . . 0.29999999999999999 111.277 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.663 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -119.06 156.59 29.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.238 0.829 . . . . 1.0800000000000001 113.238 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 87.6 m -145.93 111.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.004 -0.998 . . . . 1.3 108.927 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 3.8 pp -152.8 167.31 29.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 3.4700000000000002 111.766 -170.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -103.44 147.21 27.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 2.0800000000000001 110.414 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 108' ' ' LYS . 1.9 m -128.55 162.67 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.128 -0.487 . . . . 1.3600000000000001 110.96 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 110' ' ' ASN . . . -109.0 125.96 52.61 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.252 -1.018 . . . . 1.27 108.252 167.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.621 HG23 ' C ' ' A' ' 110' ' ' ASN . 23.2 m -105.28 -168.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.382 -0.527 . . . . 1.8500000000000001 111.121 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 113.95 -53.09 0.61 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.415 -0.674 . . . . 0.70999999999999996 111.415 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.45 -73.3 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.169 0.509 . . . . 2.3500000000000001 109.813 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 tp -166.12 137.19 3.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 1.3600000000000001 109.588 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.963 HG23 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -117.19 113.97 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.828 0.823 . . . . 1.1799999999999999 109.63 173.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 40.6 mt-10 -102.91 156.99 17.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.115 0.959 . . . . 1.74 112.267 -171.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.619 HD11 ' HB ' ' A' ' 5' ' ' VAL . 40.2 mm -133.66 133.75 56.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.232 -1.766 . . . . 1.1000000000000001 106.232 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.92 135.65 23.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.601 0.715 . . . . 0.64000000000000001 111.564 178.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -109.41 153.41 42.8 Favored Pre-proline 0 N--CA 1.431 -1.375 0 CA-C-N 114.818 -1.083 . . . . 1.47 108.977 174.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.571 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 41.7 Cg_endo -90.81 11.35 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.935 2.423 . . . . 0.34999999999999998 111.457 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.641 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 27.8 t 69.58 -59.6 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 0.91000000000000003 111.198 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.571 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.6 OUTLIER 52.73 56.89 15.06 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.097 -0.705 . . . . 1.3899999999999999 109.097 -173.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 81.6 Cg_exo -49.61 111.1 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.832 3.022 . . . . 0.97999999999999998 113.579 -168.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.584 HG21 ' CE2' ' A' ' 89' ' ' TYR . 6.0 p -87.45 -38.93 15.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 2.0899999999999999 109.417 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t 175.91 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.794 -1.094 . . . . 2.6800000000000002 108.375 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.04 -33.03 67.93 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 118.23 0.468 . . . . 1.5800000000000001 113.589 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 52.7 m-85 -52.09 148.71 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.916 0.389 . . . . 2.7200000000000002 111.897 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.03 161.42 41.95 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.648 -0.705 . . . . 1.1599999999999999 109.764 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.627 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -82.76 120.61 25.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.15 0.5 . . . . 0.42999999999999999 112.012 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.819 ' HE1' ' HE3' ' A' ' 90' ' ' MET . 0.4 OUTLIER -156.15 147.69 22.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.101 -0.703 . . . . 3.0299999999999998 109.101 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -40.93 -68.76 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.61 0.596 . . . . 0.53000000000000003 112.61 -171.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.15 17.69 2.44 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.568 -0.453 . . . . 2.3900000000000001 111.828 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.526 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 125.0 85.88 0.64 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 119.778 -1.201 . . . . 0.72999999999999998 113.075 170.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.82 12.25 10.06 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.843 -0.694 . . . . 0.85999999999999999 112.242 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -135.16 139.26 44.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.469 -0.937 . . . . 1.53 108.469 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.63 142.19 33.42 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.376 0.423 . . . . 3.0600000000000001 110.546 -173.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.56 153.12 47.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.06 0.457 . . . . 2.2999999999999998 111.505 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.827 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 18.0 t -104.77 132.87 20.51 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.8 -0.815 . . . . 2.0 108.8 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HG2' ' H ' ' A' ' 84' ' ' ALA . 9.9 Cg_exo -72.86 25.21 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.304 2.669 . . . . 1.8899999999999999 113.426 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 45' ' ' SER . 60.4 t30 -178.49 48.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.297 0.57 . . . . 2.4300000000000002 109.486 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.827 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 8.8 pt-20 -114.64 122.6 46.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.742 0.782 . . . . 3.2599999999999998 111.147 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -141.99 -39.72 0.37 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.806 -1.088 . . . . 2.48 108.819 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.855 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.77 -35.41 6.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.629 -0.714 . . . . 1.5600000000000001 110.516 176.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.855 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 9.3 m-85 -108.9 164.46 12.38 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.497 -0.927 . . . . 0.95999999999999996 108.497 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -161.84 172.08 16.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.411 0.624 . . . . 2.0099999999999998 112.598 -164.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.698 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 20.3 t -99.73 143.99 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.411 -0.813 . . . . 1.8400000000000001 111.472 -174.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.587 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 7.5 pt-20 -109.33 132.22 54.33 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.644 -0.873 . . . . 2.4500000000000002 108.644 169.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.61 131.87 53.9 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.537 -0.865 . . . . 2.3900000000000001 110.986 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.464 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.78 104.89 2.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.098 -0.955 . . . . 1.96 110.34 -172.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.583 ' CB ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 p90 -131.2 131.59 44.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.448 0.642 . . . . 1.8700000000000001 112.153 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.792 ' HB3' HD21 ' A' ' 64' ' ' LEU . 91.0 m-85 -136.29 102.48 9.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 2.73 110.507 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.92 176.48 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.924 2.416 . . . . 1.9199999999999999 112.312 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.88 170.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.968 3.112 . . . . 2.6400000000000001 116.037 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -171.35 -71.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.576 -1.647 . . . . 5.7999999999999998 108.111 -173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.3 t -174.32 -85.84 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.027 -1.442 . . . . 7.4299999999999997 108.871 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.574 ' HD3' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -81.03 -19.74 43.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.021 -0.536 . . . . 9.0800000000000001 110.828 177.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 58' ' ' PHE . 46.1 tp -55.03 -49.61 71.12 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.818 -0.808 . . . . 8.4399999999999995 108.818 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.75 HD11 ' H ' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -161.86 -66.64 0.05 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.671 -1.15 . . . . 4.8499999999999996 109.403 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.75 -60.84 4.58 Favored Glycine 0 C--N 1.319 -0.367 0 CA-C-N 114.927 -1.033 . . . . 3.02 112.889 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.71 -40.27 59.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.19 0.596 . . . . 4.54 112.337 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.75 ' H ' HD11 ' A' ' 65' ' ' LEU . . . -145.21 -55.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.476 -0.869 . . . . 3.3599999999999999 111.803 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.505 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . 137.76 -175.47 21.25 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.302 -1.119 . . . . 1.8 110.302 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.402 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -155.79 86.01 1.05 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 117.902 0.851 . . . . 1.3 112.571 -175.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.641 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 37.6 mt-10 -104.36 104.37 14.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.81000000000000005 109.716 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -114.12 163.71 14.83 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.22 1.009 . . . . 0.65000000000000002 112.577 -171.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.674 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 42.0 m-85 -140.13 104.08 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.173 -1.831 . . . . 1.4299999999999999 108.769 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.587 ' HB2' ' CG ' ' A' ' 54' ' ' GLU . 55.6 m170 -103.35 123.45 46.83 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.824 -0.548 . . . . 0.56000000000000005 110.034 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.594 HG12 HG12 ' A' ' 53' ' ' VAL . 3.4 m -105.77 123.4 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 122.23 1.014 . . . . 1.49 109.918 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.72 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 8.5 m -102.64 104.78 15.17 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.806 -1.183 . . . . 1.1399999999999999 107.806 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.6 p -150.46 142.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.118 -0.492 . . . . 1.6000000000000001 110.694 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.533 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.55 101.59 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.265 0.555 . . . . 2.1600000000000001 109.713 167.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.433 ' HB2' ' HE2' ' A' ' 50' ' ' MET . . . -167.5 145.78 4.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.406 -0.816 . . . . 1.1000000000000001 109.602 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.24 89.89 2.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 1.1100000000000001 110.81 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.12 166.93 31.69 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 110.717 -0.953 . . . . 0.33000000000000002 110.717 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.5 132.25 48.67 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.692 0.746 . . . . 1.1499999999999999 109.811 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.599 ' HD1' HG21 ' A' ' 85' ' ' VAL . 45.1 t-80 -104.42 106.14 16.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.173 -0.467 . . . . 0.52000000000000002 110.527 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.445 ' H ' ' HG2' ' A' ' 46' ' ' PRO . . . -101.2 115.23 30.02 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.325 -0.62 . . . . 1.1100000000000001 109.325 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.719 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.5 t -106.3 105.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.848 -0.615 . . . . 1.26 111.331 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 7.5 m120 -112.96 102.89 10.86 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.47 -0.567 . . . . 1.53 109.47 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 98.8 mt -107.33 123.4 48.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.674 -0.694 . . . . 1.0900000000000001 109.453 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 5.4 m -103.45 130.73 50.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.4 0.619 . . . . 1.1000000000000001 111.405 -170.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.584 ' CE2' HG21 ' A' ' 31' ' ' THR . 43.7 t80 -95.76 84.91 3.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.399 -0.819 . . . . 1.6599999999999999 109.776 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.819 ' HE3' ' HE1' ' A' ' 37' ' ' TYR . 17.4 mtm -121.53 173.7 7.24 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.905 0.383 . . . . 1.24 109.981 -175.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.551 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 3.2 ttm-85 -86.71 114.06 56.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 108.861 -0.792 . . . . 3.1299999999999999 108.861 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.8 Cg_endo -49.86 -27.33 15.64 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.976 3.118 . . . . 1.04 115.88 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 42.7 p90 -104.03 10.77 35.95 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.945 -0.472 . . . . 1.1799999999999999 111.996 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.585 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.8 t -166.05 -62.0 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.26 -0.176 . . . . 1.3500000000000001 111.034 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.585 ' H ' HG23 ' A' ' 94' ' ' THR . . . 61.86 79.24 0.14 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 112.13 -0.388 . . . . 1.1599999999999999 112.13 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.715 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 50.6 Cg_exo -36.08 128.21 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.839 3.026 . . . . 1.6899999999999999 112.562 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 p -35.01 -64.23 0.28 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 124.663 1.227 . . . . 3.02 114.059 -170.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -124.0 33.8 5.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.333 -0.547 . . . . 4.9199999999999999 110.685 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 29.1 t0 -106.82 -4.66 19.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.98 0.895 . . . . 1.6699999999999999 108.905 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.9 m -89.0 142.41 27.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.346 -1.297 . . . . 1.74 110.252 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.644 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 29.1 tt0 -92.49 179.31 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.01 -0.737 . . . . 1.9099999999999999 109.01 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.644 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 29.7 ttt180 -161.65 142.51 10.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.719 0.771 . . . . 0.78000000000000003 111.408 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.734 ' HZ ' HG13 ' A' ' 5' ' ' VAL . 1.2 t80 -105.22 154.39 20.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.237 -1.347 . . . . 1.0700000000000001 109.341 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 45.1 m -158.45 102.43 1.73 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.871 0.367 . . . . 1.03 110.97 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.825 HG12 HG22 ' A' ' 5' ' ' VAL . 12.6 p -107.21 136.62 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 120.027 -0.669 . . . . 1.5 109.53 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 13' ' ' THR . 78.4 m-85 -104.62 104.08 13.85 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 174.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.611 HD12 HG11 ' A' ' 16' ' ' VAL . 3.3 pp -122.67 145.46 48.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.947 -0.76 . . . . 2.6499999999999999 108.947 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.783 ' O ' HG23 ' A' ' 16' ' ' VAL . 71.7 tttt -103.27 124.52 48.8 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.105 -0.638 . . . . 2.3500000000000001 109.704 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.521 ' HB3' HG11 ' A' ' 18' ' ' VAL . . . -100.98 129.34 46.81 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.456 0.473 . . . . 1.1499999999999999 110.31 -170.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.621 ' C ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.747 0 CA-C-O 118.314 -0.85 . . . . 1.78 109.816 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.948 ' HB3' HG21 ' A' ' 22' ' ' VAL . 23.6 t60 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.001 -0.74 . . . . 1.1000000000000001 109.001 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -138.7 148.17 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.014 0.435 . . . . 2.8500000000000001 110.765 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 9' ' ' HIS . 1.9 t -112.41 138.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 1.23 110.928 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.543 ' H ' ' ND1' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -116.96 169.07 9.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.4 -0.818 . . . . 1.1000000000000001 110.322 170.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.3 tptp -39.72 -43.72 1.44 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.01 1.115 . . . . 1.47 114.01 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.96 -35.45 33.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.645 0.736 . . . . 1.05 111.862 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.746 ' HB2' HG11 ' A' ' 5' ' ' VAL . 76.0 m80 -66.26 -1.96 3.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.496 -0.775 . . . . 2.7000000000000002 111.654 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.711 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.9 t-20 -46.01 -21.54 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.414 0.626 . . . . 1.48 109.586 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.08 57.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.29999999999999999 111.376 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 105' ' ' VAL . . . -117.23 160.53 20.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.257 0.836 . . . . 1.0800000000000001 113.257 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 14.2 m -151.48 114.59 4.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.016 -0.993 . . . . 1.3 109.116 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.6 pt? -158.26 166.73 31.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.172 0.51 . . . . 3.4700000000000002 111.606 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -104.04 141.5 36.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 2.0800000000000001 110.523 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.7 m -126.75 152.1 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.417 -0.356 . . . . 1.3600000000000001 111.196 -175.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.54 118.26 36.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.838 -0.801 . . . . 1.27 108.838 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 22' ' ' VAL . 27.3 m -100.01 -170.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.252 0.548 . . . . 1.8500000000000001 111.584 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.631 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 128.38 -46.02 1.11 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.214 -0.754 . . . . 0.70999999999999996 111.214 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -89.48 -69.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.64 -0.504 . . . . 2.3500000000000001 109.64 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.2 tp -166.46 126.06 1.57 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.59 -0.732 . . . . 1.3600000000000001 111.177 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.948 HG21 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -107.85 114.32 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.819 0.818 . . . . 1.1799999999999999 110.05 174.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.01 153.48 20.2 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.884 0.849 . . . . 1.74 112.1 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.603 HD12 ' HB ' ' A' ' 5' ' ' VAL . 49.1 mm -133.21 102.48 4.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 113.758 -1.564 . . . . 1.1000000000000001 107.467 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -114.16 132.84 55.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.057 0.932 . . . . 0.64000000000000001 111.752 -172.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 3.9 mm? -109.27 154.54 42.09 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.584 -1.189 . . . . 1.47 108.924 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 65.3 Cg_endo -88.99 9.53 3.56 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 122.741 2.294 . . . . 0.34999999999999998 111.394 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.657 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 19.9 t 69.47 -57.21 0.54 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.219 -0.901 . . . . 0.91000000000000003 110.474 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.7 OUTLIER 54.35 62.98 7.91 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.984 -1.117 . . . . 1.3899999999999999 107.984 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.46 112.9 1.14 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.528 2.819 . . . . 0.97999999999999998 113.209 -165.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.561 HG23 ' CE2' ' A' ' 89' ' ' TYR . 8.3 p -92.5 -43.67 9.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.459 -0.791 . . . . 2.0899999999999999 110.086 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.665 HG23 ' HD1' ' A' ' 34' ' ' PHE . 5.1 t 175.79 -136.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.571 -0.9 . . . . 2.6800000000000002 108.571 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.44 -17.13 46.41 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 118.024 0.375 . . . . 1.5800000000000001 113.551 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.665 ' HD1' HG23 ' A' ' 32' ' ' THR . 2.4 m-85 -68.86 142.74 54.73 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.987 0.515 . . . . 2.7200000000000002 110.584 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.485 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -149.13 159.06 44.58 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.27 -0.641 . . . . 1.1599999999999999 109.27 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.575 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 98.2 m95 -73.48 119.32 17.55 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.361 0.601 . . . . 0.42999999999999999 111.474 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.688 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 41.6 m-85 -128.46 -177.09 4.03 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 115.425 -0.807 . . . . 3.0299999999999998 108.862 170.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.562 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.5 m-85 -78.15 -77.71 0.15 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.49 0.586 . . . . 0.53000000000000003 109.93 168.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.25 -0.54 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 2.3900000000000001 110.532 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 108.23 102.87 2.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.748 . . . . 0.72999999999999998 112.28 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.13 2.79 67.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.848 -0.692 . . . . 0.85999999999999999 111.662 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.562 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -132.33 144.56 50.65 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.834 0.453 . . . . 1.53 111.783 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.58 132.2 27.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.444 -0.798 . . . . 3.0600000000000001 110.582 167.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.47 152.57 50.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.023 -0.535 . . . . 2.2999999999999998 110.786 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.593 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 17.3 t -119.76 135.17 24.03 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.033 -0.729 . . . . 2.0 109.033 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 12.2 Cg_exo -70.7 -8.08 22.79 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.802 2.335 . . . . 1.8899999999999999 113.07 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.432 HD22 ' HA3' ' A' ' 81' ' ' GLY . 5.0 m-20 -125.72 26.23 6.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 2.4300000000000002 111.075 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 45' ' ' SER . 15.3 pt-20 -95.23 77.27 3.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.341 1.067 . . . . 3.2599999999999998 111.693 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -95.3 -56.79 2.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.858 -1.064 . . . . 2.48 110.203 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.775 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 18.1 ptt? -108.25 -31.28 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.742 -1.117 . . . . 1.5600000000000001 109.243 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.775 ' HD1' ' HG3' ' A' ' 50' ' ' MET . 12.3 m-85 -103.8 167.97 9.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.743 -1.571 . . . . 0.95999999999999996 108.009 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 14.7 t -158.63 168.75 26.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.709 0.686 . . . . 2.0099999999999998 112.427 -169.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.8 p -101.2 136.77 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.311 -0.859 . . . . 1.8400000000000001 110.988 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -127.99 141.97 51.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.43 -0.804 . . . . 2.4500000000000002 109.619 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -108.21 140.34 41.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 2.3900000000000001 111.739 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.79 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.23 104.24 3.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.103 -0.953 . . . . 1.96 109.39 171.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.6 p90 -124.63 150.26 46.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.563 -0.744 . . . . 1.8700000000000001 110.853 -172.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.1 103.02 26.97 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 121.256 0.551 . . . . 2.73 112.197 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -89.28 120.45 1.03 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 124.427 3.418 . . . . 1.9199999999999999 110.295 165.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.938 ' HG3' ' HA2' ' A' ' 69' ' ' GLY . 2.1 Cg_endo -80.13 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.774 2.983 . . . . 2.6400000000000001 113.177 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -28.93 16.01 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.65 -0.87 . . . . 5.7999999999999998 108.65 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m 65.92 11.69 7.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.598 -1.637 . . . . 7.4299999999999997 111.191 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 -11.82 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 9.0800000000000001 110.629 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.3 tp -151.17 -89.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.489 -0.323 . . . . 8.4399999999999995 111.584 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mt -176.81 111.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.204 0.526 . . . . 4.8499999999999996 111.709 -172.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.861 ' H ' ' HG2' ' A' ' 60' ' ' PRO . . . -81.89 66.86 3.77 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.296 -1.122 . . . . 3.02 110.296 172.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 74.27 -66.3 0.31 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.39 0.7 . . . . 4.54 110.292 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.79 34.37 0.63 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.366 -0.834 . . . . 3.3599999999999999 111.254 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.938 ' HA2' ' HG3' ' A' ' 60' ' ' PRO . . . 47.34 -123.44 8.27 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.978 -0.849 . . . . 1.8 110.978 -175.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.611 HG22 ' NE2' ' A' ' 72' ' ' HIS . 31.8 m 137.14 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.227 1.411 . . . . 1.3 108.733 150.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 39.4 mt-10 -103.51 115.63 30.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.671 -1.149 . . . . 0.81000000000000005 110.167 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.79 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 1.7 m170 -108.53 144.98 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.678 0.751 . . . . 0.65000000000000002 111.775 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.688 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 14.2 m-85 -116.77 112.38 21.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.513 -1.221 . . . . 1.4299999999999999 109.058 170.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -104.45 113.99 27.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.059 -0.519 . . . . 0.56000000000000005 110.764 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.3 m -104.54 118.53 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 122.252 1.025 . . . . 1.49 108.501 171.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.743 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.1 m -102.26 103.74 14.24 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.48 -1.304 . . . . 1.1399999999999999 107.48 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.615 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 4.7 p -155.94 142.01 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 123.651 0.594 . . . . 1.6000000000000001 111.158 -173.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.917 ' HZ3' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -127.14 101.78 6.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.057 -0.72 . . . . 2.1600000000000001 109.057 165.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.62 138.19 4.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 1.1000000000000001 109.92 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.65 99.48 3.11 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.746 0.654 . . . . 1.1100000000000001 111.854 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA3' HD22 ' A' ' 47' ' ' ASN . . . -165.71 166.46 38.55 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.429 -1.068 . . . . 0.33000000000000002 110.429 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 5.5 m -100.83 130.78 46.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.138 0.969 . . . . 1.1499999999999999 109.957 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.691 ' HD1' HG21 ' A' ' 85' ' ' VAL . 36.5 t-80 -102.97 105.47 15.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.211 -0.904 . . . . 0.52000000000000002 109.854 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.52 24.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.121 -0.696 . . . . 1.1100000000000001 109.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.72 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.45 103.08 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.604 -0.726 . . . . 1.26 110.928 -170.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -109.12 103.26 12.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.148 -0.686 . . . . 1.53 109.148 176.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.503 HD22 ' HA ' ' A' ' 38' ' ' PHE . 88.1 mt -105.78 126.04 51.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.691 -0.686 . . . . 1.0900000000000001 110.507 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.665 HG23 ' HG3' ' A' ' 90' ' ' MET . 6.0 m -102.55 121.2 41.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.339 0.59 . . . . 1.1000000000000001 110.98 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.621 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 54.1 t80 -86.52 97.79 10.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 1.6599999999999999 109.284 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.665 ' HG3' HG23 ' A' ' 88' ' ' THR . 27.6 mtm -134.39 159.48 40.92 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.275 -0.42 . . . . 1.24 111.83 -172.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.459 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 48.3 mtt180 -64.2 105.55 0.73 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 108.227 -1.027 . . . . 3.1299999999999999 108.227 163.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -46.63 -32.16 11.34 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.633 2.888 . . . . 1.04 114.765 -167.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 37.7 p90 -88.12 -2.82 58.84 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.133 0.42 . . . . 1.1799999999999999 112.133 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.673 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -162.23 -68.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.493 -0.129 . . . . 1.3500000000000001 111.338 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.673 ' H ' HG23 ' A' ' 94' ' ' THR . . . 73.41 78.38 0.56 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.789 -0.719 . . . . 1.1599999999999999 111.533 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 13.0 Cg_exo -32.84 114.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.103 3.202 . . . . 1.6899999999999999 113.066 172.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 p -41.27 -55.66 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.801 -1.091 . . . . 3.02 113.361 -171.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -100.11 20.07 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.626 -0.43 . . . . 4.9199999999999999 111.636 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 14.0 t0 -124.34 6.17 8.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 1.6699999999999999 110.308 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 32.8 m -98.61 147.86 24.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.454 -0.794 . . . . 1.74 111.149 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 4.7 tp10 -100.52 166.69 10.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.067 -0.716 . . . . 1.9099999999999999 109.067 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 101' ' ' GLU . 46.8 ttt180 -153.51 140.14 18.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.77 0.795 . . . . 0.78000000000000003 111.232 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.74 ' CZ ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -104.4 157.4 17.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.116 -1.402 . . . . 1.0700000000000001 109.07 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 53.5 m -159.55 102.4 1.54 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.839 0.352 . . . . 1.03 110.977 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.733 HG13 HG22 ' A' ' 5' ' ' VAL . 14.6 p -105.55 138.91 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.033 -0.667 . . . . 1.5 110.1 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.4 m-85 -104.52 104.2 14.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.458 -0.792 . . . . 1.0 109.034 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.9 pp -126.0 148.53 49.26 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.213 -0.662 . . . . 2.6499999999999999 109.213 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.704 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.4 ttmm -104.59 122.71 46.16 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.198 -0.601 . . . . 2.3500000000000001 110.165 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.515 ' HB1' HG12 ' A' ' 18' ' ' VAL . . . -101.74 128.9 47.87 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.414 0.446 . . . . 1.1499999999999999 110.134 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.6 ' C ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.52 -0.752 . . . . 1.78 110.34 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.942 ' HB3' HG23 ' A' ' 22' ' ' VAL . 26.8 t60 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 108.932 -0.766 . . . . 1.1000000000000001 108.932 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -132.28 144.65 50.74 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.938 -0.305 . . . . 2.8500000000000001 110.254 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.747 HG22 HG13 ' A' ' 105' ' ' VAL . 2.3 t -112.64 133.48 58.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 1.23 111.134 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.487 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 2.0 p -117.46 170.29 8.85 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.974 -1.012 . . . . 1.1000000000000001 109.462 170.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.727 ' HD3' HD22 ' A' ' 29' ' ' ASN . 8.6 tptm -34.82 -49.04 0.42 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.973 1.471 . . . . 1.47 114.973 -170.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.06 63.81 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.326 0.584 . . . . 1.05 112.537 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.733 ' HB2' HG12 ' A' ' 5' ' ' VAL . 75.3 m80 -64.49 -2.86 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 2.7000000000000002 110.903 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.621 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 21.7 t-20 -45.53 -19.63 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.975 0.797 . . . . 1.48 110.484 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.32 59.27 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.97 -0.852 . . . . 0.29999999999999999 110.97 175.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.67 ' HB1' HG23 ' A' ' 105' ' ' VAL . . . -120.35 148.21 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.903 0.705 . . . . 1.0800000000000001 112.903 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 85.5 m -134.73 119.08 17.8 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.42 -0.809 . . . . 1.3 109.163 168.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pt? -159.69 166.27 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 3.4700000000000002 111.036 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.0 m -103.29 148.1 26.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.255 -0.43 . . . . 2.0800000000000001 110.437 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.3 m -126.41 155.41 36.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 1.3600000000000001 111.441 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.52 111.49 22.54 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.945 -0.761 . . . . 1.27 108.945 171.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.798 HG21 ' HA ' ' A' ' 78' ' ' LYS . 12.9 m -89.84 -167.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.946 0.403 . . . . 1.8500000000000001 111.078 -173.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.0 -54.49 0.73 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.238 -0.745 . . . . 0.70999999999999996 111.238 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.2 -63.2 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.722 -0.844 . . . . 2.3500000000000001 108.722 171.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 22' ' ' VAL . 54.9 tp -165.5 163.61 19.52 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.495 -1.229 . . . . 1.3600000000000001 109.944 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.942 HG23 ' HB3' ' A' ' 3' ' ' HIS . 1.3 t -140.46 106.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.449 -0.945 . . . . 1.1799999999999999 108.449 164.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.0 pt-20 -112.25 158.36 19.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 122.222 1.011 . . . . 1.74 112.579 -172.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.591 HD12 HG13 ' A' ' 105' ' ' VAL . 46.0 mm -132.9 103.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.451 -1.704 . . . . 1.1000000000000001 108.5 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -113.27 133.5 55.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.819 0.819 . . . . 0.64000000000000001 111.535 -176.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -108.88 144.27 29.29 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.062 -0.972 . . . . 1.47 108.997 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.495 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 67.4 Cg_endo -81.09 10.1 3.55 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 122.499 2.132 . . . . 0.34999999999999998 111.264 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.692 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 19.4 t 69.37 -61.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.997 -1.001 . . . . 0.91000000000000003 111.191 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.727 HD22 ' HD3' ' A' ' 7' ' ' LYS . 1.7 m-80 56.6 62.01 6.64 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.942 -0.762 . . . . 1.3899999999999999 108.942 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 74.8 Cg_exo -52.12 103.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.369 2.712 . . . . 0.97999999999999998 113.105 -168.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.501 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.5 p -83.15 -37.27 23.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.347 -0.842 . . . . 2.0899999999999999 110.027 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.438 HG23 ' CD1' ' A' ' 34' ' ' PHE . 7.7 t 179.11 -144.53 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.402 -0.962 . . . . 2.6800000000000002 108.402 -177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.74 -11.33 29.41 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 118.093 0.406 . . . . 1.5800000000000001 113.242 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.716 ' CD2' ' HA ' ' A' ' 90' ' ' MET . 1.4 m-85 -71.78 151.71 43.29 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.003 0.521 . . . . 2.7200000000000002 111.469 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -152.15 161.67 42.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.801 -0.636 . . . . 1.1599999999999999 109.663 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.692 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -79.53 117.18 20.24 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.402 0.62 . . . . 0.42999999999999999 111.437 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 70.7 m-85 -125.17 -178.41 4.19 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 108.083 -1.08 . . . . 3.0299999999999998 108.083 168.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.642 ' HA ' HD21 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.85 -80.36 0.06 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.029 -0.669 . . . . 0.53000000000000003 109.556 169.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -104.08 -0.31 28.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.246 0.546 . . . . 2.3900000000000001 110.168 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.555 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 102.22 104.73 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.72999999999999998 111.826 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.88 -0.69 71.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.742 -0.742 . . . . 0.85999999999999999 111.955 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -129.71 141.56 50.87 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.843 0.354 . . . . 1.53 111.493 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.592 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.12 129.54 17.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.375 -0.83 . . . . 3.0600000000000001 110.334 167.074 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.09 153.79 51.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.082 0.467 . . . . 2.2999999999999998 111.257 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 18.1 t -104.71 129.2 25.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 2.0 108.712 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 10.9 Cg_endo -96.22 161.54 1.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.205 3.27 . . . . 1.8899999999999999 112.573 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 70.92 8.5 6.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.264 -0.88 . . . . 2.4300000000000002 111.176 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.621 ' HG2' ' HB2' ' A' ' 51' ' ' PHE . 5.5 tp10 -158.27 134.04 9.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.514 0.673 . . . . 3.2599999999999998 112.091 -171.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 p -130.09 28.36 5.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.799 -1.091 . . . . 2.48 109.521 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.529 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 21.5 ptt? -138.0 -40.96 0.53 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.486 -0.931 . . . . 1.5600000000000001 108.486 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.826 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.6 m-85 -103.05 149.75 24.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.72 -1.585 . . . . 0.95999999999999996 106.72 165.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 171.61 18.93 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.834 -0.746 . . . . 2.0099999999999998 111.536 -161.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.596 ' HB ' HG13 ' A' ' 75' ' ' VAL . 6.1 p -100.34 139.98 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.404 0.621 . . . . 1.8400000000000001 112.248 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 11.2 pt-20 -109.34 152.28 25.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.571 -0.9 . . . . 2.4500000000000002 108.571 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.464 ' ND2' ' HZ1' ' A' ' 43' ' ' LYS . 7.4 p30 -128.2 140.06 52.12 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.75 -0.38 . . . . 2.3900000000000001 111.289 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.852 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.34 114.5 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.332 0.587 . . . . 1.96 110.273 173.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 8.2 m-85 -109.7 105.11 14.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.796 -0.638 . . . . 1.8700000000000001 110.057 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.61 104.54 54.32 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.988 -0.551 . . . . 2.73 111.297 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -62.02 172.55 3.88 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.297 2.665 . . . . 1.9199999999999999 112.205 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.518 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 34.0 Cg_exo -62.89 -163.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.985 2.457 . . . . 2.6400000000000001 115.181 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 62' ' ' SER . 18.1 t70 170.64 -138.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.642 -1.984 . . . . 5.7999999999999998 105.642 -171.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.413 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 3.9 p -106.59 -61.07 1.58 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.966 0.412 . . . . 7.4299999999999997 109.916 170.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.623 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -92.43 -18.33 23.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 9.0800000000000001 111.64 -178.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.623 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 1.3 tm? -61.48 -51.61 67.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.951 -0.759 . . . . 8.4399999999999995 108.951 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.749 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.6 OUTLIER -160.73 -58.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.387 -0.824 . . . . 4.8499999999999996 108.903 173.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.03 -61.27 4.52 Favored Glycine 0 C--N 1.317 -0.497 0 CA-C-N 114.761 -1.108 . . . . 3.02 112.767 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.39 -55.91 28.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 4.54 111.961 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.749 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -133.91 -53.83 0.07 OUTLIER Glycine 0 C--O 1.221 -0.702 0 C-N-CA 120.569 -0.824 . . . . 3.3599999999999999 112.796 -177.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . 135.58 -165.74 24.7 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.349 -0.929 . . . . 1.8 111.065 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -156.89 92.44 1.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.711 0.634 . . . . 1.3 112.711 -174.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.7 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 37.1 mt-10 -104.09 109.11 20.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.572 -0.899 . . . . 0.81000000000000005 108.572 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.852 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.7 m170 -108.19 145.97 33.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.551 0.691 . . . . 0.65000000000000002 112.056 -170.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.604 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.5 m-85 -121.24 104.54 9.81 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.057 -1.429 . . . . 1.4299999999999999 108.596 170.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.623 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 19.6 m170 -104.24 107.87 18.99 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 122.234 -0.291 . . . . 0.56000000000000005 110.284 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.596 HG13 ' HB ' ' A' ' 53' ' ' VAL . 3.8 m -101.56 118.87 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 122.349 1.071 . . . . 1.49 108.294 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.826 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.6 m -101.74 103.98 14.76 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.702 -1.592 . . . . 1.1399999999999999 106.702 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.648 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -151.26 147.41 15.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.133 0.896 . . . . 1.6000000000000001 110.874 -170.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.798 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.61 102.07 4.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.217 0.532 . . . . 2.1600000000000001 109.988 170.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -163.23 137.1 5.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 1.1000000000000001 110.137 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.44 77.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.264 0.554 . . . . 1.1100000000000001 111.651 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.47 166.76 29.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.798 -0.921 . . . . 0.33000000000000002 110.798 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -99.98 133.08 44.87 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.519 -0.872 . . . . 1.1499999999999999 109.047 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.648 ' HB3' ' HG ' ' A' ' 107' ' ' LEU . 12.5 t-80 -103.45 103.64 13.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.184 -0.673 . . . . 0.52000000000000002 109.184 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.33 109.11 20.68 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.877 -0.786 . . . . 1.1100000000000001 108.877 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.39 106.87 21.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.166 -0.47 . . . . 1.26 111.146 -170.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 5.0 m-80 -109.42 103.8 12.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.498 -0.774 . . . . 1.53 109.232 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 38' ' ' PHE . 84.9 mt -105.23 123.6 48.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.461 -0.791 . . . . 1.0900000000000001 109.744 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.442 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.4 m -102.5 120.09 39.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 1.1000000000000001 110.933 -172.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.868 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 50.1 t80 -88.23 98.22 11.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 1.6599999999999999 109.732 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.716 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 10.2 mtm -136.3 163.98 29.15 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 110.277 -0.268 . . . . 1.24 110.277 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.453 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 12.8 ttt180 -65.41 110.59 4.56 Favored Pre-proline 0 C--O 1.221 -0.405 0 N-CA-C 107.673 -1.232 . . . . 3.1299999999999999 107.673 168.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.549 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 1.7 Cg_endo -43.98 -33.96 5.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.231 3.288 . . . . 1.04 115.42 -169.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.549 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 48.9 p90 -102.24 8.03 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.859 0.689 . . . . 1.1799999999999999 112.859 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.497 HG23 ' N ' ' A' ' 95' ' ' GLY . 12.8 t -167.8 -55.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.789 -0.364 . . . . 1.3500000000000001 111.602 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 58.1 78.75 0.12 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-O 119.703 -0.498 . . . . 1.1599999999999999 113.377 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HB2' ' HZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -29.08 115.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.236 3.291 . . . . 1.6899999999999999 113.439 170.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 m -73.42 67.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.301 -0.863 . . . . 3.02 111.261 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 t60 176.35 -30.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.18 -0.918 . . . . 4.9199999999999999 109.078 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.486 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -91.81 -7.18 50.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.6699999999999999 110.018 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -68.3 122.3 18.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.008 -0.996 . . . . 1.74 112.404 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.868 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.6 tp10 -91.05 165.33 13.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.023 -1.103 . . . . 1.9099999999999999 108.023 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 39.2 ttt180 -159.2 136.98 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.711 0.767 . . . . 0.78000000000000003 111.094 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.717 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -104.3 154.37 19.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.438 -1.256 . . . . 1.0700000000000001 109.162 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.7 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.1 m -154.87 103.25 2.41 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.866 -0.333 . . . . 1.03 110.783 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.747 HG13 HG22 ' A' ' 5' ' ' VAL . 10.6 p -104.96 136.12 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 119.676 -0.81 . . . . 1.5 109.682 168.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 13' ' ' THR . 74.4 m-85 -103.9 104.15 14.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.467 -0.938 . . . . 1.0 108.467 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.4 pp -122.68 146.17 47.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.269 -0.641 . . . . 2.6499999999999999 109.269 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.769 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.7 ttmm -103.48 116.71 32.91 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.559 -0.456 . . . . 2.3500000000000001 111.0 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.65 151.3 21.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.896 -0.779 . . . . 1.1499999999999999 108.896 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.574 ' O ' HG23 ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.804 -0.617 . . . . 1.78 111.631 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.995 ' HB3' HG21 ' A' ' 22' ' ' VAL . 43.8 t60 . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.23 -0.656 . . . . 1.1000000000000001 109.23 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -142.65 130.84 22.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.283 -0.417 . . . . 2.8500000000000001 110.499 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.781 HG13 ' CZ ' ' A' ' 103' ' ' PHE . 2.3 t -106.58 137.05 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.399 -0.52 . . . . 1.23 111.702 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.508 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 2.6 p -119.01 168.75 10.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 1.1000000000000001 109.412 170.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -40.11 -39.46 0.9 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.47 1.285 . . . . 1.47 114.47 -170.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.81 -36.45 62.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.558 0.694 . . . . 1.05 111.83 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.721 ' HB2' HG11 ' A' ' 5' ' ' VAL . 77.6 m80 -65.66 -1.59 2.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.649 -0.705 . . . . 2.7000000000000002 111.41 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.739 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.9 t-20 -46.01 -19.36 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.316 0.646 . . . . 1.48 110.161 169.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -142.12 55.33 0.59 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.427 -0.669 . . . . 0.29999999999999999 111.427 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.667 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -112.45 160.22 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.97 0.73 . . . . 1.0800000000000001 112.97 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 34.1 m -152.25 110.37 3.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.158 -0.928 . . . . 1.3 109.336 173.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.697 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.5 pt? -158.13 166.58 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 3.4700000000000002 111.195 -172.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 108' ' ' LYS . 94.5 m -104.2 148.61 26.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.945 0.403 . . . . 2.0800000000000001 110.715 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.792 HG21 ' O ' ' A' ' 108' ' ' LYS . 2.2 m -125.53 157.65 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.042 -0.526 . . . . 1.3600000000000001 110.035 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.34 104.2 12.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.65 -0.5 . . . . 1.27 109.65 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.506 HG13 HG22 ' A' ' 22' ' ' VAL . 33.2 m -84.09 175.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.234 0.54 . . . . 1.8500000000000001 112.072 -172.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.77 -32.15 3.38 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 111.211 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.74 -76.22 0.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.664 -0.495 . . . . 2.3500000000000001 109.664 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.2 tp -166.05 123.39 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.462 -0.79 . . . . 1.3600000000000001 110.66 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -107.78 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.598 0.713 . . . . 1.1799999999999999 109.645 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.557 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -113.0 159.25 19.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.869 0.842 . . . . 1.74 112.44 -172.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.696 HD12 HG11 ' A' ' 105' ' ' VAL . 47.2 mm -134.43 102.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.111 -1.404 . . . . 1.1000000000000001 108.722 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.664 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -106.03 141.57 37.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.368 0.604 . . . . 0.64000000000000001 111.334 -175.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 3.1 mt -125.93 142.65 42.94 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.562 -0.744 . . . . 1.47 110.284 172.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.463 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 43.3 Cg_endo -84.2 16.29 1.96 Allowed 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.787 2.325 . . . . 0.34999999999999998 112.427 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.693 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 8.0 t 65.8 -61.25 0.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.657 0.783 . . . . 0.91000000000000003 111.219 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.463 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 58.8 83.44 0.22 Allowed Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.292 -1.003 . . . . 1.3899999999999999 108.292 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.88 98.36 0.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.388 2.725 . . . . 0.97999999999999998 113.416 -166.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.521 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.4 p -83.13 -45.29 14.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.034 -0.728 . . . . 2.0899999999999999 109.034 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.668 HG22 ' HD1' ' A' ' 34' ' ' PHE . 8.9 t 173.91 -140.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.024 -0.989 . . . . 2.6800000000000002 108.503 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.24 -27.78 47.74 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 118.043 0.383 . . . . 1.5800000000000001 113.853 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.668 ' HD1' HG22 ' A' ' 32' ' ' THR . 41.6 m-85 -56.56 147.79 21.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.058 0.543 . . . . 2.7200000000000002 111.67 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.525 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -152.37 157.8 41.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.067 0.547 . . . . 1.1599999999999999 109.637 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.693 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 92.9 m95 -78.29 119.74 22.07 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.415 0.626 . . . . 0.42999999999999999 111.688 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 85.0 m-85 -126.55 -177.79 4.12 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.012 -1.107 . . . . 3.0299999999999998 108.012 168.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.642 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -72.88 -76.61 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.934 -0.707 . . . . 0.53000000000000003 109.576 165.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.5 3.09 8.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.77 -0.65 . . . . 2.3900000000000001 111.009 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.0 100.38 1.11 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.03 -1.081 . . . . 0.72999999999999998 113.327 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.13 22.38 60.55 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.847 -0.692 . . . . 0.85999999999999999 111.916 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.642 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -140.35 142.38 35.58 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 122.754 0.422 . . . . 1.53 111.209 -174.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.73 140.51 31.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.99 -0.55 . . . . 3.0600000000000001 110.035 164.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.76 145.44 46.6 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.915 -0.584 . . . . 2.2999999999999998 110.271 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.499 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 2.9 p -104.17 128.48 27.03 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.536 -0.913 . . . . 2.0 108.536 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.7 Cg_exo -77.83 39.83 0.8 Allowed 'Trans proline' 0 C--N 1.335 -0.166 0 C-N-CA 123.492 2.795 . . . . 1.8899999999999999 112.835 -170.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -173.99 32.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.485 -0.561 . . . . 2.4300000000000002 109.485 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.465 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 10.9 pt-20 -94.85 109.17 21.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.712 0.768 . . . . 3.2599999999999998 111.585 -173.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.2 m -145.92 10.46 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.464 -0.789 . . . . 2.48 110.118 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -178.12 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 1.5600000000000001 109.122 -172.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.757 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.5 m-85 -123.58 157.25 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.17 -1.377 . . . . 0.95999999999999996 107.835 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -152.57 166.46 31.98 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.662 0.616 . . . . 2.0099999999999998 112.662 -162.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 p -109.27 136.11 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.607 -0.724 . . . . 1.8400000000000001 111.818 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.92 137.79 51.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.59 -0.732 . . . . 2.4500000000000002 109.628 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.86 142.74 34.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.236 -0.586 . . . . 2.3900000000000001 110.784 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.42 104.92 3.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.432 -0.804 . . . . 1.96 109.861 -177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.923 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -116.62 132.39 56.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.367 0.603 . . . . 1.8700000000000001 112.189 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -132.34 98.44 16.89 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 2.73 109.723 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.49 178.78 4.07 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.968 2.445 . . . . 1.9199999999999999 111.305 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.918 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 68.3 Cg_exo -48.46 -51.91 9.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.606 2.204 . . . . 2.6400000000000001 113.665 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.486 ' HB2' HD11 ' A' ' 64' ' ' LEU . 28.6 t70 61.63 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.904 0.752 . . . . 5.7999999999999998 109.564 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.0 m -166.26 -42.35 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 7.4299999999999997 108.1 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.686 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -112.95 -27.35 8.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.959 -1.018 . . . . 9.0800000000000001 111.403 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.686 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 58.9 mt -56.63 -56.11 25.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.148 0.499 . . . . 8.4399999999999995 111.167 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.657 ' HG ' ' CA ' ' A' ' 69' ' ' GLY . 1.4 tm? -128.93 -67.54 0.78 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.042 -0.725 . . . . 4.8499999999999996 109.042 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.918 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . 110.16 -46.42 1.17 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.046 -0.979 . . . . 3.02 111.652 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.0 -82.61 0.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.734 0.272 . . . . 4.54 111.734 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -105.57 -58.7 0.64 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.54 -0.838 . . . . 3.3599999999999999 113.212 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.657 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . 143.33 -179.74 20.59 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.976 -1.107 . . . . 1.8 111.72 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.38 81.47 1.12 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.617 0.723 . . . . 1.3 110.757 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.923 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 20.9 mt-10 -104.05 102.44 12.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.949 -1.023 . . . . 0.81000000000000005 108.405 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -113.81 151.3 32.26 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.411 -0.916 . . . . 0.65000000000000002 111.324 -174.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.577 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 39.6 m-85 -118.83 104.45 10.56 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.97 -1.468 . . . . 1.4299999999999999 109.332 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.557 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 17.9 m170 -104.64 104.86 14.75 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.252 -0.431 . . . . 0.56000000000000005 110.883 -171.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.863 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.98 120.82 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 122.424 1.107 . . . . 1.49 109.785 177.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.757 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.6 m -102.92 104.43 14.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.508 -1.223 . . . . 1.1399999999999999 107.839 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.62 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.2 p -147.29 147.35 17.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.808 0.693 . . . . 1.6000000000000001 110.672 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -130.45 103.48 6.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.993 0.902 . . . . 2.1600000000000001 108.664 166.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.84 166.15 15.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.257 -0.883 . . . . 1.1000000000000001 109.189 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.91 102.74 14.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 1.1100000000000001 110.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.51 167.18 37.6 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.726 -0.67 . . . . 0.33000000000000002 111.449 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -103.31 139.71 38.38 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.909 -0.76 . . . . 1.1499999999999999 109.648 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.766 ' HB3' ' HG ' ' A' ' 107' ' ' LEU . 7.2 t-80 -113.62 104.54 12.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.847 -0.615 . . . . 0.52000000000000002 110.418 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.42 109.44 21.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.177 -0.675 . . . . 1.1100000000000001 109.177 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.41 104.35 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.123 -0.49 . . . . 1.26 111.12 -171.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -106.19 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.018 -0.734 . . . . 1.53 109.018 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 38' ' ' PHE . 85.6 mt -106.4 124.85 50.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.663 -0.699 . . . . 1.0900000000000001 110.127 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.451 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.2 m -103.54 118.31 36.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.529 0.681 . . . . 1.1000000000000001 111.381 -171.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.525 ' CE1' ' HA ' ' A' ' 35' ' ' ALA . 53.4 t80 -82.6 90.2 6.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.6599999999999999 109.408 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.518 ' HA ' ' HD2' ' A' ' 34' ' ' PHE . 25.9 mtm -120.86 158.66 27.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.984 -0.553 . . . . 1.24 111.434 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -70.48 105.45 1.22 Allowed Pre-proline 0 C--O 1.219 -0.503 0 N-CA-C 108.034 -1.099 . . . . 3.1299999999999999 108.034 167.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.569 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 10.0 Cg_endo -51.83 -27.49 27.46 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.373 2.715 . . . . 1.04 114.789 -169.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.569 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 44.2 p90 -94.58 4.59 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 1.1799999999999999 111.774 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.808 HG21 ' H ' ' A' ' 95' ' ' GLY . 1.5 t -167.99 -74.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.521 -0.309 . . . . 1.3500000000000001 110.317 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.808 ' H ' HG21 ' A' ' 94' ' ' THR . . . 68.19 75.95 0.46 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.422 -0.418 . . . . 1.1599999999999999 112.944 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.489 ' HG2' ' HZ ' ' A' ' 34' ' ' PHE . 1.8 Cg_endo -45.23 117.4 1.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.885 2.39 . . . . 1.6899999999999999 111.081 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -55.23 -39.18 69.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.404 -0.816 . . . . 3.02 112.521 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -83.78 -19.19 35.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.616 0.246 . . . . 4.9199999999999999 111.219 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -93.38 -5.96 48.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.688 0.756 . . . . 1.6699999999999999 109.343 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.9 m -90.75 145.97 24.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 1.74 110.643 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -98.43 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.332 -0.988 . . . . 1.9099999999999999 108.332 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.451 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 26.9 ttt180 -146.74 141.66 26.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.907 0.861 . . . . 0.78000000000000003 110.968 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.781 ' CZ ' HG13 ' A' ' 5' ' ' VAL . 1.3 t80 -102.75 154.94 18.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.208 -1.36 . . . . 1.0700000000000001 108.468 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 90.8 m -156.61 102.14 2.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.645 -0.422 . . . . 1.03 111.179 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.696 HG11 HD12 ' A' ' 24' ' ' ILE . 14.9 p -104.74 135.96 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 119.913 -0.715 . . . . 1.5 109.984 168.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 13' ' ' THR . 94.3 m-85 -104.57 107.59 18.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.289 -0.869 . . . . 1.0 109.036 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.766 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 1.7 pp -128.86 152.76 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.223 -0.658 . . . . 2.6499999999999999 109.223 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.792 ' O ' HG21 ' A' ' 16' ' ' VAL . 18.6 ttmm -105.17 117.56 34.31 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.334 -0.617 . . . . 2.3500000000000001 109.334 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.03 110.39 22.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.951 -0.388 . . . . 1.1499999999999999 109.951 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.359 -0.837 . . . . 1.78 110.139 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.844 ' HB3' HG23 ' A' ' 22' ' ' VAL . 70.2 t60 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.844 -0.798 . . . . 1.1000000000000001 108.844 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -140.7 140.54 34.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.847 0.356 . . . . 2.8500000000000001 110.585 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.786 HG13 ' CZ ' ' A' ' 103' ' ' PHE . 2.3 t -106.09 132.26 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.397 -0.521 . . . . 1.23 110.959 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.689 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 2.8 p -113.74 169.78 8.73 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.091 -0.959 . . . . 1.1000000000000001 110.155 169.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -41.01 -40.63 1.47 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.86 1.059 . . . . 1.47 113.86 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.88 61.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.672 0.749 . . . . 1.05 111.598 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.709 ' HB2' HG11 ' A' ' 5' ' ' VAL . 52.1 m80 -67.56 -1.74 5.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 2.7000000000000002 111.583 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.679 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 22.7 t-20 -48.33 -17.93 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.517 0.511 . . . . 1.48 109.674 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.88 56.74 0.64 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.507 -0.769 . . . . 0.29999999999999999 111.716 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.666 ' HB1' HG23 ' A' ' 105' ' ' VAL . . . -106.54 157.83 17.38 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.662 0.986 . . . . 1.0800000000000001 113.662 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 29.4 m -153.77 103.59 2.62 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.332 -0.849 . . . . 1.3 109.282 168.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.606 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.3 pt? -164.12 169.79 17.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 3.4700000000000002 111.761 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.473 HG23 ' HB3' ' A' ' 108' ' ' LYS . 88.9 m -100.7 145.95 27.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 2.0800000000000001 111.054 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.687 HG21 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -119.74 152.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.478 -0.783 . . . . 1.3600000000000001 110.701 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.36 108.02 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.551 -0.537 . . . . 1.27 109.551 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG12 HG21 ' A' ' 22' ' ' VAL . 34.4 m -86.63 -169.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.017 0.437 . . . . 1.8500000000000001 111.99 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 116.31 -50.51 0.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.70999999999999996 111.296 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.18 -77.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.286 0.565 . . . . 2.3500000000000001 110.082 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -166.89 120.51 1.02 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.348 -0.842 . . . . 1.3600000000000001 110.261 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.844 HG23 ' HB3' ' A' ' 3' ' ' HIS . 6.9 t -111.63 104.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 1.1799999999999999 110.06 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.75 160.94 15.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.005 0.907 . . . . 1.74 112.183 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.692 HG22 HG13 ' A' ' 85' ' ' VAL . 17.7 mm -130.37 101.58 5.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.647 -1.615 . . . . 1.1000000000000001 107.828 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -108.46 143.31 37.6 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.299 0.571 . . . . 0.64000000000000001 110.923 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -128.34 142.08 43.5 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.839 -0.619 . . . . 1.47 110.619 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 73.1 Cg_endo -77.41 6.14 4.62 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.34999999999999998 111.671 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.731 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 11.2 t 68.39 -55.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.249 0.968 . . . . 0.91000000000000003 110.129 -172.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.482 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.4 m-80 54.7 57.82 11.69 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.339 -1.356 . . . . 1.3899999999999999 107.339 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.46 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 51.7 Cg_exo -53.56 108.12 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.326 2.684 . . . . 0.97999999999999998 113.139 -161.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.469 ' H ' ' HH ' ' A' ' 89' ' ' TYR . 3.5 t -132.54 104.29 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.285 -1.325 . . . . 2.0899999999999999 110.023 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.45 HG21 ' H ' ' A' ' 33' ' ' GLY . 3.8 m 72.15 -177.13 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.6 -0.727 . . . . 2.6800000000000002 110.075 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' H ' HG21 ' A' ' 32' ' ' THR . . . -61.49 -15.98 48.41 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 118.505 0.593 . . . . 1.5800000000000001 114.332 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.813 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 1.2 m-85 -62.26 155.41 24.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.545 0.572 . . . . 2.7200000000000002 112.545 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.51 160.4 43.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.116 -0.947 . . . . 1.1599999999999999 108.832 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.731 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.19 117.5 20.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.635 0.731 . . . . 0.42999999999999999 111.537 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.624 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 66.2 m-85 -125.61 -176.68 3.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.955 -1.128 . . . . 3.0299999999999998 107.955 168.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.61 ' HA ' HD21 ' A' ' 87' ' ' LEU . 1.3 m-85 -74.12 -77.95 0.11 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.794 -0.762 . . . . 0.53000000000000003 109.178 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -114.3 10.56 17.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.699 -0.682 . . . . 2.3900000000000001 110.46 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 96.57 106.11 2.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.72999999999999998 112.351 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.08 -3.46 51.81 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.85999999999999999 112.414 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -128.69 142.94 50.86 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.806 0.336 . . . . 1.53 111.869 -178.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.06 132.96 27.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.316 -0.856 . . . . 3.0600000000000001 110.532 164.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.98 154.05 51.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.234 0.54 . . . . 2.2999999999999998 111.114 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.809 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 41.0 t -104.92 131.2 22.01 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.638 -0.875 . . . . 2.0 108.638 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.65 -25.67 20.76 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.487 2.791 . . . . 1.8899999999999999 113.286 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.515 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 46.8 m-20 -139.7 81.7 1.84 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 2.4300000000000002 109.957 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.0 pt-20 -117.61 58.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.599 0.714 . . . . 3.2599999999999998 110.854 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -80.94 -60.04 2.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.559 -0.746 . . . . 2.48 111.246 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.79 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.96 -29.21 8.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.589 0.709 . . . . 1.5600000000000001 109.961 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.79 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 6.3 m-85 -105.64 165.01 11.46 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.908 -1.042 . . . . 0.95999999999999996 108.795 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -153.84 167.54 29.34 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.942 -0.703 . . . . 2.0099999999999998 112.587 -163.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.99 134.0 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.383 -0.826 . . . . 1.8400000000000001 111.547 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.25 155.35 18.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.986 -1.006 . . . . 2.4500000000000002 109.294 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 4.6 p-10 -125.13 146.58 49.41 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.937 -0.574 . . . . 2.3900000000000001 110.878 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.536 ' HD2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -164.84 103.91 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.96 110.049 178.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.863 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -118.87 128.56 54.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.701 0.762 . . . . 1.8700000000000001 111.699 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 42.7 m-85 -132.54 104.38 13.29 Favored Pre-proline 0 C--O 1.211 -0.952 0 CA-C-N 114.531 -1.213 . . . . 2.73 107.755 174.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 22.6 Cg_endo -102.34 55.35 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.346 0 N-CA-C 116.888 1.842 . . . . 1.9199999999999999 116.888 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 1.022 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 52.0 Cg_exo -62.84 -179.61 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.933 2.422 . . . . 2.6400000000000001 113.687 164.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.624 ' CB ' ' HB2' ' A' ' 65' ' ' LEU . 19.0 t70 -154.05 -117.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.305 -1.316 . . . . 5.7999999999999998 109.015 -165.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.435 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 74.8 m -153.0 -48.31 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 7.4299999999999997 110.416 173.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HZ3' ' CG ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -91.89 2.74 56.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.825 0.676 . . . . 9.0800000000000001 112.825 -173.082 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.718 HD11 HD23 ' A' ' 65' ' ' LEU . 2.8 tm? -159.32 -71.98 0.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.571 -0.529 . . . . 8.4399999999999995 109.571 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.022 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 3.8 mm? -60.69 -46.38 90.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.296 -0.865 . . . . 4.8499999999999996 109.742 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.27 -64.47 3.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 116.775 1.47 . . . . 3.02 116.775 158.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.523 ' HB1' ' CG ' ' A' ' 60' ' ' PRO . . . -53.53 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.306 0.854 . . . . 4.54 113.306 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.701 ' N ' ' HB2' ' A' ' 60' ' ' PRO . . . -170.5 116.19 0.63 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.002 -1.239 . . . . 3.3599999999999999 110.002 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.89 126.15 40.04 Favored Glycine 0 CA--C 1.511 -0.172 0 C-N-CA 120.803 -0.713 . . . . 1.8 112.725 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.49 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -161.47 83.77 0.62 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.777 0.658 . . . . 1.3 112.777 -175.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.863 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 30.3 mt-10 -104.79 104.83 14.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.447 -0.946 . . . . 0.81000000000000005 108.447 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -115.43 149.28 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.394 -0.922 . . . . 0.65000000000000002 112.157 -173.011 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.624 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 41.4 m-85 -109.13 114.64 28.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.484 -1.689 . . . . 1.4299999999999999 108.476 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.536 ' CD2' ' HD2' ' A' ' 56' ' ' LYS . 5.5 m170 -104.27 109.36 21.17 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.86 -0.525 . . . . 0.56000000000000005 111.11 -173.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG23 ' HE2' ' A' ' 83' ' ' HIS . 64.3 t -103.04 110.35 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.633 0.73 . . . . 1.49 110.071 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.735 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 23.2 m -101.99 105.31 16.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.93 -1.137 . . . . 1.1399999999999999 107.93 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.626 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 7.3 p -150.89 151.68 12.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.804 -0.634 . . . . 1.6000000000000001 110.669 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.736 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -135.31 103.61 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.838 0.828 . . . . 2.1600000000000001 109.422 166.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.622 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.3 158.06 13.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.596 -0.729 . . . . 1.1000000000000001 109.307 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.565 ' HA ' ' CB ' ' A' ' 110' ' ' ASN . . . -84.39 95.28 8.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.484 0.659 . . . . 1.1100000000000001 110.217 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.515 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -146.45 169.54 27.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.219 -0.9 . . . . 0.33000000000000002 111.679 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -107.38 130.0 54.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.296 -0.631 . . . . 1.1499999999999999 109.296 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.673 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 43.3 t-80 -104.11 102.51 12.25 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.28 -0.262 . . . . 0.52000000000000002 110.324 -172.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.16 128.67 50.03 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.322 -0.622 . . . . 1.1100000000000001 109.322 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 24' ' ' ILE . 2.1 t -128.66 103.88 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 120.801 -0.36 . . . . 1.26 111.656 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.507 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -109.03 103.26 12.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.481 -0.933 . . . . 1.53 108.481 171.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 38' ' ' PHE . 91.9 mt -103.83 122.34 44.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 1.0900000000000001 109.566 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.641 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.2 m -101.31 117.86 35.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.816 0.817 . . . . 1.1000000000000001 110.941 -171.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.813 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -84.43 92.43 8.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.629 -1.168 . . . . 1.6599999999999999 109.425 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.609 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 12.6 mtm -128.72 165.05 21.65 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.433 -0.349 . . . . 1.24 110.185 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 34' ' ' PHE . 9.3 ttm180 -67.02 106.47 1.19 Allowed Pre-proline 0 C--O 1.213 -0.819 0 N-CA-C 107.954 -1.128 . . . . 3.1299999999999999 107.954 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 4.4 Cg_endo -44.96 -30.92 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 124.067 3.178 . . . . 1.04 115.25 -168.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.528 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 36.9 p90 -95.24 5.67 51.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.395 0.517 . . . . 1.1799999999999999 112.395 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -164.99 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.568 0.21 . . . . 1.3500000000000001 111.568 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.609 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 63.86 86.95 0.05 OUTLIER Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.869 -0.492 . . . . 1.1599999999999999 111.869 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 1.017 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 29.1 Cg_exo -57.32 118.4 5.26 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.269 1.98 . . . . 1.6899999999999999 110.042 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.3 t -49.4 -53.38 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.726 0.641 . . . . 3.02 112.465 -167.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -92.19 5.51 50.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.951 0.405 . . . . 4.9199999999999999 110.645 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.017 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 27.2 t70 -112.99 1.24 15.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 1.6699999999999999 109.878 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -98.86 171.5 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.594 -0.73 . . . . 1.74 111.457 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.1 tp10 -115.39 170.88 8.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.831 -0.803 . . . . 1.9099999999999999 108.831 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.641 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 34.8 ttt180 -157.18 141.69 16.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.821 0.819 . . . . 0.78000000000000003 111.184 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.786 ' CZ ' HG13 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -104.36 157.74 16.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.313 -1.312 . . . . 1.0700000000000001 108.594 177.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.0 m -157.85 102.48 1.84 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.514 . . . . 1.03 111.306 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.724 HG11 HG22 ' A' ' 5' ' ' VAL . 14.2 p -103.66 134.48 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.482 -0.562 . . . . 1.5 109.482 169.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' THR . 72.0 m-85 -105.21 112.7 25.92 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 77.8 mt -127.85 164.9 21.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.011 -0.995 . . . . 2.6499999999999999 110.024 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.687 ' O ' HG21 ' A' ' 16' ' ' VAL . 58.4 tttm -119.99 113.85 21.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.385 -0.969 . . . . 2.3500000000000001 108.385 172.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 83' ' ' HIS . . . -101.14 106.83 18.11 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.908 -0.405 . . . . 1.1499999999999999 109.908 -171.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.135 -0.936 . . . . 1.78 110.437 -168.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.966 ' HB3' HG22 ' A' ' 22' ' ' VAL . 32.2 t60 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.798 -0.815 . . . . 1.1000000000000001 108.798 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 21.5 pttp -149.55 150.44 32.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.702 0.287 . . . . 2.8500000000000001 111.423 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 1.037 HG23 HG12 ' A' ' 105' ' ' VAL . 2.1 t -120.11 136.3 57.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.433 0.635 . . . . 1.23 111.961 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.539 ' H ' ' ND1' ' A' ' 9' ' ' HIS . 1.1 p -120.33 170.34 9.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.785 -1.098 . . . . 1.1000000000000001 110.473 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 16.7 tptm -35.62 -48.6 0.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.692 1.368 . . . . 1.47 114.692 -171.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.59 -33.32 60.19 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.601 0.715 . . . . 1.05 111.817 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.746 ' HB2' HG12 ' A' ' 5' ' ' VAL . 75.0 m80 -64.75 -2.32 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 2.7000000000000002 111.227 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 25.9 t-20 -45.57 -22.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.332 0.653 . . . . 1.48 109.995 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.42 54.0 0.66 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.5 -0.773 . . . . 0.29999999999999999 111.357 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.632 ' HB2' HG23 ' A' ' 105' ' ' VAL . . . -116.76 156.03 27.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.654 0.613 . . . . 1.0800000000000001 112.654 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 39.4 m -145.95 112.91 6.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.394 -0.821 . . . . 1.3 109.433 173.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -157.88 167.62 29.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 3.4700000000000002 111.347 -173.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 16' ' ' VAL . 85.8 m -101.52 146.59 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.724 0.297 . . . . 2.0800000000000001 111.107 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 108' ' ' LYS . 2.1 m -131.76 162.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 1.3600000000000001 110.936 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.78 137.88 51.89 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.66 -1.237 . . . . 1.27 107.66 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.795 HG11 ' H ' ' A' ' 19' ' ' GLY . 1.6 t -121.06 -164.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 119.892 -0.723 . . . . 1.8500000000000001 110.25 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.795 ' H ' HG11 ' A' ' 18' ' ' VAL . . . 124.31 -48.87 0.93 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.765 -0.934 . . . . 0.70999999999999996 110.765 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -84.43 -71.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.292 0.568 . . . . 2.3500000000000001 109.685 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -165.46 144.38 6.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.246 -0.888 . . . . 1.3600000000000001 110.096 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.966 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.1 t -123.14 120.11 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 109.341 -0.615 . . . . 1.1799999999999999 109.341 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 49.8 mt-10 -103.8 151.53 22.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.933 0.873 . . . . 1.74 112.442 -171.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.646 HD13 ' HB ' ' A' ' 5' ' ' VAL . 41.6 mm -133.88 137.74 51.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.227 -1.768 . . . . 1.1000000000000001 106.227 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.4 142.12 29.05 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.662 -0.649 . . . . 0.64000000000000001 111.217 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.412 HD11 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -117.25 144.72 34.37 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.28 -0.873 . . . . 1.47 109.181 169.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HG2' HD21 ' A' ' 29' ' ' ASN . 73.8 Cg_endo -82.63 12.52 2.87 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 C-N-CA 122.862 2.375 . . . . 0.34999999999999998 111.515 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.724 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.1 t 68.11 -44.99 0.5 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.982 0.913 . . . . 0.91000000000000003 112.257 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.623 ' O ' HG21 ' A' ' 31' ' ' THR . 1.1 p30 41.89 78.81 0.36 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.443 0.64 . . . . 1.3899999999999999 110.777 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 25.9 Cg_exo -63.97 109.98 1.22 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.357 2.705 . . . . 0.97999999999999998 112.111 -169.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.623 HG21 ' O ' ' A' ' 29' ' ' ASN . 1.3 t -142.46 117.15 9.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.724 -0.671 . . . . 2.0899999999999999 111.534 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.7 m 73.52 -42.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.478 0.656 . . . . 2.6800000000000002 112.314 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 31' ' ' THR . . . 162.72 -118.58 0.83 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 107.72 -2.152 . . . . 1.5800000000000001 107.72 -172.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.776 ' HA ' ' C ' ' A' ' 90' ' ' MET . 8.5 m-30 61.77 178.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.577 0.703 . . . . 2.7200000000000002 111.607 167.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.485 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -174.35 144.79 0.95 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.634 -1.247 . . . . 1.1599999999999999 107.634 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.724 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 94.8 m95 -76.97 99.07 5.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.359 0.6 . . . . 0.42999999999999999 110.848 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.47 179.76 4.18 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.736 -1.209 . . . . 3.0299999999999998 107.736 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.609 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -68.64 -69.03 0.35 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.628 -0.829 . . . . 0.53000000000000003 109.372 167.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.52 13.33 3.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 2.3900000000000001 110.44 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.21 112.05 3.3 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.613 -0.803 . . . . 0.72999999999999998 113.101 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 4.26 34.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.475 -0.393 . . . . 0.85999999999999999 113.03 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 p -139.94 144.63 37.18 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 112.425 0.528 . . . . 1.53 112.425 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.23 127.68 18.92 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.901 -1.045 . . . . 3.0600000000000001 110.122 167.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.92 145.0 51.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.071 0.463 . . . . 2.2999999999999998 110.781 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -111.86 135.89 21.2 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.073 -0.714 . . . . 2.0 109.073 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.402 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 36.9 Cg_exo -61.51 128.78 25.76 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.278 1.986 . . . . 1.8899999999999999 111.457 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 92.8 m-20 72.19 30.76 2.04 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.954 0.784 . . . . 2.4300000000000002 112.149 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.18 45.72 1.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.579 0.704 . . . . 3.2599999999999998 110.985 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -81.29 -19.56 42.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.541 -0.754 . . . . 2.48 111.339 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.418 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 17.5 ptt? -138.76 -35.82 0.57 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.748 0.785 . . . . 1.5600000000000001 109.964 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.851 ' HB3' ' O ' ' A' ' 76' ' ' THR . 8.4 m-85 -106.2 166.19 10.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.95999999999999996 108.443 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -153.03 167.11 30.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.767 0.712 . . . . 2.0099999999999998 112.623 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.9 p -103.34 141.57 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.252 -0.886 . . . . 1.8400000000000001 111.671 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -116.36 137.94 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 2.4500000000000002 109.614 173.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -110.64 159.17 17.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.753 0.311 . . . . 2.3900000000000001 111.386 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.618 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -158.24 117.22 3.13 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.264 -0.426 . . . . 1.96 109.977 175.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.727 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 2.6 m-85 -123.51 106.46 10.63 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.296 -0.562 . . . . 1.8700000000000001 109.794 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -124.99 104.75 29.6 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 116.335 -0.393 . . . . 2.73 111.661 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.93 169.5 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.867 2.378 . . . . 1.9199999999999999 112.617 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HG3' ' C ' ' A' ' 68' ' ' GLY . 52.4 Cg_exo -52.03 -172.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.94 3.093 . . . . 2.6400000000000001 116.089 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.548 ' CG ' ' H ' ' A' ' 62' ' ' SER . 32.1 t70 -166.55 -155.78 0.22 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.791 -2.004 . . . . 5.7999999999999998 106.856 -173.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.548 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 46.3 p -99.6 -44.67 6.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.654 -0.499 . . . . 7.4299999999999997 109.654 169.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.751 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.41 -24.82 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.303 0.483 . . . . 9.0800000000000001 112.303 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.751 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 1.5 tm? -54.43 -57.52 10.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.929 -0.767 . . . . 8.4399999999999995 108.929 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.771 HD11 ' H ' ' A' ' 68' ' ' GLY . 0.3 OUTLIER -139.2 -59.59 0.58 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.153 -1.055 . . . . 4.8499999999999996 108.153 172.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 61' ' ' ASP . . . 84.1 -59.93 4.89 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.575 -1.193 . . . . 3.02 113.082 171.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -52.66 64.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.843 0.83 . . . . 4.54 110.261 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.771 ' H ' HD11 ' A' ' 65' ' ' LEU . . . -135.54 -163.55 10.06 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.5 -1.227 . . . . 3.3599999999999999 110.504 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -96.63 -149.36 25.47 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.322 -0.942 . . . . 1.8 111.346 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.27 85.22 0.24 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.472 0.654 . . . . 1.3 110.344 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.727 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.0 mt-10 -113.58 104.66 12.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.534 -0.757 . . . . 0.81000000000000005 108.991 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.618 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -110.77 165.42 11.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.753 0.787 . . . . 0.65000000000000002 111.436 -170.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.473 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 60.0 m-85 -136.57 104.51 5.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.98 -1.464 . . . . 1.4299999999999999 109.128 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.599 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 40.1 m170 -102.79 113.84 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.958 -0.464 . . . . 0.56000000000000005 109.86 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 m -103.91 125.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 122.135 0.969 . . . . 1.49 110.079 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.851 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 3.7 m -103.82 103.54 13.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.101 -1.444 . . . . 1.1399999999999999 107.101 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.643 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.1 p -157.25 129.94 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 123.292 0.37 . . . . 1.6000000000000001 111.033 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -123.2 102.55 8.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.497 0.665 . . . . 2.1600000000000001 110.606 176.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.68 140.42 4.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.52 -0.764 . . . . 1.1000000000000001 109.757 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -64.61 87.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.61 0.569 . . . . 1.1100000000000001 111.484 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.87 166.48 32.96 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 110.693 -0.963 . . . . 0.33000000000000002 110.693 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.0 OUTLIER -101.0 136.01 41.53 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.773 -0.771 . . . . 1.1499999999999999 109.228 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.494 ' O ' HD12 ' A' ' 107' ' ' LEU . 55.8 t-80 -101.63 102.42 13.11 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.836 -0.802 . . . . 0.52000000000000002 108.836 -174.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.21 103.7 13.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.188 -0.671 . . . . 1.1100000000000001 109.188 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.738 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.1 p -106.52 109.36 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.662 -0.699 . . . . 1.26 111.291 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.503 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -107.21 103.76 13.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.863 -1.062 . . . . 1.53 108.932 176.055 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.56 HD21 ' HA ' ' A' ' 38' ' ' PHE . 76.3 mt -106.2 128.39 53.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.258 -0.428 . . . . 1.0900000000000001 110.142 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.452 ' HB ' ' SD ' ' A' ' 90' ' ' MET . 3.2 m -104.51 130.84 52.41 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.931 0.396 . . . . 1.1000000000000001 110.579 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.613 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 40.6 t80 -96.23 93.82 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.283 -0.636 . . . . 1.6599999999999999 109.283 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.776 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -131.16 158.43 40.5 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.506 -0.316 . . . . 1.24 110.623 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.65 ' N ' ' HA ' ' A' ' 34' ' ' PHE . 41.5 mtt180 -58.65 108.8 1.45 Allowed Pre-proline 0 CA--C 1.512 -0.51 0 O-C-N 124.083 0.864 . . . . 3.1299999999999999 110.083 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 7.0 Cg_exo -38.38 -37.97 0.79 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.903 3.735 . . . . 1.04 115.083 -174.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -91.92 1.27 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.131 0.789 . . . . 1.1799999999999999 113.131 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.65 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.8 t -158.52 -62.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.071 -0.393 . . . . 1.3500000000000001 111.43 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.65 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.34 93.56 0.23 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.958 -0.639 . . . . 1.1599999999999999 113.263 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.806 ' HB2' ' HB2' ' A' ' 99' ' ' ASP . 17.4 Cg_exo -69.22 97.54 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.587 2.192 . . . . 1.6899999999999999 110.008 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.6 m -62.52 -25.1 67.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.655 0.74 . . . . 3.02 109.095 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -59.24 -32.26 69.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.839 -1.073 . . . . 4.9199999999999999 110.618 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.806 ' HB2' ' HB2' ' A' ' 96' ' ' PRO . 1.5 m-20 -109.34 -105.45 0.36 Allowed 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.679 -0.237 . . . . 1.6699999999999999 110.598 -174.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 99' ' ' ASP . 86.9 p 49.28 -179.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.106 1.15 . . . . 1.74 114.106 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.28 137.89 30.96 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.748 -1.204 . . . . 1.9099999999999999 107.748 165.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -121.21 142.87 49.49 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.786 -0.765 . . . . 0.78000000000000003 111.565 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.648 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . 1.1 t80 -104.38 153.9 20.5 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.216 -1.357 . . . . 1.0700000000000001 108.989 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 54.2 m -161.03 103.84 1.3 Allowed 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.147 0.28 . . . . 1.03 110.317 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 1.037 HG12 HG23 ' A' ' 5' ' ' VAL . 7.5 p -110.08 136.6 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 118.15 -1.42 . . . . 1.5 109.877 168.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' THR . 79.4 m-85 -103.94 101.95 11.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.799 -1.092 . . . . 1.0 108.15 175.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.732 HD13 HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -124.49 142.62 51.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.438 -0.949 . . . . 2.6499999999999999 108.438 176.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.706 ' O ' HG23 ' A' ' 16' ' ' VAL . 78.3 tttt -101.89 122.77 44.64 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.369 -0.532 . . . . 2.3500000000000001 110.507 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.98 159.18 15.58 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.692 0.62 . . . . 1.1499999999999999 110.71 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 4.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.353 -0.832 . . . . 1.78 109.553 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.707 ' NE2' HD13 ' A' ' 107' ' ' LEU . 20.2 t60 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 121.487 0.66 . . . . 1.1000000000000001 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 20.1 pttp -149.71 141.14 23.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 2.8500000000000001 110.771 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.825 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -103.22 140.15 22.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-O 121.018 0.437 . . . . 1.23 110.562 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.572 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 7.2 p -121.71 169.05 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.503 -0.772 . . . . 1.1000000000000001 109.73 171.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -38.0 -47.01 1.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.335 1.235 . . . . 1.47 114.335 -171.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.55 61.83 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.47 0.652 . . . . 1.05 111.871 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.733 ' HB2' HG12 ' A' ' 5' ' ' VAL . 47.9 m80 -62.57 -3.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.629 . . . . 2.7000000000000002 111.672 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.63 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 3.7 t-20 -46.91 -19.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.145 0.578 . . . . 1.48 110.171 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.33 51.87 0.74 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.955 -0.641 . . . . 0.29999999999999999 112.078 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.624 ' HB3' HG22 ' A' ' 105' ' ' VAL . . . -106.03 162.3 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.513 0.931 . . . . 1.0800000000000001 113.513 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 85.7 m -153.74 103.76 2.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.336 -0.847 . . . . 1.3 109.134 170.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.648 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 6.5 tt -156.06 164.26 38.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 110.141 -0.318 . . . . 3.4700000000000002 110.141 -170.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 m -103.15 140.91 36.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 2.0800000000000001 111.414 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 108' ' ' LYS . 2.6 m -116.97 158.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 1.3600000000000001 111.372 -174.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.77 121.28 44.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 1.27 109.586 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.604 HG21 ' C ' ' A' ' 110' ' ' ASN . 17.6 m -108.26 -173.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.8500000000000001 111.271 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 130.11 -56.65 0.74 Allowed Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 111.244 -0.742 . . . . 0.70999999999999996 111.244 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.35 -68.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.333 0.587 . . . . 2.3500000000000001 109.654 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -165.99 141.38 4.8 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 114.863 -1.062 . . . . 1.3600000000000001 109.179 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -117.65 126.63 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 110.003 -0.369 . . . . 1.1799999999999999 110.003 173.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 21.2 mt-10 -103.34 142.83 33.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.882 0.849 . . . . 1.74 112.732 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.631 HG23 HG11 ' A' ' 85' ' ' VAL . 41.7 mm -124.45 101.06 8.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.321 -1.363 . . . . 1.1000000000000001 107.321 165.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -108.93 138.24 45.58 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.492 0.663 . . . . 0.64000000000000001 111.781 -169.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -119.58 144.77 37.54 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.517 -0.765 . . . . 1.47 109.441 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.523 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 36.7 Cg_endo -86.78 13.86 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.682 2.255 . . . . 0.34999999999999998 111.66 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.704 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 34.3 t 67.6 -49.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.314 -0.857 . . . . 0.91000000000000003 111.62 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER 50.45 57.05 17.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.185 -1.043 . . . . 1.3899999999999999 108.185 -172.414 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 83.2 Cg_exo -50.11 119.59 5.11 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.88 3.054 . . . . 0.97999999999999998 114.156 -163.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.645 HG22 ' CE2' ' A' ' 89' ' ' TYR . 10.8 p -98.35 -53.37 3.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.19 -0.914 . . . . 2.0899999999999999 110.138 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.633 HG23 ' HD1' ' A' ' 34' ' ' PHE . 2.7 t -171.18 -115.76 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.048 -0.524 . . . . 2.6800000000000002 109.976 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -14.95 79.58 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.211 -0.519 . . . . 1.5800000000000001 112.561 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.633 ' HD1' HG23 ' A' ' 32' ' ' THR . 3.7 m-85 -67.94 145.92 54.08 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.094 0.558 . . . . 2.7200000000000002 110.316 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.81 157.41 43.17 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.74 -0.467 . . . . 1.1599999999999999 109.74 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.6 m95 -77.26 113.31 14.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.413 0.625 . . . . 0.42999999999999999 111.017 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 46.5 m-85 -125.48 175.36 7.57 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.544 -1.28 . . . . 3.0299999999999998 107.544 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.607 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.4 m-85 -65.17 -65.69 0.64 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.465 -0.894 . . . . 0.53000000000000003 109.532 170.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.71 21.59 3.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.997 -0.547 . . . . 2.3900000000000001 110.59 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.79 92.64 1.58 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.466 -0.873 . . . . 0.72999999999999998 113.276 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.99 -8.92 76.56 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.764 -0.731 . . . . 0.85999999999999999 112.628 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -128.4 143.92 51.07 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 111.906 0.336 . . . . 1.53 111.906 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -140.99 139.43 34.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.254 -0.884 . . . . 3.0600000000000001 110.383 172.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.39 145.29 33.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.979 0.419 . . . . 2.2999999999999998 111.594 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.743 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 40.2 m -104.76 137.02 19.1 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 2.0 109.556 173.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 31.2 Cg_exo -60.35 -22.46 71.2 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.208 2.605 . . . . 1.8899999999999999 113.421 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.615 HD22 ' HA3' ' A' ' 81' ' ' GLY . 88.4 m-20 -119.72 24.66 10.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.436 0.16 . . . . 2.4300000000000002 111.408 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.743 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 6.5 pt-20 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.946 0.879 . . . . 3.2599999999999998 111.074 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 m -160.45 -49.62 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.469 -1.308 . . . . 2.48 107.469 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.505 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -103.46 -41.04 6.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.551 -1.204 . . . . 1.5600000000000001 109.233 173.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.674 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.9 m-85 -105.62 165.75 10.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.113 -0.949 . . . . 0.95999999999999996 108.535 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -163.7 170.32 17.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 2.0099999999999998 111.575 -168.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.2 p -102.11 135.0 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.61 -0.723 . . . . 1.8400000000000001 111.37 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 1.3 pm0 -120.1 136.31 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.55 -0.907 . . . . 2.4500000000000002 108.55 170.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.879 HD21 ' HH ' ' A' ' 57' ' ' TYR . 96.2 m-20 -103.23 153.82 19.98 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.845 -0.742 . . . . 2.3900000000000001 111.494 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 108.82 3.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.011 -0.995 . . . . 1.96 109.376 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.879 ' HH ' HD21 ' A' ' 55' ' ' ASN . 0.7 OUTLIER -114.75 135.1 54.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.782 -0.644 . . . . 1.8700000000000001 110.621 -174.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -135.78 97.17 12.78 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.559 -0.291 . . . . 2.73 110.307 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -75.0 165.53 31.13 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.71 2.273 . . . . 1.9199999999999999 111.058 168.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.657 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 18.1 Cg_exo -39.94 135.19 1.59 Allowed 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 124.002 3.135 . . . . 2.6400000000000001 115.339 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -135.16 -69.65 0.5 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.625 -2.08 . . . . 5.7999999999999998 107.878 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 t 178.53 -71.32 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.876 -1.511 . . . . 7.4299999999999997 109.672 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.653 ' HD2' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.93 -32.66 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.365 . . . . 9.0800000000000001 111.024 -177.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.653 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 87.2 mt -56.66 -63.88 1.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.152 -1.055 . . . . 8.4399999999999995 108.152 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.804 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -155.92 123.62 5.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.719 -1.586 . . . . 4.8499999999999996 106.719 166.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.03 -38.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.443 -0.884 . . . . 3.02 111.559 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.29 88.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.36 0.6 . . . . 4.54 110.983 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.804 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -153.0 -153.93 6.53 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.294 -1.122 . . . . 3.3599999999999999 110.294 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.67 -178.05 18.92 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.906 -1.14 . . . . 1.8 111.955 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.39 81.3 0.97 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.485 0.659 . . . . 1.3 110.98 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 31.4 mt-10 -104.27 104.04 13.88 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.576 -0.898 . . . . 0.81000000000000005 108.576 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -108.94 150.13 28.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.517 -0.873 . . . . 0.65000000000000002 110.837 -175.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.633 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 10.0 m-85 -109.56 115.08 29.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.167 -1.379 . . . . 1.4299999999999999 108.95 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 15.8 m170 -104.24 108.24 19.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.164 -0.471 . . . . 0.56000000000000005 110.341 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.677 HG21 HG11 ' A' ' 22' ' ' VAL . 4.2 m -103.45 117.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.175 0.988 . . . . 1.49 108.777 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.674 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 68.0 m -102.62 103.71 14.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.978 -1.119 . . . . 1.1399999999999999 107.978 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 2.9 p -154.76 144.57 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.515 -0.766 . . . . 1.6000000000000001 110.619 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.5 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.1 103.05 6.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.822 0.82 . . . . 2.1600000000000001 109.006 165.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.79 134.72 2.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.375 -0.83 . . . . 1.1000000000000001 110.522 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -65.14 102.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.757 0.66 . . . . 1.1100000000000001 111.367 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA3' HD22 ' A' ' 47' ' ' ASN . . . -165.49 167.2 38.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.152 -1.179 . . . . 0.33000000000000002 110.152 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.8 m -101.85 131.54 48.14 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 118.055 0.927 . . . . 1.1499999999999999 109.436 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.595 ' HD1' HG22 ' A' ' 85' ' ' VAL . 32.5 t-80 -103.96 102.96 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.948 -0.39 . . . . 0.52000000000000002 109.948 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.85 122.13 43.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.014 -0.735 . . . . 1.1100000000000001 109.014 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.0 t -113.97 109.87 30.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.134 -0.485 . . . . 1.26 111.696 -170.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.431 ' ND2' HG21 ' A' ' 104' ' ' THR . 8.0 m120 -109.68 104.09 13.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.223 -0.658 . . . . 1.53 109.223 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.572 HD21 ' CE2' ' A' ' 73' ' ' PHE . 82.5 mt -108.49 121.34 44.76 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 1.0900000000000001 110.004 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.436 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 2.6 m -102.35 118.9 37.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.397 0.617 . . . . 1.1000000000000001 110.657 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.645 ' CE2' HG22 ' A' ' 31' ' ' THR . 53.9 t80 -86.01 91.22 8.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.942 -1.026 . . . . 1.6599999999999999 109.606 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.684 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 3.2 mtm -131.7 165.13 24.42 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.506 -0.316 . . . . 1.24 110.473 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.421 ' HB2' ' H ' ' A' ' 95' ' ' GLY . 70.5 mtt180 -57.28 112.54 4.79 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.48 -0.933 . . . . 3.1299999999999999 108.48 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -52.06 -24.81 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.236 2.624 . . . . 1.04 114.504 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.52 ' CD1' HG22 ' A' ' 94' ' ' THR . 47.6 p90 -96.94 2.77 52.01 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.881 0.326 . . . . 1.1799999999999999 111.881 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.691 HG21 ' H ' ' A' ' 95' ' ' GLY . 3.3 t -173.84 -67.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.483 -0.135 . . . . 1.3500000000000001 111.309 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.691 ' H ' HG21 ' A' ' 94' ' ' THR . . . 77.87 89.81 0.35 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.843 -0.694 . . . . 1.1599999999999999 112.065 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 11.0 Cg_exo -37.31 113.26 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.487 2.792 . . . . 1.6899999999999999 111.718 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 t -75.94 9.85 2.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 3.02 111.944 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -130.12 4.37 4.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.122 -0.325 . . . . 4.9199999999999999 110.122 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 22.8 t0 -127.05 0.82 6.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.203 0.525 . . . . 1.6699999999999999 110.916 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 m -87.91 148.27 24.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.045 -0.525 . . . . 1.74 111.084 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.5 tp10 -100.8 169.36 9.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 1.9099999999999999 108.812 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.436 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 33.5 ttt180 -153.8 140.01 18.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.806 0.812 . . . . 0.78000000000000003 110.703 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.825 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 2.5 t80 -104.13 156.87 17.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.278 -1.328 . . . . 1.0700000000000001 108.668 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.752 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 66.9 m -158.8 101.18 1.63 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 120.885 0.374 . . . . 1.03 110.121 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.635 HG12 HG21 ' A' ' 5' ' ' VAL . 9.3 p -104.65 134.7 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 119.793 -0.763 . . . . 1.5 109.73 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 13' ' ' THR . 91.1 m-85 -104.07 113.99 27.93 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.605 -0.887 . . . . 1.0 108.605 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 3' ' ' HIS . 17.3 mt -137.7 165.08 27.26 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.835 -0.62 . . . . 2.6499999999999999 109.753 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.748 ' O ' HG23 ' A' ' 16' ' ' VAL . 78.5 tttt -119.76 124.4 46.07 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.47 -0.492 . . . . 2.3500000000000001 110.237 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.436 ' HB1' HG12 ' A' ' 18' ' ' VAL . . . -101.62 127.24 48.44 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.397 0.436 . . . . 1.1499999999999999 110.066 -172.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.604 ' C ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.648 -0.705 . . . . 1.78 109.977 -174.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 1.024 ' HB3' HG21 ' A' ' 22' ' ' VAL . 28.4 t60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.415 -0.587 . . . . 1.1000000000000001 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -144.05 141.14 29.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.24 -0.436 . . . . 2.8500000000000001 110.606 177.567 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.845 HG23 HG11 ' A' ' 105' ' ' VAL . 2.1 t -106.25 134.12 48.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-O 121.166 0.508 . . . . 1.23 111.525 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.5 ' H ' ' ND1' ' A' ' 9' ' ' HIS . 0.9 OUTLIER -113.76 168.47 9.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.136 -0.938 . . . . 1.1000000000000001 110.289 170.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.298 1.592 . . . . 1.47 115.298 -171.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.23 -30.87 60.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.77 0.714 . . . . 1.05 111.757 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.731 ' HB2' HG11 ' A' ' 5' ' ' VAL . 73.9 m80 -66.06 -2.26 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.659 -0.7 . . . . 2.7000000000000002 111.267 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.65 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -49.48 -17.24 0.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.165 -0.68 . . . . 1.48 109.165 171.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.93 50.08 0.68 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.96 -0.563 . . . . 0.29999999999999999 111.787 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.651 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -110.18 158.08 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.198 0.814 . . . . 1.0800000000000001 113.198 -173.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 91.7 m -148.8 107.74 3.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.144 -0.935 . . . . 1.3 109.738 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pp -153.76 168.26 26.89 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 3.4700000000000002 111.668 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.408 HG21 ' N ' ' A' ' 16' ' ' VAL . 55.0 m -101.16 146.62 27.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.423 -0.353 . . . . 2.0800000000000001 110.608 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 108' ' ' LYS . 6.0 m -129.45 160.78 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.105 0.478 . . . . 1.3600000000000001 111.477 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.65 124.12 51.55 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.54 -0.911 . . . . 1.27 108.54 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.64 HG22 ' C ' ' A' ' 110' ' ' ASN . 22.5 m -102.49 -165.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.509 -0.476 . . . . 1.8500000000000001 111.385 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 112.12 -50.38 0.77 Allowed Glycine 0 CA--C 1.504 -0.652 0 N-CA-C 111.041 -0.823 . . . . 0.70999999999999996 111.041 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -75.61 -75.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.795 0.807 . . . . 2.3500000000000001 109.132 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -166.64 140.48 3.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.521 -1.218 . . . . 1.3600000000000001 109.349 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 1.024 HG21 ' HB3' ' A' ' 3' ' ' HIS . 1.7 t -123.57 104.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.586 0.708 . . . . 1.1799999999999999 109.155 172.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.1 pt-20 -109.45 160.19 16.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.795 0.807 . . . . 1.74 111.568 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.614 HD12 ' HB ' ' A' ' 5' ' ' VAL . 22.6 mm -134.68 104.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.072 -1.422 . . . . 1.1000000000000001 108.624 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.612 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -110.04 139.26 45.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.533 0.682 . . . . 0.64000000000000001 111.904 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.84 139.99 26.35 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 114.985 -1.007 . . . . 1.47 108.955 171.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 85.1 Cg_endo -79.06 8.77 3.64 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 122.824 2.349 . . . . 0.34999999999999998 111.893 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.647 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 7.9 t 66.22 -63.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.03 0.831 . . . . 0.91000000000000003 110.291 -173.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 60.81 65.42 2.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.059 -1.089 . . . . 1.3899999999999999 108.059 -172.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.66 112.86 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.875 3.05 . . . . 0.97999999999999998 113.57 -165.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.633 HG23 ' CE2' ' A' ' 89' ' ' TYR . 38.7 p -80.7 -73.98 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.167 -1.378 . . . . 2.0899999999999999 112.176 -174.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 t -171.19 -12.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.473 -0.785 . . . . 2.6800000000000002 110.359 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.44 -33.93 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.39 -0.684 . . . . 1.5800000000000001 111.39 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.556 ' HA ' ' C ' ' A' ' 90' ' ' MET . 45.7 m-85 -52.5 139.72 24.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.559 -0.32 . . . . 2.7200000000000002 111.284 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.629 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -137.72 151.44 48.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 1.1599999999999999 108.661 171.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.647 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.87 109.79 14.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.328 0.585 . . . . 0.42999999999999999 111.415 -174.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.432 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 51.2 m-85 -114.67 177.53 4.61 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 108.395 -0.965 . . . . 3.0299999999999998 108.395 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.741 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -70.02 -73.94 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.01 0.823 . . . . 0.53000000000000003 109.466 169.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.43 -11.86 14.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.709 -0.678 . . . . 2.3900000000000001 110.179 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.31 108.1 2.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.564 -0.827 . . . . 0.72999999999999998 112.099 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.06 -16.92 7.94 Favored Glycine 0 CA--C 1.516 0.145 0 C-N-CA 120.987 -0.625 . . . . 0.85999999999999999 112.648 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 m -128.97 142.09 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.886 -0.413 . . . . 1.53 109.886 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -139.91 141.56 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.522 -0.548 . . . . 3.0600000000000001 109.522 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.45 164.35 28.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.607 0.718 . . . . 2.2999999999999998 112.625 -172.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.841 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 15.9 p -135.23 128.41 18.39 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.315 -0.857 . . . . 2.0 108.996 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.9 150.36 86.49 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.635 2.223 . . . . 1.8899999999999999 112.138 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.426 ' HB2' HG21 ' A' ' 77' ' ' VAL . 94.6 m-20 66.35 42.78 2.88 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.573 0.546 . . . . 2.4300000000000002 110.574 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -88.72 31.15 0.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 3.2599999999999998 111.304 -173.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -88.09 12.11 14.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.392 -0.367 . . . . 2.48 111.266 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.453 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 20.5 ptt? -175.27 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.627 . . . . 1.5600000000000001 110.461 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.751 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.4 m-85 -122.5 162.87 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.121 -0.945 . . . . 0.95999999999999996 109.297 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -159.65 167.88 27.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.342 0.592 . . . . 2.0099999999999998 112.278 -164.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.841 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.5 p -103.09 139.34 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.311 -0.859 . . . . 1.8400000000000001 111.401 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.676 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -112.43 142.93 44.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.194 -0.669 . . . . 2.4500000000000002 109.194 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -111.16 161.32 16.08 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.959 -0.296 . . . . 2.3900000000000001 111.229 -176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.758 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -165.14 111.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.881 -0.785 . . . . 1.96 108.881 171.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 5.7 m-85 -111.18 112.83 24.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.173 -0.611 . . . . 1.8700000000000001 111.916 -173.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.689 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 90.5 m-85 -113.72 109.03 50.8 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.219 -0.9 . . . . 2.73 109.417 172.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.486 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 19.0 Cg_endo -104.46 55.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.381 2.72 . . . . 1.9199999999999999 116.042 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 1.032 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 18.6 Cg_endo -94.99 172.03 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.251 2.634 . . . . 2.6400000000000001 111.501 168.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.502 ' CB ' ' HB2' ' A' ' 65' ' ' LEU . 19.9 t70 -132.41 -74.58 0.51 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.024 -0.535 . . . . 5.7999999999999998 110.927 -167.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.744 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 33.9 p -173.65 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.215 -0.902 . . . . 7.4299999999999997 111.538 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.662 ' HG2' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.48 -69.26 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.495 0.188 . . . . 9.0800000000000001 110.931 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.662 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 71.3 mt -57.89 -65.66 0.6 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.939 0.876 . . . . 8.4399999999999995 109.111 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.032 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 3.1 mm? -85.91 143.02 28.43 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.06 -2.2 . . . . 4.8499999999999996 105.06 167.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.67 37.78 3.32 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 118.752 -1.69 . . . . 3.02 114.496 -156.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 62' ' ' SER . . . 64.38 142.1 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.793 0.837 . . . . 4.54 112.195 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.8 25.26 3.13 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.388 -1.386 . . . . 3.3599999999999999 112.206 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.914 ' HA2' ' HD2' ' A' ' 60' ' ' PRO . . . -55.79 108.36 1.06 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.419 -0.895 . . . . 1.8 111.805 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.7 p -156.24 86.96 1.03 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.64 0.733 . . . . 1.3 112.349 -173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 39.9 mt-10 -103.98 103.56 13.41 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.936 -1.135 . . . . 0.81000000000000005 107.936 174.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.758 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 11.0 m-70 -105.03 150.59 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.719 0.771 . . . . 0.65000000000000002 111.863 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.6 m-85 -125.2 104.5 8.54 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.912 -1.494 . . . . 1.4299999999999999 108.679 172.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.676 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 23.3 m170 -102.52 104.27 14.68 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.159 -0.312 . . . . 0.56000000000000005 110.159 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.816 HG11 ' HE2' ' A' ' 83' ' ' HIS . 0.2 OUTLIER -101.9 114.57 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.609 1.195 . . . . 1.49 109.479 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.751 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 27.7 m -101.61 104.72 15.6 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.248 -1.342 . . . . 1.1399999999999999 107.904 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.554 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 6.1 p -149.04 148.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 124.206 0.941 . . . . 1.6000000000000001 110.043 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -130.99 102.77 6.18 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.845 0.831 . . . . 2.1600000000000001 108.854 164.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.21 160.94 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.271 -0.877 . . . . 1.1000000000000001 110.063 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.25 95.99 10.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.994 0.426 . . . . 1.1100000000000001 111.151 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.14 165.84 34.95 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.308 -0.717 . . . . 0.33000000000000002 111.308 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -102.44 131.73 48.92 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.062 -0.669 . . . . 1.1499999999999999 109.846 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.816 ' HE2' HG11 ' A' ' 75' ' ' VAL . 2.8 t-80 -104.13 104.46 14.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.728 -0.669 . . . . 0.52000000000000002 110.041 -173.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.89 109.69 21.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.319 -0.993 . . . . 1.1100000000000001 108.319 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.96 104.26 16.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 116.063 -0.517 . . . . 1.26 111.191 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -113.4 103.29 11.14 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.687 0.756 . . . . 1.53 110.121 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 38' ' ' PHE . 90.8 mt -105.89 129.62 54.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.761 -1.109 . . . . 1.0900000000000001 110.137 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.719 HG23 ' HG3' ' A' ' 90' ' ' MET . 5.9 m -101.31 118.93 37.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.588 0.709 . . . . 1.1000000000000001 110.747 -171.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.67 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 1.6 t80 -87.84 83.42 7.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.568 -1.197 . . . . 1.6599999999999999 109.467 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.719 ' HG3' HG23 ' A' ' 88' ' ' THR . 30.2 mtm -117.26 158.32 24.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.858 0.361 . . . . 1.24 111.833 -171.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -70.09 105.94 1.41 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.158 -1.053 . . . . 3.1299999999999999 108.158 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.476 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.7 Cg_endo -50.71 -26.79 18.19 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.49 2.793 . . . . 1.04 114.564 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.2 p90 -92.25 -4.5 53.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.196 0.443 . . . . 1.1799999999999999 112.196 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.633 HG21 ' H ' ' A' ' 95' ' ' GLY . 5.2 t -161.89 -62.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.365 -0.209 . . . . 1.3500000000000001 111.076 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.633 ' H ' HG21 ' A' ' 94' ' ' THR . . . 53.18 66.64 2.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.962 -0.355 . . . . 1.1599999999999999 112.967 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.5 128.7 24.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.671 2.247 . . . . 1.6899999999999999 112.269 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 98' ' ' HIS . 10.8 t -57.79 138.9 55.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.752 -0.658 . . . . 3.02 109.687 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 97' ' ' SER . 56.1 m80 77.96 -8.11 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.805 0.69 . . . . 4.9199999999999999 111.574 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -99.41 -25.66 14.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.83 0.824 . . . . 1.6699999999999999 108.925 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.456 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 6.2 p -81.26 163.33 23.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.72 -1.127 . . . . 1.74 110.9 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.67 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 10.8 tp10 -103.09 172.35 6.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.727 -0.842 . . . . 1.9099999999999999 108.727 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.491 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 48.8 ttt180 -156.04 139.9 16.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.797 0.808 . . . . 0.78000000000000003 110.909 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.653 ' CZ ' HG13 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.75 156.53 17.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.228 -1.351 . . . . 1.0700000000000001 109.052 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.823 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 93.5 m -160.22 103.5 1.45 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.788 -0.365 . . . . 1.03 111.105 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.845 HG11 HG23 ' A' ' 5' ' ' VAL . 11.1 p -103.72 137.47 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 120.308 -0.557 . . . . 1.5 110.31 170.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.5 m-85 -105.29 107.87 19.08 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.772 . . . . 1.0 109.127 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.704 HD22 ' HE2' ' A' ' 3' ' ' HIS . 2.6 pp -130.69 146.13 52.1 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.443 -0.577 . . . . 2.6499999999999999 109.443 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.697 ' O ' HG23 ' A' ' 16' ' ' VAL . 11.8 tttp -103.76 114.72 29.19 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.583 -0.447 . . . . 2.3500000000000001 110.722 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HB3' HG11 ' A' ' 18' ' ' VAL . . . -100.53 132.2 46.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.306 -0.406 . . . . 1.1499999999999999 110.382 -168.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.64 ' C ' HG22 ' A' ' 18' ' ' VAL . 7.7 p30 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.26 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.921 ' HB3' HG23 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.403 -0.962 . . . . 1.1000000000000001 108.403 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.49 134.55 25.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 2.8500000000000001 111.364 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.953 HG23 HG11 ' A' ' 105' ' ' VAL . 2.0 t -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.227 -0.442 . . . . 1.23 110.786 173.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.47 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -146.85 170.82 16.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.195 0.998 . . . . 1.1000000000000001 108.621 -172.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 23.2 tptp -48.17 -39.53 21.12 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.257 0.836 . . . . 1.47 113.257 -173.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.64 77.55 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.688 0.756 . . . . 1.05 110.856 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.744 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.7 m80 -64.4 -3.9 3.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.203 -0.908 . . . . 2.7000000000000002 111.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.709 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 17.7 t-20 -48.03 -21.44 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.378 0.671 . . . . 1.48 110.548 171.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.06 54.6 0.65 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.22 -0.752 . . . . 0.29999999999999999 111.22 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.05 160.58 20.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.961 0.726 . . . . 1.0800000000000001 112.961 -174.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.4 m -151.76 117.03 5.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.231 -0.895 . . . . 1.3 109.467 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.673 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.6 pp -164.29 168.29 18.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.534 0.207 . . . . 3.4700000000000002 111.367 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.0 m -102.97 145.9 29.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.885 0.374 . . . . 2.0800000000000001 111.077 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -123.5 162.26 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.74 -0.664 . . . . 1.3600000000000001 110.15 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HA ' ' OXT' ' A' ' 110' ' ' ASN . . . -115.16 117.01 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.733 -0.84 . . . . 1.27 108.733 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.558 HG12 HG21 ' A' ' 22' ' ' VAL . 25.2 m -93.85 178.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.481 . . . . 1.8500000000000001 111.956 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.52 -52.86 0.76 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.70999999999999996 111.556 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -78.06 -72.52 0.36 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.558 -0.534 . . . . 2.3500000000000001 109.558 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -168.07 128.49 1.33 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.753 -0.658 . . . . 1.3600000000000001 110.931 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.921 HG23 ' HB3' ' A' ' 3' ' ' HIS . 1.9 t -104.41 114.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.703 0.763 . . . . 1.1799999999999999 109.725 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.6 145.07 30.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.464 -0.789 . . . . 1.74 111.854 -171.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 5' ' ' VAL . 38.5 mm -128.6 102.98 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.873 -1.158 . . . . 1.1000000000000001 107.873 169.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.523 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -114.91 138.48 50.76 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.304 -0.559 . . . . 0.64000000000000001 111.859 -173.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 26' ' ' LEU . 4.2 mm? -116.42 144.2 32.65 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.517 -0.765 . . . . 1.47 109.178 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 42.6 Cg_endo -85.73 13.26 2.8 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 122.992 2.462 . . . . 0.34999999999999998 111.858 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.537 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 12.2 t 69.34 -65.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.9 0.75 . . . . 0.91000000000000003 111.225 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.408 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.8 m-80 58.95 77.09 0.41 Allowed Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.285 0.634 . . . . 1.3899999999999999 109.832 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.702 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 79.4 Cg_exo -52.91 105.03 0.11 Allowed 'Trans proline' 0 CA--C 1.517 -0.333 0 C-N-CA 123.495 2.797 . . . . 0.97999999999999998 113.741 -166.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.577 HG23 ' CE2' ' A' ' 89' ' ' TYR . 70.2 p -83.4 -53.49 5.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.083 . . . . 2.0899999999999999 109.667 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 t -179.52 -136.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.686 -1.227 . . . . 2.6800000000000002 107.686 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.48 -25.61 65.35 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.078 -0.582 . . . . 1.5800000000000001 113.176 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.6 m-30 -53.3 150.32 6.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.123 0.487 . . . . 2.7200000000000002 112.027 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.01 163.97 36.73 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.226 -0.897 . . . . 1.1599999999999999 109.093 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.537 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -83.6 123.44 29.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.216 0.532 . . . . 0.42999999999999999 111.505 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.834 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -158.32 147.58 19.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.459 -0.791 . . . . 3.0299999999999998 109.296 173.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.613 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.6 m-85 -45.31 -68.9 0.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.232 0.456 . . . . 0.53000000000000003 112.232 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.48 ' HG3' ' OG1' ' A' ' 42' ' ' THR . 7.1 pt-20 -130.34 18.84 5.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.082 0.468 . . . . 2.3900000000000001 110.79 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 100.27 91.64 2.08 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.561 -0.828 . . . . 0.72999999999999998 113.128 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 -3.35 80.22 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.804 -0.712 . . . . 0.85999999999999999 112.388 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -128.3 142.76 51.04 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.91 0.386 . . . . 1.53 111.663 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.738 ' H ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -144.22 133.9 23.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.237 -0.892 . . . . 3.0600000000000001 111.097 173.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.71 160.25 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 2.2999999999999998 110.086 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.919 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 31.0 t -125.73 138.54 32.16 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.323 -0.621 . . . . 2.0 109.323 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 32.1 Cg_exo -58.72 129.42 32.19 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.396 2.064 . . . . 1.8899999999999999 111.006 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 92.0 m-20 72.37 42.87 0.52 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.05 0.844 . . . . 2.4300000000000002 110.629 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.73 33.67 0.48 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.859 -0.609 . . . . 3.2599999999999998 111.602 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 m -67.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.264 0.554 . . . . 2.48 110.176 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.659 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -107.36 -33.43 7.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.583 -0.735 . . . . 1.5600000000000001 110.594 -177.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 5.0 m-85 -104.83 165.24 11.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.049 -0.978 . . . . 0.95999999999999996 108.729 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -159.35 170.29 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.066 -0.654 . . . . 2.0099999999999998 112.309 -166.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.919 ' HB ' ' HB2' ' A' ' 45' ' ' SER . 2.5 p -99.86 126.21 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.522 -0.763 . . . . 1.8400000000000001 110.319 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -111.26 125.06 53.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 2.4500000000000002 108.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.77 152.94 21.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.299 0.571 . . . . 2.3900000000000001 111.463 -172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.768 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -164.9 114.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.222 -0.899 . . . . 1.96 109.333 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 m-85 -120.88 156.37 32.15 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.168 -0.613 . . . . 1.8700000000000001 110.127 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -147.16 100.65 3.87 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.837 -0.62 . . . . 2.73 110.8 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -66.99 154.08 75.8 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.735 2.29 . . . . 1.9199999999999999 110.301 170.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.2 111.56 0.07 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 124.456 3.437 . . . . 2.6400000000000001 114.998 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.586 ' CG ' ' H ' ' A' ' 62' ' ' SER . 5.2 p-10 -84.07 -80.15 0.2 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.334 -1.757 . . . . 5.7999999999999998 110.784 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.586 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 33.4 t -179.95 -39.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 7.4299999999999997 110.681 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.615 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -125.08 -27.62 3.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.184 0.809 . . . . 9.0800000000000001 113.184 -171.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.615 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 4.5 tt -61.23 -51.06 70.54 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.713 -1.217 . . . . 8.4399999999999995 107.713 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.51 HD11 ' H ' ' A' ' 69' ' ' GLY . 1.7 pt? -156.54 -51.91 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.599 -0.728 . . . . 4.8499999999999996 111.507 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.1 -35.55 1.28 Allowed Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.084 -0.579 . . . . 3.02 112.228 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 65' ' ' LEU . . . -52.89 -57.98 8.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.297 0.57 . . . . 4.54 111.126 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.702 ' HA2' ' HD3' ' A' ' 30' ' ' PRO . . . -116.56 -49.52 0.43 Allowed Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.466 -0.788 . . . . 3.3599999999999999 112.34 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.51 ' H ' HD11 ' A' ' 65' ' ' LEU . . . 116.53 -167.69 12.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.291 -0.957 . . . . 1.8 110.829 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.426 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -161.64 84.82 0.62 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.406 0.521 . . . . 1.3 112.406 -172.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.648 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.4 mt-10 -104.15 109.44 21.25 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.285 -0.635 . . . . 0.81000000000000005 109.285 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.768 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 2.1 m170 -110.89 148.92 31.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.674 0.749 . . . . 0.65000000000000002 111.899 -171.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.834 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 27.0 m-85 -118.82 109.12 15.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.284 -1.325 . . . . 1.4299999999999999 108.864 171.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -103.53 107.33 18.13 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.893 -0.41 . . . . 0.56000000000000005 109.893 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 2.4 m -103.31 118.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 122.453 1.12 . . . . 1.49 109.19 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 20.8 m -102.75 104.26 14.55 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.807 -1.182 . . . . 1.1399999999999999 107.807 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.54 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -146.59 140.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 1.6000000000000001 110.262 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.522 ' HA ' HG23 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.23 102.22 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.821 0.82 . . . . 2.1600000000000001 109.868 171.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.83 167.27 17.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.93 -1.032 . . . . 1.1000000000000001 108.58 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.767 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -99.69 89.61 4.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.184 0.516 . . . . 1.1100000000000001 110.506 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.1 168.1 31.86 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.123 -0.791 . . . . 0.33000000000000002 111.123 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.2 m -101.89 134.17 45.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.594 0.697 . . . . 1.1499999999999999 109.609 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.766 ' HD1' HG22 ' A' ' 85' ' ' VAL . 30.1 t-80 -104.4 104.64 14.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.668 -0.696 . . . . 0.52000000000000002 109.684 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.76 109.7 21.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.562 -0.533 . . . . 1.1100000000000001 109.562 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.766 HG22 ' HD1' ' A' ' 83' ' ' HIS . 1.1 t -105.55 104.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.827 -0.624 . . . . 1.26 111.235 -170.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.28 103.51 12.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.084 -0.71 . . . . 1.53 109.084 174.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.61 128.44 52.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.269 -0.641 . . . . 1.0900000000000001 109.269 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.466 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 9.0 m -102.6 137.09 41.28 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.673 0.749 . . . . 1.1000000000000001 110.922 -170.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.577 ' CE2' HG23 ' A' ' 31' ' ' THR . 0.8 OUTLIER -103.78 90.05 3.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.919 -1.037 . . . . 1.6599999999999999 109.6 -175.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.608 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 5.0 mtm -132.62 173.46 11.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 110.024 -0.361 . . . . 1.24 110.024 -175.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 -82.07 114.01 47.63 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 3.1299999999999999 109.444 170.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.88 -35.15 39.26 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 123.537 2.825 . . . . 1.04 114.133 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -85.14 2.02 45.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.738 0.273 . . . . 1.1799999999999999 111.738 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -170.88 -74.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.583 -0.28 . . . . 1.3500000000000001 111.24 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.76 ' H ' HG23 ' A' ' 94' ' ' THR . . . 80.83 108.08 0.31 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.431 -1.068 . . . . 1.1599999999999999 110.431 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.808 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 10.3 Cg_exo -73.51 40.82 0.56 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.741 2.961 . . . . 1.6899999999999999 113.558 -172.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.7 t 44.22 -85.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.393 1.077 . . . . 3.02 112.625 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.7 -21.39 66.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.263 -0.426 . . . . 4.9199999999999999 110.748 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.808 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 21.7 t0 -92.62 3.92 54.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.542 0.687 . . . . 1.6699999999999999 110.211 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 7.1 m -95.52 144.92 25.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 1.74 110.626 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.91 178.19 5.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.7 -0.852 . . . . 1.9099999999999999 108.7 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 56.3 ttt180 -161.12 144.51 12.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.78000000000000003 110.625 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.721 ' CZ ' HG12 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.45 156.29 18.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.709 -1.132 . . . . 1.0700000000000001 109.198 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 99.4 m -157.66 103.47 1.92 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.625 -0.43 . . . . 1.03 111.375 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.953 HG11 HG23 ' A' ' 5' ' ' VAL . 11.7 p -108.63 136.84 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 119.617 -0.833 . . . . 1.5 109.993 168.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.627 ' O ' ' HA ' ' A' ' 13' ' ' THR . 97.6 m-85 -106.2 103.34 12.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.295 -0.866 . . . . 1.0 108.732 173.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.673 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.19 150.89 48.01 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.198 -0.667 . . . . 2.6499999999999999 109.198 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.815 ' O ' HG23 ' A' ' 16' ' ' VAL . 48.4 tttm -102.78 119.77 39.43 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.376 -0.601 . . . . 2.3500000000000001 109.376 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.451 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -99.94 115.68 30.24 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 123.928 0.768 . . . . 1.1499999999999999 109.725 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.767 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-N 114.718 -1.128 . . . . 1.78 110.569 -171.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.908 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.408 -0.96 . . . . 1.1000000000000001 108.408 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.5 pttt -135.67 151.47 50.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.884 0.373 . . . . 2.8500000000000001 111.021 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.819 HG22 HG11 ' A' ' 105' ' ' VAL . 2.1 t -122.43 155.22 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 1.23 111.046 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.441 ' H ' ' HD1' ' A' ' 9' ' ' HIS . 7.2 p -143.67 170.55 15.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.922 -1.036 . . . . 1.1000000000000001 108.67 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 24.9 tptp -48.28 -38.16 18.12 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.573 0.582 . . . . 1.47 112.573 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.31 79.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.883 0.849 . . . . 1.05 111.073 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.747 ' HB2' HG12 ' A' ' 5' ' ' VAL . 32.9 m80 -63.9 -2.93 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 2.7000000000000002 111.346 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.719 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 15.5 t-20 -49.93 -19.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.257 0.623 . . . . 1.48 110.685 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.87 48.61 0.92 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.296 -0.722 . . . . 0.29999999999999999 111.296 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.729 ' HB2' HD13 ' A' ' 14' ' ' LEU . . . -112.54 154.92 25.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.875 0.694 . . . . 1.0800000000000001 112.875 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 41.3 m -147.9 104.38 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.271 -0.877 . . . . 1.3 109.062 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.729 HD13 ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -141.81 167.93 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.141 0.496 . . . . 3.4700000000000002 111.618 -171.254 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 m -101.59 139.03 37.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.599 -0.728 . . . . 2.0800000000000001 109.897 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -127.46 162.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.252 0.549 . . . . 1.3600000000000001 112.137 -175.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.19 120.64 38.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.452 -0.944 . . . . 1.27 108.452 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.805 HG11 ' H ' ' A' ' 19' ' ' GLY . 2.2 t -105.73 -156.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.166 -0.679 . . . . 1.8500000000000001 109.166 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.805 ' H ' HG11 ' A' ' 18' ' ' VAL . . . 108.67 -49.04 0.88 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.667 -0.973 . . . . 0.70999999999999996 110.667 -175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.62 -73.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.086 -0.709 . . . . 2.3500000000000001 109.086 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.8 tp -166.88 145.14 5.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.346 -0.843 . . . . 1.3600000000000001 109.367 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -122.63 111.71 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.568 0.699 . . . . 1.1799999999999999 109.641 171.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.669 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -104.83 139.73 39.16 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.55 0.69 . . . . 1.74 110.918 -173.637 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.617 HG23 HG12 ' A' ' 85' ' ' VAL . 47.1 mm -117.34 101.48 12.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.932 -1.136 . . . . 1.1000000000000001 107.932 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.61 142.95 34.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.243 0.544 . . . . 0.64000000000000001 111.211 -172.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 3.7 mt -128.44 138.15 32.44 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-O 121.546 0.689 . . . . 1.47 111.079 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.496 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 85.3 Cg_endo -78.78 8.66 3.61 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.035 2.49 . . . . 0.34999999999999998 112.068 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 13.7 t 69.37 -57.81 0.52 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.712 0.632 . . . . 0.91000000000000003 110.165 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.496 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 52.54 63.46 8.79 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.051 -1.092 . . . . 1.3899999999999999 108.051 -172.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.809 ' HB3' ' HA ' ' A' ' 62' ' ' SER . 48.3 Cg_exo -44.94 125.67 6.87 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 124.136 3.224 . . . . 0.97999999999999998 114.486 -165.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.1 t -157.6 96.8 1.55 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.605 -1.179 . . . . 2.0899999999999999 110.433 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.3 m 73.22 176.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.746 -0.661 . . . . 2.6800000000000002 110.102 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 91' ' ' ARG . . . -59.05 -8.71 6.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.539 -0.362 . . . . 1.5800000000000001 113.926 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.635 ' HA ' ' C ' ' A' ' 90' ' ' MET . 6.3 m-85 -55.06 154.68 5.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 2.7200000000000002 111.779 176.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.83 154.21 32.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.489 -0.56 . . . . 1.1599999999999999 109.489 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 97.7 m95 -76.52 111.28 11.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.9 0.381 . . . . 0.42999999999999999 110.944 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.824 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 10.1 p90 -149.25 146.26 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 3.0299999999999998 109.575 170.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.7 m-85 -44.86 -78.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.947 1.092 . . . . 0.53000000000000003 113.947 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -118.22 -10.57 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.3 -0.56 . . . . 2.3900000000000001 111.621 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.773 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 138.87 92.37 0.25 Allowed Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 119.937 -1.125 . . . . 0.72999999999999998 113.039 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.07 15.51 65.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.843 -0.694 . . . . 0.85999999999999999 111.865 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -138.63 144.16 39.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.462 -0.369 . . . . 1.53 111.502 -176.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.659 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.28 131.34 26.3 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.55 -0.75 . . . . 3.0600000000000001 111.285 171.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.16 160.49 40.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.715 -0.675 . . . . 2.2999999999999998 110.324 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.616 ' HB2' HG22 ' A' ' 53' ' ' VAL . 13.3 t -104.54 134.89 19.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.48 -0.933 . . . . 2.0 108.48 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.53 41.59 0.26 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.433 2.755 . . . . 1.8899999999999999 113.262 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 45' ' ' SER . 21.2 t-20 177.33 41.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.84 -1.17 . . . . 2.4300000000000002 107.84 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -80.58 45.07 0.75 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.603 -0.726 . . . . 3.2599999999999998 111.714 -173.893 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -74.9 -41.06 60.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.013 0.435 . . . . 2.48 111.003 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.656 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -134.86 -21.3 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.329 0.585 . . . . 1.5600000000000001 110.668 -177.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.733 ' HB3' ' O ' ' A' ' 76' ' ' THR . 3.7 m-85 -124.24 162.47 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.223 -0.898 . . . . 0.95999999999999996 109.662 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -152.69 170.6 19.86 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.786 0.661 . . . . 2.0099999999999998 112.786 -160.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.672 HG13 HG12 ' A' ' 75' ' ' VAL . 46.5 t -99.84 123.85 52.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.542 -0.753 . . . . 1.8400000000000001 111.175 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.21 117.82 34.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.281 -0.872 . . . . 2.4500000000000002 108.71 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -104.2 150.19 24.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 2.3900000000000001 111.438 -171.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.19 116.0 3.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.945 -0.57 . . . . 1.96 109.837 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.777 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 9.6 m-85 -113.79 136.05 53.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.479 -0.328 . . . . 1.8700000000000001 111.258 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -130.64 101.29 17.21 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.32 -0.4 . . . . 2.73 109.969 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 3.8 Cg_exo -82.18 136.88 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.199 2.599 . . . . 1.9199999999999999 111.641 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.68 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 92.5 Cg_endo -91.08 -16.38 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.912 2.408 . . . . 2.6400000000000001 113.06 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -176.39 -41.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.025 0.44 . . . . 5.7999999999999998 110.483 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.809 ' HA ' ' HB3' ' A' ' 30' ' ' PRO . 16.2 m 74.86 -50.83 0.67 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.918 -1.037 . . . . 7.4299999999999997 112.63 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.41 5.68 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.798 -0.361 . . . . 9.0800000000000001 111.588 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.431 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 3.7 tt -166.52 -88.52 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.854 -0.425 . . . . 8.4399999999999995 109.854 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.732 HD12 ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -179.95 140.02 0.13 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.473 -0.565 . . . . 4.8499999999999996 109.473 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.68 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -104.67 -18.22 13.24 Favored Glycine 0 C--O 1.234 0.11 0 C-N-CA 120.901 -0.666 . . . . 3.02 111.656 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 174.45 -42.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 4.54 107.694 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.86 -57.56 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.233 -1.349 . . . . 3.3599999999999999 110.8 173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.32 155.35 10.16 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.987 -0.845 . . . . 1.8 110.987 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.407 ' HB ' ' HE2' ' A' ' 72' ' ' HIS . 0.4 OUTLIER -152.74 80.44 1.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.556 0.693 . . . . 1.3 112.58 179.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.777 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.9 mt-10 -105.45 103.59 13.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.458 -0.942 . . . . 0.81000000000000005 108.458 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.571 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -108.59 159.19 16.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.814 0.816 . . . . 0.65000000000000002 111.499 -171.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.824 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 28.4 m-85 -122.47 108.54 13.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.909 -1.496 . . . . 1.4299999999999999 109.018 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.669 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 31.9 m170 -102.31 110.74 22.78 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.515 -0.55 . . . . 0.56000000000000005 109.515 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.672 HG12 HG13 ' A' ' 53' ' ' VAL . 3.3 m -102.18 120.06 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.58 1.181 . . . . 1.49 109.219 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.733 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 13.9 m -103.09 103.61 13.7 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.318 -1.364 . . . . 1.1399999999999999 107.318 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.1 p -160.4 118.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.396 0.435 . . . . 1.6000000000000001 111.259 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.45 104.0 11.0 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.174 0.988 . . . . 2.1600000000000001 109.869 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.452 ' HB1' ' HE2' ' A' ' 50' ' ' MET . . . -165.65 143.26 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.653 -1.158 . . . . 1.1000000000000001 109.737 178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 96.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 1.1100000000000001 111.107 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.32 166.16 38.19 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.33000000000000002 110.175 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -101.62 132.7 47.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.808 0.804 . . . . 1.1499999999999999 109.382 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.661 ' HD1' HG22 ' A' ' 85' ' ' VAL . 44.8 t-80 -103.84 104.95 15.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.494 -0.775 . . . . 0.52000000000000002 109.786 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.23 113.76 27.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.374 0.607 . . . . 1.1100000000000001 109.623 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.96 103.93 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 1.26 111.2 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -105.45 103.71 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.289 -0.634 . . . . 1.53 109.289 173.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.507 ' HG ' HG11 ' A' ' 85' ' ' VAL . 78.0 mt -107.01 123.82 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.51 -0.552 . . . . 1.0900000000000001 109.51 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.488 HG21 ' CG ' ' A' ' 90' ' ' MET . 3.3 m -105.86 119.96 40.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.24 0.543 . . . . 1.1000000000000001 112.002 -169.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 35' ' ' ALA . 28.0 t80 -88.05 85.31 6.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 1.6599999999999999 109.38 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.645 ' HE1' ' HE1' ' A' ' 37' ' ' TYR . 20.7 mtm -124.34 167.13 14.77 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.443 -0.344 . . . . 1.24 110.299 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.454 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.4 ttt180 -78.65 108.67 8.47 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.792 -0.818 . . . . 3.1299999999999999 108.792 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.59 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 5.8 Cg_endo -46.93 -32.24 12.42 Favored 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.546 2.831 . . . . 1.04 115.459 -167.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.59 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.3 p90 -96.92 11.73 34.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.684 0.624 . . . . 1.1799999999999999 112.684 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.3 t -168.63 -50.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 1.3500000000000001 111.87 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 51.48 80.56 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 O-C-N 123.303 0.377 . . . . 1.1599999999999999 112.361 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.845 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 92.4 Cg_exo -40.31 105.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.148 2.565 . . . . 1.6899999999999999 111.218 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.1 m -54.91 125.31 19.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 3.02 111.117 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 77.03 -2.27 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.406 -0.815 . . . . 4.9199999999999999 111.216 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.845 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 26.4 t0 -97.13 -27.34 14.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.941 0.877 . . . . 1.6699999999999999 108.668 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.508 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 12.4 m -68.24 157.08 36.29 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.071 -1.422 . . . . 1.74 110.846 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.1 tp10 -96.51 161.13 14.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.559 -0.904 . . . . 1.9099999999999999 108.559 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 31.5 ttt180 -148.83 139.96 23.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.432 0.634 . . . . 0.78000000000000003 110.315 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.765 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -104.22 155.86 18.38 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 1.0700000000000001 109.208 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 70.5 m -157.15 102.76 1.97 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.73 -0.388 . . . . 1.03 111.161 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.819 HG11 HG22 ' A' ' 5' ' ' VAL . 10.7 p -105.63 136.2 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.639 -0.824 . . . . 1.5 110.014 168.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.61 ' O ' ' HA ' ' A' ' 13' ' ' THR . 88.4 m-85 -104.71 104.64 14.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.047 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.656 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 pp -123.01 147.68 46.38 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.374 -0.602 . . . . 2.6499999999999999 109.374 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.733 ' O ' HG21 ' A' ' 16' ' ' VAL . 38.5 tttt -103.27 115.3 30.29 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.377 -0.529 . . . . 2.3500000000000001 110.557 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.473 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -101.19 153.56 19.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.952 -0.567 . . . . 1.1499999999999999 110.775 -169.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.7 p30 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.242 -0.89 . . . . 1.78 108.891 -178.066 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.934 ' HB3' HG22 ' A' ' 22' ' ' VAL . 6.8 t60 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.222 -0.659 . . . . 1.1000000000000001 109.222 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -141.82 130.05 22.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.283 0.364 . . . . 2.8500000000000001 111.286 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.73 HG13 ' CZ ' ' A' ' 103' ' ' PHE . 2.0 t -104.72 157.7 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.873 0.368 . . . . 1.23 110.462 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -144.81 170.2 16.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.171 0.989 . . . . 1.1000000000000001 108.904 -173.186 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.523 ' HZ1' ' ND2' ' A' ' 29' ' ' ASN . 16.5 tptm -46.9 -43.85 19.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.031 0.752 . . . . 1.47 113.031 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.2 70.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.941 0.877 . . . . 1.05 110.974 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.699 ' HB2' HG11 ' A' ' 5' ' ' VAL . 24.4 m80 -62.57 -4.02 1.76 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.928 . . . . 2.7000000000000002 111.438 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.675 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.7 t-20 -45.84 -22.29 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 1.48 110.422 172.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.65 54.95 0.73 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.904 -0.665 . . . . 0.29999999999999999 111.726 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 105' ' ' VAL . . . -117.38 146.26 43.54 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.157 0.799 . . . . 1.0800000000000001 113.157 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 36.9 m -141.24 111.19 6.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.433 -0.803 . . . . 1.3 109.779 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.0 pp -166.64 171.66 11.41 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.148 0.179 . . . . 3.4700000000000002 110.937 -173.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -99.17 143.65 29.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.106 0.479 . . . . 2.0800000000000001 111.674 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 108' ' ' LYS . 4.0 m -119.08 160.24 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.668 -0.697 . . . . 1.3600000000000001 111.624 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.49 135.99 44.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.213 -0.662 . . . . 1.27 109.213 172.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.634 ' HB ' ' O ' ' A' ' 77' ' ' VAL . 24.3 m -121.5 -166.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.962 0.411 . . . . 1.8500000000000001 111.773 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 108.95 -56.65 0.46 Allowed Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.29 -0.724 . . . . 0.70999999999999996 111.29 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -75.42 -71.99 0.33 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.955 -0.757 . . . . 2.3500000000000001 108.955 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -166.95 141.3 3.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.593 -0.73 . . . . 1.3600000000000001 110.184 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.4 t -120.57 116.7 50.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.526 -0.546 . . . . 1.1799999999999999 109.526 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.714 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -114.78 149.23 37.28 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.663 -0.815 . . . . 1.74 112.225 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 5' ' ' VAL . 44.3 mm -124.13 102.51 11.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.69 -1.141 . . . . 1.1000000000000001 108.681 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.96 141.82 36.7 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.561 -0.712 . . . . 0.64000000000000001 112.46 -172.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -116.73 147.48 39.99 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.25 -0.886 . . . . 1.47 109.403 171.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.422 ' CD ' ' HB2' ' A' ' 7' ' ' LYS . 43.1 Cg_endo -85.98 11.62 3.27 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.883 2.389 . . . . 0.34999999999999998 111.52 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.6 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 30.4 t 70.84 -51.45 0.68 Allowed 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.399 -0.818 . . . . 0.91000000000000003 111.118 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' ND2' ' HZ1' ' A' ' 7' ' ' LYS . 0.8 OUTLIER 58.4 67.36 2.18 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.008 -0.738 . . . . 1.3899999999999999 109.008 -173.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.18 97.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.439 2.759 . . . . 0.97999999999999998 112.618 -168.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.764 HG21 ' HH ' ' A' ' 89' ' ' TYR . 1.3 t -105.11 -39.44 6.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 2.0899999999999999 111.353 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 t -178.21 -150.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.951 -0.759 . . . . 2.6800000000000002 108.951 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.76 -23.36 55.66 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.71 -0.281 . . . . 1.5800000000000001 113.349 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' HA ' ' C ' ' A' ' 90' ' ' MET . 14.3 m-30 -46.01 137.19 6.02 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.212 0.529 . . . . 2.7200000000000002 112.123 172.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.533 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -141.96 149.94 40.77 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.34 -0.985 . . . . 1.1599999999999999 108.34 171.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.575 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.2 m95 -77.04 117.81 18.98 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.568 0.699 . . . . 0.42999999999999999 111.141 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 47.0 m-85 -126.03 -179.59 4.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.186 -1.042 . . . . 3.0299999999999998 108.186 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.8 m-85 -73.2 -82.07 0.05 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.818 -0.753 . . . . 0.53000000000000003 109.505 167.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.76 10.09 24.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 2.3900000000000001 110.144 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.26 105.76 2.51 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.835 -0.698 . . . . 0.72999999999999998 112.225 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 3.3 59.98 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.892 -0.671 . . . . 0.85999999999999999 111.966 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -129.98 142.61 50.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.454 -0.373 . . . . 1.53 111.566 -177.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.828 ' HZ1' ' HH ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -142.61 129.15 20.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.938 -0.573 . . . . 3.0600000000000001 110.835 166.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.35 137.41 34.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.726 -0.67 . . . . 2.2999999999999998 110.14 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.837 ' HB2' HG21 ' A' ' 52' ' ' THR . 15.4 m -104.4 138.7 19.59 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 121.24 0.543 . . . . 2.0 110.714 171.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 48' ' ' GLU . 9.8 Cg_endo -93.66 170.05 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.719 3.613 . . . . 1.8899999999999999 113.493 -168.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.564 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 59.7 t30 74.67 -36.27 0.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.991 0.916 . . . . 2.4300000000000002 111.107 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.716 ' OE1' ' HG2' ' A' ' 50' ' ' MET . 4.9 mm-40 -109.99 148.34 31.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.201 1.001 . . . . 3.2599999999999998 113.561 -170.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.4 t -130.01 -11.85 4.21 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.624 -1.626 . . . . 2.48 109.089 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.716 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 19.0 ptt? -97.89 -37.24 9.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.494 -0.483 . . . . 1.5600000000000001 110.652 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.674 ' CE2' HG21 ' A' ' 76' ' ' THR . 0.2 OUTLIER -147.4 97.01 2.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.519 -0.753 . . . . 0.95999999999999996 110.474 -174.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.837 HG21 ' HB2' ' A' ' 45' ' ' SER . 11.0 t 177.78 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.627 0.649 . . . . 2.0099999999999998 111.446 160.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.577 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -174.73 142.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.953 0.501 . . . . 1.8400000000000001 111.235 162.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.655 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 7.9 tp10 -168.76 154.31 6.42 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.959 -0.756 . . . . 2.4500000000000002 108.959 167.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.7 139.68 25.37 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.171 0.51 . . . . 2.3900000000000001 111.858 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.659 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -163.02 103.87 1.0 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.581 -0.736 . . . . 1.96 110.474 175.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.828 ' HH ' ' HZ1' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -124.81 125.11 43.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 1.8700000000000001 111.495 -177.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.634 ' HB3' HD23 ' A' ' 64' ' ' LEU . 86.9 m-85 -134.04 113.39 12.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.414 -0.812 . . . . 2.73 111.078 -176.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.7 167.62 13.23 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.211 2.607 . . . . 1.9199999999999999 112.39 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.508 ' HG3' ' C ' ' A' ' 68' ' ' GLY . 83.0 Cg_exo -49.92 173.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.859 3.04 . . . . 2.6400000000000001 115.549 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -162.01 -94.84 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.416 -1.72 . . . . 5.7999999999999998 108.117 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -165.81 -51.36 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.868 -1.06 . . . . 7.4299999999999997 108.155 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.733 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -90.69 -27.63 18.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 9.0800000000000001 110.686 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.733 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 41.1 tp -64.08 -55.53 21.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.371 0.605 . . . . 8.4399999999999995 109.668 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.758 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.3 OUTLIER -151.05 -54.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.459 -0.941 . . . . 4.8499999999999996 108.459 174.789 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.64 -59.77 4.64 Favored Glycine 0 C--N 1.322 -0.236 0 CA-C-N 114.678 -1.146 . . . . 3.02 112.677 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.91 -64.56 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.728 0.775 . . . . 4.54 109.981 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.758 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -121.24 -159.36 10.69 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.942 -1.263 . . . . 3.3599999999999999 109.942 173.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.78 -159.85 22.76 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.411 -0.899 . . . . 1.8 111.111 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.25 80.64 0.83 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.436 0.636 . . . . 1.3 111.265 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.722 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 40.4 mt-10 -104.44 103.23 12.9 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.457 -0.792 . . . . 0.81000000000000005 109.01 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.659 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -108.26 145.71 33.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.685 -0.806 . . . . 0.65000000000000002 110.973 -174.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 6.5 m-85 -117.47 109.64 17.01 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.619 -1.173 . . . . 1.4299999999999999 109.736 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.714 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -103.54 149.92 24.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.715 -0.476 . . . . 0.56000000000000005 109.715 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.577 HG12 ' HE2' ' A' ' 83' ' ' HIS . 3.5 m -132.95 126.93 54.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.882 0.848 . . . . 1.49 108.902 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.674 HG21 ' CE2' ' A' ' 51' ' ' PHE . 3.7 m -102.39 101.36 11.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 1.1399999999999999 108.452 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.634 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 3.8 p -144.14 145.88 21.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.503 -0.479 . . . . 1.6000000000000001 112.074 -167.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.694 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -138.91 103.48 4.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.55 -0.907 . . . . 2.1600000000000001 108.55 163.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.31 164.92 19.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 1.1000000000000001 109.597 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.58 86.95 2.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 1.1100000000000001 109.998 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -158.05 167.92 34.44 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.42 -0.809 . . . . 0.33000000000000002 111.184 -175.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.1 m -100.23 132.6 45.51 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.817 -0.753 . . . . 1.1499999999999999 109.908 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.85 ' HD1' HG21 ' A' ' 85' ' ' VAL . 48.2 t-80 -103.5 103.82 13.82 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.753 -0.658 . . . . 0.52000000000000002 109.586 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.17 110.97 23.06 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.957 -0.757 . . . . 1.1100000000000001 108.957 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.85 HG21 ' HD1' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -107.44 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.682 -0.69 . . . . 1.26 110.292 -171.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.507 ' N ' HD21 ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.22 103.6 12.82 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.917 -0.771 . . . . 1.53 108.917 176.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 38' ' ' PHE . 63.7 mt -107.35 123.99 49.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.641 -0.709 . . . . 1.0900000000000001 109.666 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.499 HG21 ' CG ' ' A' ' 90' ' ' MET . 4.4 m -102.15 119.8 39.4 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.871 0.844 . . . . 1.1000000000000001 110.688 -173.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.764 ' HH ' HG21 ' A' ' 31' ' ' THR . 7.4 t80 -89.3 88.37 7.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.503 -1.226 . . . . 1.6599999999999999 109.676 -175.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.575 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 14.1 mtm -129.22 166.43 19.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.245 0.545 . . . . 1.24 111.051 -172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.432 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.3 mtm180 -70.04 107.39 2.31 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.859 -1.064 . . . . 3.1299999999999999 108.786 168.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.5 Cg_endo -51.63 -27.0 24.38 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.335 2.69 . . . . 1.04 114.655 -169.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.457 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 45.7 p90 -93.46 3.89 54.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.0 0.37 . . . . 1.1799999999999999 112.0 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 95' ' ' GLY . 2.3 t -164.06 -66.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.834 -0.166 . . . . 1.3500000000000001 111.14 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.683 ' H ' HG22 ' A' ' 94' ' ' THR . . . 67.53 94.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.012 -0.435 . . . . 1.1599999999999999 112.012 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.941 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 15.8 Cg_exo -64.92 130.03 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.607 2.205 . . . . 1.6899999999999999 111.11 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.8 t -43.75 -50.32 7.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.955 0.902 . . . . 3.02 113.018 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -121.65 20.79 10.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.522 -0.471 . . . . 4.9199999999999999 111.029 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.941 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.7 t0 -103.99 -22.18 13.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.412 -0.958 . . . . 1.6699999999999999 108.412 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.3 m -80.0 148.22 31.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.614 -1.175 . . . . 1.74 110.561 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.84 172.87 7.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.096 -1.076 . . . . 1.9099999999999999 108.096 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 26.6 ttt180 -158.48 139.01 12.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.407 0.623 . . . . 0.78000000000000003 110.361 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.766 ' CZ ' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -103.76 155.88 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.875 -1.057 . . . . 1.0700000000000001 109.069 -178.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 24.3 m -157.36 104.56 2.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.881 0.372 . . . . 1.03 110.972 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.766 ' HB ' ' CZ ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -103.81 132.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 119.769 -0.772 . . . . 1.5 109.592 168.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.684 ' O ' HD12 ' A' ' 107' ' ' LEU . 73.1 m-85 -108.06 97.42 7.12 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.628 -1.249 . . . . 1.0 107.628 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.684 HD12 ' O ' ' A' ' 106' ' ' TYR . 8.9 mp -134.21 144.78 48.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.288 -0.634 . . . . 2.6499999999999999 109.288 -173.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 16' ' ' VAL . 35.5 ttpt -102.81 130.98 49.98 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.129 -0.628 . . . . 2.3500000000000001 110.946 -166.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.564 ' HB1' HG13 ' A' ' 18' ' ' VAL . . . -100.06 132.37 45.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 1.1499999999999999 109.566 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.588 ' C ' HG21 ' A' ' 18' ' ' VAL . 6.2 p30 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.386 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.973 ' HB3' HG21 ' A' ' 22' ' ' VAL . 33.3 t60 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.385 -0.598 . . . . 1.1000000000000001 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -138.91 134.15 32.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.266 -0.642 . . . . 2.8500000000000001 109.266 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.93 HG21 HG23 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -107.49 125.81 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 119.5 -0.88 . . . . 1.23 110.685 178.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.78 ' N ' ' HD1' ' A' ' 9' ' ' HIS . 0.7 OUTLIER -120.99 152.09 38.97 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.122 0.416 . . . . 1.1000000000000001 112.122 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 27.0 tptp -31.17 -45.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.252 1.945 . . . . 1.47 116.252 -153.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.61 -34.98 1.57 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.311 1.053 . . . . 1.05 111.731 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.925 ' ND1' HG11 ' A' ' 5' ' ' VAL . 2.4 p-80 -55.19 -9.36 0.4 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.126 -1.397 . . . . 2.7000000000000002 113.159 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -58.14 -15.32 9.24 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 107.633 -1.247 . . . . 1.48 107.633 -174.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.91 58.63 0.69 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.091 -1.413 . . . . 0.29999999999999999 110.169 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.762 ' HB1' ' HA ' ' A' ' 9' ' ' HIS . . . -116.09 151.91 34.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.752 0.649 . . . . 1.0800000000000001 112.752 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 23.6 m -149.43 108.45 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.772 -0.649 . . . . 1.3 109.941 173.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.743 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.1 pt? -150.67 166.85 29.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 3.4700000000000002 111.25 -171.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -103.11 144.63 31.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.638 -0.256 . . . . 2.0800000000000001 110.424 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -128.41 156.27 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 1.3600000000000001 111.493 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.2 137.73 42.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.338 -0.986 . . . . 1.27 108.338 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG11 HG22 ' A' ' 22' ' ' VAL . 29.5 m -115.74 -178.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.664 -0.414 . . . . 1.8500000000000001 111.424 -177.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.4 -60.59 0.66 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.272 -0.731 . . . . 0.70999999999999996 111.272 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.2 -72.08 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.339 0.59 . . . . 2.3500000000000001 109.725 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.4 tp -165.69 133.36 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.984 . . . . 1.3600000000000001 110.45 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.973 HG21 ' HB3' ' A' ' 3' ' ' HIS . 2.2 t -119.95 113.0 39.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.368 -0.604 . . . . 1.1799999999999999 109.368 174.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.527 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.2 pt-20 -111.48 157.32 20.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.509 1.147 . . . . 1.74 112.985 -173.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.6 mm -126.62 102.69 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.889 -1.959 . . . . 1.1000000000000001 107.405 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.531 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -114.59 135.17 54.43 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.04 0.924 . . . . 0.64000000000000001 111.91 -173.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.33 145.32 32.63 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.735 -1.12 . . . . 1.47 108.855 174.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 71.4 Cg_endo -82.12 7.08 5.3 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.648 2.232 . . . . 0.34999999999999998 111.345 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.622 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 67.77 -64.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.91000000000000003 109.658 -172.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.71 67.98 1.23 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.285 -1.006 . . . . 1.3899999999999999 108.285 -171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.655 ' HB3' ' HA ' ' A' ' 62' ' ' SER . 73.1 Cg_exo -53.82 108.83 0.31 Allowed 'Trans proline' 0 CA--C 1.52 -0.177 0 C-N-CA 123.378 2.719 . . . . 0.97999999999999998 112.813 -169.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.87 -37.25 13.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.363 -0.835 . . . . 2.0899999999999999 111.482 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 t -178.22 -44.7 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 111.748 0.277 . . . . 2.6800000000000002 111.748 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.98 -32.97 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 111.436 -0.665 . . . . 1.5800000000000001 111.436 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HE1' ' HD2' ' A' ' 96' ' ' PRO . 31.2 m-85 -43.26 141.49 1.26 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.222 -0.489 . . . . 2.7200000000000002 111.778 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.502 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -140.17 150.22 43.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.847 -1.07 . . . . 1.1599999999999999 108.438 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.622 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.4 m95 -78.83 118.37 20.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.969 0.414 . . . . 0.42999999999999999 111.01 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.798 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -150.37 145.68 26.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 3.0299999999999998 109.789 172.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 1.1 m-85 -46.37 -76.19 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.879 0.696 . . . . 0.53000000000000003 112.879 -172.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.23 -8.84 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 2.3900000000000001 110.936 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.682 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 116.75 86.64 1.24 Allowed Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 119.72 -1.228 . . . . 0.72999999999999998 112.193 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.6 -4.34 74.15 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.149 -0.78 . . . . 0.85999999999999999 111.149 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.39 137.84 52.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.836 -0.431 . . . . 1.53 109.836 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -141.52 139.59 33.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.534 -0.543 . . . . 3.0600000000000001 109.534 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.3 165.37 27.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.23 0.538 . . . . 2.2999999999999998 111.487 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.49 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 2.6 p -114.26 140.05 24.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.603 -0.726 . . . . 2.0 109.247 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.6 Cg_exo -76.16 -5.59 16.42 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 1.8899999999999999 113.128 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.492 HD21 ' HB1' ' A' ' 79' ' ' ALA . 9.4 p-10 -151.17 67.64 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.496 0.665 . . . . 2.4300000000000002 110.663 -177.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -109.45 -147.49 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 3.2599999999999998 111.518 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m 71.43 36.14 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.431 0.634 . . . . 2.48 110.894 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptt? 175.94 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.57 -1.195 . . . . 1.5600000000000001 107.879 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 11.6 m-85 -130.13 162.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.336 -1.756 . . . . 0.95999999999999996 106.291 173.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -152.46 166.13 32.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 119.48 1.036 . . . . 2.0099999999999998 112.953 -165.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.3 p -103.01 133.08 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.14 -0.936 . . . . 1.8400000000000001 110.966 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 28.9 tt0 -104.18 153.98 20.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.99 -1.004 . . . . 2.4500000000000002 108.779 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -133.47 122.73 24.09 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.094 -0.503 . . . . 2.3900000000000001 109.966 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.795 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -137.73 113.27 9.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.617 0.722 . . . . 1.96 110.07 176.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.789 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.4 m-85 -106.83 124.04 49.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.333 -0.848 . . . . 1.8700000000000001 110.49 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.456 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 96.7 m-85 -119.91 101.05 48.16 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.284 0.564 . . . . 2.73 110.586 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.463 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 1.8 Cg_endo -90.64 131.95 1.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.073 3.182 . . . . 1.9199999999999999 111.628 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.859 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 39.0 Cg_exo -64.39 -58.39 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.368 2.712 . . . . 2.6400000000000001 112.548 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.58 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 8.6 m-20 -147.66 -47.71 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.555 -0.748 . . . . 5.7999999999999998 110.312 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.655 ' HA ' ' HB3' ' A' ' 30' ' ' PRO . 21.0 t 82.99 -21.91 0.27 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.414 -1.266 . . . . 7.4299999999999997 110.765 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.58 ' HG3' ' HB3' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -74.69 -18.6 60.5 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.85 -1.166 . . . . 9.0800000000000001 107.85 165.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.795 ' HG ' ' H ' ' A' ' 65' ' ' LEU . 14.5 tp -165.12 -156.88 0.32 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.802 -1.544 . . . . 8.4399999999999995 108.005 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.795 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -109.5 164.68 12.29 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.035 -0.53 . . . . 4.8499999999999996 109.8 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.859 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -136.82 27.81 2.9 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.084 -0.962 . . . . 3.02 110.993 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 67.15 -66.24 0.2 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.632 0.773 . . . . 4.54 110.992 -171.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.27 60.65 4.73 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.922 -0.581 . . . . 3.3599999999999999 113.321 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -78.98 122.72 5.91 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.85 -1.7 . . . . 1.8 108.85 168.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.49 92.62 1.51 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.418 0.896 . . . . 1.3 113.418 -168.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.789 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 36.8 mt-10 -104.44 106.82 17.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.81000000000000005 108.741 174.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.795 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.6 m170 -107.4 152.78 23.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.413 0.625 . . . . 0.65000000000000002 111.825 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.798 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 30.8 m-85 -123.44 108.29 12.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.301 -1.318 . . . . 1.4299999999999999 108.6 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.608 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 21.0 m170 -103.6 107.65 18.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.194 -0.457 . . . . 0.56000000000000005 110.377 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.759 HG12 ' HE2' ' A' ' 83' ' ' HIS . 3.3 m -101.93 113.99 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-O 122.986 1.374 . . . . 1.49 108.463 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 16.9 m -101.52 103.23 14.08 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.723 -1.584 . . . . 1.1399999999999999 106.723 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.57 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.2 p -153.97 146.82 14.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 124.167 0.917 . . . . 1.6000000000000001 111.179 -173.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.59 102.5 6.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.561 0.696 . . . . 2.1600000000000001 109.533 166.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.492 ' HB1' HD21 ' A' ' 47' ' ' ASN . . . -165.83 140.29 4.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.69 -0.687 . . . . 1.1000000000000001 110.043 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.89 95.89 2.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.383 0.611 . . . . 1.1100000000000001 111.213 -177.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.75 34.03 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.201 -0.909 . . . . 0.33000000000000002 110.993 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.0 m -102.97 134.84 45.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.895 -0.78 . . . . 1.1499999999999999 108.895 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.884 ' HD1' HG22 ' A' ' 85' ' ' VAL . 31.0 t-80 -102.96 105.35 15.67 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.36 -0.607 . . . . 0.52000000000000002 109.36 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.11 106.63 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.808 -0.812 . . . . 1.1100000000000001 108.808 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.884 HG22 ' HD1' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -104.88 110.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 1.26 110.773 -170.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -114.39 104.28 11.89 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.962 0.789 . . . . 1.53 109.164 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.579 ' H ' ' HD1' ' A' ' 103' ' ' PHE . 76.6 mt -105.55 130.48 53.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.166 -0.679 . . . . 1.0900000000000001 109.166 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.525 HG21 ' CG ' ' A' ' 90' ' ' MET . 6.7 m -102.42 122.08 43.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.343 0.592 . . . . 1.1000000000000001 110.354 -172.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.502 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.2 t80 -91.18 85.54 5.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.308 -0.86 . . . . 1.6599999999999999 109.486 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.584 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . 7.9 mtm -128.94 172.35 11.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.177 0.513 . . . . 1.24 110.943 -175.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.501 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 5.4 mtm180 -84.23 109.84 22.19 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.485 -0.779 . . . . 3.1299999999999999 109.477 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 2.0 Cg_endo -41.63 -34.7 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.724 3.616 . . . . 1.04 115.51 -168.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -87.03 3.53 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.504 0.557 . . . . 1.1799999999999999 112.504 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 95' ' ' GLY . 6.2 t -169.22 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.409 -0.182 . . . . 1.3500000000000001 111.401 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.584 ' CA ' ' HB3' ' A' ' 90' ' ' MET . . . 66.12 78.74 0.22 Allowed Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.137 -0.554 . . . . 1.1599999999999999 111.784 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 1.019 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 71.6 Cg_exo -47.82 121.51 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.296 2.664 . . . . 1.6899999999999999 111.958 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -50.08 -39.52 42.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.969 -1.014 . . . . 3.02 113.25 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -112.79 17.53 18.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.32 -0.552 . . . . 4.9199999999999999 110.925 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 1.019 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 25.3 t0 -121.53 -0.29 9.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.737 0.78 . . . . 1.6699999999999999 109.57 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 p -97.9 156.22 16.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.104 -0.953 . . . . 1.74 110.96 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 40.6 tt0 -108.26 175.81 5.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.453 -0.943 . . . . 1.9099999999999999 108.453 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 47.8 ttt180 -158.7 142.81 15.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.685 0.755 . . . . 0.78000000000000003 110.483 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.718 ' CZ ' HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -104.16 162.81 12.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.428 -1.26 . . . . 1.0700000000000001 109.796 -177.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.761 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 38.2 m -164.67 104.82 0.82 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 123.407 0.442 . . . . 1.03 110.39 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.93 HG23 HG21 ' A' ' 5' ' ' VAL . 13.4 p -110.87 136.67 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 119.408 -0.917 . . . . 1.5 109.153 166.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 13' ' ' THR . 98.0 m-85 -103.5 103.44 13.41 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 174.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.743 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -127.26 147.24 50.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.653 -0.499 . . . . 2.6499999999999999 109.653 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.703 ' O ' HG22 ' A' ' 16' ' ' VAL . 20.1 tttm -102.38 117.02 33.82 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.78 -0.368 . . . . 2.3500000000000001 110.346 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.502 ' HB3' HG12 ' A' ' 18' ' ' VAL . . . -100.62 120.4 39.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.614 0.571 . . . . 1.1499999999999999 110.176 -170.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.513 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.516 -0.754 . . . . 1.78 110.422 -174.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.98 ' HB3' HG22 ' A' ' 22' ' ' VAL . 16.1 t60 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.072 -0.714 . . . . 0.59 109.072 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 136.65 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.567 -0.288 . . . . 2.36 110.972 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.874 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -112.36 157.5 13.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.856 0.36 . . . . 0.49 111.03 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -151.76 170.64 19.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.421 1.089 . . . . 0.51 108.113 -172.01 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 26.0 tptp -48.33 -37.06 15.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.561 0.949 . . . . 0.83 113.561 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.08 79.2 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.914 0.864 . . . . 0.33 110.742 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.773 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.6 m80 -65.32 -3.7 4.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.134 -0.939 . . . . 2.12 111.346 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.638 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 3.1 t30 -50.27 -18.92 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.679 0.612 . . . . 1.41 110.03 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.45 55.73 0.6 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.3 111.285 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.921 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -113.79 156.1 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.041 0.756 . . . . 0.32 113.041 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 m -139.39 112.69 8.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.185 -1.042 . . . . 0.95 108.185 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 23.1 tp -151.14 163.24 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 3.0 111.74 -167.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.0 m -104.58 148.04 26.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.179 -0.674 . . . . 1.73 109.179 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.8 m -127.55 156.82 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.053 -0.659 . . . . 0.78 112.429 -177.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.76 142.4 34.77 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.789 -1.189 . . . . 0.76 107.789 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG12 HG21 ' A' ' 22' ' ' VAL . 10.7 m -119.8 -176.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.792 0.329 . . . . 1.23 110.724 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.6 -59.52 0.69 Allowed Glycine 0 CA--C 1.505 -0.58 0 N-CA-C 111.224 -0.75 . . . . 0.71 111.224 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -73.68 -68.22 0.53 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 2.35 108.96 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -167.64 141.33 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.755 -1.111 . . . . 0.71 110.283 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.98 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -113.68 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.494 -0.928 . . . . 0.4 108.494 169.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.666 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -108.88 157.35 18.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.056 0.931 . . . . 1.09 112.524 -169.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.593 HD13 ' HB ' ' A' ' 5' ' ' VAL . 29.7 mm -134.28 103.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.579 -1.646 . . . . 0.54 108.428 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.528 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -112.73 139.0 48.71 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.528 -0.733 . . . . 0.64 112.194 -175.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -111.59 148.41 38.8 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.531 -0.759 . . . . 0.85 109.947 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 40.3 Cg_endo -87.09 11.84 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.229 2.619 . . . . 0.35 111.976 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.519 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 21.5 t 69.3 -66.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.343 -0.844 . . . . 0.91 110.83 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.23 64.05 2.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.438 -0.949 . . . . 1.39 108.438 -170.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.41 117.76 2.5 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.88 3.053 . . . . 0.83 113.272 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.422 HG23 ' CZ ' ' A' ' 89' ' ' TYR . 22.3 p -91.64 -89.1 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.212 -0.904 . . . . 1.83 112.849 -170.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 t -163.26 22.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.007 0.908 . . . . 2.36 110.141 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.26 -35.83 1.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.46 -0.791 . . . . 1.3 111.377 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' HA ' ' C ' ' A' ' 90' ' ' MET . 2.2 m-85 -62.43 143.99 56.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.974 -0.613 . . . . 2.22 111.189 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -139.53 156.04 47.15 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.387 -0.968 . . . . 0.44 108.387 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.519 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -81.0 117.27 21.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.518 0.675 . . . . 0.43 111.51 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.73 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 56.2 m-85 -127.46 175.78 7.97 Favored 'General case' 0 C--O 1.212 -0.882 0 N-CA-C 108.179 -1.045 . . . . 2.78 108.179 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.72 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -67.2 -74.38 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.773 0.715 . . . . 0.43 109.715 171.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -110.51 -8.16 14.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.048 -0.524 . . . . 2.39 110.157 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.08 106.59 2.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.366 -0.921 . . . . 0.73 112.047 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.25 -23.92 5.86 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.674 . . . . 0.7 112.448 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 m -128.33 141.84 51.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.653 0.263 . . . . 1.13 110.41 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -136.97 134.85 37.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.682 -0.69 . . . . 2.52 110.048 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -128.54 145.85 51.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.754 0.788 . . . . 2.3 112.136 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.867 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 6.2 p -111.43 137.75 21.19 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.584 -0.895 . . . . 1.61 108.584 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 7.5 Cg_exo -74.42 137.16 22.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.434 2.089 . . . . 1.88 111.431 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 69.18 34.46 3.0 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.902 0.751 . . . . 2.43 110.949 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.04 137.93 34.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.787 0.803 . . . . 3.26 110.945 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.7 t 177.56 -55.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.045 -1.434 . . . . 2.06 107.396 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -89.84 -32.41 16.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.015 -0.993 . . . . 1.25 109.336 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.787 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.5 m-85 -119.46 160.36 22.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.463 -1.244 . . . . 0.74 107.767 176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -165.74 169.44 15.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.651 0.66 . . . . 1.46 112.131 -168.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.867 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.2 p -103.1 139.66 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.696 -0.684 . . . . 1.31 111.952 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.836 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.38 142.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.893 -0.78 . . . . 2.45 108.893 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -122.44 133.4 54.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.384 0.611 . . . . 1.93 111.195 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -150.1 111.0 4.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.268 -0.878 . . . . 1.42 110.495 -176.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.913 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -123.92 127.02 47.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.671 -0.695 . . . . 1.66 111.257 -174.247 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.3 -0.864 . . . . 2.14 111.003 -177.563 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 109.808 -1.317 . . . . 1.49 109.808 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.497 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -153.99 90.18 1.35 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 113.836 1.05 . . . . 0.97 113.836 -168.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.7 mt-10 -110.31 104.12 12.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.54 -0.754 . . . . 0.81 109.083 175.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.633 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -113.64 159.4 19.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.777 0.799 . . . . 0.53 112.445 -171.303 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.73 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 44.9 m-85 -132.28 108.91 9.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.933 -1.485 . . . . 1.13 109.4 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.836 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 26.0 m170 -108.61 107.46 17.96 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.203 -0.31 . . . . 0.5 111.339 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -103.75 119.34 52.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.047 0.927 . . . . 0.87 110.419 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.8 m -102.85 105.75 16.2 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.979 -1.119 . . . . 0.46 107.979 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.538 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.3 p -147.45 149.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 123.633 0.583 . . . . 1.04 110.335 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -133.91 102.3 5.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.966 0.888 . . . . 1.54 109.884 167.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -168.34 127.56 1.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.34 -0.845 . . . . 0.67 109.887 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.32 101.42 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 O-C-N 123.648 0.592 . . . . 0.44 111.916 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.87 167.57 36.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.349 -0.7 . . . . 0.29 111.349 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.594 HG23 ' HD2' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -103.43 128.63 50.53 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.9 -0.765 . . . . 0.4 109.883 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.632 ' CE1' HG22 ' A' ' 85' ' ' VAL . 1.8 t-80 -103.38 106.35 16.84 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.526 -0.546 . . . . 0.4 109.526 -175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.38 109.34 21.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.497 -0.927 . . . . 0.35 108.497 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.36 103.83 15.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.027 -0.533 . . . . 0.59 110.257 -169.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 2.8 m-20 -109.65 103.41 12.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.504 -0.771 . . . . 1.53 109.118 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' A' ' 38' ' ' PHE . 96.0 mt -104.72 125.56 50.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.763 -0.653 . . . . 0.24 109.571 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.68 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.8 m -100.87 122.46 43.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.658 0.742 . . . . 0.29 110.762 -169.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -92.8 87.18 5.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.686 -1.143 . . . . 1.11 109.884 -174.181 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.57 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 1.4 mtm -134.1 165.94 23.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.203 0.525 . . . . 0.65 110.993 -173.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.53 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 77.2 mtt180 -64.86 111.28 5.45 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.971 -1.013 . . . . 2.59 109.272 170.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.97 -26.25 24.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.288 2.658 . . . . 1.04 114.405 -171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 94' ' ' THR . 42.9 p90 -90.11 -3.22 58.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.002 0.371 . . . . 1.17 112.002 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 95' ' ' GLY . 6.8 t -169.25 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.462 -0.149 . . . . 1.09 111.369 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.29 98.13 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 1.16 111.838 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.733 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.7 Cg_exo -49.55 126.69 16.67 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.916 2.411 . . . . 1.2 111.334 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -54.17 -29.75 46.79 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.503 0.927 . . . . 2.64 113.503 -168.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -129.43 14.78 6.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.147 -0.621 . . . . 4.09 111.594 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 16.1 t0 -112.29 -1.82 15.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.857 0.837 . . . . 1.67 109.528 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.7 m -95.0 136.98 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.765 -1.107 . . . . 1.39 110.13 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.681 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.9 tt0 -86.86 179.03 6.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 1.91 108.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.681 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 46.7 ttt180 -158.09 145.05 17.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.903 0.859 . . . . 0.62 110.071 174.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.812 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -103.36 150.79 23.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.004 -1.453 . . . . 0.86 109.124 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.4 m -153.41 102.78 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.862 -0.335 . . . . 0.31 110.862 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.921 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.6 p -104.86 136.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 119.663 -0.815 . . . . 0.88 109.395 167.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -104.4 103.49 13.21 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.271 -0.877 . . . . 0.7 108.703 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 3.1 pp -126.95 152.51 47.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.218 -0.447 . . . . 2.12 109.95 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.762 ' O ' HG22 ' A' ' 16' ' ' VAL . 30.9 tptt -104.91 111.23 23.91 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.681 -0.407 . . . . 1.89 110.099 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -103.47 122.8 45.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 123.409 0.443 . . . . 0.53 110.139 -174.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.468 HD21 ' CG ' ' A' ' 108' ' ' LYS . 10.5 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.188 -0.91 . . . . 1.78 110.687 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.962 ' HB3' HG22 ' A' ' 22' ' ' VAL . 42.8 t60 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.59 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 19.1 ptmt -143.92 142.3 30.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.684 0.278 . . . . 2.36 110.83 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.84 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -107.41 138.97 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 0.49 111.458 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 168.06 10.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.926 -1.034 . . . . 0.51 110.335 171.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.7 tptp -37.5 -45.57 0.74 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.739 1.385 . . . . 0.83 114.739 -172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.96 62.52 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.61 0.719 . . . . 0.33 111.803 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.813 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.5 m80 -65.95 -1.79 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 2.12 111.282 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.564 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 4.6 t30 -47.38 -17.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.847 0.717 . . . . 1.41 110.089 170.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.93 55.9 0.61 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.7 -0.682 . . . . 0.3 111.74 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.028 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -108.53 158.35 17.64 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.582 0.956 . . . . 0.32 113.582 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.7 m -147.11 104.98 3.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.018 -0.992 . . . . 0.95 108.856 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 17.9 mt -146.29 167.28 23.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.855 0.687 . . . . 3.0 112.855 -170.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.4 m -103.54 136.0 44.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.714 -0.676 . . . . 1.73 110.139 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.597 HG11 ' CD2' ' A' ' 3' ' ' HIS . 30.9 m -126.2 154.04 35.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 0.78 112.11 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.55 143.17 33.42 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.83 -0.804 . . . . 0.76 108.83 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.683 HG12 HG21 ' A' ' 22' ' ' VAL . 23.7 m -121.48 -179.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.952 0.406 . . . . 1.23 111.747 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.97 -60.61 0.67 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.65 -0.704 . . . . 0.71 111.403 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.58 -74.15 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.424 0.63 . . . . 2.35 109.994 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.8 tp -165.61 136.03 3.65 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.977 -1.01 . . . . 0.71 109.681 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.962 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.4 t -120.17 110.18 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.353 0.597 . . . . 0.4 109.663 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 4.4 pt-20 -111.33 159.67 17.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.805 0.812 . . . . 1.09 111.901 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.632 HD12 HG11 ' A' ' 105' ' ' VAL . 29.9 mm -134.26 103.8 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.174 -1.376 . . . . 0.54 108.527 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -108.11 141.44 39.81 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.299 0.571 . . . . 0.64 111.55 -174.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 7' ' ' LYS . 4.1 mm? -117.11 146.75 38.79 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.128 -0.942 . . . . 0.85 108.864 171.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.612 ' HG2' ' ND2' ' A' ' 29' ' ' ASN . 67.7 Cg_endo -83.98 9.62 4.04 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 122.685 2.257 . . . . 0.35 111.804 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.61 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 69.53 -47.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.042 0.839 . . . . 0.91 110.667 -174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' ND2' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m120 58.08 63.05 4.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.124 -1.065 . . . . 1.39 108.124 -173.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.5 100.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.669 2.913 . . . . 0.83 113.501 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.446 HG22 ' OH ' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -106.89 -36.67 6.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.091 -0.959 . . . . 1.83 111.074 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 34' ' ' PHE . 11.6 t -176.47 -157.44 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.024 -0.732 . . . . 2.36 109.024 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.41 -22.99 17.24 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.483 -0.389 . . . . 1.3 113.16 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' A' ' 90' ' ' MET . 15.4 m-30 -40.23 137.93 0.95 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.765 0.654 . . . . 2.22 112.765 171.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.26 154.83 41.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.975 -1.011 . . . . 0.44 109.021 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.61 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.3 m95 -85.12 124.29 31.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 0.43 111.369 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.912 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -157.81 145.07 18.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 2.78 109.733 175.258 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.578 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -48.77 -75.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.333 0.494 . . . . 0.43 112.333 -173.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.21 -17.85 18.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.445 0.64 . . . . 2.39 110.298 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.766 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 113.6 85.56 1.4 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.299 -0.953 . . . . 0.73 111.525 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.29 70.07 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.535 -0.84 . . . . 0.7 111.576 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.7 m -129.1 140.36 51.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 1.13 109.648 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -140.63 141.02 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.655 -0.498 . . . . 2.52 109.655 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.04 161.66 37.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.171 0.51 . . . . 2.3 111.832 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.752 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 20.6 t -115.03 130.88 23.85 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.928 -0.767 . . . . 1.61 108.928 170.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 14.8 Cg_exo -68.91 -4.29 13.12 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.569 2.179 . . . . 1.88 112.064 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.19 4.65 10.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.947 -0.569 . . . . 2.43 111.416 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.6 pt-20 -84.08 101.05 11.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.863 0.84 . . . . 3.26 111.709 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -127.95 5.71 5.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 2.06 110.558 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -170.04 -36.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.214 1.007 . . . . 1.25 108.579 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.833 ' HB3' ' O ' ' A' ' 76' ' ' THR . 4.1 m-85 -104.84 165.33 11.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.581 -1.645 . . . . 0.74 107.424 172.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -157.46 172.04 19.28 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.764 0.711 . . . . 1.46 112.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.752 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 21.8 t -99.57 134.17 39.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.535 -0.757 . . . . 1.31 111.716 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -111.34 125.02 53.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.711 -0.677 . . . . 2.45 109.194 170.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -103.9 152.28 22.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 1.93 110.905 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -162.4 111.77 1.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.42 109.81 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.855 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.2 m-85 -111.39 118.73 36.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.446 -0.343 . . . . 1.66 110.292 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.205 0.526 . . . . 2.14 110.658 176.382 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 110.449 -1.06 . . . . 1.49 110.449 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.25 87.82 1.34 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.638 0.732 . . . . 0.97 112.38 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.855 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.2 mt-10 -104.55 105.78 16.02 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.022 -0.99 . . . . 0.81 108.481 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.722 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 7.5 m-70 -104.98 150.29 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.747 0.784 . . . . 0.53 111.805 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.912 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.6 m-85 -122.82 104.89 9.57 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.303 -1.317 . . . . 1.13 108.864 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -102.47 107.15 18.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.963 -0.384 . . . . 0.5 109.963 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.4 m -102.62 116.53 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 122.706 1.241 . . . . 0.87 108.33 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.833 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.7 m -102.64 106.37 17.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.177 -1.416 . . . . 0.46 107.177 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.0 p -154.58 149.81 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 123.692 0.62 . . . . 1.04 111.13 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -131.18 103.5 6.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.523 -0.547 . . . . 1.54 109.523 167.091 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.42 127.26 2.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.315 -0.402 . . . . 0.67 110.672 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -60.54 100.53 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.787 0.679 . . . . 0.44 111.089 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.49 169.58 40.0 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.474 -1.051 . . . . 0.29 110.474 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -101.99 132.09 48.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.642 -0.917 . . . . 0.4 109.698 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 85' ' ' VAL . 40.1 t-80 -102.64 104.16 14.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.691 -0.485 . . . . 0.4 109.691 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.53 111.99 24.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.417 -0.586 . . . . 0.35 109.417 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.62 103.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.95 -0.568 . . . . 0.59 110.852 -171.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 102' ' ' ARG . 3.8 m-20 -108.15 102.87 11.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.88 -0.785 . . . . 1.53 108.88 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.447 ' HG ' HG12 ' A' ' 85' ' ' VAL . 96.0 mt -108.09 127.41 53.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.773 -0.649 . . . . 0.24 109.96 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.459 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.7 m -102.75 130.59 49.75 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.525 0.679 . . . . 0.29 110.968 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 10.9 t80 -102.6 88.75 3.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.272 -0.877 . . . . 1.11 109.633 -175.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 15.5 mtm -126.75 177.94 6.24 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.457 -0.571 . . . . 0.65 109.457 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.646 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 7.6 ttm180 -93.17 112.73 57.53 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.533 -0.914 . . . . 2.59 108.533 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 93' ' ' TRP . 1.5 Cg_endo -44.74 -48.3 10.68 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.573 2.848 . . . . 1.04 114.293 -169.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 92' ' ' PRO . 39.5 p90 -80.34 0.39 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.566 . . . . 1.17 112.527 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.812 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.3 t -158.4 -79.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.57 -0.159 . . . . 1.09 110.57 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.812 ' H ' HG23 ' A' ' 94' ' ' THR . . . 76.62 82.44 0.53 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 121.066 -0.587 . . . . 1.16 112.013 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.77 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 1.5 Cg_endo -42.17 125.35 3.31 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.852 3.035 . . . . 1.2 112.09 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.6 m -55.01 -39.35 69.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.921 -1.036 . . . . 2.64 112.969 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.76 1.61 19.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.825 -0.35 . . . . 4.09 110.925 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.77 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.2 t0 -100.91 -16.29 17.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.518 0.675 . . . . 1.67 109.427 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.3 p -73.79 133.75 43.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.051 -0.977 . . . . 1.39 111.486 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 8.3 tp10 -86.96 169.64 12.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.596 -0.89 . . . . 1.91 108.596 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 22.0 ttt180 -155.82 142.41 18.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.843 0.83 . . . . 0.62 110.648 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.84 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 3.1 t80 -104.65 154.87 19.41 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.096 -1.411 . . . . 0.86 109.378 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 52.4 m -158.8 101.95 1.66 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.043 0.449 . . . . 0.31 110.253 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 12' ' ' ALA . 11.0 p -104.87 132.0 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.079 -0.648 . . . . 0.88 109.602 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' THR . 69.5 m-85 -105.17 113.55 27.21 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.697 -0.683 . . . . 0.7 109.386 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.681 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -136.27 158.53 44.19 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.351 -0.611 . . . . 2.12 109.351 178.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 30.9 tttm -103.99 114.22 28.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.872 -0.418 . . . . 1.89 109.872 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.498 ' HA ' HG23 ' A' ' 16' ' ' VAL . . . -101.18 125.42 47.81 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.402 0.438 . . . . 0.53 109.851 -171.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.643 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.09 -0.957 . . . . 1.78 110.125 -171.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.813 ' HB3' HG22 ' A' ' 22' ' ' VAL . 5.3 t60 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.33 -0.989 . . . . 0.59 108.33 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -135.41 134.26 39.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.853 0.359 . . . . 2.36 111.402 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.86 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.5 t -118.68 127.49 75.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 0.49 111.004 170.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.14 169.58 8.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.529 -1.214 . . . . 0.51 109.864 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 19.4 tptp -35.2 -44.92 0.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.451 1.278 . . . . 0.83 114.451 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.16 -31.63 53.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.546 0.688 . . . . 0.33 112.385 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.86 ' HB2' HG13 ' A' ' 5' ' ' VAL . 74.1 m80 -68.1 -1.46 5.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.735 -0.666 . . . . 2.12 111.201 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 28.4 t30 -45.94 -20.92 0.1 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.697 0.623 . . . . 1.41 109.765 168.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.84 58.03 0.62 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.371 -0.831 . . . . 0.3 111.256 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.35 151.57 36.72 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.72 0.637 . . . . 0.32 112.72 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 35.4 m -146.12 108.84 4.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.404 -0.817 . . . . 0.95 109.332 174.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.768 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -161.51 167.46 25.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.727 0.299 . . . . 3.0 111.562 -172.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.666 HG23 ' HB3' ' A' ' 108' ' ' LYS . 87.2 m -102.84 144.16 31.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.669 -0.241 . . . . 1.73 110.725 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.9 m -124.96 151.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.058 0.456 . . . . 0.78 111.533 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.63 132.3 51.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.346 -0.983 . . . . 0.76 108.346 167.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 22' ' ' VAL . 1.4 t -109.96 -141.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.375 -0.53 . . . . 1.23 109.895 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -50.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.71 110.906 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.82 -71.06 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.77 136.84 8.36 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.182 -0.917 . . . . 0.71 109.47 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -108.64 117.18 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.123 -0.695 . . . . 0.4 109.123 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.34 140.3 38.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.397 0.618 . . . . 1.09 112.284 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.581 HD12 HG11 ' A' ' 105' ' ' VAL . 40.2 mm -129.21 101.61 6.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.621 -1.172 . . . . 0.54 107.907 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -113.89 138.24 50.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.42 0.628 . . . . 0.64 111.4 -173.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.73 148.25 39.97 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.523 -0.762 . . . . 0.85 109.315 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 16.1 Cg_endo -88.34 13.3 2.59 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 122.74 2.293 . . . . 0.35 110.849 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.622 ' OG ' ' HG3' ' A' ' 71' ' ' GLU . 2.4 m 71.23 -49.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.885 -1.052 . . . . 0.91 111.92 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 m120 56.42 63.09 5.96 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.491 -0.929 . . . . 1.39 108.491 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.83 104.22 0.1 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 123.728 2.952 . . . . 0.83 113.424 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -100.88 -49.99 3.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.003 -0.999 . . . . 1.83 111.044 178.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.534 HG23 ' H ' ' A' ' 34' ' ' PHE . 12.4 t -164.75 -147.88 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.364 -0.606 . . . . 2.36 109.364 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.21 -22.64 37.38 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.61 -0.329 . . . . 1.3 112.633 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CE2' ' HA ' ' A' ' 100' ' ' SER . 4.1 m-30 -35.74 138.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.621 0.971 . . . . 2.22 113.621 169.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -148.19 148.86 31.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.318 -1.31 . . . . 0.44 108.568 172.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.606 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.3 m95 -80.08 112.73 17.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.039 0.447 . . . . 0.43 110.778 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.695 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 58.1 m-85 -118.99 179.79 4.05 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.477 -0.934 . . . . 2.78 108.477 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.64 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -70.24 -78.89 0.07 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.26 -0.576 . . . . 0.43 109.659 170.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -106.16 3.91 28.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.16 0.505 . . . . 2.39 109.815 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.475 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 90.18 112.16 1.49 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.5 -0.773 . . . . 0.73 111.458 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 -19.16 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.7 112.227 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -128.55 142.18 51.14 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.081 0.467 . . . . 1.13 111.834 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.748 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -142.01 127.8 19.3 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.853 -1.067 . . . . 2.52 109.487 168.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.05 155.44 46.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.208 0.528 . . . . 2.3 111.423 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.583 ' OG ' ' HB ' ' A' ' 53' ' ' VAL . 11.1 p -115.42 127.59 26.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.764 -0.653 . . . . 1.61 109.644 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 44.9 Cg_exo -58.21 124.97 17.11 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.695 2.263 . . . . 1.88 112.249 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 91.7 m-20 77.63 30.04 0.5 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.189 0.931 . . . . 2.43 111.981 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.423 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 11.9 pt-20 -79.18 48.79 0.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 3.26 111.769 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.6 m -85.96 -34.49 20.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.372 -0.376 . . . . 2.06 111.415 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -125.54 -31.35 3.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.793 0.806 . . . . 1.25 109.523 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.742 ' HB3' ' O ' ' A' ' 76' ' ' THR . 2.3 m-85 -103.44 167.23 9.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.414 -1.266 . . . . 0.74 107.834 176.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -148.4 165.08 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.046 -0.662 . . . . 1.46 111.198 -160.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.583 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 4.0 p -109.34 150.9 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.408 0.623 . . . . 1.31 111.446 -175.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -124.59 144.67 50.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.264 -0.88 . . . . 2.45 109.817 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 8.6 p30 -123.96 133.82 53.62 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.877 -0.601 . . . . 1.93 109.556 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -154.53 105.24 2.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.771 -0.649 . . . . 1.42 110.738 -175.212 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.898 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -120.25 142.9 48.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.532 -0.758 . . . . 1.66 110.774 -176.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--N 1.321 -0.669 0 CA-C-O 121.118 0.485 . . . . 2.14 110.127 173.22 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.253 0 CA-C-O 121.249 0.36 . . . . 1.49 113.708 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.403 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -157.1 86.99 0.97 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.406 0.521 . . . . 0.97 112.406 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.898 ' HG2' ' HB3' ' A' ' 57' ' ' TYR . 40.9 mt-10 -102.14 106.92 17.85 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.57 . . . . 0.81 109.821 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -112.52 152.6 28.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.628 -0.829 . . . . 0.53 111.669 -174.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.748 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 39.4 m-85 -115.36 119.02 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.912 -1.495 . . . . 1.13 109.08 172.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -113.86 103.72 11.46 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.961 -0.296 . . . . 0.5 110.794 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -105.2 117.9 51.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.104 0.954 . . . . 0.87 110.127 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.742 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 10.5 m -103.65 103.81 13.78 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.77 -1.105 . . . . 0.46 108.428 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.547 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 10.3 p -151.36 144.61 16.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 123.563 0.54 . . . . 1.04 110.341 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -129.29 103.65 7.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.771 0.796 . . . . 1.54 109.742 169.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.98 145.06 6.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.141 -0.936 . . . . 0.67 109.208 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.33 94.07 2.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.141 0.496 . . . . 0.44 111.329 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.89 168.17 31.17 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.29 111.041 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 108' ' ' LYS . 3.1 m -101.35 128.59 47.44 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.837 -0.802 . . . . 0.4 109.566 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.588 ' ND1' HG22 ' A' ' 85' ' ' VAL . 19.2 t-80 -104.29 103.83 13.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.4 109.827 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.75 122.2 42.97 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.325 -0.991 . . . . 0.35 108.325 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -114.86 102.07 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.482 -0.487 . . . . 0.59 110.702 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 2.5 m-20 -108.75 103.37 12.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.323 -0.991 . . . . 1.53 108.323 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 38' ' ' PHE . 78.5 mt -105.07 124.84 50.22 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.734 -0.666 . . . . 0.24 109.698 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.441 HG22 ' CG ' ' A' ' 90' ' ' MET . 5.6 m -101.74 116.81 33.55 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.958 0.885 . . . . 0.29 110.742 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 2.5 t80 -84.81 96.73 9.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.321 -1.309 . . . . 1.11 109.574 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.475 ' CE ' ' HA3' ' A' ' 40' ' ' GLY . 7.2 mtm -137.77 167.29 22.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.833 0.349 . . . . 0.65 110.214 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 12.4 mtm180 -70.21 103.87 0.7 Allowed Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.659 -0.867 . . . . 2.59 108.659 169.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 3.2 Cg_endo -45.23 -37.88 14.07 Favored 'Trans proline' 0 N--CA 1.477 0.522 0 C-N-CA 123.871 3.047 . . . . 1.04 114.851 -166.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 94' ' ' THR . 43.1 p90 -80.8 -2.14 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 1.17 112.457 -175.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.669 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -162.47 -65.03 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.338 0.113 . . . . 1.09 110.844 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.669 ' H ' HG23 ' A' ' 94' ' ' THR . . . 72.44 85.53 0.21 Allowed Glycine 0 CA--C 1.505 -0.533 0 C-N-CA 121.237 -0.506 . . . . 1.16 111.935 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 72.2 Cg_exo -44.09 113.59 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.41 2.74 . . . . 1.2 112.246 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.5 m -74.24 53.99 0.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.73 -0.668 . . . . 2.64 111.112 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -175.69 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.083 -0.962 . . . . 4.09 109.052 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 34.0 t70 -106.87 -17.61 14.16 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.609 -0.723 . . . . 1.67 109.497 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.616 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 10.0 p -72.96 143.02 47.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.057 -0.974 . . . . 1.39 112.457 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -103.62 171.33 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.193 -1.039 . . . . 1.91 108.193 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.439 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 45.1 ttt180 -153.56 140.36 19.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.804 0.812 . . . . 0.62 110.675 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.796 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -102.9 155.3 18.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.209 -1.359 . . . . 0.86 108.615 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.6 m -158.23 102.25 1.76 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.58 -0.448 . . . . 0.31 111.28 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.9 p -104.78 133.79 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.911 -0.716 . . . . 0.88 109.439 166.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' THR . 73.9 m-85 -104.25 104.44 14.35 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.545 -0.752 . . . . 0.7 109.062 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.768 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 1.5 pp -128.28 154.08 46.29 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.707 -0.397 . . . . 2.12 110.602 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.691 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.0 tptm -104.5 115.51 30.49 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.1 -0.704 . . . . 1.89 109.1 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.13 127.09 49.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.852 0.358 . . . . 0.53 110.75 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.19 -0.91 . . . . 1.78 110.553 -177.632 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.945 ' HB3' HG22 ' A' ' 22' ' ' VAL . 12.3 t-80 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.462 -0.94 . . . . 0.59 108.462 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 23' ' ' GLU . 17.6 ptpt -146.01 153.35 40.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.801 0.334 . . . . 2.36 110.672 172.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.871 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.1 t -115.05 135.01 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.158 0.504 . . . . 0.49 111.089 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.92 170.76 8.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 0.51 110.003 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 24.5 tptp -35.72 -49.26 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.75 1.389 . . . . 0.83 114.75 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.13 63.03 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.387 0.613 . . . . 0.33 112.124 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.871 ' HB2' HG13 ' A' ' 5' ' ' VAL . 69.9 m80 -64.91 -2.95 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.556 . . . . 2.12 111.177 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.614 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 4.2 t30 -44.99 -22.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.214 0 O-C-N 123.694 0.621 . . . . 1.41 110.392 170.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.39 55.1 0.68 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.566 -0.743 . . . . 0.3 111.277 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.883 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -119.06 156.59 29.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.238 0.829 . . . . 0.32 113.238 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 87.6 m -145.93 111.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.004 -0.998 . . . . 0.95 108.927 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 3.8 pp -152.8 167.31 29.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 3.0 111.766 -170.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -103.44 147.21 27.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 1.73 110.414 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.9 m -128.55 162.67 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.78 110.96 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 110' ' ' ASN . . . -109.0 125.96 52.61 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.252 -1.018 . . . . 0.76 108.252 167.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 22' ' ' VAL . 23.2 m -105.28 -168.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.382 -0.527 . . . . 1.23 111.121 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 113.95 -53.09 0.61 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.415 -0.674 . . . . 0.71 111.415 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.45 -73.3 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.169 0.509 . . . . 2.35 109.813 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 tp -166.12 137.19 3.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.71 109.588 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.945 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -117.19 113.97 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.828 0.823 . . . . 0.4 109.63 173.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 4' ' ' LYS . 40.6 mt-10 -102.91 156.99 17.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.115 0.959 . . . . 1.09 112.267 -171.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.694 HD13 ' HB ' ' A' ' 5' ' ' VAL . 40.2 mm -133.66 133.75 56.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.232 -1.766 . . . . 0.54 106.232 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.92 135.65 23.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.601 0.715 . . . . 0.64 111.564 178.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -109.41 153.41 42.8 Favored Pre-proline 0 N--CA 1.431 -1.375 0 CA-C-N 114.818 -1.083 . . . . 0.85 108.977 174.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.586 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 41.7 Cg_endo -90.81 11.35 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.935 2.423 . . . . 0.35 111.457 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.644 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 27.8 t 69.58 -59.6 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 0.91 111.198 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.6 OUTLIER 52.73 56.89 15.06 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.097 -0.705 . . . . 1.39 109.097 -173.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.599 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 81.6 Cg_exo -49.61 111.1 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.832 3.022 . . . . 0.83 113.579 -168.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.492 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.0 p -87.45 -38.93 15.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 1.83 109.417 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t 175.91 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.794 -1.094 . . . . 2.36 108.375 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.04 -33.03 67.93 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 118.23 0.468 . . . . 1.3 113.589 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.603 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 52.7 m-85 -52.09 148.71 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.916 0.389 . . . . 2.22 111.897 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.03 161.42 41.95 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.648 -0.705 . . . . 0.44 109.764 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.644 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -82.76 120.61 25.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.15 0.5 . . . . 0.43 112.012 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.71 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -156.15 147.69 22.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.101 -0.703 . . . . 2.78 109.101 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -40.93 -68.76 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.61 0.596 . . . . 0.43 112.61 -171.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.15 17.69 2.44 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.568 -0.453 . . . . 2.39 111.828 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.535 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 125.0 85.88 0.64 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 119.778 -1.201 . . . . 0.73 113.075 170.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.82 12.25 10.06 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.843 -0.694 . . . . 0.7 112.242 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -135.16 139.26 44.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.469 -0.937 . . . . 1.13 108.469 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.63 142.19 33.42 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.376 0.423 . . . . 2.52 110.546 -173.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.56 153.12 47.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.06 0.457 . . . . 2.3 111.505 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.831 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 18.0 t -104.77 132.87 20.51 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.8 -0.815 . . . . 1.61 108.8 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 84' ' ' ALA . 9.9 Cg_exo -72.86 25.21 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.304 2.669 . . . . 1.88 113.426 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -178.49 48.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.297 0.57 . . . . 2.43 109.486 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.831 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 8.8 pt-20 -114.64 122.6 46.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.742 0.782 . . . . 3.26 111.147 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -141.99 -39.72 0.37 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.806 -1.088 . . . . 2.06 108.819 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.869 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.77 -35.41 6.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.629 -0.714 . . . . 1.25 110.516 176.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.869 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 9.3 m-85 -108.9 164.46 12.38 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.497 -0.927 . . . . 0.74 108.497 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -161.84 172.08 16.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.411 0.624 . . . . 1.46 112.598 -164.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 20.3 t -99.73 143.99 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.411 -0.813 . . . . 1.31 111.472 -174.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 7.5 pt-20 -109.33 132.22 54.33 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.644 -0.873 . . . . 2.45 108.644 169.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.61 131.87 53.9 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.537 -0.865 . . . . 1.93 110.986 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.78 104.89 2.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.098 -0.955 . . . . 1.42 110.34 -172.447 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CB ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 p90 -131.2 131.59 44.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.448 0.642 . . . . 1.66 112.153 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 2.14 110.507 -175.962 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.748 0 N-CA-C 110.302 -1.119 . . . . 1.49 110.302 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 86.01 1.05 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 117.902 0.851 . . . . 0.97 112.571 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.634 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 37.6 mt-10 -104.36 104.37 14.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.81 109.716 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -114.12 163.71 14.83 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.22 1.009 . . . . 0.53 112.577 -171.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 42.0 m-85 -140.13 104.08 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.173 -1.831 . . . . 1.13 108.769 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.601 ' HB2' ' CG ' ' A' ' 54' ' ' GLU . 55.6 m170 -103.35 123.45 46.83 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.824 -0.548 . . . . 0.5 110.034 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 53' ' ' VAL . 3.4 m -105.77 123.4 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 122.23 1.014 . . . . 0.87 109.918 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.719 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 8.5 m -102.64 104.78 15.17 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.806 -1.183 . . . . 0.46 107.806 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.6 p -150.46 142.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.118 -0.492 . . . . 1.04 110.694 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.55 101.59 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.265 0.555 . . . . 1.54 109.713 167.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -167.5 145.78 4.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.406 -0.816 . . . . 0.67 109.602 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.24 89.89 2.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.44 110.81 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.12 166.93 31.69 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 110.717 -0.953 . . . . 0.29 110.717 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.5 132.25 48.67 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.692 0.746 . . . . 0.4 109.811 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.569 ' ND1' HG22 ' A' ' 85' ' ' VAL . 45.1 t-80 -104.42 106.14 16.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.173 -0.467 . . . . 0.4 110.527 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 46' ' ' PRO . . . -101.2 115.23 30.02 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.325 -0.62 . . . . 0.35 109.325 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.5 t -106.3 105.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.848 -0.615 . . . . 0.59 111.331 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.9 m-20 -112.96 102.89 10.86 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.47 -0.567 . . . . 1.53 109.47 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 98.8 mt -107.33 123.4 48.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.674 -0.694 . . . . 0.24 109.453 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.448 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 5.4 m -103.45 130.73 50.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.4 0.619 . . . . 0.29 111.405 -170.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 43.7 t80 -95.76 84.91 3.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.399 -0.819 . . . . 1.11 109.776 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.689 ' HE2' ' HE1' ' A' ' 37' ' ' TYR . 17.4 mtm -121.53 173.7 7.24 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.905 0.383 . . . . 0.65 109.981 -175.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.611 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 3.2 ttm-85 -86.71 114.06 56.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 108.861 -0.792 . . . . 2.59 108.861 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.8 Cg_endo -49.86 -27.33 15.64 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.976 3.118 . . . . 1.04 115.88 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 42.7 p90 -104.03 10.77 35.95 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.945 -0.472 . . . . 1.17 111.996 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.8 t -166.05 -62.0 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.26 -0.176 . . . . 1.09 111.034 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.611 ' HA2' ' H ' ' A' ' 91' ' ' ARG . . . 61.86 79.24 0.14 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 112.13 -0.388 . . . . 1.16 112.13 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.764 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 50.6 Cg_exo -36.08 128.21 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.839 3.026 . . . . 1.2 112.562 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 p -35.01 -64.23 0.28 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 124.663 1.227 . . . . 2.64 114.059 -170.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -124.0 33.8 5.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.333 -0.547 . . . . 4.09 110.685 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.764 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 29.1 t0 -106.82 -4.66 19.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.98 0.895 . . . . 1.67 108.905 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.461 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.9 m -89.0 142.41 27.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.346 -1.297 . . . . 1.39 110.252 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.651 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 29.1 tt0 -92.49 179.31 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.01 -0.737 . . . . 1.91 109.01 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.651 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 29.7 ttt180 -161.65 142.51 10.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.719 0.771 . . . . 0.62 111.408 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.794 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 1.2 t80 -105.22 154.39 20.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.237 -1.347 . . . . 0.86 109.341 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 45.1 m -158.45 102.43 1.73 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.31 110.97 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.883 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.6 p -107.21 136.62 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 120.027 -0.669 . . . . 0.88 109.53 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' THR . 78.4 m-85 -104.62 104.08 13.85 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.629 -0.878 . . . . 0.7 108.629 174.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.624 HD13 HG11 ' A' ' 16' ' ' VAL . 3.3 pp -122.67 145.46 48.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.947 -0.76 . . . . 2.12 108.947 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.784 ' O ' HG22 ' A' ' 16' ' ' VAL . 71.7 tttt -103.27 124.52 48.8 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.105 -0.638 . . . . 1.89 109.704 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.98 129.34 46.81 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.456 0.473 . . . . 0.53 110.31 -170.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.634 ' C ' HG22 ' A' ' 18' ' ' VAL . 19.3 p-10 . . . . . 0 C--O 1.243 0.747 0 CA-C-O 118.314 -0.85 . . . . 1.78 109.816 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.953 ' HB3' HG22 ' A' ' 22' ' ' VAL . 23.6 t60 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.001 -0.74 . . . . 0.59 109.001 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -138.7 148.17 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.014 0.435 . . . . 2.36 110.765 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.866 HG13 ' HB2' ' A' ' 9' ' ' HIS . 1.9 t -112.41 138.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 0.49 110.928 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.96 169.07 9.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.4 -0.818 . . . . 0.51 110.322 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.3 tptp -39.72 -43.72 1.44 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.01 1.115 . . . . 0.83 114.01 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.96 -35.45 33.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.645 0.736 . . . . 0.33 111.862 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.866 ' HB2' HG13 ' A' ' 5' ' ' VAL . 76.0 m80 -66.26 -1.96 3.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.496 -0.775 . . . . 2.12 111.654 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 27.1 t30 -46.01 -21.54 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.414 0.626 . . . . 1.41 109.586 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.08 57.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.3 111.376 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.875 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.23 160.53 20.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.257 0.836 . . . . 0.32 113.257 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 14.2 m -151.48 114.59 4.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.016 -0.993 . . . . 0.95 109.116 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.6 pt? -158.26 166.73 31.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.172 0.51 . . . . 3.0 111.606 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -104.04 141.5 36.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 1.73 110.523 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.7 m -126.75 152.1 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.417 -0.356 . . . . 0.78 111.196 -175.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.54 118.26 36.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.838 -0.801 . . . . 0.76 108.838 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.718 HG12 HG21 ' A' ' 22' ' ' VAL . 27.3 m -100.01 -170.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.252 0.548 . . . . 1.23 111.584 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.641 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 128.38 -46.02 1.11 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.214 -0.754 . . . . 0.71 111.214 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -89.48 -69.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.64 -0.504 . . . . 2.35 109.64 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.2 tp -166.46 126.06 1.57 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.59 -0.732 . . . . 0.71 111.177 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -107.85 114.32 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.819 0.818 . . . . 0.4 110.05 174.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.01 153.48 20.2 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.884 0.849 . . . . 1.09 112.1 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.599 HD13 ' HB ' ' A' ' 5' ' ' VAL . 49.1 mm -133.21 102.48 4.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 113.758 -1.564 . . . . 0.54 107.467 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -114.16 132.84 55.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.057 0.932 . . . . 0.64 111.752 -172.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.47 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 3.9 mm? -109.27 154.54 42.09 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.584 -1.189 . . . . 0.85 108.924 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 65.3 Cg_endo -88.99 9.53 3.56 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 122.741 2.294 . . . . 0.35 111.394 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.665 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 19.9 t 69.47 -57.21 0.54 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.219 -0.901 . . . . 0.91 110.474 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.7 OUTLIER 54.35 62.98 7.91 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.984 -1.117 . . . . 1.39 107.984 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 52.9 Cg_exo -54.46 112.9 1.14 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.528 2.819 . . . . 0.83 113.209 -165.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.464 HG23 ' CE2' ' A' ' 89' ' ' TYR . 8.3 p -92.5 -43.67 9.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.459 -0.791 . . . . 1.83 110.086 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.677 HG23 ' HD1' ' A' ' 34' ' ' PHE . 5.1 t 175.79 -136.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.571 -0.9 . . . . 2.36 108.571 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.44 -17.13 46.41 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 118.024 0.375 . . . . 1.3 113.551 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.677 ' HD1' HG23 ' A' ' 32' ' ' THR . 2.4 m-85 -68.86 142.74 54.73 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.987 0.515 . . . . 2.22 110.584 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -149.13 159.06 44.58 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.27 -0.641 . . . . 0.44 109.27 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.58 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 98.2 m95 -73.48 119.32 17.55 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.361 0.601 . . . . 0.43 111.474 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 41.6 m-85 -128.46 -177.09 4.03 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 115.425 -0.807 . . . . 2.78 108.862 170.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.5 m-85 -78.15 -77.71 0.15 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.49 0.586 . . . . 0.43 109.93 168.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.25 -0.54 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 2.39 110.532 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 108.23 102.87 2.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.748 . . . . 0.73 112.28 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.13 2.79 67.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.848 -0.692 . . . . 0.7 111.662 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -132.33 144.56 50.65 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.834 0.453 . . . . 1.13 111.783 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.629 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.58 132.2 27.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.444 -0.798 . . . . 2.52 110.582 167.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.47 152.57 50.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.023 -0.535 . . . . 2.3 110.786 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.598 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 17.3 t -119.76 135.17 24.03 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.033 -0.729 . . . . 1.61 109.033 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 12.2 Cg_exo -70.7 -8.08 22.79 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.802 2.335 . . . . 1.88 113.07 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.437 HD21 ' HA3' ' A' ' 81' ' ' GLY . 5.0 m-20 -125.72 26.23 6.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 2.43 111.075 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 45' ' ' SER . 15.3 pt-20 -95.23 77.27 3.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.341 1.067 . . . . 3.26 111.693 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -95.3 -56.79 2.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.858 -1.064 . . . . 2.06 110.203 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.772 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 18.1 ptt? -108.25 -31.28 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.742 -1.117 . . . . 1.25 109.243 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.772 ' HD1' ' HG3' ' A' ' 50' ' ' MET . 12.3 m-85 -103.8 167.97 9.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.743 -1.571 . . . . 0.74 108.009 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 14.7 t -158.63 168.75 26.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.709 0.686 . . . . 1.46 112.427 -169.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.8 p -101.2 136.77 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.311 -0.859 . . . . 1.31 110.988 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 8.2 pt-20 -127.99 141.97 51.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.43 -0.804 . . . . 2.45 109.619 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -108.21 140.34 41.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 1.93 111.739 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.823 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.23 104.24 3.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.103 -0.953 . . . . 1.42 109.39 171.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.6 p90 -124.63 150.26 46.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.563 -0.744 . . . . 1.66 110.853 -172.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.256 0.551 . . . . 2.14 112.197 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.375 0 N-CA-C 110.978 -0.849 . . . . 1.49 110.978 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.6 HG22 ' NE2' ' A' ' 72' ' ' HIS . 31.8 m 137.14 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.227 1.411 . . . . 0.97 108.733 150.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 39.4 mt-10 -103.51 115.63 30.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.671 -1.149 . . . . 0.81 110.167 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.823 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 1.7 m170 -108.53 144.98 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.678 0.751 . . . . 0.53 111.775 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.633 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 14.2 m-85 -116.77 112.38 21.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.513 -1.221 . . . . 1.13 109.058 170.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.428 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 15.8 m170 -104.45 113.99 27.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.059 -0.519 . . . . 0.5 110.764 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.3 m -104.54 118.53 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 122.252 1.025 . . . . 0.87 108.501 171.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.744 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.1 m -102.26 103.74 14.24 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.48 -1.304 . . . . 0.46 107.48 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.621 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 4.7 p -155.94 142.01 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 123.651 0.594 . . . . 1.04 111.158 -173.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.641 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -127.14 101.78 6.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.057 -0.72 . . . . 1.54 109.057 165.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.62 138.19 4.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 0.67 109.92 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.65 99.48 3.11 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.746 0.654 . . . . 0.44 111.854 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 47' ' ' ASN . . . -165.71 166.46 38.55 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.429 -1.068 . . . . 0.29 110.429 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 5.5 m -100.83 130.78 46.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.138 0.969 . . . . 0.4 109.957 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.732 ' HD1' HG22 ' A' ' 85' ' ' VAL . 36.5 t-80 -102.97 105.47 15.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.211 -0.904 . . . . 0.4 109.854 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.52 24.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.121 -0.696 . . . . 0.35 109.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.732 HG22 ' HD1' ' A' ' 83' ' ' HIS . 2.3 t -105.45 103.08 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.604 -0.726 . . . . 0.59 110.928 -170.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 2.8 m-20 -109.12 103.26 12.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.148 -0.686 . . . . 1.53 109.148 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 38' ' ' PHE . 88.1 mt -105.78 126.04 51.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.691 -0.686 . . . . 0.24 110.507 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.699 HG22 ' HG3' ' A' ' 90' ' ' MET . 6.0 m -102.55 121.2 41.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.339 0.59 . . . . 0.29 110.98 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.637 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 54.1 t80 -86.52 97.79 10.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 1.11 109.284 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.699 ' HG3' HG22 ' A' ' 88' ' ' THR . 27.6 mtm -134.39 159.48 40.92 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.275 -0.42 . . . . 0.65 111.83 -172.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 48.3 mtt180 -64.2 105.55 0.73 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 108.227 -1.027 . . . . 2.59 108.227 163.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -46.63 -32.16 11.34 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.633 2.888 . . . . 1.04 114.765 -167.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.423 ' CD1' HG22 ' A' ' 94' ' ' THR . 37.7 p90 -88.12 -2.82 58.84 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.133 0.42 . . . . 1.17 112.133 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -162.23 -68.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.493 -0.129 . . . . 1.09 111.338 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.683 ' H ' HG23 ' A' ' 94' ' ' THR . . . 73.41 78.38 0.56 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.789 -0.719 . . . . 1.16 111.533 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 13.0 Cg_exo -32.84 114.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.103 3.202 . . . . 1.2 113.066 172.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 p -41.27 -55.66 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.801 -1.091 . . . . 2.64 113.361 -171.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -100.11 20.07 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.626 -0.43 . . . . 4.09 111.636 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 14.0 t0 -124.34 6.17 8.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 1.67 110.308 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 32.8 m -98.61 147.86 24.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.454 -0.794 . . . . 1.39 111.149 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.637 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 4.7 tp10 -100.52 166.69 10.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.067 -0.716 . . . . 1.91 109.067 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 46.8 ttt180 -153.51 140.14 18.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.77 0.795 . . . . 0.62 111.232 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.777 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -104.4 157.4 17.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.116 -1.402 . . . . 0.86 109.07 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 53.5 m -159.55 102.4 1.54 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.839 0.352 . . . . 0.31 110.977 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.875 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.6 p -105.55 138.91 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.033 -0.667 . . . . 0.88 110.1 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.4 m-85 -104.52 104.2 14.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.458 -0.792 . . . . 0.7 109.034 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.9 pp -126.0 148.53 49.26 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.213 -0.662 . . . . 2.12 109.213 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.719 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.4 ttmm -104.59 122.71 46.16 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.198 -0.601 . . . . 1.89 110.165 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -101.74 128.9 47.87 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.414 0.446 . . . . 0.53 110.134 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.608 ' C ' HG22 ' A' ' 18' ' ' VAL . 21.0 p-10 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.52 -0.752 . . . . 1.78 110.34 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.953 ' HB3' HG22 ' A' ' 22' ' ' VAL . 8.2 t-80 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 108.932 -0.766 . . . . 0.59 108.932 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -132.28 144.65 50.74 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.938 -0.305 . . . . 2.36 110.254 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.857 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -112.64 133.48 58.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.49 111.134 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -117.46 170.29 8.85 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.974 -1.012 . . . . 0.51 109.462 170.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 8.6 tptm -34.82 -49.04 0.42 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.973 1.471 . . . . 0.83 114.973 -170.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.06 63.81 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.326 0.584 . . . . 0.33 112.537 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.857 ' HB2' HG13 ' A' ' 5' ' ' VAL . 75.3 m80 -64.49 -2.86 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 2.12 110.903 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.61 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 4.9 t30 -45.53 -19.63 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.975 0.797 . . . . 1.41 110.484 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.32 59.27 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.97 -0.852 . . . . 0.3 110.97 175.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.805 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -120.35 148.21 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.903 0.705 . . . . 0.32 112.903 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 106' ' ' TYR . 85.5 m -134.73 119.08 17.8 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.42 -0.809 . . . . 0.95 109.163 168.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pt? -159.69 166.27 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 3.0 111.036 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.0 m -103.29 148.1 26.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.255 -0.43 . . . . 1.73 110.437 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.3 m -126.41 155.41 36.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.78 111.441 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.52 111.49 22.54 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.945 -0.761 . . . . 0.76 108.945 171.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.814 HG21 ' HA ' ' A' ' 78' ' ' LYS . 12.9 m -89.84 -167.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.946 0.403 . . . . 1.23 111.078 -173.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.0 -54.49 0.73 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.238 -0.745 . . . . 0.71 111.238 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.2 -63.2 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.722 -0.844 . . . . 2.35 108.722 171.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 22' ' ' VAL . 54.9 tp -165.5 163.61 19.52 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.495 -1.229 . . . . 0.71 109.944 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.3 t -140.46 106.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.449 -0.945 . . . . 0.4 108.449 164.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.604 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.0 pt-20 -112.25 158.36 19.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 122.222 1.011 . . . . 1.09 112.579 -172.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.576 HD12 HG11 ' A' ' 105' ' ' VAL . 46.0 mm -132.9 103.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.451 -1.704 . . . . 0.54 108.5 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -113.27 133.5 55.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.819 0.819 . . . . 0.64 111.535 -176.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -108.88 144.27 29.29 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.062 -0.972 . . . . 0.85 108.997 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 67.4 Cg_endo -81.09 10.1 3.55 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 122.499 2.132 . . . . 0.35 111.264 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.704 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 19.4 t 69.37 -61.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.997 -1.001 . . . . 0.91 111.191 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.436 ' ND2' ' HG2' ' A' ' 27' ' ' PRO . 2.2 m120 56.6 62.01 6.64 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.942 -0.762 . . . . 1.39 108.942 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 74.8 Cg_exo -52.12 103.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.369 2.712 . . . . 0.83 113.105 -168.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.5 p -83.15 -37.27 23.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.347 -0.842 . . . . 1.83 110.027 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 34' ' ' PHE . 7.7 t 179.11 -144.53 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.402 -0.962 . . . . 2.36 108.402 -177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.74 -11.33 29.41 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 118.093 0.406 . . . . 1.3 113.242 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 90' ' ' MET . 1.4 m-85 -71.78 151.71 43.29 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.003 0.521 . . . . 2.22 111.469 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -152.15 161.67 42.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.801 -0.636 . . . . 0.44 109.663 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -79.53 117.18 20.24 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.402 0.62 . . . . 0.43 111.437 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.586 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 70.7 m-85 -125.17 -178.41 4.19 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 108.083 -1.08 . . . . 2.78 108.083 168.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.85 -80.36 0.06 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.029 -0.669 . . . . 0.43 109.556 169.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -104.08 -0.31 28.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.246 0.546 . . . . 2.39 110.168 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.574 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 102.22 104.73 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.73 111.826 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.88 -0.69 71.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.742 -0.742 . . . . 0.7 111.955 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.625 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -129.71 141.56 50.87 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.843 0.354 . . . . 1.13 111.493 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.12 129.54 17.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.375 -0.83 . . . . 2.52 110.334 167.074 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.09 153.79 51.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.082 0.467 . . . . 2.3 111.257 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.539 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 18.1 t -104.71 129.2 25.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 1.61 108.712 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 10.9 Cg_endo -96.22 161.54 1.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.205 3.27 . . . . 1.88 112.573 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 70.92 8.5 6.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.264 -0.88 . . . . 2.43 111.176 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 51' ' ' PHE . 5.5 tp10 -158.27 134.04 9.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.514 0.673 . . . . 3.26 112.091 -171.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 p -130.09 28.36 5.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.799 -1.091 . . . . 2.06 109.521 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.544 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 21.5 ptt? -138.0 -40.96 0.53 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.486 -0.931 . . . . 1.25 108.486 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.816 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.6 m-85 -103.05 149.75 24.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.72 -1.585 . . . . 0.74 106.72 165.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 171.61 18.93 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.834 -0.746 . . . . 1.46 111.536 -161.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.6 ' HB ' HG12 ' A' ' 75' ' ' VAL . 6.1 p -100.34 139.98 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.404 0.621 . . . . 1.31 112.248 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 11.2 pt-20 -109.34 152.28 25.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.571 -0.9 . . . . 2.45 108.571 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -128.2 140.06 52.12 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.75 -0.38 . . . . 1.93 111.289 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.86 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.34 114.5 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.332 0.587 . . . . 1.42 110.273 173.376 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 8.2 m-85 -109.7 105.11 14.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.796 -0.638 . . . . 1.66 110.057 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.988 -0.551 . . . . 2.14 111.297 -177.454 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 111.065 -0.814 . . . . 1.49 111.065 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -156.89 92.44 1.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.711 0.634 . . . . 0.97 112.711 -174.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 37.1 mt-10 -104.09 109.11 20.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.572 -0.899 . . . . 0.81 108.572 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.7 m170 -108.19 145.97 33.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.551 0.691 . . . . 0.53 112.056 -170.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.586 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.5 m-85 -121.24 104.54 9.81 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.057 -1.429 . . . . 1.13 108.596 170.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.643 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 19.6 m170 -104.24 107.87 18.99 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 122.234 -0.291 . . . . 0.5 110.284 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.6 HG12 ' HB ' ' A' ' 53' ' ' VAL . 3.8 m -101.56 118.87 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 122.349 1.071 . . . . 0.87 108.294 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.6 m -101.74 103.98 14.76 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.702 -1.592 . . . . 0.46 106.702 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.676 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -151.26 147.41 15.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.133 0.896 . . . . 1.04 110.874 -170.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.814 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.61 102.07 4.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.217 0.532 . . . . 1.54 109.988 170.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -163.23 137.1 5.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 0.67 110.137 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.44 77.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.264 0.554 . . . . 0.44 111.651 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.47 166.76 29.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.798 -0.921 . . . . 0.29 110.798 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -99.98 133.08 44.87 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.519 -0.872 . . . . 0.4 109.047 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.648 ' ND1' HG22 ' A' ' 85' ' ' VAL . 12.5 t-80 -103.45 103.64 13.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.184 -0.673 . . . . 0.4 109.184 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.33 109.11 20.68 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.877 -0.786 . . . . 0.35 108.877 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.39 106.87 21.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.166 -0.47 . . . . 0.59 111.146 -170.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 5.0 m-80 -109.42 103.8 12.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.498 -0.774 . . . . 1.53 109.232 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.667 HD23 ' HA ' ' A' ' 38' ' ' PHE . 84.9 mt -105.23 123.6 48.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.461 -0.791 . . . . 0.24 109.744 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.4 m -102.5 120.09 39.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.29 110.933 -172.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.869 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 50.1 t80 -88.23 98.22 11.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 1.11 109.732 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.71 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 10.2 mtm -136.3 163.98 29.15 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 110.277 -0.268 . . . . 0.65 110.277 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.558 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 12.8 ttt180 -65.41 110.59 4.56 Favored Pre-proline 0 C--O 1.221 -0.405 0 N-CA-C 107.673 -1.232 . . . . 2.59 107.673 168.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.544 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 1.7 Cg_endo -43.98 -33.96 5.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.231 3.288 . . . . 1.04 115.42 -169.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 48.9 p90 -102.24 8.03 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.859 0.689 . . . . 1.17 112.859 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 95' ' ' GLY . 12.8 t -167.8 -55.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.789 -0.364 . . . . 1.09 111.602 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 58.1 78.75 0.12 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-O 119.703 -0.498 . . . . 1.16 113.377 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.55 ' HB2' ' HZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -29.08 115.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.236 3.291 . . . . 1.2 113.439 170.118 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 m -73.42 67.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.301 -0.863 . . . . 2.64 111.261 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 t60 176.35 -30.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.18 -0.918 . . . . 4.09 109.078 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.508 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -91.81 -7.18 50.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.67 110.018 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -68.3 122.3 18.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.008 -0.996 . . . . 1.39 112.404 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.869 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.6 tp10 -91.05 165.33 13.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.023 -1.103 . . . . 1.91 108.023 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.434 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 39.2 ttt180 -159.2 136.98 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.711 0.767 . . . . 0.62 111.094 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -104.3 154.37 19.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.438 -1.256 . . . . 0.86 109.162 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.1 m -154.87 103.25 2.41 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.866 -0.333 . . . . 0.31 110.783 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.805 HG23 ' HB3' ' A' ' 12' ' ' ALA . 10.6 p -104.96 136.12 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 119.676 -0.81 . . . . 0.88 109.682 168.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 13' ' ' THR . 74.4 m-85 -103.9 104.15 14.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.467 -0.938 . . . . 0.7 108.467 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.4 pp -122.68 146.17 47.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.269 -0.641 . . . . 2.12 109.269 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.771 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.7 ttmm -103.48 116.71 32.91 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.559 -0.456 . . . . 1.89 111.0 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.65 151.3 21.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.896 -0.779 . . . . 0.53 108.896 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.582 ' O ' HG22 ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.804 -0.617 . . . . 1.78 111.631 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 1.026 ' HB3' HG22 ' A' ' 22' ' ' VAL . 43.8 t60 . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.23 -0.656 . . . . 0.59 109.23 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -142.65 130.84 22.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.283 -0.417 . . . . 2.36 110.499 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.864 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -106.58 137.05 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.399 -0.52 . . . . 0.49 111.702 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -119.01 168.75 10.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.51 109.412 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -40.11 -39.46 0.9 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.47 1.285 . . . . 0.83 114.47 -170.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.81 -36.45 62.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.558 0.694 . . . . 0.33 111.83 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.864 ' HB2' HG13 ' A' ' 5' ' ' VAL . 77.6 m80 -65.66 -1.59 2.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.649 -0.705 . . . . 2.12 111.41 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.603 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 33.1 t30 -46.01 -19.36 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.316 0.646 . . . . 1.41 110.161 169.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -142.12 55.33 0.59 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.427 -0.669 . . . . 0.3 111.427 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.819 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -112.45 160.22 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.97 0.73 . . . . 0.32 112.97 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 34.1 m -152.25 110.37 3.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.158 -0.928 . . . . 0.95 109.336 173.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.724 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.5 pt? -158.13 166.58 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 3.0 111.195 -172.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 108' ' ' LYS . 94.5 m -104.2 148.61 26.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.945 0.403 . . . . 1.73 110.715 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.2 m -125.53 157.65 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.78 110.035 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.34 104.2 12.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.65 -0.5 . . . . 0.76 109.65 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 22' ' ' VAL . 33.2 m -84.09 175.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.234 0.54 . . . . 1.23 112.072 -172.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.77 -32.15 3.38 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.71 111.211 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.74 -76.22 0.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.664 -0.495 . . . . 2.35 109.664 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.2 tp -166.05 123.39 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.462 -0.79 . . . . 0.71 110.66 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -107.78 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.598 0.713 . . . . 0.4 109.645 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -113.0 159.25 19.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.869 0.842 . . . . 1.09 112.44 -172.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.709 HD12 HG11 ' A' ' 105' ' ' VAL . 47.2 mm -134.43 102.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.111 -1.404 . . . . 0.54 108.722 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -106.03 141.57 37.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.368 0.604 . . . . 0.64 111.334 -175.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.93 142.65 42.94 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.562 -0.744 . . . . 0.85 110.284 172.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 43.3 Cg_endo -84.2 16.29 1.96 Allowed 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.787 2.325 . . . . 0.35 112.427 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.7 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.0 t 65.8 -61.25 0.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.657 0.783 . . . . 0.91 111.219 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.494 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 58.8 83.44 0.22 Allowed Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.292 -1.003 . . . . 1.39 108.292 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.88 98.36 0.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.388 2.725 . . . . 0.83 113.416 -166.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.486 ' OG1' ' HE2' ' A' ' 89' ' ' TYR . 6.4 p -83.13 -45.29 14.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.034 -0.728 . . . . 1.83 109.034 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.689 HG23 ' HD1' ' A' ' 34' ' ' PHE . 8.9 t 173.91 -140.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.024 -0.989 . . . . 2.36 108.503 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.24 -27.78 47.74 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 118.043 0.383 . . . . 1.3 113.853 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.689 ' HD1' HG23 ' A' ' 32' ' ' THR . 41.6 m-85 -56.56 147.79 21.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.058 0.543 . . . . 2.22 111.67 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.524 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -152.37 157.8 41.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.067 0.547 . . . . 0.44 109.637 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.7 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 92.9 m95 -78.29 119.74 22.07 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.415 0.626 . . . . 0.43 111.688 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.54 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 85.0 m-85 -126.55 -177.79 4.12 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.012 -1.107 . . . . 2.78 108.012 168.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -72.88 -76.61 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.934 -0.707 . . . . 0.43 109.576 165.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.5 3.09 8.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.77 -0.65 . . . . 2.39 111.009 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.0 100.38 1.11 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.03 -1.081 . . . . 0.73 113.327 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.13 22.38 60.55 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.847 -0.692 . . . . 0.7 111.916 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -140.35 142.38 35.58 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 122.754 0.422 . . . . 1.13 111.209 -174.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.73 140.51 31.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.99 -0.55 . . . . 2.52 110.035 164.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.76 145.44 46.6 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.915 -0.584 . . . . 2.3 110.271 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 2.9 p -104.17 128.48 27.03 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.536 -0.913 . . . . 1.61 108.536 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.7 Cg_exo -77.83 39.83 0.8 Allowed 'Trans proline' 0 C--N 1.335 -0.166 0 C-N-CA 123.492 2.795 . . . . 1.88 112.835 -170.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.406 ' HB3' HG21 ' A' ' 77' ' ' VAL . 7.4 t-20 -173.99 32.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.485 -0.561 . . . . 2.43 109.485 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.471 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 10.9 pt-20 -94.85 109.17 21.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.712 0.768 . . . . 3.26 111.585 -173.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.2 m -145.92 10.46 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.464 -0.789 . . . . 2.06 110.118 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -178.12 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 1.25 109.122 -172.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.754 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.5 m-85 -123.58 157.25 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.17 -1.377 . . . . 0.74 107.835 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -152.57 166.46 31.98 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.662 0.616 . . . . 1.46 112.662 -162.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.888 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 p -109.27 136.11 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.607 -0.724 . . . . 1.31 111.818 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.92 137.79 51.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.59 -0.732 . . . . 2.45 109.628 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.86 142.74 34.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.236 -0.586 . . . . 1.93 110.784 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.42 104.92 3.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.432 -0.804 . . . . 1.42 109.861 -177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.929 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -116.62 132.39 56.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.367 0.603 . . . . 1.66 112.189 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 2.14 109.723 172.735 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.0 0 N-CA-C 111.72 -0.552 . . . . 1.49 111.72 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.38 81.47 1.12 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.617 0.723 . . . . 0.97 110.757 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.929 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 20.9 mt-10 -104.05 102.44 12.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.949 -1.023 . . . . 0.81 108.405 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -113.81 151.3 32.26 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.411 -0.916 . . . . 0.53 111.324 -174.334 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.54 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 39.6 m-85 -118.83 104.45 10.56 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.97 -1.468 . . . . 1.13 109.332 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.58 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 17.9 m170 -104.64 104.86 14.75 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.252 -0.431 . . . . 0.5 110.883 -171.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.888 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.98 120.82 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 122.424 1.107 . . . . 0.87 109.785 177.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.6 m -102.92 104.43 14.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.508 -1.223 . . . . 0.46 107.839 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.624 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.2 p -147.29 147.35 17.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.808 0.693 . . . . 1.04 110.672 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -130.45 103.48 6.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.993 0.902 . . . . 1.54 108.664 166.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.84 166.15 15.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.257 -0.883 . . . . 0.67 109.189 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.91 102.74 14.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 0.44 110.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.51 167.18 37.6 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.726 -0.67 . . . . 0.29 111.449 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -103.31 139.71 38.38 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.909 -0.76 . . . . 0.4 109.648 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.758 ' HB3' ' HG ' ' A' ' 107' ' ' LEU . 7.2 t-80 -113.62 104.54 12.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.847 -0.615 . . . . 0.4 110.418 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.42 109.44 21.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.177 -0.675 . . . . 0.35 109.177 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.41 104.35 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.123 -0.49 . . . . 0.59 111.12 -171.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 2.8 m-20 -106.19 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.018 -0.734 . . . . 1.53 109.018 175.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 38' ' ' PHE . 85.6 mt -106.4 124.85 50.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.663 -0.699 . . . . 0.24 110.127 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.44 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.2 m -103.54 118.31 36.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.529 0.681 . . . . 0.29 111.381 -171.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.524 ' CE1' ' HA ' ' A' ' 35' ' ' ALA . 53.4 t80 -82.6 90.2 6.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.11 109.408 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.541 ' HA ' ' HD2' ' A' ' 34' ' ' PHE . 25.9 mtm -120.86 158.66 27.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.65 111.434 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -70.48 105.45 1.22 Allowed Pre-proline 0 C--O 1.219 -0.503 0 N-CA-C 108.034 -1.099 . . . . 2.59 108.034 167.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.562 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 10.0 Cg_endo -51.83 -27.49 27.46 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.373 2.715 . . . . 1.04 114.789 -169.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.562 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 44.2 p90 -94.58 4.59 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 1.17 111.774 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.5 t -167.99 -74.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.521 -0.309 . . . . 1.09 110.317 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 94' ' ' THR . . . 68.19 75.95 0.46 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.422 -0.418 . . . . 1.16 112.944 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HG2' ' HZ ' ' A' ' 34' ' ' PHE . 1.8 Cg_endo -45.23 117.4 1.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.885 2.39 . . . . 1.2 111.081 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -55.23 -39.18 69.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.404 -0.816 . . . . 2.64 112.521 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -83.78 -19.19 35.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.616 0.246 . . . . 4.09 111.219 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -93.38 -5.96 48.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.688 0.756 . . . . 1.67 109.343 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.9 m -90.75 145.97 24.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 1.39 110.643 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -98.43 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.332 -0.988 . . . . 1.91 108.332 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 26.9 ttt180 -146.74 141.66 26.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.907 0.861 . . . . 0.62 110.968 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.819 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 1.3 t80 -102.75 154.94 18.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.208 -1.36 . . . . 0.86 108.468 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 90.8 m -156.61 102.14 2.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.645 -0.422 . . . . 0.31 111.179 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.819 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.9 p -104.74 135.96 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 119.913 -0.715 . . . . 0.88 109.984 168.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 13' ' ' THR . 94.3 m-85 -104.57 107.59 18.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.289 -0.869 . . . . 0.7 109.036 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.758 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 1.7 pp -128.86 152.76 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.223 -0.658 . . . . 2.12 109.223 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.812 ' O ' HG22 ' A' ' 16' ' ' VAL . 18.6 ttmm -105.17 117.56 34.31 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.334 -0.617 . . . . 1.89 109.334 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.03 110.39 22.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.951 -0.388 . . . . 0.53 109.951 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 25.4 p-10 . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.359 -0.837 . . . . 1.78 110.139 -170.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.927 ' HB3' HG22 ' A' ' 22' ' ' VAL . 70.2 t60 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.844 -0.798 . . . . 0.59 108.844 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -140.7 140.54 34.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.847 0.356 . . . . 2.36 110.585 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.839 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -106.09 132.26 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.397 -0.521 . . . . 0.49 110.959 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 p -113.74 169.78 8.73 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.091 -0.959 . . . . 0.51 110.155 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -41.01 -40.63 1.47 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.86 1.059 . . . . 0.83 113.86 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.88 61.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.672 0.749 . . . . 0.33 111.598 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.839 ' HB2' HG13 ' A' ' 5' ' ' VAL . 52.1 m80 -67.56 -1.74 5.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 2.12 111.583 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 3.3 t30 -48.33 -17.93 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.517 0.511 . . . . 1.41 109.674 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.88 56.74 0.64 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.507 -0.769 . . . . 0.3 111.716 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.028 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -106.54 157.83 17.38 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.662 0.986 . . . . 0.32 113.662 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 29.4 m -153.77 103.59 2.62 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.332 -0.849 . . . . 0.95 109.282 168.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.3 pt? -164.12 169.79 17.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 3.0 111.761 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 108' ' ' LYS . 88.9 m -100.7 145.95 27.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 1.73 111.054 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -119.74 152.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.478 -0.783 . . . . 0.78 110.701 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.36 108.02 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.551 -0.537 . . . . 0.76 109.551 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.679 HG12 HG21 ' A' ' 22' ' ' VAL . 34.4 m -86.63 -169.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.017 0.437 . . . . 1.23 111.99 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 116.31 -50.51 0.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.71 111.296 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.18 -77.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.286 0.565 . . . . 2.35 110.082 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -166.89 120.51 1.02 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.348 -0.842 . . . . 0.71 110.261 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' A' ' 3' ' ' HIS . 6.9 t -111.63 104.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.4 110.06 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.75 160.94 15.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.005 0.907 . . . . 1.09 112.183 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 85' ' ' VAL . 17.7 mm -130.37 101.58 5.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.647 -1.615 . . . . 0.54 107.828 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -108.46 143.31 37.6 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.299 0.571 . . . . 0.64 110.923 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -128.34 142.08 43.5 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.839 -0.619 . . . . 0.85 110.619 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 73.1 Cg_endo -77.41 6.14 4.62 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.35 111.671 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.733 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 11.2 t 68.39 -55.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.249 0.968 . . . . 0.91 110.129 -172.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.4 m-80 54.7 57.82 11.69 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.339 -1.356 . . . . 1.39 107.339 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.56 108.12 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.326 2.684 . . . . 0.83 113.139 -161.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' CE2' ' A' ' 89' ' ' TYR . 3.5 t -132.54 104.29 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.285 -1.325 . . . . 1.83 110.023 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 33' ' ' GLY . 3.8 m 72.15 -177.13 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.6 -0.727 . . . . 2.36 110.075 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.678 ' H ' HG22 ' A' ' 32' ' ' THR . . . -61.49 -15.98 48.41 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 118.505 0.593 . . . . 1.3 114.332 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.826 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 1.2 m-85 -62.26 155.41 24.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.545 0.572 . . . . 2.22 112.545 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.51 160.4 43.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.116 -0.947 . . . . 0.44 108.832 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.733 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.19 117.5 20.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.635 0.731 . . . . 0.43 111.537 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.61 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 66.2 m-85 -125.61 -176.68 3.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.955 -1.128 . . . . 2.78 107.955 168.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.648 ' HA ' HD23 ' A' ' 87' ' ' LEU . 1.3 m-85 -74.12 -77.95 0.11 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.794 -0.762 . . . . 0.43 109.178 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -114.3 10.56 17.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.699 -0.682 . . . . 2.39 110.46 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.494 ' HA3' ' HE1' ' A' ' 90' ' ' MET . . . 96.57 106.11 2.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.73 112.351 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.08 -3.46 51.81 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.7 112.414 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -128.69 142.94 50.86 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.806 0.336 . . . . 1.13 111.869 -178.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.622 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.06 132.96 27.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.316 -0.856 . . . . 2.52 110.532 164.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.98 154.05 51.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.234 0.54 . . . . 2.3 111.114 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.82 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 41.0 t -104.92 131.2 22.01 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.638 -0.875 . . . . 1.61 108.638 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.65 -25.67 20.76 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.487 2.791 . . . . 1.88 113.286 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.531 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 46.8 m-20 -139.7 81.7 1.84 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 2.43 109.957 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.0 pt-20 -117.61 58.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.599 0.714 . . . . 3.26 110.854 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -80.94 -60.04 2.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.559 -0.746 . . . . 2.06 111.246 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.801 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.96 -29.21 8.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.589 0.709 . . . . 1.25 109.961 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.801 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 6.3 m-85 -105.64 165.01 11.46 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.908 -1.042 . . . . 0.74 108.795 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -153.84 167.54 29.34 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.942 -0.703 . . . . 1.46 112.587 -163.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.99 134.0 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.383 -0.826 . . . . 1.31 111.547 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.25 155.35 18.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.986 -1.006 . . . . 2.45 109.294 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 4.6 p-10 -125.13 146.58 49.41 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.937 -0.574 . . . . 1.93 110.878 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.551 ' HD2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -164.84 103.91 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.42 110.049 178.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.898 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -118.87 128.56 54.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.701 0.762 . . . . 1.66 111.699 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 C--O 1.211 -0.952 0 CA-C-N 114.531 -1.213 . . . . 2.14 107.755 174.268 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.172 0 N-CA-C 112.725 -0.15 . . . . 1.49 112.725 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.431 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -161.47 83.77 0.62 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.777 0.658 . . . . 0.97 112.777 -175.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 30.3 mt-10 -104.79 104.83 14.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.447 -0.946 . . . . 0.81 108.447 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -115.43 149.28 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.394 -0.922 . . . . 0.53 112.157 -173.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.61 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 41.4 m-85 -109.13 114.64 28.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.484 -1.689 . . . . 1.13 108.476 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.551 ' CD2' ' HD2' ' A' ' 56' ' ' LYS . 5.5 m170 -104.27 109.36 21.17 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.86 -0.525 . . . . 0.5 111.11 -173.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.56 HG21 ' HE2' ' A' ' 83' ' ' HIS . 64.3 t -103.04 110.35 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.633 0.73 . . . . 0.87 110.071 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 23.2 m -101.99 105.31 16.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.93 -1.137 . . . . 0.46 107.93 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 7.3 p -150.89 151.68 12.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.804 -0.634 . . . . 1.04 110.669 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -135.31 103.61 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.838 0.828 . . . . 1.54 109.422 166.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.3 158.06 13.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.596 -0.729 . . . . 0.67 109.307 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 110' ' ' ASN . . . -84.39 95.28 8.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.484 0.659 . . . . 0.44 110.217 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -146.45 169.54 27.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.219 -0.9 . . . . 0.29 111.679 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -107.38 130.0 54.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.296 -0.631 . . . . 0.4 109.296 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 43.3 t-80 -104.11 102.51 12.25 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.28 -0.262 . . . . 0.4 110.324 -172.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.16 128.67 50.03 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.322 -0.622 . . . . 0.35 109.322 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -128.66 103.88 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 120.801 -0.36 . . . . 0.59 111.656 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 102' ' ' ARG . 2.4 m120 -109.03 103.26 12.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.481 -0.933 . . . . 1.53 108.481 171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 38' ' ' PHE . 91.9 mt -103.83 122.34 44.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 0.24 109.566 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.64 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.2 m -101.31 117.86 35.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.816 0.817 . . . . 0.29 110.941 -171.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.826 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -84.43 92.43 8.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.629 -1.168 . . . . 1.11 109.425 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.639 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 12.6 mtm -128.72 165.05 21.65 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.433 -0.349 . . . . 0.65 110.185 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' PHE . 9.3 ttm180 -67.02 106.47 1.19 Allowed Pre-proline 0 C--O 1.213 -0.819 0 N-CA-C 107.954 -1.128 . . . . 2.59 107.954 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.524 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 4.4 Cg_endo -44.96 -30.92 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 124.067 3.178 . . . . 1.04 115.25 -168.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.524 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 36.9 p90 -95.24 5.67 51.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.395 0.517 . . . . 1.17 112.395 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -164.99 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.568 0.21 . . . . 1.09 111.568 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 63.86 86.95 0.05 OUTLIER Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.869 -0.492 . . . . 1.16 111.869 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 1.051 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 29.1 Cg_exo -57.32 118.4 5.26 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.269 1.98 . . . . 1.2 110.042 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.3 t -49.4 -53.38 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.726 0.641 . . . . 2.64 112.465 -167.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -92.19 5.51 50.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.951 0.405 . . . . 4.09 110.645 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 1.051 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 27.2 t70 -112.99 1.24 15.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 1.67 109.878 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -98.86 171.5 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.594 -0.73 . . . . 1.39 111.457 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.687 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.1 tp10 -115.39 170.88 8.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.831 -0.803 . . . . 1.91 108.831 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.64 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 34.8 ttt180 -157.18 141.69 16.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.821 0.819 . . . . 0.62 111.184 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.805 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -104.36 157.74 16.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.313 -1.312 . . . . 0.86 108.594 177.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.0 m -157.85 102.48 1.84 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.514 . . . . 0.31 111.306 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.2 p -103.66 134.48 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.482 -0.562 . . . . 0.88 109.482 169.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' THR . 72.0 m-85 -105.21 112.7 25.92 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.138 -0.69 . . . . 0.7 109.138 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.695 ' HG ' HG22 ' A' ' 105' ' ' VAL . 77.8 mt -127.85 164.9 21.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.011 -0.995 . . . . 2.12 110.024 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 16' ' ' VAL . 58.4 tttm -119.99 113.85 21.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.385 -0.969 . . . . 1.89 108.385 172.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 83' ' ' HIS . . . -101.14 106.83 18.11 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.908 -0.405 . . . . 0.53 109.908 -171.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.631 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.135 -0.936 . . . . 1.78 110.437 -168.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.959 ' HB3' HG22 ' A' ' 22' ' ' VAL . 8.7 t-80 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.59 108.798 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 21.5 pttp -149.55 150.44 32.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.702 0.287 . . . . 2.36 111.423 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.003 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -120.11 136.3 57.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.433 0.635 . . . . 0.49 111.961 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p -120.33 170.34 9.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.785 -1.098 . . . . 0.51 110.473 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 16.7 tptm -35.62 -48.6 0.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.692 1.368 . . . . 0.83 114.692 -171.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.59 -33.32 60.19 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.601 0.715 . . . . 0.33 111.817 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.831 ' HB2' HG13 ' A' ' 5' ' ' VAL . 75.0 m80 -64.75 -2.32 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 2.12 111.227 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.526 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 3.4 t30 -45.57 -22.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.332 0.653 . . . . 1.41 109.995 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.42 54.0 0.66 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.5 -0.773 . . . . 0.3 111.357 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.944 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -116.76 156.03 27.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.654 0.613 . . . . 0.32 112.654 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 39.4 m -145.95 112.91 6.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.394 -0.821 . . . . 0.95 109.433 173.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -157.88 167.62 29.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 3.0 111.347 -173.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.8 m -101.52 146.59 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.724 0.297 . . . . 1.73 111.107 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.1 m -131.76 162.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.78 110.936 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.78 137.88 51.89 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.66 -1.237 . . . . 0.76 107.66 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.821 HG12 ' H ' ' A' ' 19' ' ' GLY . 1.6 t -121.06 -164.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 119.892 -0.723 . . . . 1.23 110.25 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.821 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 124.31 -48.87 0.93 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.765 -0.934 . . . . 0.71 110.765 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -84.43 -71.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.292 0.568 . . . . 2.35 109.685 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -165.46 144.38 6.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.246 -0.888 . . . . 0.71 110.096 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.959 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.1 t -123.14 120.11 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 109.341 -0.615 . . . . 0.4 109.341 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 49.8 mt-10 -103.8 151.53 22.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.933 0.873 . . . . 1.09 112.442 -171.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.713 HD13 ' HB ' ' A' ' 5' ' ' VAL . 41.6 mm -133.88 137.74 51.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.227 -1.768 . . . . 0.54 106.227 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.9 OUTLIER -145.4 142.12 29.05 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.662 -0.649 . . . . 0.64 111.217 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -117.25 144.72 34.37 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.28 -0.873 . . . . 0.85 109.181 169.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 73.8 Cg_endo -82.63 12.52 2.87 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 C-N-CA 122.862 2.375 . . . . 0.35 111.515 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.746 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.1 t 68.11 -44.99 0.5 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.982 0.913 . . . . 0.91 112.257 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 31' ' ' THR . 1.2 p-10 41.89 78.81 0.36 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.443 0.64 . . . . 1.39 110.777 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.574 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 25.9 Cg_exo -63.97 109.98 1.22 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.357 2.705 . . . . 0.83 112.111 -169.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 29' ' ' ASN . 1.3 t -142.46 117.15 9.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.724 -0.671 . . . . 1.83 111.534 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.7 m 73.52 -42.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.478 0.656 . . . . 2.36 112.314 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 31' ' ' THR . . . 162.72 -118.58 0.83 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 107.72 -2.152 . . . . 1.3 107.72 -172.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.764 ' HA ' ' C ' ' A' ' 90' ' ' MET . 8.5 m-30 61.77 178.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.577 0.703 . . . . 2.22 111.607 167.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -174.35 144.79 0.95 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.634 -1.247 . . . . 0.44 107.634 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.746 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 94.8 m95 -76.97 99.07 5.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.359 0.6 . . . . 0.43 110.848 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.47 179.76 4.18 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.736 -1.209 . . . . 2.78 107.736 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -68.64 -69.03 0.35 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.628 -0.829 . . . . 0.43 109.372 167.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.52 13.33 3.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 2.39 110.44 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.21 112.05 3.3 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.613 -0.803 . . . . 0.73 113.101 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 4.26 34.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.475 -0.393 . . . . 0.7 113.03 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 p -139.94 144.63 37.18 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 112.425 0.528 . . . . 1.13 112.425 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.534 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -142.23 127.68 18.92 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.901 -1.045 . . . . 2.52 110.122 167.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.92 145.0 51.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.071 0.463 . . . . 2.3 110.781 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -111.86 135.89 21.2 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.073 -0.714 . . . . 1.61 109.073 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 36.9 Cg_exo -61.51 128.78 25.76 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.278 1.986 . . . . 1.88 111.457 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 72.19 30.76 2.04 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.954 0.784 . . . . 2.43 112.149 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.18 45.72 1.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.579 0.704 . . . . 3.26 110.985 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -81.29 -19.56 42.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.541 -0.754 . . . . 2.06 111.339 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.4 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 17.5 ptt? -138.76 -35.82 0.57 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.748 0.785 . . . . 1.25 109.964 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.853 ' HB3' ' O ' ' A' ' 76' ' ' THR . 8.4 m-85 -106.2 166.19 10.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.74 108.443 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -153.03 167.11 30.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.767 0.712 . . . . 1.46 112.623 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.9 p -103.34 141.57 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.252 -0.886 . . . . 1.31 111.671 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -116.36 137.94 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 2.45 109.614 173.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -110.64 159.17 17.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.753 0.311 . . . . 1.93 111.386 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.64 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -158.24 117.22 3.13 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.264 -0.426 . . . . 1.42 109.977 175.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 2.6 m-85 -123.51 106.46 10.63 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.296 -0.562 . . . . 1.66 109.794 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 . . . . . 0 N--CA 1.444 -0.774 0 CA-C-N 116.335 -0.393 . . . . 2.14 111.661 -175.886 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 N-CA-C 111.346 -0.701 . . . . 1.49 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.27 85.22 0.24 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.472 0.654 . . . . 0.97 110.344 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.767 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.0 mt-10 -113.58 104.66 12.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.534 -0.757 . . . . 0.81 108.991 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.64 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -110.77 165.42 11.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.753 0.787 . . . . 0.53 111.436 -170.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.482 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 60.0 m-85 -136.57 104.51 5.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.98 -1.464 . . . . 1.13 109.128 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.626 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 40.1 m170 -102.79 113.84 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.958 -0.464 . . . . 0.5 109.86 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 m -103.91 125.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 122.135 0.969 . . . . 0.87 110.079 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.853 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 3.7 m -103.82 103.54 13.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.101 -1.444 . . . . 0.46 107.101 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.653 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.1 p -157.25 129.94 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 123.292 0.37 . . . . 1.04 111.033 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -123.2 102.55 8.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.497 0.665 . . . . 1.54 110.606 176.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.68 140.42 4.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.52 -0.764 . . . . 0.67 109.757 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -64.61 87.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.61 0.569 . . . . 0.44 111.484 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.87 166.48 32.96 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 110.693 -0.963 . . . . 0.29 110.693 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.0 OUTLIER -101.0 136.01 41.53 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.773 -0.771 . . . . 0.4 109.228 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.499 ' O ' HD13 ' A' ' 107' ' ' LEU . 55.8 t-80 -101.63 102.42 13.11 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.836 -0.802 . . . . 0.4 108.836 -174.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.21 103.7 13.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.188 -0.671 . . . . 0.35 109.188 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.1 p -106.52 109.36 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.662 -0.699 . . . . 0.59 111.291 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 3.0 m-20 -107.21 103.76 13.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.863 -1.062 . . . . 1.53 108.932 176.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 38' ' ' PHE . 76.3 mt -106.2 128.39 53.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.258 -0.428 . . . . 0.24 110.142 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 90' ' ' MET . 3.2 m -104.51 130.84 52.41 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.931 0.396 . . . . 0.29 110.579 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.626 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 40.6 t80 -96.23 93.82 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.283 -0.636 . . . . 1.11 109.283 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.764 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -131.16 158.43 40.5 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.506 -0.316 . . . . 0.65 110.623 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.643 ' N ' ' HA ' ' A' ' 34' ' ' PHE . 41.5 mtt180 -58.65 108.8 1.45 Allowed Pre-proline 0 CA--C 1.512 -0.51 0 O-C-N 124.083 0.864 . . . . 2.59 110.083 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 7.0 Cg_exo -38.38 -37.97 0.79 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.903 3.735 . . . . 1.04 115.083 -174.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -91.92 1.27 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.131 0.789 . . . . 1.17 113.131 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.8 t -158.52 -62.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.071 -0.393 . . . . 1.09 111.43 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.623 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.34 93.56 0.23 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.958 -0.639 . . . . 1.16 113.263 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.824 ' HB2' ' HB2' ' A' ' 99' ' ' ASP . 17.4 Cg_exo -69.22 97.54 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.587 2.192 . . . . 1.2 110.008 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.6 m -62.52 -25.1 67.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.655 0.74 . . . . 2.64 109.095 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -59.24 -32.26 69.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.839 -1.073 . . . . 4.09 110.618 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.824 ' HB2' ' HB2' ' A' ' 96' ' ' PRO . 1.5 m-20 -109.34 -105.45 0.36 Allowed 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.679 -0.237 . . . . 1.67 110.598 -174.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.9 p 49.28 -179.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.106 1.15 . . . . 1.39 114.106 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.28 137.89 30.96 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.748 -1.204 . . . . 1.91 107.748 165.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -121.21 142.87 49.49 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.786 -0.765 . . . . 0.62 111.565 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 1.1 t80 -104.38 153.9 20.5 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.216 -1.357 . . . . 0.86 108.989 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 54.2 m -161.03 103.84 1.3 Allowed 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.147 0.28 . . . . 0.31 110.317 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.003 HG11 HG21 ' A' ' 5' ' ' VAL . 7.5 p -110.08 136.6 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 118.15 -1.42 . . . . 0.88 109.877 168.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' THR . 79.4 m-85 -103.94 101.95 11.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.799 -1.092 . . . . 0.7 108.15 175.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.774 HD12 HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -124.49 142.62 51.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.438 -0.949 . . . . 2.12 108.438 176.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.721 ' O ' HG22 ' A' ' 16' ' ' VAL . 78.3 tttt -101.89 122.77 44.64 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.369 -0.532 . . . . 1.89 110.507 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.98 159.18 15.58 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.692 0.62 . . . . 0.53 110.71 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.527 ' H ' HG23 ' A' ' 18' ' ' VAL . 2.8 p-10 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.353 -0.832 . . . . 1.78 109.553 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.707 ' NE2' HD13 ' A' ' 107' ' ' LEU . 20.2 t60 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 121.487 0.66 . . . . 0.59 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 20.1 pttp -149.71 141.14 23.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 2.36 110.771 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.84 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -103.22 140.15 22.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.49 110.562 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -121.71 169.05 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.503 -0.772 . . . . 0.51 109.73 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -38.0 -47.01 1.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.335 1.235 . . . . 0.83 114.335 -171.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.55 61.83 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.47 0.652 . . . . 0.33 111.871 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.824 ' HB2' HG13 ' A' ' 5' ' ' VAL . 47.9 m80 -62.57 -3.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.629 . . . . 2.12 111.672 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.494 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 19.2 t30 -46.91 -19.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.145 0.578 . . . . 1.41 110.171 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.33 51.87 0.74 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.955 -0.641 . . . . 0.3 112.078 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 1.077 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -106.03 162.3 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.513 0.931 . . . . 0.32 113.513 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 85.7 m -153.74 103.76 2.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.336 -0.847 . . . . 0.95 109.134 170.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 6.5 tt -156.06 164.26 38.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 110.141 -0.318 . . . . 3.0 110.141 -170.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 m -103.15 140.91 36.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 1.73 111.414 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.6 m -116.97 158.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.78 111.372 -174.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.77 121.28 44.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 0.76 109.586 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.615 HG22 ' C ' ' A' ' 110' ' ' ASN . 17.6 m -108.26 -173.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.23 111.271 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 130.11 -56.65 0.74 Allowed Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 111.244 -0.742 . . . . 0.71 111.244 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.35 -68.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.333 0.587 . . . . 2.35 109.654 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -165.99 141.38 4.8 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 114.863 -1.062 . . . . 0.71 109.179 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 3' ' ' HIS . 0.9 OUTLIER -117.65 126.63 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 110.003 -0.369 . . . . 0.4 110.003 173.164 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 21.2 mt-10 -103.34 142.83 33.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.882 0.849 . . . . 1.09 112.732 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.643 HG21 HG11 ' A' ' 85' ' ' VAL . 41.7 mm -124.45 101.06 8.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.321 -1.363 . . . . 0.54 107.321 165.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -108.93 138.24 45.58 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.492 0.663 . . . . 0.64 111.781 -169.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -119.58 144.77 37.54 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.517 -0.765 . . . . 0.85 109.441 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.543 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 36.7 Cg_endo -86.78 13.86 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.682 2.255 . . . . 0.35 111.66 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.714 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 34.3 t 67.6 -49.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.314 -0.857 . . . . 0.91 111.62 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.543 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER 50.45 57.05 17.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.185 -1.043 . . . . 1.39 108.185 -172.414 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 83.2 Cg_exo -50.11 119.59 5.11 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.88 3.054 . . . . 0.83 114.156 -163.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' CE2' ' A' ' 89' ' ' TYR . 10.8 p -98.35 -53.37 3.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.19 -0.914 . . . . 1.83 110.138 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.632 HG23 ' HD1' ' A' ' 34' ' ' PHE . 2.7 t -171.18 -115.76 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.048 -0.524 . . . . 2.36 109.976 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -14.95 79.58 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.211 -0.519 . . . . 1.3 112.561 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.632 ' HD1' HG23 ' A' ' 32' ' ' THR . 3.7 m-85 -67.94 145.92 54.08 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.094 0.558 . . . . 2.22 110.316 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.81 157.41 43.17 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.74 -0.467 . . . . 0.44 109.74 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.714 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.6 m95 -77.26 113.31 14.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.413 0.625 . . . . 0.43 111.017 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 46.5 m-85 -125.48 175.36 7.57 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.544 -1.28 . . . . 2.78 107.544 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.4 m-85 -65.17 -65.69 0.64 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.465 -0.894 . . . . 0.43 109.532 170.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.71 21.59 3.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.997 -0.547 . . . . 2.39 110.59 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.79 92.64 1.58 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.466 -0.873 . . . . 0.73 113.276 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.99 -8.92 76.56 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.764 -0.731 . . . . 0.7 112.628 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -128.4 143.92 51.07 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 111.906 0.336 . . . . 1.13 111.906 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.618 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -140.99 139.43 34.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.254 -0.884 . . . . 2.52 110.383 172.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.39 145.29 33.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.979 0.419 . . . . 2.3 111.594 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.756 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 40.2 m -104.76 137.02 19.1 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 1.61 109.556 173.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 31.2 Cg_exo -60.35 -22.46 71.2 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.208 2.605 . . . . 1.88 113.421 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -119.72 24.66 10.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.436 0.16 . . . . 2.43 111.408 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 6.5 pt-20 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.946 0.879 . . . . 3.26 111.074 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 m -160.45 -49.62 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.469 -1.308 . . . . 2.06 107.469 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.514 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -103.46 -41.04 6.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.551 -1.204 . . . . 1.25 109.233 173.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.67 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.9 m-85 -105.62 165.75 10.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.113 -0.949 . . . . 0.74 108.535 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -163.7 170.32 17.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.46 111.575 -168.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' A' ' 75' ' ' VAL . 2.2 p -102.11 135.0 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.61 -0.723 . . . . 1.31 111.37 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 1.3 pm0 -120.1 136.31 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.55 -0.907 . . . . 2.45 108.55 170.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -103.23 153.82 19.98 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.845 -0.742 . . . . 1.93 111.494 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 108.82 3.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.011 -0.995 . . . . 1.42 109.376 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.838 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -114.75 135.1 54.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.782 -0.644 . . . . 1.66 110.621 -174.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.559 -0.291 . . . . 2.14 110.307 169.926 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.849 0 N-CA-C 111.955 -0.458 . . . . 1.49 111.955 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.39 81.3 0.97 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.485 0.659 . . . . 0.97 110.98 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.838 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 31.4 mt-10 -104.27 104.04 13.88 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.576 -0.898 . . . . 0.81 108.576 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -108.94 150.13 28.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.517 -0.873 . . . . 0.53 110.837 -175.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.604 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 10.0 m-85 -109.56 115.08 29.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.167 -1.379 . . . . 1.13 108.95 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 15.8 m170 -104.24 108.24 19.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.341 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 22' ' ' VAL . 4.2 m -103.45 117.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.175 0.988 . . . . 0.87 108.777 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 68.0 m -102.62 103.71 14.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.978 -1.119 . . . . 0.46 107.978 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 2.9 p -154.76 144.57 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.515 -0.766 . . . . 1.04 110.619 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.1 103.05 6.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.822 0.82 . . . . 1.54 109.006 165.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.79 134.72 2.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.375 -0.83 . . . . 0.67 110.522 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -65.14 102.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.757 0.66 . . . . 0.44 111.367 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.49 167.2 38.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.152 -1.179 . . . . 0.29 110.152 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.8 m -101.85 131.54 48.14 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 118.055 0.927 . . . . 0.4 109.436 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.568 ' ND1' HG22 ' A' ' 85' ' ' VAL . 32.5 t-80 -103.96 102.96 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.948 -0.39 . . . . 0.4 109.948 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.85 122.13 43.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.014 -0.735 . . . . 0.35 109.014 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.0 t -113.97 109.87 30.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.134 -0.485 . . . . 0.59 111.696 -170.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -109.68 104.09 13.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.223 -0.658 . . . . 1.53 109.223 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 38' ' ' PHE . 82.5 mt -108.49 121.34 44.76 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.24 110.004 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 2.6 m -102.35 118.9 37.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.397 0.617 . . . . 0.29 110.657 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.605 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 53.9 t80 -86.01 91.22 8.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.942 -1.026 . . . . 1.11 109.606 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.725 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 3.2 mtm -131.7 165.13 24.42 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.506 -0.316 . . . . 0.65 110.473 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.532 ' HB2' ' H ' ' A' ' 95' ' ' GLY . 70.5 mtt180 -57.28 112.54 4.79 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.48 -0.933 . . . . 2.59 108.48 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -52.06 -24.81 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.236 2.624 . . . . 1.04 114.504 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.533 ' CD1' HG22 ' A' ' 94' ' ' THR . 47.6 p90 -96.94 2.77 52.01 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.881 0.326 . . . . 1.17 111.881 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.3 t -173.84 -67.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.483 -0.135 . . . . 1.09 111.309 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.725 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 77.87 89.81 0.35 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.843 -0.694 . . . . 1.16 112.065 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 11.0 Cg_exo -37.31 113.26 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.487 2.792 . . . . 1.2 111.718 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 t -75.94 9.85 2.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 2.64 111.944 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -130.12 4.37 4.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.122 -0.325 . . . . 4.09 110.122 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 22.8 t0 -127.05 0.82 6.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.203 0.525 . . . . 1.67 110.916 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 m -87.91 148.27 24.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.045 -0.525 . . . . 1.39 111.084 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.5 tp10 -100.8 169.36 9.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 1.91 108.812 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 33.5 ttt180 -153.8 140.01 18.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.806 0.812 . . . . 0.62 110.703 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.84 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 2.5 t80 -104.13 156.87 17.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.278 -1.328 . . . . 0.86 108.668 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 66.9 m -158.8 101.18 1.63 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 120.885 0.374 . . . . 0.31 110.121 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.077 HG23 ' HB3' ' A' ' 12' ' ' ALA . 9.3 p -104.65 134.7 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 119.793 -0.763 . . . . 0.88 109.73 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 13' ' ' THR . 91.1 m-85 -104.07 113.99 27.93 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.7 108.605 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 3' ' ' HIS . 17.3 mt -137.7 165.08 27.26 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.835 -0.62 . . . . 2.12 109.753 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.766 ' O ' HG22 ' A' ' 16' ' ' VAL . 78.5 tttt -119.76 124.4 46.07 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.47 -0.492 . . . . 1.89 110.237 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.427 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.62 127.24 48.44 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.397 0.436 . . . . 0.53 110.066 -172.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.615 ' C ' HG22 ' A' ' 18' ' ' VAL . 19.6 p-10 . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.648 -0.705 . . . . 1.78 109.977 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 1.009 ' HB3' HG22 ' A' ' 22' ' ' VAL . 28.4 t60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.415 -0.587 . . . . 0.59 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -144.05 141.14 29.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.24 -0.436 . . . . 2.36 110.606 177.567 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.846 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -106.25 134.12 48.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.49 111.525 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.76 168.47 9.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.136 -0.938 . . . . 0.51 110.289 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 25.7 tptp -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.298 1.592 . . . . 0.83 115.298 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.23 -30.87 60.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.77 0.714 . . . . 0.33 111.757 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.837 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.9 m80 -66.06 -2.26 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.659 -0.7 . . . . 2.12 111.267 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.668 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -49.48 -17.24 0.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.165 -0.68 . . . . 1.41 109.165 171.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.93 50.08 0.68 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.96 -0.563 . . . . 0.3 111.787 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -110.18 158.08 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.198 0.814 . . . . 0.32 113.198 -173.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 91.7 m -148.8 107.74 3.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.144 -0.935 . . . . 0.95 109.738 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pp -153.76 168.26 26.89 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 3.0 111.668 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.0 m -101.16 146.62 27.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.423 -0.353 . . . . 1.73 110.608 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 108' ' ' LYS . 6.0 m -129.45 160.78 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.105 0.478 . . . . 0.78 111.477 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.65 124.12 51.55 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.54 -0.911 . . . . 0.76 108.54 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.648 HG22 ' C ' ' A' ' 110' ' ' ASN . 22.5 m -102.49 -165.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.509 -0.476 . . . . 1.23 111.385 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 112.12 -50.38 0.77 Allowed Glycine 0 CA--C 1.504 -0.652 0 N-CA-C 111.041 -0.823 . . . . 0.71 111.041 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -75.61 -75.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.795 0.807 . . . . 2.35 109.132 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -166.64 140.48 3.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.521 -1.218 . . . . 0.71 109.349 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.009 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.7 t -123.57 104.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.586 0.708 . . . . 0.4 109.155 172.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.1 pt-20 -109.45 160.19 16.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.795 0.807 . . . . 1.09 111.568 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 5' ' ' VAL . 22.6 mm -134.68 104.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.072 -1.422 . . . . 0.54 108.624 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.618 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -110.04 139.26 45.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.533 0.682 . . . . 0.64 111.904 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.477 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.9 mm? -116.84 139.99 26.35 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 114.985 -1.007 . . . . 0.85 108.955 171.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 85.1 Cg_endo -79.06 8.77 3.64 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 122.824 2.349 . . . . 0.35 111.893 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.651 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 7.9 t 66.22 -63.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.03 0.831 . . . . 0.91 110.291 -173.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.406 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.1 m-80 60.81 65.42 2.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.059 -1.089 . . . . 1.39 108.059 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.66 112.86 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.875 3.05 . . . . 0.83 113.57 -165.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.545 HG23 ' CE2' ' A' ' 89' ' ' TYR . 38.7 p -80.7 -73.98 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.167 -1.378 . . . . 1.83 112.176 -174.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.445 ' H ' ' H ' ' A' ' 33' ' ' GLY . 6.3 t -171.19 -12.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.473 -0.785 . . . . 2.36 110.359 -174.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' H ' ' H ' ' A' ' 32' ' ' THR . . . 176.44 -33.93 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.39 -0.684 . . . . 1.3 111.39 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.556 ' HA ' ' C ' ' A' ' 90' ' ' MET . 45.7 m-85 -52.5 139.72 24.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.559 -0.32 . . . . 2.22 111.284 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -137.72 151.44 48.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 0.44 108.661 171.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.87 109.79 14.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.328 0.585 . . . . 0.43 111.415 -174.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 51.2 m-85 -114.67 177.53 4.61 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 108.395 -0.965 . . . . 2.78 108.395 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.776 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -70.02 -73.94 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.01 0.823 . . . . 0.43 109.466 169.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.43 -11.86 14.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.709 -0.678 . . . . 2.39 110.179 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.31 108.1 2.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.564 -0.827 . . . . 0.73 112.099 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.06 -16.92 7.94 Favored Glycine 0 CA--C 1.516 0.145 0 C-N-CA 120.987 -0.625 . . . . 0.7 112.648 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 m -128.97 142.09 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.886 -0.413 . . . . 1.13 109.886 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -139.91 141.56 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.522 -0.548 . . . . 2.52 109.522 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.45 164.35 28.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.607 0.718 . . . . 2.3 112.625 -172.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.851 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 15.9 p -135.23 128.41 18.39 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.61 108.996 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.9 150.36 86.49 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.635 2.223 . . . . 1.88 112.138 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.471 ' HB2' HG21 ' A' ' 77' ' ' VAL . 94.6 m-20 66.35 42.78 2.88 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.573 0.546 . . . . 2.43 110.574 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -88.72 31.15 0.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 3.26 111.304 -173.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -88.09 12.11 14.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.392 -0.367 . . . . 2.06 111.266 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.442 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 20.5 ptt? -175.27 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.627 . . . . 1.25 110.461 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.754 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.4 m-85 -122.5 162.87 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.121 -0.945 . . . . 0.74 109.297 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -159.65 167.88 27.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.342 0.592 . . . . 1.46 112.278 -164.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.5 p -103.09 139.34 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.311 -0.859 . . . . 1.31 111.401 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.702 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -112.43 142.93 44.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.194 -0.669 . . . . 2.45 109.194 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . 3.7 p-10 -111.16 161.32 16.08 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.959 -0.296 . . . . 1.93 111.229 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.786 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -165.14 111.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.881 -0.785 . . . . 1.42 108.881 171.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 5.7 m-85 -111.18 112.83 24.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.173 -0.611 . . . . 1.66 111.916 -173.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.219 -0.9 . . . . 2.14 109.417 172.773 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 111.805 -0.518 . . . . 1.49 111.805 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 69' ' ' GLY . 2.7 p -156.24 86.96 1.03 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.64 0.733 . . . . 0.97 112.349 -173.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.718 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 39.9 mt-10 -103.98 103.56 13.41 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.936 -1.135 . . . . 0.81 107.936 174.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.786 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 11.0 m-70 -105.03 150.59 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.719 0.771 . . . . 0.53 111.863 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 32.6 m-85 -125.2 104.5 8.54 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.912 -1.494 . . . . 1.13 108.679 172.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.702 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 23.3 m170 -102.52 104.27 14.68 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.159 -0.312 . . . . 0.5 110.159 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -101.9 114.57 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.609 1.195 . . . . 0.87 109.479 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 27.7 m -101.61 104.72 15.6 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.248 -1.342 . . . . 0.46 107.904 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.565 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 6.1 p -149.04 148.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 124.206 0.941 . . . . 1.04 110.043 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -130.99 102.77 6.18 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.845 0.831 . . . . 1.54 108.854 164.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.21 160.94 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.271 -0.877 . . . . 0.67 110.063 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.25 95.99 10.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.994 0.426 . . . . 0.44 111.151 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.14 165.84 34.95 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.308 -0.717 . . . . 0.29 111.308 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -102.44 131.73 48.92 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.062 -0.669 . . . . 0.4 109.846 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.692 ' ND1' HG22 ' A' ' 85' ' ' VAL . 2.8 t-80 -104.13 104.46 14.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.728 -0.669 . . . . 0.4 110.041 -173.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.89 109.69 21.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.319 -0.993 . . . . 0.35 108.319 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.96 104.26 16.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 116.063 -0.517 . . . . 0.59 111.191 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -113.4 103.29 11.14 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.687 0.756 . . . . 1.53 110.121 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 38' ' ' PHE . 90.8 mt -105.89 129.62 54.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.761 -1.109 . . . . 0.24 110.137 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.741 HG22 ' HG3' ' A' ' 90' ' ' MET . 5.9 m -101.31 118.93 37.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.588 0.709 . . . . 0.29 110.747 -171.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.683 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 1.6 t80 -87.84 83.42 7.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.568 -1.197 . . . . 1.11 109.467 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.741 ' HG3' HG22 ' A' ' 88' ' ' THR . 30.2 mtm -117.26 158.32 24.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.858 0.361 . . . . 0.65 111.833 -171.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -70.09 105.94 1.41 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.158 -1.053 . . . . 2.59 108.158 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.7 Cg_endo -50.71 -26.79 18.19 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.49 2.793 . . . . 1.04 114.564 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.2 p90 -92.25 -4.5 53.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.196 0.443 . . . . 1.17 112.196 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.616 HG23 ' H ' ' A' ' 95' ' ' GLY . 5.2 t -161.89 -62.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.365 -0.209 . . . . 1.09 111.076 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' H ' HG23 ' A' ' 94' ' ' THR . . . 53.18 66.64 2.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.962 -0.355 . . . . 1.16 112.967 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.5 128.7 24.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.671 2.247 . . . . 1.2 112.269 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.8 t -57.79 138.9 55.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.752 -0.658 . . . . 2.64 109.687 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.1 m80 77.96 -8.11 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.805 0.69 . . . . 4.09 111.574 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -99.41 -25.66 14.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.83 0.824 . . . . 1.67 108.925 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 6.2 p -81.26 163.33 23.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.72 -1.127 . . . . 1.39 110.9 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 10.8 tp10 -103.09 172.35 6.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.727 -0.842 . . . . 1.91 108.727 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 48.8 ttt180 -156.04 139.9 16.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.797 0.808 . . . . 0.62 110.909 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.709 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.75 156.53 17.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.228 -1.351 . . . . 0.86 109.052 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.83 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 93.5 m -160.22 103.5 1.45 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.788 -0.365 . . . . 0.31 111.105 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.846 HG11 HG21 ' A' ' 5' ' ' VAL . 11.1 p -103.72 137.47 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.88 110.31 170.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.5 m-85 -105.29 107.87 19.08 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.772 . . . . 0.7 109.127 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.6 pp -130.69 146.13 52.1 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.443 -0.577 . . . . 2.12 109.443 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.692 ' O ' HG22 ' A' ' 16' ' ' VAL . 11.8 tttp -103.76 114.72 29.19 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.583 -0.447 . . . . 1.89 110.722 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.532 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.53 132.2 46.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.306 -0.406 . . . . 0.53 110.382 -168.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.648 ' C ' HG22 ' A' ' 18' ' ' VAL . 7.7 p30 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.26 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.968 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.403 -0.962 . . . . 0.59 108.403 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.49 134.55 25.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 2.36 111.364 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.944 HG21 HG11 ' A' ' 105' ' ' VAL . 2.0 t -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.227 -0.442 . . . . 0.49 110.786 173.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -146.85 170.82 16.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.195 0.998 . . . . 0.51 108.621 -172.043 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 23.2 tptp -48.17 -39.53 21.12 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.257 0.836 . . . . 0.83 113.257 -173.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.64 77.55 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.688 0.756 . . . . 0.33 110.856 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.779 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.7 m80 -64.4 -3.9 3.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.203 -0.908 . . . . 2.12 111.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.655 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 3.6 t30 -48.03 -21.44 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.378 0.671 . . . . 1.41 110.548 171.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.06 54.6 0.65 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.22 -0.752 . . . . 0.3 111.22 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.843 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.05 160.58 20.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.961 0.726 . . . . 0.32 112.961 -174.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.4 m -151.76 117.03 5.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.231 -0.895 . . . . 0.95 109.467 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.6 pp -164.29 168.29 18.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.534 0.207 . . . . 3.0 111.367 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.0 m -102.97 145.9 29.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.885 0.374 . . . . 1.73 111.077 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -123.5 162.26 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.74 -0.664 . . . . 0.78 110.15 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.448 ' HA ' ' OXT' ' A' ' 110' ' ' ASN . . . -115.16 117.01 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.733 -0.84 . . . . 0.76 108.733 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 22' ' ' VAL . 25.2 m -93.85 178.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.481 . . . . 1.23 111.956 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.52 -52.86 0.76 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.71 111.556 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -78.06 -72.52 0.36 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.558 -0.534 . . . . 2.35 109.558 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -168.07 128.49 1.33 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.753 -0.658 . . . . 0.71 110.931 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.968 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.9 t -104.41 114.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.703 0.763 . . . . 0.4 109.725 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.6 145.07 30.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.464 -0.789 . . . . 1.09 111.854 -171.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 38.5 mm -128.6 102.98 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.873 -1.158 . . . . 0.54 107.873 169.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -114.91 138.48 50.76 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.304 -0.559 . . . . 0.64 111.859 -173.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.2 mm? -116.42 144.2 32.65 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.517 -0.765 . . . . 0.85 109.178 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 42.6 Cg_endo -85.73 13.26 2.8 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 122.992 2.462 . . . . 0.35 111.858 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.549 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 12.2 t 69.34 -65.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.9 0.75 . . . . 0.91 111.225 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.8 m-80 58.95 77.09 0.41 Allowed Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.285 0.634 . . . . 1.39 109.832 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -52.91 105.03 0.11 Allowed 'Trans proline' 0 CA--C 1.517 -0.333 0 C-N-CA 123.495 2.797 . . . . 0.83 113.741 -166.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.413 HG23 ' CE2' ' A' ' 89' ' ' TYR . 70.2 p -83.4 -53.49 5.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.083 . . . . 1.83 109.667 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 t -179.52 -136.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.686 -1.227 . . . . 2.36 107.686 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.48 -25.61 65.35 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.078 -0.582 . . . . 1.3 113.176 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.6 m-30 -53.3 150.32 6.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.123 0.487 . . . . 2.22 112.027 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.01 163.97 36.73 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.226 -0.897 . . . . 0.44 109.093 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.549 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -83.6 123.44 29.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.216 0.532 . . . . 0.43 111.505 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.881 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -158.32 147.58 19.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.459 -0.791 . . . . 2.78 109.296 173.379 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.6 m-85 -45.31 -68.9 0.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.232 0.456 . . . . 0.43 112.232 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 42' ' ' THR . 7.1 pt-20 -130.34 18.84 5.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.082 0.468 . . . . 2.39 110.79 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 100.27 91.64 2.08 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.561 -0.828 . . . . 0.73 113.128 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 -3.35 80.22 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.804 -0.712 . . . . 0.7 112.388 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.635 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -128.3 142.76 51.04 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.91 0.386 . . . . 1.13 111.663 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.778 ' H ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -144.22 133.9 23.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.237 -0.892 . . . . 2.52 111.097 173.799 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.71 160.25 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 2.3 110.086 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.926 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 31.0 t -125.73 138.54 32.16 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.323 -0.621 . . . . 1.61 109.323 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 32.1 Cg_exo -58.72 129.42 32.19 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.396 2.064 . . . . 1.88 111.006 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 92.0 m-20 72.37 42.87 0.52 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.05 0.844 . . . . 2.43 110.629 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.73 33.67 0.48 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.859 -0.609 . . . . 3.26 111.602 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 m -67.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.264 0.554 . . . . 2.06 110.176 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.668 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -107.36 -33.43 7.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.583 -0.735 . . . . 1.25 110.594 -177.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.739 ' HB3' ' O ' ' A' ' 76' ' ' THR . 5.0 m-85 -104.83 165.24 11.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.049 -0.978 . . . . 0.74 108.729 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -159.35 170.29 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.066 -0.654 . . . . 1.46 112.309 -166.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.926 ' HB ' ' HB2' ' A' ' 45' ' ' SER . 2.5 p -99.86 126.21 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.522 -0.763 . . . . 1.31 110.319 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -111.26 125.06 53.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 2.45 108.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.77 152.94 21.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.299 0.571 . . . . 1.93 111.463 -172.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.82 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -164.9 114.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.222 -0.899 . . . . 1.42 109.333 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 m-85 -120.88 156.37 32.15 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.168 -0.613 . . . . 1.66 110.127 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.433 -1.308 0 CA-C-N 115.837 -0.62 . . . . 2.14 110.8 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.087 0 N-CA-C 110.829 -0.908 . . . . 1.49 110.829 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.64 84.82 0.62 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.406 0.521 . . . . 0.97 112.406 -172.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.4 mt-10 -104.15 109.44 21.25 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.285 -0.635 . . . . 0.81 109.285 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.82 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 2.1 m170 -110.89 148.92 31.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.674 0.749 . . . . 0.53 111.899 -171.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.881 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 27.0 m-85 -118.82 109.12 15.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.284 -1.325 . . . . 1.13 108.864 171.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -103.53 107.33 18.13 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.893 -0.41 . . . . 0.5 109.893 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 2.4 m -103.31 118.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 122.453 1.12 . . . . 0.87 109.19 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 20.8 m -102.75 104.26 14.55 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.807 -1.182 . . . . 0.46 107.807 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -146.59 140.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.262 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.23 102.22 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.821 0.82 . . . . 1.54 109.868 171.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.83 167.27 17.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.93 -1.032 . . . . 0.67 108.58 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.797 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -99.69 89.61 4.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.184 0.516 . . . . 0.44 110.506 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.1 168.1 31.86 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.123 -0.791 . . . . 0.29 111.123 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.2 m -101.89 134.17 45.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.594 0.697 . . . . 0.4 109.609 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 85' ' ' VAL . 30.1 t-80 -104.4 104.64 14.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.668 -0.696 . . . . 0.4 109.684 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.76 109.7 21.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.562 -0.533 . . . . 0.35 109.562 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 83' ' ' HIS . 1.1 t -105.55 104.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.827 -0.624 . . . . 0.59 111.235 -170.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 3.1 m-20 -108.28 103.51 12.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.084 -0.71 . . . . 1.53 109.084 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.61 128.44 52.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.269 -0.641 . . . . 0.24 109.269 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 9.0 m -102.6 137.09 41.28 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.673 0.749 . . . . 0.29 110.922 -170.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.413 ' CE2' HG23 ' A' ' 31' ' ' THR . 0.8 OUTLIER -103.78 90.05 3.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.919 -1.037 . . . . 1.11 109.6 -175.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 5.0 mtm -132.62 173.46 11.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 110.024 -0.361 . . . . 0.65 110.024 -175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.43 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 18.9 mtt180 -82.07 114.01 47.63 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 2.59 109.444 170.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.88 -35.15 39.26 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 123.537 2.825 . . . . 1.04 114.133 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -85.14 2.02 45.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.738 0.273 . . . . 1.17 111.738 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -170.88 -74.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.583 -0.28 . . . . 1.09 111.24 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.777 ' H ' HG23 ' A' ' 94' ' ' THR . . . 80.83 108.08 0.31 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.431 -1.068 . . . . 1.16 110.431 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 10.3 Cg_exo -73.51 40.82 0.56 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.741 2.961 . . . . 1.2 113.558 -172.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.7 t 44.22 -85.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.393 1.077 . . . . 2.64 112.625 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.7 -21.39 66.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.263 -0.426 . . . . 4.09 110.748 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 21.7 t0 -92.62 3.92 54.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.542 0.687 . . . . 1.67 110.211 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 7.1 m -95.52 144.92 25.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 1.39 110.626 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.91 178.19 5.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.7 -0.852 . . . . 1.91 108.7 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 56.3 ttt180 -161.12 144.51 12.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.62 110.625 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.731 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.45 156.29 18.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.709 -1.132 . . . . 0.86 109.198 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.665 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 99.4 m -157.66 103.47 1.92 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.625 -0.43 . . . . 0.31 111.375 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.944 HG11 HG21 ' A' ' 5' ' ' VAL . 11.7 p -108.63 136.84 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 119.617 -0.833 . . . . 0.88 109.993 168.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 13' ' ' THR . 97.6 m-85 -106.2 103.34 12.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.295 -0.866 . . . . 0.7 108.732 173.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.696 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.19 150.89 48.01 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.198 -0.667 . . . . 2.12 109.198 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.817 ' O ' HG22 ' A' ' 16' ' ' VAL . 48.4 tttm -102.78 119.77 39.43 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.376 -0.601 . . . . 1.89 109.376 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -99.94 115.68 30.24 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 123.928 0.768 . . . . 0.53 109.725 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.797 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-N 114.718 -1.128 . . . . 1.78 110.569 -171.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.929 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.408 -0.96 . . . . 0.59 108.408 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.5 pttt -135.67 151.47 50.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.884 0.373 . . . . 2.36 111.021 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.839 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -122.43 155.22 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 0.49 111.046 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 7.2 p -143.67 170.55 15.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.922 -1.036 . . . . 0.51 108.67 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 24.9 tptp -48.28 -38.16 18.12 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.573 0.582 . . . . 0.83 112.573 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.31 79.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.883 0.849 . . . . 0.33 111.073 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.77 ' HB2' HG13 ' A' ' 5' ' ' VAL . 32.9 m80 -63.9 -2.93 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 2.12 111.346 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.585 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 3.8 t30 -49.93 -19.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.257 0.623 . . . . 1.41 110.685 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.87 48.61 0.92 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.296 -0.722 . . . . 0.3 111.296 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.92 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -112.54 154.92 25.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.875 0.694 . . . . 0.32 112.875 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 41.3 m -147.9 104.38 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.271 -0.877 . . . . 0.95 109.062 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.571 HD11 ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -141.81 167.93 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.141 0.496 . . . . 3.0 111.618 -171.254 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 m -101.59 139.03 37.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.599 -0.728 . . . . 1.73 109.897 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -127.46 162.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.252 0.549 . . . . 0.78 112.137 -175.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.19 120.64 38.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.452 -0.944 . . . . 0.76 108.452 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 19' ' ' GLY . 2.2 t -105.73 -156.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.166 -0.679 . . . . 1.23 109.166 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.795 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 108.67 -49.04 0.88 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.667 -0.973 . . . . 0.71 110.667 -175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.62 -73.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.086 -0.709 . . . . 2.35 109.086 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.8 tp -166.88 145.14 5.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.346 -0.843 . . . . 0.71 109.367 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.929 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -122.63 111.71 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.4 109.641 171.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -104.83 139.73 39.16 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.55 0.69 . . . . 1.09 110.918 -173.637 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 85' ' ' VAL . 47.1 mm -117.34 101.48 12.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.932 -1.136 . . . . 0.54 107.932 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.507 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.61 142.95 34.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.243 0.544 . . . . 0.64 111.211 -172.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 3.7 mt -128.44 138.15 32.44 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-O 121.546 0.689 . . . . 0.85 111.079 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.521 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 85.3 Cg_endo -78.78 8.66 3.61 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.035 2.49 . . . . 0.35 112.068 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.653 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 13.7 t 69.37 -57.81 0.52 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.712 0.632 . . . . 0.91 110.165 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 52.54 63.46 8.79 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.051 -1.092 . . . . 1.39 108.051 -172.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 48.3 Cg_exo -44.94 125.67 6.87 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 124.136 3.224 . . . . 0.83 114.486 -165.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.444 HG23 ' CE2' ' A' ' 89' ' ' TYR . 4.1 t -157.6 96.8 1.55 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.605 -1.179 . . . . 1.83 110.433 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 33' ' ' GLY . 16.3 m 73.22 176.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.746 -0.661 . . . . 2.36 110.102 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.554 ' H ' HG22 ' A' ' 32' ' ' THR . . . -59.05 -8.71 6.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.539 -0.362 . . . . 1.3 113.926 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.629 ' HA ' ' C ' ' A' ' 90' ' ' MET . 6.3 m-85 -55.06 154.68 5.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 2.22 111.779 176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.83 154.21 32.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.489 -0.56 . . . . 0.44 109.489 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.653 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 97.7 m95 -76.52 111.28 11.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.9 0.381 . . . . 0.43 110.944 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.853 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 10.1 p90 -149.25 146.26 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 2.78 109.575 170.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.7 m-85 -44.86 -78.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.947 1.092 . . . . 0.43 113.947 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -118.22 -10.57 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.3 -0.56 . . . . 2.39 111.621 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.782 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 138.87 92.37 0.25 Allowed Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 119.937 -1.125 . . . . 0.73 113.039 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.07 15.51 65.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.843 -0.694 . . . . 0.7 111.865 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -138.63 144.16 39.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.462 -0.369 . . . . 1.13 111.502 -176.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.28 131.34 26.3 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.55 -0.75 . . . . 2.52 111.285 171.492 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.16 160.49 40.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.715 -0.675 . . . . 2.3 110.324 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.643 ' HB2' HG23 ' A' ' 53' ' ' VAL . 13.3 t -104.54 134.89 19.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.48 -0.933 . . . . 1.61 108.48 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.53 41.59 0.26 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.433 2.755 . . . . 1.88 113.262 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 177.33 41.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.84 -1.17 . . . . 2.43 107.84 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -80.58 45.07 0.75 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.603 -0.726 . . . . 3.26 111.714 -173.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -74.9 -41.06 60.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.013 0.435 . . . . 2.06 111.003 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.661 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -134.86 -21.3 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.329 0.585 . . . . 1.25 110.668 -177.615 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 76' ' ' THR . 3.7 m-85 -124.24 162.47 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.223 -0.898 . . . . 0.74 109.662 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -152.69 170.6 19.86 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.786 0.661 . . . . 1.46 112.786 -160.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 45' ' ' SER . 46.5 t -99.84 123.85 52.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.542 -0.753 . . . . 1.31 111.175 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.21 117.82 34.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.281 -0.872 . . . . 2.45 108.71 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -104.2 150.19 24.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 1.93 111.438 -171.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.581 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.19 116.0 3.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.945 -0.57 . . . . 1.42 109.837 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.797 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 9.6 m-85 -113.79 136.05 53.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.479 -0.328 . . . . 1.66 111.258 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.32 -0.4 . . . . 2.14 109.969 171.845 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 110.987 -0.845 . . . . 1.49 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.74 80.44 1.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.556 0.693 . . . . 0.97 112.58 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.797 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.9 mt-10 -105.45 103.59 13.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.458 -0.942 . . . . 0.81 108.458 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.581 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -108.59 159.19 16.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.814 0.816 . . . . 0.53 111.499 -171.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.853 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 28.4 m-85 -122.47 108.54 13.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.909 -1.496 . . . . 1.13 109.018 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.676 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 31.9 m170 -102.31 110.74 22.78 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.515 -0.55 . . . . 0.5 109.515 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 53' ' ' VAL . 3.3 m -102.18 120.06 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.58 1.181 . . . . 0.87 109.219 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.737 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 13.9 m -103.09 103.61 13.7 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.318 -1.364 . . . . 0.46 107.318 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.579 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.1 p -160.4 118.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.396 0.435 . . . . 1.04 111.259 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.45 104.0 11.0 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.174 0.988 . . . . 1.54 109.869 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.65 143.26 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.653 -1.158 . . . . 0.67 109.737 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 96.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.44 111.107 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.32 166.16 38.19 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.29 110.175 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.6 m -101.62 132.7 47.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.808 0.804 . . . . 0.4 109.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.688 ' HD1' HG22 ' A' ' 85' ' ' VAL . 44.8 t-80 -103.84 104.95 15.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.494 -0.775 . . . . 0.4 109.786 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.23 113.76 27.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.374 0.607 . . . . 0.35 109.623 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.96 103.93 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.59 111.2 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 3.4 m-20 -105.45 103.71 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.289 -0.634 . . . . 1.53 109.289 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HG ' HG12 ' A' ' 85' ' ' VAL . 78.0 mt -107.01 123.82 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.51 -0.552 . . . . 0.24 109.51 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.513 HG22 ' CG ' ' A' ' 90' ' ' MET . 3.3 m -105.86 119.96 40.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.24 0.543 . . . . 0.29 112.002 -169.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 35' ' ' ALA . 28.0 t80 -88.05 85.31 6.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 1.11 109.38 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.665 ' HE2' ' HE1' ' A' ' 37' ' ' TYR . 20.7 mtm -124.34 167.13 14.77 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.443 -0.344 . . . . 0.65 110.299 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.455 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.4 ttt180 -78.65 108.67 8.47 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.792 -0.818 . . . . 2.59 108.792 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.584 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 5.8 Cg_endo -46.93 -32.24 12.42 Favored 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.546 2.831 . . . . 1.04 115.459 -167.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.584 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.3 p90 -96.92 11.73 34.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.684 0.624 . . . . 1.17 112.684 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.412 HG23 ' HD3' ' A' ' 96' ' ' PRO . 5.3 t -168.63 -50.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 1.09 111.87 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 51.48 80.56 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 O-C-N 123.303 0.377 . . . . 1.16 112.361 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.878 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 92.4 Cg_exo -40.31 105.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.148 2.565 . . . . 1.2 111.218 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.1 m -54.91 125.31 19.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 2.64 111.117 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 77.03 -2.27 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.406 -0.815 . . . . 4.09 111.216 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.878 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 26.4 t0 -97.13 -27.34 14.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.941 0.877 . . . . 1.67 108.668 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.512 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 12.4 m -68.24 157.08 36.29 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.071 -1.422 . . . . 1.39 110.846 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.1 tp10 -96.51 161.13 14.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.559 -0.904 . . . . 1.91 108.559 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 31.5 ttt180 -148.83 139.96 23.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.432 0.634 . . . . 0.62 110.315 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.774 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -104.22 155.86 18.38 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.86 109.208 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 70.5 m -157.15 102.76 1.97 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.73 -0.388 . . . . 0.31 111.161 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.92 HG23 ' HB3' ' A' ' 12' ' ' ALA . 10.7 p -105.63 136.2 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.639 -0.824 . . . . 0.88 110.014 168.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' THR . 88.4 m-85 -104.71 104.64 14.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.443 -0.799 . . . . 0.7 109.047 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.663 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 pp -123.01 147.68 46.38 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.374 -0.602 . . . . 2.12 109.374 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 16' ' ' VAL . 38.5 tttt -103.27 115.3 30.29 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.377 -0.529 . . . . 1.89 110.557 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.405 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.19 153.56 19.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.952 -0.567 . . . . 0.53 110.775 -169.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.557 ' H ' HG23 ' A' ' 18' ' ' VAL . 4.6 p-10 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.242 -0.89 . . . . 1.78 108.891 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.954 ' HB3' HG22 ' A' ' 22' ' ' VAL . 5.0 t-80 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.222 -0.659 . . . . 0.59 109.222 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.456 ' N ' ' CD2' ' A' ' 3' ' ' HIS . 84.6 tttt -141.82 130.05 22.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.283 0.364 . . . . 2.36 111.286 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.752 HG11 ' CZ ' ' A' ' 103' ' ' PHE . 2.0 t -104.72 157.7 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.873 0.368 . . . . 0.49 110.462 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -144.81 170.2 16.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.171 0.989 . . . . 0.51 108.904 -173.186 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HB2' ' CD ' ' A' ' 27' ' ' PRO . 16.5 tptm -46.9 -43.85 19.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.031 0.752 . . . . 0.83 113.031 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.2 70.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.941 0.877 . . . . 0.33 110.974 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.75 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.4 m80 -62.57 -4.02 1.76 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.928 . . . . 2.12 111.438 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 22.2 t30 -45.84 -22.29 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 1.41 110.422 172.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.65 54.95 0.73 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.904 -0.665 . . . . 0.3 111.726 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . . . -117.38 146.26 43.54 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.157 0.799 . . . . 0.32 113.157 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 36.9 m -141.24 111.19 6.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.433 -0.803 . . . . 0.95 109.779 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.0 pp -166.64 171.66 11.41 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.148 0.179 . . . . 3.0 110.937 -173.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -99.17 143.65 29.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.106 0.479 . . . . 1.73 111.674 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 108' ' ' LYS . 4.0 m -119.08 160.24 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.668 -0.697 . . . . 0.78 111.624 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.49 135.99 44.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.213 -0.662 . . . . 0.76 109.213 172.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 77' ' ' VAL . 24.3 m -121.5 -166.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.962 0.411 . . . . 1.23 111.773 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.718 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 108.95 -56.65 0.46 Allowed Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.29 -0.724 . . . . 0.71 111.29 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -75.42 -71.99 0.33 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.955 -0.757 . . . . 2.35 108.955 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -166.95 141.3 3.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.593 -0.73 . . . . 0.71 110.184 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.954 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.4 t -120.57 116.7 50.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.526 -0.546 . . . . 0.4 109.526 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.733 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -114.78 149.23 37.28 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.663 -0.815 . . . . 1.09 112.225 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.532 HD13 ' HB ' ' A' ' 5' ' ' VAL . 44.3 mm -124.13 102.51 11.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.69 -1.141 . . . . 0.54 108.681 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.96 141.82 36.7 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.561 -0.712 . . . . 0.64 112.46 -172.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -116.73 147.48 39.99 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.25 -0.886 . . . . 0.85 109.403 171.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 7' ' ' LYS . 43.1 Cg_endo -85.98 11.62 3.27 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.883 2.389 . . . . 0.35 111.52 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 30.4 t 70.84 -51.45 0.68 Allowed 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.399 -0.818 . . . . 0.91 111.118 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.4 67.36 2.18 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.008 -0.738 . . . . 1.39 109.008 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.18 97.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.439 2.759 . . . . 0.83 112.618 -168.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.426 HG22 ' CE2' ' A' ' 89' ' ' TYR . 1.3 t -105.11 -39.44 6.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 1.83 111.353 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 34' ' ' PHE . 9.0 t -178.21 -150.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.951 -0.759 . . . . 2.36 108.951 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.76 -23.36 55.66 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.71 -0.281 . . . . 1.3 113.349 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.571 ' HA ' ' C ' ' A' ' 90' ' ' MET . 14.3 m-30 -46.01 137.19 6.02 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.212 0.529 . . . . 2.22 112.123 172.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.501 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -141.96 149.94 40.77 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.34 -0.985 . . . . 0.44 108.34 171.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.594 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.2 m95 -77.04 117.81 18.98 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.568 0.699 . . . . 0.43 111.141 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 47.0 m-85 -126.03 -179.59 4.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.186 -1.042 . . . . 2.78 108.186 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.8 m-85 -73.2 -82.07 0.05 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.818 -0.753 . . . . 0.43 109.505 167.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.76 10.09 24.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 2.39 110.144 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.26 105.76 2.51 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.835 -0.698 . . . . 0.73 112.225 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 3.3 59.98 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.892 -0.671 . . . . 0.7 111.966 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -129.98 142.61 50.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.454 -0.373 . . . . 1.13 111.566 -177.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -142.61 129.15 20.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.938 -0.573 . . . . 2.52 110.835 166.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.35 137.41 34.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.726 -0.67 . . . . 2.3 110.14 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.883 ' HB2' HG23 ' A' ' 52' ' ' THR . 15.4 m -104.4 138.7 19.59 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 121.24 0.543 . . . . 1.61 110.714 171.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 9.8 Cg_endo -93.66 170.05 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.719 3.613 . . . . 1.88 113.493 -168.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.561 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 59.7 t30 74.67 -36.27 0.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.991 0.916 . . . . 2.43 111.107 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.73 ' OE1' ' HG2' ' A' ' 50' ' ' MET . 4.9 mm-40 -109.99 148.34 31.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.201 1.001 . . . . 3.26 113.561 -170.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.4 t -130.01 -11.85 4.21 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.624 -1.626 . . . . 2.06 109.089 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.73 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 19.0 ptt? -97.89 -37.24 9.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.494 -0.483 . . . . 1.25 110.652 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 76' ' ' THR . 0.2 OUTLIER -147.4 97.01 2.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.519 -0.753 . . . . 0.74 110.474 -174.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.883 HG23 ' HB2' ' A' ' 45' ' ' SER . 11.0 t 177.78 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.627 0.649 . . . . 1.46 111.446 160.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -174.73 142.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.953 0.501 . . . . 1.31 111.235 162.223 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 7.9 tp10 -168.76 154.31 6.42 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.959 -0.756 . . . . 2.45 108.959 167.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.7 139.68 25.37 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.171 0.51 . . . . 1.93 111.858 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.689 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -163.02 103.87 1.0 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.581 -0.736 . . . . 1.42 110.474 175.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.749 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -124.81 125.11 43.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 1.66 111.495 -177.16 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.414 -0.812 . . . . 2.14 111.078 -176.084 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.982 0 N-CA-C 111.111 -0.796 . . . . 1.49 111.111 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.25 80.64 0.83 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.436 0.636 . . . . 0.97 111.265 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.749 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 40.4 mt-10 -104.44 103.23 12.9 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.457 -0.792 . . . . 0.81 109.01 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.689 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -108.26 145.71 33.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.685 -0.806 . . . . 0.53 110.973 -174.372 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 6.5 m-85 -117.47 109.64 17.01 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.619 -1.173 . . . . 1.13 109.736 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.733 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -103.54 149.92 24.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.715 -0.476 . . . . 0.5 109.715 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.563 HG22 HG12 ' A' ' 22' ' ' VAL . 3.5 m -132.95 126.93 54.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.882 0.848 . . . . 0.87 108.902 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.665 HG22 ' CE2' ' A' ' 51' ' ' PHE . 3.7 m -102.39 101.36 11.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 0.46 108.452 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 3.8 p -144.14 145.88 21.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.503 -0.479 . . . . 1.04 112.074 -167.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -138.91 103.48 4.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.55 -0.907 . . . . 1.54 108.55 163.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.31 164.92 19.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.67 109.597 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.58 86.95 2.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.44 109.998 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -158.05 167.92 34.44 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.42 -0.809 . . . . 0.29 111.184 -175.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.1 m -100.23 132.6 45.51 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.817 -0.753 . . . . 0.4 109.908 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.667 ' ND1' HG22 ' A' ' 85' ' ' VAL . 48.2 t-80 -103.5 103.82 13.82 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.753 -0.658 . . . . 0.4 109.586 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.17 110.97 23.06 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.957 -0.757 . . . . 0.35 108.957 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -107.44 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.682 -0.69 . . . . 0.59 110.292 -171.113 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 102' ' ' ARG . 3.3 m-20 -108.22 103.6 12.82 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.917 -0.771 . . . . 1.53 108.917 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 38' ' ' PHE . 63.7 mt -107.35 123.99 49.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.641 -0.709 . . . . 0.24 109.666 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.48 HG22 ' CG ' ' A' ' 90' ' ' MET . 4.4 m -102.15 119.8 39.4 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.871 0.844 . . . . 0.29 110.688 -173.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.501 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 7.4 t80 -89.3 88.37 7.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.503 -1.226 . . . . 1.11 109.676 -175.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.571 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 14.1 mtm -129.22 166.43 19.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.245 0.545 . . . . 0.65 111.051 -172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.433 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.3 mtm180 -70.04 107.39 2.31 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.859 -1.064 . . . . 2.59 108.786 168.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.5 Cg_endo -51.63 -27.0 24.38 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.335 2.69 . . . . 1.04 114.655 -169.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.456 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 45.7 p90 -93.46 3.89 54.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.0 0.37 . . . . 1.17 112.0 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.3 t -164.06 -66.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.834 -0.166 . . . . 1.09 111.14 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.681 ' H ' HG23 ' A' ' 94' ' ' THR . . . 67.53 94.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.012 -0.435 . . . . 1.16 112.012 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.975 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 15.8 Cg_exo -64.92 130.03 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.607 2.205 . . . . 1.2 111.11 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.8 t -43.75 -50.32 7.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.955 0.902 . . . . 2.64 113.018 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -121.65 20.79 10.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.522 -0.471 . . . . 4.09 111.029 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.975 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.7 t0 -103.99 -22.18 13.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.412 -0.958 . . . . 1.67 108.412 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 16.3 m -80.0 148.22 31.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.614 -1.175 . . . . 1.39 110.561 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.84 172.87 7.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.096 -1.076 . . . . 1.91 108.096 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 26.6 ttt180 -158.48 139.01 12.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.407 0.623 . . . . 0.62 110.361 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.773 ' CZ ' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -103.76 155.88 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.875 -1.057 . . . . 0.86 109.069 -178.607 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 24.3 m -157.36 104.56 2.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.881 0.372 . . . . 0.31 110.972 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.773 ' HB ' ' CZ ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -103.81 132.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 119.769 -0.772 . . . . 0.88 109.592 168.117 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.689 ' O ' HD12 ' A' ' 107' ' ' LEU . 73.1 m-85 -108.06 97.42 7.12 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.628 -1.249 . . . . 0.7 107.628 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 106' ' ' TYR . 8.9 mp -134.21 144.78 48.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.288 -0.634 . . . . 2.12 109.288 -173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 16' ' ' VAL . 35.5 ttpt -102.81 130.98 49.98 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.129 -0.628 . . . . 1.89 110.946 -166.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.06 132.37 45.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 0.53 109.566 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.598 ' C ' HG22 ' A' ' 18' ' ' VAL . 5.6 p-10 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.386 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 1.015 ' HB3' HG22 ' A' ' 22' ' ' VAL . 11.6 t-80 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.385 -0.598 . . . . 0.59 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -138.91 134.15 32.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.266 -0.642 . . . . 2.36 109.266 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -107.49 125.81 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 119.5 -0.88 . . . . 0.49 110.685 178.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.474 ' C ' ' ND1' ' A' ' 9' ' ' HIS . 0.7 OUTLIER -120.99 152.09 38.97 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.122 0.416 . . . . 0.51 112.122 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 27.0 tptp -31.17 -45.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.252 1.945 . . . . 0.83 116.252 -153.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.61 -34.98 1.57 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.311 1.053 . . . . 0.33 111.731 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.935 ' ND1' HG13 ' A' ' 5' ' ' VAL . 2.4 p-80 -55.19 -9.36 0.4 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.126 -1.397 . . . . 2.12 113.159 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -58.14 -15.32 9.24 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 107.633 -1.247 . . . . 1.41 107.633 -174.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.91 58.63 0.69 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.091 -1.413 . . . . 0.3 110.169 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.891 ' HB2' ' HA ' ' A' ' 9' ' ' HIS . . . -116.09 151.91 34.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.752 0.649 . . . . 0.32 112.752 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 23.6 m -149.43 108.45 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.772 -0.649 . . . . 0.95 109.941 173.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.766 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.1 pt? -150.67 166.85 29.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 3.0 111.25 -171.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -103.11 144.63 31.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.638 -0.256 . . . . 1.73 110.424 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -128.41 156.27 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 0.78 111.493 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.2 137.73 42.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.338 -0.986 . . . . 0.76 108.338 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 HG21 ' A' ' 22' ' ' VAL . 29.5 m -115.74 -178.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.664 -0.414 . . . . 1.23 111.424 -177.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.4 -60.59 0.66 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.272 -0.731 . . . . 0.71 111.272 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.2 -72.08 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.339 0.59 . . . . 2.35 109.725 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.4 tp -165.69 133.36 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.984 . . . . 0.71 110.45 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.015 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.2 t -119.95 113.0 39.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.368 -0.604 . . . . 0.4 109.368 174.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.2 pt-20 -111.48 157.32 20.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.509 1.147 . . . . 1.09 112.985 -173.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.426 HG21 HG11 ' A' ' 85' ' ' VAL . 40.6 mm -126.62 102.69 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.889 -1.959 . . . . 0.54 107.405 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -114.59 135.17 54.43 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.04 0.924 . . . . 0.64 111.91 -173.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -112.33 145.32 32.63 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.735 -1.12 . . . . 0.85 108.855 174.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 71.4 Cg_endo -82.12 7.08 5.3 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.648 2.232 . . . . 0.35 111.345 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.627 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 67.77 -64.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.91 109.658 -172.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.71 67.98 1.23 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.285 -1.006 . . . . 1.39 108.285 -171.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.82 108.83 0.31 Allowed 'Trans proline' 0 CA--C 1.52 -0.177 0 C-N-CA 123.378 2.719 . . . . 0.83 112.813 -169.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.87 -37.25 13.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.363 -0.835 . . . . 1.83 111.482 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 t -178.22 -44.7 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 111.748 0.277 . . . . 2.36 111.748 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.98 -32.97 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 111.436 -0.665 . . . . 1.3 111.436 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HE1' ' HD2' ' A' ' 96' ' ' PRO . 31.2 m-85 -43.26 141.49 1.26 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.222 -0.489 . . . . 2.22 111.778 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -140.17 150.22 43.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.847 -1.07 . . . . 0.44 108.438 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.4 m95 -78.83 118.37 20.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.969 0.414 . . . . 0.43 111.01 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.822 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -150.37 145.68 26.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 2.78 109.789 172.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 1.1 m-85 -46.37 -76.19 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.879 0.696 . . . . 0.43 112.879 -172.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.23 -8.84 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 2.39 110.936 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.686 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 116.75 86.64 1.24 Allowed Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 119.72 -1.228 . . . . 0.73 112.193 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.6 -4.34 74.15 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.149 -0.78 . . . . 0.7 111.149 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.39 137.84 52.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.836 -0.431 . . . . 1.13 109.836 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -141.52 139.59 33.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.534 -0.543 . . . . 2.52 109.534 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.3 165.37 27.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.23 0.538 . . . . 2.3 111.487 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.6 p -114.26 140.05 24.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.603 -0.726 . . . . 1.61 109.247 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.6 Cg_exo -76.16 -5.59 16.42 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 1.88 113.128 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' A' ' 79' ' ' ALA . 9.4 p-10 -151.17 67.64 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.496 0.665 . . . . 2.43 110.663 -177.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -109.45 -147.49 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 3.26 111.518 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m 71.43 36.14 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.431 0.634 . . . . 2.06 110.894 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptt? 175.94 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.57 -1.195 . . . . 1.25 107.879 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 11.6 m-85 -130.13 162.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.336 -1.756 . . . . 0.74 106.291 173.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -152.46 166.13 32.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 119.48 1.036 . . . . 1.46 112.953 -165.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.3 p -103.01 133.08 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.14 -0.936 . . . . 1.31 110.966 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 28.9 tt0 -104.18 153.98 20.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.99 -1.004 . . . . 2.45 108.779 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 54' ' ' GLU . 21.4 p-10 -133.47 122.73 24.09 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.094 -0.503 . . . . 1.93 109.966 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.807 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -137.73 113.27 9.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.617 0.722 . . . . 1.42 110.07 176.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.82 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.4 m-85 -106.83 124.04 49.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.333 -0.848 . . . . 1.66 110.49 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 96.7 m-85 . . . . . 0 C--N 1.32 -0.715 0 CA-C-O 121.284 0.564 . . . . 2.14 110.586 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 108.85 -1.7 . . . . 1.49 108.85 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.49 92.62 1.51 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.418 0.896 . . . . 0.97 113.418 -168.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 36.8 mt-10 -104.44 106.82 17.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.81 108.741 174.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.807 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.6 m170 -107.4 152.78 23.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.413 0.625 . . . . 0.53 111.825 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.822 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 30.8 m-85 -123.44 108.29 12.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.301 -1.318 . . . . 1.13 108.6 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.615 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 21.0 m170 -103.6 107.65 18.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.194 -0.457 . . . . 0.5 110.377 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 3.3 m -101.93 113.99 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-O 122.986 1.374 . . . . 0.87 108.463 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 16.9 m -101.52 103.23 14.08 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.723 -1.584 . . . . 0.46 106.723 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.568 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.2 p -153.97 146.82 14.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 124.167 0.917 . . . . 1.04 111.179 -173.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.59 102.5 6.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.561 0.696 . . . . 1.54 109.533 166.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' HD22 ' A' ' 47' ' ' ASN . . . -165.83 140.29 4.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.69 -0.687 . . . . 0.67 110.043 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.89 95.89 2.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.383 0.611 . . . . 0.44 111.213 -177.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.75 34.03 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.201 -0.909 . . . . 0.29 110.993 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.0 m -102.97 134.84 45.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.895 -0.78 . . . . 0.4 108.895 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.905 ' HD1' HG22 ' A' ' 85' ' ' VAL . 31.0 t-80 -102.96 105.35 15.67 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.36 -0.607 . . . . 0.4 109.36 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.11 106.63 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.808 -0.812 . . . . 0.35 108.808 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.905 HG22 ' HD1' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -104.88 110.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 0.59 110.773 -170.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 4.8 m-20 -114.39 104.28 11.89 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.962 0.789 . . . . 1.53 109.164 174.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.652 ' H ' ' HD1' ' A' ' 103' ' ' PHE . 76.6 mt -105.55 130.48 53.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.166 -0.679 . . . . 0.24 109.166 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.517 HG22 ' CG ' ' A' ' 90' ' ' MET . 6.7 m -102.42 122.08 43.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.343 0.592 . . . . 0.29 110.354 -172.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.478 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.2 t80 -91.18 85.54 5.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.308 -0.86 . . . . 1.11 109.486 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.604 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . 7.9 mtm -128.94 172.35 11.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.65 110.943 -175.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.536 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 5.4 mtm180 -84.23 109.84 22.19 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.485 -0.779 . . . . 2.59 109.477 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 2.0 Cg_endo -41.63 -34.7 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.724 3.616 . . . . 1.04 115.51 -168.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -87.03 3.53 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.504 0.557 . . . . 1.17 112.504 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.472 HG23 ' N ' ' A' ' 95' ' ' GLY . 6.2 t -169.22 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.409 -0.182 . . . . 1.09 111.401 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.604 ' CA ' ' HB3' ' A' ' 90' ' ' MET . . . 66.12 78.74 0.22 Allowed Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.137 -0.554 . . . . 1.16 111.784 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 1.061 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 71.6 Cg_exo -47.82 121.51 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.296 2.664 . . . . 1.2 111.958 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -50.08 -39.52 42.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.969 -1.014 . . . . 2.64 113.25 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -112.79 17.53 18.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.32 -0.552 . . . . 4.09 110.925 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 1.061 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 25.3 t0 -121.53 -0.29 9.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.737 0.78 . . . . 1.67 109.57 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 p -97.9 156.22 16.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.104 -0.953 . . . . 1.39 110.96 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 40.6 tt0 -108.26 175.81 5.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.453 -0.943 . . . . 1.91 108.453 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 47.8 ttt180 -158.7 142.81 15.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.685 0.755 . . . . 0.62 110.483 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.757 ' HZ ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -104.16 162.81 12.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.428 -1.26 . . . . 0.86 109.796 -177.443 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 38.2 m -164.67 104.82 0.82 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 123.407 0.442 . . . . 0.31 110.39 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 5' ' ' VAL . 13.4 p -110.87 136.67 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 119.408 -0.917 . . . . 0.88 109.153 166.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' THR . 98.0 m-85 -103.5 103.44 13.41 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.409 -0.96 . . . . 0.7 108.409 174.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.766 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -127.26 147.24 50.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.653 -0.499 . . . . 2.12 109.653 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.688 ' O ' HG22 ' A' ' 16' ' ' VAL . 20.1 tttm -102.38 117.02 33.82 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.78 -0.368 . . . . 1.89 110.346 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.62 120.4 39.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.614 0.571 . . . . 0.53 110.176 -170.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 22.5 p-10 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.516 -0.754 . . . . 1.78 110.422 -174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.98 ' HB3' HG22 ' A' ' 22' ' ' VAL . 16.1 t60 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.072 -0.714 . . . . 0.59 109.072 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 136.65 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.567 -0.288 . . . . 2.36 110.972 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.874 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -112.36 157.5 13.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.856 0.36 . . . . 0.49 111.03 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -151.76 170.64 19.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.421 1.089 . . . . 0.51 108.113 -172.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 26.0 tptp -48.33 -37.06 15.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.561 0.949 . . . . 0.83 113.561 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.08 79.2 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.914 0.864 . . . . 0.33 110.742 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.773 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.6 m80 -65.32 -3.7 4.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.134 -0.939 . . . . 2.12 111.346 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.638 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 3.1 t30 -50.27 -18.92 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.679 0.612 . . . . 1.41 110.03 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.45 55.73 0.6 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.3 111.285 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.921 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -113.79 156.1 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.041 0.756 . . . . 0.32 113.041 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 m -139.39 112.69 8.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.185 -1.042 . . . . 0.95 108.185 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 23.1 tp -151.14 163.24 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 3.0 111.74 -167.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.0 m -104.58 148.04 26.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.179 -0.674 . . . . 1.73 109.179 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.8 m -127.55 156.82 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.053 -0.659 . . . . 0.78 112.429 -177.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.76 142.4 34.77 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.789 -1.189 . . . . 0.76 107.789 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG12 HG21 ' A' ' 22' ' ' VAL . 10.7 m -119.8 -176.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.792 0.329 . . . . 1.23 110.724 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.6 -59.52 0.69 Allowed Glycine 0 CA--C 1.505 -0.58 0 N-CA-C 111.224 -0.75 . . . . 0.71 111.224 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -73.68 -68.22 0.53 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 2.35 108.96 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -167.64 141.33 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.755 -1.111 . . . . 0.71 110.283 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.98 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -113.68 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.494 -0.928 . . . . 0.4 108.494 169.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.666 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -108.88 157.35 18.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.056 0.931 . . . . 1.09 112.524 -169.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.593 HD13 ' HB ' ' A' ' 5' ' ' VAL . 29.7 mm -134.28 103.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.579 -1.646 . . . . 0.54 108.428 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.528 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -112.73 139.0 48.71 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.528 -0.733 . . . . 0.64 112.194 -175.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -111.59 148.41 38.8 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.531 -0.759 . . . . 0.85 109.947 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 40.3 Cg_endo -87.09 11.84 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.229 2.619 . . . . 0.35 111.976 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.519 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 21.5 t 69.3 -66.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.343 -0.844 . . . . 0.91 110.83 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.23 64.05 2.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.438 -0.949 . . . . 1.39 108.438 -170.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.41 117.76 2.5 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.88 3.053 . . . . 0.83 113.272 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.422 HG23 ' CZ ' ' A' ' 89' ' ' TYR . 22.3 p -91.64 -89.1 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.212 -0.904 . . . . 1.83 112.849 -170.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 t -163.26 22.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.007 0.908 . . . . 2.36 110.141 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.26 -35.83 1.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.46 -0.791 . . . . 1.3 111.377 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' HA ' ' C ' ' A' ' 90' ' ' MET . 2.2 m-85 -62.43 143.99 56.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.974 -0.613 . . . . 2.22 111.189 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -139.53 156.04 47.15 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.387 -0.968 . . . . 0.44 108.387 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.519 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -81.0 117.27 21.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.518 0.675 . . . . 0.43 111.51 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.73 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 56.2 m-85 -127.46 175.78 7.97 Favored 'General case' 0 C--O 1.212 -0.882 0 N-CA-C 108.179 -1.045 . . . . 2.78 108.179 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.72 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -67.2 -74.38 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.773 0.715 . . . . 0.43 109.715 171.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -110.51 -8.16 14.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.048 -0.524 . . . . 2.39 110.157 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.08 106.59 2.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.366 -0.921 . . . . 0.73 112.047 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.25 -23.92 5.86 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.674 . . . . 0.7 112.448 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 m -128.33 141.84 51.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.653 0.263 . . . . 1.13 110.41 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -136.97 134.85 37.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.682 -0.69 . . . . 2.52 110.048 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -128.54 145.85 51.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.754 0.788 . . . . 2.3 112.136 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.867 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 6.2 p -111.43 137.75 21.19 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.584 -0.895 . . . . 1.61 108.584 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 7.5 Cg_exo -74.42 137.16 22.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.434 2.089 . . . . 1.88 111.431 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 69.18 34.46 3.0 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.902 0.751 . . . . 2.43 110.949 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.04 137.93 34.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.787 0.803 . . . . 3.26 110.945 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.7 t 177.56 -55.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.045 -1.434 . . . . 2.06 107.396 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -89.84 -32.41 16.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.015 -0.993 . . . . 1.25 109.336 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.787 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.5 m-85 -119.46 160.36 22.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.463 -1.244 . . . . 0.74 107.767 176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -165.74 169.44 15.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.651 0.66 . . . . 1.46 112.131 -168.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.867 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.2 p -103.1 139.66 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.696 -0.684 . . . . 1.31 111.952 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.836 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.38 142.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.893 -0.78 . . . . 2.45 108.893 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -122.44 133.4 54.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.384 0.611 . . . . 1.93 111.195 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -150.1 111.0 4.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.268 -0.878 . . . . 1.42 110.495 -176.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.913 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -123.92 127.02 47.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.671 -0.695 . . . . 1.66 111.257 -174.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.448 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 93.1 m-85 -126.04 103.71 26.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.3 -0.864 . . . . 2.14 111.003 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.0 Cg_endo -91.52 104.56 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.827 3.018 . . . . 1.92 111.758 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 1.026 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 19.8 Cg_exo -72.64 -24.06 18.95 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 124.101 3.201 . . . . 2.64 112.83 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.789 ' OD2' ' HD3' ' A' ' 63' ' ' LYS . 8.2 t70 -147.31 -174.55 4.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.735 -0.839 . . . . 5.8 108.735 -171.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.6 t -153.9 4.95 0.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.806 0.669 . . . . 7.43 112.806 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HD3' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -135.97 -12.79 1.93 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.584 -0.446 . . . . 8.71 110.845 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 46.6 tp -142.57 -80.55 0.21 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.069 -0.514 . . . . 8.1 110.582 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 17.0 tp 169.81 124.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 4.74 109.113 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 1.026 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -81.43 52.84 4.6 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 121.088 -0.577 . . . . 3.02 111.768 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.46 -71.37 0.11 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.119 0.568 . . . . 4.02 111.085 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -119.88 73.56 0.32 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.698 -0.763 . . . . 2.84 112.578 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -56.48 134.23 51.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.808 -1.317 . . . . 1.49 109.808 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.497 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -153.99 90.18 1.35 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 113.836 1.05 . . . . 0.97 113.836 -168.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.7 mt-10 -110.31 104.12 12.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.54 -0.754 . . . . 0.81 109.083 175.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.633 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -113.64 159.4 19.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.777 0.799 . . . . 0.53 112.445 -171.303 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.73 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 44.9 m-85 -132.28 108.91 9.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.933 -1.485 . . . . 1.13 109.4 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.836 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 26.0 m170 -108.61 107.46 17.96 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.203 -0.31 . . . . 0.5 111.339 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -103.75 119.34 52.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.047 0.927 . . . . 0.87 110.419 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.8 m -102.85 105.75 16.2 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.979 -1.119 . . . . 0.46 107.979 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.538 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.3 p -147.45 149.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 123.633 0.583 . . . . 1.04 110.335 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -133.91 102.3 5.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.966 0.888 . . . . 1.54 109.884 167.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -168.34 127.56 1.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.34 -0.845 . . . . 0.67 109.887 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.32 101.42 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 O-C-N 123.648 0.592 . . . . 0.44 111.916 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.87 167.57 36.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.349 -0.7 . . . . 0.29 111.349 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.594 HG23 ' HD2' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -103.43 128.63 50.53 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.9 -0.765 . . . . 0.4 109.883 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.632 ' CE1' HG22 ' A' ' 85' ' ' VAL . 1.8 t-80 -103.38 106.35 16.84 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.526 -0.546 . . . . 0.4 109.526 -175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.38 109.34 21.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.497 -0.927 . . . . 0.35 108.497 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.36 103.83 15.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.027 -0.533 . . . . 0.59 110.257 -169.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 2.8 m-20 -109.65 103.41 12.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.504 -0.771 . . . . 1.53 109.118 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' A' ' 38' ' ' PHE . 96.0 mt -104.72 125.56 50.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.763 -0.653 . . . . 0.24 109.571 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.68 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.8 m -100.87 122.46 43.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.658 0.742 . . . . 0.29 110.762 -169.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -92.8 87.18 5.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.686 -1.143 . . . . 1.11 109.884 -174.181 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.57 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 1.4 mtm -134.1 165.94 23.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.203 0.525 . . . . 0.65 110.993 -173.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.53 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 77.2 mtt180 -64.86 111.28 5.45 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.971 -1.013 . . . . 2.59 109.272 170.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.97 -26.25 24.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.288 2.658 . . . . 1.04 114.405 -171.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 94' ' ' THR . 42.9 p90 -90.11 -3.22 58.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.002 0.371 . . . . 1.17 112.002 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 95' ' ' GLY . 6.8 t -169.25 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.462 -0.149 . . . . 1.09 111.369 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.29 98.13 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 1.16 111.838 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.733 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.7 Cg_exo -49.55 126.69 16.67 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.916 2.411 . . . . 1.2 111.334 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -54.17 -29.75 46.79 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.503 0.927 . . . . 2.64 113.503 -168.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -129.43 14.78 6.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.147 -0.621 . . . . 4.09 111.594 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 16.1 t0 -112.29 -1.82 15.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.857 0.837 . . . . 1.67 109.528 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.7 m -95.0 136.98 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.765 -1.107 . . . . 1.39 110.13 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.681 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.9 tt0 -86.86 179.03 6.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 1.91 108.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.681 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 46.7 ttt180 -158.09 145.05 17.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.903 0.859 . . . . 0.62 110.071 174.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.812 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -103.36 150.79 23.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.004 -1.453 . . . . 0.86 109.124 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.4 m -153.41 102.78 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.862 -0.335 . . . . 0.31 110.862 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.921 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.6 p -104.86 136.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 119.663 -0.815 . . . . 0.88 109.395 167.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -104.4 103.49 13.21 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.271 -0.877 . . . . 0.7 108.703 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 3.1 pp -126.95 152.51 47.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.218 -0.447 . . . . 2.12 109.95 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.762 ' O ' HG22 ' A' ' 16' ' ' VAL . 30.9 tptt -104.91 111.23 23.91 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.681 -0.407 . . . . 1.89 110.099 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -103.47 122.8 45.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 123.409 0.443 . . . . 0.53 110.139 -174.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.468 HD21 ' CG ' ' A' ' 108' ' ' LYS . 10.5 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.188 -0.91 . . . . 1.78 110.687 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.962 ' HB3' HG22 ' A' ' 22' ' ' VAL . 42.8 t60 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.59 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 19.1 ptmt -143.92 142.3 30.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.684 0.278 . . . . 2.36 110.83 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.84 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -107.41 138.97 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 0.49 111.458 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 168.06 10.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.926 -1.034 . . . . 0.51 110.335 171.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.7 tptp -37.5 -45.57 0.74 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.739 1.385 . . . . 0.83 114.739 -172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.96 62.52 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.61 0.719 . . . . 0.33 111.803 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.813 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.5 m80 -65.95 -1.79 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 2.12 111.282 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.564 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 4.6 t30 -47.38 -17.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.847 0.717 . . . . 1.41 110.089 170.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.93 55.9 0.61 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.7 -0.682 . . . . 0.3 111.74 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.028 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -108.53 158.35 17.64 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.582 0.956 . . . . 0.32 113.582 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.7 m -147.11 104.98 3.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.018 -0.992 . . . . 0.95 108.856 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 17.9 mt -146.29 167.28 23.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.855 0.687 . . . . 3.0 112.855 -170.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.4 m -103.54 136.0 44.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.714 -0.676 . . . . 1.73 110.139 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.597 HG11 ' CD2' ' A' ' 3' ' ' HIS . 30.9 m -126.2 154.04 35.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 0.78 112.11 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.55 143.17 33.42 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.83 -0.804 . . . . 0.76 108.83 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.683 HG12 HG21 ' A' ' 22' ' ' VAL . 23.7 m -121.48 -179.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.952 0.406 . . . . 1.23 111.747 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.97 -60.61 0.67 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.65 -0.704 . . . . 0.71 111.403 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.58 -74.15 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.424 0.63 . . . . 2.35 109.994 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.8 tp -165.61 136.03 3.65 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.977 -1.01 . . . . 0.71 109.681 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.962 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.4 t -120.17 110.18 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.353 0.597 . . . . 0.4 109.663 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 4.4 pt-20 -111.33 159.67 17.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.805 0.812 . . . . 1.09 111.901 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.632 HD12 HG11 ' A' ' 105' ' ' VAL . 29.9 mm -134.26 103.8 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.174 -1.376 . . . . 0.54 108.527 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -108.11 141.44 39.81 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.299 0.571 . . . . 0.64 111.55 -174.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 7' ' ' LYS . 4.1 mm? -117.11 146.75 38.79 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.128 -0.942 . . . . 0.85 108.864 171.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.612 ' HG2' ' ND2' ' A' ' 29' ' ' ASN . 67.7 Cg_endo -83.98 9.62 4.04 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 122.685 2.257 . . . . 0.35 111.804 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.61 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 69.53 -47.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.042 0.839 . . . . 0.91 110.667 -174.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' ND2' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m120 58.08 63.05 4.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.124 -1.065 . . . . 1.39 108.124 -173.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.5 100.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.669 2.913 . . . . 0.83 113.501 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.446 HG22 ' OH ' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -106.89 -36.67 6.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.091 -0.959 . . . . 1.83 111.074 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 34' ' ' PHE . 11.6 t -176.47 -157.44 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.024 -0.732 . . . . 2.36 109.024 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.41 -22.99 17.24 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.483 -0.389 . . . . 1.3 113.16 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' A' ' 90' ' ' MET . 15.4 m-30 -40.23 137.93 0.95 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.765 0.654 . . . . 2.22 112.765 171.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.26 154.83 41.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.975 -1.011 . . . . 0.44 109.021 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.61 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.3 m95 -85.12 124.29 31.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 0.43 111.369 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.912 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -157.81 145.07 18.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 2.78 109.733 175.258 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.578 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -48.77 -75.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.333 0.494 . . . . 0.43 112.333 -173.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.21 -17.85 18.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.445 0.64 . . . . 2.39 110.298 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.766 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 113.6 85.56 1.4 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.299 -0.953 . . . . 0.73 111.525 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.29 70.07 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.535 -0.84 . . . . 0.7 111.576 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.7 m -129.1 140.36 51.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 1.13 109.648 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -140.63 141.02 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.655 -0.498 . . . . 2.52 109.655 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.04 161.66 37.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.171 0.51 . . . . 2.3 111.832 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.752 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 20.6 t -115.03 130.88 23.85 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.928 -0.767 . . . . 1.61 108.928 170.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 14.8 Cg_exo -68.91 -4.29 13.12 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.569 2.179 . . . . 1.88 112.064 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.19 4.65 10.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.947 -0.569 . . . . 2.43 111.416 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.6 pt-20 -84.08 101.05 11.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.863 0.84 . . . . 3.26 111.709 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -127.95 5.71 5.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 2.06 110.558 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -170.04 -36.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.214 1.007 . . . . 1.25 108.579 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.833 ' HB3' ' O ' ' A' ' 76' ' ' THR . 4.1 m-85 -104.84 165.33 11.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.581 -1.645 . . . . 0.74 107.424 172.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -157.46 172.04 19.28 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.764 0.711 . . . . 1.46 112.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.752 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 21.8 t -99.57 134.17 39.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.535 -0.757 . . . . 1.31 111.716 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -111.34 125.02 53.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.711 -0.677 . . . . 2.45 109.194 170.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -103.9 152.28 22.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 1.93 110.905 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -162.4 111.77 1.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.42 109.81 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.855 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.2 m-85 -111.39 118.73 36.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.446 -0.343 . . . . 1.66 110.292 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.06 100.09 38.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.205 0.526 . . . . 2.14 110.658 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 3.5 Cg_exo -83.29 132.02 5.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.688 2.925 . . . . 1.92 111.129 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.615 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 72.5 Cg_endo -90.9 -11.85 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.509 2.139 . . . . 2.64 112.76 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' OD2' ' HD3' ' A' ' 63' ' ' LYS . 22.0 t70 -178.07 -57.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 5.8 110.927 -173.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m 74.72 15.84 3.17 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.833 -1.076 . . . . 7.43 113.633 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.52 ' HD3' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -145.25 21.97 1.54 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.954 0.883 . . . . 8.71 108.92 166.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 22.8 tp -177.98 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.99 -1.459 . . . . 8.1 108.647 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 168.72 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.533 0.733 . . . . 4.74 109.174 175.113 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -88.84 -52.34 2.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.104 -0.57 . . . . 3.02 111.937 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.71 -68.51 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.327 0.584 . . . . 4.02 110.121 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.98 95.28 0.21 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.289 -0.869 . . . . 2.84 111.443 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -62.89 139.22 44.73 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.449 -1.06 . . . . 1.49 110.449 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.25 87.82 1.34 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.638 0.732 . . . . 0.97 112.38 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.855 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.2 mt-10 -104.55 105.78 16.02 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.022 -0.99 . . . . 0.81 108.481 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.722 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 7.5 m-70 -104.98 150.29 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.747 0.784 . . . . 0.53 111.805 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.912 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.6 m-85 -122.82 104.89 9.57 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.303 -1.317 . . . . 1.13 108.864 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -102.47 107.15 18.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.963 -0.384 . . . . 0.5 109.963 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.4 m -102.62 116.53 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 122.706 1.241 . . . . 0.87 108.33 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.833 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.7 m -102.64 106.37 17.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.177 -1.416 . . . . 0.46 107.177 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.0 p -154.58 149.81 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 123.692 0.62 . . . . 1.04 111.13 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -131.18 103.5 6.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.523 -0.547 . . . . 1.54 109.523 167.091 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.42 127.26 2.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.315 -0.402 . . . . 0.67 110.672 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -60.54 100.53 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.787 0.679 . . . . 0.44 111.089 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.49 169.58 40.0 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.474 -1.051 . . . . 0.29 110.474 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -101.99 132.09 48.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.642 -0.917 . . . . 0.4 109.698 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 85' ' ' VAL . 40.1 t-80 -102.64 104.16 14.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.691 -0.485 . . . . 0.4 109.691 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.53 111.99 24.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.417 -0.586 . . . . 0.35 109.417 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.62 103.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.95 -0.568 . . . . 0.59 110.852 -171.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 102' ' ' ARG . 3.8 m-20 -108.15 102.87 11.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.88 -0.785 . . . . 1.53 108.88 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.447 ' HG ' HG12 ' A' ' 85' ' ' VAL . 96.0 mt -108.09 127.41 53.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.773 -0.649 . . . . 0.24 109.96 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.459 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.7 m -102.75 130.59 49.75 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.525 0.679 . . . . 0.29 110.968 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 10.9 t80 -102.6 88.75 3.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.272 -0.877 . . . . 1.11 109.633 -175.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 15.5 mtm -126.75 177.94 6.24 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.457 -0.571 . . . . 0.65 109.457 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.646 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 7.6 ttm180 -93.17 112.73 57.53 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.533 -0.914 . . . . 2.59 108.533 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 93' ' ' TRP . 1.5 Cg_endo -44.74 -48.3 10.68 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.573 2.848 . . . . 1.04 114.293 -169.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 92' ' ' PRO . 39.5 p90 -80.34 0.39 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.566 . . . . 1.17 112.527 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.812 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.3 t -158.4 -79.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.57 -0.159 . . . . 1.09 110.57 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.812 ' H ' HG23 ' A' ' 94' ' ' THR . . . 76.62 82.44 0.53 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 121.066 -0.587 . . . . 1.16 112.013 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.77 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 1.5 Cg_endo -42.17 125.35 3.31 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.852 3.035 . . . . 1.2 112.09 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.6 m -55.01 -39.35 69.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.921 -1.036 . . . . 2.64 112.969 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.76 1.61 19.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.825 -0.35 . . . . 4.09 110.925 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.77 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.2 t0 -100.91 -16.29 17.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.518 0.675 . . . . 1.67 109.427 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.3 p -73.79 133.75 43.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.051 -0.977 . . . . 1.39 111.486 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 8.3 tp10 -86.96 169.64 12.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.596 -0.89 . . . . 1.91 108.596 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 22.0 ttt180 -155.82 142.41 18.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.843 0.83 . . . . 0.62 110.648 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.84 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 3.1 t80 -104.65 154.87 19.41 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.096 -1.411 . . . . 0.86 109.378 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 52.4 m -158.8 101.95 1.66 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.043 0.449 . . . . 0.31 110.253 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 12' ' ' ALA . 11.0 p -104.87 132.0 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.079 -0.648 . . . . 0.88 109.602 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' THR . 69.5 m-85 -105.17 113.55 27.21 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.697 -0.683 . . . . 0.7 109.386 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.681 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -136.27 158.53 44.19 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.351 -0.611 . . . . 2.12 109.351 178.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 30.9 tttm -103.99 114.22 28.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.872 -0.418 . . . . 1.89 109.872 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.498 ' HA ' HG23 ' A' ' 16' ' ' VAL . . . -101.18 125.42 47.81 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.402 0.438 . . . . 0.53 109.851 -171.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.643 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.09 -0.957 . . . . 1.78 110.125 -171.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.813 ' HB3' HG22 ' A' ' 22' ' ' VAL . 5.3 t60 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.33 -0.989 . . . . 0.59 108.33 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -135.41 134.26 39.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.853 0.359 . . . . 2.36 111.402 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.86 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.5 t -118.68 127.49 75.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 0.49 111.004 170.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.14 169.58 8.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.529 -1.214 . . . . 0.51 109.864 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 19.4 tptp -35.2 -44.92 0.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.451 1.278 . . . . 0.83 114.451 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.16 -31.63 53.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.546 0.688 . . . . 0.33 112.385 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.86 ' HB2' HG13 ' A' ' 5' ' ' VAL . 74.1 m80 -68.1 -1.46 5.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.735 -0.666 . . . . 2.12 111.201 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 28.4 t30 -45.94 -20.92 0.1 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.697 0.623 . . . . 1.41 109.765 168.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.84 58.03 0.62 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.371 -0.831 . . . . 0.3 111.256 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.35 151.57 36.72 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.72 0.637 . . . . 0.32 112.72 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 35.4 m -146.12 108.84 4.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.404 -0.817 . . . . 0.95 109.332 174.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.768 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -161.51 167.46 25.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.727 0.299 . . . . 3.0 111.562 -172.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.666 HG23 ' HB3' ' A' ' 108' ' ' LYS . 87.2 m -102.84 144.16 31.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.669 -0.241 . . . . 1.73 110.725 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.9 m -124.96 151.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.058 0.456 . . . . 0.78 111.533 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.63 132.3 51.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.346 -0.983 . . . . 0.76 108.346 167.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 22' ' ' VAL . 1.4 t -109.96 -141.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.375 -0.53 . . . . 1.23 109.895 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -50.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.71 110.906 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.82 -71.06 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.77 136.84 8.36 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.182 -0.917 . . . . 0.71 109.47 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -108.64 117.18 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.123 -0.695 . . . . 0.4 109.123 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.34 140.3 38.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.397 0.618 . . . . 1.09 112.284 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.581 HD12 HG11 ' A' ' 105' ' ' VAL . 40.2 mm -129.21 101.61 6.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.621 -1.172 . . . . 0.54 107.907 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -113.89 138.24 50.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.42 0.628 . . . . 0.64 111.4 -173.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.73 148.25 39.97 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.523 -0.762 . . . . 0.85 109.315 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 16.1 Cg_endo -88.34 13.3 2.59 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 122.74 2.293 . . . . 0.35 110.849 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.622 ' OG ' ' HG3' ' A' ' 71' ' ' GLU . 2.4 m 71.23 -49.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.885 -1.052 . . . . 0.91 111.92 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 m120 56.42 63.09 5.96 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.491 -0.929 . . . . 1.39 108.491 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HG2' ' HG2' ' A' ' 60' ' ' PRO . 72.9 Cg_exo -52.83 104.22 0.1 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 123.728 2.952 . . . . 0.83 113.424 -168.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -100.88 -49.99 3.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.003 -0.999 . . . . 1.83 111.044 178.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.534 HG23 ' H ' ' A' ' 34' ' ' PHE . 12.4 t -164.75 -147.88 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.364 -0.606 . . . . 2.36 109.364 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.21 -22.64 37.38 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.61 -0.329 . . . . 1.3 112.633 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CE2' ' HA ' ' A' ' 100' ' ' SER . 4.1 m-30 -35.74 138.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.621 0.971 . . . . 2.22 113.621 169.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -148.19 148.86 31.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.318 -1.31 . . . . 0.44 108.568 172.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.606 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.3 m95 -80.08 112.73 17.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.039 0.447 . . . . 0.43 110.778 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.695 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 58.1 m-85 -118.99 179.79 4.05 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.477 -0.934 . . . . 2.78 108.477 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.64 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -70.24 -78.89 0.07 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.26 -0.576 . . . . 0.43 109.659 170.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -106.16 3.91 28.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.16 0.505 . . . . 2.39 109.815 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.475 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 90.18 112.16 1.49 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.5 -0.773 . . . . 0.73 111.458 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 -19.16 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.7 112.227 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -128.55 142.18 51.14 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.081 0.467 . . . . 1.13 111.834 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.748 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -142.01 127.8 19.3 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.853 -1.067 . . . . 2.52 109.487 168.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.05 155.44 46.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.208 0.528 . . . . 2.3 111.423 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.583 ' OG ' ' HB ' ' A' ' 53' ' ' VAL . 11.1 p -115.42 127.59 26.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.764 -0.653 . . . . 1.61 109.644 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 44.9 Cg_exo -58.21 124.97 17.11 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.695 2.263 . . . . 1.88 112.249 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 91.7 m-20 77.63 30.04 0.5 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.189 0.931 . . . . 2.43 111.981 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 11.9 pt-20 -79.18 48.79 0.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 3.26 111.769 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.6 m -85.96 -34.49 20.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.372 -0.376 . . . . 2.06 111.415 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -125.54 -31.35 3.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.793 0.806 . . . . 1.25 109.523 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.742 ' HB3' ' O ' ' A' ' 76' ' ' THR . 2.3 m-85 -103.44 167.23 9.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.414 -1.266 . . . . 0.74 107.834 176.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -148.4 165.08 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.046 -0.662 . . . . 1.46 111.198 -160.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.583 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 4.0 p -109.34 150.9 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.408 0.623 . . . . 1.31 111.446 -175.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -124.59 144.67 50.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.264 -0.88 . . . . 2.45 109.817 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 8.6 p30 -123.96 133.82 53.62 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.877 -0.601 . . . . 1.93 109.556 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -154.53 105.24 2.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.771 -0.649 . . . . 1.42 110.738 -175.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.898 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -120.25 142.9 48.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.532 -0.758 . . . . 1.66 110.774 -176.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -122.45 98.86 43.27 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.118 0.485 . . . . 2.14 110.127 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 3.1 Cg_exo -83.2 136.33 7.78 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.891 3.06 . . . . 1.92 111.11 170.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.767 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 50.7 Cg_exo -63.64 -167.49 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.263 2.642 . . . . 2.64 114.736 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -167.92 -65.17 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.471 -1.695 . . . . 5.8 107.738 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.5 p -162.96 -75.51 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 113.678 -1.601 . . . . 7.43 109.752 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.665 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -86.51 -12.48 48.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.55 -0.75 . . . . 8.71 112.424 -177.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.665 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 66.4 mt -58.46 -56.22 24.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.334 0.588 . . . . 8.1 110.524 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.57 ' CD2' ' HA2' ' A' ' 69' ' ' GLY . 1.5 tp -167.45 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.985 -1.007 . . . . 4.74 109.172 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.767 ' HA2' ' HB3' ' A' ' 60' ' ' PRO . . . 78.73 -64.42 3.62 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.866 -1.061 . . . . 3.02 114.407 162.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' O ' ' HD2' ' A' ' 30' ' ' PRO . . . -61.91 -66.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.088 0.471 . . . . 4.02 111.455 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.478 ' O ' HD21 ' A' ' 65' ' ' LEU . . . -132.51 106.22 0.64 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.678 -0.772 . . . . 2.84 111.259 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 65' ' ' LEU . . . -66.41 -151.32 0.15 Allowed Glycine 0 C--N 1.331 0.298 0 O-C-N 123.832 0.372 . . . . 1.49 113.708 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.403 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -157.1 86.99 0.97 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.406 0.521 . . . . 0.97 112.406 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.898 ' HG2' ' HB3' ' A' ' 57' ' ' TYR . 40.9 mt-10 -102.14 106.92 17.85 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.57 . . . . 0.81 109.821 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -112.52 152.6 28.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.628 -0.829 . . . . 0.53 111.669 -174.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.748 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 39.4 m-85 -115.36 119.02 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.912 -1.495 . . . . 1.13 109.08 172.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -113.86 103.72 11.46 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.961 -0.296 . . . . 0.5 110.794 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -105.2 117.9 51.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.104 0.954 . . . . 0.87 110.127 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.742 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 10.5 m -103.65 103.81 13.78 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.77 -1.105 . . . . 0.46 108.428 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.547 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 10.3 p -151.36 144.61 16.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 123.563 0.54 . . . . 1.04 110.341 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -129.29 103.65 7.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.771 0.796 . . . . 1.54 109.742 169.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.98 145.06 6.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.141 -0.936 . . . . 0.67 109.208 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.33 94.07 2.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.141 0.496 . . . . 0.44 111.329 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.89 168.17 31.17 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.29 111.041 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 108' ' ' LYS . 3.1 m -101.35 128.59 47.44 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.837 -0.802 . . . . 0.4 109.566 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.588 ' ND1' HG22 ' A' ' 85' ' ' VAL . 19.2 t-80 -104.29 103.83 13.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.4 109.827 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.75 122.2 42.97 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.325 -0.991 . . . . 0.35 108.325 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -114.86 102.07 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.482 -0.487 . . . . 0.59 110.702 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 2.5 m-20 -108.75 103.37 12.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.323 -0.991 . . . . 1.53 108.323 173.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 38' ' ' PHE . 78.5 mt -105.07 124.84 50.22 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.734 -0.666 . . . . 0.24 109.698 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.441 HG22 ' CG ' ' A' ' 90' ' ' MET . 5.6 m -101.74 116.81 33.55 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.958 0.885 . . . . 0.29 110.742 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 2.5 t80 -84.81 96.73 9.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.321 -1.309 . . . . 1.11 109.574 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.475 ' CE ' ' HA3' ' A' ' 40' ' ' GLY . 7.2 mtm -137.77 167.29 22.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.833 0.349 . . . . 0.65 110.214 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 12.4 mtm180 -70.21 103.87 0.7 Allowed Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.659 -0.867 . . . . 2.59 108.659 169.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 3.2 Cg_endo -45.23 -37.88 14.07 Favored 'Trans proline' 0 N--CA 1.477 0.522 0 C-N-CA 123.871 3.047 . . . . 1.04 114.851 -166.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 94' ' ' THR . 43.1 p90 -80.8 -2.14 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 1.17 112.457 -175.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.669 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -162.47 -65.03 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.338 0.113 . . . . 1.09 110.844 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.669 ' H ' HG23 ' A' ' 94' ' ' THR . . . 72.44 85.53 0.21 Allowed Glycine 0 CA--C 1.505 -0.533 0 C-N-CA 121.237 -0.506 . . . . 1.16 111.935 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 72.2 Cg_exo -44.09 113.59 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.41 2.74 . . . . 1.2 112.246 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.5 m -74.24 53.99 0.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.73 -0.668 . . . . 2.64 111.112 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -175.69 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.083 -0.962 . . . . 4.09 109.052 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 34.0 t70 -106.87 -17.61 14.16 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.609 -0.723 . . . . 1.67 109.497 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.616 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 10.0 p -72.96 143.02 47.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.057 -0.974 . . . . 1.39 112.457 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -103.62 171.33 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.193 -1.039 . . . . 1.91 108.193 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.439 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 45.1 ttt180 -153.56 140.36 19.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.804 0.812 . . . . 0.62 110.675 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.796 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -102.9 155.3 18.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.209 -1.359 . . . . 0.86 108.615 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.6 m -158.23 102.25 1.76 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.58 -0.448 . . . . 0.31 111.28 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.9 p -104.78 133.79 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.911 -0.716 . . . . 0.88 109.439 166.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' THR . 73.9 m-85 -104.25 104.44 14.35 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.545 -0.752 . . . . 0.7 109.062 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.768 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 1.5 pp -128.28 154.08 46.29 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.707 -0.397 . . . . 2.12 110.602 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.691 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.0 tptm -104.5 115.51 30.49 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.1 -0.704 . . . . 1.89 109.1 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.13 127.09 49.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.852 0.358 . . . . 0.53 110.75 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.19 -0.91 . . . . 1.78 110.553 -177.632 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.945 ' HB3' HG22 ' A' ' 22' ' ' VAL . 12.3 t-80 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.462 -0.94 . . . . 0.59 108.462 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 23' ' ' GLU . 17.6 ptpt -146.01 153.35 40.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.801 0.334 . . . . 2.36 110.672 172.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.871 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.1 t -115.05 135.01 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.158 0.504 . . . . 0.49 111.089 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.92 170.76 8.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 0.51 110.003 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 24.5 tptp -35.72 -49.26 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.75 1.389 . . . . 0.83 114.75 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.13 63.03 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.387 0.613 . . . . 0.33 112.124 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.871 ' HB2' HG13 ' A' ' 5' ' ' VAL . 69.9 m80 -64.91 -2.95 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.556 . . . . 2.12 111.177 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.614 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 4.2 t30 -44.99 -22.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.214 0 O-C-N 123.694 0.621 . . . . 1.41 110.392 170.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.39 55.1 0.68 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.566 -0.743 . . . . 0.3 111.277 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.883 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -119.06 156.59 29.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.238 0.829 . . . . 0.32 113.238 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 87.6 m -145.93 111.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.004 -0.998 . . . . 0.95 108.927 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 3.8 pp -152.8 167.31 29.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 3.0 111.766 -170.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -103.44 147.21 27.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 1.73 110.414 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.9 m -128.55 162.67 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.78 110.96 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 110' ' ' ASN . . . -109.0 125.96 52.61 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.252 -1.018 . . . . 0.76 108.252 167.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 22' ' ' VAL . 23.2 m -105.28 -168.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.382 -0.527 . . . . 1.23 111.121 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 113.95 -53.09 0.61 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.415 -0.674 . . . . 0.71 111.415 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.45 -73.3 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.169 0.509 . . . . 2.35 109.813 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 tp -166.12 137.19 3.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.71 109.588 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.945 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -117.19 113.97 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.828 0.823 . . . . 0.4 109.63 173.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 4' ' ' LYS . 40.6 mt-10 -102.91 156.99 17.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.115 0.959 . . . . 1.09 112.267 -171.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.694 HD13 ' HB ' ' A' ' 5' ' ' VAL . 40.2 mm -133.66 133.75 56.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.232 -1.766 . . . . 0.54 106.232 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.92 135.65 23.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.601 0.715 . . . . 0.64 111.564 178.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -109.41 153.41 42.8 Favored Pre-proline 0 N--CA 1.431 -1.375 0 CA-C-N 114.818 -1.083 . . . . 0.85 108.977 174.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.586 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 41.7 Cg_endo -90.81 11.35 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.935 2.423 . . . . 0.35 111.457 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.644 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 27.8 t 69.58 -59.6 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 0.91 111.198 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.6 OUTLIER 52.73 56.89 15.06 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.097 -0.705 . . . . 1.39 109.097 -173.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.599 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 81.6 Cg_exo -49.61 111.1 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.832 3.022 . . . . 0.83 113.579 -168.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.492 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.0 p -87.45 -38.93 15.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 1.83 109.417 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t 175.91 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.794 -1.094 . . . . 2.36 108.375 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.04 -33.03 67.93 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 118.23 0.468 . . . . 1.3 113.589 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.603 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 52.7 m-85 -52.09 148.71 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.916 0.389 . . . . 2.22 111.897 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.03 161.42 41.95 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.648 -0.705 . . . . 0.44 109.764 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.644 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -82.76 120.61 25.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.15 0.5 . . . . 0.43 112.012 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.71 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -156.15 147.69 22.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.101 -0.703 . . . . 2.78 109.101 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -40.93 -68.76 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.61 0.596 . . . . 0.43 112.61 -171.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.15 17.69 2.44 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.568 -0.453 . . . . 2.39 111.828 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.535 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 125.0 85.88 0.64 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 119.778 -1.201 . . . . 0.73 113.075 170.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.82 12.25 10.06 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.843 -0.694 . . . . 0.7 112.242 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -135.16 139.26 44.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.469 -0.937 . . . . 1.13 108.469 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.63 142.19 33.42 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.376 0.423 . . . . 2.52 110.546 -173.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.56 153.12 47.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.06 0.457 . . . . 2.3 111.505 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.831 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 18.0 t -104.77 132.87 20.51 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.8 -0.815 . . . . 1.61 108.8 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 84' ' ' ALA . 9.9 Cg_exo -72.86 25.21 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.304 2.669 . . . . 1.88 113.426 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -178.49 48.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.297 0.57 . . . . 2.43 109.486 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.831 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 8.8 pt-20 -114.64 122.6 46.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.742 0.782 . . . . 3.26 111.147 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -141.99 -39.72 0.37 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.806 -1.088 . . . . 2.06 108.819 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.869 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.77 -35.41 6.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.629 -0.714 . . . . 1.25 110.516 176.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.869 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 9.3 m-85 -108.9 164.46 12.38 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.497 -0.927 . . . . 0.74 108.497 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -161.84 172.08 16.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.411 0.624 . . . . 1.46 112.598 -164.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 20.3 t -99.73 143.99 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.411 -0.813 . . . . 1.31 111.472 -174.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 7.5 pt-20 -109.33 132.22 54.33 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.644 -0.873 . . . . 2.45 108.644 169.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.61 131.87 53.9 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.537 -0.865 . . . . 1.93 110.986 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.78 104.89 2.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.098 -0.955 . . . . 1.42 110.34 -172.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CB ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 p90 -131.2 131.59 44.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.448 0.642 . . . . 1.66 112.153 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.811 ' HB3' HD21 ' A' ' 64' ' ' LEU . 91.0 m-85 -136.29 102.48 9.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 2.14 110.507 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.92 176.48 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.924 2.416 . . . . 1.92 112.312 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.88 170.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.968 3.112 . . . . 2.64 116.037 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . 15.7 t70 -171.35 -71.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.576 -1.647 . . . . 5.8 108.111 -173.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.3 t -174.32 -85.84 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.027 -1.442 . . . . 7.43 108.871 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.573 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -81.03 -19.74 43.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.021 -0.536 . . . . 8.71 110.828 177.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 58' ' ' PHE . 46.1 tp -55.03 -49.61 71.12 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.818 -0.808 . . . . 8.1 108.818 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.796 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -161.86 -66.64 0.05 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.671 -1.15 . . . . 4.74 109.403 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.75 -60.84 4.58 Favored Glycine 0 C--N 1.319 -0.367 0 CA-C-N 114.927 -1.033 . . . . 3.02 112.889 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.71 -40.27 59.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.19 0.596 . . . . 4.02 112.337 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.796 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -145.21 -55.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.476 -0.869 . . . . 2.84 111.803 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . 137.76 -175.47 21.25 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.302 -1.119 . . . . 1.49 110.302 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 86.01 1.05 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 117.902 0.851 . . . . 0.97 112.571 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.634 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 37.6 mt-10 -104.36 104.37 14.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.81 109.716 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -114.12 163.71 14.83 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.22 1.009 . . . . 0.53 112.577 -171.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 42.0 m-85 -140.13 104.08 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.173 -1.831 . . . . 1.13 108.769 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.601 ' HB2' ' CG ' ' A' ' 54' ' ' GLU . 55.6 m170 -103.35 123.45 46.83 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.824 -0.548 . . . . 0.5 110.034 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 53' ' ' VAL . 3.4 m -105.77 123.4 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 122.23 1.014 . . . . 0.87 109.918 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.719 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 8.5 m -102.64 104.78 15.17 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.806 -1.183 . . . . 0.46 107.806 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.6 p -150.46 142.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.118 -0.492 . . . . 1.04 110.694 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.55 101.59 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.265 0.555 . . . . 1.54 109.713 167.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -167.5 145.78 4.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.406 -0.816 . . . . 0.67 109.602 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.24 89.89 2.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.44 110.81 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.12 166.93 31.69 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 110.717 -0.953 . . . . 0.29 110.717 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.5 132.25 48.67 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.692 0.746 . . . . 0.4 109.811 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.569 ' ND1' HG22 ' A' ' 85' ' ' VAL . 45.1 t-80 -104.42 106.14 16.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.173 -0.467 . . . . 0.4 110.527 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 46' ' ' PRO . . . -101.2 115.23 30.02 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.325 -0.62 . . . . 0.35 109.325 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.5 t -106.3 105.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.848 -0.615 . . . . 0.59 111.331 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 31.9 m-20 -112.96 102.89 10.86 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.47 -0.567 . . . . 1.53 109.47 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 98.8 mt -107.33 123.4 48.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.674 -0.694 . . . . 0.24 109.453 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.448 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 5.4 m -103.45 130.73 50.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.4 0.619 . . . . 0.29 111.405 -170.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 43.7 t80 -95.76 84.91 3.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.399 -0.819 . . . . 1.11 109.776 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.689 ' HE2' ' HE1' ' A' ' 37' ' ' TYR . 17.4 mtm -121.53 173.7 7.24 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.905 0.383 . . . . 0.65 109.981 -175.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.611 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 3.2 ttm-85 -86.71 114.06 56.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 108.861 -0.792 . . . . 2.59 108.861 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.8 Cg_endo -49.86 -27.33 15.64 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.976 3.118 . . . . 1.04 115.88 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 42.7 p90 -104.03 10.77 35.95 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.945 -0.472 . . . . 1.17 111.996 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.8 t -166.05 -62.0 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.26 -0.176 . . . . 1.09 111.034 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.611 ' HA2' ' H ' ' A' ' 91' ' ' ARG . . . 61.86 79.24 0.14 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 112.13 -0.388 . . . . 1.16 112.13 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.764 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 50.6 Cg_exo -36.08 128.21 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.839 3.026 . . . . 1.2 112.562 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 p -35.01 -64.23 0.28 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 124.663 1.227 . . . . 2.64 114.059 -170.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -124.0 33.8 5.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.333 -0.547 . . . . 4.09 110.685 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.764 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 29.1 t0 -106.82 -4.66 19.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.98 0.895 . . . . 1.67 108.905 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.461 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.9 m -89.0 142.41 27.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.346 -1.297 . . . . 1.39 110.252 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.651 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 29.1 tt0 -92.49 179.31 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.01 -0.737 . . . . 1.91 109.01 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.651 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 29.7 ttt180 -161.65 142.51 10.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.719 0.771 . . . . 0.62 111.408 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.794 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 1.2 t80 -105.22 154.39 20.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.237 -1.347 . . . . 0.86 109.341 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 45.1 m -158.45 102.43 1.73 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.31 110.97 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.883 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.6 p -107.21 136.62 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 120.027 -0.669 . . . . 0.88 109.53 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' THR . 78.4 m-85 -104.62 104.08 13.85 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.629 -0.878 . . . . 0.7 108.629 174.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.624 HD13 HG11 ' A' ' 16' ' ' VAL . 3.3 pp -122.67 145.46 48.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.947 -0.76 . . . . 2.12 108.947 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.784 ' O ' HG22 ' A' ' 16' ' ' VAL . 71.7 tttt -103.27 124.52 48.8 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.105 -0.638 . . . . 1.89 109.704 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.98 129.34 46.81 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.456 0.473 . . . . 0.53 110.31 -170.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.634 ' C ' HG22 ' A' ' 18' ' ' VAL . 19.3 p-10 . . . . . 0 C--O 1.243 0.747 0 CA-C-O 118.314 -0.85 . . . . 1.78 109.816 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.953 ' HB3' HG22 ' A' ' 22' ' ' VAL . 23.6 t60 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.001 -0.74 . . . . 0.59 109.001 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -138.7 148.17 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.014 0.435 . . . . 2.36 110.765 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.866 HG13 ' HB2' ' A' ' 9' ' ' HIS . 1.9 t -112.41 138.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 0.49 110.928 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.96 169.07 9.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.4 -0.818 . . . . 0.51 110.322 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.3 tptp -39.72 -43.72 1.44 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.01 1.115 . . . . 0.83 114.01 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.96 -35.45 33.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.645 0.736 . . . . 0.33 111.862 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.866 ' HB2' HG13 ' A' ' 5' ' ' VAL . 76.0 m80 -66.26 -1.96 3.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.496 -0.775 . . . . 2.12 111.654 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 27.1 t30 -46.01 -21.54 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.414 0.626 . . . . 1.41 109.586 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.08 57.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.3 111.376 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.875 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.23 160.53 20.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.257 0.836 . . . . 0.32 113.257 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 14.2 m -151.48 114.59 4.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.016 -0.993 . . . . 0.95 109.116 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.6 pt? -158.26 166.73 31.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.172 0.51 . . . . 3.0 111.606 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -104.04 141.5 36.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 1.73 110.523 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.7 m -126.75 152.1 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.417 -0.356 . . . . 0.78 111.196 -175.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.54 118.26 36.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.838 -0.801 . . . . 0.76 108.838 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.718 HG12 HG21 ' A' ' 22' ' ' VAL . 27.3 m -100.01 -170.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.252 0.548 . . . . 1.23 111.584 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.641 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 128.38 -46.02 1.11 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.214 -0.754 . . . . 0.71 111.214 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -89.48 -69.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.64 -0.504 . . . . 2.35 109.64 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.2 tp -166.46 126.06 1.57 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.59 -0.732 . . . . 0.71 111.177 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -107.85 114.32 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.819 0.818 . . . . 0.4 110.05 174.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.01 153.48 20.2 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.884 0.849 . . . . 1.09 112.1 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.599 HD13 ' HB ' ' A' ' 5' ' ' VAL . 49.1 mm -133.21 102.48 4.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 113.758 -1.564 . . . . 0.54 107.467 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -114.16 132.84 55.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.057 0.932 . . . . 0.64 111.752 -172.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.47 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 3.9 mm? -109.27 154.54 42.09 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.584 -1.189 . . . . 0.85 108.924 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 65.3 Cg_endo -88.99 9.53 3.56 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 122.741 2.294 . . . . 0.35 111.394 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.665 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 19.9 t 69.47 -57.21 0.54 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.219 -0.901 . . . . 0.91 110.474 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.7 OUTLIER 54.35 62.98 7.91 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.984 -1.117 . . . . 1.39 107.984 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 52.9 Cg_exo -54.46 112.9 1.14 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.528 2.819 . . . . 0.83 113.209 -165.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.464 HG23 ' CE2' ' A' ' 89' ' ' TYR . 8.3 p -92.5 -43.67 9.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.459 -0.791 . . . . 1.83 110.086 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.677 HG23 ' HD1' ' A' ' 34' ' ' PHE . 5.1 t 175.79 -136.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.571 -0.9 . . . . 2.36 108.571 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.44 -17.13 46.41 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 118.024 0.375 . . . . 1.3 113.551 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.677 ' HD1' HG23 ' A' ' 32' ' ' THR . 2.4 m-85 -68.86 142.74 54.73 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.987 0.515 . . . . 2.22 110.584 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -149.13 159.06 44.58 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.27 -0.641 . . . . 0.44 109.27 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.58 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 98.2 m95 -73.48 119.32 17.55 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.361 0.601 . . . . 0.43 111.474 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 41.6 m-85 -128.46 -177.09 4.03 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 115.425 -0.807 . . . . 2.78 108.862 170.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.5 m-85 -78.15 -77.71 0.15 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.49 0.586 . . . . 0.43 109.93 168.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.25 -0.54 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 2.39 110.532 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 108.23 102.87 2.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.748 . . . . 0.73 112.28 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.13 2.79 67.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.848 -0.692 . . . . 0.7 111.662 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -132.33 144.56 50.65 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.834 0.453 . . . . 1.13 111.783 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.629 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.58 132.2 27.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.444 -0.798 . . . . 2.52 110.582 167.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.47 152.57 50.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.023 -0.535 . . . . 2.3 110.786 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.598 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 17.3 t -119.76 135.17 24.03 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.033 -0.729 . . . . 1.61 109.033 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 12.2 Cg_exo -70.7 -8.08 22.79 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.802 2.335 . . . . 1.88 113.07 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.437 HD21 ' HA3' ' A' ' 81' ' ' GLY . 5.0 m-20 -125.72 26.23 6.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 2.43 111.075 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 45' ' ' SER . 15.3 pt-20 -95.23 77.27 3.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.341 1.067 . . . . 3.26 111.693 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -95.3 -56.79 2.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.858 -1.064 . . . . 2.06 110.203 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.772 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 18.1 ptt? -108.25 -31.28 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.742 -1.117 . . . . 1.25 109.243 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.772 ' HD1' ' HG3' ' A' ' 50' ' ' MET . 12.3 m-85 -103.8 167.97 9.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.743 -1.571 . . . . 0.74 108.009 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 14.7 t -158.63 168.75 26.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.709 0.686 . . . . 1.46 112.427 -169.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.8 p -101.2 136.77 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.311 -0.859 . . . . 1.31 110.988 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 8.2 pt-20 -127.99 141.97 51.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.43 -0.804 . . . . 2.45 109.619 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -108.21 140.34 41.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 1.93 111.739 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.823 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.23 104.24 3.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.103 -0.953 . . . . 1.42 109.39 171.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.6 p90 -124.63 150.26 46.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.563 -0.744 . . . . 1.66 110.853 -172.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.1 103.02 26.97 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 121.256 0.551 . . . . 2.14 112.197 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.487 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -89.28 120.45 1.03 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 124.427 3.418 . . . . 1.92 110.295 165.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.979 ' HG3' ' HA2' ' A' ' 69' ' ' GLY . 2.1 Cg_endo -80.13 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.774 2.983 . . . . 2.64 113.177 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.16 -28.93 16.01 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.65 -0.87 . . . . 5.8 108.65 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m 65.92 11.69 7.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.598 -1.637 . . . . 7.43 111.191 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -125.37 -11.82 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 8.71 110.629 175.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.3 tp -151.17 -89.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.489 -0.323 . . . . 8.1 111.584 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mt -176.81 111.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.204 0.526 . . . . 4.74 111.709 -172.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.937 ' H ' ' HG2' ' A' ' 60' ' ' PRO . . . -81.89 66.86 3.77 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.296 -1.122 . . . . 3.02 110.296 172.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 66' ' ' GLY . . . 74.27 -66.3 0.31 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.39 0.7 . . . . 4.02 110.292 -175.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.79 34.37 0.63 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.366 -0.834 . . . . 2.84 111.254 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.979 ' HA2' ' HG3' ' A' ' 60' ' ' PRO . . . 47.34 -123.44 8.27 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.978 -0.849 . . . . 1.49 110.978 -175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.6 HG22 ' NE2' ' A' ' 72' ' ' HIS . 31.8 m 137.14 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.227 1.411 . . . . 0.97 108.733 150.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 39.4 mt-10 -103.51 115.63 30.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.671 -1.149 . . . . 0.81 110.167 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.823 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 1.7 m170 -108.53 144.98 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.678 0.751 . . . . 0.53 111.775 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.633 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 14.2 m-85 -116.77 112.38 21.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.513 -1.221 . . . . 1.13 109.058 170.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.428 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 15.8 m170 -104.45 113.99 27.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.059 -0.519 . . . . 0.5 110.764 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.3 m -104.54 118.53 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 122.252 1.025 . . . . 0.87 108.501 171.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.744 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.1 m -102.26 103.74 14.24 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.48 -1.304 . . . . 0.46 107.48 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.621 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 4.7 p -155.94 142.01 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 123.651 0.594 . . . . 1.04 111.158 -173.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.641 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -127.14 101.78 6.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.057 -0.72 . . . . 1.54 109.057 165.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.62 138.19 4.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 0.67 109.92 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.65 99.48 3.11 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.746 0.654 . . . . 0.44 111.854 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 47' ' ' ASN . . . -165.71 166.46 38.55 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.429 -1.068 . . . . 0.29 110.429 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 5.5 m -100.83 130.78 46.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.138 0.969 . . . . 0.4 109.957 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.732 ' HD1' HG22 ' A' ' 85' ' ' VAL . 36.5 t-80 -102.97 105.47 15.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.211 -0.904 . . . . 0.4 109.854 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.52 24.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.121 -0.696 . . . . 0.35 109.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.732 HG22 ' HD1' ' A' ' 83' ' ' HIS . 2.3 t -105.45 103.08 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.604 -0.726 . . . . 0.59 110.928 -170.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 2.8 m-20 -109.12 103.26 12.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.148 -0.686 . . . . 1.53 109.148 176.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 38' ' ' PHE . 88.1 mt -105.78 126.04 51.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.691 -0.686 . . . . 0.24 110.507 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.699 HG22 ' HG3' ' A' ' 90' ' ' MET . 6.0 m -102.55 121.2 41.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.339 0.59 . . . . 0.29 110.98 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.637 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 54.1 t80 -86.52 97.79 10.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 1.11 109.284 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.699 ' HG3' HG22 ' A' ' 88' ' ' THR . 27.6 mtm -134.39 159.48 40.92 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.275 -0.42 . . . . 0.65 111.83 -172.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 48.3 mtt180 -64.2 105.55 0.73 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 108.227 -1.027 . . . . 2.59 108.227 163.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -46.63 -32.16 11.34 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.633 2.888 . . . . 1.04 114.765 -167.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.423 ' CD1' HG22 ' A' ' 94' ' ' THR . 37.7 p90 -88.12 -2.82 58.84 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.133 0.42 . . . . 1.17 112.133 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -162.23 -68.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.493 -0.129 . . . . 1.09 111.338 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.683 ' H ' HG23 ' A' ' 94' ' ' THR . . . 73.41 78.38 0.56 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.789 -0.719 . . . . 1.16 111.533 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 13.0 Cg_exo -32.84 114.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.103 3.202 . . . . 1.2 113.066 172.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 p -41.27 -55.66 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.801 -1.091 . . . . 2.64 113.361 -171.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -100.11 20.07 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.626 -0.43 . . . . 4.09 111.636 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 14.0 t0 -124.34 6.17 8.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 1.67 110.308 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 32.8 m -98.61 147.86 24.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.454 -0.794 . . . . 1.39 111.149 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.637 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 4.7 tp10 -100.52 166.69 10.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.067 -0.716 . . . . 1.91 109.067 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 46.8 ttt180 -153.51 140.14 18.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.77 0.795 . . . . 0.62 111.232 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.777 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -104.4 157.4 17.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.116 -1.402 . . . . 0.86 109.07 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 53.5 m -159.55 102.4 1.54 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.839 0.352 . . . . 0.31 110.977 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.875 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.6 p -105.55 138.91 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.033 -0.667 . . . . 0.88 110.1 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.4 m-85 -104.52 104.2 14.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.458 -0.792 . . . . 0.7 109.034 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.9 pp -126.0 148.53 49.26 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.213 -0.662 . . . . 2.12 109.213 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.719 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.4 ttmm -104.59 122.71 46.16 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.198 -0.601 . . . . 1.89 110.165 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -101.74 128.9 47.87 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.414 0.446 . . . . 0.53 110.134 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.608 ' C ' HG22 ' A' ' 18' ' ' VAL . 21.0 p-10 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.52 -0.752 . . . . 1.78 110.34 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.953 ' HB3' HG22 ' A' ' 22' ' ' VAL . 8.2 t-80 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 108.932 -0.766 . . . . 0.59 108.932 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -132.28 144.65 50.74 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.938 -0.305 . . . . 2.36 110.254 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.857 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -112.64 133.48 58.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.49 111.134 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -117.46 170.29 8.85 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.974 -1.012 . . . . 0.51 109.462 170.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.513 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 8.6 tptm -34.82 -49.04 0.42 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.973 1.471 . . . . 0.83 114.973 -170.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.06 63.81 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.326 0.584 . . . . 0.33 112.537 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.857 ' HB2' HG13 ' A' ' 5' ' ' VAL . 75.3 m80 -64.49 -2.86 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 2.12 110.903 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.61 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 4.9 t30 -45.53 -19.63 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.975 0.797 . . . . 1.41 110.484 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.32 59.27 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.97 -0.852 . . . . 0.3 110.97 175.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.805 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -120.35 148.21 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.903 0.705 . . . . 0.32 112.903 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 106' ' ' TYR . 85.5 m -134.73 119.08 17.8 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.42 -0.809 . . . . 0.95 109.163 168.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pt? -159.69 166.27 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 3.0 111.036 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.0 m -103.29 148.1 26.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.255 -0.43 . . . . 1.73 110.437 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.3 m -126.41 155.41 36.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.78 111.441 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.52 111.49 22.54 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.945 -0.761 . . . . 0.76 108.945 171.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.814 HG21 ' HA ' ' A' ' 78' ' ' LYS . 12.9 m -89.84 -167.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.946 0.403 . . . . 1.23 111.078 -173.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.0 -54.49 0.73 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.238 -0.745 . . . . 0.71 111.238 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.2 -63.2 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.722 -0.844 . . . . 2.35 108.722 171.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 22' ' ' VAL . 54.9 tp -165.5 163.61 19.52 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.495 -1.229 . . . . 0.71 109.944 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.3 t -140.46 106.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.449 -0.945 . . . . 0.4 108.449 164.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.604 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.0 pt-20 -112.25 158.36 19.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 122.222 1.011 . . . . 1.09 112.579 -172.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.576 HD12 HG11 ' A' ' 105' ' ' VAL . 46.0 mm -132.9 103.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.451 -1.704 . . . . 0.54 108.5 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -113.27 133.5 55.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.819 0.819 . . . . 0.64 111.535 -176.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -108.88 144.27 29.29 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.062 -0.972 . . . . 0.85 108.997 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 67.4 Cg_endo -81.09 10.1 3.55 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 122.499 2.132 . . . . 0.35 111.264 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.704 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 19.4 t 69.37 -61.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.997 -1.001 . . . . 0.91 111.191 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.436 ' ND2' ' HG2' ' A' ' 27' ' ' PRO . 2.2 m120 56.6 62.01 6.64 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.942 -0.762 . . . . 1.39 108.942 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 74.8 Cg_exo -52.12 103.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.369 2.712 . . . . 0.83 113.105 -168.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.5 p -83.15 -37.27 23.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.347 -0.842 . . . . 1.83 110.027 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 34' ' ' PHE . 7.7 t 179.11 -144.53 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.402 -0.962 . . . . 2.36 108.402 -177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.74 -11.33 29.41 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 118.093 0.406 . . . . 1.3 113.242 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 90' ' ' MET . 1.4 m-85 -71.78 151.71 43.29 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.003 0.521 . . . . 2.22 111.469 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -152.15 161.67 42.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.801 -0.636 . . . . 0.44 109.663 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -79.53 117.18 20.24 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.402 0.62 . . . . 0.43 111.437 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.586 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 70.7 m-85 -125.17 -178.41 4.19 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 108.083 -1.08 . . . . 2.78 108.083 168.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.85 -80.36 0.06 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.029 -0.669 . . . . 0.43 109.556 169.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -104.08 -0.31 28.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.246 0.546 . . . . 2.39 110.168 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.574 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 102.22 104.73 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.73 111.826 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.88 -0.69 71.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.742 -0.742 . . . . 0.7 111.955 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.625 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -129.71 141.56 50.87 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.843 0.354 . . . . 1.13 111.493 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.12 129.54 17.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.375 -0.83 . . . . 2.52 110.334 167.074 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.09 153.79 51.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.082 0.467 . . . . 2.3 111.257 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.539 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 18.1 t -104.71 129.2 25.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 1.61 108.712 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 10.9 Cg_endo -96.22 161.54 1.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.205 3.27 . . . . 1.88 112.573 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 70.92 8.5 6.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.264 -0.88 . . . . 2.43 111.176 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 51' ' ' PHE . 5.5 tp10 -158.27 134.04 9.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.514 0.673 . . . . 3.26 112.091 -171.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 p -130.09 28.36 5.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.799 -1.091 . . . . 2.06 109.521 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.544 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 21.5 ptt? -138.0 -40.96 0.53 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.486 -0.931 . . . . 1.25 108.486 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.816 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.6 m-85 -103.05 149.75 24.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.72 -1.585 . . . . 0.74 106.72 165.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 171.61 18.93 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.834 -0.746 . . . . 1.46 111.536 -161.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.6 ' HB ' HG12 ' A' ' 75' ' ' VAL . 6.1 p -100.34 139.98 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.404 0.621 . . . . 1.31 112.248 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 11.2 pt-20 -109.34 152.28 25.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.571 -0.9 . . . . 2.45 108.571 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -128.2 140.06 52.12 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.75 -0.38 . . . . 1.93 111.289 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.86 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.34 114.5 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.332 0.587 . . . . 1.42 110.273 173.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 8.2 m-85 -109.7 105.11 14.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.796 -0.638 . . . . 1.66 110.057 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.61 104.54 54.32 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.988 -0.551 . . . . 2.14 111.297 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -62.02 172.55 3.88 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.297 2.665 . . . . 1.92 112.205 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.544 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 34.0 Cg_exo -62.89 -163.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.985 2.457 . . . . 2.64 115.181 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 62' ' ' SER . 18.1 t70 170.64 -138.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.642 -1.984 . . . . 5.8 105.642 -171.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.441 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 3.9 p -106.59 -61.07 1.58 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.966 0.412 . . . . 7.43 109.916 170.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.615 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -92.43 -18.33 23.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 8.71 111.64 -178.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.615 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 1.3 tm? -61.48 -51.61 67.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.951 -0.759 . . . . 8.1 108.951 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.811 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.6 OUTLIER -160.73 -58.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.387 -0.824 . . . . 4.74 108.903 173.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.03 -61.27 4.52 Favored Glycine 0 C--N 1.317 -0.497 0 CA-C-N 114.761 -1.108 . . . . 3.02 112.767 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.39 -55.91 28.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 4.02 111.961 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.811 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -133.91 -53.83 0.07 OUTLIER Glycine 0 C--O 1.221 -0.702 0 C-N-CA 120.569 -0.824 . . . . 2.84 112.796 -177.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . 135.58 -165.74 24.7 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.349 -0.929 . . . . 1.49 111.065 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -156.89 92.44 1.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.711 0.634 . . . . 0.97 112.711 -174.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 37.1 mt-10 -104.09 109.11 20.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.572 -0.899 . . . . 0.81 108.572 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.7 m170 -108.19 145.97 33.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.551 0.691 . . . . 0.53 112.056 -170.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.586 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.5 m-85 -121.24 104.54 9.81 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.057 -1.429 . . . . 1.13 108.596 170.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.643 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 19.6 m170 -104.24 107.87 18.99 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 122.234 -0.291 . . . . 0.5 110.284 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.6 HG12 ' HB ' ' A' ' 53' ' ' VAL . 3.8 m -101.56 118.87 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 122.349 1.071 . . . . 0.87 108.294 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.6 m -101.74 103.98 14.76 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.702 -1.592 . . . . 0.46 106.702 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.676 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -151.26 147.41 15.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.133 0.896 . . . . 1.04 110.874 -170.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.814 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.61 102.07 4.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.217 0.532 . . . . 1.54 109.988 170.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -163.23 137.1 5.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 0.67 110.137 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.44 77.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.264 0.554 . . . . 0.44 111.651 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.47 166.76 29.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.798 -0.921 . . . . 0.29 110.798 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -99.98 133.08 44.87 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.519 -0.872 . . . . 0.4 109.047 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.648 ' ND1' HG22 ' A' ' 85' ' ' VAL . 12.5 t-80 -103.45 103.64 13.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.184 -0.673 . . . . 0.4 109.184 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.33 109.11 20.68 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.877 -0.786 . . . . 0.35 108.877 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.39 106.87 21.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.166 -0.47 . . . . 0.59 111.146 -170.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 5.0 m-80 -109.42 103.8 12.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.498 -0.774 . . . . 1.53 109.232 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.667 HD23 ' HA ' ' A' ' 38' ' ' PHE . 84.9 mt -105.23 123.6 48.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.461 -0.791 . . . . 0.24 109.744 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.4 m -102.5 120.09 39.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.29 110.933 -172.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.869 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 50.1 t80 -88.23 98.22 11.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 1.11 109.732 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.71 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 10.2 mtm -136.3 163.98 29.15 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 110.277 -0.268 . . . . 0.65 110.277 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.558 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 12.8 ttt180 -65.41 110.59 4.56 Favored Pre-proline 0 C--O 1.221 -0.405 0 N-CA-C 107.673 -1.232 . . . . 2.59 107.673 168.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.544 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 1.7 Cg_endo -43.98 -33.96 5.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.231 3.288 . . . . 1.04 115.42 -169.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 48.9 p90 -102.24 8.03 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.859 0.689 . . . . 1.17 112.859 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 95' ' ' GLY . 12.8 t -167.8 -55.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.789 -0.364 . . . . 1.09 111.602 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 58.1 78.75 0.12 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-O 119.703 -0.498 . . . . 1.16 113.377 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.55 ' HB2' ' HZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -29.08 115.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.236 3.291 . . . . 1.2 113.439 170.118 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 m -73.42 67.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.301 -0.863 . . . . 2.64 111.261 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 t60 176.35 -30.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.18 -0.918 . . . . 4.09 109.078 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.508 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -91.81 -7.18 50.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.67 110.018 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -68.3 122.3 18.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.008 -0.996 . . . . 1.39 112.404 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.869 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.6 tp10 -91.05 165.33 13.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.023 -1.103 . . . . 1.91 108.023 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.434 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 39.2 ttt180 -159.2 136.98 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.711 0.767 . . . . 0.62 111.094 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -104.3 154.37 19.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.438 -1.256 . . . . 0.86 109.162 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.1 m -154.87 103.25 2.41 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.866 -0.333 . . . . 0.31 110.783 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.805 HG23 ' HB3' ' A' ' 12' ' ' ALA . 10.6 p -104.96 136.12 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 119.676 -0.81 . . . . 0.88 109.682 168.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 13' ' ' THR . 74.4 m-85 -103.9 104.15 14.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.467 -0.938 . . . . 0.7 108.467 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.4 pp -122.68 146.17 47.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.269 -0.641 . . . . 2.12 109.269 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.771 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.7 ttmm -103.48 116.71 32.91 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.559 -0.456 . . . . 1.89 111.0 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.65 151.3 21.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.896 -0.779 . . . . 0.53 108.896 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.582 ' O ' HG22 ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.804 -0.617 . . . . 1.78 111.631 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 1.026 ' HB3' HG22 ' A' ' 22' ' ' VAL . 43.8 t60 . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.23 -0.656 . . . . 0.59 109.23 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -142.65 130.84 22.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.283 -0.417 . . . . 2.36 110.499 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.864 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -106.58 137.05 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.399 -0.52 . . . . 0.49 111.702 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -119.01 168.75 10.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.51 109.412 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -40.11 -39.46 0.9 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.47 1.285 . . . . 0.83 114.47 -170.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.81 -36.45 62.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.558 0.694 . . . . 0.33 111.83 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.864 ' HB2' HG13 ' A' ' 5' ' ' VAL . 77.6 m80 -65.66 -1.59 2.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.649 -0.705 . . . . 2.12 111.41 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.603 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 33.1 t30 -46.01 -19.36 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.316 0.646 . . . . 1.41 110.161 169.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -142.12 55.33 0.59 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.427 -0.669 . . . . 0.3 111.427 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.819 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -112.45 160.22 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.97 0.73 . . . . 0.32 112.97 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 34.1 m -152.25 110.37 3.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.158 -0.928 . . . . 0.95 109.336 173.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.724 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.5 pt? -158.13 166.58 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 3.0 111.195 -172.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 108' ' ' LYS . 94.5 m -104.2 148.61 26.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.945 0.403 . . . . 1.73 110.715 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.2 m -125.53 157.65 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.78 110.035 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.34 104.2 12.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.65 -0.5 . . . . 0.76 109.65 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 22' ' ' VAL . 33.2 m -84.09 175.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.234 0.54 . . . . 1.23 112.072 -172.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.77 -32.15 3.38 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.71 111.211 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.74 -76.22 0.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.664 -0.495 . . . . 2.35 109.664 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.2 tp -166.05 123.39 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.462 -0.79 . . . . 0.71 110.66 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -107.78 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.598 0.713 . . . . 0.4 109.645 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -113.0 159.25 19.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.869 0.842 . . . . 1.09 112.44 -172.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.709 HD12 HG11 ' A' ' 105' ' ' VAL . 47.2 mm -134.43 102.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.111 -1.404 . . . . 0.54 108.722 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -106.03 141.57 37.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.368 0.604 . . . . 0.64 111.334 -175.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.93 142.65 42.94 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.562 -0.744 . . . . 0.85 110.284 172.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 43.3 Cg_endo -84.2 16.29 1.96 Allowed 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.787 2.325 . . . . 0.35 112.427 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.7 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.0 t 65.8 -61.25 0.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.657 0.783 . . . . 0.91 111.219 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.494 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 58.8 83.44 0.22 Allowed Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.292 -1.003 . . . . 1.39 108.292 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 31.6 Cg_exo -60.88 98.36 0.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.388 2.725 . . . . 0.83 113.416 -166.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.486 ' OG1' ' HE2' ' A' ' 89' ' ' TYR . 6.4 p -83.13 -45.29 14.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.034 -0.728 . . . . 1.83 109.034 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.689 HG23 ' HD1' ' A' ' 34' ' ' PHE . 8.9 t 173.91 -140.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.024 -0.989 . . . . 2.36 108.503 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.24 -27.78 47.74 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 118.043 0.383 . . . . 1.3 113.853 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.689 ' HD1' HG23 ' A' ' 32' ' ' THR . 41.6 m-85 -56.56 147.79 21.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.058 0.543 . . . . 2.22 111.67 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.524 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -152.37 157.8 41.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.067 0.547 . . . . 0.44 109.637 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.7 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 92.9 m95 -78.29 119.74 22.07 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.415 0.626 . . . . 0.43 111.688 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.54 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 85.0 m-85 -126.55 -177.79 4.12 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.012 -1.107 . . . . 2.78 108.012 168.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -72.88 -76.61 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.934 -0.707 . . . . 0.43 109.576 165.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.5 3.09 8.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.77 -0.65 . . . . 2.39 111.009 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.0 100.38 1.11 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.03 -1.081 . . . . 0.73 113.327 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.13 22.38 60.55 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.847 -0.692 . . . . 0.7 111.916 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -140.35 142.38 35.58 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 122.754 0.422 . . . . 1.13 111.209 -174.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.73 140.51 31.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.99 -0.55 . . . . 2.52 110.035 164.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.76 145.44 46.6 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.915 -0.584 . . . . 2.3 110.271 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 2.9 p -104.17 128.48 27.03 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.536 -0.913 . . . . 1.61 108.536 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.7 Cg_exo -77.83 39.83 0.8 Allowed 'Trans proline' 0 C--N 1.335 -0.166 0 C-N-CA 123.492 2.795 . . . . 1.88 112.835 -170.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.406 ' HB3' HG21 ' A' ' 77' ' ' VAL . 7.4 t-20 -173.99 32.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.485 -0.561 . . . . 2.43 109.485 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.471 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 10.9 pt-20 -94.85 109.17 21.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.712 0.768 . . . . 3.26 111.585 -173.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.2 m -145.92 10.46 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.464 -0.789 . . . . 2.06 110.118 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -178.12 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 1.25 109.122 -172.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.754 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.5 m-85 -123.58 157.25 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.17 -1.377 . . . . 0.74 107.835 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -152.57 166.46 31.98 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.662 0.616 . . . . 1.46 112.662 -162.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.888 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 p -109.27 136.11 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.607 -0.724 . . . . 1.31 111.818 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.92 137.79 51.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.59 -0.732 . . . . 2.45 109.628 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.86 142.74 34.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.236 -0.586 . . . . 1.93 110.784 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.42 104.92 3.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.432 -0.804 . . . . 1.42 109.861 -177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.929 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -116.62 132.39 56.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.367 0.603 . . . . 1.66 112.189 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -132.34 98.44 16.89 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 2.14 109.723 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.49 178.78 4.07 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.968 2.445 . . . . 1.92 111.305 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.984 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 68.3 Cg_exo -48.46 -51.91 9.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.606 2.204 . . . . 2.64 113.665 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.503 ' HB2' HD12 ' A' ' 64' ' ' LEU . 28.6 t70 61.63 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.904 0.752 . . . . 5.8 109.564 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.0 m -166.26 -42.35 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 7.43 108.1 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.673 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -112.95 -27.35 8.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.959 -1.018 . . . . 8.71 111.403 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 58.9 mt -56.63 -56.11 25.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.148 0.499 . . . . 8.1 111.167 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.677 ' HG ' ' CA ' ' A' ' 69' ' ' GLY . 1.4 tm? -128.93 -67.54 0.78 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.042 -0.725 . . . . 4.74 109.042 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.984 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . 110.16 -46.42 1.17 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.046 -0.979 . . . . 3.02 111.652 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.0 -82.61 0.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.734 0.272 . . . . 4.02 111.734 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -105.57 -58.7 0.64 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.54 -0.838 . . . . 2.84 113.212 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.677 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . 143.33 -179.74 20.59 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.976 -1.107 . . . . 1.49 111.72 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.38 81.47 1.12 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.617 0.723 . . . . 0.97 110.757 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.929 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 20.9 mt-10 -104.05 102.44 12.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.949 -1.023 . . . . 0.81 108.405 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -113.81 151.3 32.26 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.411 -0.916 . . . . 0.53 111.324 -174.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.54 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 39.6 m-85 -118.83 104.45 10.56 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.97 -1.468 . . . . 1.13 109.332 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.58 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 17.9 m170 -104.64 104.86 14.75 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.252 -0.431 . . . . 0.5 110.883 -171.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.888 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.98 120.82 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 122.424 1.107 . . . . 0.87 109.785 177.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.6 m -102.92 104.43 14.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.508 -1.223 . . . . 0.46 107.839 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.624 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.2 p -147.29 147.35 17.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.808 0.693 . . . . 1.04 110.672 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -130.45 103.48 6.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.993 0.902 . . . . 1.54 108.664 166.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.84 166.15 15.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.257 -0.883 . . . . 0.67 109.189 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.91 102.74 14.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 0.44 110.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.51 167.18 37.6 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.726 -0.67 . . . . 0.29 111.449 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -103.31 139.71 38.38 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.909 -0.76 . . . . 0.4 109.648 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.758 ' HB3' ' HG ' ' A' ' 107' ' ' LEU . 7.2 t-80 -113.62 104.54 12.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.847 -0.615 . . . . 0.4 110.418 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.42 109.44 21.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.177 -0.675 . . . . 0.35 109.177 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.41 104.35 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.123 -0.49 . . . . 0.59 111.12 -171.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 2.8 m-20 -106.19 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.018 -0.734 . . . . 1.53 109.018 175.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 38' ' ' PHE . 85.6 mt -106.4 124.85 50.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.663 -0.699 . . . . 0.24 110.127 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.44 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.2 m -103.54 118.31 36.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.529 0.681 . . . . 0.29 111.381 -171.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.524 ' CE1' ' HA ' ' A' ' 35' ' ' ALA . 53.4 t80 -82.6 90.2 6.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.11 109.408 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.541 ' HA ' ' HD2' ' A' ' 34' ' ' PHE . 25.9 mtm -120.86 158.66 27.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.65 111.434 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -70.48 105.45 1.22 Allowed Pre-proline 0 C--O 1.219 -0.503 0 N-CA-C 108.034 -1.099 . . . . 2.59 108.034 167.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.562 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 10.0 Cg_endo -51.83 -27.49 27.46 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.373 2.715 . . . . 1.04 114.789 -169.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.562 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 44.2 p90 -94.58 4.59 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 1.17 111.774 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.5 t -167.99 -74.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.521 -0.309 . . . . 1.09 110.317 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 94' ' ' THR . . . 68.19 75.95 0.46 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.422 -0.418 . . . . 1.16 112.944 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HG2' ' HZ ' ' A' ' 34' ' ' PHE . 1.8 Cg_endo -45.23 117.4 1.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.885 2.39 . . . . 1.2 111.081 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -55.23 -39.18 69.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.404 -0.816 . . . . 2.64 112.521 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -83.78 -19.19 35.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.616 0.246 . . . . 4.09 111.219 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -93.38 -5.96 48.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.688 0.756 . . . . 1.67 109.343 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.9 m -90.75 145.97 24.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 1.39 110.643 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -98.43 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.332 -0.988 . . . . 1.91 108.332 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 26.9 ttt180 -146.74 141.66 26.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.907 0.861 . . . . 0.62 110.968 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.819 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 1.3 t80 -102.75 154.94 18.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.208 -1.36 . . . . 0.86 108.468 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 90.8 m -156.61 102.14 2.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.645 -0.422 . . . . 0.31 111.179 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.819 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.9 p -104.74 135.96 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 119.913 -0.715 . . . . 0.88 109.984 168.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 13' ' ' THR . 94.3 m-85 -104.57 107.59 18.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.289 -0.869 . . . . 0.7 109.036 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.758 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 1.7 pp -128.86 152.76 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.223 -0.658 . . . . 2.12 109.223 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.812 ' O ' HG22 ' A' ' 16' ' ' VAL . 18.6 ttmm -105.17 117.56 34.31 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.334 -0.617 . . . . 1.89 109.334 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.03 110.39 22.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.951 -0.388 . . . . 0.53 109.951 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 25.4 p-10 . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.359 -0.837 . . . . 1.78 110.139 -170.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.927 ' HB3' HG22 ' A' ' 22' ' ' VAL . 70.2 t60 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.844 -0.798 . . . . 0.59 108.844 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -140.7 140.54 34.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.847 0.356 . . . . 2.36 110.585 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.839 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -106.09 132.26 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.397 -0.521 . . . . 0.49 110.959 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 p -113.74 169.78 8.73 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.091 -0.959 . . . . 0.51 110.155 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -41.01 -40.63 1.47 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.86 1.059 . . . . 0.83 113.86 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.88 61.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.672 0.749 . . . . 0.33 111.598 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.839 ' HB2' HG13 ' A' ' 5' ' ' VAL . 52.1 m80 -67.56 -1.74 5.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 2.12 111.583 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 3.3 t30 -48.33 -17.93 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.517 0.511 . . . . 1.41 109.674 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.88 56.74 0.64 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.507 -0.769 . . . . 0.3 111.716 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.028 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -106.54 157.83 17.38 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.662 0.986 . . . . 0.32 113.662 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 29.4 m -153.77 103.59 2.62 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.332 -0.849 . . . . 0.95 109.282 168.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.3 pt? -164.12 169.79 17.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 3.0 111.761 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 108' ' ' LYS . 88.9 m -100.7 145.95 27.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 1.73 111.054 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -119.74 152.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.478 -0.783 . . . . 0.78 110.701 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.36 108.02 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.551 -0.537 . . . . 0.76 109.551 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.679 HG12 HG21 ' A' ' 22' ' ' VAL . 34.4 m -86.63 -169.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.017 0.437 . . . . 1.23 111.99 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 116.31 -50.51 0.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.71 111.296 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.18 -77.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.286 0.565 . . . . 2.35 110.082 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -166.89 120.51 1.02 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.348 -0.842 . . . . 0.71 110.261 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' A' ' 3' ' ' HIS . 6.9 t -111.63 104.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.4 110.06 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.75 160.94 15.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.005 0.907 . . . . 1.09 112.183 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 85' ' ' VAL . 17.7 mm -130.37 101.58 5.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.647 -1.615 . . . . 0.54 107.828 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -108.46 143.31 37.6 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.299 0.571 . . . . 0.64 110.923 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -128.34 142.08 43.5 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.839 -0.619 . . . . 0.85 110.619 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 73.1 Cg_endo -77.41 6.14 4.62 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.35 111.671 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.733 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 11.2 t 68.39 -55.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.249 0.968 . . . . 0.91 110.129 -172.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.4 m-80 54.7 57.82 11.69 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.339 -1.356 . . . . 1.39 107.339 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.56 108.12 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.326 2.684 . . . . 0.83 113.139 -161.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' CE2' ' A' ' 89' ' ' TYR . 3.5 t -132.54 104.29 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.285 -1.325 . . . . 1.83 110.023 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 33' ' ' GLY . 3.8 m 72.15 -177.13 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.6 -0.727 . . . . 2.36 110.075 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.678 ' H ' HG22 ' A' ' 32' ' ' THR . . . -61.49 -15.98 48.41 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 118.505 0.593 . . . . 1.3 114.332 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.826 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 1.2 m-85 -62.26 155.41 24.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.545 0.572 . . . . 2.22 112.545 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.51 160.4 43.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.116 -0.947 . . . . 0.44 108.832 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.733 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.19 117.5 20.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.635 0.731 . . . . 0.43 111.537 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.61 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 66.2 m-85 -125.61 -176.68 3.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.955 -1.128 . . . . 2.78 107.955 168.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.648 ' HA ' HD23 ' A' ' 87' ' ' LEU . 1.3 m-85 -74.12 -77.95 0.11 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.794 -0.762 . . . . 0.43 109.178 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -114.3 10.56 17.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.699 -0.682 . . . . 2.39 110.46 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.494 ' HA3' ' HE1' ' A' ' 90' ' ' MET . . . 96.57 106.11 2.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.73 112.351 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.08 -3.46 51.81 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.7 112.414 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -128.69 142.94 50.86 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.806 0.336 . . . . 1.13 111.869 -178.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.622 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.06 132.96 27.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.316 -0.856 . . . . 2.52 110.532 164.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.98 154.05 51.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.234 0.54 . . . . 2.3 111.114 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.82 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 41.0 t -104.92 131.2 22.01 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.638 -0.875 . . . . 1.61 108.638 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.65 -25.67 20.76 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.487 2.791 . . . . 1.88 113.286 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.531 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 46.8 m-20 -139.7 81.7 1.84 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 2.43 109.957 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.0 pt-20 -117.61 58.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.599 0.714 . . . . 3.26 110.854 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -80.94 -60.04 2.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.559 -0.746 . . . . 2.06 111.246 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.801 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.96 -29.21 8.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.589 0.709 . . . . 1.25 109.961 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.801 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 6.3 m-85 -105.64 165.01 11.46 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.908 -1.042 . . . . 0.74 108.795 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -153.84 167.54 29.34 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.942 -0.703 . . . . 1.46 112.587 -163.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.99 134.0 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.383 -0.826 . . . . 1.31 111.547 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.25 155.35 18.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.986 -1.006 . . . . 2.45 109.294 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 4.6 p-10 -125.13 146.58 49.41 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.937 -0.574 . . . . 1.93 110.878 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' HD2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -164.84 103.91 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.42 110.049 178.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.898 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -118.87 128.56 54.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.701 0.762 . . . . 1.66 111.699 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 42.7 m-85 -132.54 104.38 13.29 Favored Pre-proline 0 C--O 1.211 -0.952 0 CA-C-N 114.531 -1.213 . . . . 2.14 107.755 174.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 22.6 Cg_endo -102.34 55.35 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.346 0 N-CA-C 116.888 1.842 . . . . 1.92 116.888 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.958 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 52.0 Cg_exo -62.84 -179.61 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.933 2.422 . . . . 2.64 113.687 164.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.636 ' CB ' ' HB2' ' A' ' 65' ' ' LEU . 19.0 t70 -154.05 -117.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.305 -1.316 . . . . 5.8 109.015 -165.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.8 m -153.0 -48.31 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 7.43 110.416 173.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.89 2.74 56.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.825 0.676 . . . . 8.71 112.825 -173.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.725 HD12 HD22 ' A' ' 65' ' ' LEU . 2.8 tm? -159.32 -71.98 0.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.571 -0.529 . . . . 8.1 109.571 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.958 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 3.8 mm? -60.69 -46.38 90.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.296 -0.865 . . . . 4.74 109.742 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' N ' ' H ' ' A' ' 61' ' ' ASP . . . 88.27 -64.47 3.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 116.775 1.47 . . . . 3.02 116.775 158.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' HB3' ' CG ' ' A' ' 60' ' ' PRO . . . -53.53 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.306 0.854 . . . . 4.02 113.306 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.735 ' N ' ' HB2' ' A' ' 60' ' ' PRO . . . -170.5 116.19 0.63 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.002 -1.239 . . . . 2.84 110.002 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.89 126.15 40.04 Favored Glycine 0 CA--C 1.511 -0.172 0 C-N-CA 120.803 -0.713 . . . . 1.49 112.725 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.431 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -161.47 83.77 0.62 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.777 0.658 . . . . 0.97 112.777 -175.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 30.3 mt-10 -104.79 104.83 14.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.447 -0.946 . . . . 0.81 108.447 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -115.43 149.28 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.394 -0.922 . . . . 0.53 112.157 -173.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.61 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 41.4 m-85 -109.13 114.64 28.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.484 -1.689 . . . . 1.13 108.476 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.551 ' CD2' ' HD2' ' A' ' 56' ' ' LYS . 5.5 m170 -104.27 109.36 21.17 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.86 -0.525 . . . . 0.5 111.11 -173.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.56 HG21 ' HE2' ' A' ' 83' ' ' HIS . 64.3 t -103.04 110.35 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.633 0.73 . . . . 0.87 110.071 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 23.2 m -101.99 105.31 16.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.93 -1.137 . . . . 0.46 107.93 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 7.3 p -150.89 151.68 12.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.804 -0.634 . . . . 1.04 110.669 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -135.31 103.61 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.838 0.828 . . . . 1.54 109.422 166.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.3 158.06 13.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.596 -0.729 . . . . 0.67 109.307 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 110' ' ' ASN . . . -84.39 95.28 8.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.484 0.659 . . . . 0.44 110.217 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -146.45 169.54 27.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.219 -0.9 . . . . 0.29 111.679 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -107.38 130.0 54.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.296 -0.631 . . . . 0.4 109.296 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 43.3 t-80 -104.11 102.51 12.25 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.28 -0.262 . . . . 0.4 110.324 -172.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.16 128.67 50.03 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.322 -0.622 . . . . 0.35 109.322 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -128.66 103.88 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 120.801 -0.36 . . . . 0.59 111.656 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 102' ' ' ARG . 2.4 m120 -109.03 103.26 12.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.481 -0.933 . . . . 1.53 108.481 171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 38' ' ' PHE . 91.9 mt -103.83 122.34 44.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 0.24 109.566 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.64 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.2 m -101.31 117.86 35.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.816 0.817 . . . . 0.29 110.941 -171.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.826 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -84.43 92.43 8.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.629 -1.168 . . . . 1.11 109.425 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.639 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 12.6 mtm -128.72 165.05 21.65 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.433 -0.349 . . . . 0.65 110.185 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' PHE . 9.3 ttm180 -67.02 106.47 1.19 Allowed Pre-proline 0 C--O 1.213 -0.819 0 N-CA-C 107.954 -1.128 . . . . 2.59 107.954 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.524 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 4.4 Cg_endo -44.96 -30.92 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 124.067 3.178 . . . . 1.04 115.25 -168.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.524 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 36.9 p90 -95.24 5.67 51.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.395 0.517 . . . . 1.17 112.395 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -164.99 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.568 0.21 . . . . 1.09 111.568 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 63.86 86.95 0.05 OUTLIER Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.869 -0.492 . . . . 1.16 111.869 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 1.051 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 29.1 Cg_exo -57.32 118.4 5.26 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.269 1.98 . . . . 1.2 110.042 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.3 t -49.4 -53.38 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.726 0.641 . . . . 2.64 112.465 -167.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -92.19 5.51 50.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.951 0.405 . . . . 4.09 110.645 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.051 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 27.2 t70 -112.99 1.24 15.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 1.67 109.878 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -98.86 171.5 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.594 -0.73 . . . . 1.39 111.457 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.687 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.1 tp10 -115.39 170.88 8.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.831 -0.803 . . . . 1.91 108.831 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.64 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 34.8 ttt180 -157.18 141.69 16.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.821 0.819 . . . . 0.62 111.184 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.805 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -104.36 157.74 16.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.313 -1.312 . . . . 0.86 108.594 177.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.0 m -157.85 102.48 1.84 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.514 . . . . 0.31 111.306 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.2 p -103.66 134.48 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.482 -0.562 . . . . 0.88 109.482 169.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' THR . 72.0 m-85 -105.21 112.7 25.92 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.138 -0.69 . . . . 0.7 109.138 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.695 ' HG ' HG22 ' A' ' 105' ' ' VAL . 77.8 mt -127.85 164.9 21.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.011 -0.995 . . . . 2.12 110.024 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 16' ' ' VAL . 58.4 tttm -119.99 113.85 21.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.385 -0.969 . . . . 1.89 108.385 172.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 83' ' ' HIS . . . -101.14 106.83 18.11 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.908 -0.405 . . . . 0.53 109.908 -171.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.631 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.135 -0.936 . . . . 1.78 110.437 -168.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.959 ' HB3' HG22 ' A' ' 22' ' ' VAL . 8.7 t-80 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.59 108.798 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 21.5 pttp -149.55 150.44 32.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.702 0.287 . . . . 2.36 111.423 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.003 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -120.11 136.3 57.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.433 0.635 . . . . 0.49 111.961 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p -120.33 170.34 9.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.785 -1.098 . . . . 0.51 110.473 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 16.7 tptm -35.62 -48.6 0.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.692 1.368 . . . . 0.83 114.692 -171.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.59 -33.32 60.19 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.601 0.715 . . . . 0.33 111.817 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.831 ' HB2' HG13 ' A' ' 5' ' ' VAL . 75.0 m80 -64.75 -2.32 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 2.12 111.227 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.526 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 3.4 t30 -45.57 -22.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.332 0.653 . . . . 1.41 109.995 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.42 54.0 0.66 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.5 -0.773 . . . . 0.3 111.357 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.944 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -116.76 156.03 27.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.654 0.613 . . . . 0.32 112.654 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 39.4 m -145.95 112.91 6.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.394 -0.821 . . . . 0.95 109.433 173.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -157.88 167.62 29.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 3.0 111.347 -173.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.8 m -101.52 146.59 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.724 0.297 . . . . 1.73 111.107 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.1 m -131.76 162.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.78 110.936 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.78 137.88 51.89 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.66 -1.237 . . . . 0.76 107.66 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.821 HG12 ' H ' ' A' ' 19' ' ' GLY . 1.6 t -121.06 -164.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 119.892 -0.723 . . . . 1.23 110.25 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.821 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 124.31 -48.87 0.93 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.765 -0.934 . . . . 0.71 110.765 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -84.43 -71.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.292 0.568 . . . . 2.35 109.685 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -165.46 144.38 6.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.246 -0.888 . . . . 0.71 110.096 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.959 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.1 t -123.14 120.11 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 109.341 -0.615 . . . . 0.4 109.341 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 49.8 mt-10 -103.8 151.53 22.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.933 0.873 . . . . 1.09 112.442 -171.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.713 HD13 ' HB ' ' A' ' 5' ' ' VAL . 41.6 mm -133.88 137.74 51.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.227 -1.768 . . . . 0.54 106.227 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.9 OUTLIER -145.4 142.12 29.05 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.662 -0.649 . . . . 0.64 111.217 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -117.25 144.72 34.37 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.28 -0.873 . . . . 0.85 109.181 169.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 73.8 Cg_endo -82.63 12.52 2.87 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 C-N-CA 122.862 2.375 . . . . 0.35 111.515 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.746 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.1 t 68.11 -44.99 0.5 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.982 0.913 . . . . 0.91 112.257 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 31' ' ' THR . 1.2 p-10 41.89 78.81 0.36 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.443 0.64 . . . . 1.39 110.777 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.574 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 25.9 Cg_exo -63.97 109.98 1.22 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.357 2.705 . . . . 0.83 112.111 -169.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 29' ' ' ASN . 1.3 t -142.46 117.15 9.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.724 -0.671 . . . . 1.83 111.534 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.7 m 73.52 -42.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.478 0.656 . . . . 2.36 112.314 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 31' ' ' THR . . . 162.72 -118.58 0.83 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 107.72 -2.152 . . . . 1.3 107.72 -172.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.764 ' HA ' ' C ' ' A' ' 90' ' ' MET . 8.5 m-30 61.77 178.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.577 0.703 . . . . 2.22 111.607 167.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -174.35 144.79 0.95 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.634 -1.247 . . . . 0.44 107.634 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.746 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 94.8 m95 -76.97 99.07 5.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.359 0.6 . . . . 0.43 110.848 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.47 179.76 4.18 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.736 -1.209 . . . . 2.78 107.736 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -68.64 -69.03 0.35 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.628 -0.829 . . . . 0.43 109.372 167.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.52 13.33 3.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 2.39 110.44 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.21 112.05 3.3 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.613 -0.803 . . . . 0.73 113.101 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 4.26 34.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.475 -0.393 . . . . 0.7 113.03 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 p -139.94 144.63 37.18 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 112.425 0.528 . . . . 1.13 112.425 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.534 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -142.23 127.68 18.92 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.901 -1.045 . . . . 2.52 110.122 167.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.92 145.0 51.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.071 0.463 . . . . 2.3 110.781 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -111.86 135.89 21.2 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.073 -0.714 . . . . 1.61 109.073 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 36.9 Cg_exo -61.51 128.78 25.76 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.278 1.986 . . . . 1.88 111.457 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 72.19 30.76 2.04 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.954 0.784 . . . . 2.43 112.149 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.18 45.72 1.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.579 0.704 . . . . 3.26 110.985 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -81.29 -19.56 42.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.541 -0.754 . . . . 2.06 111.339 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.4 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 17.5 ptt? -138.76 -35.82 0.57 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.748 0.785 . . . . 1.25 109.964 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.853 ' HB3' ' O ' ' A' ' 76' ' ' THR . 8.4 m-85 -106.2 166.19 10.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.74 108.443 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -153.03 167.11 30.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.767 0.712 . . . . 1.46 112.623 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.9 p -103.34 141.57 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.252 -0.886 . . . . 1.31 111.671 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -116.36 137.94 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 2.45 109.614 173.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -110.64 159.17 17.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.753 0.311 . . . . 1.93 111.386 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.64 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -158.24 117.22 3.13 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.264 -0.426 . . . . 1.42 109.977 175.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 2.6 m-85 -123.51 106.46 10.63 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.296 -0.562 . . . . 1.66 109.794 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -124.99 104.75 29.6 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 116.335 -0.393 . . . . 2.14 111.661 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.93 169.5 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.867 2.378 . . . . 1.92 112.617 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HG3' ' C ' ' A' ' 68' ' ' GLY . 52.4 Cg_exo -52.03 -172.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.94 3.093 . . . . 2.64 116.089 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 62' ' ' SER . 32.1 t70 -166.55 -155.78 0.22 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.791 -2.004 . . . . 5.8 106.856 -173.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.529 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 46.3 p -99.6 -44.67 6.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.654 -0.499 . . . . 7.43 109.654 169.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.739 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.41 -24.82 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.303 0.483 . . . . 8.71 112.303 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.739 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 1.5 tm? -54.43 -57.52 10.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.929 -0.767 . . . . 8.1 108.929 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.837 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.3 OUTLIER -139.2 -59.59 0.58 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.153 -1.055 . . . . 4.74 108.153 172.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 61' ' ' ASP . . . 84.1 -59.93 4.89 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.575 -1.193 . . . . 3.02 113.082 171.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -52.66 64.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.843 0.83 . . . . 4.02 110.261 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.837 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -135.54 -163.55 10.06 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.5 -1.227 . . . . 2.84 110.504 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -96.63 -149.36 25.47 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.322 -0.942 . . . . 1.49 111.346 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.27 85.22 0.24 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.472 0.654 . . . . 0.97 110.344 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.767 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.0 mt-10 -113.58 104.66 12.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.534 -0.757 . . . . 0.81 108.991 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.64 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -110.77 165.42 11.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.753 0.787 . . . . 0.53 111.436 -170.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.482 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 60.0 m-85 -136.57 104.51 5.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.98 -1.464 . . . . 1.13 109.128 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.626 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 40.1 m170 -102.79 113.84 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.958 -0.464 . . . . 0.5 109.86 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 m -103.91 125.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 122.135 0.969 . . . . 0.87 110.079 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.853 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 3.7 m -103.82 103.54 13.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.101 -1.444 . . . . 0.46 107.101 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.653 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.1 p -157.25 129.94 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 123.292 0.37 . . . . 1.04 111.033 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -123.2 102.55 8.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.497 0.665 . . . . 1.54 110.606 176.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.68 140.42 4.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.52 -0.764 . . . . 0.67 109.757 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -64.61 87.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.61 0.569 . . . . 0.44 111.484 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.87 166.48 32.96 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 110.693 -0.963 . . . . 0.29 110.693 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.0 OUTLIER -101.0 136.01 41.53 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.773 -0.771 . . . . 0.4 109.228 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.499 ' O ' HD13 ' A' ' 107' ' ' LEU . 55.8 t-80 -101.63 102.42 13.11 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.836 -0.802 . . . . 0.4 108.836 -174.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.21 103.7 13.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.188 -0.671 . . . . 0.35 109.188 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.1 p -106.52 109.36 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.662 -0.699 . . . . 0.59 111.291 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 3.0 m-20 -107.21 103.76 13.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.863 -1.062 . . . . 1.53 108.932 176.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 38' ' ' PHE . 76.3 mt -106.2 128.39 53.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.258 -0.428 . . . . 0.24 110.142 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 90' ' ' MET . 3.2 m -104.51 130.84 52.41 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.931 0.396 . . . . 0.29 110.579 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.626 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 40.6 t80 -96.23 93.82 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.283 -0.636 . . . . 1.11 109.283 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.764 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -131.16 158.43 40.5 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.506 -0.316 . . . . 0.65 110.623 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.643 ' N ' ' HA ' ' A' ' 34' ' ' PHE . 41.5 mtt180 -58.65 108.8 1.45 Allowed Pre-proline 0 CA--C 1.512 -0.51 0 O-C-N 124.083 0.864 . . . . 2.59 110.083 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 7.0 Cg_exo -38.38 -37.97 0.79 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.903 3.735 . . . . 1.04 115.083 -174.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -91.92 1.27 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.131 0.789 . . . . 1.17 113.131 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.8 t -158.52 -62.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.071 -0.393 . . . . 1.09 111.43 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.623 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.34 93.56 0.23 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.958 -0.639 . . . . 1.16 113.263 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.824 ' HB2' ' HB2' ' A' ' 99' ' ' ASP . 17.4 Cg_exo -69.22 97.54 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.587 2.192 . . . . 1.2 110.008 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.6 m -62.52 -25.1 67.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.655 0.74 . . . . 2.64 109.095 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -59.24 -32.26 69.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.839 -1.073 . . . . 4.09 110.618 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.824 ' HB2' ' HB2' ' A' ' 96' ' ' PRO . 1.5 m-20 -109.34 -105.45 0.36 Allowed 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.679 -0.237 . . . . 1.67 110.598 -174.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.9 p 49.28 -179.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.106 1.15 . . . . 1.39 114.106 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.28 137.89 30.96 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.748 -1.204 . . . . 1.91 107.748 165.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -121.21 142.87 49.49 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.786 -0.765 . . . . 0.62 111.565 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.617 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 1.1 t80 -104.38 153.9 20.5 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.216 -1.357 . . . . 0.86 108.989 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 54.2 m -161.03 103.84 1.3 Allowed 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.147 0.28 . . . . 0.31 110.317 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.003 HG11 HG21 ' A' ' 5' ' ' VAL . 7.5 p -110.08 136.6 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 118.15 -1.42 . . . . 0.88 109.877 168.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' THR . 79.4 m-85 -103.94 101.95 11.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.799 -1.092 . . . . 0.7 108.15 175.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.774 HD12 HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -124.49 142.62 51.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.438 -0.949 . . . . 2.12 108.438 176.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.721 ' O ' HG22 ' A' ' 16' ' ' VAL . 78.3 tttt -101.89 122.77 44.64 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.369 -0.532 . . . . 1.89 110.507 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.98 159.18 15.58 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.692 0.62 . . . . 0.53 110.71 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.527 ' H ' HG23 ' A' ' 18' ' ' VAL . 2.8 p-10 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.353 -0.832 . . . . 1.78 109.553 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.707 ' NE2' HD13 ' A' ' 107' ' ' LEU . 20.2 t60 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 121.487 0.66 . . . . 0.59 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 20.1 pttp -149.71 141.14 23.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 2.36 110.771 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.84 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -103.22 140.15 22.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.49 110.562 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -121.71 169.05 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.503 -0.772 . . . . 0.51 109.73 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -38.0 -47.01 1.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.335 1.235 . . . . 0.83 114.335 -171.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.55 61.83 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.47 0.652 . . . . 0.33 111.871 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.824 ' HB2' HG13 ' A' ' 5' ' ' VAL . 47.9 m80 -62.57 -3.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.629 . . . . 2.12 111.672 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.494 ' OD1' ' HA ' ' A' ' 103' ' ' PHE . 19.2 t30 -46.91 -19.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.145 0.578 . . . . 1.41 110.171 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.33 51.87 0.74 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.955 -0.641 . . . . 0.3 112.078 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 1.077 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -106.03 162.3 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.513 0.931 . . . . 0.32 113.513 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 85.7 m -153.74 103.76 2.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.336 -0.847 . . . . 0.95 109.134 170.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 6.5 tt -156.06 164.26 38.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 110.141 -0.318 . . . . 3.0 110.141 -170.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 m -103.15 140.91 36.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 1.73 111.414 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.6 m -116.97 158.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.78 111.372 -174.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.77 121.28 44.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 0.76 109.586 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.615 HG22 ' C ' ' A' ' 110' ' ' ASN . 17.6 m -108.26 -173.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.23 111.271 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 130.11 -56.65 0.74 Allowed Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 111.244 -0.742 . . . . 0.71 111.244 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.35 -68.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.333 0.587 . . . . 2.35 109.654 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -165.99 141.38 4.8 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 114.863 -1.062 . . . . 0.71 109.179 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 3' ' ' HIS . 0.9 OUTLIER -117.65 126.63 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 110.003 -0.369 . . . . 0.4 110.003 173.164 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 21.2 mt-10 -103.34 142.83 33.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.882 0.849 . . . . 1.09 112.732 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.643 HG21 HG11 ' A' ' 85' ' ' VAL . 41.7 mm -124.45 101.06 8.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.321 -1.363 . . . . 0.54 107.321 165.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -108.93 138.24 45.58 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.492 0.663 . . . . 0.64 111.781 -169.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -119.58 144.77 37.54 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.517 -0.765 . . . . 0.85 109.441 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.543 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 36.7 Cg_endo -86.78 13.86 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.682 2.255 . . . . 0.35 111.66 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.714 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 34.3 t 67.6 -49.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.314 -0.857 . . . . 0.91 111.62 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.543 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER 50.45 57.05 17.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.185 -1.043 . . . . 1.39 108.185 -172.414 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 83.2 Cg_exo -50.11 119.59 5.11 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.88 3.054 . . . . 0.83 114.156 -163.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' CE2' ' A' ' 89' ' ' TYR . 10.8 p -98.35 -53.37 3.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.19 -0.914 . . . . 1.83 110.138 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.632 HG23 ' HD1' ' A' ' 34' ' ' PHE . 2.7 t -171.18 -115.76 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.048 -0.524 . . . . 2.36 109.976 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -14.95 79.58 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.211 -0.519 . . . . 1.3 112.561 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.632 ' HD1' HG23 ' A' ' 32' ' ' THR . 3.7 m-85 -67.94 145.92 54.08 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.094 0.558 . . . . 2.22 110.316 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.81 157.41 43.17 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.74 -0.467 . . . . 0.44 109.74 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.714 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.6 m95 -77.26 113.31 14.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.413 0.625 . . . . 0.43 111.017 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 46.5 m-85 -125.48 175.36 7.57 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.544 -1.28 . . . . 2.78 107.544 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.4 m-85 -65.17 -65.69 0.64 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.465 -0.894 . . . . 0.43 109.532 170.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.71 21.59 3.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.997 -0.547 . . . . 2.39 110.59 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.79 92.64 1.58 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.466 -0.873 . . . . 0.73 113.276 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.99 -8.92 76.56 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.764 -0.731 . . . . 0.7 112.628 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -128.4 143.92 51.07 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 111.906 0.336 . . . . 1.13 111.906 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.618 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -140.99 139.43 34.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.254 -0.884 . . . . 2.52 110.383 172.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.39 145.29 33.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.979 0.419 . . . . 2.3 111.594 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.756 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 40.2 m -104.76 137.02 19.1 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 1.61 109.556 173.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 31.2 Cg_exo -60.35 -22.46 71.2 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.208 2.605 . . . . 1.88 113.421 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -119.72 24.66 10.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.436 0.16 . . . . 2.43 111.408 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 6.5 pt-20 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.946 0.879 . . . . 3.26 111.074 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 m -160.45 -49.62 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.469 -1.308 . . . . 2.06 107.469 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.514 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -103.46 -41.04 6.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.551 -1.204 . . . . 1.25 109.233 173.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.67 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.9 m-85 -105.62 165.75 10.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.113 -0.949 . . . . 0.74 108.535 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -163.7 170.32 17.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.46 111.575 -168.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' A' ' 75' ' ' VAL . 2.2 p -102.11 135.0 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.61 -0.723 . . . . 1.31 111.37 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 1.3 pm0 -120.1 136.31 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.55 -0.907 . . . . 2.45 108.55 170.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -103.23 153.82 19.98 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.845 -0.742 . . . . 1.93 111.494 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 108.82 3.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.011 -0.995 . . . . 1.42 109.376 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.838 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -114.75 135.1 54.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.782 -0.644 . . . . 1.66 110.621 -174.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -135.78 97.17 12.78 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.559 -0.291 . . . . 2.14 110.307 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -75.0 165.53 31.13 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.71 2.273 . . . . 1.92 111.058 168.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 18.1 Cg_exo -39.94 135.19 1.59 Allowed 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 124.002 3.135 . . . . 2.64 115.339 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -135.16 -69.65 0.5 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.625 -2.08 . . . . 5.8 107.878 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 t 178.53 -71.32 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.876 -1.511 . . . . 7.43 109.672 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.641 ' HD2' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.93 -32.66 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.365 . . . . 8.71 111.024 -177.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.641 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 87.2 mt -56.66 -63.88 1.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.152 -1.055 . . . . 8.1 108.152 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.887 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -155.92 123.62 5.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.719 -1.586 . . . . 4.74 106.719 166.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.03 -38.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.443 -0.884 . . . . 3.02 111.559 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.29 88.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.36 0.6 . . . . 4.02 110.983 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.887 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -153.0 -153.93 6.53 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.294 -1.122 . . . . 2.84 110.294 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.67 -178.05 18.92 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.906 -1.14 . . . . 1.49 111.955 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.39 81.3 0.97 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.485 0.659 . . . . 0.97 110.98 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.838 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 31.4 mt-10 -104.27 104.04 13.88 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.576 -0.898 . . . . 0.81 108.576 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -108.94 150.13 28.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.517 -0.873 . . . . 0.53 110.837 -175.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.604 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 10.0 m-85 -109.56 115.08 29.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.167 -1.379 . . . . 1.13 108.95 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 15.8 m170 -104.24 108.24 19.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.341 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 22' ' ' VAL . 4.2 m -103.45 117.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.175 0.988 . . . . 0.87 108.777 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 68.0 m -102.62 103.71 14.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.978 -1.119 . . . . 0.46 107.978 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 2.9 p -154.76 144.57 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.515 -0.766 . . . . 1.04 110.619 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.1 103.05 6.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.822 0.82 . . . . 1.54 109.006 165.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.79 134.72 2.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.375 -0.83 . . . . 0.67 110.522 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -65.14 102.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.757 0.66 . . . . 0.44 111.367 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.49 167.2 38.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.152 -1.179 . . . . 0.29 110.152 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.8 m -101.85 131.54 48.14 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 118.055 0.927 . . . . 0.4 109.436 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.568 ' ND1' HG22 ' A' ' 85' ' ' VAL . 32.5 t-80 -103.96 102.96 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.948 -0.39 . . . . 0.4 109.948 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.85 122.13 43.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.014 -0.735 . . . . 0.35 109.014 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.0 t -113.97 109.87 30.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.134 -0.485 . . . . 0.59 111.696 -170.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -109.68 104.09 13.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.223 -0.658 . . . . 1.53 109.223 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 38' ' ' PHE . 82.5 mt -108.49 121.34 44.76 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.24 110.004 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 2.6 m -102.35 118.9 37.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.397 0.617 . . . . 0.29 110.657 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.605 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 53.9 t80 -86.01 91.22 8.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.942 -1.026 . . . . 1.11 109.606 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.725 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 3.2 mtm -131.7 165.13 24.42 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.506 -0.316 . . . . 0.65 110.473 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.532 ' HB2' ' H ' ' A' ' 95' ' ' GLY . 70.5 mtt180 -57.28 112.54 4.79 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.48 -0.933 . . . . 2.59 108.48 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -52.06 -24.81 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.236 2.624 . . . . 1.04 114.504 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.533 ' CD1' HG22 ' A' ' 94' ' ' THR . 47.6 p90 -96.94 2.77 52.01 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.881 0.326 . . . . 1.17 111.881 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.3 t -173.84 -67.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.483 -0.135 . . . . 1.09 111.309 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.725 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 77.87 89.81 0.35 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.843 -0.694 . . . . 1.16 112.065 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 11.0 Cg_exo -37.31 113.26 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.487 2.792 . . . . 1.2 111.718 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 t -75.94 9.85 2.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 2.64 111.944 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -130.12 4.37 4.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.122 -0.325 . . . . 4.09 110.122 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 22.8 t0 -127.05 0.82 6.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.203 0.525 . . . . 1.67 110.916 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 m -87.91 148.27 24.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.045 -0.525 . . . . 1.39 111.084 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.5 tp10 -100.8 169.36 9.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 1.91 108.812 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 33.5 ttt180 -153.8 140.01 18.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.806 0.812 . . . . 0.62 110.703 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.84 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 2.5 t80 -104.13 156.87 17.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.278 -1.328 . . . . 0.86 108.668 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 66.9 m -158.8 101.18 1.63 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 120.885 0.374 . . . . 0.31 110.121 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.077 HG23 ' HB3' ' A' ' 12' ' ' ALA . 9.3 p -104.65 134.7 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 119.793 -0.763 . . . . 0.88 109.73 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 13' ' ' THR . 91.1 m-85 -104.07 113.99 27.93 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.7 108.605 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 3' ' ' HIS . 17.3 mt -137.7 165.08 27.26 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.835 -0.62 . . . . 2.12 109.753 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.766 ' O ' HG22 ' A' ' 16' ' ' VAL . 78.5 tttt -119.76 124.4 46.07 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.47 -0.492 . . . . 1.89 110.237 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.427 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.62 127.24 48.44 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.397 0.436 . . . . 0.53 110.066 -172.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.615 ' C ' HG22 ' A' ' 18' ' ' VAL . 19.6 p-10 . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.648 -0.705 . . . . 1.78 109.977 -174.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 1.009 ' HB3' HG22 ' A' ' 22' ' ' VAL . 28.4 t60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.415 -0.587 . . . . 0.59 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -144.05 141.14 29.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.24 -0.436 . . . . 2.36 110.606 177.567 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.846 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -106.25 134.12 48.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.49 111.525 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.76 168.47 9.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.136 -0.938 . . . . 0.51 110.289 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 25.7 tptp -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.298 1.592 . . . . 0.83 115.298 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.23 -30.87 60.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.77 0.714 . . . . 0.33 111.757 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.837 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.9 m80 -66.06 -2.26 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.659 -0.7 . . . . 2.12 111.267 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.668 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -49.48 -17.24 0.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.165 -0.68 . . . . 1.41 109.165 171.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.93 50.08 0.68 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.96 -0.563 . . . . 0.3 111.787 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -110.18 158.08 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.198 0.814 . . . . 0.32 113.198 -173.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 91.7 m -148.8 107.74 3.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.144 -0.935 . . . . 0.95 109.738 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pp -153.76 168.26 26.89 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 3.0 111.668 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.0 m -101.16 146.62 27.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.423 -0.353 . . . . 1.73 110.608 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 108' ' ' LYS . 6.0 m -129.45 160.78 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.105 0.478 . . . . 0.78 111.477 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.65 124.12 51.55 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.54 -0.911 . . . . 0.76 108.54 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.648 HG22 ' C ' ' A' ' 110' ' ' ASN . 22.5 m -102.49 -165.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.509 -0.476 . . . . 1.23 111.385 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 112.12 -50.38 0.77 Allowed Glycine 0 CA--C 1.504 -0.652 0 N-CA-C 111.041 -0.823 . . . . 0.71 111.041 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -75.61 -75.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.795 0.807 . . . . 2.35 109.132 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -166.64 140.48 3.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.521 -1.218 . . . . 0.71 109.349 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.009 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.7 t -123.57 104.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.586 0.708 . . . . 0.4 109.155 172.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.1 pt-20 -109.45 160.19 16.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.795 0.807 . . . . 1.09 111.568 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 5' ' ' VAL . 22.6 mm -134.68 104.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.072 -1.422 . . . . 0.54 108.624 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.618 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -110.04 139.26 45.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.533 0.682 . . . . 0.64 111.904 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.477 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.9 mm? -116.84 139.99 26.35 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 114.985 -1.007 . . . . 0.85 108.955 171.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 85.1 Cg_endo -79.06 8.77 3.64 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 122.824 2.349 . . . . 0.35 111.893 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.651 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 7.9 t 66.22 -63.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.03 0.831 . . . . 0.91 110.291 -173.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.406 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.1 m-80 60.81 65.42 2.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.059 -1.089 . . . . 1.39 108.059 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.66 112.86 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.875 3.05 . . . . 0.83 113.57 -165.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.545 HG23 ' CE2' ' A' ' 89' ' ' TYR . 38.7 p -80.7 -73.98 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.167 -1.378 . . . . 1.83 112.176 -174.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.445 ' H ' ' H ' ' A' ' 33' ' ' GLY . 6.3 t -171.19 -12.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.473 -0.785 . . . . 2.36 110.359 -174.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' H ' ' H ' ' A' ' 32' ' ' THR . . . 176.44 -33.93 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.39 -0.684 . . . . 1.3 111.39 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.556 ' HA ' ' C ' ' A' ' 90' ' ' MET . 45.7 m-85 -52.5 139.72 24.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.559 -0.32 . . . . 2.22 111.284 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -137.72 151.44 48.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 0.44 108.661 171.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.87 109.79 14.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.328 0.585 . . . . 0.43 111.415 -174.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 51.2 m-85 -114.67 177.53 4.61 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 108.395 -0.965 . . . . 2.78 108.395 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.776 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -70.02 -73.94 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.01 0.823 . . . . 0.43 109.466 169.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.43 -11.86 14.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.709 -0.678 . . . . 2.39 110.179 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.31 108.1 2.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.564 -0.827 . . . . 0.73 112.099 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.06 -16.92 7.94 Favored Glycine 0 CA--C 1.516 0.145 0 C-N-CA 120.987 -0.625 . . . . 0.7 112.648 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 m -128.97 142.09 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.886 -0.413 . . . . 1.13 109.886 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -139.91 141.56 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.522 -0.548 . . . . 2.52 109.522 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.45 164.35 28.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.607 0.718 . . . . 2.3 112.625 -172.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.851 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 15.9 p -135.23 128.41 18.39 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.61 108.996 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.9 150.36 86.49 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.635 2.223 . . . . 1.88 112.138 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.471 ' HB2' HG21 ' A' ' 77' ' ' VAL . 94.6 m-20 66.35 42.78 2.88 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.573 0.546 . . . . 2.43 110.574 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -88.72 31.15 0.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 3.26 111.304 -173.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -88.09 12.11 14.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.392 -0.367 . . . . 2.06 111.266 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.442 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 20.5 ptt? -175.27 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.627 . . . . 1.25 110.461 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.754 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.4 m-85 -122.5 162.87 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.121 -0.945 . . . . 0.74 109.297 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -159.65 167.88 27.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.342 0.592 . . . . 1.46 112.278 -164.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.5 p -103.09 139.34 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.311 -0.859 . . . . 1.31 111.401 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.702 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -112.43 142.93 44.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.194 -0.669 . . . . 2.45 109.194 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . 3.7 p-10 -111.16 161.32 16.08 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.959 -0.296 . . . . 1.93 111.229 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.786 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -165.14 111.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.881 -0.785 . . . . 1.42 108.881 171.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 5.7 m-85 -111.18 112.83 24.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.173 -0.611 . . . . 1.66 111.916 -173.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.707 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 90.5 m-85 -113.72 109.03 50.8 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.219 -0.9 . . . . 2.14 109.417 172.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 19.0 Cg_endo -104.46 55.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.381 2.72 . . . . 1.92 116.042 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 1.027 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 18.6 Cg_endo -94.99 172.03 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.251 2.634 . . . . 2.64 111.501 168.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 65' ' ' LEU . 19.9 t70 -132.41 -74.58 0.51 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.024 -0.535 . . . . 5.8 110.927 -167.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.788 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 33.9 p -173.65 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.215 -0.902 . . . . 7.43 111.538 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.48 -69.26 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.495 0.188 . . . . 8.71 110.931 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.649 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 71.3 mt -57.89 -65.66 0.6 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.939 0.876 . . . . 8.1 109.111 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.027 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 3.1 mm? -85.91 143.02 28.43 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.06 -2.2 . . . . 4.74 105.06 167.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.67 37.78 3.32 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 118.752 -1.69 . . . . 3.02 114.496 -156.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.788 ' HB2' ' HA ' ' A' ' 62' ' ' SER . . . 64.38 142.1 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.793 0.837 . . . . 4.02 112.195 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.8 25.26 3.13 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.388 -1.386 . . . . 2.84 112.206 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.918 ' HA2' ' HD2' ' A' ' 60' ' ' PRO . . . -55.79 108.36 1.06 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.419 -0.895 . . . . 1.49 111.805 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 69' ' ' GLY . 2.7 p -156.24 86.96 1.03 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.64 0.733 . . . . 0.97 112.349 -173.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.718 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 39.9 mt-10 -103.98 103.56 13.41 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.936 -1.135 . . . . 0.81 107.936 174.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.786 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 11.0 m-70 -105.03 150.59 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.719 0.771 . . . . 0.53 111.863 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 32.6 m-85 -125.2 104.5 8.54 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.912 -1.494 . . . . 1.13 108.679 172.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.702 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 23.3 m170 -102.52 104.27 14.68 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.159 -0.312 . . . . 0.5 110.159 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -101.9 114.57 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.609 1.195 . . . . 0.87 109.479 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 27.7 m -101.61 104.72 15.6 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.248 -1.342 . . . . 0.46 107.904 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.565 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 6.1 p -149.04 148.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 124.206 0.941 . . . . 1.04 110.043 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -130.99 102.77 6.18 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.845 0.831 . . . . 1.54 108.854 164.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.21 160.94 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.271 -0.877 . . . . 0.67 110.063 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.25 95.99 10.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.994 0.426 . . . . 0.44 111.151 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.14 165.84 34.95 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.308 -0.717 . . . . 0.29 111.308 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -102.44 131.73 48.92 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.062 -0.669 . . . . 0.4 109.846 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.692 ' ND1' HG22 ' A' ' 85' ' ' VAL . 2.8 t-80 -104.13 104.46 14.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.728 -0.669 . . . . 0.4 110.041 -173.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.89 109.69 21.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.319 -0.993 . . . . 0.35 108.319 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.96 104.26 16.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 116.063 -0.517 . . . . 0.59 111.191 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -113.4 103.29 11.14 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.687 0.756 . . . . 1.53 110.121 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 38' ' ' PHE . 90.8 mt -105.89 129.62 54.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.761 -1.109 . . . . 0.24 110.137 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.741 HG22 ' HG3' ' A' ' 90' ' ' MET . 5.9 m -101.31 118.93 37.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.588 0.709 . . . . 0.29 110.747 -171.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.683 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 1.6 t80 -87.84 83.42 7.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.568 -1.197 . . . . 1.11 109.467 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.741 ' HG3' HG22 ' A' ' 88' ' ' THR . 30.2 mtm -117.26 158.32 24.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.858 0.361 . . . . 0.65 111.833 -171.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -70.09 105.94 1.41 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.158 -1.053 . . . . 2.59 108.158 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.7 Cg_endo -50.71 -26.79 18.19 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.49 2.793 . . . . 1.04 114.564 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.2 p90 -92.25 -4.5 53.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.196 0.443 . . . . 1.17 112.196 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.616 HG23 ' H ' ' A' ' 95' ' ' GLY . 5.2 t -161.89 -62.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.365 -0.209 . . . . 1.09 111.076 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' H ' HG23 ' A' ' 94' ' ' THR . . . 53.18 66.64 2.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.962 -0.355 . . . . 1.16 112.967 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.5 128.7 24.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.671 2.247 . . . . 1.2 112.269 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.8 t -57.79 138.9 55.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.752 -0.658 . . . . 2.64 109.687 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.1 m80 77.96 -8.11 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.805 0.69 . . . . 4.09 111.574 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -99.41 -25.66 14.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.83 0.824 . . . . 1.67 108.925 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 6.2 p -81.26 163.33 23.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.72 -1.127 . . . . 1.39 110.9 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 10.8 tp10 -103.09 172.35 6.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.727 -0.842 . . . . 1.91 108.727 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 48.8 ttt180 -156.04 139.9 16.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.797 0.808 . . . . 0.62 110.909 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.709 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.75 156.53 17.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.228 -1.351 . . . . 0.86 109.052 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.83 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 93.5 m -160.22 103.5 1.45 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.788 -0.365 . . . . 0.31 111.105 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.846 HG11 HG21 ' A' ' 5' ' ' VAL . 11.1 p -103.72 137.47 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.88 110.31 170.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.5 m-85 -105.29 107.87 19.08 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.772 . . . . 0.7 109.127 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.6 pp -130.69 146.13 52.1 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.443 -0.577 . . . . 2.12 109.443 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.692 ' O ' HG22 ' A' ' 16' ' ' VAL . 11.8 tttp -103.76 114.72 29.19 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.583 -0.447 . . . . 1.89 110.722 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.532 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.53 132.2 46.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.306 -0.406 . . . . 0.53 110.382 -168.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.648 ' C ' HG22 ' A' ' 18' ' ' VAL . 7.7 p30 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.26 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.968 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.403 -0.962 . . . . 0.59 108.403 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.49 134.55 25.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 2.36 111.364 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.944 HG21 HG11 ' A' ' 105' ' ' VAL . 2.0 t -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.227 -0.442 . . . . 0.49 110.786 173.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -146.85 170.82 16.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.195 0.998 . . . . 0.51 108.621 -172.043 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 23.2 tptp -48.17 -39.53 21.12 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.257 0.836 . . . . 0.83 113.257 -173.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.64 77.55 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.688 0.756 . . . . 0.33 110.856 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.779 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.7 m80 -64.4 -3.9 3.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.203 -0.908 . . . . 2.12 111.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.655 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 3.6 t30 -48.03 -21.44 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.378 0.671 . . . . 1.41 110.548 171.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.06 54.6 0.65 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.22 -0.752 . . . . 0.3 111.22 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.843 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.05 160.58 20.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.961 0.726 . . . . 0.32 112.961 -174.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.4 m -151.76 117.03 5.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.231 -0.895 . . . . 0.95 109.467 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.6 pp -164.29 168.29 18.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.534 0.207 . . . . 3.0 111.367 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.0 m -102.97 145.9 29.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.885 0.374 . . . . 1.73 111.077 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -123.5 162.26 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.74 -0.664 . . . . 0.78 110.15 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.448 ' HA ' ' OXT' ' A' ' 110' ' ' ASN . . . -115.16 117.01 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.733 -0.84 . . . . 0.76 108.733 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 22' ' ' VAL . 25.2 m -93.85 178.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.481 . . . . 1.23 111.956 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.52 -52.86 0.76 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.71 111.556 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -78.06 -72.52 0.36 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.558 -0.534 . . . . 2.35 109.558 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -168.07 128.49 1.33 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.753 -0.658 . . . . 0.71 110.931 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.968 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.9 t -104.41 114.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.703 0.763 . . . . 0.4 109.725 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.6 145.07 30.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.464 -0.789 . . . . 1.09 111.854 -171.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 38.5 mm -128.6 102.98 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.873 -1.158 . . . . 0.54 107.873 169.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -114.91 138.48 50.76 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.304 -0.559 . . . . 0.64 111.859 -173.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.2 mm? -116.42 144.2 32.65 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.517 -0.765 . . . . 0.85 109.178 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 42.6 Cg_endo -85.73 13.26 2.8 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 122.992 2.462 . . . . 0.35 111.858 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.549 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 12.2 t 69.34 -65.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.9 0.75 . . . . 0.91 111.225 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.8 m-80 58.95 77.09 0.41 Allowed Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.285 0.634 . . . . 1.39 109.832 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.746 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 79.4 Cg_exo -52.91 105.03 0.11 Allowed 'Trans proline' 0 CA--C 1.517 -0.333 0 C-N-CA 123.495 2.797 . . . . 0.83 113.741 -166.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.413 HG23 ' CE2' ' A' ' 89' ' ' TYR . 70.2 p -83.4 -53.49 5.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.083 . . . . 1.83 109.667 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 t -179.52 -136.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.686 -1.227 . . . . 2.36 107.686 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.48 -25.61 65.35 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.078 -0.582 . . . . 1.3 113.176 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.6 m-30 -53.3 150.32 6.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.123 0.487 . . . . 2.22 112.027 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.01 163.97 36.73 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.226 -0.897 . . . . 0.44 109.093 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.549 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -83.6 123.44 29.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.216 0.532 . . . . 0.43 111.505 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.881 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -158.32 147.58 19.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.459 -0.791 . . . . 2.78 109.296 173.379 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.6 m-85 -45.31 -68.9 0.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.232 0.456 . . . . 0.43 112.232 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 42' ' ' THR . 7.1 pt-20 -130.34 18.84 5.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.082 0.468 . . . . 2.39 110.79 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 100.27 91.64 2.08 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.561 -0.828 . . . . 0.73 113.128 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 -3.35 80.22 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.804 -0.712 . . . . 0.7 112.388 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.635 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -128.3 142.76 51.04 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.91 0.386 . . . . 1.13 111.663 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.778 ' H ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -144.22 133.9 23.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.237 -0.892 . . . . 2.52 111.097 173.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.71 160.25 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 2.3 110.086 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.926 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 31.0 t -125.73 138.54 32.16 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.323 -0.621 . . . . 1.61 109.323 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 32.1 Cg_exo -58.72 129.42 32.19 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.396 2.064 . . . . 1.88 111.006 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 92.0 m-20 72.37 42.87 0.52 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.05 0.844 . . . . 2.43 110.629 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.73 33.67 0.48 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.859 -0.609 . . . . 3.26 111.602 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 m -67.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.264 0.554 . . . . 2.06 110.176 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.668 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -107.36 -33.43 7.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.583 -0.735 . . . . 1.25 110.594 -177.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.739 ' HB3' ' O ' ' A' ' 76' ' ' THR . 5.0 m-85 -104.83 165.24 11.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.049 -0.978 . . . . 0.74 108.729 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -159.35 170.29 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.066 -0.654 . . . . 1.46 112.309 -166.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.926 ' HB ' ' HB2' ' A' ' 45' ' ' SER . 2.5 p -99.86 126.21 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.522 -0.763 . . . . 1.31 110.319 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -111.26 125.06 53.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 2.45 108.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.77 152.94 21.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.299 0.571 . . . . 1.93 111.463 -172.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.82 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -164.9 114.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.222 -0.899 . . . . 1.42 109.333 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 m-85 -120.88 156.37 32.15 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.168 -0.613 . . . . 1.66 110.127 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -147.16 100.65 3.87 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.837 -0.62 . . . . 2.14 110.8 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -66.99 154.08 75.8 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.735 2.29 . . . . 1.92 110.301 170.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.2 111.56 0.07 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 124.456 3.437 . . . . 2.64 114.998 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 62' ' ' SER . 5.2 p-10 -84.07 -80.15 0.2 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.334 -1.757 . . . . 5.8 110.784 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.567 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 33.4 t -179.95 -39.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 7.43 110.681 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -125.08 -27.62 3.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.184 0.809 . . . . 8.71 113.184 -171.202 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.603 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 4.5 tt -61.23 -51.06 70.54 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.713 -1.217 . . . . 8.1 107.713 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.531 HD22 HD22 ' A' ' 64' ' ' LEU . 1.7 pt? -156.54 -51.91 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.599 -0.728 . . . . 4.74 111.507 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.1 -35.55 1.28 Allowed Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.084 -0.579 . . . . 3.02 112.228 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 65' ' ' LEU . . . -52.89 -57.98 8.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.297 0.57 . . . . 4.02 111.126 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.746 ' HA2' ' HD3' ' A' ' 30' ' ' PRO . . . -116.56 -49.52 0.43 Allowed Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.466 -0.788 . . . . 2.84 112.34 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.526 ' H ' HD11 ' A' ' 65' ' ' LEU . . . 116.53 -167.69 12.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.291 -0.957 . . . . 1.49 110.829 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.64 84.82 0.62 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.406 0.521 . . . . 0.97 112.406 -172.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.4 mt-10 -104.15 109.44 21.25 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.285 -0.635 . . . . 0.81 109.285 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.82 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 2.1 m170 -110.89 148.92 31.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.674 0.749 . . . . 0.53 111.899 -171.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.881 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 27.0 m-85 -118.82 109.12 15.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.284 -1.325 . . . . 1.13 108.864 171.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -103.53 107.33 18.13 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.893 -0.41 . . . . 0.5 109.893 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 2.4 m -103.31 118.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 122.453 1.12 . . . . 0.87 109.19 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 20.8 m -102.75 104.26 14.55 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.807 -1.182 . . . . 0.46 107.807 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -146.59 140.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.262 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.23 102.22 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.821 0.82 . . . . 1.54 109.868 171.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.83 167.27 17.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.93 -1.032 . . . . 0.67 108.58 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.797 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -99.69 89.61 4.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.184 0.516 . . . . 0.44 110.506 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.1 168.1 31.86 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.123 -0.791 . . . . 0.29 111.123 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.2 m -101.89 134.17 45.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.594 0.697 . . . . 0.4 109.609 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 85' ' ' VAL . 30.1 t-80 -104.4 104.64 14.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.668 -0.696 . . . . 0.4 109.684 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.76 109.7 21.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.562 -0.533 . . . . 0.35 109.562 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 83' ' ' HIS . 1.1 t -105.55 104.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.827 -0.624 . . . . 0.59 111.235 -170.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 3.1 m-20 -108.28 103.51 12.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.084 -0.71 . . . . 1.53 109.084 174.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.61 128.44 52.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.269 -0.641 . . . . 0.24 109.269 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 9.0 m -102.6 137.09 41.28 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.673 0.749 . . . . 0.29 110.922 -170.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.413 ' CE2' HG23 ' A' ' 31' ' ' THR . 0.8 OUTLIER -103.78 90.05 3.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.919 -1.037 . . . . 1.11 109.6 -175.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 5.0 mtm -132.62 173.46 11.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 110.024 -0.361 . . . . 0.65 110.024 -175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 18.9 mtt180 -82.07 114.01 47.63 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 2.59 109.444 170.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.88 -35.15 39.26 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 123.537 2.825 . . . . 1.04 114.133 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -85.14 2.02 45.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.738 0.273 . . . . 1.17 111.738 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -170.88 -74.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.583 -0.28 . . . . 1.09 111.24 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.777 ' H ' HG23 ' A' ' 94' ' ' THR . . . 80.83 108.08 0.31 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.431 -1.068 . . . . 1.16 110.431 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 10.3 Cg_exo -73.51 40.82 0.56 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.741 2.961 . . . . 1.2 113.558 -172.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.7 t 44.22 -85.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.393 1.077 . . . . 2.64 112.625 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.7 -21.39 66.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.263 -0.426 . . . . 4.09 110.748 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 21.7 t0 -92.62 3.92 54.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.542 0.687 . . . . 1.67 110.211 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 7.1 m -95.52 144.92 25.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 1.39 110.626 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.91 178.19 5.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.7 -0.852 . . . . 1.91 108.7 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 56.3 ttt180 -161.12 144.51 12.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.62 110.625 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.731 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.45 156.29 18.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.709 -1.132 . . . . 0.86 109.198 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.665 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 99.4 m -157.66 103.47 1.92 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.625 -0.43 . . . . 0.31 111.375 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.944 HG11 HG21 ' A' ' 5' ' ' VAL . 11.7 p -108.63 136.84 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 119.617 -0.833 . . . . 0.88 109.993 168.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 13' ' ' THR . 97.6 m-85 -106.2 103.34 12.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.295 -0.866 . . . . 0.7 108.732 173.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.696 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.19 150.89 48.01 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.198 -0.667 . . . . 2.12 109.198 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.817 ' O ' HG22 ' A' ' 16' ' ' VAL . 48.4 tttm -102.78 119.77 39.43 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.376 -0.601 . . . . 1.89 109.376 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -99.94 115.68 30.24 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 123.928 0.768 . . . . 0.53 109.725 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.797 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-N 114.718 -1.128 . . . . 1.78 110.569 -171.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.929 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.408 -0.96 . . . . 0.59 108.408 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.5 pttt -135.67 151.47 50.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.884 0.373 . . . . 2.36 111.021 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.839 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -122.43 155.22 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 0.49 111.046 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 7.2 p -143.67 170.55 15.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.922 -1.036 . . . . 0.51 108.67 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 24.9 tptp -48.28 -38.16 18.12 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.573 0.582 . . . . 0.83 112.573 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.31 79.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.883 0.849 . . . . 0.33 111.073 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.77 ' HB2' HG13 ' A' ' 5' ' ' VAL . 32.9 m80 -63.9 -2.93 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 2.12 111.346 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.585 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 3.8 t30 -49.93 -19.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.257 0.623 . . . . 1.41 110.685 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.87 48.61 0.92 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.296 -0.722 . . . . 0.3 111.296 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.92 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -112.54 154.92 25.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.875 0.694 . . . . 0.32 112.875 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 41.3 m -147.9 104.38 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.271 -0.877 . . . . 0.95 109.062 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.571 HD11 ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -141.81 167.93 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.141 0.496 . . . . 3.0 111.618 -171.254 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 m -101.59 139.03 37.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.599 -0.728 . . . . 1.73 109.897 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -127.46 162.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.252 0.549 . . . . 0.78 112.137 -175.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.19 120.64 38.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.452 -0.944 . . . . 0.76 108.452 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 19' ' ' GLY . 2.2 t -105.73 -156.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.166 -0.679 . . . . 1.23 109.166 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.795 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 108.67 -49.04 0.88 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.667 -0.973 . . . . 0.71 110.667 -175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.62 -73.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.086 -0.709 . . . . 2.35 109.086 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.8 tp -166.88 145.14 5.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.346 -0.843 . . . . 0.71 109.367 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.929 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -122.63 111.71 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.4 109.641 171.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -104.83 139.73 39.16 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.55 0.69 . . . . 1.09 110.918 -173.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 85' ' ' VAL . 47.1 mm -117.34 101.48 12.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.932 -1.136 . . . . 0.54 107.932 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.507 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.61 142.95 34.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.243 0.544 . . . . 0.64 111.211 -172.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 3.7 mt -128.44 138.15 32.44 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-O 121.546 0.689 . . . . 0.85 111.079 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.521 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 85.3 Cg_endo -78.78 8.66 3.61 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.035 2.49 . . . . 0.35 112.068 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.653 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 13.7 t 69.37 -57.81 0.52 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.712 0.632 . . . . 0.91 110.165 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 52.54 63.46 8.79 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.051 -1.092 . . . . 1.39 108.051 -172.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.806 ' HB3' ' HA ' ' A' ' 62' ' ' SER . 48.3 Cg_exo -44.94 125.67 6.87 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 124.136 3.224 . . . . 0.83 114.486 -165.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.444 HG23 ' CE2' ' A' ' 89' ' ' TYR . 4.1 t -157.6 96.8 1.55 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.605 -1.179 . . . . 1.83 110.433 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 33' ' ' GLY . 16.3 m 73.22 176.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.746 -0.661 . . . . 2.36 110.102 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.554 ' H ' HG22 ' A' ' 32' ' ' THR . . . -59.05 -8.71 6.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.539 -0.362 . . . . 1.3 113.926 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.629 ' HA ' ' C ' ' A' ' 90' ' ' MET . 6.3 m-85 -55.06 154.68 5.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 2.22 111.779 176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.83 154.21 32.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.489 -0.56 . . . . 0.44 109.489 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.653 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 97.7 m95 -76.52 111.28 11.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.9 0.381 . . . . 0.43 110.944 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.853 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 10.1 p90 -149.25 146.26 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 2.78 109.575 170.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.7 m-85 -44.86 -78.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.947 1.092 . . . . 0.43 113.947 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -118.22 -10.57 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.3 -0.56 . . . . 2.39 111.621 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.782 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 138.87 92.37 0.25 Allowed Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 119.937 -1.125 . . . . 0.73 113.039 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.07 15.51 65.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.843 -0.694 . . . . 0.7 111.865 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -138.63 144.16 39.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.462 -0.369 . . . . 1.13 111.502 -176.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.28 131.34 26.3 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.55 -0.75 . . . . 2.52 111.285 171.492 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.16 160.49 40.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.715 -0.675 . . . . 2.3 110.324 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.643 ' HB2' HG23 ' A' ' 53' ' ' VAL . 13.3 t -104.54 134.89 19.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.48 -0.933 . . . . 1.61 108.48 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.53 41.59 0.26 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.433 2.755 . . . . 1.88 113.262 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 177.33 41.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.84 -1.17 . . . . 2.43 107.84 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -80.58 45.07 0.75 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.603 -0.726 . . . . 3.26 111.714 -173.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -74.9 -41.06 60.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.013 0.435 . . . . 2.06 111.003 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.661 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -134.86 -21.3 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.329 0.585 . . . . 1.25 110.668 -177.615 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 76' ' ' THR . 3.7 m-85 -124.24 162.47 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.223 -0.898 . . . . 0.74 109.662 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -152.69 170.6 19.86 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.786 0.661 . . . . 1.46 112.786 -160.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 45' ' ' SER . 46.5 t -99.84 123.85 52.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.542 -0.753 . . . . 1.31 111.175 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.21 117.82 34.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.281 -0.872 . . . . 2.45 108.71 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -104.2 150.19 24.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 1.93 111.438 -171.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.581 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.19 116.0 3.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.945 -0.57 . . . . 1.42 109.837 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.797 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 9.6 m-85 -113.79 136.05 53.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.479 -0.328 . . . . 1.66 111.258 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -130.64 101.29 17.21 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.32 -0.4 . . . . 2.14 109.969 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 3.8 Cg_exo -82.18 136.88 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.199 2.599 . . . . 1.92 111.641 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.669 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 92.5 Cg_endo -91.08 -16.38 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.912 2.408 . . . . 2.64 113.06 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -176.39 -41.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.025 0.44 . . . . 5.8 110.483 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.806 ' HA ' ' HB3' ' A' ' 30' ' ' PRO . 16.2 m 74.86 -50.83 0.67 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.918 -1.037 . . . . 7.43 112.63 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.41 5.68 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.798 -0.361 . . . . 8.71 111.588 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.411 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 3.7 tt -166.52 -88.52 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.854 -0.425 . . . . 8.1 109.854 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.709 HD12 ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -179.95 140.02 0.13 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.473 -0.565 . . . . 4.74 109.473 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.669 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -104.67 -18.22 13.24 Favored Glycine 0 C--O 1.234 0.11 0 C-N-CA 120.901 -0.666 . . . . 3.02 111.656 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 174.45 -42.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 4.02 107.694 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.86 -57.56 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.233 -1.349 . . . . 2.84 110.8 173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.32 155.35 10.16 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.987 -0.845 . . . . 1.49 110.987 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.74 80.44 1.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.556 0.693 . . . . 0.97 112.58 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.797 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.9 mt-10 -105.45 103.59 13.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.458 -0.942 . . . . 0.81 108.458 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.581 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -108.59 159.19 16.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.814 0.816 . . . . 0.53 111.499 -171.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.853 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 28.4 m-85 -122.47 108.54 13.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.909 -1.496 . . . . 1.13 109.018 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.676 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 31.9 m170 -102.31 110.74 22.78 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.515 -0.55 . . . . 0.5 109.515 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 53' ' ' VAL . 3.3 m -102.18 120.06 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.58 1.181 . . . . 0.87 109.219 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.737 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 13.9 m -103.09 103.61 13.7 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.318 -1.364 . . . . 0.46 107.318 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.579 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.1 p -160.4 118.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.396 0.435 . . . . 1.04 111.259 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.45 104.0 11.0 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.174 0.988 . . . . 1.54 109.869 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.65 143.26 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.653 -1.158 . . . . 0.67 109.737 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 96.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.44 111.107 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.32 166.16 38.19 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.29 110.175 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.6 m -101.62 132.7 47.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.808 0.804 . . . . 0.4 109.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.688 ' HD1' HG22 ' A' ' 85' ' ' VAL . 44.8 t-80 -103.84 104.95 15.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.494 -0.775 . . . . 0.4 109.786 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.23 113.76 27.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.374 0.607 . . . . 0.35 109.623 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.96 103.93 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.59 111.2 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 3.4 m-20 -105.45 103.71 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.289 -0.634 . . . . 1.53 109.289 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HG ' HG12 ' A' ' 85' ' ' VAL . 78.0 mt -107.01 123.82 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.51 -0.552 . . . . 0.24 109.51 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.513 HG22 ' CG ' ' A' ' 90' ' ' MET . 3.3 m -105.86 119.96 40.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.24 0.543 . . . . 0.29 112.002 -169.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 35' ' ' ALA . 28.0 t80 -88.05 85.31 6.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 1.11 109.38 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.665 ' HE2' ' HE1' ' A' ' 37' ' ' TYR . 20.7 mtm -124.34 167.13 14.77 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.443 -0.344 . . . . 0.65 110.299 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.455 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.4 ttt180 -78.65 108.67 8.47 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.792 -0.818 . . . . 2.59 108.792 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.584 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 5.8 Cg_endo -46.93 -32.24 12.42 Favored 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.546 2.831 . . . . 1.04 115.459 -167.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.584 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.3 p90 -96.92 11.73 34.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.684 0.624 . . . . 1.17 112.684 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.412 HG23 ' HD3' ' A' ' 96' ' ' PRO . 5.3 t -168.63 -50.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 1.09 111.87 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 51.48 80.56 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 O-C-N 123.303 0.377 . . . . 1.16 112.361 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.878 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 92.4 Cg_exo -40.31 105.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.148 2.565 . . . . 1.2 111.218 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.1 m -54.91 125.31 19.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 2.64 111.117 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 77.03 -2.27 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.406 -0.815 . . . . 4.09 111.216 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.878 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 26.4 t0 -97.13 -27.34 14.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.941 0.877 . . . . 1.67 108.668 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.512 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 12.4 m -68.24 157.08 36.29 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.071 -1.422 . . . . 1.39 110.846 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.1 tp10 -96.51 161.13 14.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.559 -0.904 . . . . 1.91 108.559 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 31.5 ttt180 -148.83 139.96 23.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.432 0.634 . . . . 0.62 110.315 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.774 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -104.22 155.86 18.38 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.86 109.208 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 70.5 m -157.15 102.76 1.97 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.73 -0.388 . . . . 0.31 111.161 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.92 HG23 ' HB3' ' A' ' 12' ' ' ALA . 10.7 p -105.63 136.2 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.639 -0.824 . . . . 0.88 110.014 168.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' THR . 88.4 m-85 -104.71 104.64 14.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.443 -0.799 . . . . 0.7 109.047 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.663 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 pp -123.01 147.68 46.38 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.374 -0.602 . . . . 2.12 109.374 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 16' ' ' VAL . 38.5 tttt -103.27 115.3 30.29 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.377 -0.529 . . . . 1.89 110.557 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.405 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.19 153.56 19.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.952 -0.567 . . . . 0.53 110.775 -169.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.557 ' H ' HG23 ' A' ' 18' ' ' VAL . 4.6 p-10 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.242 -0.89 . . . . 1.78 108.891 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.954 ' HB3' HG22 ' A' ' 22' ' ' VAL . 5.0 t-80 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.222 -0.659 . . . . 0.59 109.222 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' N ' ' CD2' ' A' ' 3' ' ' HIS . 84.6 tttt -141.82 130.05 22.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.283 0.364 . . . . 2.36 111.286 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.752 HG11 ' CZ ' ' A' ' 103' ' ' PHE . 2.0 t -104.72 157.7 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.873 0.368 . . . . 0.49 110.462 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -144.81 170.2 16.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.171 0.989 . . . . 0.51 108.904 -173.186 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HB2' ' CD ' ' A' ' 27' ' ' PRO . 16.5 tptm -46.9 -43.85 19.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.031 0.752 . . . . 0.83 113.031 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.2 70.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.941 0.877 . . . . 0.33 110.974 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.75 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.4 m80 -62.57 -4.02 1.76 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.928 . . . . 2.12 111.438 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 103' ' ' PHE . 22.2 t30 -45.84 -22.29 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 1.41 110.422 172.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.65 54.95 0.73 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.904 -0.665 . . . . 0.3 111.726 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . . . -117.38 146.26 43.54 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.157 0.799 . . . . 0.32 113.157 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 36.9 m -141.24 111.19 6.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.433 -0.803 . . . . 0.95 109.779 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.0 pp -166.64 171.66 11.41 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.148 0.179 . . . . 3.0 110.937 -173.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -99.17 143.65 29.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.106 0.479 . . . . 1.73 111.674 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 108' ' ' LYS . 4.0 m -119.08 160.24 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.668 -0.697 . . . . 0.78 111.624 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.49 135.99 44.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.213 -0.662 . . . . 0.76 109.213 172.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 77' ' ' VAL . 24.3 m -121.5 -166.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.962 0.411 . . . . 1.23 111.773 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.718 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 108.95 -56.65 0.46 Allowed Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.29 -0.724 . . . . 0.71 111.29 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -75.42 -71.99 0.33 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.955 -0.757 . . . . 2.35 108.955 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -166.95 141.3 3.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.593 -0.73 . . . . 0.71 110.184 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.954 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.4 t -120.57 116.7 50.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.526 -0.546 . . . . 0.4 109.526 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.733 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -114.78 149.23 37.28 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.663 -0.815 . . . . 1.09 112.225 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.532 HD13 ' HB ' ' A' ' 5' ' ' VAL . 44.3 mm -124.13 102.51 11.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.69 -1.141 . . . . 0.54 108.681 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.96 141.82 36.7 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.561 -0.712 . . . . 0.64 112.46 -172.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -116.73 147.48 39.99 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.25 -0.886 . . . . 0.85 109.403 171.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 7' ' ' LYS . 43.1 Cg_endo -85.98 11.62 3.27 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.883 2.389 . . . . 0.35 111.52 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 30.4 t 70.84 -51.45 0.68 Allowed 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.399 -0.818 . . . . 0.91 111.118 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.4 67.36 2.18 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.008 -0.738 . . . . 1.39 109.008 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.18 97.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.439 2.759 . . . . 0.83 112.618 -168.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.426 HG22 ' CE2' ' A' ' 89' ' ' TYR . 1.3 t -105.11 -39.44 6.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 1.83 111.353 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 34' ' ' PHE . 9.0 t -178.21 -150.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.951 -0.759 . . . . 2.36 108.951 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.76 -23.36 55.66 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.71 -0.281 . . . . 1.3 113.349 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.571 ' HA ' ' C ' ' A' ' 90' ' ' MET . 14.3 m-30 -46.01 137.19 6.02 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.212 0.529 . . . . 2.22 112.123 172.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.501 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -141.96 149.94 40.77 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.34 -0.985 . . . . 0.44 108.34 171.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.594 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.2 m95 -77.04 117.81 18.98 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.568 0.699 . . . . 0.43 111.141 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 47.0 m-85 -126.03 -179.59 4.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.186 -1.042 . . . . 2.78 108.186 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.8 m-85 -73.2 -82.07 0.05 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.818 -0.753 . . . . 0.43 109.505 167.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.76 10.09 24.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 2.39 110.144 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.26 105.76 2.51 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.835 -0.698 . . . . 0.73 112.225 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 3.3 59.98 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.892 -0.671 . . . . 0.7 111.966 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -129.98 142.61 50.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.454 -0.373 . . . . 1.13 111.566 -177.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -142.61 129.15 20.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.938 -0.573 . . . . 2.52 110.835 166.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.35 137.41 34.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.726 -0.67 . . . . 2.3 110.14 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.883 ' HB2' HG23 ' A' ' 52' ' ' THR . 15.4 m -104.4 138.7 19.59 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 121.24 0.543 . . . . 1.61 110.714 171.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 9.8 Cg_endo -93.66 170.05 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.719 3.613 . . . . 1.88 113.493 -168.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.561 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 59.7 t30 74.67 -36.27 0.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.991 0.916 . . . . 2.43 111.107 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.73 ' OE1' ' HG2' ' A' ' 50' ' ' MET . 4.9 mm-40 -109.99 148.34 31.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.201 1.001 . . . . 3.26 113.561 -170.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.4 t -130.01 -11.85 4.21 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.624 -1.626 . . . . 2.06 109.089 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.73 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 19.0 ptt? -97.89 -37.24 9.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.494 -0.483 . . . . 1.25 110.652 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 76' ' ' THR . 0.2 OUTLIER -147.4 97.01 2.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.519 -0.753 . . . . 0.74 110.474 -174.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.883 HG23 ' HB2' ' A' ' 45' ' ' SER . 11.0 t 177.78 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.627 0.649 . . . . 1.46 111.446 160.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -174.73 142.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.953 0.501 . . . . 1.31 111.235 162.223 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 7.9 tp10 -168.76 154.31 6.42 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.959 -0.756 . . . . 2.45 108.959 167.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.7 139.68 25.37 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.171 0.51 . . . . 1.93 111.858 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.689 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -163.02 103.87 1.0 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.581 -0.736 . . . . 1.42 110.474 175.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.749 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -124.81 125.11 43.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 1.66 111.495 -177.16 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.661 ' HB3' HD21 ' A' ' 64' ' ' LEU . 86.9 m-85 -134.04 113.39 12.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.414 -0.812 . . . . 2.14 111.078 -176.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.7 167.62 13.23 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.211 2.607 . . . . 1.92 112.39 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.512 ' HG3' ' C ' ' A' ' 68' ' ' GLY . 83.0 Cg_exo -49.92 173.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.859 3.04 . . . . 2.64 115.549 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -162.01 -94.84 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.416 -1.72 . . . . 5.8 108.117 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -165.81 -51.36 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.868 -1.06 . . . . 7.43 108.155 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -90.69 -27.63 18.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 8.71 110.686 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.736 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 41.1 tp -64.08 -55.53 21.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.371 0.605 . . . . 8.1 109.668 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.823 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.3 OUTLIER -151.05 -54.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.459 -0.941 . . . . 4.74 108.459 174.789 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.64 -59.77 4.64 Favored Glycine 0 C--N 1.322 -0.236 0 CA-C-N 114.678 -1.146 . . . . 3.02 112.677 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.91 -64.56 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.728 0.775 . . . . 4.02 109.981 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.823 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -121.24 -159.36 10.69 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.942 -1.263 . . . . 2.84 109.942 173.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.78 -159.85 22.76 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.411 -0.899 . . . . 1.49 111.111 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.25 80.64 0.83 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.436 0.636 . . . . 0.97 111.265 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.749 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 40.4 mt-10 -104.44 103.23 12.9 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.457 -0.792 . . . . 0.81 109.01 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.689 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -108.26 145.71 33.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.685 -0.806 . . . . 0.53 110.973 -174.372 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 6.5 m-85 -117.47 109.64 17.01 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.619 -1.173 . . . . 1.13 109.736 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.733 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -103.54 149.92 24.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.715 -0.476 . . . . 0.5 109.715 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.563 HG22 HG12 ' A' ' 22' ' ' VAL . 3.5 m -132.95 126.93 54.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.882 0.848 . . . . 0.87 108.902 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.665 HG22 ' CE2' ' A' ' 51' ' ' PHE . 3.7 m -102.39 101.36 11.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 0.46 108.452 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 3.8 p -144.14 145.88 21.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.503 -0.479 . . . . 1.04 112.074 -167.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -138.91 103.48 4.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.55 -0.907 . . . . 1.54 108.55 163.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.31 164.92 19.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.67 109.597 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.58 86.95 2.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.44 109.998 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -158.05 167.92 34.44 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.42 -0.809 . . . . 0.29 111.184 -175.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.1 m -100.23 132.6 45.51 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.817 -0.753 . . . . 0.4 109.908 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.667 ' ND1' HG22 ' A' ' 85' ' ' VAL . 48.2 t-80 -103.5 103.82 13.82 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.753 -0.658 . . . . 0.4 109.586 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.17 110.97 23.06 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.957 -0.757 . . . . 0.35 108.957 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -107.44 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.682 -0.69 . . . . 0.59 110.292 -171.113 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 102' ' ' ARG . 3.3 m-20 -108.22 103.6 12.82 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.917 -0.771 . . . . 1.53 108.917 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 38' ' ' PHE . 63.7 mt -107.35 123.99 49.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.641 -0.709 . . . . 0.24 109.666 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.48 HG22 ' CG ' ' A' ' 90' ' ' MET . 4.4 m -102.15 119.8 39.4 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.871 0.844 . . . . 0.29 110.688 -173.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.501 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 7.4 t80 -89.3 88.37 7.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.503 -1.226 . . . . 1.11 109.676 -175.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.571 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 14.1 mtm -129.22 166.43 19.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.245 0.545 . . . . 0.65 111.051 -172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.433 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.3 mtm180 -70.04 107.39 2.31 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.859 -1.064 . . . . 2.59 108.786 168.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.5 Cg_endo -51.63 -27.0 24.38 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.335 2.69 . . . . 1.04 114.655 -169.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.456 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 45.7 p90 -93.46 3.89 54.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.0 0.37 . . . . 1.17 112.0 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.3 t -164.06 -66.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.834 -0.166 . . . . 1.09 111.14 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.681 ' H ' HG23 ' A' ' 94' ' ' THR . . . 67.53 94.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.012 -0.435 . . . . 1.16 112.012 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.975 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 15.8 Cg_exo -64.92 130.03 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.607 2.205 . . . . 1.2 111.11 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.8 t -43.75 -50.32 7.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.955 0.902 . . . . 2.64 113.018 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -121.65 20.79 10.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.522 -0.471 . . . . 4.09 111.029 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.975 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.7 t0 -103.99 -22.18 13.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.412 -0.958 . . . . 1.67 108.412 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 16.3 m -80.0 148.22 31.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.614 -1.175 . . . . 1.39 110.561 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.84 172.87 7.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.096 -1.076 . . . . 1.91 108.096 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 26.6 ttt180 -158.48 139.01 12.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.407 0.623 . . . . 0.62 110.361 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.773 ' CZ ' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -103.76 155.88 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.875 -1.057 . . . . 0.86 109.069 -178.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 24.3 m -157.36 104.56 2.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.881 0.372 . . . . 0.31 110.972 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.773 ' HB ' ' CZ ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -103.81 132.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 119.769 -0.772 . . . . 0.88 109.592 168.117 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.689 ' O ' HD12 ' A' ' 107' ' ' LEU . 73.1 m-85 -108.06 97.42 7.12 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.628 -1.249 . . . . 0.7 107.628 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 106' ' ' TYR . 8.9 mp -134.21 144.78 48.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.288 -0.634 . . . . 2.12 109.288 -173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 16' ' ' VAL . 35.5 ttpt -102.81 130.98 49.98 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.129 -0.628 . . . . 1.89 110.946 -166.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.06 132.37 45.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 0.53 109.566 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.598 ' C ' HG22 ' A' ' 18' ' ' VAL . 5.6 p-10 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.386 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 1.015 ' HB3' HG22 ' A' ' 22' ' ' VAL . 11.6 t-80 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.385 -0.598 . . . . 0.59 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -138.91 134.15 32.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.266 -0.642 . . . . 2.36 109.266 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -107.49 125.81 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 119.5 -0.88 . . . . 0.49 110.685 178.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.474 ' C ' ' ND1' ' A' ' 9' ' ' HIS . 0.7 OUTLIER -120.99 152.09 38.97 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.122 0.416 . . . . 0.51 112.122 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 27.0 tptp -31.17 -45.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.252 1.945 . . . . 0.83 116.252 -153.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.61 -34.98 1.57 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.311 1.053 . . . . 0.33 111.731 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.935 ' ND1' HG13 ' A' ' 5' ' ' VAL . 2.4 p-80 -55.19 -9.36 0.4 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.126 -1.397 . . . . 2.12 113.159 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -58.14 -15.32 9.24 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 107.633 -1.247 . . . . 1.41 107.633 -174.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.91 58.63 0.69 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.091 -1.413 . . . . 0.3 110.169 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.891 ' HB2' ' HA ' ' A' ' 9' ' ' HIS . . . -116.09 151.91 34.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.752 0.649 . . . . 0.32 112.752 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 23.6 m -149.43 108.45 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.772 -0.649 . . . . 0.95 109.941 173.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.766 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.1 pt? -150.67 166.85 29.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 3.0 111.25 -171.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -103.11 144.63 31.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.638 -0.256 . . . . 1.73 110.424 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -128.41 156.27 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 0.78 111.493 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.2 137.73 42.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.338 -0.986 . . . . 0.76 108.338 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 HG21 ' A' ' 22' ' ' VAL . 29.5 m -115.74 -178.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.664 -0.414 . . . . 1.23 111.424 -177.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.4 -60.59 0.66 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.272 -0.731 . . . . 0.71 111.272 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.2 -72.08 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.339 0.59 . . . . 2.35 109.725 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.4 tp -165.69 133.36 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.984 . . . . 0.71 110.45 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.015 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.2 t -119.95 113.0 39.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.368 -0.604 . . . . 0.4 109.368 174.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.2 pt-20 -111.48 157.32 20.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.509 1.147 . . . . 1.09 112.985 -173.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.426 HG21 HG11 ' A' ' 85' ' ' VAL . 40.6 mm -126.62 102.69 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.889 -1.959 . . . . 0.54 107.405 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -114.59 135.17 54.43 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.04 0.924 . . . . 0.64 111.91 -173.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -112.33 145.32 32.63 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.735 -1.12 . . . . 0.85 108.855 174.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 71.4 Cg_endo -82.12 7.08 5.3 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.648 2.232 . . . . 0.35 111.345 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.627 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 67.77 -64.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.91 109.658 -172.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.71 67.98 1.23 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.285 -1.006 . . . . 1.39 108.285 -171.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.717 ' HB3' ' HA ' ' A' ' 62' ' ' SER . 73.1 Cg_exo -53.82 108.83 0.31 Allowed 'Trans proline' 0 CA--C 1.52 -0.177 0 C-N-CA 123.378 2.719 . . . . 0.83 112.813 -169.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.87 -37.25 13.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.363 -0.835 . . . . 1.83 111.482 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 t -178.22 -44.7 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 111.748 0.277 . . . . 2.36 111.748 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.98 -32.97 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 111.436 -0.665 . . . . 1.3 111.436 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HE1' ' HD2' ' A' ' 96' ' ' PRO . 31.2 m-85 -43.26 141.49 1.26 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.222 -0.489 . . . . 2.22 111.778 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -140.17 150.22 43.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.847 -1.07 . . . . 0.44 108.438 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.4 m95 -78.83 118.37 20.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.969 0.414 . . . . 0.43 111.01 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.822 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -150.37 145.68 26.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 2.78 109.789 172.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 1.1 m-85 -46.37 -76.19 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.879 0.696 . . . . 0.43 112.879 -172.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.23 -8.84 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 2.39 110.936 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.686 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 116.75 86.64 1.24 Allowed Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 119.72 -1.228 . . . . 0.73 112.193 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.6 -4.34 74.15 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.149 -0.78 . . . . 0.7 111.149 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.39 137.84 52.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.836 -0.431 . . . . 1.13 109.836 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -141.52 139.59 33.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.534 -0.543 . . . . 2.52 109.534 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.3 165.37 27.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.23 0.538 . . . . 2.3 111.487 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.6 p -114.26 140.05 24.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.603 -0.726 . . . . 1.61 109.247 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.6 Cg_exo -76.16 -5.59 16.42 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 1.88 113.128 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' A' ' 79' ' ' ALA . 9.4 p-10 -151.17 67.64 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.496 0.665 . . . . 2.43 110.663 -177.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -109.45 -147.49 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 3.26 111.518 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m 71.43 36.14 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.431 0.634 . . . . 2.06 110.894 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptt? 175.94 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.57 -1.195 . . . . 1.25 107.879 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 11.6 m-85 -130.13 162.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.336 -1.756 . . . . 0.74 106.291 173.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -152.46 166.13 32.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 119.48 1.036 . . . . 1.46 112.953 -165.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.3 p -103.01 133.08 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.14 -0.936 . . . . 1.31 110.966 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 28.9 tt0 -104.18 153.98 20.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.99 -1.004 . . . . 2.45 108.779 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 54' ' ' GLU . 21.4 p-10 -133.47 122.73 24.09 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.094 -0.503 . . . . 1.93 109.966 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.807 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -137.73 113.27 9.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.617 0.722 . . . . 1.42 110.07 176.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.82 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.4 m-85 -106.83 124.04 49.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.333 -0.848 . . . . 1.66 110.49 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 96.7 m-85 -119.91 101.05 48.16 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.284 0.564 . . . . 2.14 110.586 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 1.8 Cg_endo -90.64 131.95 1.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.073 3.182 . . . . 1.92 111.628 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.851 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 39.0 Cg_exo -64.39 -58.39 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.368 2.712 . . . . 2.64 112.548 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.614 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 8.6 m-20 -147.66 -47.71 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.555 -0.748 . . . . 5.8 110.312 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.717 ' HA ' ' HB3' ' A' ' 30' ' ' PRO . 21.0 t 82.99 -21.91 0.27 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.414 -1.266 . . . . 7.43 110.765 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -74.69 -18.6 60.5 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.85 -1.166 . . . . 8.71 107.85 165.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.827 ' HG ' ' H ' ' A' ' 65' ' ' LEU . 14.5 tp -165.12 -156.88 0.32 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.802 -1.544 . . . . 8.1 108.005 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.827 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -109.5 164.68 12.29 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.035 -0.53 . . . . 4.74 109.8 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.851 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -136.82 27.81 2.9 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.084 -0.962 . . . . 3.02 110.993 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 67.15 -66.24 0.2 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.632 0.773 . . . . 4.02 110.992 -171.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.27 60.65 4.73 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.922 -0.581 . . . . 2.84 113.321 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -78.98 122.72 5.91 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.85 -1.7 . . . . 1.49 108.85 168.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.49 92.62 1.51 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.418 0.896 . . . . 0.97 113.418 -168.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 36.8 mt-10 -104.44 106.82 17.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.81 108.741 174.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.807 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.6 m170 -107.4 152.78 23.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.413 0.625 . . . . 0.53 111.825 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.822 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 30.8 m-85 -123.44 108.29 12.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.301 -1.318 . . . . 1.13 108.6 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.615 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 21.0 m170 -103.6 107.65 18.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.194 -0.457 . . . . 0.5 110.377 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 3.3 m -101.93 113.99 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-O 122.986 1.374 . . . . 0.87 108.463 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 16.9 m -101.52 103.23 14.08 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.723 -1.584 . . . . 0.46 106.723 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.568 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.2 p -153.97 146.82 14.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 124.167 0.917 . . . . 1.04 111.179 -173.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.59 102.5 6.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.561 0.696 . . . . 1.54 109.533 166.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' HD22 ' A' ' 47' ' ' ASN . . . -165.83 140.29 4.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.69 -0.687 . . . . 0.67 110.043 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.89 95.89 2.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.383 0.611 . . . . 0.44 111.213 -177.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.75 34.03 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.201 -0.909 . . . . 0.29 110.993 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.0 m -102.97 134.84 45.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.895 -0.78 . . . . 0.4 108.895 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.905 ' HD1' HG22 ' A' ' 85' ' ' VAL . 31.0 t-80 -102.96 105.35 15.67 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.36 -0.607 . . . . 0.4 109.36 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.11 106.63 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.808 -0.812 . . . . 0.35 108.808 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.905 HG22 ' HD1' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -104.88 110.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 0.59 110.773 -170.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 4.8 m-20 -114.39 104.28 11.89 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.962 0.789 . . . . 1.53 109.164 174.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.652 ' H ' ' HD1' ' A' ' 103' ' ' PHE . 76.6 mt -105.55 130.48 53.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.166 -0.679 . . . . 0.24 109.166 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.517 HG22 ' CG ' ' A' ' 90' ' ' MET . 6.7 m -102.42 122.08 43.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.343 0.592 . . . . 0.29 110.354 -172.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.478 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.2 t80 -91.18 85.54 5.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.308 -0.86 . . . . 1.11 109.486 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.604 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . 7.9 mtm -128.94 172.35 11.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.65 110.943 -175.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.536 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 5.4 mtm180 -84.23 109.84 22.19 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.485 -0.779 . . . . 2.59 109.477 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 2.0 Cg_endo -41.63 -34.7 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.724 3.616 . . . . 1.04 115.51 -168.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -87.03 3.53 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.504 0.557 . . . . 1.17 112.504 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.472 HG23 ' N ' ' A' ' 95' ' ' GLY . 6.2 t -169.22 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.409 -0.182 . . . . 1.09 111.401 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.604 ' CA ' ' HB3' ' A' ' 90' ' ' MET . . . 66.12 78.74 0.22 Allowed Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.137 -0.554 . . . . 1.16 111.784 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 1.061 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 71.6 Cg_exo -47.82 121.51 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.296 2.664 . . . . 1.2 111.958 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -50.08 -39.52 42.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.969 -1.014 . . . . 2.64 113.25 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -112.79 17.53 18.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.32 -0.552 . . . . 4.09 110.925 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 1.061 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 25.3 t0 -121.53 -0.29 9.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.737 0.78 . . . . 1.67 109.57 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 p -97.9 156.22 16.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.104 -0.953 . . . . 1.39 110.96 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 40.6 tt0 -108.26 175.81 5.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.453 -0.943 . . . . 1.91 108.453 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 47.8 ttt180 -158.7 142.81 15.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.685 0.755 . . . . 0.62 110.483 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.757 ' HZ ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -104.16 162.81 12.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.428 -1.26 . . . . 0.86 109.796 -177.443 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 38.2 m -164.67 104.82 0.82 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 123.407 0.442 . . . . 0.31 110.39 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 5' ' ' VAL . 13.4 p -110.87 136.67 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 119.408 -0.917 . . . . 0.88 109.153 166.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' THR . 98.0 m-85 -103.5 103.44 13.41 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.409 -0.96 . . . . 0.7 108.409 174.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.766 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -127.26 147.24 50.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.653 -0.499 . . . . 2.12 109.653 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.688 ' O ' HG22 ' A' ' 16' ' ' VAL . 20.1 tttm -102.38 117.02 33.82 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.78 -0.368 . . . . 1.89 110.346 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.62 120.4 39.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.614 0.571 . . . . 0.53 110.176 -170.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 22.5 p-10 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.516 -0.754 . . . . 1.78 110.422 -174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.98 ' HB3' HG22 ' A' ' 22' ' ' VAL . 16.1 t60 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.072 -0.714 . . . . 0.59 109.072 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 136.65 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.567 -0.288 . . . . 2.36 110.972 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.874 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -112.36 157.5 13.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.856 0.36 . . . . 0.49 111.03 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -151.76 170.64 19.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.421 1.089 . . . . 0.51 108.113 -172.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 26.0 tptp -48.33 -37.06 15.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.561 0.949 . . . . 0.83 113.561 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.08 79.2 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.914 0.864 . . . . 0.33 110.742 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.773 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.6 m80 -65.32 -3.7 4.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.134 -0.939 . . . . 2.12 111.346 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.703 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 26.0 t-20 -50.27 -18.92 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.679 0.612 . . . . 1.41 110.03 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.45 55.73 0.6 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.3 111.285 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.921 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -113.79 156.1 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.041 0.756 . . . . 0.32 113.041 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 m -139.39 112.69 8.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.185 -1.042 . . . . 0.95 108.185 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 23.1 tp -151.14 163.24 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 3.0 111.74 -167.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.0 m -104.58 148.04 26.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.179 -0.674 . . . . 1.73 109.179 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.8 m -127.55 156.82 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.053 -0.659 . . . . 0.78 112.429 -177.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.76 142.4 34.77 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.789 -1.189 . . . . 0.76 107.789 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG12 HG21 ' A' ' 22' ' ' VAL . 10.7 m -119.8 -176.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.792 0.329 . . . . 1.23 110.724 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.6 -59.52 0.69 Allowed Glycine 0 CA--C 1.505 -0.58 0 N-CA-C 111.224 -0.75 . . . . 0.71 111.224 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -73.68 -68.22 0.53 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 2.35 108.96 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -167.64 141.33 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.755 -1.111 . . . . 0.71 110.283 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.98 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -113.68 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.494 -0.928 . . . . 0.4 108.494 169.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.666 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -108.88 157.35 18.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.056 0.931 . . . . 1.09 112.524 -169.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.593 HD13 ' HB ' ' A' ' 5' ' ' VAL . 29.7 mm -134.28 103.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.579 -1.646 . . . . 0.54 108.428 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.528 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -112.73 139.0 48.71 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.528 -0.733 . . . . 0.64 112.194 -175.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -111.59 148.41 38.8 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.531 -0.759 . . . . 0.85 109.947 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 40.3 Cg_endo -87.09 11.84 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.229 2.619 . . . . 0.35 111.976 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.519 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 21.5 t 69.3 -66.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.343 -0.844 . . . . 0.91 110.83 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.23 64.05 2.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.438 -0.949 . . . . 1.39 108.438 -170.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.41 117.76 2.5 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.88 3.053 . . . . 0.83 113.272 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.422 HG23 ' CZ ' ' A' ' 89' ' ' TYR . 22.3 p -91.64 -89.1 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.212 -0.904 . . . . 1.83 112.849 -170.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 t -163.26 22.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.007 0.908 . . . . 2.36 110.141 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.26 -35.83 1.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.46 -0.791 . . . . 1.3 111.377 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' HA ' ' C ' ' A' ' 90' ' ' MET . 2.2 m-85 -62.43 143.99 56.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.974 -0.613 . . . . 2.22 111.189 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -139.53 156.04 47.15 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.387 -0.968 . . . . 0.44 108.387 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.519 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -81.0 117.27 21.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.518 0.675 . . . . 0.43 111.51 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.73 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 56.2 m-85 -127.46 175.78 7.97 Favored 'General case' 0 C--O 1.212 -0.882 0 N-CA-C 108.179 -1.045 . . . . 2.78 108.179 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.72 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -67.2 -74.38 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.773 0.715 . . . . 0.43 109.715 171.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -110.51 -8.16 14.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.048 -0.524 . . . . 2.39 110.157 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.08 106.59 2.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.366 -0.921 . . . . 0.73 112.047 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.25 -23.92 5.86 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.674 . . . . 0.7 112.448 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 m -128.33 141.84 51.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.653 0.263 . . . . 1.13 110.41 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -136.97 134.85 37.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.682 -0.69 . . . . 2.52 110.048 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -128.54 145.85 51.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.754 0.788 . . . . 2.3 112.136 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.867 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 6.2 p -111.43 137.75 21.19 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.584 -0.895 . . . . 1.61 108.584 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 7.5 Cg_exo -74.42 137.16 22.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.434 2.089 . . . . 1.88 111.431 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 69.18 34.46 3.0 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.902 0.751 . . . . 2.43 110.949 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.04 137.93 34.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.787 0.803 . . . . 3.26 110.945 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.7 t 177.56 -55.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.045 -1.434 . . . . 2.06 107.396 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -89.84 -32.41 16.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.015 -0.993 . . . . 1.25 109.336 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.787 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.5 m-85 -119.46 160.36 22.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.463 -1.244 . . . . 0.74 107.767 176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -165.74 169.44 15.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.651 0.66 . . . . 1.46 112.131 -168.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.867 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.2 p -103.1 139.66 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.696 -0.684 . . . . 1.31 111.952 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.836 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.38 142.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.893 -0.78 . . . . 2.45 108.893 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -122.44 133.4 54.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.384 0.611 . . . . 1.93 111.195 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -150.1 111.0 4.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.268 -0.878 . . . . 1.42 110.495 -176.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.913 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -123.92 127.02 47.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.671 -0.695 . . . . 1.66 111.257 -174.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.3 -0.864 . . . . 2.14 111.003 -177.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 109.808 -1.317 . . . . 1.49 109.808 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.497 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -153.99 90.18 1.35 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 113.836 1.05 . . . . 0.97 113.836 -168.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.7 mt-10 -110.31 104.12 12.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.54 -0.754 . . . . 0.81 109.083 175.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.633 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -113.64 159.4 19.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.777 0.799 . . . . 0.53 112.445 -171.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.73 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 44.9 m-85 -132.28 108.91 9.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.933 -1.485 . . . . 1.13 109.4 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.836 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 26.0 m170 -108.61 107.46 17.96 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.203 -0.31 . . . . 0.5 111.339 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -103.75 119.34 52.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.047 0.927 . . . . 0.87 110.419 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.8 m -102.85 105.75 16.2 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.979 -1.119 . . . . 0.46 107.979 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.538 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.3 p -147.45 149.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 123.633 0.583 . . . . 1.04 110.335 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -133.91 102.3 5.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.966 0.888 . . . . 1.54 109.884 167.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -168.34 127.56 1.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.34 -0.845 . . . . 0.67 109.887 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.32 101.42 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 O-C-N 123.648 0.592 . . . . 0.44 111.916 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.87 167.57 36.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.349 -0.7 . . . . 0.29 111.349 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.594 HG23 ' HD2' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -103.43 128.63 50.53 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.9 -0.765 . . . . 0.4 109.883 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.632 ' CE1' HG22 ' A' ' 85' ' ' VAL . 1.8 t-80 -103.38 106.35 16.84 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.526 -0.546 . . . . 0.4 109.526 -175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.38 109.34 21.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.497 -0.927 . . . . 0.35 108.497 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.36 103.83 15.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.027 -0.533 . . . . 0.59 110.257 -169.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.8 OUTLIER -109.65 103.41 12.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.504 -0.771 . . . . 1.53 109.118 177.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' A' ' 38' ' ' PHE . 96.0 mt -104.72 125.56 50.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.763 -0.653 . . . . 0.24 109.571 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.68 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.8 m -100.87 122.46 43.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.658 0.742 . . . . 0.29 110.762 -169.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -92.8 87.18 5.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.686 -1.143 . . . . 1.11 109.884 -174.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.57 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 1.4 mtm -134.1 165.94 23.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.203 0.525 . . . . 0.65 110.993 -173.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.53 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 77.2 mtt180 -64.86 111.28 5.45 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.971 -1.013 . . . . 2.59 109.272 170.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.97 -26.25 24.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.288 2.658 . . . . 1.04 114.405 -171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 94' ' ' THR . 42.9 p90 -90.11 -3.22 58.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.002 0.371 . . . . 1.17 112.002 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 95' ' ' GLY . 6.8 t -169.25 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.462 -0.149 . . . . 1.09 111.369 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.615 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.29 98.13 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 1.16 111.838 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.733 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.7 Cg_exo -49.55 126.69 16.67 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.916 2.411 . . . . 1.2 111.334 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -54.17 -29.75 46.79 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.503 0.927 . . . . 2.64 113.503 -168.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -129.43 14.78 6.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.147 -0.621 . . . . 4.09 111.594 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 16.1 t0 -112.29 -1.82 15.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.857 0.837 . . . . 1.67 109.528 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.7 m -95.0 136.98 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.765 -1.107 . . . . 1.39 110.13 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.681 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.9 tt0 -86.86 179.03 6.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 1.91 108.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.681 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 46.7 ttt180 -158.09 145.05 17.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.903 0.859 . . . . 0.62 110.071 174.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.812 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -103.36 150.79 23.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.004 -1.453 . . . . 0.86 109.124 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.4 m -153.41 102.78 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.862 -0.335 . . . . 0.31 110.862 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.921 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.6 p -104.86 136.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 119.663 -0.815 . . . . 0.88 109.395 167.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -104.4 103.49 13.21 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.271 -0.877 . . . . 0.7 108.703 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 3.1 pp -126.95 152.51 47.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.218 -0.447 . . . . 2.12 109.95 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.762 ' O ' HG22 ' A' ' 16' ' ' VAL . 30.9 tptt -104.91 111.23 23.91 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.681 -0.407 . . . . 1.89 110.099 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -103.47 122.8 45.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 123.409 0.443 . . . . 0.53 110.139 -174.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.468 HD21 ' CG ' ' A' ' 108' ' ' LYS . 10.5 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.188 -0.91 . . . . 1.78 110.687 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.962 ' HB3' HG22 ' A' ' 22' ' ' VAL . 42.8 t60 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.59 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 19.1 ptmt -143.92 142.3 30.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.684 0.278 . . . . 2.36 110.83 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.84 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -107.41 138.97 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 0.49 111.458 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 168.06 10.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.926 -1.034 . . . . 0.51 110.335 171.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.7 tptp -37.5 -45.57 0.74 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.739 1.385 . . . . 0.83 114.739 -172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.96 62.52 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.61 0.719 . . . . 0.33 111.803 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.813 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.5 m80 -65.95 -1.79 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 2.12 111.282 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.715 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 26.2 t-20 -47.38 -17.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.847 0.717 . . . . 1.41 110.089 170.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.93 55.9 0.61 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.7 -0.682 . . . . 0.3 111.74 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.028 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -108.53 158.35 17.64 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.582 0.956 . . . . 0.32 113.582 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.7 m -147.11 104.98 3.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.018 -0.992 . . . . 0.95 108.856 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 17.9 mt -146.29 167.28 23.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.855 0.687 . . . . 3.0 112.855 -170.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.4 m -103.54 136.0 44.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.714 -0.676 . . . . 1.73 110.139 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.597 HG11 ' CD2' ' A' ' 3' ' ' HIS . 30.9 m -126.2 154.04 35.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 0.78 112.11 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.55 143.17 33.42 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.83 -0.804 . . . . 0.76 108.83 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.683 HG12 HG21 ' A' ' 22' ' ' VAL . 23.7 m -121.48 -179.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.952 0.406 . . . . 1.23 111.747 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.97 -60.61 0.67 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.65 -0.704 . . . . 0.71 111.403 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.58 -74.15 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.424 0.63 . . . . 2.35 109.994 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.8 tp -165.61 136.03 3.65 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.977 -1.01 . . . . 0.71 109.681 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.962 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.4 t -120.17 110.18 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.353 0.597 . . . . 0.4 109.663 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 4.4 pt-20 -111.33 159.67 17.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.805 0.812 . . . . 1.09 111.901 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.632 HD12 HG11 ' A' ' 105' ' ' VAL . 29.9 mm -134.26 103.8 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.174 -1.376 . . . . 0.54 108.527 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -108.11 141.44 39.81 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.299 0.571 . . . . 0.64 111.55 -174.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 7' ' ' LYS . 4.1 mm? -117.11 146.75 38.79 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.128 -0.942 . . . . 0.85 108.864 171.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 67.7 Cg_endo -83.98 9.62 4.04 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 122.685 2.257 . . . . 0.35 111.804 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.61 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 69.53 -47.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.042 0.839 . . . . 0.91 110.667 -174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.9 OUTLIER 58.08 63.05 4.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.124 -1.065 . . . . 1.39 108.124 -173.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.5 100.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.669 2.913 . . . . 0.83 113.501 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.446 HG22 ' OH ' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -106.89 -36.67 6.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.091 -0.959 . . . . 1.83 111.074 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 34' ' ' PHE . 11.6 t -176.47 -157.44 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.024 -0.732 . . . . 2.36 109.024 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.41 -22.99 17.24 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.483 -0.389 . . . . 1.3 113.16 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' A' ' 90' ' ' MET . 15.4 m-30 -40.23 137.93 0.95 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.765 0.654 . . . . 2.22 112.765 171.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.26 154.83 41.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.975 -1.011 . . . . 0.44 109.021 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.61 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.3 m95 -85.12 124.29 31.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 0.43 111.369 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.912 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -157.81 145.07 18.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 2.78 109.733 175.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.578 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -48.77 -75.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.333 0.494 . . . . 0.43 112.333 -173.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.21 -17.85 18.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.445 0.64 . . . . 2.39 110.298 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.766 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 113.6 85.56 1.4 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.299 -0.953 . . . . 0.73 111.525 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.29 70.07 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.535 -0.84 . . . . 0.7 111.576 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.7 m -129.1 140.36 51.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 1.13 109.648 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -140.63 141.02 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.655 -0.498 . . . . 2.52 109.655 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.04 161.66 37.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.171 0.51 . . . . 2.3 111.832 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.752 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 20.6 t -115.03 130.88 23.85 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.928 -0.767 . . . . 1.61 108.928 170.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 14.8 Cg_exo -68.91 -4.29 13.12 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.569 2.179 . . . . 1.88 112.064 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.19 4.65 10.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.947 -0.569 . . . . 2.43 111.416 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.6 pt-20 -84.08 101.05 11.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.863 0.84 . . . . 3.26 111.709 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -127.95 5.71 5.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 2.06 110.558 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -170.04 -36.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.214 1.007 . . . . 1.25 108.579 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.833 ' HB3' ' O ' ' A' ' 76' ' ' THR . 4.1 m-85 -104.84 165.33 11.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.581 -1.645 . . . . 0.74 107.424 172.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -157.46 172.04 19.28 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.764 0.711 . . . . 1.46 112.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.752 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 21.8 t -99.57 134.17 39.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.535 -0.757 . . . . 1.31 111.716 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -111.34 125.02 53.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.711 -0.677 . . . . 2.45 109.194 170.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -103.9 152.28 22.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 1.93 110.905 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -162.4 111.77 1.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.42 109.81 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.855 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.2 m-85 -111.39 118.73 36.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.446 -0.343 . . . . 1.66 110.292 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 C--N 1.322 -0.589 0 CA-C-O 121.205 0.526 . . . . 2.14 110.658 176.382 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 110.449 -1.06 . . . . 1.49 110.449 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.25 87.82 1.34 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.638 0.732 . . . . 0.97 112.38 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.855 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.2 mt-10 -104.55 105.78 16.02 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.022 -0.99 . . . . 0.81 108.481 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.722 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 7.5 m-70 -104.98 150.29 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.747 0.784 . . . . 0.53 111.805 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.912 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.6 m-85 -122.82 104.89 9.57 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.303 -1.317 . . . . 1.13 108.864 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -102.47 107.15 18.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.963 -0.384 . . . . 0.5 109.963 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.4 m -102.62 116.53 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 122.706 1.241 . . . . 0.87 108.33 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.833 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.7 m -102.64 106.37 17.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.177 -1.416 . . . . 0.46 107.177 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.0 p -154.58 149.81 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 123.692 0.62 . . . . 1.04 111.13 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -131.18 103.5 6.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.523 -0.547 . . . . 1.54 109.523 167.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.42 127.26 2.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.315 -0.402 . . . . 0.67 110.672 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -60.54 100.53 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.787 0.679 . . . . 0.44 111.089 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.49 169.58 40.0 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.474 -1.051 . . . . 0.29 110.474 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -101.99 132.09 48.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.642 -0.917 . . . . 0.4 109.698 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 85' ' ' VAL . 40.1 t-80 -102.64 104.16 14.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.691 -0.485 . . . . 0.4 109.691 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.53 111.99 24.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.417 -0.586 . . . . 0.35 109.417 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.62 103.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.95 -0.568 . . . . 0.59 110.852 -171.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.483 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.15 102.87 11.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.88 -0.785 . . . . 1.53 108.88 176.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.447 ' HG ' HG12 ' A' ' 85' ' ' VAL . 96.0 mt -108.09 127.41 53.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.773 -0.649 . . . . 0.24 109.96 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.459 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.7 m -102.75 130.59 49.75 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.525 0.679 . . . . 0.29 110.968 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 10.9 t80 -102.6 88.75 3.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.272 -0.877 . . . . 1.11 109.633 -175.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 15.5 mtm -126.75 177.94 6.24 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.457 -0.571 . . . . 0.65 109.457 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.646 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 7.6 ttm180 -93.17 112.73 57.53 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.533 -0.914 . . . . 2.59 108.533 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 93' ' ' TRP . 1.5 Cg_endo -44.74 -48.3 10.68 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.573 2.848 . . . . 1.04 114.293 -169.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 92' ' ' PRO . 39.5 p90 -80.34 0.39 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.566 . . . . 1.17 112.527 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.812 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.3 t -158.4 -79.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.57 -0.159 . . . . 1.09 110.57 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.812 ' H ' HG23 ' A' ' 94' ' ' THR . . . 76.62 82.44 0.53 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 121.066 -0.587 . . . . 1.16 112.013 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.77 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 1.5 Cg_endo -42.17 125.35 3.31 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.852 3.035 . . . . 1.2 112.09 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.6 m -55.01 -39.35 69.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.921 -1.036 . . . . 2.64 112.969 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.76 1.61 19.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.825 -0.35 . . . . 4.09 110.925 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.77 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.2 t0 -100.91 -16.29 17.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.518 0.675 . . . . 1.67 109.427 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.3 p -73.79 133.75 43.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.051 -0.977 . . . . 1.39 111.486 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 8.3 tp10 -86.96 169.64 12.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.596 -0.89 . . . . 1.91 108.596 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 22.0 ttt180 -155.82 142.41 18.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.843 0.83 . . . . 0.62 110.648 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.84 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 3.1 t80 -104.65 154.87 19.41 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.096 -1.411 . . . . 0.86 109.378 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 52.4 m -158.8 101.95 1.66 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.043 0.449 . . . . 0.31 110.253 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 12' ' ' ALA . 11.0 p -104.87 132.0 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.079 -0.648 . . . . 0.88 109.602 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' THR . 69.5 m-85 -105.17 113.55 27.21 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.697 -0.683 . . . . 0.7 109.386 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.681 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -136.27 158.53 44.19 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.351 -0.611 . . . . 2.12 109.351 178.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 30.9 tttm -103.99 114.22 28.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.872 -0.418 . . . . 1.89 109.872 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.498 ' HA ' HG23 ' A' ' 16' ' ' VAL . . . -101.18 125.42 47.81 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.402 0.438 . . . . 0.53 109.851 -171.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.643 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.09 -0.957 . . . . 1.78 110.125 -171.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.813 ' HB3' HG22 ' A' ' 22' ' ' VAL . 5.3 t60 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.33 -0.989 . . . . 0.59 108.33 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -135.41 134.26 39.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.853 0.359 . . . . 2.36 111.402 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.86 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.5 t -118.68 127.49 75.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 0.49 111.004 170.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.14 169.58 8.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.529 -1.214 . . . . 0.51 109.864 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 19.4 tptp -35.2 -44.92 0.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.451 1.278 . . . . 0.83 114.451 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.16 -31.63 53.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.546 0.688 . . . . 0.33 112.385 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.86 ' HB2' HG13 ' A' ' 5' ' ' VAL . 74.1 m80 -68.1 -1.46 5.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.735 -0.666 . . . . 2.12 111.201 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.724 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.8 t-20 -45.94 -20.92 0.1 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.697 0.623 . . . . 1.41 109.765 168.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.84 58.03 0.62 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.371 -0.831 . . . . 0.3 111.256 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.35 151.57 36.72 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.72 0.637 . . . . 0.32 112.72 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 35.4 m -146.12 108.84 4.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.404 -0.817 . . . . 0.95 109.332 174.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.768 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -161.51 167.46 25.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.727 0.299 . . . . 3.0 111.562 -172.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.666 HG23 ' HB3' ' A' ' 108' ' ' LYS . 87.2 m -102.84 144.16 31.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.669 -0.241 . . . . 1.73 110.725 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.9 m -124.96 151.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.058 0.456 . . . . 0.78 111.533 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.63 132.3 51.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.346 -0.983 . . . . 0.76 108.346 167.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 22' ' ' VAL . 1.4 t -109.96 -141.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.375 -0.53 . . . . 1.23 109.895 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -50.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.71 110.906 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.82 -71.06 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.77 136.84 8.36 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.182 -0.917 . . . . 0.71 109.47 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -108.64 117.18 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.123 -0.695 . . . . 0.4 109.123 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.34 140.3 38.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.397 0.618 . . . . 1.09 112.284 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.581 HD12 HG11 ' A' ' 105' ' ' VAL . 40.2 mm -129.21 101.61 6.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.621 -1.172 . . . . 0.54 107.907 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -113.89 138.24 50.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.42 0.628 . . . . 0.64 111.4 -173.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.73 148.25 39.97 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.523 -0.762 . . . . 0.85 109.315 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 16.1 Cg_endo -88.34 13.3 2.59 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 122.74 2.293 . . . . 0.35 110.849 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.622 ' OG ' ' HG3' ' A' ' 71' ' ' GLU . 2.4 m 71.23 -49.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.885 -1.052 . . . . 0.91 111.92 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.42 63.09 5.96 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.491 -0.929 . . . . 1.39 108.491 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -52.83 104.22 0.1 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 123.728 2.952 . . . . 0.83 113.424 -168.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -100.88 -49.99 3.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.003 -0.999 . . . . 1.83 111.044 178.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.534 HG23 ' H ' ' A' ' 34' ' ' PHE . 12.4 t -164.75 -147.88 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.364 -0.606 . . . . 2.36 109.364 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.21 -22.64 37.38 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.61 -0.329 . . . . 1.3 112.633 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CE2' ' HA ' ' A' ' 100' ' ' SER . 4.1 m-30 -35.74 138.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.621 0.971 . . . . 2.22 113.621 169.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -148.19 148.86 31.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.318 -1.31 . . . . 0.44 108.568 172.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.606 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.3 m95 -80.08 112.73 17.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.039 0.447 . . . . 0.43 110.778 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.695 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 58.1 m-85 -118.99 179.79 4.05 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.477 -0.934 . . . . 2.78 108.477 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.64 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -70.24 -78.89 0.07 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.26 -0.576 . . . . 0.43 109.659 170.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -106.16 3.91 28.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.16 0.505 . . . . 2.39 109.815 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.475 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 90.18 112.16 1.49 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.5 -0.773 . . . . 0.73 111.458 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 -19.16 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.7 112.227 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -128.55 142.18 51.14 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.081 0.467 . . . . 1.13 111.834 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.748 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -142.01 127.8 19.3 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.853 -1.067 . . . . 2.52 109.487 168.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.05 155.44 46.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.208 0.528 . . . . 2.3 111.423 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.583 ' OG ' ' HB ' ' A' ' 53' ' ' VAL . 11.1 p -115.42 127.59 26.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.764 -0.653 . . . . 1.61 109.644 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 44.9 Cg_exo -58.21 124.97 17.11 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.695 2.263 . . . . 1.88 112.249 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 91.7 m-20 77.63 30.04 0.5 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.189 0.931 . . . . 2.43 111.981 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.423 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 11.9 pt-20 -79.18 48.79 0.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 3.26 111.769 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.6 m -85.96 -34.49 20.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.372 -0.376 . . . . 2.06 111.415 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -125.54 -31.35 3.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.793 0.806 . . . . 1.25 109.523 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.742 ' HB3' ' O ' ' A' ' 76' ' ' THR . 2.3 m-85 -103.44 167.23 9.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.414 -1.266 . . . . 0.74 107.834 176.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -148.4 165.08 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.046 -0.662 . . . . 1.46 111.198 -160.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.583 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 4.0 p -109.34 150.9 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.408 0.623 . . . . 1.31 111.446 -175.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -124.59 144.67 50.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.264 -0.88 . . . . 2.45 109.817 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 8.6 p30 -123.96 133.82 53.62 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.877 -0.601 . . . . 1.93 109.556 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -154.53 105.24 2.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.771 -0.649 . . . . 1.42 110.738 -175.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.898 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -120.25 142.9 48.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.532 -0.758 . . . . 1.66 110.774 -176.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 C--N 1.321 -0.669 0 CA-C-O 121.118 0.485 . . . . 2.14 110.127 173.22 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.253 0 CA-C-O 121.249 0.36 . . . . 1.49 113.708 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.403 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -157.1 86.99 0.97 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.406 0.521 . . . . 0.97 112.406 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.898 ' HG2' ' HB3' ' A' ' 57' ' ' TYR . 40.9 mt-10 -102.14 106.92 17.85 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.57 . . . . 0.81 109.821 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -112.52 152.6 28.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.628 -0.829 . . . . 0.53 111.669 -174.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.748 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 39.4 m-85 -115.36 119.02 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.912 -1.495 . . . . 1.13 109.08 172.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -113.86 103.72 11.46 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.961 -0.296 . . . . 0.5 110.794 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -105.2 117.9 51.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.104 0.954 . . . . 0.87 110.127 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.742 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 10.5 m -103.65 103.81 13.78 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.77 -1.105 . . . . 0.46 108.428 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.547 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 10.3 p -151.36 144.61 16.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 123.563 0.54 . . . . 1.04 110.341 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -129.29 103.65 7.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.771 0.796 . . . . 1.54 109.742 169.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.98 145.06 6.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.141 -0.936 . . . . 0.67 109.208 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.33 94.07 2.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.141 0.496 . . . . 0.44 111.329 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.89 168.17 31.17 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.29 111.041 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 108' ' ' LYS . 3.1 m -101.35 128.59 47.44 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.837 -0.802 . . . . 0.4 109.566 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.588 ' ND1' HG22 ' A' ' 85' ' ' VAL . 19.2 t-80 -104.29 103.83 13.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.4 109.827 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.75 122.2 42.97 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.325 -0.991 . . . . 0.35 108.325 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -114.86 102.07 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.482 -0.487 . . . . 0.59 110.702 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.551 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -108.75 103.37 12.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.323 -0.991 . . . . 1.53 108.323 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 38' ' ' PHE . 78.5 mt -105.07 124.84 50.22 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.734 -0.666 . . . . 0.24 109.698 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.441 HG22 ' CG ' ' A' ' 90' ' ' MET . 5.6 m -101.74 116.81 33.55 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.958 0.885 . . . . 0.29 110.742 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 2.5 t80 -84.81 96.73 9.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.321 -1.309 . . . . 1.11 109.574 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.475 ' CE ' ' HA3' ' A' ' 40' ' ' GLY . 7.2 mtm -137.77 167.29 22.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.833 0.349 . . . . 0.65 110.214 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 12.4 mtm180 -70.21 103.87 0.7 Allowed Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.659 -0.867 . . . . 2.59 108.659 169.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 3.2 Cg_endo -45.23 -37.88 14.07 Favored 'Trans proline' 0 N--CA 1.477 0.522 0 C-N-CA 123.871 3.047 . . . . 1.04 114.851 -166.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 94' ' ' THR . 43.1 p90 -80.8 -2.14 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 1.17 112.457 -175.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.669 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -162.47 -65.03 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.338 0.113 . . . . 1.09 110.844 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.669 ' H ' HG23 ' A' ' 94' ' ' THR . . . 72.44 85.53 0.21 Allowed Glycine 0 CA--C 1.505 -0.533 0 C-N-CA 121.237 -0.506 . . . . 1.16 111.935 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 72.2 Cg_exo -44.09 113.59 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.41 2.74 . . . . 1.2 112.246 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.5 m -74.24 53.99 0.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.73 -0.668 . . . . 2.64 111.112 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -175.69 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.083 -0.962 . . . . 4.09 109.052 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 34.0 t70 -106.87 -17.61 14.16 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.609 -0.723 . . . . 1.67 109.497 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.616 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 10.0 p -72.96 143.02 47.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.057 -0.974 . . . . 1.39 112.457 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -103.62 171.33 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.193 -1.039 . . . . 1.91 108.193 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.439 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 45.1 ttt180 -153.56 140.36 19.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.804 0.812 . . . . 0.62 110.675 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.796 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -102.9 155.3 18.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.209 -1.359 . . . . 0.86 108.615 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.6 m -158.23 102.25 1.76 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.58 -0.448 . . . . 0.31 111.28 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.9 p -104.78 133.79 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.911 -0.716 . . . . 0.88 109.439 166.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' THR . 73.9 m-85 -104.25 104.44 14.35 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.545 -0.752 . . . . 0.7 109.062 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.768 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 1.5 pp -128.28 154.08 46.29 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.707 -0.397 . . . . 2.12 110.602 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.691 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.0 tptm -104.5 115.51 30.49 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.1 -0.704 . . . . 1.89 109.1 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.13 127.09 49.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.852 0.358 . . . . 0.53 110.75 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.19 -0.91 . . . . 1.78 110.553 -177.632 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.945 ' HB3' HG22 ' A' ' 22' ' ' VAL . 35.8 t60 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.462 -0.94 . . . . 0.59 108.462 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 23' ' ' GLU . 17.6 ptpt -146.01 153.35 40.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.801 0.334 . . . . 2.36 110.672 172.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.871 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.1 t -115.05 135.01 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.158 0.504 . . . . 0.49 111.089 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.453 HG22 ' NE2' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -115.92 170.76 8.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 0.51 110.003 171.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 24.5 tptp -35.72 -49.26 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.75 1.389 . . . . 0.83 114.75 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.13 63.03 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.387 0.613 . . . . 0.33 112.124 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.871 ' HB2' HG13 ' A' ' 5' ' ' VAL . 69.9 m80 -64.91 -2.95 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.556 . . . . 2.12 111.177 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.623 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 21.2 t-20 -44.99 -22.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.214 0 O-C-N 123.694 0.621 . . . . 1.41 110.392 170.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.39 55.1 0.68 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.566 -0.743 . . . . 0.3 111.277 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.883 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -119.06 156.59 29.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.238 0.829 . . . . 0.32 113.238 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 87.6 m -145.93 111.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.004 -0.998 . . . . 0.95 108.927 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 3.8 pp -152.8 167.31 29.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 3.0 111.766 -170.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -103.44 147.21 27.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 1.73 110.414 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.9 m -128.55 162.67 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.78 110.96 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 110' ' ' ASN . . . -109.0 125.96 52.61 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.252 -1.018 . . . . 0.76 108.252 167.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 22' ' ' VAL . 23.2 m -105.28 -168.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.382 -0.527 . . . . 1.23 111.121 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 113.95 -53.09 0.61 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.415 -0.674 . . . . 0.71 111.415 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.45 -73.3 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.169 0.509 . . . . 2.35 109.813 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 tp -166.12 137.19 3.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.71 109.588 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.945 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -117.19 113.97 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.828 0.823 . . . . 0.4 109.63 173.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 4' ' ' LYS . 40.6 mt-10 -102.91 156.99 17.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.115 0.959 . . . . 1.09 112.267 -171.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.694 HD13 ' HB ' ' A' ' 5' ' ' VAL . 40.2 mm -133.66 133.75 56.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.232 -1.766 . . . . 0.54 106.232 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.92 135.65 23.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.601 0.715 . . . . 0.64 111.564 178.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -109.41 153.41 42.8 Favored Pre-proline 0 N--CA 1.431 -1.375 0 CA-C-N 114.818 -1.083 . . . . 0.85 108.977 174.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.586 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 41.7 Cg_endo -90.81 11.35 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.935 2.423 . . . . 0.35 111.457 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.644 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 27.8 t 69.58 -59.6 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 0.91 111.198 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.6 OUTLIER 52.73 56.89 15.06 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.097 -0.705 . . . . 1.39 109.097 -173.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.599 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 81.6 Cg_exo -49.61 111.1 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.832 3.022 . . . . 0.83 113.579 -168.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.492 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.0 p -87.45 -38.93 15.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 1.83 109.417 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t 175.91 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.794 -1.094 . . . . 2.36 108.375 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.04 -33.03 67.93 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 118.23 0.468 . . . . 1.3 113.589 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.603 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 52.7 m-85 -52.09 148.71 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.916 0.389 . . . . 2.22 111.897 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.03 161.42 41.95 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.648 -0.705 . . . . 0.44 109.764 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.644 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -82.76 120.61 25.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.15 0.5 . . . . 0.43 112.012 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.71 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -156.15 147.69 22.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.101 -0.703 . . . . 2.78 109.101 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -40.93 -68.76 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.61 0.596 . . . . 0.43 112.61 -171.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.15 17.69 2.44 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.568 -0.453 . . . . 2.39 111.828 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.535 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 125.0 85.88 0.64 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 119.778 -1.201 . . . . 0.73 113.075 170.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.82 12.25 10.06 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.843 -0.694 . . . . 0.7 112.242 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -135.16 139.26 44.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.469 -0.937 . . . . 1.13 108.469 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.63 142.19 33.42 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.376 0.423 . . . . 2.52 110.546 -173.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.56 153.12 47.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.06 0.457 . . . . 2.3 111.505 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.831 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 18.0 t -104.77 132.87 20.51 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.8 -0.815 . . . . 1.61 108.8 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 84' ' ' ALA . 9.9 Cg_exo -72.86 25.21 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.304 2.669 . . . . 1.88 113.426 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -178.49 48.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.297 0.57 . . . . 2.43 109.486 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.831 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 8.8 pt-20 -114.64 122.6 46.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.742 0.782 . . . . 3.26 111.147 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -141.99 -39.72 0.37 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.806 -1.088 . . . . 2.06 108.819 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.869 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.77 -35.41 6.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.629 -0.714 . . . . 1.25 110.516 176.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.869 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 9.3 m-85 -108.9 164.46 12.38 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.497 -0.927 . . . . 0.74 108.497 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -161.84 172.08 16.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.411 0.624 . . . . 1.46 112.598 -164.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 20.3 t -99.73 143.99 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.411 -0.813 . . . . 1.31 111.472 -174.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 7.5 pt-20 -109.33 132.22 54.33 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.644 -0.873 . . . . 2.45 108.644 169.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.61 131.87 53.9 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.537 -0.865 . . . . 1.93 110.986 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.78 104.89 2.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.098 -0.955 . . . . 1.42 110.34 -172.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CB ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 p90 -131.2 131.59 44.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.448 0.642 . . . . 1.66 112.153 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 2.14 110.507 -175.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.748 0 N-CA-C 110.302 -1.119 . . . . 1.49 110.302 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 86.01 1.05 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 117.902 0.851 . . . . 0.97 112.571 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.634 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 37.6 mt-10 -104.36 104.37 14.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.81 109.716 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -114.12 163.71 14.83 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.22 1.009 . . . . 0.53 112.577 -171.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 42.0 m-85 -140.13 104.08 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.173 -1.831 . . . . 1.13 108.769 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.601 ' HB2' ' CG ' ' A' ' 54' ' ' GLU . 55.6 m170 -103.35 123.45 46.83 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.824 -0.548 . . . . 0.5 110.034 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 53' ' ' VAL . 3.4 m -105.77 123.4 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 122.23 1.014 . . . . 0.87 109.918 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.719 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 8.5 m -102.64 104.78 15.17 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.806 -1.183 . . . . 0.46 107.806 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.6 p -150.46 142.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.118 -0.492 . . . . 1.04 110.694 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.55 101.59 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.265 0.555 . . . . 1.54 109.713 167.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -167.5 145.78 4.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.406 -0.816 . . . . 0.67 109.602 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.24 89.89 2.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.44 110.81 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.12 166.93 31.69 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 110.717 -0.953 . . . . 0.29 110.717 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.5 132.25 48.67 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.692 0.746 . . . . 0.4 109.811 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.569 ' ND1' HG22 ' A' ' 85' ' ' VAL . 45.1 t-80 -104.42 106.14 16.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.173 -0.467 . . . . 0.4 110.527 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 46' ' ' PRO . . . -101.2 115.23 30.02 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.325 -0.62 . . . . 0.35 109.325 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.5 t -106.3 105.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.848 -0.615 . . . . 0.59 111.331 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 7.5 m120 -112.96 102.89 10.86 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.47 -0.567 . . . . 1.53 109.47 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 98.8 mt -107.33 123.4 48.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.674 -0.694 . . . . 0.24 109.453 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.448 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 5.4 m -103.45 130.73 50.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.4 0.619 . . . . 0.29 111.405 -170.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 43.7 t80 -95.76 84.91 3.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.399 -0.819 . . . . 1.11 109.776 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.689 ' HE2' ' HE1' ' A' ' 37' ' ' TYR . 17.4 mtm -121.53 173.7 7.24 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.905 0.383 . . . . 0.65 109.981 -175.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.611 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 3.2 ttm-85 -86.71 114.06 56.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 108.861 -0.792 . . . . 2.59 108.861 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.8 Cg_endo -49.86 -27.33 15.64 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.976 3.118 . . . . 1.04 115.88 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 42.7 p90 -104.03 10.77 35.95 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.945 -0.472 . . . . 1.17 111.996 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.8 t -166.05 -62.0 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.26 -0.176 . . . . 1.09 111.034 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.611 ' HA2' ' H ' ' A' ' 91' ' ' ARG . . . 61.86 79.24 0.14 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 112.13 -0.388 . . . . 1.16 112.13 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.764 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 50.6 Cg_exo -36.08 128.21 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.839 3.026 . . . . 1.2 112.562 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 p -35.01 -64.23 0.28 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 124.663 1.227 . . . . 2.64 114.059 -170.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -124.0 33.8 5.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.333 -0.547 . . . . 4.09 110.685 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.764 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 29.1 t0 -106.82 -4.66 19.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.98 0.895 . . . . 1.67 108.905 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.461 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.9 m -89.0 142.41 27.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.346 -1.297 . . . . 1.39 110.252 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.651 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 29.1 tt0 -92.49 179.31 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.01 -0.737 . . . . 1.91 109.01 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.651 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 29.7 ttt180 -161.65 142.51 10.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.719 0.771 . . . . 0.62 111.408 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.794 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 1.2 t80 -105.22 154.39 20.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.237 -1.347 . . . . 0.86 109.341 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 45.1 m -158.45 102.43 1.73 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.31 110.97 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.883 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.6 p -107.21 136.62 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 120.027 -0.669 . . . . 0.88 109.53 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' THR . 78.4 m-85 -104.62 104.08 13.85 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.629 -0.878 . . . . 0.7 108.629 174.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.624 HD13 HG11 ' A' ' 16' ' ' VAL . 3.3 pp -122.67 145.46 48.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.947 -0.76 . . . . 2.12 108.947 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.784 ' O ' HG22 ' A' ' 16' ' ' VAL . 71.7 tttt -103.27 124.52 48.8 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.105 -0.638 . . . . 1.89 109.704 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.98 129.34 46.81 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.456 0.473 . . . . 0.53 110.31 -170.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.634 ' C ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.747 0 CA-C-O 118.314 -0.85 . . . . 1.78 109.816 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.953 ' HB3' HG22 ' A' ' 22' ' ' VAL . 23.6 t60 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.001 -0.74 . . . . 0.59 109.001 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -138.7 148.17 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.014 0.435 . . . . 2.36 110.765 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.866 HG13 ' HB2' ' A' ' 9' ' ' HIS . 1.9 t -112.41 138.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 0.49 110.928 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.96 169.07 9.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.4 -0.818 . . . . 0.51 110.322 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.3 tptp -39.72 -43.72 1.44 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.01 1.115 . . . . 0.83 114.01 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.96 -35.45 33.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.645 0.736 . . . . 0.33 111.862 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.866 ' HB2' HG13 ' A' ' 5' ' ' VAL . 76.0 m80 -66.26 -1.96 3.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.496 -0.775 . . . . 2.12 111.654 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.721 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.9 t-20 -46.01 -21.54 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.414 0.626 . . . . 1.41 109.586 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.08 57.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.3 111.376 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.875 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.23 160.53 20.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.257 0.836 . . . . 0.32 113.257 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 14.2 m -151.48 114.59 4.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.016 -0.993 . . . . 0.95 109.116 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.6 pt? -158.26 166.73 31.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.172 0.51 . . . . 3.0 111.606 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -104.04 141.5 36.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 1.73 110.523 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.7 m -126.75 152.1 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.417 -0.356 . . . . 0.78 111.196 -175.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.54 118.26 36.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.838 -0.801 . . . . 0.76 108.838 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.718 HG12 HG21 ' A' ' 22' ' ' VAL . 27.3 m -100.01 -170.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.252 0.548 . . . . 1.23 111.584 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.641 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 128.38 -46.02 1.11 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.214 -0.754 . . . . 0.71 111.214 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -89.48 -69.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.64 -0.504 . . . . 2.35 109.64 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.2 tp -166.46 126.06 1.57 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.59 -0.732 . . . . 0.71 111.177 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -107.85 114.32 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.819 0.818 . . . . 0.4 110.05 174.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.01 153.48 20.2 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.884 0.849 . . . . 1.09 112.1 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.599 HD13 ' HB ' ' A' ' 5' ' ' VAL . 49.1 mm -133.21 102.48 4.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 113.758 -1.564 . . . . 0.54 107.467 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -114.16 132.84 55.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.057 0.932 . . . . 0.64 111.752 -172.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.47 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 3.9 mm? -109.27 154.54 42.09 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.584 -1.189 . . . . 0.85 108.924 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 65.3 Cg_endo -88.99 9.53 3.56 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 122.741 2.294 . . . . 0.35 111.394 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.665 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 19.9 t 69.47 -57.21 0.54 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.219 -0.901 . . . . 0.91 110.474 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.7 OUTLIER 54.35 62.98 7.91 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.984 -1.117 . . . . 1.39 107.984 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 52.9 Cg_exo -54.46 112.9 1.14 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.528 2.819 . . . . 0.83 113.209 -165.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.464 HG23 ' CE2' ' A' ' 89' ' ' TYR . 8.3 p -92.5 -43.67 9.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.459 -0.791 . . . . 1.83 110.086 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.677 HG23 ' HD1' ' A' ' 34' ' ' PHE . 5.1 t 175.79 -136.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.571 -0.9 . . . . 2.36 108.571 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.44 -17.13 46.41 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 118.024 0.375 . . . . 1.3 113.551 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.677 ' HD1' HG23 ' A' ' 32' ' ' THR . 2.4 m-85 -68.86 142.74 54.73 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.987 0.515 . . . . 2.22 110.584 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -149.13 159.06 44.58 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.27 -0.641 . . . . 0.44 109.27 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.58 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 98.2 m95 -73.48 119.32 17.55 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.361 0.601 . . . . 0.43 111.474 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 41.6 m-85 -128.46 -177.09 4.03 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 115.425 -0.807 . . . . 2.78 108.862 170.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.5 m-85 -78.15 -77.71 0.15 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.49 0.586 . . . . 0.43 109.93 168.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.25 -0.54 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 2.39 110.532 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 108.23 102.87 2.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.748 . . . . 0.73 112.28 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.13 2.79 67.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.848 -0.692 . . . . 0.7 111.662 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -132.33 144.56 50.65 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.834 0.453 . . . . 1.13 111.783 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.629 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.58 132.2 27.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.444 -0.798 . . . . 2.52 110.582 167.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.47 152.57 50.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.023 -0.535 . . . . 2.3 110.786 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.598 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 17.3 t -119.76 135.17 24.03 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.033 -0.729 . . . . 1.61 109.033 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 12.2 Cg_exo -70.7 -8.08 22.79 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.802 2.335 . . . . 1.88 113.07 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.437 HD21 ' HA3' ' A' ' 81' ' ' GLY . 5.0 m-20 -125.72 26.23 6.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 2.43 111.075 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 45' ' ' SER . 15.3 pt-20 -95.23 77.27 3.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.341 1.067 . . . . 3.26 111.693 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -95.3 -56.79 2.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.858 -1.064 . . . . 2.06 110.203 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.772 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 18.1 ptt? -108.25 -31.28 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.742 -1.117 . . . . 1.25 109.243 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.772 ' HD1' ' HG3' ' A' ' 50' ' ' MET . 12.3 m-85 -103.8 167.97 9.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.743 -1.571 . . . . 0.74 108.009 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 14.7 t -158.63 168.75 26.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.709 0.686 . . . . 1.46 112.427 -169.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.8 p -101.2 136.77 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.311 -0.859 . . . . 1.31 110.988 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 8.2 pt-20 -127.99 141.97 51.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.43 -0.804 . . . . 2.45 109.619 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -108.21 140.34 41.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 1.93 111.739 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.823 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.23 104.24 3.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.103 -0.953 . . . . 1.42 109.39 171.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.6 p90 -124.63 150.26 46.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.563 -0.744 . . . . 1.66 110.853 -172.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.256 0.551 . . . . 2.14 112.197 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.375 0 N-CA-C 110.978 -0.849 . . . . 1.49 110.978 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.6 HG22 ' NE2' ' A' ' 72' ' ' HIS . 31.8 m 137.14 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.227 1.411 . . . . 0.97 108.733 150.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 39.4 mt-10 -103.51 115.63 30.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.671 -1.149 . . . . 0.81 110.167 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.823 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 1.7 m170 -108.53 144.98 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.678 0.751 . . . . 0.53 111.775 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.633 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 14.2 m-85 -116.77 112.38 21.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.513 -1.221 . . . . 1.13 109.058 170.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.428 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 15.8 m170 -104.45 113.99 27.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.059 -0.519 . . . . 0.5 110.764 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.3 m -104.54 118.53 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 122.252 1.025 . . . . 0.87 108.501 171.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.744 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.1 m -102.26 103.74 14.24 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.48 -1.304 . . . . 0.46 107.48 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.621 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 4.7 p -155.94 142.01 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 123.651 0.594 . . . . 1.04 111.158 -173.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.641 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -127.14 101.78 6.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.057 -0.72 . . . . 1.54 109.057 165.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.62 138.19 4.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 0.67 109.92 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.65 99.48 3.11 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.746 0.654 . . . . 0.44 111.854 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 47' ' ' ASN . . . -165.71 166.46 38.55 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.429 -1.068 . . . . 0.29 110.429 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 5.5 m -100.83 130.78 46.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.138 0.969 . . . . 0.4 109.957 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.732 ' HD1' HG22 ' A' ' 85' ' ' VAL . 36.5 t-80 -102.97 105.47 15.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.211 -0.904 . . . . 0.4 109.854 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.52 24.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.121 -0.696 . . . . 0.35 109.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.732 HG22 ' HD1' ' A' ' 83' ' ' HIS . 2.3 t -105.45 103.08 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.604 -0.726 . . . . 0.59 110.928 -170.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -109.12 103.26 12.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.148 -0.686 . . . . 1.53 109.148 176.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 38' ' ' PHE . 88.1 mt -105.78 126.04 51.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.691 -0.686 . . . . 0.24 110.507 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.699 HG22 ' HG3' ' A' ' 90' ' ' MET . 6.0 m -102.55 121.2 41.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.339 0.59 . . . . 0.29 110.98 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.637 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 54.1 t80 -86.52 97.79 10.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 1.11 109.284 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.699 ' HG3' HG22 ' A' ' 88' ' ' THR . 27.6 mtm -134.39 159.48 40.92 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.275 -0.42 . . . . 0.65 111.83 -172.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 48.3 mtt180 -64.2 105.55 0.73 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 108.227 -1.027 . . . . 2.59 108.227 163.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -46.63 -32.16 11.34 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.633 2.888 . . . . 1.04 114.765 -167.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.423 ' CD1' HG22 ' A' ' 94' ' ' THR . 37.7 p90 -88.12 -2.82 58.84 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.133 0.42 . . . . 1.17 112.133 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -162.23 -68.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.493 -0.129 . . . . 1.09 111.338 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.683 ' H ' HG23 ' A' ' 94' ' ' THR . . . 73.41 78.38 0.56 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.789 -0.719 . . . . 1.16 111.533 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 13.0 Cg_exo -32.84 114.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.103 3.202 . . . . 1.2 113.066 172.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 p -41.27 -55.66 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.801 -1.091 . . . . 2.64 113.361 -171.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -100.11 20.07 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.626 -0.43 . . . . 4.09 111.636 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 14.0 t0 -124.34 6.17 8.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 1.67 110.308 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 32.8 m -98.61 147.86 24.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.454 -0.794 . . . . 1.39 111.149 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.637 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 4.7 tp10 -100.52 166.69 10.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.067 -0.716 . . . . 1.91 109.067 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 46.8 ttt180 -153.51 140.14 18.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.77 0.795 . . . . 0.62 111.232 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.777 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -104.4 157.4 17.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.116 -1.402 . . . . 0.86 109.07 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 53.5 m -159.55 102.4 1.54 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.839 0.352 . . . . 0.31 110.977 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.875 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.6 p -105.55 138.91 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.033 -0.667 . . . . 0.88 110.1 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.4 m-85 -104.52 104.2 14.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.458 -0.792 . . . . 0.7 109.034 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.9 pp -126.0 148.53 49.26 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.213 -0.662 . . . . 2.12 109.213 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.719 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.4 ttmm -104.59 122.71 46.16 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.198 -0.601 . . . . 1.89 110.165 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -101.74 128.9 47.87 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.414 0.446 . . . . 0.53 110.134 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.608 ' C ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.52 -0.752 . . . . 1.78 110.34 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.953 ' HB3' HG22 ' A' ' 22' ' ' VAL . 26.8 t60 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 108.932 -0.766 . . . . 0.59 108.932 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -132.28 144.65 50.74 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.938 -0.305 . . . . 2.36 110.254 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.857 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -112.64 133.48 58.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.49 111.134 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -117.46 170.29 8.85 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.974 -1.012 . . . . 0.51 109.462 170.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.792 ' HD3' HD21 ' A' ' 29' ' ' ASN . 8.6 tptm -34.82 -49.04 0.42 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.973 1.471 . . . . 0.83 114.973 -170.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.06 63.81 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.326 0.584 . . . . 0.33 112.537 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.857 ' HB2' HG13 ' A' ' 5' ' ' VAL . 75.3 m80 -64.49 -2.86 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 2.12 110.903 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 21.7 t-20 -45.53 -19.63 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.975 0.797 . . . . 1.41 110.484 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.32 59.27 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.97 -0.852 . . . . 0.3 110.97 175.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.805 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -120.35 148.21 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.903 0.705 . . . . 0.32 112.903 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 106' ' ' TYR . 85.5 m -134.73 119.08 17.8 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.42 -0.809 . . . . 0.95 109.163 168.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pt? -159.69 166.27 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 3.0 111.036 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.0 m -103.29 148.1 26.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.255 -0.43 . . . . 1.73 110.437 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.3 m -126.41 155.41 36.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.78 111.441 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.52 111.49 22.54 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.945 -0.761 . . . . 0.76 108.945 171.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.814 HG21 ' HA ' ' A' ' 78' ' ' LYS . 12.9 m -89.84 -167.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.946 0.403 . . . . 1.23 111.078 -173.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.0 -54.49 0.73 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.238 -0.745 . . . . 0.71 111.238 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.2 -63.2 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.722 -0.844 . . . . 2.35 108.722 171.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 22' ' ' VAL . 54.9 tp -165.5 163.61 19.52 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.495 -1.229 . . . . 0.71 109.944 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.3 t -140.46 106.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.449 -0.945 . . . . 0.4 108.449 164.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.604 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.0 pt-20 -112.25 158.36 19.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 122.222 1.011 . . . . 1.09 112.579 -172.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.576 HD12 HG11 ' A' ' 105' ' ' VAL . 46.0 mm -132.9 103.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.451 -1.704 . . . . 0.54 108.5 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -113.27 133.5 55.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.819 0.819 . . . . 0.64 111.535 -176.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -108.88 144.27 29.29 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.062 -0.972 . . . . 0.85 108.997 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 67.4 Cg_endo -81.09 10.1 3.55 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 122.499 2.132 . . . . 0.35 111.264 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.704 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 19.4 t 69.37 -61.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.997 -1.001 . . . . 0.91 111.191 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.792 HD21 ' HD3' ' A' ' 7' ' ' LYS . 1.7 m-80 56.6 62.01 6.64 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.942 -0.762 . . . . 1.39 108.942 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 74.8 Cg_exo -52.12 103.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.369 2.712 . . . . 0.83 113.105 -168.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.5 p -83.15 -37.27 23.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.347 -0.842 . . . . 1.83 110.027 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 34' ' ' PHE . 7.7 t 179.11 -144.53 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.402 -0.962 . . . . 2.36 108.402 -177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.74 -11.33 29.41 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 118.093 0.406 . . . . 1.3 113.242 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 90' ' ' MET . 1.4 m-85 -71.78 151.71 43.29 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.003 0.521 . . . . 2.22 111.469 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -152.15 161.67 42.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.801 -0.636 . . . . 0.44 109.663 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -79.53 117.18 20.24 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.402 0.62 . . . . 0.43 111.437 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.586 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 70.7 m-85 -125.17 -178.41 4.19 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 108.083 -1.08 . . . . 2.78 108.083 168.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.85 -80.36 0.06 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.029 -0.669 . . . . 0.43 109.556 169.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -104.08 -0.31 28.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.246 0.546 . . . . 2.39 110.168 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.574 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 102.22 104.73 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.73 111.826 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.88 -0.69 71.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.742 -0.742 . . . . 0.7 111.955 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.625 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -129.71 141.56 50.87 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.843 0.354 . . . . 1.13 111.493 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.12 129.54 17.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.375 -0.83 . . . . 2.52 110.334 167.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.09 153.79 51.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.082 0.467 . . . . 2.3 111.257 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.539 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 18.1 t -104.71 129.2 25.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 1.61 108.712 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 10.9 Cg_endo -96.22 161.54 1.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.205 3.27 . . . . 1.88 112.573 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 70.92 8.5 6.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.264 -0.88 . . . . 2.43 111.176 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 51' ' ' PHE . 5.5 tp10 -158.27 134.04 9.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.514 0.673 . . . . 3.26 112.091 -171.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 p -130.09 28.36 5.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.799 -1.091 . . . . 2.06 109.521 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.544 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 21.5 ptt? -138.0 -40.96 0.53 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.486 -0.931 . . . . 1.25 108.486 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.816 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.6 m-85 -103.05 149.75 24.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.72 -1.585 . . . . 0.74 106.72 165.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 171.61 18.93 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.834 -0.746 . . . . 1.46 111.536 -161.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.6 ' HB ' HG12 ' A' ' 75' ' ' VAL . 6.1 p -100.34 139.98 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.404 0.621 . . . . 1.31 112.248 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 11.2 pt-20 -109.34 152.28 25.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.571 -0.9 . . . . 2.45 108.571 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -128.2 140.06 52.12 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.75 -0.38 . . . . 1.93 111.289 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.86 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.34 114.5 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.332 0.587 . . . . 1.42 110.273 173.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 8.2 m-85 -109.7 105.11 14.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.796 -0.638 . . . . 1.66 110.057 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 115.988 -0.551 . . . . 2.14 111.297 -177.454 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 111.065 -0.814 . . . . 1.49 111.065 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -156.89 92.44 1.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.711 0.634 . . . . 0.97 112.711 -174.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 37.1 mt-10 -104.09 109.11 20.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.572 -0.899 . . . . 0.81 108.572 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.7 m170 -108.19 145.97 33.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.551 0.691 . . . . 0.53 112.056 -170.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.586 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.5 m-85 -121.24 104.54 9.81 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.057 -1.429 . . . . 1.13 108.596 170.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.643 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 19.6 m170 -104.24 107.87 18.99 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 122.234 -0.291 . . . . 0.5 110.284 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.6 HG12 ' HB ' ' A' ' 53' ' ' VAL . 3.8 m -101.56 118.87 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 122.349 1.071 . . . . 0.87 108.294 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.6 m -101.74 103.98 14.76 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.702 -1.592 . . . . 0.46 106.702 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.676 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -151.26 147.41 15.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.133 0.896 . . . . 1.04 110.874 -170.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.814 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.61 102.07 4.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.217 0.532 . . . . 1.54 109.988 170.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -163.23 137.1 5.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 0.67 110.137 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.44 77.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.264 0.554 . . . . 0.44 111.651 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.47 166.76 29.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.798 -0.921 . . . . 0.29 110.798 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -99.98 133.08 44.87 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.519 -0.872 . . . . 0.4 109.047 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.648 ' ND1' HG22 ' A' ' 85' ' ' VAL . 12.5 t-80 -103.45 103.64 13.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.184 -0.673 . . . . 0.4 109.184 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.33 109.11 20.68 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.877 -0.786 . . . . 0.35 108.877 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.39 106.87 21.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.166 -0.47 . . . . 0.59 111.146 -170.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 5.0 m-80 -109.42 103.8 12.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.498 -0.774 . . . . 1.53 109.232 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.667 HD23 ' HA ' ' A' ' 38' ' ' PHE . 84.9 mt -105.23 123.6 48.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.461 -0.791 . . . . 0.24 109.744 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.4 m -102.5 120.09 39.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.29 110.933 -172.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.869 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 50.1 t80 -88.23 98.22 11.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 1.11 109.732 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.71 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 10.2 mtm -136.3 163.98 29.15 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 110.277 -0.268 . . . . 0.65 110.277 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.558 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 12.8 ttt180 -65.41 110.59 4.56 Favored Pre-proline 0 C--O 1.221 -0.405 0 N-CA-C 107.673 -1.232 . . . . 2.59 107.673 168.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.544 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 1.7 Cg_endo -43.98 -33.96 5.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.231 3.288 . . . . 1.04 115.42 -169.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 48.9 p90 -102.24 8.03 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.859 0.689 . . . . 1.17 112.859 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 95' ' ' GLY . 12.8 t -167.8 -55.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.789 -0.364 . . . . 1.09 111.602 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 58.1 78.75 0.12 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-O 119.703 -0.498 . . . . 1.16 113.377 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.55 ' HB2' ' HZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -29.08 115.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.236 3.291 . . . . 1.2 113.439 170.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 m -73.42 67.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.301 -0.863 . . . . 2.64 111.261 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 t60 176.35 -30.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.18 -0.918 . . . . 4.09 109.078 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.508 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -91.81 -7.18 50.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.67 110.018 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -68.3 122.3 18.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.008 -0.996 . . . . 1.39 112.404 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.869 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.6 tp10 -91.05 165.33 13.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.023 -1.103 . . . . 1.91 108.023 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.434 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 39.2 ttt180 -159.2 136.98 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.711 0.767 . . . . 0.62 111.094 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -104.3 154.37 19.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.438 -1.256 . . . . 0.86 109.162 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.1 m -154.87 103.25 2.41 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.866 -0.333 . . . . 0.31 110.783 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.805 HG23 ' HB3' ' A' ' 12' ' ' ALA . 10.6 p -104.96 136.12 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 119.676 -0.81 . . . . 0.88 109.682 168.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 13' ' ' THR . 74.4 m-85 -103.9 104.15 14.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.467 -0.938 . . . . 0.7 108.467 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.4 pp -122.68 146.17 47.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.269 -0.641 . . . . 2.12 109.269 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.771 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.7 ttmm -103.48 116.71 32.91 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.559 -0.456 . . . . 1.89 111.0 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.65 151.3 21.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.896 -0.779 . . . . 0.53 108.896 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.582 ' O ' HG22 ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.804 -0.617 . . . . 1.78 111.631 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 1.026 ' HB3' HG22 ' A' ' 22' ' ' VAL . 43.8 t60 . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.23 -0.656 . . . . 0.59 109.23 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -142.65 130.84 22.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.283 -0.417 . . . . 2.36 110.499 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.864 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -106.58 137.05 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.399 -0.52 . . . . 0.49 111.702 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -119.01 168.75 10.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.51 109.412 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -40.11 -39.46 0.9 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.47 1.285 . . . . 0.83 114.47 -170.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.81 -36.45 62.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.558 0.694 . . . . 0.33 111.83 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.864 ' HB2' HG13 ' A' ' 5' ' ' VAL . 77.6 m80 -65.66 -1.59 2.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.649 -0.705 . . . . 2.12 111.41 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.752 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.9 t-20 -46.01 -19.36 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.316 0.646 . . . . 1.41 110.161 169.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -142.12 55.33 0.59 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.427 -0.669 . . . . 0.3 111.427 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.819 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -112.45 160.22 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.97 0.73 . . . . 0.32 112.97 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 34.1 m -152.25 110.37 3.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.158 -0.928 . . . . 0.95 109.336 173.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.724 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.5 pt? -158.13 166.58 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 3.0 111.195 -172.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 108' ' ' LYS . 94.5 m -104.2 148.61 26.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.945 0.403 . . . . 1.73 110.715 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.2 m -125.53 157.65 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.78 110.035 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.34 104.2 12.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.65 -0.5 . . . . 0.76 109.65 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 22' ' ' VAL . 33.2 m -84.09 175.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.234 0.54 . . . . 1.23 112.072 -172.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.77 -32.15 3.38 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.71 111.211 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.74 -76.22 0.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.664 -0.495 . . . . 2.35 109.664 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.2 tp -166.05 123.39 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.462 -0.79 . . . . 0.71 110.66 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -107.78 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.598 0.713 . . . . 0.4 109.645 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -113.0 159.25 19.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.869 0.842 . . . . 1.09 112.44 -172.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.709 HD12 HG11 ' A' ' 105' ' ' VAL . 47.2 mm -134.43 102.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.111 -1.404 . . . . 0.54 108.722 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -106.03 141.57 37.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.368 0.604 . . . . 0.64 111.334 -175.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.93 142.65 42.94 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.562 -0.744 . . . . 0.85 110.284 172.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.494 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 43.3 Cg_endo -84.2 16.29 1.96 Allowed 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.787 2.325 . . . . 0.35 112.427 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.7 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.0 t 65.8 -61.25 0.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.657 0.783 . . . . 0.91 111.219 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.494 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 58.8 83.44 0.22 Allowed Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.292 -1.003 . . . . 1.39 108.292 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.88 98.36 0.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.388 2.725 . . . . 0.83 113.416 -166.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.486 ' OG1' ' HE2' ' A' ' 89' ' ' TYR . 6.4 p -83.13 -45.29 14.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.034 -0.728 . . . . 1.83 109.034 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.689 HG23 ' HD1' ' A' ' 34' ' ' PHE . 8.9 t 173.91 -140.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.024 -0.989 . . . . 2.36 108.503 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.24 -27.78 47.74 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 118.043 0.383 . . . . 1.3 113.853 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.689 ' HD1' HG23 ' A' ' 32' ' ' THR . 41.6 m-85 -56.56 147.79 21.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.058 0.543 . . . . 2.22 111.67 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.524 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -152.37 157.8 41.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.067 0.547 . . . . 0.44 109.637 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.7 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 92.9 m95 -78.29 119.74 22.07 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.415 0.626 . . . . 0.43 111.688 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.54 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 85.0 m-85 -126.55 -177.79 4.12 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.012 -1.107 . . . . 2.78 108.012 168.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -72.88 -76.61 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.934 -0.707 . . . . 0.43 109.576 165.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.5 3.09 8.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.77 -0.65 . . . . 2.39 111.009 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.0 100.38 1.11 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.03 -1.081 . . . . 0.73 113.327 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.13 22.38 60.55 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.847 -0.692 . . . . 0.7 111.916 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -140.35 142.38 35.58 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 122.754 0.422 . . . . 1.13 111.209 -174.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.73 140.51 31.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.99 -0.55 . . . . 2.52 110.035 164.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.76 145.44 46.6 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.915 -0.584 . . . . 2.3 110.271 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 2.9 p -104.17 128.48 27.03 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.536 -0.913 . . . . 1.61 108.536 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.7 Cg_exo -77.83 39.83 0.8 Allowed 'Trans proline' 0 C--N 1.335 -0.166 0 C-N-CA 123.492 2.795 . . . . 1.88 112.835 -170.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.406 ' HB3' HG21 ' A' ' 77' ' ' VAL . 7.4 t-20 -173.99 32.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.485 -0.561 . . . . 2.43 109.485 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.471 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 10.9 pt-20 -94.85 109.17 21.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.712 0.768 . . . . 3.26 111.585 -173.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.2 m -145.92 10.46 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.464 -0.789 . . . . 2.06 110.118 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -178.12 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 1.25 109.122 -172.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.754 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.5 m-85 -123.58 157.25 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.17 -1.377 . . . . 0.74 107.835 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -152.57 166.46 31.98 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.662 0.616 . . . . 1.46 112.662 -162.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.888 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 p -109.27 136.11 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.607 -0.724 . . . . 1.31 111.818 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.92 137.79 51.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.59 -0.732 . . . . 2.45 109.628 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.86 142.74 34.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.236 -0.586 . . . . 1.93 110.784 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.42 104.92 3.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.432 -0.804 . . . . 1.42 109.861 -177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.929 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -116.62 132.39 56.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.367 0.603 . . . . 1.66 112.189 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 2.14 109.723 172.735 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.0 0 N-CA-C 111.72 -0.552 . . . . 1.49 111.72 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.38 81.47 1.12 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.617 0.723 . . . . 0.97 110.757 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.929 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 20.9 mt-10 -104.05 102.44 12.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.949 -1.023 . . . . 0.81 108.405 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -113.81 151.3 32.26 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.411 -0.916 . . . . 0.53 111.324 -174.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.54 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 39.6 m-85 -118.83 104.45 10.56 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.97 -1.468 . . . . 1.13 109.332 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.58 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 17.9 m170 -104.64 104.86 14.75 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.252 -0.431 . . . . 0.5 110.883 -171.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.888 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.98 120.82 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 122.424 1.107 . . . . 0.87 109.785 177.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.6 m -102.92 104.43 14.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.508 -1.223 . . . . 0.46 107.839 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.624 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.2 p -147.29 147.35 17.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.808 0.693 . . . . 1.04 110.672 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -130.45 103.48 6.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.993 0.902 . . . . 1.54 108.664 166.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.84 166.15 15.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.257 -0.883 . . . . 0.67 109.189 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.91 102.74 14.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 0.44 110.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.51 167.18 37.6 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.726 -0.67 . . . . 0.29 111.449 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -103.31 139.71 38.38 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.909 -0.76 . . . . 0.4 109.648 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.758 ' HB3' ' HG ' ' A' ' 107' ' ' LEU . 7.2 t-80 -113.62 104.54 12.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.847 -0.615 . . . . 0.4 110.418 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.42 109.44 21.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.177 -0.675 . . . . 0.35 109.177 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.41 104.35 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.123 -0.49 . . . . 0.59 111.12 -171.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -106.19 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.018 -0.734 . . . . 1.53 109.018 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 38' ' ' PHE . 85.6 mt -106.4 124.85 50.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.663 -0.699 . . . . 0.24 110.127 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.44 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.2 m -103.54 118.31 36.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.529 0.681 . . . . 0.29 111.381 -171.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.524 ' CE1' ' HA ' ' A' ' 35' ' ' ALA . 53.4 t80 -82.6 90.2 6.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.11 109.408 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.541 ' HA ' ' HD2' ' A' ' 34' ' ' PHE . 25.9 mtm -120.86 158.66 27.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.65 111.434 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -70.48 105.45 1.22 Allowed Pre-proline 0 C--O 1.219 -0.503 0 N-CA-C 108.034 -1.099 . . . . 2.59 108.034 167.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.562 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 10.0 Cg_endo -51.83 -27.49 27.46 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.373 2.715 . . . . 1.04 114.789 -169.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.562 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 44.2 p90 -94.58 4.59 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 1.17 111.774 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.5 t -167.99 -74.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.521 -0.309 . . . . 1.09 110.317 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 94' ' ' THR . . . 68.19 75.95 0.46 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.422 -0.418 . . . . 1.16 112.944 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HG2' ' HZ ' ' A' ' 34' ' ' PHE . 1.8 Cg_endo -45.23 117.4 1.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.885 2.39 . . . . 1.2 111.081 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -55.23 -39.18 69.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.404 -0.816 . . . . 2.64 112.521 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -83.78 -19.19 35.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.616 0.246 . . . . 4.09 111.219 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -93.38 -5.96 48.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.688 0.756 . . . . 1.67 109.343 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.9 m -90.75 145.97 24.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 1.39 110.643 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -98.43 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.332 -0.988 . . . . 1.91 108.332 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 26.9 ttt180 -146.74 141.66 26.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.907 0.861 . . . . 0.62 110.968 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.819 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 1.3 t80 -102.75 154.94 18.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.208 -1.36 . . . . 0.86 108.468 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 90.8 m -156.61 102.14 2.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.645 -0.422 . . . . 0.31 111.179 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.819 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.9 p -104.74 135.96 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 119.913 -0.715 . . . . 0.88 109.984 168.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 13' ' ' THR . 94.3 m-85 -104.57 107.59 18.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.289 -0.869 . . . . 0.7 109.036 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.758 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 1.7 pp -128.86 152.76 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.223 -0.658 . . . . 2.12 109.223 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.812 ' O ' HG22 ' A' ' 16' ' ' VAL . 18.6 ttmm -105.17 117.56 34.31 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.334 -0.617 . . . . 1.89 109.334 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.03 110.39 22.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.951 -0.388 . . . . 0.53 109.951 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.359 -0.837 . . . . 1.78 110.139 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.927 ' HB3' HG22 ' A' ' 22' ' ' VAL . 70.2 t60 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.844 -0.798 . . . . 0.59 108.844 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -140.7 140.54 34.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.847 0.356 . . . . 2.36 110.585 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.839 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -106.09 132.26 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.397 -0.521 . . . . 0.49 110.959 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 p -113.74 169.78 8.73 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.091 -0.959 . . . . 0.51 110.155 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -41.01 -40.63 1.47 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.86 1.059 . . . . 0.83 113.86 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.88 61.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.672 0.749 . . . . 0.33 111.598 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.839 ' HB2' HG13 ' A' ' 5' ' ' VAL . 52.1 m80 -67.56 -1.74 5.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 2.12 111.583 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.69 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 22.7 t-20 -48.33 -17.93 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.517 0.511 . . . . 1.41 109.674 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.88 56.74 0.64 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.507 -0.769 . . . . 0.3 111.716 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.028 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -106.54 157.83 17.38 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.662 0.986 . . . . 0.32 113.662 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 29.4 m -153.77 103.59 2.62 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.332 -0.849 . . . . 0.95 109.282 168.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.3 pt? -164.12 169.79 17.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 3.0 111.761 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 108' ' ' LYS . 88.9 m -100.7 145.95 27.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 1.73 111.054 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -119.74 152.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.478 -0.783 . . . . 0.78 110.701 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.36 108.02 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.551 -0.537 . . . . 0.76 109.551 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.679 HG12 HG21 ' A' ' 22' ' ' VAL . 34.4 m -86.63 -169.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.017 0.437 . . . . 1.23 111.99 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 116.31 -50.51 0.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.71 111.296 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.18 -77.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.286 0.565 . . . . 2.35 110.082 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -166.89 120.51 1.02 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.348 -0.842 . . . . 0.71 110.261 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' A' ' 3' ' ' HIS . 6.9 t -111.63 104.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.4 110.06 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.75 160.94 15.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.005 0.907 . . . . 1.09 112.183 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 85' ' ' VAL . 17.7 mm -130.37 101.58 5.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.647 -1.615 . . . . 0.54 107.828 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -108.46 143.31 37.6 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.299 0.571 . . . . 0.64 110.923 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -128.34 142.08 43.5 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.839 -0.619 . . . . 0.85 110.619 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 73.1 Cg_endo -77.41 6.14 4.62 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.35 111.671 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.733 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 11.2 t 68.39 -55.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.249 0.968 . . . . 0.91 110.129 -172.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.4 m-80 54.7 57.82 11.69 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.339 -1.356 . . . . 1.39 107.339 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.56 108.12 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.326 2.684 . . . . 0.83 113.139 -161.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' CE2' ' A' ' 89' ' ' TYR . 3.5 t -132.54 104.29 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.285 -1.325 . . . . 1.83 110.023 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 33' ' ' GLY . 3.8 m 72.15 -177.13 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.6 -0.727 . . . . 2.36 110.075 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.678 ' H ' HG22 ' A' ' 32' ' ' THR . . . -61.49 -15.98 48.41 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 118.505 0.593 . . . . 1.3 114.332 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.826 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 1.2 m-85 -62.26 155.41 24.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.545 0.572 . . . . 2.22 112.545 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.51 160.4 43.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.116 -0.947 . . . . 0.44 108.832 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.733 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.19 117.5 20.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.635 0.731 . . . . 0.43 111.537 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.61 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 66.2 m-85 -125.61 -176.68 3.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.955 -1.128 . . . . 2.78 107.955 168.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.648 ' HA ' HD23 ' A' ' 87' ' ' LEU . 1.3 m-85 -74.12 -77.95 0.11 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.794 -0.762 . . . . 0.43 109.178 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -114.3 10.56 17.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.699 -0.682 . . . . 2.39 110.46 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.494 ' HA3' ' HE1' ' A' ' 90' ' ' MET . . . 96.57 106.11 2.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.73 112.351 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.08 -3.46 51.81 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.7 112.414 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -128.69 142.94 50.86 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.806 0.336 . . . . 1.13 111.869 -178.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.622 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.06 132.96 27.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.316 -0.856 . . . . 2.52 110.532 164.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.98 154.05 51.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.234 0.54 . . . . 2.3 111.114 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.82 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 41.0 t -104.92 131.2 22.01 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.638 -0.875 . . . . 1.61 108.638 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.65 -25.67 20.76 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.487 2.791 . . . . 1.88 113.286 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.531 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 46.8 m-20 -139.7 81.7 1.84 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 2.43 109.957 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.0 pt-20 -117.61 58.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.599 0.714 . . . . 3.26 110.854 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -80.94 -60.04 2.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.559 -0.746 . . . . 2.06 111.246 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.801 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.96 -29.21 8.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.589 0.709 . . . . 1.25 109.961 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.801 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 6.3 m-85 -105.64 165.01 11.46 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.908 -1.042 . . . . 0.74 108.795 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -153.84 167.54 29.34 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.942 -0.703 . . . . 1.46 112.587 -163.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.99 134.0 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.383 -0.826 . . . . 1.31 111.547 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.25 155.35 18.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.986 -1.006 . . . . 2.45 109.294 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 4.6 p-10 -125.13 146.58 49.41 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.937 -0.574 . . . . 1.93 110.878 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.551 ' HD2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -164.84 103.91 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.42 110.049 178.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.898 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -118.87 128.56 54.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.701 0.762 . . . . 1.66 111.699 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 . . . . . 0 C--O 1.211 -0.952 0 CA-C-N 114.531 -1.213 . . . . 2.14 107.755 174.268 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.172 0 N-CA-C 112.725 -0.15 . . . . 1.49 112.725 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.431 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -161.47 83.77 0.62 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.777 0.658 . . . . 0.97 112.777 -175.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 30.3 mt-10 -104.79 104.83 14.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.447 -0.946 . . . . 0.81 108.447 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -115.43 149.28 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.394 -0.922 . . . . 0.53 112.157 -173.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.61 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 41.4 m-85 -109.13 114.64 28.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.484 -1.689 . . . . 1.13 108.476 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.551 ' CD2' ' HD2' ' A' ' 56' ' ' LYS . 5.5 m170 -104.27 109.36 21.17 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.86 -0.525 . . . . 0.5 111.11 -173.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.56 HG21 ' HE2' ' A' ' 83' ' ' HIS . 64.3 t -103.04 110.35 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.633 0.73 . . . . 0.87 110.071 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 23.2 m -101.99 105.31 16.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.93 -1.137 . . . . 0.46 107.93 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 7.3 p -150.89 151.68 12.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.804 -0.634 . . . . 1.04 110.669 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -135.31 103.61 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.838 0.828 . . . . 1.54 109.422 166.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.3 158.06 13.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.596 -0.729 . . . . 0.67 109.307 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 110' ' ' ASN . . . -84.39 95.28 8.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.484 0.659 . . . . 0.44 110.217 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -146.45 169.54 27.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.219 -0.9 . . . . 0.29 111.679 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -107.38 130.0 54.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.296 -0.631 . . . . 0.4 109.296 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 43.3 t-80 -104.11 102.51 12.25 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.28 -0.262 . . . . 0.4 110.324 -172.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.16 128.67 50.03 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.322 -0.622 . . . . 0.35 109.322 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -128.66 103.88 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 120.801 -0.36 . . . . 0.59 111.656 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -109.03 103.26 12.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.481 -0.933 . . . . 1.53 108.481 171.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 38' ' ' PHE . 91.9 mt -103.83 122.34 44.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 0.24 109.566 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.64 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.2 m -101.31 117.86 35.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.816 0.817 . . . . 0.29 110.941 -171.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.826 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -84.43 92.43 8.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.629 -1.168 . . . . 1.11 109.425 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.639 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 12.6 mtm -128.72 165.05 21.65 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.433 -0.349 . . . . 0.65 110.185 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' PHE . 9.3 ttm180 -67.02 106.47 1.19 Allowed Pre-proline 0 C--O 1.213 -0.819 0 N-CA-C 107.954 -1.128 . . . . 2.59 107.954 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.524 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 4.4 Cg_endo -44.96 -30.92 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 124.067 3.178 . . . . 1.04 115.25 -168.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.524 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 36.9 p90 -95.24 5.67 51.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.395 0.517 . . . . 1.17 112.395 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -164.99 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.568 0.21 . . . . 1.09 111.568 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 63.86 86.95 0.05 OUTLIER Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.869 -0.492 . . . . 1.16 111.869 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 1.051 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 29.1 Cg_exo -57.32 118.4 5.26 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.269 1.98 . . . . 1.2 110.042 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.3 t -49.4 -53.38 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.726 0.641 . . . . 2.64 112.465 -167.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -92.19 5.51 50.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.951 0.405 . . . . 4.09 110.645 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 1.051 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 27.2 t70 -112.99 1.24 15.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 1.67 109.878 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -98.86 171.5 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.594 -0.73 . . . . 1.39 111.457 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.687 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.1 tp10 -115.39 170.88 8.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.831 -0.803 . . . . 1.91 108.831 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.64 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 34.8 ttt180 -157.18 141.69 16.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.821 0.819 . . . . 0.62 111.184 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.805 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -104.36 157.74 16.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.313 -1.312 . . . . 0.86 108.594 177.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.0 m -157.85 102.48 1.84 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.514 . . . . 0.31 111.306 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.2 p -103.66 134.48 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.482 -0.562 . . . . 0.88 109.482 169.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' THR . 72.0 m-85 -105.21 112.7 25.92 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.138 -0.69 . . . . 0.7 109.138 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.695 ' HG ' HG22 ' A' ' 105' ' ' VAL . 77.8 mt -127.85 164.9 21.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.011 -0.995 . . . . 2.12 110.024 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 16' ' ' VAL . 58.4 tttm -119.99 113.85 21.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.385 -0.969 . . . . 1.89 108.385 172.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 83' ' ' HIS . . . -101.14 106.83 18.11 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.908 -0.405 . . . . 0.53 109.908 -171.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.631 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.135 -0.936 . . . . 1.78 110.437 -168.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.959 ' HB3' HG22 ' A' ' 22' ' ' VAL . 32.2 t60 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.59 108.798 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 21.5 pttp -149.55 150.44 32.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.702 0.287 . . . . 2.36 111.423 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.003 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -120.11 136.3 57.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.433 0.635 . . . . 0.49 111.961 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.462 HG22 ' NE2' ' A' ' 25' ' ' GLN . 1.1 p -120.33 170.34 9.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.785 -1.098 . . . . 0.51 110.473 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 16.7 tptm -35.62 -48.6 0.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.692 1.368 . . . . 0.83 114.692 -171.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.59 -33.32 60.19 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.601 0.715 . . . . 0.33 111.817 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.831 ' HB2' HG13 ' A' ' 5' ' ' VAL . 75.0 m80 -64.75 -2.32 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 2.12 111.227 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 25.9 t-20 -45.57 -22.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.332 0.653 . . . . 1.41 109.995 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.42 54.0 0.66 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.5 -0.773 . . . . 0.3 111.357 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.944 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -116.76 156.03 27.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.654 0.613 . . . . 0.32 112.654 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 39.4 m -145.95 112.91 6.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.394 -0.821 . . . . 0.95 109.433 173.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -157.88 167.62 29.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 3.0 111.347 -173.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.8 m -101.52 146.59 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.724 0.297 . . . . 1.73 111.107 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.1 m -131.76 162.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.78 110.936 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.78 137.88 51.89 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.66 -1.237 . . . . 0.76 107.66 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.821 HG12 ' H ' ' A' ' 19' ' ' GLY . 1.6 t -121.06 -164.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 119.892 -0.723 . . . . 1.23 110.25 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.821 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 124.31 -48.87 0.93 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.765 -0.934 . . . . 0.71 110.765 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -84.43 -71.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.292 0.568 . . . . 2.35 109.685 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -165.46 144.38 6.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.246 -0.888 . . . . 0.71 110.096 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.959 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.1 t -123.14 120.11 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 109.341 -0.615 . . . . 0.4 109.341 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 49.8 mt-10 -103.8 151.53 22.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.933 0.873 . . . . 1.09 112.442 -171.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.713 HD13 ' HB ' ' A' ' 5' ' ' VAL . 41.6 mm -133.88 137.74 51.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.227 -1.768 . . . . 0.54 106.227 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.4 142.12 29.05 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.662 -0.649 . . . . 0.64 111.217 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -117.25 144.72 34.37 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.28 -0.873 . . . . 0.85 109.181 169.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.611 ' HG2' HD22 ' A' ' 29' ' ' ASN . 73.8 Cg_endo -82.63 12.52 2.87 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 C-N-CA 122.862 2.375 . . . . 0.35 111.515 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.746 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.1 t 68.11 -44.99 0.5 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.982 0.913 . . . . 0.91 112.257 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 31' ' ' THR . 1.1 p30 41.89 78.81 0.36 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.443 0.64 . . . . 1.39 110.777 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.574 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 25.9 Cg_exo -63.97 109.98 1.22 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.357 2.705 . . . . 0.83 112.111 -169.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 29' ' ' ASN . 1.3 t -142.46 117.15 9.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.724 -0.671 . . . . 1.83 111.534 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.7 m 73.52 -42.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.478 0.656 . . . . 2.36 112.314 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 31' ' ' THR . . . 162.72 -118.58 0.83 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 107.72 -2.152 . . . . 1.3 107.72 -172.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.764 ' HA ' ' C ' ' A' ' 90' ' ' MET . 8.5 m-30 61.77 178.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.577 0.703 . . . . 2.22 111.607 167.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -174.35 144.79 0.95 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.634 -1.247 . . . . 0.44 107.634 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.746 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 94.8 m95 -76.97 99.07 5.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.359 0.6 . . . . 0.43 110.848 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.47 179.76 4.18 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.736 -1.209 . . . . 2.78 107.736 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -68.64 -69.03 0.35 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.628 -0.829 . . . . 0.43 109.372 167.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.52 13.33 3.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 2.39 110.44 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.21 112.05 3.3 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.613 -0.803 . . . . 0.73 113.101 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 4.26 34.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.475 -0.393 . . . . 0.7 113.03 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 p -139.94 144.63 37.18 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 112.425 0.528 . . . . 1.13 112.425 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.534 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -142.23 127.68 18.92 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.901 -1.045 . . . . 2.52 110.122 167.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.92 145.0 51.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.071 0.463 . . . . 2.3 110.781 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -111.86 135.89 21.2 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.073 -0.714 . . . . 1.61 109.073 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 36.9 Cg_exo -61.51 128.78 25.76 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.278 1.986 . . . . 1.88 111.457 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 72.19 30.76 2.04 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.954 0.784 . . . . 2.43 112.149 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.18 45.72 1.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.579 0.704 . . . . 3.26 110.985 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -81.29 -19.56 42.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.541 -0.754 . . . . 2.06 111.339 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.4 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 17.5 ptt? -138.76 -35.82 0.57 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.748 0.785 . . . . 1.25 109.964 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.853 ' HB3' ' O ' ' A' ' 76' ' ' THR . 8.4 m-85 -106.2 166.19 10.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.74 108.443 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -153.03 167.11 30.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.767 0.712 . . . . 1.46 112.623 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.9 p -103.34 141.57 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.252 -0.886 . . . . 1.31 111.671 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -116.36 137.94 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 2.45 109.614 173.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -110.64 159.17 17.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.753 0.311 . . . . 1.93 111.386 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.64 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -158.24 117.22 3.13 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.264 -0.426 . . . . 1.42 109.977 175.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 2.6 m-85 -123.51 106.46 10.63 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.296 -0.562 . . . . 1.66 109.794 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 . . . . . 0 N--CA 1.444 -0.774 0 CA-C-N 116.335 -0.393 . . . . 2.14 111.661 -175.886 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 N-CA-C 111.346 -0.701 . . . . 1.49 111.346 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.27 85.22 0.24 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.472 0.654 . . . . 0.97 110.344 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.767 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.0 mt-10 -113.58 104.66 12.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.534 -0.757 . . . . 0.81 108.991 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.64 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -110.77 165.42 11.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.753 0.787 . . . . 0.53 111.436 -170.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.482 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 60.0 m-85 -136.57 104.51 5.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.98 -1.464 . . . . 1.13 109.128 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.626 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 40.1 m170 -102.79 113.84 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.958 -0.464 . . . . 0.5 109.86 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 m -103.91 125.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 122.135 0.969 . . . . 0.87 110.079 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.853 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 3.7 m -103.82 103.54 13.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.101 -1.444 . . . . 0.46 107.101 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.653 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.1 p -157.25 129.94 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 123.292 0.37 . . . . 1.04 111.033 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -123.2 102.55 8.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.497 0.665 . . . . 1.54 110.606 176.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.68 140.42 4.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.52 -0.764 . . . . 0.67 109.757 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -64.61 87.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.61 0.569 . . . . 0.44 111.484 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.87 166.48 32.96 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 110.693 -0.963 . . . . 0.29 110.693 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.0 OUTLIER -101.0 136.01 41.53 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.773 -0.771 . . . . 0.4 109.228 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.499 ' O ' HD13 ' A' ' 107' ' ' LEU . 55.8 t-80 -101.63 102.42 13.11 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.836 -0.802 . . . . 0.4 108.836 -174.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.21 103.7 13.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.188 -0.671 . . . . 0.35 109.188 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.1 p -106.52 109.36 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.662 -0.699 . . . . 0.59 111.291 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.507 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -107.21 103.76 13.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.863 -1.062 . . . . 1.53 108.932 176.055 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 38' ' ' PHE . 76.3 mt -106.2 128.39 53.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.258 -0.428 . . . . 0.24 110.142 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 90' ' ' MET . 3.2 m -104.51 130.84 52.41 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.931 0.396 . . . . 0.29 110.579 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.626 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 40.6 t80 -96.23 93.82 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.283 -0.636 . . . . 1.11 109.283 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.764 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -131.16 158.43 40.5 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.506 -0.316 . . . . 0.65 110.623 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.643 ' N ' ' HA ' ' A' ' 34' ' ' PHE . 41.5 mtt180 -58.65 108.8 1.45 Allowed Pre-proline 0 CA--C 1.512 -0.51 0 O-C-N 124.083 0.864 . . . . 2.59 110.083 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 7.0 Cg_exo -38.38 -37.97 0.79 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.903 3.735 . . . . 1.04 115.083 -174.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -91.92 1.27 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.131 0.789 . . . . 1.17 113.131 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.8 t -158.52 -62.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.071 -0.393 . . . . 1.09 111.43 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.623 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.34 93.56 0.23 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.958 -0.639 . . . . 1.16 113.263 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.824 ' HB2' ' HB2' ' A' ' 99' ' ' ASP . 17.4 Cg_exo -69.22 97.54 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.587 2.192 . . . . 1.2 110.008 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.6 m -62.52 -25.1 67.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.655 0.74 . . . . 2.64 109.095 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -59.24 -32.26 69.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.839 -1.073 . . . . 4.09 110.618 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.824 ' HB2' ' HB2' ' A' ' 96' ' ' PRO . 1.5 m-20 -109.34 -105.45 0.36 Allowed 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.679 -0.237 . . . . 1.67 110.598 -174.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.9 p 49.28 -179.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.106 1.15 . . . . 1.39 114.106 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.28 137.89 30.96 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.748 -1.204 . . . . 1.91 107.748 165.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -121.21 142.87 49.49 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.786 -0.765 . . . . 0.62 111.565 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.648 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . 1.1 t80 -104.38 153.9 20.5 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.216 -1.357 . . . . 0.86 108.989 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 54.2 m -161.03 103.84 1.3 Allowed 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.147 0.28 . . . . 0.31 110.317 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.003 HG11 HG21 ' A' ' 5' ' ' VAL . 7.5 p -110.08 136.6 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 118.15 -1.42 . . . . 0.88 109.877 168.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' THR . 79.4 m-85 -103.94 101.95 11.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.799 -1.092 . . . . 0.7 108.15 175.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.774 HD12 HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -124.49 142.62 51.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.438 -0.949 . . . . 2.12 108.438 176.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.721 ' O ' HG22 ' A' ' 16' ' ' VAL . 78.3 tttt -101.89 122.77 44.64 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.369 -0.532 . . . . 1.89 110.507 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.98 159.18 15.58 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.692 0.62 . . . . 0.53 110.71 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.527 ' H ' HG23 ' A' ' 18' ' ' VAL . 4.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.353 -0.832 . . . . 1.78 109.553 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.707 ' NE2' HD13 ' A' ' 107' ' ' LEU . 20.2 t60 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 121.487 0.66 . . . . 0.59 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 20.1 pttp -149.71 141.14 23.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 2.36 110.771 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.84 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -103.22 140.15 22.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.49 110.562 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -121.71 169.05 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.503 -0.772 . . . . 0.51 109.73 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -38.0 -47.01 1.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.335 1.235 . . . . 0.83 114.335 -171.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.55 61.83 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.47 0.652 . . . . 0.33 111.871 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.824 ' HB2' HG13 ' A' ' 5' ' ' VAL . 47.9 m80 -62.57 -3.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.629 . . . . 2.12 111.672 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.661 HD22 ' HA ' ' A' ' 103' ' ' PHE . 3.7 t-20 -46.91 -19.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.145 0.578 . . . . 1.41 110.171 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.33 51.87 0.74 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.955 -0.641 . . . . 0.3 112.078 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 1.077 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -106.03 162.3 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.513 0.931 . . . . 0.32 113.513 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 85.7 m -153.74 103.76 2.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.336 -0.847 . . . . 0.95 109.134 170.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 6.5 tt -156.06 164.26 38.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 110.141 -0.318 . . . . 3.0 110.141 -170.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 m -103.15 140.91 36.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 1.73 111.414 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.6 m -116.97 158.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.78 111.372 -174.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.77 121.28 44.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 0.76 109.586 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.615 HG22 ' C ' ' A' ' 110' ' ' ASN . 17.6 m -108.26 -173.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.23 111.271 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 130.11 -56.65 0.74 Allowed Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 111.244 -0.742 . . . . 0.71 111.244 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.35 -68.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.333 0.587 . . . . 2.35 109.654 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -165.99 141.38 4.8 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 114.863 -1.062 . . . . 0.71 109.179 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 3' ' ' HIS . 0.9 OUTLIER -117.65 126.63 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 110.003 -0.369 . . . . 0.4 110.003 173.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 21.2 mt-10 -103.34 142.83 33.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.882 0.849 . . . . 1.09 112.732 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.643 HG21 HG11 ' A' ' 85' ' ' VAL . 41.7 mm -124.45 101.06 8.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.321 -1.363 . . . . 0.54 107.321 165.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -108.93 138.24 45.58 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.492 0.663 . . . . 0.64 111.781 -169.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -119.58 144.77 37.54 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.517 -0.765 . . . . 0.85 109.441 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.543 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 36.7 Cg_endo -86.78 13.86 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.682 2.255 . . . . 0.35 111.66 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.714 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 34.3 t 67.6 -49.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.314 -0.857 . . . . 0.91 111.62 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.543 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER 50.45 57.05 17.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.185 -1.043 . . . . 1.39 108.185 -172.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 83.2 Cg_exo -50.11 119.59 5.11 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.88 3.054 . . . . 0.83 114.156 -163.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' CE2' ' A' ' 89' ' ' TYR . 10.8 p -98.35 -53.37 3.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.19 -0.914 . . . . 1.83 110.138 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.632 HG23 ' HD1' ' A' ' 34' ' ' PHE . 2.7 t -171.18 -115.76 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.048 -0.524 . . . . 2.36 109.976 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -14.95 79.58 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.211 -0.519 . . . . 1.3 112.561 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.632 ' HD1' HG23 ' A' ' 32' ' ' THR . 3.7 m-85 -67.94 145.92 54.08 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.094 0.558 . . . . 2.22 110.316 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.81 157.41 43.17 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.74 -0.467 . . . . 0.44 109.74 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.714 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.6 m95 -77.26 113.31 14.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.413 0.625 . . . . 0.43 111.017 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 46.5 m-85 -125.48 175.36 7.57 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.544 -1.28 . . . . 2.78 107.544 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.4 m-85 -65.17 -65.69 0.64 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.465 -0.894 . . . . 0.43 109.532 170.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.71 21.59 3.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.997 -0.547 . . . . 2.39 110.59 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.79 92.64 1.58 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.466 -0.873 . . . . 0.73 113.276 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.99 -8.92 76.56 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.764 -0.731 . . . . 0.7 112.628 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -128.4 143.92 51.07 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 111.906 0.336 . . . . 1.13 111.906 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.618 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -140.99 139.43 34.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.254 -0.884 . . . . 2.52 110.383 172.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.39 145.29 33.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.979 0.419 . . . . 2.3 111.594 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.756 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 40.2 m -104.76 137.02 19.1 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 1.61 109.556 173.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 31.2 Cg_exo -60.35 -22.46 71.2 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.208 2.605 . . . . 1.88 113.421 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.624 HD21 ' HA3' ' A' ' 81' ' ' GLY . 88.4 m-20 -119.72 24.66 10.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.436 0.16 . . . . 2.43 111.408 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 6.5 pt-20 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.946 0.879 . . . . 3.26 111.074 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 m -160.45 -49.62 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.469 -1.308 . . . . 2.06 107.469 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.514 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -103.46 -41.04 6.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.551 -1.204 . . . . 1.25 109.233 173.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.67 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.9 m-85 -105.62 165.75 10.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.113 -0.949 . . . . 0.74 108.535 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -163.7 170.32 17.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.46 111.575 -168.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' A' ' 75' ' ' VAL . 2.2 p -102.11 135.0 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.61 -0.723 . . . . 1.31 111.37 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 1.3 pm0 -120.1 136.31 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.55 -0.907 . . . . 2.45 108.55 170.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 43' ' ' LYS . 96.2 m-20 -103.23 153.82 19.98 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.845 -0.742 . . . . 1.93 111.494 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 108.82 3.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.011 -0.995 . . . . 1.42 109.376 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.838 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -114.75 135.1 54.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.782 -0.644 . . . . 1.66 110.621 -174.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 116.559 -0.291 . . . . 2.14 110.307 169.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.849 0 N-CA-C 111.955 -0.458 . . . . 1.49 111.955 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.39 81.3 0.97 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.485 0.659 . . . . 0.97 110.98 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.838 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 31.4 mt-10 -104.27 104.04 13.88 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.576 -0.898 . . . . 0.81 108.576 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -108.94 150.13 28.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.517 -0.873 . . . . 0.53 110.837 -175.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.604 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 10.0 m-85 -109.56 115.08 29.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.167 -1.379 . . . . 1.13 108.95 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 15.8 m170 -104.24 108.24 19.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.341 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 22' ' ' VAL . 4.2 m -103.45 117.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.175 0.988 . . . . 0.87 108.777 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 68.0 m -102.62 103.71 14.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.978 -1.119 . . . . 0.46 107.978 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 2.9 p -154.76 144.57 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.515 -0.766 . . . . 1.04 110.619 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.1 103.05 6.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.822 0.82 . . . . 1.54 109.006 165.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.79 134.72 2.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.375 -0.83 . . . . 0.67 110.522 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -65.14 102.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.757 0.66 . . . . 0.44 111.367 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.624 ' HA3' HD21 ' A' ' 47' ' ' ASN . . . -165.49 167.2 38.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.152 -1.179 . . . . 0.29 110.152 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.8 m -101.85 131.54 48.14 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 118.055 0.927 . . . . 0.4 109.436 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.568 ' ND1' HG22 ' A' ' 85' ' ' VAL . 32.5 t-80 -103.96 102.96 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.948 -0.39 . . . . 0.4 109.948 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.85 122.13 43.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.014 -0.735 . . . . 0.35 109.014 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.0 t -113.97 109.87 30.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.134 -0.485 . . . . 0.59 111.696 -170.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.44 ' ND2' HG23 ' A' ' 104' ' ' THR . 8.0 m120 -109.68 104.09 13.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.223 -0.658 . . . . 1.53 109.223 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 38' ' ' PHE . 82.5 mt -108.49 121.34 44.76 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.24 110.004 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 2.6 m -102.35 118.9 37.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.397 0.617 . . . . 0.29 110.657 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.605 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 53.9 t80 -86.01 91.22 8.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.942 -1.026 . . . . 1.11 109.606 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.725 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 3.2 mtm -131.7 165.13 24.42 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.506 -0.316 . . . . 0.65 110.473 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.532 ' HB2' ' H ' ' A' ' 95' ' ' GLY . 70.5 mtt180 -57.28 112.54 4.79 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.48 -0.933 . . . . 2.59 108.48 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -52.06 -24.81 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.236 2.624 . . . . 1.04 114.504 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.533 ' CD1' HG22 ' A' ' 94' ' ' THR . 47.6 p90 -96.94 2.77 52.01 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.881 0.326 . . . . 1.17 111.881 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.3 t -173.84 -67.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.483 -0.135 . . . . 1.09 111.309 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.725 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 77.87 89.81 0.35 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.843 -0.694 . . . . 1.16 112.065 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 11.0 Cg_exo -37.31 113.26 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.487 2.792 . . . . 1.2 111.718 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 t -75.94 9.85 2.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 2.64 111.944 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -130.12 4.37 4.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.122 -0.325 . . . . 4.09 110.122 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 22.8 t0 -127.05 0.82 6.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.203 0.525 . . . . 1.67 110.916 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 m -87.91 148.27 24.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.045 -0.525 . . . . 1.39 111.084 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.5 tp10 -100.8 169.36 9.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 1.91 108.812 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 33.5 ttt180 -153.8 140.01 18.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.806 0.812 . . . . 0.62 110.703 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.84 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 2.5 t80 -104.13 156.87 17.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.278 -1.328 . . . . 0.86 108.668 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 66.9 m -158.8 101.18 1.63 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 120.885 0.374 . . . . 0.31 110.121 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.077 HG23 ' HB3' ' A' ' 12' ' ' ALA . 9.3 p -104.65 134.7 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 119.793 -0.763 . . . . 0.88 109.73 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 13' ' ' THR . 91.1 m-85 -104.07 113.99 27.93 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.7 108.605 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 3' ' ' HIS . 17.3 mt -137.7 165.08 27.26 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.835 -0.62 . . . . 2.12 109.753 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.766 ' O ' HG22 ' A' ' 16' ' ' VAL . 78.5 tttt -119.76 124.4 46.07 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.47 -0.492 . . . . 1.89 110.237 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.427 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.62 127.24 48.44 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.397 0.436 . . . . 0.53 110.066 -172.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.615 ' C ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.648 -0.705 . . . . 1.78 109.977 -174.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 1.009 ' HB3' HG22 ' A' ' 22' ' ' VAL . 28.4 t60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.415 -0.587 . . . . 0.59 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -144.05 141.14 29.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.24 -0.436 . . . . 2.36 110.606 177.567 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.846 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -106.25 134.12 48.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.49 111.525 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.76 168.47 9.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.136 -0.938 . . . . 0.51 110.289 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 25.7 tptp -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.298 1.592 . . . . 0.83 115.298 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.23 -30.87 60.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.77 0.714 . . . . 0.33 111.757 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.837 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.9 m80 -66.06 -2.26 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.659 -0.7 . . . . 2.12 111.267 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.668 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -49.48 -17.24 0.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.165 -0.68 . . . . 1.41 109.165 171.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.93 50.08 0.68 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.96 -0.563 . . . . 0.3 111.787 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -110.18 158.08 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.198 0.814 . . . . 0.32 113.198 -173.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 91.7 m -148.8 107.74 3.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.144 -0.935 . . . . 0.95 109.738 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pp -153.76 168.26 26.89 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 3.0 111.668 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.0 m -101.16 146.62 27.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.423 -0.353 . . . . 1.73 110.608 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 108' ' ' LYS . 6.0 m -129.45 160.78 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.105 0.478 . . . . 0.78 111.477 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.65 124.12 51.55 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.54 -0.911 . . . . 0.76 108.54 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.648 HG22 ' C ' ' A' ' 110' ' ' ASN . 22.5 m -102.49 -165.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.509 -0.476 . . . . 1.23 111.385 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 112.12 -50.38 0.77 Allowed Glycine 0 CA--C 1.504 -0.652 0 N-CA-C 111.041 -0.823 . . . . 0.71 111.041 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -75.61 -75.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.795 0.807 . . . . 2.35 109.132 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -166.64 140.48 3.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.521 -1.218 . . . . 0.71 109.349 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.009 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.7 t -123.57 104.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.586 0.708 . . . . 0.4 109.155 172.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.1 pt-20 -109.45 160.19 16.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.795 0.807 . . . . 1.09 111.568 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 5' ' ' VAL . 22.6 mm -134.68 104.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.072 -1.422 . . . . 0.54 108.624 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.618 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -110.04 139.26 45.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.533 0.682 . . . . 0.64 111.904 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.477 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.9 mm? -116.84 139.99 26.35 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 114.985 -1.007 . . . . 0.85 108.955 171.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 85.1 Cg_endo -79.06 8.77 3.64 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 122.824 2.349 . . . . 0.35 111.893 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.651 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 7.9 t 66.22 -63.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.03 0.831 . . . . 0.91 110.291 -173.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.406 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.1 m-80 60.81 65.42 2.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.059 -1.089 . . . . 1.39 108.059 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.66 112.86 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.875 3.05 . . . . 0.83 113.57 -165.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.545 HG23 ' CE2' ' A' ' 89' ' ' TYR . 38.7 p -80.7 -73.98 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.167 -1.378 . . . . 1.83 112.176 -174.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.445 ' H ' ' H ' ' A' ' 33' ' ' GLY . 6.3 t -171.19 -12.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.473 -0.785 . . . . 2.36 110.359 -174.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' H ' ' H ' ' A' ' 32' ' ' THR . . . 176.44 -33.93 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.39 -0.684 . . . . 1.3 111.39 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.556 ' HA ' ' C ' ' A' ' 90' ' ' MET . 45.7 m-85 -52.5 139.72 24.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.559 -0.32 . . . . 2.22 111.284 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -137.72 151.44 48.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 0.44 108.661 171.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.87 109.79 14.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.328 0.585 . . . . 0.43 111.415 -174.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 51.2 m-85 -114.67 177.53 4.61 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 108.395 -0.965 . . . . 2.78 108.395 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.776 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -70.02 -73.94 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.01 0.823 . . . . 0.43 109.466 169.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.43 -11.86 14.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.709 -0.678 . . . . 2.39 110.179 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.31 108.1 2.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.564 -0.827 . . . . 0.73 112.099 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.06 -16.92 7.94 Favored Glycine 0 CA--C 1.516 0.145 0 C-N-CA 120.987 -0.625 . . . . 0.7 112.648 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 m -128.97 142.09 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.886 -0.413 . . . . 1.13 109.886 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -139.91 141.56 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.522 -0.548 . . . . 2.52 109.522 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.45 164.35 28.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.607 0.718 . . . . 2.3 112.625 -172.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.851 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 15.9 p -135.23 128.41 18.39 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.61 108.996 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.9 150.36 86.49 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.635 2.223 . . . . 1.88 112.138 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.471 ' HB2' HG21 ' A' ' 77' ' ' VAL . 94.6 m-20 66.35 42.78 2.88 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.573 0.546 . . . . 2.43 110.574 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -88.72 31.15 0.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 3.26 111.304 -173.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -88.09 12.11 14.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.392 -0.367 . . . . 2.06 111.266 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.442 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 20.5 ptt? -175.27 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.627 . . . . 1.25 110.461 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.754 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.4 m-85 -122.5 162.87 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.121 -0.945 . . . . 0.74 109.297 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -159.65 167.88 27.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.342 0.592 . . . . 1.46 112.278 -164.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.5 p -103.09 139.34 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.311 -0.859 . . . . 1.31 111.401 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.702 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -112.43 142.93 44.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.194 -0.669 . . . . 2.45 109.194 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . 3.7 p-10 -111.16 161.32 16.08 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.959 -0.296 . . . . 1.93 111.229 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.786 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -165.14 111.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.881 -0.785 . . . . 1.42 108.881 171.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 5.7 m-85 -111.18 112.83 24.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.173 -0.611 . . . . 1.66 111.916 -173.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.219 -0.9 . . . . 2.14 109.417 172.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 111.805 -0.518 . . . . 1.49 111.805 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 69' ' ' GLY . 2.7 p -156.24 86.96 1.03 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.64 0.733 . . . . 0.97 112.349 -173.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.718 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 39.9 mt-10 -103.98 103.56 13.41 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.936 -1.135 . . . . 0.81 107.936 174.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.786 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 11.0 m-70 -105.03 150.59 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.719 0.771 . . . . 0.53 111.863 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 32.6 m-85 -125.2 104.5 8.54 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.912 -1.494 . . . . 1.13 108.679 172.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.702 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 23.3 m170 -102.52 104.27 14.68 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.159 -0.312 . . . . 0.5 110.159 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -101.9 114.57 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.609 1.195 . . . . 0.87 109.479 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 27.7 m -101.61 104.72 15.6 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.248 -1.342 . . . . 0.46 107.904 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.565 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 6.1 p -149.04 148.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 124.206 0.941 . . . . 1.04 110.043 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -130.99 102.77 6.18 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.845 0.831 . . . . 1.54 108.854 164.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.21 160.94 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.271 -0.877 . . . . 0.67 110.063 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.25 95.99 10.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.994 0.426 . . . . 0.44 111.151 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.14 165.84 34.95 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.308 -0.717 . . . . 0.29 111.308 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -102.44 131.73 48.92 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.062 -0.669 . . . . 0.4 109.846 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.692 ' ND1' HG22 ' A' ' 85' ' ' VAL . 2.8 t-80 -104.13 104.46 14.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.728 -0.669 . . . . 0.4 110.041 -173.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.89 109.69 21.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.319 -0.993 . . . . 0.35 108.319 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.96 104.26 16.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 116.063 -0.517 . . . . 0.59 111.191 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -113.4 103.29 11.14 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.687 0.756 . . . . 1.53 110.121 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 38' ' ' PHE . 90.8 mt -105.89 129.62 54.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.761 -1.109 . . . . 0.24 110.137 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.741 HG22 ' HG3' ' A' ' 90' ' ' MET . 5.9 m -101.31 118.93 37.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.588 0.709 . . . . 0.29 110.747 -171.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.683 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 1.6 t80 -87.84 83.42 7.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.568 -1.197 . . . . 1.11 109.467 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.741 ' HG3' HG22 ' A' ' 88' ' ' THR . 30.2 mtm -117.26 158.32 24.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.858 0.361 . . . . 0.65 111.833 -171.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -70.09 105.94 1.41 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.158 -1.053 . . . . 2.59 108.158 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.7 Cg_endo -50.71 -26.79 18.19 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.49 2.793 . . . . 1.04 114.564 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.2 p90 -92.25 -4.5 53.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.196 0.443 . . . . 1.17 112.196 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.616 HG23 ' H ' ' A' ' 95' ' ' GLY . 5.2 t -161.89 -62.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.365 -0.209 . . . . 1.09 111.076 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.616 ' H ' HG23 ' A' ' 94' ' ' THR . . . 53.18 66.64 2.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.962 -0.355 . . . . 1.16 112.967 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.5 128.7 24.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.671 2.247 . . . . 1.2 112.269 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.8 t -57.79 138.9 55.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.752 -0.658 . . . . 2.64 109.687 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.1 m80 77.96 -8.11 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.805 0.69 . . . . 4.09 111.574 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -99.41 -25.66 14.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.83 0.824 . . . . 1.67 108.925 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 6.2 p -81.26 163.33 23.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.72 -1.127 . . . . 1.39 110.9 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 10.8 tp10 -103.09 172.35 6.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.727 -0.842 . . . . 1.91 108.727 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 48.8 ttt180 -156.04 139.9 16.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.797 0.808 . . . . 0.62 110.909 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.709 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.75 156.53 17.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.228 -1.351 . . . . 0.86 109.052 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.83 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 93.5 m -160.22 103.5 1.45 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.788 -0.365 . . . . 0.31 111.105 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.846 HG11 HG21 ' A' ' 5' ' ' VAL . 11.1 p -103.72 137.47 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.88 110.31 170.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.5 m-85 -105.29 107.87 19.08 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.772 . . . . 0.7 109.127 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.6 pp -130.69 146.13 52.1 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.443 -0.577 . . . . 2.12 109.443 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.692 ' O ' HG22 ' A' ' 16' ' ' VAL . 11.8 tttp -103.76 114.72 29.19 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.583 -0.447 . . . . 1.89 110.722 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.532 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.53 132.2 46.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.306 -0.406 . . . . 0.53 110.382 -168.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.648 ' C ' HG22 ' A' ' 18' ' ' VAL . 7.7 p30 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.26 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.968 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.403 -0.962 . . . . 0.59 108.403 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.49 134.55 25.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 2.36 111.364 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.944 HG21 HG11 ' A' ' 105' ' ' VAL . 2.0 t -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.227 -0.442 . . . . 0.49 110.786 173.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -146.85 170.82 16.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.195 0.998 . . . . 0.51 108.621 -172.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 23.2 tptp -48.17 -39.53 21.12 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.257 0.836 . . . . 0.83 113.257 -173.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.64 77.55 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.688 0.756 . . . . 0.33 110.856 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.779 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.7 m80 -64.4 -3.9 3.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.203 -0.908 . . . . 2.12 111.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.71 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 17.7 t-20 -48.03 -21.44 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.378 0.671 . . . . 1.41 110.548 171.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.06 54.6 0.65 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.22 -0.752 . . . . 0.3 111.22 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.843 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.05 160.58 20.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.961 0.726 . . . . 0.32 112.961 -174.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.4 m -151.76 117.03 5.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.231 -0.895 . . . . 0.95 109.467 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.6 pp -164.29 168.29 18.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.534 0.207 . . . . 3.0 111.367 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.0 m -102.97 145.9 29.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.885 0.374 . . . . 1.73 111.077 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -123.5 162.26 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.74 -0.664 . . . . 0.78 110.15 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.448 ' HA ' ' OXT' ' A' ' 110' ' ' ASN . . . -115.16 117.01 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.733 -0.84 . . . . 0.76 108.733 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 22' ' ' VAL . 25.2 m -93.85 178.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.481 . . . . 1.23 111.956 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.52 -52.86 0.76 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.71 111.556 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -78.06 -72.52 0.36 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.558 -0.534 . . . . 2.35 109.558 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -168.07 128.49 1.33 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.753 -0.658 . . . . 0.71 110.931 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.968 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.9 t -104.41 114.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.703 0.763 . . . . 0.4 109.725 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.6 145.07 30.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.464 -0.789 . . . . 1.09 111.854 -171.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 38.5 mm -128.6 102.98 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.873 -1.158 . . . . 0.54 107.873 169.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -114.91 138.48 50.76 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.304 -0.559 . . . . 0.64 111.859 -173.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.2 mm? -116.42 144.2 32.65 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.517 -0.765 . . . . 0.85 109.178 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 42.6 Cg_endo -85.73 13.26 2.8 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 122.992 2.462 . . . . 0.35 111.858 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.549 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 12.2 t 69.34 -65.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.9 0.75 . . . . 0.91 111.225 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.8 m-80 58.95 77.09 0.41 Allowed Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.285 0.634 . . . . 1.39 109.832 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -52.91 105.03 0.11 Allowed 'Trans proline' 0 CA--C 1.517 -0.333 0 C-N-CA 123.495 2.797 . . . . 0.83 113.741 -166.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.413 HG23 ' CE2' ' A' ' 89' ' ' TYR . 70.2 p -83.4 -53.49 5.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.083 . . . . 1.83 109.667 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 t -179.52 -136.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.686 -1.227 . . . . 2.36 107.686 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.48 -25.61 65.35 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.078 -0.582 . . . . 1.3 113.176 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.6 m-30 -53.3 150.32 6.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.123 0.487 . . . . 2.22 112.027 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.01 163.97 36.73 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.226 -0.897 . . . . 0.44 109.093 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.549 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -83.6 123.44 29.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.216 0.532 . . . . 0.43 111.505 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.881 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -158.32 147.58 19.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.459 -0.791 . . . . 2.78 109.296 173.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.6 m-85 -45.31 -68.9 0.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.232 0.456 . . . . 0.43 112.232 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 42' ' ' THR . 7.1 pt-20 -130.34 18.84 5.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.082 0.468 . . . . 2.39 110.79 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 100.27 91.64 2.08 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.561 -0.828 . . . . 0.73 113.128 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 -3.35 80.22 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.804 -0.712 . . . . 0.7 112.388 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.635 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -128.3 142.76 51.04 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.91 0.386 . . . . 1.13 111.663 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.778 ' H ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -144.22 133.9 23.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.237 -0.892 . . . . 2.52 111.097 173.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.71 160.25 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 2.3 110.086 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.926 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 31.0 t -125.73 138.54 32.16 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.323 -0.621 . . . . 1.61 109.323 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 32.1 Cg_exo -58.72 129.42 32.19 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.396 2.064 . . . . 1.88 111.006 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 92.0 m-20 72.37 42.87 0.52 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.05 0.844 . . . . 2.43 110.629 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.73 33.67 0.48 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.859 -0.609 . . . . 3.26 111.602 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 m -67.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.264 0.554 . . . . 2.06 110.176 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.668 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -107.36 -33.43 7.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.583 -0.735 . . . . 1.25 110.594 -177.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.739 ' HB3' ' O ' ' A' ' 76' ' ' THR . 5.0 m-85 -104.83 165.24 11.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.049 -0.978 . . . . 0.74 108.729 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -159.35 170.29 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.066 -0.654 . . . . 1.46 112.309 -166.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.926 ' HB ' ' HB2' ' A' ' 45' ' ' SER . 2.5 p -99.86 126.21 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.522 -0.763 . . . . 1.31 110.319 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -111.26 125.06 53.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 2.45 108.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.77 152.94 21.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.299 0.571 . . . . 1.93 111.463 -172.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.82 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -164.9 114.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.222 -0.899 . . . . 1.42 109.333 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 m-85 -120.88 156.37 32.15 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.168 -0.613 . . . . 1.66 110.127 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.433 -1.308 0 CA-C-N 115.837 -0.62 . . . . 2.14 110.8 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.087 0 N-CA-C 110.829 -0.908 . . . . 1.49 110.829 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.64 84.82 0.62 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.406 0.521 . . . . 0.97 112.406 -172.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.4 mt-10 -104.15 109.44 21.25 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.285 -0.635 . . . . 0.81 109.285 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.82 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 2.1 m170 -110.89 148.92 31.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.674 0.749 . . . . 0.53 111.899 -171.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.881 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 27.0 m-85 -118.82 109.12 15.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.284 -1.325 . . . . 1.13 108.864 171.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -103.53 107.33 18.13 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.893 -0.41 . . . . 0.5 109.893 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 2.4 m -103.31 118.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 122.453 1.12 . . . . 0.87 109.19 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 20.8 m -102.75 104.26 14.55 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.807 -1.182 . . . . 0.46 107.807 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -146.59 140.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.262 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.23 102.22 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.821 0.82 . . . . 1.54 109.868 171.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.83 167.27 17.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.93 -1.032 . . . . 0.67 108.58 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.797 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -99.69 89.61 4.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.184 0.516 . . . . 0.44 110.506 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.1 168.1 31.86 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.123 -0.791 . . . . 0.29 111.123 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.2 m -101.89 134.17 45.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.594 0.697 . . . . 0.4 109.609 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 85' ' ' VAL . 30.1 t-80 -104.4 104.64 14.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.668 -0.696 . . . . 0.4 109.684 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.76 109.7 21.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.562 -0.533 . . . . 0.35 109.562 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 83' ' ' HIS . 1.1 t -105.55 104.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.827 -0.624 . . . . 0.59 111.235 -170.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.502 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.28 103.51 12.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.084 -0.71 . . . . 1.53 109.084 174.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.61 128.44 52.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.269 -0.641 . . . . 0.24 109.269 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 9.0 m -102.6 137.09 41.28 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.673 0.749 . . . . 0.29 110.922 -170.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.413 ' CE2' HG23 ' A' ' 31' ' ' THR . 0.8 OUTLIER -103.78 90.05 3.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.919 -1.037 . . . . 1.11 109.6 -175.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 5.0 mtm -132.62 173.46 11.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 110.024 -0.361 . . . . 0.65 110.024 -175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.43 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 18.9 mtt180 -82.07 114.01 47.63 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 2.59 109.444 170.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.88 -35.15 39.26 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 123.537 2.825 . . . . 1.04 114.133 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -85.14 2.02 45.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.738 0.273 . . . . 1.17 111.738 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -170.88 -74.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.583 -0.28 . . . . 1.09 111.24 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.777 ' H ' HG23 ' A' ' 94' ' ' THR . . . 80.83 108.08 0.31 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.431 -1.068 . . . . 1.16 110.431 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 10.3 Cg_exo -73.51 40.82 0.56 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.741 2.961 . . . . 1.2 113.558 -172.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.7 t 44.22 -85.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.393 1.077 . . . . 2.64 112.625 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.7 -21.39 66.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.263 -0.426 . . . . 4.09 110.748 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 21.7 t0 -92.62 3.92 54.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.542 0.687 . . . . 1.67 110.211 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 7.1 m -95.52 144.92 25.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 1.39 110.626 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.91 178.19 5.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.7 -0.852 . . . . 1.91 108.7 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 56.3 ttt180 -161.12 144.51 12.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.62 110.625 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.731 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.45 156.29 18.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.709 -1.132 . . . . 0.86 109.198 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.665 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 99.4 m -157.66 103.47 1.92 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.625 -0.43 . . . . 0.31 111.375 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.944 HG11 HG21 ' A' ' 5' ' ' VAL . 11.7 p -108.63 136.84 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 119.617 -0.833 . . . . 0.88 109.993 168.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 13' ' ' THR . 97.6 m-85 -106.2 103.34 12.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.295 -0.866 . . . . 0.7 108.732 173.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.696 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.19 150.89 48.01 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.198 -0.667 . . . . 2.12 109.198 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.817 ' O ' HG22 ' A' ' 16' ' ' VAL . 48.4 tttm -102.78 119.77 39.43 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.376 -0.601 . . . . 1.89 109.376 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -99.94 115.68 30.24 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 123.928 0.768 . . . . 0.53 109.725 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.797 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-N 114.718 -1.128 . . . . 1.78 110.569 -171.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.929 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.408 -0.96 . . . . 0.59 108.408 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.5 pttt -135.67 151.47 50.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.884 0.373 . . . . 2.36 111.021 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.839 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -122.43 155.22 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 0.49 111.046 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 7.2 p -143.67 170.55 15.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.922 -1.036 . . . . 0.51 108.67 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 24.9 tptp -48.28 -38.16 18.12 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.573 0.582 . . . . 0.83 112.573 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.31 79.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.883 0.849 . . . . 0.33 111.073 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.77 ' HB2' HG13 ' A' ' 5' ' ' VAL . 32.9 m80 -63.9 -2.93 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 2.12 111.346 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.733 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 15.5 t-20 -49.93 -19.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.257 0.623 . . . . 1.41 110.685 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.87 48.61 0.92 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.296 -0.722 . . . . 0.3 111.296 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.92 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -112.54 154.92 25.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.875 0.694 . . . . 0.32 112.875 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 41.3 m -147.9 104.38 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.271 -0.877 . . . . 0.95 109.062 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.571 HD11 ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -141.81 167.93 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.141 0.496 . . . . 3.0 111.618 -171.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 m -101.59 139.03 37.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.599 -0.728 . . . . 1.73 109.897 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -127.46 162.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.252 0.549 . . . . 0.78 112.137 -175.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.19 120.64 38.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.452 -0.944 . . . . 0.76 108.452 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 19' ' ' GLY . 2.2 t -105.73 -156.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.166 -0.679 . . . . 1.23 109.166 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.795 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 108.67 -49.04 0.88 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.667 -0.973 . . . . 0.71 110.667 -175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.62 -73.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.086 -0.709 . . . . 2.35 109.086 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.8 tp -166.88 145.14 5.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.346 -0.843 . . . . 0.71 109.367 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.929 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -122.63 111.71 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.4 109.641 171.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -104.83 139.73 39.16 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.55 0.69 . . . . 1.09 110.918 -173.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 85' ' ' VAL . 47.1 mm -117.34 101.48 12.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.932 -1.136 . . . . 0.54 107.932 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.507 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.61 142.95 34.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.243 0.544 . . . . 0.64 111.211 -172.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 3.7 mt -128.44 138.15 32.44 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-O 121.546 0.689 . . . . 0.85 111.079 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.521 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 85.3 Cg_endo -78.78 8.66 3.61 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.035 2.49 . . . . 0.35 112.068 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.653 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 13.7 t 69.37 -57.81 0.52 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.712 0.632 . . . . 0.91 110.165 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 52.54 63.46 8.79 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.051 -1.092 . . . . 1.39 108.051 -172.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 48.3 Cg_exo -44.94 125.67 6.87 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 124.136 3.224 . . . . 0.83 114.486 -165.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.444 HG23 ' CE2' ' A' ' 89' ' ' TYR . 4.1 t -157.6 96.8 1.55 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.605 -1.179 . . . . 1.83 110.433 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 33' ' ' GLY . 16.3 m 73.22 176.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.746 -0.661 . . . . 2.36 110.102 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.554 ' H ' HG22 ' A' ' 32' ' ' THR . . . -59.05 -8.71 6.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.539 -0.362 . . . . 1.3 113.926 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.629 ' HA ' ' C ' ' A' ' 90' ' ' MET . 6.3 m-85 -55.06 154.68 5.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 2.22 111.779 176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.83 154.21 32.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.489 -0.56 . . . . 0.44 109.489 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.653 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 97.7 m95 -76.52 111.28 11.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.9 0.381 . . . . 0.43 110.944 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.853 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 10.1 p90 -149.25 146.26 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 2.78 109.575 170.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.7 m-85 -44.86 -78.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.947 1.092 . . . . 0.43 113.947 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -118.22 -10.57 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.3 -0.56 . . . . 2.39 111.621 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.782 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 138.87 92.37 0.25 Allowed Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 119.937 -1.125 . . . . 0.73 113.039 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.07 15.51 65.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.843 -0.694 . . . . 0.7 111.865 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -138.63 144.16 39.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.462 -0.369 . . . . 1.13 111.502 -176.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.28 131.34 26.3 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.55 -0.75 . . . . 2.52 111.285 171.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.16 160.49 40.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.715 -0.675 . . . . 2.3 110.324 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.643 ' HB2' HG23 ' A' ' 53' ' ' VAL . 13.3 t -104.54 134.89 19.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.48 -0.933 . . . . 1.61 108.48 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.53 41.59 0.26 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.433 2.755 . . . . 1.88 113.262 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 177.33 41.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.84 -1.17 . . . . 2.43 107.84 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -80.58 45.07 0.75 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.603 -0.726 . . . . 3.26 111.714 -173.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -74.9 -41.06 60.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.013 0.435 . . . . 2.06 111.003 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.661 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -134.86 -21.3 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.329 0.585 . . . . 1.25 110.668 -177.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 76' ' ' THR . 3.7 m-85 -124.24 162.47 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.223 -0.898 . . . . 0.74 109.662 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -152.69 170.6 19.86 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.786 0.661 . . . . 1.46 112.786 -160.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 45' ' ' SER . 46.5 t -99.84 123.85 52.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.542 -0.753 . . . . 1.31 111.175 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.21 117.82 34.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.281 -0.872 . . . . 2.45 108.71 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -104.2 150.19 24.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 1.93 111.438 -171.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.581 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.19 116.0 3.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.945 -0.57 . . . . 1.42 109.837 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.797 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 9.6 m-85 -113.79 136.05 53.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.479 -0.328 . . . . 1.66 111.258 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.32 -0.4 . . . . 2.14 109.969 171.845 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 110.987 -0.845 . . . . 1.49 110.987 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.74 80.44 1.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.556 0.693 . . . . 0.97 112.58 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.797 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.9 mt-10 -105.45 103.59 13.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.458 -0.942 . . . . 0.81 108.458 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.581 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -108.59 159.19 16.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.814 0.816 . . . . 0.53 111.499 -171.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.853 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 28.4 m-85 -122.47 108.54 13.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.909 -1.496 . . . . 1.13 109.018 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.676 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 31.9 m170 -102.31 110.74 22.78 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.515 -0.55 . . . . 0.5 109.515 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 53' ' ' VAL . 3.3 m -102.18 120.06 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.58 1.181 . . . . 0.87 109.219 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.737 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 13.9 m -103.09 103.61 13.7 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.318 -1.364 . . . . 0.46 107.318 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.579 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.1 p -160.4 118.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.396 0.435 . . . . 1.04 111.259 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.45 104.0 11.0 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.174 0.988 . . . . 1.54 109.869 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.65 143.26 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.653 -1.158 . . . . 0.67 109.737 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 96.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.44 111.107 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.32 166.16 38.19 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.29 110.175 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.6 m -101.62 132.7 47.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.808 0.804 . . . . 0.4 109.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.688 ' HD1' HG22 ' A' ' 85' ' ' VAL . 44.8 t-80 -103.84 104.95 15.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.494 -0.775 . . . . 0.4 109.786 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.23 113.76 27.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.374 0.607 . . . . 0.35 109.623 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.96 103.93 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.59 111.2 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -105.45 103.71 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.289 -0.634 . . . . 1.53 109.289 173.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HG ' HG12 ' A' ' 85' ' ' VAL . 78.0 mt -107.01 123.82 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.51 -0.552 . . . . 0.24 109.51 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.513 HG22 ' CG ' ' A' ' 90' ' ' MET . 3.3 m -105.86 119.96 40.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.24 0.543 . . . . 0.29 112.002 -169.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 35' ' ' ALA . 28.0 t80 -88.05 85.31 6.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 1.11 109.38 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.665 ' HE2' ' HE1' ' A' ' 37' ' ' TYR . 20.7 mtm -124.34 167.13 14.77 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.443 -0.344 . . . . 0.65 110.299 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.455 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.4 ttt180 -78.65 108.67 8.47 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.792 -0.818 . . . . 2.59 108.792 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.584 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 5.8 Cg_endo -46.93 -32.24 12.42 Favored 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.546 2.831 . . . . 1.04 115.459 -167.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.584 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.3 p90 -96.92 11.73 34.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.684 0.624 . . . . 1.17 112.684 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.412 HG23 ' HD3' ' A' ' 96' ' ' PRO . 5.3 t -168.63 -50.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 1.09 111.87 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 51.48 80.56 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 O-C-N 123.303 0.377 . . . . 1.16 112.361 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.878 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 92.4 Cg_exo -40.31 105.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.148 2.565 . . . . 1.2 111.218 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.1 m -54.91 125.31 19.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 2.64 111.117 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 77.03 -2.27 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.406 -0.815 . . . . 4.09 111.216 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.878 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 26.4 t0 -97.13 -27.34 14.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.941 0.877 . . . . 1.67 108.668 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.512 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 12.4 m -68.24 157.08 36.29 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.071 -1.422 . . . . 1.39 110.846 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.1 tp10 -96.51 161.13 14.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.559 -0.904 . . . . 1.91 108.559 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 31.5 ttt180 -148.83 139.96 23.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.432 0.634 . . . . 0.62 110.315 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.774 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -104.22 155.86 18.38 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.86 109.208 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 70.5 m -157.15 102.76 1.97 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.73 -0.388 . . . . 0.31 111.161 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.92 HG23 ' HB3' ' A' ' 12' ' ' ALA . 10.7 p -105.63 136.2 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.639 -0.824 . . . . 0.88 110.014 168.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' THR . 88.4 m-85 -104.71 104.64 14.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.443 -0.799 . . . . 0.7 109.047 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.663 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 pp -123.01 147.68 46.38 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.374 -0.602 . . . . 2.12 109.374 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 16' ' ' VAL . 38.5 tttt -103.27 115.3 30.29 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.377 -0.529 . . . . 1.89 110.557 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.405 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.19 153.56 19.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.952 -0.567 . . . . 0.53 110.775 -169.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.557 ' H ' HG23 ' A' ' 18' ' ' VAL . 4.7 p30 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.242 -0.89 . . . . 1.78 108.891 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.954 ' HB3' HG22 ' A' ' 22' ' ' VAL . 6.8 t60 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.222 -0.659 . . . . 0.59 109.222 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -141.82 130.05 22.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.283 0.364 . . . . 2.36 111.286 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.752 HG11 ' CZ ' ' A' ' 103' ' ' PHE . 2.0 t -104.72 157.7 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.873 0.368 . . . . 0.49 110.462 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -144.81 170.2 16.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.171 0.989 . . . . 0.51 108.904 -173.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HB2' ' CD ' ' A' ' 27' ' ' PRO . 16.5 tptm -46.9 -43.85 19.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.031 0.752 . . . . 0.83 113.031 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.2 70.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.941 0.877 . . . . 0.33 110.974 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.75 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.4 m80 -62.57 -4.02 1.76 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.928 . . . . 2.12 111.438 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.688 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.7 t-20 -45.84 -22.29 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 1.41 110.422 172.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.65 54.95 0.73 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.904 -0.665 . . . . 0.3 111.726 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . . . -117.38 146.26 43.54 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.157 0.799 . . . . 0.32 113.157 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 36.9 m -141.24 111.19 6.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.433 -0.803 . . . . 0.95 109.779 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.0 pp -166.64 171.66 11.41 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.148 0.179 . . . . 3.0 110.937 -173.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -99.17 143.65 29.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.106 0.479 . . . . 1.73 111.674 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 108' ' ' LYS . 4.0 m -119.08 160.24 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.668 -0.697 . . . . 0.78 111.624 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.49 135.99 44.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.213 -0.662 . . . . 0.76 109.213 172.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 77' ' ' VAL . 24.3 m -121.5 -166.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.962 0.411 . . . . 1.23 111.773 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.718 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 108.95 -56.65 0.46 Allowed Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.29 -0.724 . . . . 0.71 111.29 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -75.42 -71.99 0.33 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.955 -0.757 . . . . 2.35 108.955 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -166.95 141.3 3.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.593 -0.73 . . . . 0.71 110.184 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.954 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.4 t -120.57 116.7 50.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.526 -0.546 . . . . 0.4 109.526 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.733 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -114.78 149.23 37.28 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.663 -0.815 . . . . 1.09 112.225 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.532 HD13 ' HB ' ' A' ' 5' ' ' VAL . 44.3 mm -124.13 102.51 11.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.69 -1.141 . . . . 0.54 108.681 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.96 141.82 36.7 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.561 -0.712 . . . . 0.64 112.46 -172.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -116.73 147.48 39.99 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.25 -0.886 . . . . 0.85 109.403 171.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 7' ' ' LYS . 43.1 Cg_endo -85.98 11.62 3.27 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.883 2.389 . . . . 0.35 111.52 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 30.4 t 70.84 -51.45 0.68 Allowed 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.399 -0.818 . . . . 0.91 111.118 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.4 67.36 2.18 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.008 -0.738 . . . . 1.39 109.008 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.18 97.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.439 2.759 . . . . 0.83 112.618 -168.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.426 HG22 ' CE2' ' A' ' 89' ' ' TYR . 1.3 t -105.11 -39.44 6.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 1.83 111.353 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 34' ' ' PHE . 9.0 t -178.21 -150.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.951 -0.759 . . . . 2.36 108.951 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.76 -23.36 55.66 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.71 -0.281 . . . . 1.3 113.349 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.571 ' HA ' ' C ' ' A' ' 90' ' ' MET . 14.3 m-30 -46.01 137.19 6.02 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.212 0.529 . . . . 2.22 112.123 172.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.501 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -141.96 149.94 40.77 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.34 -0.985 . . . . 0.44 108.34 171.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.594 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.2 m95 -77.04 117.81 18.98 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.568 0.699 . . . . 0.43 111.141 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 47.0 m-85 -126.03 -179.59 4.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.186 -1.042 . . . . 2.78 108.186 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.8 m-85 -73.2 -82.07 0.05 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.818 -0.753 . . . . 0.43 109.505 167.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.76 10.09 24.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 2.39 110.144 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.26 105.76 2.51 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.835 -0.698 . . . . 0.73 112.225 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 3.3 59.98 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.892 -0.671 . . . . 0.7 111.966 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -129.98 142.61 50.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.454 -0.373 . . . . 1.13 111.566 -177.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -142.61 129.15 20.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.938 -0.573 . . . . 2.52 110.835 166.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.35 137.41 34.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.726 -0.67 . . . . 2.3 110.14 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.883 ' HB2' HG23 ' A' ' 52' ' ' THR . 15.4 m -104.4 138.7 19.59 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 121.24 0.543 . . . . 1.61 110.714 171.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 9.8 Cg_endo -93.66 170.05 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.719 3.613 . . . . 1.88 113.493 -168.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.561 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 59.7 t30 74.67 -36.27 0.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.991 0.916 . . . . 2.43 111.107 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.73 ' OE1' ' HG2' ' A' ' 50' ' ' MET . 4.9 mm-40 -109.99 148.34 31.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.201 1.001 . . . . 3.26 113.561 -170.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.4 t -130.01 -11.85 4.21 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.624 -1.626 . . . . 2.06 109.089 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.73 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 19.0 ptt? -97.89 -37.24 9.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.494 -0.483 . . . . 1.25 110.652 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 76' ' ' THR . 0.2 OUTLIER -147.4 97.01 2.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.519 -0.753 . . . . 0.74 110.474 -174.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.883 HG23 ' HB2' ' A' ' 45' ' ' SER . 11.0 t 177.78 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.627 0.649 . . . . 1.46 111.446 160.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -174.73 142.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.953 0.501 . . . . 1.31 111.235 162.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 7.9 tp10 -168.76 154.31 6.42 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.959 -0.756 . . . . 2.45 108.959 167.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.7 139.68 25.37 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.171 0.51 . . . . 1.93 111.858 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.689 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -163.02 103.87 1.0 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.581 -0.736 . . . . 1.42 110.474 175.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.749 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -124.81 125.11 43.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 1.66 111.495 -177.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.414 -0.812 . . . . 2.14 111.078 -176.084 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.982 0 N-CA-C 111.111 -0.796 . . . . 1.49 111.111 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.25 80.64 0.83 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.436 0.636 . . . . 0.97 111.265 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.749 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 40.4 mt-10 -104.44 103.23 12.9 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.457 -0.792 . . . . 0.81 109.01 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.689 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -108.26 145.71 33.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.685 -0.806 . . . . 0.53 110.973 -174.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 6.5 m-85 -117.47 109.64 17.01 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.619 -1.173 . . . . 1.13 109.736 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.733 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -103.54 149.92 24.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.715 -0.476 . . . . 0.5 109.715 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.563 HG22 HG12 ' A' ' 22' ' ' VAL . 3.5 m -132.95 126.93 54.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.882 0.848 . . . . 0.87 108.902 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.665 HG22 ' CE2' ' A' ' 51' ' ' PHE . 3.7 m -102.39 101.36 11.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 0.46 108.452 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 3.8 p -144.14 145.88 21.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.503 -0.479 . . . . 1.04 112.074 -167.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -138.91 103.48 4.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.55 -0.907 . . . . 1.54 108.55 163.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.31 164.92 19.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.67 109.597 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.58 86.95 2.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.44 109.998 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -158.05 167.92 34.44 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.42 -0.809 . . . . 0.29 111.184 -175.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.1 m -100.23 132.6 45.51 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.817 -0.753 . . . . 0.4 109.908 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.667 ' ND1' HG22 ' A' ' 85' ' ' VAL . 48.2 t-80 -103.5 103.82 13.82 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.753 -0.658 . . . . 0.4 109.586 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.17 110.97 23.06 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.957 -0.757 . . . . 0.35 108.957 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -107.44 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.682 -0.69 . . . . 0.59 110.292 -171.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.22 103.6 12.82 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.917 -0.771 . . . . 1.53 108.917 176.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 38' ' ' PHE . 63.7 mt -107.35 123.99 49.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.641 -0.709 . . . . 0.24 109.666 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.48 HG22 ' CG ' ' A' ' 90' ' ' MET . 4.4 m -102.15 119.8 39.4 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.871 0.844 . . . . 0.29 110.688 -173.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.501 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 7.4 t80 -89.3 88.37 7.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.503 -1.226 . . . . 1.11 109.676 -175.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.571 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 14.1 mtm -129.22 166.43 19.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.245 0.545 . . . . 0.65 111.051 -172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.433 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.3 mtm180 -70.04 107.39 2.31 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.859 -1.064 . . . . 2.59 108.786 168.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.5 Cg_endo -51.63 -27.0 24.38 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.335 2.69 . . . . 1.04 114.655 -169.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.456 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 45.7 p90 -93.46 3.89 54.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.0 0.37 . . . . 1.17 112.0 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.3 t -164.06 -66.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.834 -0.166 . . . . 1.09 111.14 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.681 ' H ' HG23 ' A' ' 94' ' ' THR . . . 67.53 94.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.012 -0.435 . . . . 1.16 112.012 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.975 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 15.8 Cg_exo -64.92 130.03 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.607 2.205 . . . . 1.2 111.11 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.8 t -43.75 -50.32 7.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.955 0.902 . . . . 2.64 113.018 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -121.65 20.79 10.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.522 -0.471 . . . . 4.09 111.029 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.975 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.7 t0 -103.99 -22.18 13.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.412 -0.958 . . . . 1.67 108.412 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 16.3 m -80.0 148.22 31.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.614 -1.175 . . . . 1.39 110.561 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.84 172.87 7.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.096 -1.076 . . . . 1.91 108.096 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 26.6 ttt180 -158.48 139.01 12.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.407 0.623 . . . . 0.62 110.361 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.773 ' CZ ' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -103.76 155.88 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.875 -1.057 . . . . 0.86 109.069 -178.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 24.3 m -157.36 104.56 2.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.881 0.372 . . . . 0.31 110.972 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.773 ' HB ' ' CZ ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -103.81 132.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 119.769 -0.772 . . . . 0.88 109.592 168.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.689 ' O ' HD12 ' A' ' 107' ' ' LEU . 73.1 m-85 -108.06 97.42 7.12 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.628 -1.249 . . . . 0.7 107.628 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 106' ' ' TYR . 8.9 mp -134.21 144.78 48.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.288 -0.634 . . . . 2.12 109.288 -173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 16' ' ' VAL . 35.5 ttpt -102.81 130.98 49.98 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.129 -0.628 . . . . 1.89 110.946 -166.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.06 132.37 45.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 0.53 109.566 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.598 ' C ' HG22 ' A' ' 18' ' ' VAL . 6.2 p30 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.386 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 1.015 ' HB3' HG22 ' A' ' 22' ' ' VAL . 33.3 t60 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.385 -0.598 . . . . 0.59 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -138.91 134.15 32.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.266 -0.642 . . . . 2.36 109.266 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -107.49 125.81 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 119.5 -0.88 . . . . 0.49 110.685 178.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.474 ' C ' ' ND1' ' A' ' 9' ' ' HIS . 0.7 OUTLIER -120.99 152.09 38.97 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.122 0.416 . . . . 0.51 112.122 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 27.0 tptp -31.17 -45.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.252 1.945 . . . . 0.83 116.252 -153.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.61 -34.98 1.57 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.311 1.053 . . . . 0.33 111.731 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.935 ' ND1' HG13 ' A' ' 5' ' ' VAL . 2.4 p-80 -55.19 -9.36 0.4 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.126 -1.397 . . . . 2.12 113.159 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -58.14 -15.32 9.24 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 107.633 -1.247 . . . . 1.41 107.633 -174.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.91 58.63 0.69 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.091 -1.413 . . . . 0.3 110.169 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.891 ' HB2' ' HA ' ' A' ' 9' ' ' HIS . . . -116.09 151.91 34.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.752 0.649 . . . . 0.32 112.752 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 23.6 m -149.43 108.45 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.772 -0.649 . . . . 0.95 109.941 173.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.766 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.1 pt? -150.67 166.85 29.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 3.0 111.25 -171.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -103.11 144.63 31.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.638 -0.256 . . . . 1.73 110.424 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -128.41 156.27 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 0.78 111.493 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.2 137.73 42.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.338 -0.986 . . . . 0.76 108.338 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 HG21 ' A' ' 22' ' ' VAL . 29.5 m -115.74 -178.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.664 -0.414 . . . . 1.23 111.424 -177.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.4 -60.59 0.66 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.272 -0.731 . . . . 0.71 111.272 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.2 -72.08 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.339 0.59 . . . . 2.35 109.725 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.4 tp -165.69 133.36 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.984 . . . . 0.71 110.45 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.015 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.2 t -119.95 113.0 39.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.368 -0.604 . . . . 0.4 109.368 174.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.2 pt-20 -111.48 157.32 20.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.509 1.147 . . . . 1.09 112.985 -173.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.426 HG21 HG11 ' A' ' 85' ' ' VAL . 40.6 mm -126.62 102.69 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.889 -1.959 . . . . 0.54 107.405 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -114.59 135.17 54.43 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.04 0.924 . . . . 0.64 111.91 -173.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -112.33 145.32 32.63 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.735 -1.12 . . . . 0.85 108.855 174.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 71.4 Cg_endo -82.12 7.08 5.3 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.648 2.232 . . . . 0.35 111.345 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.627 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 67.77 -64.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.91 109.658 -172.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.71 67.98 1.23 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.285 -1.006 . . . . 1.39 108.285 -171.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -53.82 108.83 0.31 Allowed 'Trans proline' 0 CA--C 1.52 -0.177 0 C-N-CA 123.378 2.719 . . . . 0.83 112.813 -169.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.87 -37.25 13.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.363 -0.835 . . . . 1.83 111.482 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 t -178.22 -44.7 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 111.748 0.277 . . . . 2.36 111.748 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.98 -32.97 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 111.436 -0.665 . . . . 1.3 111.436 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HE1' ' HD2' ' A' ' 96' ' ' PRO . 31.2 m-85 -43.26 141.49 1.26 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.222 -0.489 . . . . 2.22 111.778 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -140.17 150.22 43.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.847 -1.07 . . . . 0.44 108.438 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.4 m95 -78.83 118.37 20.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.969 0.414 . . . . 0.43 111.01 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.822 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -150.37 145.68 26.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 2.78 109.789 172.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 1.1 m-85 -46.37 -76.19 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.879 0.696 . . . . 0.43 112.879 -172.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.23 -8.84 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 2.39 110.936 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.686 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 116.75 86.64 1.24 Allowed Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 119.72 -1.228 . . . . 0.73 112.193 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.6 -4.34 74.15 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.149 -0.78 . . . . 0.7 111.149 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.39 137.84 52.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.836 -0.431 . . . . 1.13 109.836 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -141.52 139.59 33.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.534 -0.543 . . . . 2.52 109.534 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.3 165.37 27.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.23 0.538 . . . . 2.3 111.487 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.6 p -114.26 140.05 24.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.603 -0.726 . . . . 1.61 109.247 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.6 Cg_exo -76.16 -5.59 16.42 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 1.88 113.128 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' A' ' 79' ' ' ALA . 9.4 p-10 -151.17 67.64 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.496 0.665 . . . . 2.43 110.663 -177.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -109.45 -147.49 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 3.26 111.518 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m 71.43 36.14 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.431 0.634 . . . . 2.06 110.894 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptt? 175.94 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.57 -1.195 . . . . 1.25 107.879 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 11.6 m-85 -130.13 162.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.336 -1.756 . . . . 0.74 106.291 173.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -152.46 166.13 32.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 119.48 1.036 . . . . 1.46 112.953 -165.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.3 p -103.01 133.08 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.14 -0.936 . . . . 1.31 110.966 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 28.9 tt0 -104.18 153.98 20.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.99 -1.004 . . . . 2.45 108.779 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 54' ' ' GLU . 21.4 p-10 -133.47 122.73 24.09 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.094 -0.503 . . . . 1.93 109.966 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.807 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -137.73 113.27 9.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.617 0.722 . . . . 1.42 110.07 176.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.82 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.4 m-85 -106.83 124.04 49.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.333 -0.848 . . . . 1.66 110.49 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 96.7 m-85 . . . . . 0 C--N 1.32 -0.715 0 CA-C-O 121.284 0.564 . . . . 2.14 110.586 175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 108.85 -1.7 . . . . 1.49 108.85 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.49 92.62 1.51 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.418 0.896 . . . . 0.97 113.418 -168.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 36.8 mt-10 -104.44 106.82 17.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.81 108.741 174.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.807 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.6 m170 -107.4 152.78 23.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.413 0.625 . . . . 0.53 111.825 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.822 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 30.8 m-85 -123.44 108.29 12.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.301 -1.318 . . . . 1.13 108.6 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.615 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 21.0 m170 -103.6 107.65 18.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.194 -0.457 . . . . 0.5 110.377 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 3.3 m -101.93 113.99 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-O 122.986 1.374 . . . . 0.87 108.463 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 16.9 m -101.52 103.23 14.08 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.723 -1.584 . . . . 0.46 106.723 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.568 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.2 p -153.97 146.82 14.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 124.167 0.917 . . . . 1.04 111.179 -173.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.59 102.5 6.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.561 0.696 . . . . 1.54 109.533 166.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' HD22 ' A' ' 47' ' ' ASN . . . -165.83 140.29 4.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.69 -0.687 . . . . 0.67 110.043 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.89 95.89 2.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.383 0.611 . . . . 0.44 111.213 -177.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.75 34.03 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.201 -0.909 . . . . 0.29 110.993 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.0 m -102.97 134.84 45.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.895 -0.78 . . . . 0.4 108.895 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.905 ' HD1' HG22 ' A' ' 85' ' ' VAL . 31.0 t-80 -102.96 105.35 15.67 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.36 -0.607 . . . . 0.4 109.36 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.11 106.63 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.808 -0.812 . . . . 0.35 108.808 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.905 HG22 ' HD1' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -104.88 110.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 0.59 110.773 -170.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -114.39 104.28 11.89 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.962 0.789 . . . . 1.53 109.164 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.652 ' H ' ' HD1' ' A' ' 103' ' ' PHE . 76.6 mt -105.55 130.48 53.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.166 -0.679 . . . . 0.24 109.166 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.517 HG22 ' CG ' ' A' ' 90' ' ' MET . 6.7 m -102.42 122.08 43.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.343 0.592 . . . . 0.29 110.354 -172.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.478 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.2 t80 -91.18 85.54 5.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.308 -0.86 . . . . 1.11 109.486 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.604 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . 7.9 mtm -128.94 172.35 11.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.65 110.943 -175.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.536 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 5.4 mtm180 -84.23 109.84 22.19 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.485 -0.779 . . . . 2.59 109.477 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 2.0 Cg_endo -41.63 -34.7 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.724 3.616 . . . . 1.04 115.51 -168.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -87.03 3.53 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.504 0.557 . . . . 1.17 112.504 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.472 HG23 ' N ' ' A' ' 95' ' ' GLY . 6.2 t -169.22 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.409 -0.182 . . . . 1.09 111.401 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.604 ' CA ' ' HB3' ' A' ' 90' ' ' MET . . . 66.12 78.74 0.22 Allowed Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.137 -0.554 . . . . 1.16 111.784 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 1.061 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 71.6 Cg_exo -47.82 121.51 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.296 2.664 . . . . 1.2 111.958 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -50.08 -39.52 42.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.969 -1.014 . . . . 2.64 113.25 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -112.79 17.53 18.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.32 -0.552 . . . . 4.09 110.925 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 1.061 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 25.3 t0 -121.53 -0.29 9.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.737 0.78 . . . . 1.67 109.57 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 p -97.9 156.22 16.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.104 -0.953 . . . . 1.39 110.96 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 40.6 tt0 -108.26 175.81 5.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.453 -0.943 . . . . 1.91 108.453 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 47.8 ttt180 -158.7 142.81 15.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.685 0.755 . . . . 0.62 110.483 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.757 ' HZ ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -104.16 162.81 12.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.428 -1.26 . . . . 0.86 109.796 -177.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 38.2 m -164.67 104.82 0.82 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 123.407 0.442 . . . . 0.31 110.39 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 5' ' ' VAL . 13.4 p -110.87 136.67 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 119.408 -0.917 . . . . 0.88 109.153 166.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' THR . 98.0 m-85 -103.5 103.44 13.41 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.409 -0.96 . . . . 0.7 108.409 174.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.766 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -127.26 147.24 50.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.653 -0.499 . . . . 2.12 109.653 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.688 ' O ' HG22 ' A' ' 16' ' ' VAL . 20.1 tttm -102.38 117.02 33.82 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.78 -0.368 . . . . 1.89 110.346 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.62 120.4 39.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.614 0.571 . . . . 0.53 110.176 -170.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.527 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.516 -0.754 . . . . 1.78 110.422 -174.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.98 ' HB3' HG22 ' A' ' 22' ' ' VAL . 16.1 t60 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 109.072 -0.714 . . . . 0.59 109.072 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 136.65 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.567 -0.288 . . . . 2.36 110.972 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.874 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -112.36 157.5 13.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.856 0.36 . . . . 0.49 111.03 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -151.76 170.64 19.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.421 1.089 . . . . 0.51 108.113 -172.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.507 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 26.0 tptp -48.33 -37.06 15.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.561 0.949 . . . . 0.83 113.561 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.08 79.2 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.914 0.864 . . . . 0.33 110.742 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.773 ' HB2' HG13 ' A' ' 5' ' ' VAL . 33.6 m80 -65.32 -3.7 4.44 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.134 -0.939 . . . . 2.12 111.346 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.703 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 26.0 t-20 -50.27 -18.92 0.68 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.679 0.612 . . . . 1.41 110.03 173.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.45 55.73 0.6 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.3 111.285 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.921 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -113.79 156.1 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 113.041 0.756 . . . . 0.32 113.041 -175.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 m -139.39 112.69 8.21 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.185 -1.042 . . . . 0.95 108.185 171.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 23.1 tp -151.14 163.24 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 3.0 111.74 -167.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.0 m -104.58 148.04 26.95 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.179 -0.674 . . . . 1.73 109.179 172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.8 m -127.55 156.82 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.053 -0.659 . . . . 0.78 112.429 -177.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.76 142.4 34.77 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.789 -1.189 . . . . 0.76 107.789 167.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG12 HG21 ' A' ' 22' ' ' VAL . 10.7 m -119.8 -176.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.792 0.329 . . . . 1.23 110.724 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.6 -59.52 0.69 Allowed Glycine 0 CA--C 1.505 -0.58 0 N-CA-C 111.224 -0.75 . . . . 0.71 111.224 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -73.68 -68.22 0.53 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 2.35 108.96 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -167.64 141.33 3.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.755 -1.111 . . . . 0.71 110.283 -176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.98 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -113.68 104.02 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 108.494 -0.928 . . . . 0.4 108.494 169.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.666 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -108.88 157.35 18.7 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 122.056 0.931 . . . . 1.09 112.524 -169.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.593 HD13 ' HB ' ' A' ' 5' ' ' VAL . 29.7 mm -134.28 103.07 4.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.579 -1.646 . . . . 0.54 108.428 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.528 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -112.73 139.0 48.71 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 121.528 -0.733 . . . . 0.64 112.194 -175.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -111.59 148.41 38.8 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 115.531 -0.759 . . . . 0.85 109.947 173.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 40.3 Cg_endo -87.09 11.84 3.14 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.229 2.619 . . . . 0.35 111.976 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.519 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 21.5 t 69.3 -66.96 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.343 -0.844 . . . . 0.91 110.83 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 60.23 64.05 2.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.438 -0.949 . . . . 1.39 108.438 -170.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.41 117.76 2.5 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.88 3.053 . . . . 0.83 113.272 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.422 HG23 ' CZ ' ' A' ' 89' ' ' TYR . 22.3 p -91.64 -89.1 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.212 -0.904 . . . . 1.83 112.849 -170.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.6 t -163.26 22.57 0.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 122.007 0.908 . . . . 2.36 110.141 -175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 143.26 -35.83 1.63 Allowed Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.46 -0.791 . . . . 1.3 111.377 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' HA ' ' C ' ' A' ' 90' ' ' MET . 2.2 m-85 -62.43 143.99 56.41 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.974 -0.613 . . . . 2.22 111.189 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -139.53 156.04 47.15 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.387 -0.968 . . . . 0.44 108.387 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.519 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -81.0 117.27 21.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.518 0.675 . . . . 0.43 111.51 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.73 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 56.2 m-85 -127.46 175.78 7.97 Favored 'General case' 0 C--O 1.212 -0.882 0 N-CA-C 108.179 -1.045 . . . . 2.78 108.179 169.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.72 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -67.2 -74.38 0.12 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 118.773 0.715 . . . . 0.43 109.715 171.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -110.51 -8.16 14.67 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.048 -0.524 . . . . 2.39 110.157 173.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.08 106.59 2.78 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.366 -0.921 . . . . 0.73 112.047 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.25 -23.92 5.86 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.886 -0.674 . . . . 0.7 112.448 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.8 m -128.33 141.84 51.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.653 0.263 . . . . 1.13 110.41 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -136.97 134.85 37.12 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.682 -0.69 . . . . 2.52 110.048 179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -128.54 145.85 51.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.754 0.788 . . . . 2.3 112.136 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.867 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 6.2 p -111.43 137.75 21.19 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.584 -0.895 . . . . 1.61 108.584 173.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 7.5 Cg_exo -74.42 137.16 22.73 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.434 2.089 . . . . 1.88 111.431 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 69.18 34.46 3.0 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.902 0.751 . . . . 2.43 110.949 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -96.04 137.93 34.4 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.787 0.803 . . . . 3.26 110.945 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.7 t 177.56 -55.52 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.045 -1.434 . . . . 2.06 107.396 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.9 ptt? -89.84 -32.41 16.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.015 -0.993 . . . . 1.25 109.336 171.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.787 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.5 m-85 -119.46 160.36 22.51 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.463 -1.244 . . . . 0.74 107.767 176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -165.74 169.44 15.11 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.651 0.66 . . . . 1.46 112.131 -168.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.867 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.2 p -103.1 139.66 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 115.696 -0.684 . . . . 1.31 111.952 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.836 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.6 OUTLIER -107.38 142.91 36.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.893 -0.78 . . . . 2.45 108.893 171.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -122.44 133.4 54.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.384 0.611 . . . . 1.93 111.195 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -150.1 111.0 4.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.268 -0.878 . . . . 1.42 110.495 -176.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.913 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -123.92 127.02 47.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.671 -0.695 . . . . 1.66 111.257 -174.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.448 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 93.1 m-85 -126.04 103.71 26.71 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.3 -0.864 . . . . 2.14 111.003 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 8.0 Cg_endo -91.52 104.56 0.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.827 3.018 . . . . 1.92 111.758 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 1.026 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 19.8 Cg_exo -72.64 -24.06 18.95 Favored 'Trans proline' 0 CA--C 1.517 -0.373 0 C-N-CA 124.101 3.201 . . . . 2.64 112.83 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.789 ' OD2' ' HD3' ' A' ' 63' ' ' LYS . 8.2 t70 -147.31 -174.55 4.55 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.735 -0.839 . . . . 5.8 108.735 -171.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.6 t -153.9 4.95 0.29 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 112.806 0.669 . . . . 7.43 112.806 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.789 ' HD3' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -135.97 -12.79 1.93 Allowed 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.584 -0.446 . . . . 8.71 110.845 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 46.6 tp -142.57 -80.55 0.21 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.069 -0.514 . . . . 8.1 110.582 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 17.0 tp 169.81 124.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.415 -0.811 . . . . 4.74 109.113 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 1.026 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -81.43 52.84 4.6 Favored Glycine 0 C--N 1.319 -0.368 0 C-N-CA 121.088 -0.577 . . . . 3.02 111.768 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 68.46 -71.37 0.11 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.119 0.568 . . . . 4.02 111.085 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -119.88 73.56 0.32 Allowed Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.698 -0.763 . . . . 2.84 112.578 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -56.48 134.23 51.25 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.808 -1.317 . . . . 1.49 109.808 170.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.497 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -153.99 90.18 1.35 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 113.836 1.05 . . . . 0.97 113.836 -168.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.913 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.7 mt-10 -110.31 104.12 12.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.54 -0.754 . . . . 0.81 109.083 175.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.633 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -113.64 159.4 19.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.777 0.799 . . . . 0.53 112.445 -171.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.73 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 44.9 m-85 -132.28 108.91 9.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.933 -1.485 . . . . 1.13 109.4 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.836 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 26.0 m170 -108.61 107.46 17.96 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 122.203 -0.31 . . . . 0.5 111.339 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -103.75 119.34 52.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 122.047 0.927 . . . . 0.87 110.419 -179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.787 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.8 m -102.85 105.75 16.2 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.979 -1.119 . . . . 0.46 107.979 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.538 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.3 p -147.45 149.18 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 123.633 0.583 . . . . 1.04 110.335 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -133.91 102.3 5.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.966 0.888 . . . . 1.54 109.884 167.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -168.34 127.56 1.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.34 -0.845 . . . . 0.67 109.887 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.32 101.42 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 O-C-N 123.648 0.592 . . . . 0.44 111.916 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.87 167.57 36.64 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.349 -0.7 . . . . 0.29 111.349 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.594 HG23 ' HD2' ' A' ' 108' ' ' LYS . 0.2 OUTLIER -103.43 128.63 50.53 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.9 -0.765 . . . . 0.4 109.883 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.632 ' CE1' HG22 ' A' ' 85' ' ' VAL . 1.8 t-80 -103.38 106.35 16.84 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.526 -0.546 . . . . 0.4 109.526 -175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.38 109.34 21.16 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.497 -0.927 . . . . 0.35 108.497 176.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.36 103.83 15.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.027 -0.533 . . . . 0.59 110.257 -169.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.8 OUTLIER -109.65 103.41 12.25 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.504 -0.771 . . . . 1.53 109.118 177.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.72 HD23 ' HA ' ' A' ' 38' ' ' PHE . 96.0 mt -104.72 125.56 50.93 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.763 -0.653 . . . . 0.24 109.571 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.68 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.8 m -100.87 122.46 43.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.658 0.742 . . . . 0.29 110.762 -169.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.0 OUTLIER -92.8 87.18 5.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.686 -1.143 . . . . 1.11 109.884 -174.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.57 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 1.4 mtm -134.1 165.94 23.9 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.203 0.525 . . . . 0.65 110.993 -173.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.53 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 77.2 mtt180 -64.86 111.28 5.45 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.971 -1.013 . . . . 2.59 109.272 170.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.97 -26.25 24.5 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.288 2.658 . . . . 1.04 114.405 -171.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.434 ' CD1' HG22 ' A' ' 94' ' ' THR . 42.9 p90 -90.11 -3.22 58.04 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.002 0.371 . . . . 1.17 112.002 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.615 HG23 ' H ' ' A' ' 95' ' ' GLY . 6.8 t -169.25 -64.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.462 -0.149 . . . . 1.09 111.369 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.615 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.29 98.13 0.19 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.824 -0.703 . . . . 1.16 111.838 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.733 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 69.7 Cg_exo -49.55 126.69 16.67 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.916 2.411 . . . . 1.2 111.334 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.4 m -54.17 -29.75 46.79 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.503 0.927 . . . . 2.64 113.503 -168.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -129.43 14.78 6.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.147 -0.621 . . . . 4.09 111.594 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 16.1 t0 -112.29 -1.82 15.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.857 0.837 . . . . 1.67 109.528 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.7 m -95.0 136.98 34.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.765 -1.107 . . . . 1.39 110.13 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.681 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 24.9 tt0 -86.86 179.03 6.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 1.91 108.734 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.681 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 46.7 ttt180 -158.09 145.05 17.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.903 0.859 . . . . 0.62 110.071 174.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.812 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -103.36 150.79 23.46 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.004 -1.453 . . . . 0.86 109.124 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.669 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.4 m -153.41 102.78 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 120.862 -0.335 . . . . 0.31 110.862 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.921 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.6 p -104.86 136.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 119.663 -0.815 . . . . 0.88 109.395 167.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -104.4 103.49 13.21 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.271 -0.877 . . . . 0.7 108.703 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 3.1 pp -126.95 152.51 47.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.218 -0.447 . . . . 2.12 109.95 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.762 ' O ' HG22 ' A' ' 16' ' ' VAL . 30.9 tptt -104.91 111.23 23.91 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.681 -0.407 . . . . 1.89 110.099 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -103.47 122.8 45.64 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 123.409 0.443 . . . . 0.53 110.139 -174.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.468 HD21 ' CG ' ' A' ' 108' ' ' LYS . 10.5 m-80 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.188 -0.91 . . . . 1.78 110.687 -171.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.962 ' HB3' HG22 ' A' ' 22' ' ' VAL . 42.8 t60 . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.59 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 19.1 ptmt -143.92 142.3 30.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.684 0.278 . . . . 2.36 110.83 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.84 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -107.41 138.97 30.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 0.49 111.458 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.12 168.06 10.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.926 -1.034 . . . . 0.51 110.335 171.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.7 tptp -37.5 -45.57 0.74 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.739 1.385 . . . . 0.83 114.739 -172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.96 62.52 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.61 0.719 . . . . 0.33 111.803 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.813 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.5 m80 -65.95 -1.79 3.35 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.792 -0.64 . . . . 2.12 111.282 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.715 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 26.2 t-20 -47.38 -17.7 0.09 Allowed 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.847 0.717 . . . . 1.41 110.089 170.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.93 55.9 0.61 Allowed Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.7 -0.682 . . . . 0.3 111.74 174.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.028 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -108.53 158.35 17.64 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.582 0.956 . . . . 0.32 113.582 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.7 m -147.11 104.98 3.72 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.018 -0.992 . . . . 0.95 108.856 171.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 17.9 mt -146.29 167.28 23.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 112.855 0.687 . . . . 3.0 112.855 -170.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.4 m -103.54 136.0 44.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.714 -0.676 . . . . 1.73 110.139 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.597 HG11 ' CD2' ' A' ' 3' ' ' HIS . 30.9 m -126.2 154.04 35.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.972 -0.558 . . . . 0.78 112.11 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.55 143.17 33.42 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.83 -0.804 . . . . 0.76 108.83 173.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.683 HG12 HG21 ' A' ' 22' ' ' VAL . 23.7 m -121.48 -179.92 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.952 0.406 . . . . 1.23 111.747 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.97 -60.61 0.67 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.65 -0.704 . . . . 0.71 111.403 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.58 -74.15 0.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.424 0.63 . . . . 2.35 109.994 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.8 tp -165.61 136.03 3.65 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.977 -1.01 . . . . 0.71 109.681 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.962 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.4 t -120.17 110.18 28.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.353 0.597 . . . . 0.4 109.663 172.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 4.4 pt-20 -111.33 159.67 17.76 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.805 0.812 . . . . 1.09 111.901 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.632 HD12 HG11 ' A' ' 105' ' ' VAL . 29.9 mm -134.26 103.8 5.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.174 -1.376 . . . . 0.54 108.527 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -108.11 141.44 39.81 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.299 0.571 . . . . 0.64 111.55 -174.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.467 HD12 ' HD3' ' A' ' 7' ' ' LYS . 4.1 mm? -117.11 146.75 38.79 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.128 -0.942 . . . . 0.85 108.864 171.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 67.7 Cg_endo -83.98 9.62 4.04 Favored 'Trans proline' 0 C--N 1.329 -0.452 0 C-N-CA 122.685 2.257 . . . . 0.35 111.804 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.61 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 69.53 -47.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.042 0.839 . . . . 0.91 110.667 -174.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.9 OUTLIER 58.08 63.05 4.64 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.124 -1.065 . . . . 1.39 108.124 -173.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.5 100.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.669 2.913 . . . . 0.83 113.501 -166.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.446 HG22 ' OH ' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -106.89 -36.67 6.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.091 -0.959 . . . . 1.83 111.074 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.577 HG23 ' H ' ' A' ' 34' ' ' PHE . 11.6 t -176.47 -157.44 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.024 -0.732 . . . . 2.36 109.024 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -53.41 -22.99 17.24 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 121.483 -0.389 . . . . 1.3 113.16 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' A' ' 90' ' ' MET . 15.4 m-30 -40.23 137.93 0.95 Allowed 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 112.765 0.654 . . . . 2.22 112.765 171.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -147.26 154.83 41.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.975 -1.011 . . . . 0.44 109.021 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.61 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.3 m95 -85.12 124.29 31.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.121 0.486 . . . . 0.43 111.369 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.912 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -157.81 145.07 18.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 2.78 109.733 175.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.578 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -48.77 -75.62 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.333 0.494 . . . . 0.43 112.333 -173.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.21 -17.85 18.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.445 0.64 . . . . 2.39 110.298 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.766 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 113.6 85.56 1.4 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.299 -0.953 . . . . 0.73 111.525 -175.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.29 70.07 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.535 -0.84 . . . . 0.7 111.576 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.7 m -129.1 140.36 51.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.648 -0.501 . . . . 1.13 109.648 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -140.63 141.02 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.655 -0.498 . . . . 2.52 109.655 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -141.04 161.66 37.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.171 0.51 . . . . 2.3 111.832 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.752 ' HB2' ' CG2' ' A' ' 53' ' ' VAL . 20.6 t -115.03 130.88 23.85 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.928 -0.767 . . . . 1.61 108.928 170.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 14.8 Cg_exo -68.91 -4.29 13.12 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.569 2.179 . . . . 1.88 112.064 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -120.19 4.65 10.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.947 -0.569 . . . . 2.43 111.416 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.6 pt-20 -84.08 101.05 11.51 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.863 0.84 . . . . 3.26 111.709 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -127.95 5.71 5.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.335 -0.848 . . . . 2.06 110.558 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -170.04 -36.18 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.214 1.007 . . . . 1.25 108.579 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.833 ' HB3' ' O ' ' A' ' 76' ' ' THR . 4.1 m-85 -104.84 165.33 11.14 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 113.581 -1.645 . . . . 0.74 107.424 172.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.1 t -157.46 172.04 19.28 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.764 0.711 . . . . 1.46 112.336 -164.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.752 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 21.8 t -99.57 134.17 39.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.535 -0.757 . . . . 1.31 111.716 -174.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -111.34 125.02 53.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.711 -0.677 . . . . 2.45 109.194 170.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -103.9 152.28 22.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.799 0.333 . . . . 1.93 110.905 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.722 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -162.4 111.77 1.44 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.42 109.81 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.855 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.2 m-85 -111.39 118.73 36.61 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.446 -0.343 . . . . 1.66 110.292 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -109.06 100.09 38.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 121.205 0.526 . . . . 2.14 110.658 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 3.5 Cg_exo -83.29 132.02 5.9 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 123.688 2.925 . . . . 1.92 111.129 172.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.615 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 72.5 Cg_endo -90.9 -11.85 2.52 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.509 2.139 . . . . 2.64 112.76 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.52 ' OD2' ' HD3' ' A' ' 63' ' ' LYS . 22.0 t70 -178.07 -57.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 5.8 110.927 -173.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.7 m 74.72 15.84 3.17 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.833 -1.076 . . . . 7.43 113.633 170.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.52 ' HD3' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -145.25 21.97 1.54 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.954 0.883 . . . . 8.71 108.92 166.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 22.8 tp -177.98 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.99 -1.459 . . . . 8.1 108.647 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 168.72 133.09 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.533 0.733 . . . . 4.74 109.174 175.113 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.615 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -88.84 -52.34 2.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.104 -0.57 . . . . 3.02 111.937 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.71 -68.51 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.327 0.584 . . . . 4.02 110.121 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.98 95.28 0.21 Allowed Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.289 -0.869 . . . . 2.84 111.443 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -62.89 139.22 44.73 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.449 -1.06 . . . . 1.49 110.449 177.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.25 87.82 1.34 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.638 0.732 . . . . 0.97 112.38 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.855 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.2 mt-10 -104.55 105.78 16.02 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.022 -0.99 . . . . 0.81 108.481 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.722 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 7.5 m-70 -104.98 150.29 25.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.747 0.784 . . . . 0.53 111.805 -170.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.912 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.6 m-85 -122.82 104.89 9.57 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.303 -1.317 . . . . 1.13 108.864 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.563 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -102.47 107.15 18.03 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.963 -0.384 . . . . 0.5 109.963 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 22' ' ' VAL . 2.4 m -102.62 116.53 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 122.706 1.241 . . . . 0.87 108.33 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.833 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.7 m -102.64 106.37 17.02 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.177 -1.416 . . . . 0.46 107.177 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.657 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.0 p -154.58 149.81 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 123.692 0.62 . . . . 1.04 111.13 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -131.18 103.5 6.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.523 -0.547 . . . . 1.54 109.523 167.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.42 127.26 2.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.315 -0.402 . . . . 0.67 110.672 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -60.54 100.53 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.787 0.679 . . . . 0.44 111.089 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.49 169.58 40.0 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 110.474 -1.051 . . . . 0.29 110.474 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -101.99 132.09 48.02 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.642 -0.917 . . . . 0.4 109.698 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 85' ' ' VAL . 40.1 t-80 -102.64 104.16 14.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 109.691 -0.485 . . . . 0.4 109.691 -174.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.53 111.99 24.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.417 -0.586 . . . . 0.35 109.417 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.62 103.36 15.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.95 -0.568 . . . . 0.59 110.852 -171.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.483 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.15 102.87 11.98 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.88 -0.785 . . . . 1.53 108.88 176.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.447 ' HG ' HG12 ' A' ' 85' ' ' VAL . 96.0 mt -108.09 127.41 53.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.773 -0.649 . . . . 0.24 109.96 -176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.459 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.7 m -102.75 130.59 49.75 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.525 0.679 . . . . 0.29 110.968 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 10.9 t80 -102.6 88.75 3.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.272 -0.877 . . . . 1.11 109.633 -175.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.596 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 15.5 mtm -126.75 177.94 6.24 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 109.457 -0.571 . . . . 0.65 109.457 -174.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.646 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 7.6 ttm180 -93.17 112.73 57.53 Favored Pre-proline 0 C--N 1.316 -0.876 0 N-CA-C 108.533 -0.914 . . . . 2.59 108.533 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 93' ' ' TRP . 1.5 Cg_endo -44.74 -48.3 10.68 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.573 2.848 . . . . 1.04 114.293 -169.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 92' ' ' PRO . 39.5 p90 -80.34 0.39 33.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.566 . . . . 1.17 112.527 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.812 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.3 t -158.4 -79.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.57 -0.159 . . . . 1.09 110.57 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.812 ' H ' HG23 ' A' ' 94' ' ' THR . . . 76.62 82.44 0.53 Allowed Glycine 0 CA--C 1.508 -0.404 0 C-N-CA 121.066 -0.587 . . . . 1.16 112.013 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.77 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 1.5 Cg_endo -42.17 125.35 3.31 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.852 3.035 . . . . 1.2 112.09 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.6 m -55.01 -39.35 69.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.921 -1.036 . . . . 2.64 112.969 -169.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -109.76 1.61 19.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.825 -0.35 . . . . 4.09 110.925 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.77 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.2 t0 -100.91 -16.29 17.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.518 0.675 . . . . 1.67 109.427 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.3 p -73.79 133.75 43.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.051 -0.977 . . . . 1.39 111.486 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.641 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 8.3 tp10 -86.96 169.64 12.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.596 -0.89 . . . . 1.91 108.596 176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.459 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 22.0 ttt180 -155.82 142.41 18.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.843 0.83 . . . . 0.62 110.648 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.84 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 3.1 t80 -104.65 154.87 19.41 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.096 -1.411 . . . . 0.86 109.378 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 52.4 m -158.8 101.95 1.66 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.043 0.449 . . . . 0.31 110.253 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 12' ' ' ALA . 11.0 p -104.87 132.0 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 120.079 -0.648 . . . . 0.88 109.602 169.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' THR . 69.5 m-85 -105.17 113.55 27.21 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.697 -0.683 . . . . 0.7 109.386 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.681 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -136.27 158.53 44.19 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 109.351 -0.611 . . . . 2.12 109.351 178.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 82' ' ' THR . 30.9 tttm -103.99 114.22 28.32 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.872 -0.418 . . . . 1.89 109.872 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.498 ' HA ' HG23 ' A' ' 16' ' ' VAL . . . -101.18 125.42 47.81 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.402 0.438 . . . . 0.53 109.851 -171.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.643 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.09 -0.957 . . . . 1.78 110.125 -171.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.813 ' HB3' HG22 ' A' ' 22' ' ' VAL . 5.3 t60 . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.33 -0.989 . . . . 0.59 108.33 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.8 tptt -135.41 134.26 39.49 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.853 0.359 . . . . 2.36 111.402 -176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.86 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.5 t -118.68 127.49 75.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.394 0.616 . . . . 0.49 111.004 170.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.14 169.58 8.91 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.529 -1.214 . . . . 0.51 109.864 169.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 19.4 tptp -35.2 -44.92 0.28 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.451 1.278 . . . . 0.83 114.451 -173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.16 -31.63 53.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.546 0.688 . . . . 0.33 112.385 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.86 ' HB2' HG13 ' A' ' 5' ' ' VAL . 74.1 m80 -68.1 -1.46 5.99 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.735 -0.666 . . . . 2.12 111.201 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.724 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.8 t-20 -45.94 -20.92 0.1 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.697 0.623 . . . . 1.41 109.765 168.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.84 58.03 0.62 Allowed Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.371 -0.831 . . . . 0.3 111.256 175.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.858 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.35 151.57 36.72 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.72 0.637 . . . . 0.32 112.72 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 35.4 m -146.12 108.84 4.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.404 -0.817 . . . . 0.95 109.332 174.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.768 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -161.51 167.46 25.42 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.727 0.299 . . . . 3.0 111.562 -172.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.666 HG23 ' HB3' ' A' ' 108' ' ' LYS . 87.2 m -102.84 144.16 31.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.669 -0.241 . . . . 1.73 110.725 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.9 m -124.96 151.27 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-O 121.058 0.456 . . . . 0.78 111.533 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.63 132.3 51.95 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.346 -0.983 . . . . 0.76 108.346 167.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 22' ' ' VAL . 1.4 t -109.96 -141.02 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.375 -0.53 . . . . 1.23 109.895 177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.38 -50.78 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.906 -0.878 . . . . 0.71 110.906 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -87.82 -71.06 0.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.437 -0.579 . . . . 2.35 109.437 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.77 136.84 8.36 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.182 -0.917 . . . . 0.71 109.47 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.813 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.2 t -108.64 117.18 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.123 -0.695 . . . . 0.4 109.123 171.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.34 140.3 38.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.397 0.618 . . . . 1.09 112.284 -174.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.581 HD12 HG11 ' A' ' 105' ' ' VAL . 40.2 mm -129.21 101.61 6.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.621 -1.172 . . . . 0.54 107.907 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -113.89 138.24 50.59 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.42 0.628 . . . . 0.64 111.4 -173.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.73 148.25 39.97 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 115.523 -0.762 . . . . 0.85 109.315 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 16.1 Cg_endo -88.34 13.3 2.59 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 122.74 2.293 . . . . 0.35 110.849 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.622 ' OG ' ' HG3' ' A' ' 71' ' ' GLU . 2.4 m 71.23 -49.83 0.68 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.885 -1.052 . . . . 0.91 111.92 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.42 63.09 5.96 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 108.491 -0.929 . . . . 1.39 108.491 -173.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' HG2' ' HG2' ' A' ' 60' ' ' PRO . 72.9 Cg_exo -52.83 104.22 0.1 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.275 0 C-N-CA 123.728 2.952 . . . . 0.83 113.424 -168.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -100.88 -49.99 3.97 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.003 -0.999 . . . . 1.83 111.044 178.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.534 HG23 ' H ' ' A' ' 34' ' ' PHE . 12.4 t -164.75 -147.88 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.364 -0.606 . . . . 2.36 109.364 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.21 -22.64 37.38 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.61 -0.329 . . . . 1.3 112.633 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.616 ' CE2' ' HA ' ' A' ' 100' ' ' SER . 4.1 m-30 -35.74 138.34 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.621 0.971 . . . . 2.22 113.621 169.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HB1' ' OE1' ' A' ' 71' ' ' GLU . . . -148.19 148.86 31.0 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.318 -1.31 . . . . 0.44 108.568 172.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.606 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.3 m95 -80.08 112.73 17.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.039 0.447 . . . . 0.43 110.778 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.695 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 58.1 m-85 -118.99 179.79 4.05 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.477 -0.934 . . . . 2.78 108.477 169.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.64 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -70.24 -78.89 0.07 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.26 -0.576 . . . . 0.43 109.659 170.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -106.16 3.91 28.45 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.16 0.505 . . . . 2.39 109.815 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.475 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 90.18 112.16 1.49 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.5 -0.773 . . . . 0.73 111.458 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.97 -19.16 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.569 -0.824 . . . . 0.7 112.227 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -128.55 142.18 51.14 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.081 0.467 . . . . 1.13 111.834 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.748 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -142.01 127.8 19.3 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.853 -1.067 . . . . 2.52 109.487 168.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.05 155.44 46.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.208 0.528 . . . . 2.3 111.423 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.583 ' OG ' ' HB ' ' A' ' 53' ' ' VAL . 11.1 p -115.42 127.59 26.67 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.764 -0.653 . . . . 1.61 109.644 176.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 44.9 Cg_exo -58.21 124.97 17.11 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.695 2.263 . . . . 1.88 112.249 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 91.7 m-20 77.63 30.04 0.5 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.189 0.931 . . . . 2.43 111.981 175.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.423 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 11.9 pt-20 -79.18 48.79 0.9 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.385 0.612 . . . . 3.26 111.769 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.6 m -85.96 -34.49 20.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.372 -0.376 . . . . 2.06 111.415 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' A' ' 50' ' ' MET . 0.0 OUTLIER -125.54 -31.35 3.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.793 0.806 . . . . 1.25 109.523 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.742 ' HB3' ' O ' ' A' ' 76' ' ' THR . 2.3 m-85 -103.44 167.23 9.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.414 -1.266 . . . . 0.74 107.834 176.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.0 t -148.4 165.08 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.046 -0.662 . . . . 1.46 111.198 -160.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.583 ' HB ' ' OG ' ' A' ' 45' ' ' SER . 4.0 p -109.34 150.9 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.408 0.623 . . . . 1.31 111.446 -175.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -124.59 144.67 50.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.264 -0.88 . . . . 2.45 109.817 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 8.6 p30 -123.96 133.82 53.62 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.877 -0.601 . . . . 1.93 109.556 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.576 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -154.53 105.24 2.62 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.771 -0.649 . . . . 1.42 110.738 -175.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.898 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -120.25 142.9 48.62 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.532 -0.758 . . . . 1.66 110.774 -176.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -122.45 98.86 43.27 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.118 0.485 . . . . 2.14 110.127 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.453 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 3.1 Cg_exo -83.2 136.33 7.78 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 123.891 3.06 . . . . 1.92 111.11 170.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.767 ' HB3' ' HA2' ' A' ' 66' ' ' GLY . 50.7 Cg_exo -63.64 -167.49 0.08 OUTLIER 'Trans proline' 0 C--O 1.23 0.106 0 C-N-CA 123.263 2.642 . . . . 2.64 114.736 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -167.92 -65.17 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.471 -1.695 . . . . 5.8 107.738 -171.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.5 p -162.96 -75.51 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 113.678 -1.601 . . . . 7.43 109.752 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.665 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -86.51 -12.48 48.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.55 -0.75 . . . . 8.71 112.424 -177.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.665 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 66.4 mt -58.46 -56.22 24.98 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.334 0.588 . . . . 8.1 110.524 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.57 ' CD2' ' HA2' ' A' ' 69' ' ' GLY . 1.5 tp -167.45 -50.92 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.985 -1.007 . . . . 4.74 109.172 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.767 ' HA2' ' HB3' ' A' ' 60' ' ' PRO . . . 78.73 -64.42 3.62 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.866 -1.061 . . . . 3.02 114.407 162.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' O ' ' HD2' ' A' ' 30' ' ' PRO . . . -61.91 -66.94 0.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.088 0.471 . . . . 4.02 111.455 -174.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.478 ' O ' HD21 ' A' ' 65' ' ' LEU . . . -132.51 106.22 0.64 Allowed Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.678 -0.772 . . . . 2.84 111.259 176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.57 ' HA2' ' CD2' ' A' ' 65' ' ' LEU . . . -66.41 -151.32 0.15 Allowed Glycine 0 C--N 1.331 0.298 0 O-C-N 123.832 0.372 . . . . 1.49 113.708 -174.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.403 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -157.1 86.99 0.97 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.406 0.521 . . . . 0.97 112.406 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.898 ' HG2' ' HB3' ' A' ' 57' ' ' TYR . 40.9 mt-10 -102.14 106.92 17.85 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.57 . . . . 0.81 109.821 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -112.52 152.6 28.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.628 -0.829 . . . . 0.53 111.669 -174.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.748 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 39.4 m-85 -115.36 119.02 34.89 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.912 -1.495 . . . . 1.13 109.08 172.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -113.86 103.72 11.46 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.961 -0.296 . . . . 0.5 110.794 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.644 HG13 HG12 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -105.2 117.9 51.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 122.104 0.954 . . . . 0.87 110.127 177.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.742 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 10.5 m -103.65 103.81 13.78 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.77 -1.105 . . . . 0.46 108.428 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.547 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 10.3 p -151.36 144.61 16.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 O-C-N 123.563 0.54 . . . . 1.04 110.341 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -129.29 103.65 7.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.771 0.796 . . . . 1.54 109.742 169.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.98 145.06 6.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.141 -0.936 . . . . 0.67 109.208 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.33 94.07 2.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.141 0.496 . . . . 0.44 111.329 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -151.89 168.17 31.17 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.29 111.041 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.464 ' HA ' ' HD2' ' A' ' 108' ' ' LYS . 3.1 m -101.35 128.59 47.44 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.837 -0.802 . . . . 0.4 109.566 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.588 ' ND1' HG22 ' A' ' 85' ' ' VAL . 19.2 t-80 -104.29 103.83 13.64 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.676 -0.693 . . . . 0.4 109.827 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.75 122.2 42.97 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.325 -0.991 . . . . 0.35 108.325 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -114.86 102.07 13.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.482 -0.487 . . . . 0.59 110.702 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.551 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -108.75 103.37 12.44 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.323 -0.991 . . . . 1.53 108.323 173.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.64 HD23 ' HA ' ' A' ' 38' ' ' PHE . 78.5 mt -105.07 124.84 50.22 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.734 -0.666 . . . . 0.24 109.698 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.441 HG22 ' CG ' ' A' ' 90' ' ' MET . 5.6 m -101.74 116.81 33.55 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.958 0.885 . . . . 0.29 110.742 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 2.5 t80 -84.81 96.73 9.38 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.321 -1.309 . . . . 1.11 109.574 -177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.475 ' CE ' ' HA3' ' A' ' 40' ' ' GLY . 7.2 mtm -137.77 167.29 22.02 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.833 0.349 . . . . 0.65 110.214 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 12.4 mtm180 -70.21 103.87 0.7 Allowed Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 108.659 -0.867 . . . . 2.59 108.659 169.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 3.2 Cg_endo -45.23 -37.88 14.07 Favored 'Trans proline' 0 N--CA 1.477 0.522 0 C-N-CA 123.871 3.047 . . . . 1.04 114.851 -166.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.431 ' CD1' HG22 ' A' ' 94' ' ' THR . 43.1 p90 -80.8 -2.14 45.95 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.457 0.54 . . . . 1.17 112.457 -175.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.669 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -162.47 -65.03 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.338 0.113 . . . . 1.09 110.844 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.669 ' H ' HG23 ' A' ' 94' ' ' THR . . . 72.44 85.53 0.21 Allowed Glycine 0 CA--C 1.505 -0.533 0 C-N-CA 121.237 -0.506 . . . . 1.16 111.935 179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 72.2 Cg_exo -44.09 113.59 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.41 2.74 . . . . 1.2 112.246 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.5 m -74.24 53.99 0.53 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.73 -0.668 . . . . 2.64 111.112 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -175.69 -20.86 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.083 -0.962 . . . . 4.09 109.052 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 34.0 t70 -106.87 -17.61 14.16 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.609 -0.723 . . . . 1.67 109.497 -175.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.616 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 10.0 p -72.96 143.02 47.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.057 -0.974 . . . . 1.39 112.457 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -103.62 171.33 7.42 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.193 -1.039 . . . . 1.91 108.193 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.439 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 45.1 ttt180 -153.56 140.36 19.07 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.804 0.812 . . . . 0.62 110.675 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.796 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -102.9 155.3 18.44 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.209 -1.359 . . . . 0.86 108.615 -179.307 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.6 m -158.23 102.25 1.76 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.58 -0.448 . . . . 0.31 111.28 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.858 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.9 p -104.78 133.79 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 C-N-CA 119.911 -0.716 . . . . 0.88 109.439 166.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' THR . 73.9 m-85 -104.25 104.44 14.35 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.545 -0.752 . . . . 0.7 109.062 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.768 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 1.5 pp -128.28 154.08 46.29 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.707 -0.397 . . . . 2.12 110.602 -175.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.691 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.0 tptm -104.5 115.51 30.49 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.1 -0.704 . . . . 1.89 109.1 177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -102.13 127.09 49.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.852 0.358 . . . . 0.53 110.75 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.0 p30 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.19 -0.91 . . . . 1.78 110.553 -177.632 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.945 ' HB3' HG22 ' A' ' 22' ' ' VAL . 35.8 t60 . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 108.462 -0.94 . . . . 0.59 108.462 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.411 ' CB ' ' HB2' ' A' ' 23' ' ' GLU . 17.6 ptpt -146.01 153.35 40.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.801 0.334 . . . . 2.36 110.672 172.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.871 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.1 t -115.05 135.01 56.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.158 0.504 . . . . 0.49 111.089 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.453 HG22 ' NE2' ' A' ' 25' ' ' GLN . 0.9 OUTLIER -115.92 170.76 8.23 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.342 -0.845 . . . . 0.51 110.003 171.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 24.5 tptp -35.72 -49.26 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.75 1.389 . . . . 0.83 114.75 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.13 63.03 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 121.387 0.613 . . . . 0.33 112.124 -174.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.871 ' HB2' HG13 ' A' ' 5' ' ' VAL . 69.9 m80 -64.91 -2.95 2.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.556 . . . . 2.12 111.177 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.623 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 21.2 t-20 -44.99 -22.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.214 0 O-C-N 123.694 0.621 . . . . 1.41 110.392 170.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.39 55.1 0.68 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.566 -0.743 . . . . 0.3 111.277 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.883 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -119.06 156.59 29.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.238 0.829 . . . . 0.32 113.238 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 87.6 m -145.93 111.3 5.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.004 -0.998 . . . . 0.95 108.927 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 3.8 pp -152.8 167.31 29.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.843 0.354 . . . . 3.0 111.766 -170.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -103.44 147.21 27.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.273 -0.421 . . . . 1.73 110.414 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.9 m -128.55 162.67 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 116.128 -0.487 . . . . 0.78 110.96 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 110' ' ' ASN . . . -109.0 125.96 52.61 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.252 -1.018 . . . . 0.76 108.252 167.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 22' ' ' VAL . 23.2 m -105.28 -168.35 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.382 -0.527 . . . . 1.23 111.121 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 113.95 -53.09 0.61 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.415 -0.674 . . . . 0.71 111.415 -177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -77.45 -73.3 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.169 0.509 . . . . 2.35 109.813 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 57.9 tp -166.12 137.19 3.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.48 -0.782 . . . . 0.71 109.588 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.945 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -117.19 113.97 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.828 0.823 . . . . 0.4 109.63 173.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' HB2' ' CB ' ' A' ' 4' ' ' LYS . 40.6 mt-10 -102.91 156.99 17.28 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.115 0.959 . . . . 1.09 112.267 -171.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.694 HD13 ' HB ' ' A' ' 5' ' ' VAL . 40.2 mm -133.66 133.75 56.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.232 -1.766 . . . . 0.54 106.232 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.584 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.92 135.65 23.34 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.601 0.715 . . . . 0.64 111.564 178.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -109.41 153.41 42.8 Favored Pre-proline 0 N--CA 1.431 -1.375 0 CA-C-N 114.818 -1.083 . . . . 0.85 108.977 174.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.586 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 41.7 Cg_endo -90.81 11.35 2.64 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.935 2.423 . . . . 0.35 111.457 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.644 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 27.8 t 69.58 -59.6 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 0.91 111.198 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.6 OUTLIER 52.73 56.89 15.06 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.097 -0.705 . . . . 1.39 109.097 -173.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.599 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 81.6 Cg_exo -49.61 111.1 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.832 3.022 . . . . 0.83 113.579 -168.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.492 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.0 p -87.45 -38.93 15.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.722 -1.126 . . . . 1.83 109.417 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 t 175.91 -135.54 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.794 -1.094 . . . . 2.36 108.375 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.04 -33.03 67.93 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 118.23 0.468 . . . . 1.3 113.589 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.603 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 52.7 m-85 -52.09 148.71 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.916 0.389 . . . . 2.22 111.897 175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.03 161.42 41.95 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.648 -0.705 . . . . 0.44 109.764 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.644 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -82.76 120.61 25.82 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.15 0.5 . . . . 0.43 112.012 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.71 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -156.15 147.69 22.73 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.101 -0.703 . . . . 2.78 109.101 169.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -40.93 -68.76 0.16 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.61 0.596 . . . . 0.43 112.61 -171.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.15 17.69 2.44 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.568 -0.453 . . . . 2.39 111.828 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.535 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 125.0 85.88 0.64 Allowed Glycine 0 CA--C 1.507 -0.433 0 C-N-CA 119.778 -1.201 . . . . 0.73 113.075 170.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.82 12.25 10.06 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.843 -0.694 . . . . 0.7 112.242 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -135.16 139.26 44.45 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.469 -0.937 . . . . 1.13 108.469 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.429 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.63 142.19 33.42 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.376 0.423 . . . . 2.52 110.546 -173.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -139.56 153.12 47.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.06 0.457 . . . . 2.3 111.505 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.831 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 18.0 t -104.77 132.87 20.51 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.8 -0.815 . . . . 1.61 108.8 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HG2' ' H ' ' A' ' 84' ' ' ALA . 9.9 Cg_exo -72.86 25.21 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 123.304 2.669 . . . . 1.88 113.426 -177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -178.49 48.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.297 0.57 . . . . 2.43 109.486 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.831 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 8.8 pt-20 -114.64 122.6 46.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.742 0.782 . . . . 3.26 111.147 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -141.99 -39.72 0.37 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.806 -1.088 . . . . 2.06 108.819 173.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.869 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.77 -35.41 6.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.629 -0.714 . . . . 1.25 110.516 176.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.869 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 9.3 m-85 -108.9 164.46 12.38 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.497 -0.927 . . . . 0.74 108.497 175.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.8 t -161.84 172.08 16.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.411 0.624 . . . . 1.46 112.598 -164.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.702 ' CG2' ' HB2' ' A' ' 45' ' ' SER . 20.3 t -99.73 143.99 12.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.411 -0.813 . . . . 1.31 111.472 -174.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.601 ' CG ' ' HB2' ' A' ' 74' ' ' HIS . 7.5 pt-20 -109.33 132.22 54.33 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.644 -0.873 . . . . 2.45 108.644 169.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.61 131.87 53.9 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.537 -0.865 . . . . 1.93 110.986 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.78 104.89 2.16 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.098 -0.955 . . . . 1.42 110.34 -172.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CB ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 p90 -131.2 131.59 44.09 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.448 0.642 . . . . 1.66 112.153 -175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.811 ' HB3' HD21 ' A' ' 64' ' ' LEU . 91.0 m-85 -136.29 102.48 9.82 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 2.14 110.507 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -62.92 176.48 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.924 2.416 . . . . 1.92 112.312 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -45.88 170.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 123.968 3.112 . . . . 2.64 116.037 -176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 64' ' ' LEU . 15.7 t70 -171.35 -71.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 113.576 -1.647 . . . . 5.8 108.111 -173.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.3 t -174.32 -85.84 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.027 -1.442 . . . . 7.43 108.871 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.573 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -81.03 -19.74 43.24 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.021 -0.536 . . . . 8.71 110.828 177.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 58' ' ' PHE . 46.1 tp -55.03 -49.61 71.12 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.818 -0.808 . . . . 8.1 108.818 175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.796 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -161.86 -66.64 0.05 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.671 -1.15 . . . . 4.74 109.403 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.75 -60.84 4.58 Favored Glycine 0 C--N 1.319 -0.367 0 CA-C-N 114.927 -1.033 . . . . 3.02 112.889 175.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -51.71 -40.27 59.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.19 0.596 . . . . 4.02 112.337 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.796 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -145.21 -55.59 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.476 -0.869 . . . . 2.84 111.803 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . 137.76 -175.47 21.25 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.302 -1.119 . . . . 1.49 110.302 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.79 86.01 1.05 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 117.902 0.851 . . . . 0.97 112.571 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.634 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 37.6 mt-10 -104.36 104.37 14.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.81 109.716 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -114.12 163.71 14.83 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 122.22 1.009 . . . . 0.53 112.577 -171.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 42.0 m-85 -140.13 104.08 4.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.173 -1.831 . . . . 1.13 108.769 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.601 ' HB2' ' CG ' ' A' ' 54' ' ' GLU . 55.6 m170 -103.35 123.45 46.83 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 121.824 -0.548 . . . . 0.5 110.034 -173.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.583 HG12 HG22 ' A' ' 53' ' ' VAL . 3.4 m -105.77 123.4 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 122.23 1.014 . . . . 0.87 109.918 178.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.719 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 8.5 m -102.64 104.78 15.17 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.806 -1.183 . . . . 0.46 107.806 176.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.574 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.6 p -150.46 142.54 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.118 -0.492 . . . . 1.04 110.694 -176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -130.55 101.59 5.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.265 0.555 . . . . 1.54 109.713 167.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -167.5 145.78 4.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.406 -0.816 . . . . 0.67 109.602 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.24 89.89 2.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.44 110.81 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.12 166.93 31.69 Favored Glycine 0 C--O 1.22 -0.777 0 N-CA-C 110.717 -0.953 . . . . 0.29 110.717 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.5 132.25 48.67 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.692 0.746 . . . . 0.4 109.811 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.569 ' ND1' HG22 ' A' ' 85' ' ' VAL . 45.1 t-80 -104.42 106.14 16.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.173 -0.467 . . . . 0.4 110.527 -174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' H ' ' HG2' ' A' ' 46' ' ' PRO . . . -101.2 115.23 30.02 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.325 -0.62 . . . . 0.35 109.325 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.5 t -106.3 105.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.848 -0.615 . . . . 0.59 111.331 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 7.5 m120 -112.96 102.89 10.86 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.47 -0.567 . . . . 1.53 109.47 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 98.8 mt -107.33 123.4 48.29 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.674 -0.694 . . . . 0.24 109.453 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.448 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 5.4 m -103.45 130.73 50.86 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.4 0.619 . . . . 0.29 111.405 -170.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 43.7 t80 -95.76 84.91 3.99 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.399 -0.819 . . . . 1.11 109.776 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.689 ' HE2' ' HE1' ' A' ' 37' ' ' TYR . 17.4 mtm -121.53 173.7 7.24 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 120.905 0.383 . . . . 0.65 109.981 -175.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.611 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 3.2 ttm-85 -86.71 114.06 56.11 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 108.861 -0.792 . . . . 2.59 108.861 171.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.617 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.8 Cg_endo -49.86 -27.33 15.64 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.976 3.118 . . . . 1.04 115.88 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.617 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 42.7 p90 -104.03 10.77 35.95 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.945 -0.472 . . . . 1.17 111.996 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.8 t -166.05 -62.0 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.26 -0.176 . . . . 1.09 111.034 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.611 ' HA2' ' H ' ' A' ' 91' ' ' ARG . . . 61.86 79.24 0.14 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 112.13 -0.388 . . . . 1.16 112.13 -179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.764 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 50.6 Cg_exo -36.08 128.21 0.38 Allowed 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.839 3.026 . . . . 1.2 112.562 174.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 5.7 p -35.01 -64.23 0.28 Allowed 'General case' 0 N--CA 1.466 0.332 0 O-C-N 124.663 1.227 . . . . 2.64 114.059 -170.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -124.0 33.8 5.21 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.333 -0.547 . . . . 4.09 110.685 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.764 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 29.1 t0 -106.82 -4.66 19.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.98 0.895 . . . . 1.67 108.905 175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.461 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 19.9 m -89.0 142.41 27.66 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.346 -1.297 . . . . 1.39 110.252 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.651 ' HG2' ' H ' ' A' ' 102' ' ' ARG . 29.1 tt0 -92.49 179.31 5.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.01 -0.737 . . . . 1.91 109.01 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.651 ' H ' ' HG2' ' A' ' 101' ' ' GLU . 29.7 ttt180 -161.65 142.51 10.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.719 0.771 . . . . 0.62 111.408 178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.794 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 1.2 t80 -105.22 154.39 20.28 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.237 -1.347 . . . . 0.86 109.341 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 45.1 m -158.45 102.43 1.73 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.871 0.367 . . . . 0.31 110.97 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.883 HG23 ' HB3' ' A' ' 12' ' ' ALA . 12.6 p -107.21 136.62 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 120.027 -0.669 . . . . 0.88 109.53 168.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' THR . 78.4 m-85 -104.62 104.08 13.85 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.629 -0.878 . . . . 0.7 108.629 174.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.624 HD13 HG11 ' A' ' 16' ' ' VAL . 3.3 pp -122.67 145.46 48.36 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.947 -0.76 . . . . 2.12 108.947 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.784 ' O ' HG22 ' A' ' 16' ' ' VAL . 71.7 tttt -103.27 124.52 48.8 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.105 -0.638 . . . . 1.89 109.704 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.98 129.34 46.81 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.456 0.473 . . . . 0.53 110.31 -170.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.634 ' C ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.747 0 CA-C-O 118.314 -0.85 . . . . 1.78 109.816 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.953 ' HB3' HG22 ' A' ' 22' ' ' VAL . 23.6 t60 . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.001 -0.74 . . . . 0.59 109.001 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -138.7 148.17 43.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.014 0.435 . . . . 2.36 110.765 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.866 HG13 ' HB2' ' A' ' 9' ' ' HIS . 1.9 t -112.41 138.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.271 -0.422 . . . . 0.49 110.928 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -116.96 169.07 9.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.4 -0.818 . . . . 0.51 110.322 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.58 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 23.3 tptp -39.72 -43.72 1.44 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.01 1.115 . . . . 0.83 114.01 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.96 -35.45 33.65 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.645 0.736 . . . . 0.33 111.862 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.866 ' HB2' HG13 ' A' ' 5' ' ' VAL . 76.0 m80 -66.26 -1.96 3.87 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.496 -0.775 . . . . 2.12 111.654 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.721 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.9 t-20 -46.01 -21.54 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.414 0.626 . . . . 1.41 109.586 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -140.08 57.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.489 -0.778 . . . . 0.3 111.376 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.875 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.23 160.53 20.92 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 113.257 0.836 . . . . 0.32 113.257 -174.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 14.2 m -151.48 114.59 4.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.016 -0.993 . . . . 0.95 109.116 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.6 pt? -158.26 166.73 31.65 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.172 0.51 . . . . 3.0 111.606 -174.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 62.8 m -104.04 141.5 36.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.962 -0.563 . . . . 1.73 110.523 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 108' ' ' LYS . 1.7 m -126.75 152.1 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.417 -0.356 . . . . 0.78 111.196 -175.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.54 118.26 36.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.838 -0.801 . . . . 0.76 108.838 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.718 HG12 HG21 ' A' ' 22' ' ' VAL . 27.3 m -100.01 -170.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.252 0.548 . . . . 1.23 111.584 -175.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.641 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 128.38 -46.02 1.11 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.214 -0.754 . . . . 0.71 111.214 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -89.48 -69.71 0.7 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.64 -0.504 . . . . 2.35 109.64 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 58.2 tp -166.46 126.06 1.57 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.59 -0.732 . . . . 0.71 111.177 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -107.85 114.32 46.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.819 0.818 . . . . 0.4 110.05 174.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -103.01 153.48 20.2 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.884 0.849 . . . . 1.09 112.1 -172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.599 HD13 ' HB ' ' A' ' 5' ' ' VAL . 49.1 mm -133.21 102.48 4.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 113.758 -1.564 . . . . 0.54 107.467 170.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -114.16 132.84 55.94 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 122.057 0.932 . . . . 0.64 111.752 -172.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.47 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 3.9 mm? -109.27 154.54 42.09 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 114.584 -1.189 . . . . 0.85 108.924 177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 7' ' ' LYS . 65.3 Cg_endo -88.99 9.53 3.56 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 C-N-CA 122.741 2.294 . . . . 0.35 111.394 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.665 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 19.9 t 69.47 -57.21 0.54 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.219 -0.901 . . . . 0.91 110.474 -174.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.7 OUTLIER 54.35 62.98 7.91 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 107.984 -1.117 . . . . 1.39 107.984 -172.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.443 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 52.9 Cg_exo -54.46 112.9 1.14 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.528 2.819 . . . . 0.83 113.209 -165.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.464 HG23 ' CE2' ' A' ' 89' ' ' TYR . 8.3 p -92.5 -43.67 9.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.459 -0.791 . . . . 1.83 110.086 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.677 HG23 ' HD1' ' A' ' 34' ' ' PHE . 5.1 t 175.79 -136.93 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.571 -0.9 . . . . 2.36 108.571 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.44 -17.13 46.41 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-N 118.024 0.375 . . . . 1.3 113.551 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.677 ' HD1' HG23 ' A' ' 32' ' ' THR . 2.4 m-85 -68.86 142.74 54.73 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 122.987 0.515 . . . . 2.22 110.584 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.481 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -149.13 159.06 44.58 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.27 -0.641 . . . . 0.44 109.27 175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.58 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 98.2 m95 -73.48 119.32 17.55 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.361 0.601 . . . . 0.43 111.474 -175.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.633 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 41.6 m-85 -128.46 -177.09 4.03 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 115.425 -0.807 . . . . 2.78 108.862 170.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.582 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.5 m-85 -78.15 -77.71 0.15 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 118.49 0.586 . . . . 0.43 109.93 168.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -106.25 -0.54 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 2.39 110.532 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 108.23 102.87 2.81 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.728 -0.748 . . . . 0.73 112.28 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.13 2.79 67.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.848 -0.692 . . . . 0.7 111.662 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.582 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.7 OUTLIER -132.33 144.56 50.65 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.834 0.453 . . . . 1.13 111.783 -176.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.629 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.58 132.2 27.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.444 -0.798 . . . . 2.52 110.582 167.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.47 152.57 50.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.023 -0.535 . . . . 2.3 110.786 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.598 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 17.3 t -119.76 135.17 24.03 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.033 -0.729 . . . . 1.61 109.033 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 12.2 Cg_exo -70.7 -8.08 22.79 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 122.802 2.335 . . . . 1.88 113.07 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.437 HD21 ' HA3' ' A' ' 81' ' ' GLY . 5.0 m-20 -125.72 26.23 6.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.426 -0.352 . . . . 2.43 111.075 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 45' ' ' SER . 15.3 pt-20 -95.23 77.27 3.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.341 1.067 . . . . 3.26 111.693 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -95.3 -56.79 2.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.858 -1.064 . . . . 2.06 110.203 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.772 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 18.1 ptt? -108.25 -31.28 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.742 -1.117 . . . . 1.25 109.243 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.772 ' HD1' ' HG3' ' A' ' 50' ' ' MET . 12.3 m-85 -103.8 167.97 9.44 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.743 -1.571 . . . . 0.74 108.009 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 14.7 t -158.63 168.75 26.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 118.709 0.686 . . . . 1.46 112.427 -169.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.8 p -101.2 136.77 31.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.311 -0.859 . . . . 1.31 110.988 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 8.2 pt-20 -127.99 141.97 51.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.43 -0.804 . . . . 2.45 109.619 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -108.21 140.34 41.58 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.331 0.586 . . . . 1.93 111.739 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.823 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.23 104.24 3.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.103 -0.953 . . . . 1.42 109.39 171.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.6 p90 -124.63 150.26 46.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.563 -0.744 . . . . 1.66 110.853 -172.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.1 103.02 26.97 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-O 121.256 0.551 . . . . 2.14 112.197 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.487 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.3 Cg_endo -89.28 120.45 1.03 Allowed 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 124.427 3.418 . . . . 1.92 110.295 165.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.979 ' HG3' ' HA2' ' A' ' 69' ' ' GLY . 2.1 Cg_endo -80.13 -82.89 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.774 2.983 . . . . 2.64 113.177 -169.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -93.16 -28.93 16.01 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.65 -0.87 . . . . 5.8 108.65 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.8 m 65.92 11.69 7.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.598 -1.637 . . . . 7.43 111.191 -175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.4 ' HG3' ' HB2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -125.37 -11.82 6.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.845 -0.616 . . . . 8.71 110.629 175.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 56.3 tp -151.17 -89.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.489 -0.323 . . . . 8.1 111.584 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 mt -176.81 111.65 0.09 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.204 0.526 . . . . 4.74 111.709 -172.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.937 ' H ' ' HG2' ' A' ' 60' ' ' PRO . . . -81.89 66.86 3.77 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 110.296 -1.122 . . . . 3.02 110.296 172.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 66' ' ' GLY . . . 74.27 -66.3 0.31 Allowed 'General case' 0 N--CA 1.468 0.426 0 O-C-N 124.39 0.7 . . . . 4.02 110.292 -175.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.79 34.37 0.63 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.366 -0.834 . . . . 2.84 111.254 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.979 ' HA2' ' HG3' ' A' ' 60' ' ' PRO . . . 47.34 -123.44 8.27 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.978 -0.849 . . . . 1.49 110.978 -175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.6 HG22 ' NE2' ' A' ' 72' ' ' HIS . 31.8 m 137.14 89.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.227 1.411 . . . . 0.97 108.733 150.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HG3' ' HB2' ' A' ' 28' ' ' SER . 39.4 mt-10 -103.51 115.63 30.88 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.671 -1.149 . . . . 0.81 110.167 -174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.823 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 1.7 m170 -108.53 144.98 35.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.678 0.751 . . . . 0.53 111.775 -175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.633 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 14.2 m-85 -116.77 112.38 21.08 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.513 -1.221 . . . . 1.13 109.058 170.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.428 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 15.8 m170 -104.45 113.99 27.93 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.059 -0.519 . . . . 0.5 110.764 -174.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.3 m -104.54 118.53 51.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 122.252 1.025 . . . . 0.87 108.501 171.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.744 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.1 m -102.26 103.74 14.24 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.48 -1.304 . . . . 0.46 107.48 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.621 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 4.7 p -155.94 142.01 10.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 O-C-N 123.651 0.594 . . . . 1.04 111.158 -173.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.641 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -127.14 101.78 6.67 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 109.057 -0.72 . . . . 1.54 109.057 165.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.62 138.19 4.21 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 0.67 109.92 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.65 99.48 3.11 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.746 0.654 . . . . 0.44 111.854 -174.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 47' ' ' ASN . . . -165.71 166.46 38.55 Favored Glycine 0 C--O 1.223 -0.553 0 N-CA-C 110.429 -1.068 . . . . 0.29 110.429 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 5.5 m -100.83 130.78 46.9 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 118.138 0.969 . . . . 0.4 109.957 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.732 ' HD1' HG22 ' A' ' 85' ' ' VAL . 36.5 t-80 -102.97 105.47 15.81 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.211 -0.904 . . . . 0.4 109.854 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.52 24.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.121 -0.696 . . . . 0.35 109.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.732 HG22 ' HD1' ' A' ' 83' ' ' HIS . 2.3 t -105.45 103.08 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.604 -0.726 . . . . 0.59 110.928 -170.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -109.12 103.26 12.23 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.148 -0.686 . . . . 1.53 109.148 176.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 38' ' ' PHE . 88.1 mt -105.78 126.04 51.7 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.691 -0.686 . . . . 0.24 110.507 -176.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.699 HG22 ' HG3' ' A' ' 90' ' ' MET . 6.0 m -102.55 121.2 41.9 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.339 0.59 . . . . 0.29 110.98 -174.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.637 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 54.1 t80 -86.52 97.79 10.7 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.279 -0.873 . . . . 1.11 109.284 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.699 ' HG3' HG22 ' A' ' 88' ' ' THR . 27.6 mtm -134.39 159.48 40.92 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 116.275 -0.42 . . . . 0.65 111.83 -172.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.466 ' HG3' ' CD1' ' A' ' 34' ' ' PHE . 48.3 mtt180 -64.2 105.55 0.73 Allowed Pre-proline 0 C--O 1.217 -0.654 0 N-CA-C 108.227 -1.027 . . . . 2.59 108.227 163.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.411 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 3.2 Cg_endo -46.63 -32.16 11.34 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.633 2.888 . . . . 1.04 114.765 -167.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.423 ' CD1' HG22 ' A' ' 94' ' ' THR . 37.7 p90 -88.12 -2.82 58.84 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.133 0.42 . . . . 1.17 112.133 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -162.23 -68.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 122.493 -0.129 . . . . 1.09 111.338 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.683 ' H ' HG23 ' A' ' 94' ' ' THR . . . 73.41 78.38 0.56 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.789 -0.719 . . . . 1.16 111.533 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 13.0 Cg_exo -32.84 114.9 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.103 3.202 . . . . 1.2 113.066 172.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.6 p -41.27 -55.66 2.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.801 -1.091 . . . . 2.64 113.361 -171.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -100.11 20.07 15.22 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.626 -0.43 . . . . 4.09 111.636 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 14.0 t0 -124.34 6.17 8.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.47 0.652 . . . . 1.67 110.308 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.481 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 32.8 m -98.61 147.86 24.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.454 -0.794 . . . . 1.39 111.149 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.637 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 4.7 tp10 -100.52 166.69 10.8 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.067 -0.716 . . . . 1.91 109.067 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 46.8 ttt180 -153.51 140.14 18.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.77 0.795 . . . . 0.62 111.232 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.777 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -104.4 157.4 17.18 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.116 -1.402 . . . . 0.86 109.07 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.724 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 53.5 m -159.55 102.4 1.54 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.839 0.352 . . . . 0.31 110.977 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.875 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.6 p -105.55 138.91 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.033 -0.667 . . . . 0.88 110.1 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.4 m-85 -104.52 104.2 14.01 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.458 -0.792 . . . . 0.7 109.034 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.9 pp -126.0 148.53 49.26 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.213 -0.662 . . . . 2.12 109.213 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.719 ' O ' HG22 ' A' ' 16' ' ' VAL . 22.4 ttmm -104.59 122.71 46.16 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.198 -0.601 . . . . 1.89 110.165 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -101.74 128.9 47.87 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 123.414 0.446 . . . . 0.53 110.134 -172.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.608 ' C ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.52 -0.752 . . . . 1.78 110.34 -177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.953 ' HB3' HG22 ' A' ' 22' ' ' VAL . 26.8 t60 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 108.932 -0.766 . . . . 0.59 108.932 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -132.28 144.65 50.74 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.938 -0.305 . . . . 2.36 110.254 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.857 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -112.64 133.48 58.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.144 0.497 . . . . 0.49 111.134 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -117.46 170.29 8.85 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.974 -1.012 . . . . 0.51 109.462 170.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.792 ' HD3' HD21 ' A' ' 29' ' ' ASN . 8.6 tptm -34.82 -49.04 0.42 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.973 1.471 . . . . 0.83 114.973 -170.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.55 -31.06 63.81 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.326 0.584 . . . . 0.33 112.537 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.857 ' HB2' HG13 ' A' ' 5' ' ' VAL . 75.3 m80 -64.49 -2.86 2.55 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 2.12 110.903 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 21.7 t-20 -45.53 -19.63 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 123.975 0.797 . . . . 1.41 110.484 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.32 59.27 0.53 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.97 -0.852 . . . . 0.3 110.97 175.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.805 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -120.35 148.21 44.04 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.903 0.705 . . . . 0.32 112.903 -175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.428 ' HA ' ' HB2' ' A' ' 106' ' ' TYR . 85.5 m -134.73 119.08 17.8 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.42 -0.809 . . . . 0.95 109.163 168.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pt? -159.69 166.27 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.948 0.404 . . . . 3.0 111.036 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.0 m -103.29 148.1 26.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.255 -0.43 . . . . 1.73 110.437 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.3 m -126.41 155.41 36.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.78 111.441 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.52 111.49 22.54 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.945 -0.761 . . . . 0.76 108.945 171.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.814 HG21 ' HA ' ' A' ' 78' ' ' LYS . 12.9 m -89.84 -167.82 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 120.946 0.403 . . . . 1.23 111.078 -173.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.0 -54.49 0.73 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.238 -0.745 . . . . 0.71 111.238 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -77.2 -63.2 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.722 -0.844 . . . . 2.35 108.722 171.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 22' ' ' VAL . 54.9 tp -165.5 163.61 19.52 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 114.495 -1.229 . . . . 0.71 109.944 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.3 t -140.46 106.6 2.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 108.449 -0.945 . . . . 0.4 108.449 164.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.604 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.0 pt-20 -112.25 158.36 19.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 122.222 1.011 . . . . 1.09 112.579 -172.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.576 HD12 HG11 ' A' ' 105' ' ' VAL . 46.0 mm -132.9 103.38 5.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.451 -1.704 . . . . 0.54 108.5 178.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -113.27 133.5 55.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.819 0.819 . . . . 0.64 111.535 -176.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -108.88 144.27 29.29 Favored Pre-proline 0 C--N 1.311 -1.094 0 CA-C-N 115.062 -0.972 . . . . 0.85 108.997 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 67.4 Cg_endo -81.09 10.1 3.55 Favored 'Trans proline' 0 C--N 1.329 -0.472 0 C-N-CA 122.499 2.132 . . . . 0.35 111.264 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.704 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 19.4 t 69.37 -61.74 0.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.997 -1.001 . . . . 0.91 111.191 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.792 HD21 ' HD3' ' A' ' 7' ' ' LYS . 1.7 m-80 56.6 62.01 6.64 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.942 -0.762 . . . . 1.39 108.942 -174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 74.8 Cg_exo -52.12 103.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.369 2.712 . . . . 0.83 113.105 -168.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 89' ' ' TYR . 6.5 p -83.15 -37.27 23.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.347 -0.842 . . . . 1.83 110.027 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 34' ' ' PHE . 7.7 t 179.11 -144.53 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.402 -0.962 . . . . 2.36 108.402 -177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.74 -11.33 29.41 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 118.093 0.406 . . . . 1.3 113.242 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.71 ' CD2' ' HA ' ' A' ' 90' ' ' MET . 1.4 m-85 -71.78 151.71 43.29 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.003 0.521 . . . . 2.22 111.469 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -152.15 161.67 42.28 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.801 -0.636 . . . . 0.44 109.663 177.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.704 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.5 m95 -79.53 117.18 20.24 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.402 0.62 . . . . 0.43 111.437 -177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.586 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 70.7 m-85 -125.17 -178.41 4.19 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 108.083 -1.08 . . . . 2.78 108.083 168.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.85 -80.36 0.06 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.029 -0.669 . . . . 0.43 109.556 169.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -104.08 -0.31 28.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.246 0.546 . . . . 2.39 110.168 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.574 ' HA3' ' CE ' ' A' ' 90' ' ' MET . . . 102.22 104.73 2.83 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.523 -0.762 . . . . 0.73 111.826 -178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.88 -0.69 71.09 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.742 -0.742 . . . . 0.7 111.955 -176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.625 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -129.71 141.56 50.87 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.843 0.354 . . . . 1.13 111.493 179.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -145.12 129.54 17.86 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.375 -0.83 . . . . 2.52 110.334 167.074 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.09 153.79 51.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.082 0.467 . . . . 2.3 111.257 176.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.539 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 18.1 t -104.71 129.2 25.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 1.61 108.712 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 10.9 Cg_endo -96.22 161.54 1.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.205 3.27 . . . . 1.88 112.573 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 70.92 8.5 6.55 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.264 -0.88 . . . . 2.43 111.176 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.654 ' HG2' ' HB2' ' A' ' 51' ' ' PHE . 5.5 tp10 -158.27 134.04 9.03 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.514 0.673 . . . . 3.26 112.091 -171.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.3 p -130.09 28.36 5.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.799 -1.091 . . . . 2.06 109.521 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.544 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 21.5 ptt? -138.0 -40.96 0.53 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.486 -0.931 . . . . 1.25 108.486 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.816 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.6 m-85 -103.05 149.75 24.27 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.72 -1.585 . . . . 0.74 106.72 165.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.17 171.61 18.93 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 119.834 -0.746 . . . . 1.46 111.536 -161.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.6 ' HB ' HG12 ' A' ' 75' ' ' VAL . 6.1 p -100.34 139.98 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.404 0.621 . . . . 1.31 112.248 -168.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.607 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 11.2 pt-20 -109.34 152.28 25.49 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.571 -0.9 . . . . 2.45 108.571 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -128.2 140.06 52.12 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.75 -0.38 . . . . 1.93 111.289 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.86 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -151.34 114.5 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.332 0.587 . . . . 1.42 110.273 173.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.747 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 8.2 m-85 -109.7 105.11 14.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.796 -0.638 . . . . 1.66 110.057 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -114.61 104.54 54.32 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.988 -0.551 . . . . 2.14 111.297 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -62.02 172.55 3.88 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 123.297 2.665 . . . . 1.92 112.205 173.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.544 ' HG3' ' O ' ' A' ' 68' ' ' GLY . 34.0 Cg_exo -62.89 -163.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.985 2.457 . . . . 2.64 115.181 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 62' ' ' SER . 18.1 t70 170.64 -138.39 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 105.642 -1.984 . . . . 5.8 105.642 -171.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.441 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 3.9 p -106.59 -61.07 1.58 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.966 0.412 . . . . 7.43 109.916 170.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.615 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -92.43 -18.33 23.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 8.71 111.64 -178.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.615 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 1.3 tm? -61.48 -51.61 67.93 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.951 -0.759 . . . . 8.1 108.951 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.811 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.6 OUTLIER -160.73 -58.29 0.05 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.387 -0.824 . . . . 4.74 108.903 173.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.03 -61.27 4.52 Favored Glycine 0 C--N 1.317 -0.497 0 CA-C-N 114.761 -1.108 . . . . 3.02 112.767 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.39 -55.91 28.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.91 0.386 . . . . 4.02 111.961 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.811 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -133.91 -53.83 0.07 OUTLIER Glycine 0 C--O 1.221 -0.702 0 C-N-CA 120.569 -0.824 . . . . 2.84 112.796 -177.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . 135.58 -165.74 24.7 Favored Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.349 -0.929 . . . . 1.49 111.065 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.6 OUTLIER -156.89 92.44 1.28 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.711 0.634 . . . . 0.97 112.711 -174.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 37.1 mt-10 -104.09 109.11 20.78 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.572 -0.899 . . . . 0.81 108.572 175.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.7 m170 -108.19 145.97 33.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.551 0.691 . . . . 0.53 112.056 -170.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.586 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 32.5 m-85 -121.24 104.54 9.81 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.057 -1.429 . . . . 1.13 108.596 170.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.643 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 19.6 m170 -104.24 107.87 18.99 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 122.234 -0.291 . . . . 0.5 110.284 -175.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.6 HG12 ' HB ' ' A' ' 53' ' ' VAL . 3.8 m -101.56 118.87 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 122.349 1.071 . . . . 0.87 108.294 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.816 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 5.6 m -101.74 103.98 14.76 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.702 -1.592 . . . . 0.46 106.702 178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.676 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -151.26 147.41 15.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.133 0.896 . . . . 1.04 110.874 -170.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.814 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -137.61 102.07 4.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.217 0.532 . . . . 1.54 109.988 170.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -163.23 137.1 5.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.735 -0.666 . . . . 0.67 110.137 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.44 77.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.264 0.554 . . . . 0.44 111.651 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.47 166.76 29.66 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.798 -0.921 . . . . 0.29 110.798 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -99.98 133.08 44.87 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.519 -0.872 . . . . 0.4 109.047 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.648 ' ND1' HG22 ' A' ' 85' ' ' VAL . 12.5 t-80 -103.45 103.64 13.63 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.184 -0.673 . . . . 0.4 109.184 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.33 109.11 20.68 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.877 -0.786 . . . . 0.35 108.877 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.39 106.87 21.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.166 -0.47 . . . . 0.59 111.146 -170.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 5.0 m-80 -109.42 103.8 12.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.498 -0.774 . . . . 1.53 109.232 176.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.667 HD23 ' HA ' ' A' ' 38' ' ' PHE . 84.9 mt -105.23 123.6 48.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.461 -0.791 . . . . 0.24 109.744 -177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.434 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.4 m -102.5 120.09 39.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.409 0.623 . . . . 0.29 110.933 -172.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.869 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 50.1 t80 -88.23 98.22 11.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.096 -0.956 . . . . 1.11 109.732 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.71 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 10.2 mtm -136.3 163.98 29.15 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 110.277 -0.268 . . . . 0.65 110.277 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.558 ' HB3' ' H ' ' A' ' 95' ' ' GLY . 12.8 ttt180 -65.41 110.59 4.56 Favored Pre-proline 0 C--O 1.221 -0.405 0 N-CA-C 107.673 -1.232 . . . . 2.59 107.673 168.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.544 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 1.7 Cg_endo -43.98 -33.96 5.9 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 124.231 3.288 . . . . 1.04 115.42 -169.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.544 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 48.9 p90 -102.24 8.03 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.859 0.689 . . . . 1.17 112.859 -174.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 95' ' ' GLY . 12.8 t -167.8 -55.42 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.789 -0.364 . . . . 1.09 111.602 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 58.1 78.75 0.12 Allowed Glycine 0 C--N 1.332 0.32 0 CA-C-O 119.703 -0.498 . . . . 1.16 113.377 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.55 ' HB2' ' HZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -29.08 115.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 124.236 3.291 . . . . 1.2 113.439 170.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.0 m -73.42 67.15 1.01 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.301 -0.863 . . . . 2.64 111.261 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.2 t60 176.35 -30.26 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.18 -0.918 . . . . 4.09 109.078 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.508 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -91.81 -7.18 50.21 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.737 -0.665 . . . . 1.67 110.018 -178.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 2.8 p -68.3 122.3 18.08 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.008 -0.996 . . . . 1.39 112.404 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.869 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.6 tp10 -91.05 165.33 13.58 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.023 -1.103 . . . . 1.91 108.023 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.434 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 39.2 ttt180 -159.2 136.98 10.19 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.711 0.767 . . . . 0.62 111.094 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -104.3 154.37 19.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.438 -1.256 . . . . 0.86 109.162 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 85.1 m -154.87 103.25 2.41 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 120.866 -0.333 . . . . 0.31 110.783 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.805 HG23 ' HB3' ' A' ' 12' ' ' ALA . 10.6 p -104.96 136.12 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 119.676 -0.81 . . . . 0.88 109.682 168.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 13' ' ' THR . 74.4 m-85 -103.9 104.15 14.1 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.467 -0.938 . . . . 0.7 108.467 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.4 pp -122.68 146.17 47.72 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.269 -0.641 . . . . 2.12 109.269 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.771 ' O ' HG22 ' A' ' 16' ' ' VAL . 9.7 ttmm -103.48 116.71 32.91 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.559 -0.456 . . . . 1.89 111.0 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.65 151.3 21.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.896 -0.779 . . . . 0.53 108.896 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.582 ' O ' HG22 ' A' ' 18' ' ' VAL . 7.2 p30 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.804 -0.617 . . . . 1.78 111.631 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 1.026 ' HB3' HG22 ' A' ' 22' ' ' VAL . 43.8 t60 . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 109.23 -0.656 . . . . 0.59 109.23 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -142.65 130.84 22.03 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.283 -0.417 . . . . 2.36 110.499 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.864 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -106.58 137.05 39.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 120.399 -0.52 . . . . 0.49 111.702 176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -119.01 168.75 10.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.028 -0.987 . . . . 0.51 109.412 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -40.11 -39.46 0.9 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 114.47 1.285 . . . . 0.83 114.47 -170.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.81 -36.45 62.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.558 0.694 . . . . 0.33 111.83 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.864 ' HB2' HG13 ' A' ' 5' ' ' VAL . 77.6 m80 -65.66 -1.59 2.85 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.649 -0.705 . . . . 2.12 111.41 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.752 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.9 t-20 -46.01 -19.36 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.316 0.646 . . . . 1.41 110.161 169.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -142.12 55.33 0.59 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.427 -0.669 . . . . 0.3 111.427 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.819 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -112.45 160.22 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.97 0.73 . . . . 0.32 112.97 -174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 34.1 m -152.25 110.37 3.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.158 -0.928 . . . . 0.95 109.336 173.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.724 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.5 pt? -158.13 166.58 32.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.841 0.353 . . . . 3.0 111.195 -172.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.499 HG23 ' HB3' ' A' ' 108' ' ' LYS . 94.5 m -104.2 148.61 26.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.945 0.403 . . . . 1.73 110.715 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.2 m -125.53 157.65 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-N 116.042 -0.526 . . . . 0.78 110.035 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.34 104.2 12.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.65 -0.5 . . . . 0.76 109.65 174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 22' ' ' VAL . 33.2 m -84.09 175.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.234 0.54 . . . . 1.23 112.072 -172.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.77 -32.15 3.38 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.359 -0.837 . . . . 0.71 111.211 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -97.74 -76.22 0.53 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.664 -0.495 . . . . 2.35 109.664 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 54.2 tp -166.05 123.39 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.462 -0.79 . . . . 0.71 110.66 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.026 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.1 t -107.78 104.87 17.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.598 0.713 . . . . 0.4 109.645 176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.0 pt-20 -113.0 159.25 19.33 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.869 0.842 . . . . 1.09 112.44 -172.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.709 HD12 HG11 ' A' ' 105' ' ' VAL . 47.2 mm -134.43 102.98 4.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.111 -1.404 . . . . 0.54 108.722 177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.677 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -106.03 141.57 37.19 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.368 0.604 . . . . 0.64 111.334 -175.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mt -125.93 142.65 42.94 Favored Pre-proline 0 N--CA 1.434 -1.261 0 CA-C-N 115.562 -0.744 . . . . 0.85 110.284 172.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.494 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 43.3 Cg_endo -84.2 16.29 1.96 Allowed 'Trans proline' 0 C--N 1.325 -0.682 0 C-N-CA 122.787 2.325 . . . . 0.35 112.427 -175.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.7 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.0 t 65.8 -61.25 0.27 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.657 0.783 . . . . 0.91 111.219 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.494 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 58.8 83.44 0.22 Allowed Pre-proline 0 C--N 1.319 -0.74 0 N-CA-C 108.292 -1.003 . . . . 1.39 108.292 -173.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 31.6 Cg_exo -60.88 98.36 0.14 Allowed 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.388 2.725 . . . . 0.83 113.416 -166.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.486 ' OG1' ' HE2' ' A' ' 89' ' ' TYR . 6.4 p -83.13 -45.29 14.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.034 -0.728 . . . . 1.83 109.034 176.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.689 HG23 ' HD1' ' A' ' 34' ' ' PHE . 8.9 t 173.91 -140.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.024 -0.989 . . . . 2.36 108.503 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -55.24 -27.78 47.74 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 118.043 0.383 . . . . 1.3 113.853 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.689 ' HD1' HG23 ' A' ' 32' ' ' THR . 41.6 m-85 -56.56 147.79 21.28 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.058 0.543 . . . . 2.22 111.67 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.524 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -152.37 157.8 41.78 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.067 0.547 . . . . 0.44 109.637 176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.7 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 92.9 m95 -78.29 119.74 22.07 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.415 0.626 . . . . 0.43 111.688 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.54 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 85.0 m-85 -126.55 -177.79 4.12 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.012 -1.107 . . . . 2.78 108.012 168.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -72.88 -76.61 0.11 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.934 -0.707 . . . . 0.43 109.576 165.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.5 3.09 8.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.77 -0.65 . . . . 2.39 111.009 177.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.0 100.38 1.11 Allowed Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.03 -1.081 . . . . 0.73 113.327 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.13 22.38 60.55 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.847 -0.692 . . . . 0.7 111.916 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -140.35 142.38 35.58 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 122.754 0.422 . . . . 1.13 111.209 -174.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -142.73 140.51 31.5 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.99 -0.55 . . . . 2.52 110.035 164.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.76 145.44 46.6 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.915 -0.584 . . . . 2.3 110.271 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 2.9 p -104.17 128.48 27.03 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.536 -0.913 . . . . 1.61 108.536 174.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.7 Cg_exo -77.83 39.83 0.8 Allowed 'Trans proline' 0 C--N 1.335 -0.166 0 C-N-CA 123.492 2.795 . . . . 1.88 112.835 -170.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.406 ' HB3' HG21 ' A' ' 77' ' ' VAL . 7.4 t-20 -173.99 32.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.485 -0.561 . . . . 2.43 109.485 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.471 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 10.9 pt-20 -94.85 109.17 21.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.712 0.768 . . . . 3.26 111.585 -173.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.2 m -145.92 10.46 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.464 -0.789 . . . . 2.06 110.118 175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -178.12 -29.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.234 -0.894 . . . . 1.25 109.122 -172.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.754 ' HB3' ' O ' ' A' ' 76' ' ' THR . 7.5 m-85 -123.58 157.25 34.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.17 -1.377 . . . . 0.74 107.835 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 t -152.57 166.46 31.98 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.662 0.616 . . . . 1.46 112.662 -162.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.888 ' HB ' ' HB ' ' A' ' 75' ' ' VAL . 7.6 p -109.27 136.11 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.607 -0.724 . . . . 1.31 111.818 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -116.92 137.79 51.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.59 -0.732 . . . . 2.45 109.628 175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.86 142.74 34.21 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.236 -0.586 . . . . 1.93 110.784 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.42 104.92 3.55 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.432 -0.804 . . . . 1.42 109.861 -177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.929 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -116.62 132.39 56.7 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.367 0.603 . . . . 1.66 112.189 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -132.34 98.44 16.89 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.317 -0.856 . . . . 2.14 109.723 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -69.49 178.78 4.07 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.968 2.445 . . . . 1.92 111.305 171.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.984 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 68.3 Cg_exo -48.46 -51.91 9.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.606 2.204 . . . . 2.64 113.665 -176.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.503 ' HB2' HD12 ' A' ' 64' ' ' LEU . 28.6 t70 61.63 -90.18 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.904 0.752 . . . . 5.8 109.564 -177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.0 m -166.26 -42.35 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.461 -1.245 . . . . 7.43 108.1 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.673 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -112.95 -27.35 8.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.959 -1.018 . . . . 8.71 111.403 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 58.9 mt -56.63 -56.11 25.57 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.148 0.499 . . . . 8.1 111.167 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.677 ' HG ' ' CA ' ' A' ' 69' ' ' GLY . 1.4 tm? -128.93 -67.54 0.78 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.042 -0.725 . . . . 4.74 109.042 176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.984 ' H ' ' HA ' ' A' ' 60' ' ' PRO . . . 110.16 -46.42 1.17 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.046 -0.979 . . . . 3.02 111.652 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.0 -82.61 0.29 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.734 0.272 . . . . 4.02 111.734 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -105.57 -58.7 0.64 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.54 -0.838 . . . . 2.84 113.212 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.677 ' CA ' ' HG ' ' A' ' 65' ' ' LEU . . . 143.33 -179.74 20.59 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.976 -1.107 . . . . 1.49 111.72 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.38 81.47 1.12 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.617 0.723 . . . . 0.97 110.757 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.929 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 20.9 mt-10 -104.05 102.44 12.2 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.949 -1.023 . . . . 0.81 108.405 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -113.81 151.3 32.26 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.411 -0.916 . . . . 0.53 111.324 -174.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.54 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 39.6 m-85 -118.83 104.45 10.56 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 113.97 -1.468 . . . . 1.13 109.332 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.58 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 17.9 m170 -104.64 104.86 14.75 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.252 -0.431 . . . . 0.5 110.883 -171.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.888 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -102.98 120.82 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 122.424 1.107 . . . . 0.87 109.785 177.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 6.6 m -102.92 104.43 14.66 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.508 -1.223 . . . . 0.46 107.839 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.624 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 7.2 p -147.29 147.35 17.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.808 0.693 . . . . 1.04 110.672 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -130.45 103.48 6.69 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.993 0.902 . . . . 1.54 108.664 166.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.84 166.15 15.79 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.257 -0.883 . . . . 0.67 109.189 -177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.91 102.74 14.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.075 0.464 . . . . 0.44 110.92 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.51 167.18 37.6 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.726 -0.67 . . . . 0.29 111.449 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -103.31 139.71 38.38 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 121.909 -0.76 . . . . 0.4 109.648 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.758 ' HB3' ' HG ' ' A' ' 107' ' ' LEU . 7.2 t-80 -113.62 104.54 12.34 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.847 -0.615 . . . . 0.4 110.418 -172.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.42 109.44 21.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.177 -0.675 . . . . 0.35 109.177 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 104' ' ' THR . 1.9 t -104.41 104.35 16.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.123 -0.49 . . . . 0.59 111.12 -171.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -106.19 104.26 13.92 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.018 -0.734 . . . . 1.53 109.018 175.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 38' ' ' PHE . 85.6 mt -106.4 124.85 50.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.663 -0.699 . . . . 0.24 110.127 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.44 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 3.2 m -103.54 118.31 36.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.529 0.681 . . . . 0.29 111.381 -171.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.524 ' CE1' ' HA ' ' A' ' 35' ' ' ALA . 53.4 t80 -82.6 90.2 6.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.884 -1.053 . . . . 1.11 109.408 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.541 ' HA ' ' HD2' ' A' ' 34' ' ' PHE . 25.9 mtm -120.86 158.66 27.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.984 -0.553 . . . . 0.65 111.434 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -70.48 105.45 1.22 Allowed Pre-proline 0 C--O 1.219 -0.503 0 N-CA-C 108.034 -1.099 . . . . 2.59 108.034 167.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.562 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 10.0 Cg_endo -51.83 -27.49 27.46 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.373 2.715 . . . . 1.04 114.789 -169.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.562 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 44.2 p90 -94.58 4.59 53.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 1.17 111.774 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 95' ' ' GLY . 1.5 t -167.99 -74.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.521 -0.309 . . . . 1.09 110.317 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 94' ' ' THR . . . 68.19 75.95 0.46 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.422 -0.418 . . . . 1.16 112.944 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.509 ' HG2' ' HZ ' ' A' ' 34' ' ' PHE . 1.8 Cg_endo -45.23 117.4 1.62 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.885 2.39 . . . . 1.2 111.081 168.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.4 m -55.23 -39.18 69.4 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.404 -0.816 . . . . 2.64 112.521 -170.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -83.78 -19.19 35.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.616 0.246 . . . . 4.09 111.219 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -93.38 -5.96 48.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.688 0.756 . . . . 1.67 109.343 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.9 m -90.75 145.97 24.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.985 -1.007 . . . . 1.39 110.643 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -98.43 164.88 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.332 -0.988 . . . . 1.91 108.332 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 26.9 ttt180 -146.74 141.66 26.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.907 0.861 . . . . 0.62 110.968 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.819 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 1.3 t80 -102.75 154.94 18.67 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.208 -1.36 . . . . 0.86 108.468 179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 90.8 m -156.61 102.14 2.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.645 -0.422 . . . . 0.31 111.179 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.819 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.9 p -104.74 135.96 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 119.913 -0.715 . . . . 0.88 109.984 168.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 13' ' ' THR . 94.3 m-85 -104.57 107.59 18.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.289 -0.869 . . . . 0.7 109.036 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.758 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 1.7 pp -128.86 152.76 48.16 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.223 -0.658 . . . . 2.12 109.223 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.812 ' O ' HG22 ' A' ' 16' ' ' VAL . 18.6 ttmm -105.17 117.56 34.31 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.334 -0.617 . . . . 1.89 109.334 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.426 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.03 110.39 22.41 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.951 -0.388 . . . . 0.53 109.951 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-N 115.359 -0.837 . . . . 1.78 110.139 -170.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.927 ' HB3' HG22 ' A' ' 22' ' ' VAL . 70.2 t60 . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 108.844 -0.798 . . . . 0.59 108.844 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -140.7 140.54 34.92 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.847 0.356 . . . . 2.36 110.585 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.839 HG13 ' HB2' ' A' ' 9' ' ' HIS . 2.3 t -106.09 132.26 53.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.397 -0.521 . . . . 0.49 110.959 172.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.8 p -113.74 169.78 8.73 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.091 -0.959 . . . . 0.51 110.155 169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptm -41.01 -40.63 1.47 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.86 1.059 . . . . 0.83 113.86 -173.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.64 -33.88 61.28 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.672 0.749 . . . . 0.33 111.598 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.839 ' HB2' HG13 ' A' ' 5' ' ' VAL . 52.1 m80 -67.56 -1.74 5.53 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.74 -0.664 . . . . 2.12 111.583 -179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.69 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 22.7 t-20 -48.33 -17.93 0.18 Allowed 'General case' 0 CA--C 1.535 0.4 0 O-C-N 123.517 0.511 . . . . 1.41 109.674 170.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -138.88 56.74 0.64 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.507 -0.769 . . . . 0.3 111.716 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.028 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -106.54 157.83 17.38 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.662 0.986 . . . . 0.32 113.662 -175.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 29.4 m -153.77 103.59 2.62 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.332 -0.849 . . . . 0.95 109.282 168.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.3 pt? -164.12 169.79 17.31 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.01 0.434 . . . . 3.0 111.761 -175.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 108' ' ' LYS . 88.9 m -100.7 145.95 27.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.093 -0.503 . . . . 1.73 111.054 -177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -119.74 152.27 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.478 -0.783 . . . . 0.78 110.701 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.36 108.02 19.22 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.551 -0.537 . . . . 0.76 109.551 173.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.679 HG12 HG21 ' A' ' 22' ' ' VAL . 34.4 m -86.63 -169.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.017 0.437 . . . . 1.23 111.99 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 116.31 -50.51 0.78 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.609 -0.723 . . . . 0.71 111.296 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -81.18 -77.08 0.22 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.286 0.565 . . . . 2.35 110.082 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.6 tp -166.89 120.51 1.02 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.348 -0.842 . . . . 0.71 110.261 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' A' ' 3' ' ' HIS . 6.9 t -111.63 104.23 16.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.664 0.745 . . . . 0.4 110.06 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -106.75 160.94 15.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 122.005 0.907 . . . . 1.09 112.183 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 85' ' ' VAL . 17.7 mm -130.37 101.58 5.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 113.647 -1.615 . . . . 0.54 107.828 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -108.46 143.31 37.6 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.299 0.571 . . . . 0.64 110.923 -173.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -128.34 142.08 43.5 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.839 -0.619 . . . . 0.85 110.619 173.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 73.1 Cg_endo -77.41 6.14 4.62 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 122.728 2.285 . . . . 0.35 111.671 -175.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.733 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 11.2 t 68.39 -55.94 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.249 0.968 . . . . 0.91 110.129 -172.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.502 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.4 m-80 54.7 57.82 11.69 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 107.339 -1.356 . . . . 1.39 107.339 -172.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.56 108.12 0.25 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.326 2.684 . . . . 0.83 113.139 -161.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.468 HG23 ' CE2' ' A' ' 89' ' ' TYR . 3.5 t -132.54 104.29 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.285 -1.325 . . . . 1.83 110.023 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 33' ' ' GLY . 3.8 m 72.15 -177.13 0.19 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.6 -0.727 . . . . 2.36 110.075 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.678 ' H ' HG22 ' A' ' 32' ' ' THR . . . -61.49 -15.98 48.41 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 118.505 0.593 . . . . 1.3 114.332 -177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.826 ' HB2' ' CE2' ' A' ' 89' ' ' TYR . 1.2 m-85 -62.26 155.41 24.87 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.545 0.572 . . . . 2.22 112.545 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.51 160.4 43.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.116 -0.947 . . . . 0.44 108.832 174.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.733 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.19 117.5 20.26 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.635 0.731 . . . . 0.43 111.537 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.61 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 66.2 m-85 -125.61 -176.68 3.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.955 -1.128 . . . . 2.78 107.955 168.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.648 ' HA ' HD23 ' A' ' 87' ' ' LEU . 1.3 m-85 -74.12 -77.95 0.11 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 119.794 -0.762 . . . . 0.43 109.178 166.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -114.3 10.56 17.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.699 -0.682 . . . . 2.39 110.46 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.494 ' HA3' ' HE1' ' A' ' 90' ' ' MET . . . 96.57 106.11 2.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.729 . . . . 0.73 112.351 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.08 -3.46 51.81 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.874 -0.679 . . . . 0.7 112.414 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -128.69 142.94 50.86 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 120.806 0.336 . . . . 1.13 111.869 -178.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.622 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -141.06 132.96 27.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.316 -0.856 . . . . 2.52 110.532 164.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.98 154.05 51.37 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.234 0.54 . . . . 2.3 111.114 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.82 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 41.0 t -104.92 131.2 22.01 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.638 -0.875 . . . . 1.61 108.638 175.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.65 -25.67 20.76 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.487 2.791 . . . . 1.88 113.286 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.531 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 46.8 m-20 -139.7 81.7 1.84 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 2.43 109.957 175.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.82 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 10.0 pt-20 -117.61 58.53 0.8 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.599 0.714 . . . . 3.26 110.854 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.4 p -80.94 -60.04 2.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.559 -0.746 . . . . 2.06 111.246 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.801 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -108.96 -29.21 8.71 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.589 0.709 . . . . 1.25 109.961 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.801 ' HD1' ' HG2' ' A' ' 50' ' ' MET . 6.3 m-85 -105.64 165.01 11.46 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.908 -1.042 . . . . 0.74 108.795 176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.4 t -153.84 167.54 29.34 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 119.942 -0.703 . . . . 1.46 112.587 -163.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.5 p -103.99 134.0 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.383 -0.826 . . . . 1.31 111.547 -174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.25 155.35 18.81 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.986 -1.006 . . . . 2.45 109.294 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 57' ' ' TYR . 4.6 p-10 -125.13 146.58 49.41 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.937 -0.574 . . . . 1.93 110.878 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' HD2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -164.84 103.91 0.79 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.509 -0.769 . . . . 1.42 110.049 178.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.898 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -118.87 128.56 54.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 121.701 0.762 . . . . 1.66 111.699 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 42.7 m-85 -132.54 104.38 13.29 Favored Pre-proline 0 C--O 1.211 -0.952 0 CA-C-N 114.531 -1.213 . . . . 2.14 107.755 174.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.506 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 22.6 Cg_endo -102.34 55.35 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.346 0 N-CA-C 116.888 1.842 . . . . 1.92 116.888 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.958 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 52.0 Cg_exo -62.84 -179.61 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.933 2.422 . . . . 2.64 113.687 164.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.636 ' CB ' ' HB2' ' A' ' 65' ' ' LEU . 19.0 t70 -154.05 -117.27 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.305 -1.316 . . . . 5.8 109.015 -165.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.8 m -153.0 -48.31 0.1 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.834 0.35 . . . . 7.43 110.416 173.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.89 2.74 56.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.825 0.676 . . . . 8.71 112.825 -173.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.725 HD12 HD22 ' A' ' 65' ' ' LEU . 2.8 tm? -159.32 -71.98 0.08 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.571 -0.529 . . . . 8.1 109.571 -177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.958 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 3.8 mm? -60.69 -46.38 90.6 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.296 -0.865 . . . . 4.74 109.742 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' N ' ' H ' ' A' ' 61' ' ' ASP . . . 88.27 -64.47 3.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 116.775 1.47 . . . . 3.02 116.775 158.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' HB3' ' CG ' ' A' ' 60' ' ' PRO . . . -53.53 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.306 0.854 . . . . 4.02 113.306 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.735 ' N ' ' HB2' ' A' ' 60' ' ' PRO . . . -170.5 116.19 0.63 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.002 -1.239 . . . . 2.84 110.002 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.89 126.15 40.04 Favored Glycine 0 CA--C 1.511 -0.172 0 C-N-CA 120.803 -0.713 . . . . 1.49 112.725 -175.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.431 ' HB ' ' NE2' ' A' ' 72' ' ' HIS . 0.1 OUTLIER -161.47 83.77 0.62 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 112.777 0.658 . . . . 0.97 112.777 -175.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.898 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 30.3 mt-10 -104.79 104.83 14.68 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.447 -0.946 . . . . 0.81 108.447 174.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -115.43 149.28 38.27 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.394 -0.922 . . . . 0.53 112.157 -173.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.61 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 41.4 m-85 -109.13 114.64 28.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.484 -1.689 . . . . 1.13 108.476 171.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.551 ' CD2' ' HD2' ' A' ' 56' ' ' LYS . 5.5 m170 -104.27 109.36 21.17 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.86 -0.525 . . . . 0.5 111.11 -173.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.56 HG21 ' HE2' ' A' ' 83' ' ' HIS . 64.3 t -103.04 110.35 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.633 0.73 . . . . 0.87 110.071 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.731 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 23.2 m -101.99 105.31 16.06 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.93 -1.137 . . . . 0.46 107.93 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 7.3 p -150.89 151.68 12.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.804 -0.634 . . . . 1.04 110.669 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.741 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -135.31 103.61 5.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.838 0.828 . . . . 1.54 109.422 166.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -166.3 158.06 13.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.596 -0.729 . . . . 0.67 109.307 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HA ' ' CB ' ' A' ' 110' ' ' ASN . . . -84.39 95.28 8.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.484 0.659 . . . . 0.44 110.217 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -146.45 169.54 27.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.219 -0.9 . . . . 0.29 111.679 -177.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 2.8 m -107.38 130.0 54.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.296 -0.631 . . . . 0.4 109.296 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.613 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 43.3 t-80 -104.11 102.51 12.25 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.28 -0.262 . . . . 0.4 110.324 -172.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.16 128.67 50.03 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.322 -0.622 . . . . 0.35 109.322 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -128.66 103.88 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 C-N-CA 120.801 -0.36 . . . . 0.59 111.656 -173.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -109.03 103.26 12.25 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.481 -0.933 . . . . 1.53 108.481 171.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.648 HD23 ' HA ' ' A' ' 38' ' ' PHE . 91.9 mt -103.83 122.34 44.93 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.459 -0.791 . . . . 0.24 109.566 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.64 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 4.2 m -101.31 117.86 35.82 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.816 0.817 . . . . 0.29 110.941 -171.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.826 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -84.43 92.43 8.05 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.629 -1.168 . . . . 1.11 109.425 -179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.639 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 12.6 mtm -128.72 165.05 21.65 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 116.433 -0.349 . . . . 0.65 110.185 -176.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' PHE . 9.3 ttm180 -67.02 106.47 1.19 Allowed Pre-proline 0 C--O 1.213 -0.819 0 N-CA-C 107.954 -1.128 . . . . 2.59 107.954 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.524 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 4.4 Cg_endo -44.96 -30.92 4.9 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 124.067 3.178 . . . . 1.04 115.25 -168.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.524 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 36.9 p90 -95.24 5.67 51.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.395 0.517 . . . . 1.17 112.395 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.533 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.2 t -164.99 -60.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.568 0.21 . . . . 1.09 111.568 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 63.86 86.95 0.05 OUTLIER Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 111.869 -0.492 . . . . 1.16 111.869 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 1.051 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 29.1 Cg_exo -57.32 118.4 5.26 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.269 1.98 . . . . 1.2 110.042 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.3 t -49.4 -53.38 22.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.726 0.641 . . . . 2.64 112.465 -167.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -92.19 5.51 50.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.951 0.405 . . . . 4.09 110.645 -175.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.051 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 27.2 t70 -112.99 1.24 15.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 1.67 109.878 -174.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.2 m -98.86 171.5 8.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.594 -0.73 . . . . 1.39 111.457 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.687 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 6.1 tp10 -115.39 170.88 8.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.831 -0.803 . . . . 1.91 108.831 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.64 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 34.8 ttt180 -157.18 141.69 16.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.821 0.819 . . . . 0.62 111.184 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.805 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -104.36 157.74 16.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.313 -1.312 . . . . 0.86 108.594 177.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.691 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 96.0 m -157.85 102.48 1.84 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 120.416 -0.514 . . . . 0.31 111.306 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.028 HG23 ' HB3' ' A' ' 12' ' ' ALA . 14.2 p -103.66 134.48 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.482 -0.562 . . . . 0.88 109.482 169.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' THR . 72.0 m-85 -105.21 112.7 25.92 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.138 -0.69 . . . . 0.7 109.138 174.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.695 ' HG ' HG22 ' A' ' 105' ' ' VAL . 77.8 mt -127.85 164.9 21.21 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.011 -0.995 . . . . 2.12 110.024 -174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.69 ' O ' HG22 ' A' ' 16' ' ' VAL . 58.4 tttm -119.99 113.85 21.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.385 -0.969 . . . . 1.89 108.385 172.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 83' ' ' HIS . . . -101.14 106.83 18.11 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.908 -0.405 . . . . 0.53 109.908 -171.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.631 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.244 0.794 0 CA-C-O 118.135 -0.936 . . . . 1.78 110.437 -168.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.959 ' HB3' HG22 ' A' ' 22' ' ' VAL . 32.2 t60 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.798 -0.815 . . . . 0.59 108.798 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 21.5 pttp -149.55 150.44 32.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.702 0.287 . . . . 2.36 111.423 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.003 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -120.11 136.3 57.63 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 121.433 0.635 . . . . 0.49 111.961 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.462 HG22 ' NE2' ' A' ' 25' ' ' GLN . 1.1 p -120.33 170.34 9.45 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.785 -1.098 . . . . 0.51 110.473 173.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 16.7 tptm -35.62 -48.6 0.53 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.692 1.368 . . . . 0.83 114.692 -171.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.59 -33.32 60.19 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.601 0.715 . . . . 0.33 111.817 -175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.831 ' HB2' HG13 ' A' ' 5' ' ' VAL . 75.0 m80 -64.75 -2.32 2.44 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 2.12 111.227 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 25.9 t-20 -45.57 -22.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.332 0.653 . . . . 1.41 109.995 171.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.42 54.0 0.66 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.5 -0.773 . . . . 0.3 111.357 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.944 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -116.76 156.03 27.9 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.654 0.613 . . . . 0.32 112.654 -175.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 39.4 m -145.95 112.91 6.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.394 -0.821 . . . . 0.95 109.433 173.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -157.88 167.62 29.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 3.0 111.347 -173.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.8 m -101.52 146.59 27.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.724 0.297 . . . . 1.73 111.107 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.1 m -131.76 162.07 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.78 110.936 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.78 137.88 51.89 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.66 -1.237 . . . . 0.76 107.66 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.821 HG12 ' H ' ' A' ' 19' ' ' GLY . 1.6 t -121.06 -164.07 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 119.892 -0.723 . . . . 1.23 110.25 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.821 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 124.31 -48.87 0.93 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.765 -0.934 . . . . 0.71 110.765 -172.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -84.43 -71.01 0.53 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.292 0.568 . . . . 2.35 109.685 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.3 tp -165.46 144.38 6.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.246 -0.888 . . . . 0.71 110.096 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.959 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.1 t -123.14 120.11 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 109.341 -0.615 . . . . 0.4 109.341 171.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 49.8 mt-10 -103.8 151.53 22.96 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.933 0.873 . . . . 1.09 112.442 -171.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.713 HD13 ' HB ' ' A' ' 5' ' ' VAL . 41.6 mm -133.88 137.74 51.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.227 -1.768 . . . . 0.54 106.227 168.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.618 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -145.4 142.12 29.05 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.662 -0.649 . . . . 0.64 111.217 178.616 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -117.25 144.72 34.37 Favored Pre-proline 0 N--CA 1.434 -1.266 0 CA-C-N 115.28 -0.873 . . . . 0.85 109.181 169.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.611 ' HG2' HD22 ' A' ' 29' ' ' ASN . 73.8 Cg_endo -82.63 12.52 2.87 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 C-N-CA 122.862 2.375 . . . . 0.35 111.515 178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.746 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 8.1 t 68.11 -44.99 0.5 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.982 0.913 . . . . 0.91 112.257 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 31' ' ' THR . 1.1 p30 41.89 78.81 0.36 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-O 121.443 0.64 . . . . 1.39 110.777 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.574 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 25.9 Cg_exo -63.97 109.98 1.22 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.357 2.705 . . . . 0.83 112.111 -169.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 29' ' ' ASN . 1.3 t -142.46 117.15 9.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.724 -0.671 . . . . 1.83 111.534 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.7 m 73.52 -42.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.478 0.656 . . . . 2.36 112.314 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 31' ' ' THR . . . 162.72 -118.58 0.83 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 107.72 -2.152 . . . . 1.3 107.72 -172.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.764 ' HA ' ' C ' ' A' ' 90' ' ' MET . 8.5 m-30 61.77 178.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.577 0.703 . . . . 2.22 111.607 167.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HA ' ' CE1' ' A' ' 89' ' ' TYR . . . -174.35 144.79 0.95 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.634 -1.247 . . . . 0.44 107.634 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.746 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 94.8 m95 -76.97 99.07 5.14 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.359 0.6 . . . . 0.43 110.848 -176.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -105.47 179.76 4.18 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.736 -1.209 . . . . 2.78 107.736 168.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.628 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.1 m-85 -68.64 -69.03 0.35 Allowed 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 119.628 -0.829 . . . . 0.43 109.372 167.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -136.52 13.33 3.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.181 -0.463 . . . . 2.39 110.44 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.21 112.05 3.3 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.613 -0.803 . . . . 0.73 113.101 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 4.26 34.69 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.475 -0.393 . . . . 0.7 113.03 178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 p -139.94 144.63 37.18 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 112.425 0.528 . . . . 1.13 112.425 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.534 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -142.23 127.68 18.92 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.901 -1.045 . . . . 2.52 110.122 167.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.92 145.0 51.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.071 0.463 . . . . 2.3 110.781 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.4 t -111.86 135.89 21.2 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.073 -0.714 . . . . 1.61 109.073 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 36.9 Cg_exo -61.51 128.78 25.76 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.278 1.986 . . . . 1.88 111.457 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 72.19 30.76 2.04 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.954 0.784 . . . . 2.43 112.149 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.18 45.72 1.05 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.579 0.704 . . . . 3.26 110.985 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.6 m -81.29 -19.56 42.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.541 -0.754 . . . . 2.06 111.339 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.4 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 17.5 ptt? -138.76 -35.82 0.57 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.748 0.785 . . . . 1.25 109.964 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.853 ' HB3' ' O ' ' A' ' 76' ' ' THR . 8.4 m-85 -106.2 166.19 10.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.567 -1.197 . . . . 0.74 108.443 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 t -153.03 167.11 30.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.767 0.712 . . . . 1.46 112.623 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 2.9 p -103.34 141.57 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.252 -0.886 . . . . 1.31 111.671 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.626 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -116.36 137.94 51.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.78 -0.645 . . . . 2.45 109.614 173.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -110.64 159.17 17.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.753 0.311 . . . . 1.93 111.386 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.64 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -158.24 117.22 3.13 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.264 -0.426 . . . . 1.42 109.977 175.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 2.6 m-85 -123.51 106.46 10.63 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.296 -0.562 . . . . 1.66 109.794 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -124.99 104.75 29.6 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 116.335 -0.393 . . . . 2.14 111.661 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.93 169.5 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.867 2.378 . . . . 1.92 112.617 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' HG3' ' C ' ' A' ' 68' ' ' GLY . 52.4 Cg_exo -52.03 -172.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.94 3.093 . . . . 2.64 116.089 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 62' ' ' SER . 32.1 t70 -166.55 -155.78 0.22 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.791 -2.004 . . . . 5.8 106.856 -173.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.529 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 46.3 p -99.6 -44.67 6.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.654 -0.499 . . . . 7.43 109.654 169.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.739 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -117.41 -24.82 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.303 0.483 . . . . 8.71 112.303 -176.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.739 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 1.5 tm? -54.43 -57.52 10.99 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.929 -0.767 . . . . 8.1 108.929 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.837 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.3 OUTLIER -139.2 -59.59 0.58 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.153 -1.055 . . . . 4.74 108.153 172.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 61' ' ' ASP . . . 84.1 -59.93 4.89 Favored Glycine 0 C--N 1.317 -0.519 0 CA-C-N 114.575 -1.193 . . . . 3.02 113.082 171.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.26 -52.66 64.44 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.843 0.83 . . . . 4.02 110.261 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.837 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -135.54 -163.55 10.06 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 114.5 -1.227 . . . . 2.84 110.504 175.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 65' ' ' LEU . . . -96.63 -149.36 25.47 Favored Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.322 -0.942 . . . . 1.49 111.346 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -167.27 85.22 0.24 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.472 0.654 . . . . 0.97 110.344 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.767 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.0 mt-10 -113.58 104.66 12.47 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.534 -0.757 . . . . 0.81 108.991 -178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.64 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -110.77 165.42 11.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.753 0.787 . . . . 0.53 111.436 -170.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.482 ' HE2' ' HB3' ' A' ' 43' ' ' LYS . 60.0 m-85 -136.57 104.51 5.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.98 -1.464 . . . . 1.13 109.128 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.626 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 40.1 m170 -102.79 113.84 27.6 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 121.958 -0.464 . . . . 0.5 109.86 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 4.4 m -103.91 125.28 58.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 122.135 0.969 . . . . 0.87 110.079 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.853 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 3.7 m -103.82 103.54 13.43 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.101 -1.444 . . . . 0.46 107.101 173.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.653 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 5.1 p -157.25 129.94 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 O-C-N 123.292 0.37 . . . . 1.04 111.033 -176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -123.2 102.55 8.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.497 0.665 . . . . 1.54 110.606 176.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.68 140.42 4.8 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.52 -0.764 . . . . 0.67 109.757 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -64.61 87.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.61 0.569 . . . . 0.44 111.484 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.87 166.48 32.96 Favored Glycine 0 CA--C 1.501 -0.821 0 N-CA-C 110.693 -0.963 . . . . 0.29 110.693 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.0 OUTLIER -101.0 136.01 41.53 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.773 -0.771 . . . . 0.4 109.228 179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.499 ' O ' HD13 ' A' ' 107' ' ' LEU . 55.8 t-80 -101.63 102.42 13.11 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.836 -0.802 . . . . 0.4 108.836 -174.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -103.21 103.7 13.77 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.188 -0.671 . . . . 0.35 109.188 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.1 p -106.52 109.36 27.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.662 -0.699 . . . . 0.59 111.291 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.507 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -107.21 103.76 13.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.863 -1.062 . . . . 1.53 108.932 176.055 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 38' ' ' PHE . 76.3 mt -106.2 128.39 53.9 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.258 -0.428 . . . . 0.24 110.142 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 90' ' ' MET . 3.2 m -104.51 130.84 52.41 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.931 0.396 . . . . 0.29 110.579 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.626 ' CE2' ' HB2' ' A' ' 34' ' ' PHE . 40.6 t80 -96.23 93.82 7.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.283 -0.636 . . . . 1.11 109.283 177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.764 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -131.16 158.43 40.5 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 116.506 -0.316 . . . . 0.65 110.623 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.643 ' N ' ' HA ' ' A' ' 34' ' ' PHE . 41.5 mtt180 -58.65 108.8 1.45 Allowed Pre-proline 0 CA--C 1.512 -0.51 0 O-C-N 124.083 0.864 . . . . 2.59 110.083 176.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 7.0 Cg_exo -38.38 -37.97 0.79 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.903 3.735 . . . . 1.04 115.083 -174.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -91.92 1.27 57.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.131 0.789 . . . . 1.17 113.131 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.8 t -158.52 -62.78 0.08 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.071 -0.393 . . . . 1.09 111.43 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.623 ' H ' HG23 ' A' ' 94' ' ' THR . . . 77.34 93.56 0.23 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.958 -0.639 . . . . 1.16 113.263 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.824 ' HB2' ' HB2' ' A' ' 99' ' ' ASP . 17.4 Cg_exo -69.22 97.54 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.587 2.192 . . . . 1.2 110.008 170.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.6 m -62.52 -25.1 67.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.655 0.74 . . . . 2.64 109.095 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -59.24 -32.26 69.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 114.839 -1.073 . . . . 4.09 110.618 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.824 ' HB2' ' HB2' ' A' ' 96' ' ' PRO . 1.5 m-20 -109.34 -105.45 0.36 Allowed 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.679 -0.237 . . . . 1.67 110.598 -174.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 86.9 p 49.28 -179.14 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.106 1.15 . . . . 1.39 114.106 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -142.28 137.89 30.96 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.748 -1.204 . . . . 1.91 107.748 165.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -121.21 142.87 49.49 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.786 -0.765 . . . . 0.62 111.565 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.648 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . 1.1 t80 -104.38 153.9 20.5 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.216 -1.357 . . . . 0.86 108.989 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 54.2 m -161.03 103.84 1.3 Allowed 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.147 0.28 . . . . 0.31 110.317 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.003 HG11 HG21 ' A' ' 5' ' ' VAL . 7.5 p -110.08 136.6 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 118.15 -1.42 . . . . 0.88 109.877 168.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 13' ' ' THR . 79.4 m-85 -103.94 101.95 11.74 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 114.799 -1.092 . . . . 0.7 108.15 175.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.774 HD12 HG13 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -124.49 142.62 51.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.438 -0.949 . . . . 2.12 108.438 176.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.721 ' O ' HG22 ' A' ' 16' ' ' VAL . 78.3 tttt -101.89 122.77 44.64 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 120.369 -0.532 . . . . 1.89 110.507 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -101.98 159.18 15.58 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.692 0.62 . . . . 0.53 110.71 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.527 ' H ' HG23 ' A' ' 18' ' ' VAL . 4.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.353 -0.832 . . . . 1.78 109.553 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.707 ' NE2' HD13 ' A' ' 107' ' ' LEU . 20.2 t60 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 121.487 0.66 . . . . 0.59 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 20.1 pttp -149.71 141.14 23.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 2.36 110.771 173.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.84 HG11 ' HZ ' ' A' ' 103' ' ' PHE . 2.0 t -103.22 140.15 22.21 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.49 110.562 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.2 p -121.71 169.05 11.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.503 -0.772 . . . . 0.51 109.73 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -38.0 -47.01 1.05 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.335 1.235 . . . . 0.83 114.335 -171.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.35 -31.55 61.83 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.47 0.652 . . . . 0.33 111.871 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.824 ' HB2' HG13 ' A' ' 5' ' ' VAL . 47.9 m80 -62.57 -3.07 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.815 -0.629 . . . . 2.12 111.672 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.661 HD22 ' HA ' ' A' ' 103' ' ' PHE . 3.7 t-20 -46.91 -19.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.145 0.578 . . . . 1.41 110.171 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.33 51.87 0.74 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.955 -0.641 . . . . 0.3 112.078 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 1.077 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -106.03 162.3 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.513 0.931 . . . . 0.32 113.513 -173.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 85.7 m -153.74 103.76 2.64 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.336 -0.847 . . . . 0.95 109.134 170.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 6.5 tt -156.06 164.26 38.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 110.141 -0.318 . . . . 3.0 110.141 -170.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.7 m -103.15 140.91 36.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 1.73 111.414 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.6 m -116.97 158.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.008 -0.542 . . . . 0.78 111.372 -174.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.77 121.28 44.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.024 -0.534 . . . . 0.76 109.586 171.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.615 HG22 ' C ' ' A' ' 110' ' ' ASN . 17.6 m -108.26 -173.59 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.23 111.271 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 130.11 -56.65 0.74 Allowed Glycine 0 CA--C 1.506 -0.469 0 N-CA-C 111.244 -0.742 . . . . 0.71 111.244 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -81.35 -68.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.333 0.587 . . . . 2.35 109.654 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 29.1 tp -165.99 141.38 4.8 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 114.863 -1.062 . . . . 0.71 109.179 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.662 HG22 ' HB3' ' A' ' 3' ' ' HIS . 0.9 OUTLIER -117.65 126.63 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 110.003 -0.369 . . . . 0.4 110.003 173.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 21.2 mt-10 -103.34 142.83 33.53 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.882 0.849 . . . . 1.09 112.732 -178.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.643 HG21 HG11 ' A' ' 85' ' ' VAL . 41.7 mm -124.45 101.06 8.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.321 -1.363 . . . . 0.54 107.321 165.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.5 OUTLIER -108.93 138.24 45.58 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.492 0.663 . . . . 0.64 111.781 -169.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.1 mm? -119.58 144.77 37.54 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.517 -0.765 . . . . 0.85 109.441 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.543 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 36.7 Cg_endo -86.78 13.86 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.682 2.255 . . . . 0.35 111.66 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.714 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 34.3 t 67.6 -49.53 0.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.314 -0.857 . . . . 0.91 111.62 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.543 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 0.3 OUTLIER 50.45 57.05 17.73 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.185 -1.043 . . . . 1.39 108.185 -172.414 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HA ' ' OH ' ' A' ' 89' ' ' TYR . 83.2 Cg_exo -50.11 119.59 5.11 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.88 3.054 . . . . 0.83 114.156 -163.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.527 HG23 ' CE2' ' A' ' 89' ' ' TYR . 10.8 p -98.35 -53.37 3.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.19 -0.914 . . . . 1.83 110.138 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.632 HG23 ' HD1' ' A' ' 34' ' ' PHE . 2.7 t -171.18 -115.76 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.048 -0.524 . . . . 2.36 109.976 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.26 -14.95 79.58 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 121.211 -0.519 . . . . 1.3 112.561 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.632 ' HD1' HG23 ' A' ' 32' ' ' THR . 3.7 m-85 -67.94 145.92 54.08 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 123.094 0.558 . . . . 2.22 110.316 177.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -149.81 157.41 43.17 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.74 -0.467 . . . . 0.44 109.74 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.714 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 96.6 m95 -77.26 113.31 14.88 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.413 0.625 . . . . 0.43 111.017 -177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 46.5 m-85 -125.48 175.36 7.57 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.544 -1.28 . . . . 2.78 107.544 167.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.4 m-85 -65.17 -65.69 0.64 Allowed 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.465 -0.894 . . . . 0.43 109.532 170.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -133.71 21.59 3.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.997 -0.547 . . . . 2.39 110.59 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.79 92.64 1.58 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.466 -0.873 . . . . 0.73 113.276 173.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.99 -8.92 76.56 Favored Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.764 -0.731 . . . . 0.7 112.628 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -128.4 143.92 51.07 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 111.906 0.336 . . . . 1.13 111.906 -178.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.618 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -140.99 139.43 34.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.254 -0.884 . . . . 2.52 110.383 172.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.39 145.29 33.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.979 0.419 . . . . 2.3 111.594 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.756 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 40.2 m -104.76 137.02 19.1 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.007 -0.542 . . . . 1.61 109.556 173.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 31.2 Cg_exo -60.35 -22.46 71.2 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.208 2.605 . . . . 1.88 113.421 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.624 HD21 ' HA3' ' A' ' 81' ' ' GLY . 88.4 m-20 -119.72 24.66 10.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.436 0.16 . . . . 2.43 111.408 -177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.756 ' HB3' ' HB2' ' A' ' 45' ' ' SER . 6.5 pt-20 -86.9 124.15 32.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.946 0.879 . . . . 3.26 111.074 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 m -160.45 -49.62 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.469 -1.308 . . . . 2.06 107.469 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.514 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -103.46 -41.04 6.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.551 -1.204 . . . . 1.25 109.233 173.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.67 ' HB3' ' O ' ' A' ' 76' ' ' THR . 6.9 m-85 -105.62 165.75 10.94 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.113 -0.949 . . . . 0.74 108.535 173.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 t -163.7 170.32 17.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.095 0.474 . . . . 1.46 111.575 -168.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' A' ' 75' ' ' VAL . 2.2 p -102.11 135.0 41.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.61 -0.723 . . . . 1.31 111.37 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 74' ' ' HIS . 1.3 pm0 -120.1 136.31 54.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.55 -0.907 . . . . 2.45 108.55 170.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 43' ' ' LYS . 96.2 m-20 -103.23 153.82 19.98 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 119.845 -0.742 . . . . 1.93 111.494 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.37 108.82 3.79 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.011 -0.995 . . . . 1.42 109.376 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.838 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.7 OUTLIER -114.75 135.1 54.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.782 -0.644 . . . . 1.66 110.621 -174.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -135.78 97.17 12.78 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.559 -0.291 . . . . 2.14 110.307 169.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -75.0 165.53 31.13 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.71 2.273 . . . . 1.92 111.058 168.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 18.1 Cg_exo -39.94 135.19 1.59 Allowed 'Trans proline' 0 CA--C 1.514 -0.489 0 C-N-CA 124.002 3.135 . . . . 2.64 115.339 -174.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -135.16 -69.65 0.5 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 112.625 -2.08 . . . . 5.8 107.878 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.2 t 178.53 -71.32 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.876 -1.511 . . . . 7.43 109.672 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.641 ' HD2' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -92.93 -32.66 14.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.396 -0.365 . . . . 8.71 111.024 -177.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.641 ' H ' ' HD2' ' A' ' 63' ' ' LYS . 87.2 mt -56.66 -63.88 1.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 108.152 -1.055 . . . . 8.1 108.152 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.887 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.0 OUTLIER -155.92 123.62 5.59 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.719 -1.586 . . . . 4.74 106.719 166.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.03 -38.58 1.24 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.443 -0.884 . . . . 3.02 111.559 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.29 88.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.36 0.6 . . . . 4.02 110.983 177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.887 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -153.0 -153.93 6.53 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.294 -1.122 . . . . 2.84 110.294 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -114.67 -178.05 18.92 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 119.906 -1.14 . . . . 1.49 111.955 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.39 81.3 0.97 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.485 0.659 . . . . 0.97 110.98 177.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.838 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 31.4 mt-10 -104.27 104.04 13.88 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.576 -0.898 . . . . 0.81 108.576 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -108.94 150.13 28.18 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 119.517 -0.873 . . . . 0.53 110.837 -175.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.604 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 10.0 m-85 -109.56 115.08 29.24 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.167 -1.379 . . . . 1.13 108.95 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 15.8 m170 -104.24 108.24 19.54 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.341 -174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.642 HG22 HG12 ' A' ' 22' ' ' VAL . 4.2 m -103.45 117.94 49.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.175 0.988 . . . . 0.87 108.777 175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 68.0 m -102.62 103.71 14.02 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.978 -1.119 . . . . 0.46 107.978 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 2.9 p -154.76 144.57 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.515 -0.766 . . . . 1.04 110.619 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -131.1 103.05 6.28 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.822 0.82 . . . . 1.54 109.006 165.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.79 134.72 2.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.375 -0.83 . . . . 0.67 110.522 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -65.14 102.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.757 0.66 . . . . 0.44 111.367 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.624 ' HA3' HD21 ' A' ' 47' ' ' ASN . . . -165.49 167.2 38.84 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.152 -1.179 . . . . 0.29 110.152 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.8 m -101.85 131.54 48.14 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 118.055 0.927 . . . . 0.4 109.436 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.568 ' ND1' HG22 ' A' ' 85' ' ' VAL . 32.5 t-80 -103.96 102.96 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.948 -0.39 . . . . 0.4 109.948 -174.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.85 122.13 43.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.014 -0.735 . . . . 0.35 109.014 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 104' ' ' THR . 3.0 t -113.97 109.87 30.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.134 -0.485 . . . . 0.59 111.696 -170.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.44 ' ND2' HG23 ' A' ' 104' ' ' THR . 8.0 m120 -109.68 104.09 13.04 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.223 -0.658 . . . . 1.53 109.223 174.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.588 HD23 ' HA ' ' A' ' 38' ' ' PHE . 82.5 mt -108.49 121.34 44.76 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.24 110.004 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.432 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 2.6 m -102.35 118.9 37.86 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.397 0.617 . . . . 0.29 110.657 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.605 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 53.9 t80 -86.01 91.22 8.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.942 -1.026 . . . . 1.11 109.606 -178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.725 ' HB3' ' HA3' ' A' ' 95' ' ' GLY . 3.2 mtm -131.7 165.13 24.42 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 116.506 -0.316 . . . . 0.65 110.473 -176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.532 ' HB2' ' H ' ' A' ' 95' ' ' GLY . 70.5 mtt180 -57.28 112.54 4.79 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.48 -0.933 . . . . 2.59 108.48 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -52.06 -24.81 20.72 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 123.236 2.624 . . . . 1.04 114.504 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.533 ' CD1' HG22 ' A' ' 94' ' ' THR . 47.6 p90 -96.94 2.77 52.01 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.881 0.326 . . . . 1.17 111.881 -178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.7 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.3 t -173.84 -67.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 O-C-N 122.483 -0.135 . . . . 1.09 111.309 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.725 ' HA3' ' HB3' ' A' ' 90' ' ' MET . . . 77.87 89.81 0.35 Allowed Glycine 0 CA--C 1.505 -0.549 0 C-N-CA 120.843 -0.694 . . . . 1.16 112.065 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 11.0 Cg_exo -37.31 113.26 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.487 2.792 . . . . 1.2 111.718 169.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.1 t -75.94 9.85 2.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.025 -0.534 . . . . 2.64 111.944 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -130.12 4.37 4.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.122 -0.325 . . . . 4.09 110.122 174.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 22.8 t0 -127.05 0.82 6.53 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.203 0.525 . . . . 1.67 110.916 -176.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 29.8 m -87.91 148.27 24.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.045 -0.525 . . . . 1.39 111.084 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.5 tp10 -100.8 169.36 9.05 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.812 -0.81 . . . . 1.91 108.812 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 33.5 ttt180 -153.8 140.01 18.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.806 0.812 . . . . 0.62 110.703 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.84 ' HZ ' HG11 ' A' ' 5' ' ' VAL . 2.5 t80 -104.13 156.87 17.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.278 -1.328 . . . . 0.86 108.668 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 66.9 m -158.8 101.18 1.63 Allowed 'General case' 0 N--CA 1.442 -0.834 0 CA-C-O 120.885 0.374 . . . . 0.31 110.121 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.077 HG23 ' HB3' ' A' ' 12' ' ' ALA . 9.3 p -104.65 134.7 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 C-N-CA 119.793 -0.763 . . . . 0.88 109.73 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 13' ' ' THR . 91.1 m-85 -104.07 113.99 27.93 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.605 -0.887 . . . . 0.7 108.605 175.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 3' ' ' HIS . 17.3 mt -137.7 165.08 27.26 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.835 -0.62 . . . . 2.12 109.753 -176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.766 ' O ' HG22 ' A' ' 16' ' ' VAL . 78.5 tttt -119.76 124.4 46.07 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.47 -0.492 . . . . 1.89 110.237 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.427 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.62 127.24 48.44 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.397 0.436 . . . . 0.53 110.066 -172.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.615 ' C ' HG22 ' A' ' 18' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.648 -0.705 . . . . 1.78 109.977 -174.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 1.009 ' HB3' HG22 ' A' ' 22' ' ' VAL . 28.4 t60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.415 -0.587 . . . . 0.59 109.415 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -144.05 141.14 29.91 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.24 -0.436 . . . . 2.36 110.606 177.567 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.846 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -106.25 134.12 48.74 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 CA-C-O 121.166 0.508 . . . . 0.49 111.525 176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.76 168.47 9.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.136 -0.938 . . . . 0.51 110.289 170.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 10' ' ' ASN . 25.7 tptp -38.64 -44.61 1.0 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.298 1.592 . . . . 0.83 115.298 -171.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.23 -30.87 60.87 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.77 0.714 . . . . 0.33 111.757 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.837 ' HB2' HG13 ' A' ' 5' ' ' VAL . 73.9 m80 -66.06 -2.26 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.659 -0.7 . . . . 2.12 111.267 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.668 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -49.48 -17.24 0.27 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.165 -0.68 . . . . 1.41 109.165 171.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 9' ' ' HIS . . . -143.93 50.08 0.68 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.96 -0.563 . . . . 0.3 111.787 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.82 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -110.18 158.08 18.73 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.198 0.814 . . . . 0.32 113.198 -173.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 91.7 m -148.8 107.74 3.87 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.144 -0.935 . . . . 0.95 109.738 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.4 pp -153.76 168.26 26.89 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 3.0 111.668 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.0 m -101.16 146.62 27.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.423 -0.353 . . . . 1.73 110.608 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 108' ' ' LYS . 6.0 m -129.45 160.78 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-O 121.105 0.478 . . . . 0.78 111.477 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.65 124.12 51.55 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.54 -0.911 . . . . 0.76 108.54 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.648 HG22 ' C ' ' A' ' 110' ' ' ASN . 22.5 m -102.49 -165.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.509 -0.476 . . . . 1.23 111.385 -177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 112.12 -50.38 0.77 Allowed Glycine 0 CA--C 1.504 -0.652 0 N-CA-C 111.041 -0.823 . . . . 0.71 111.041 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -75.61 -75.79 0.17 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.795 0.807 . . . . 2.35 109.132 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.6 tp -166.64 140.48 3.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.521 -1.218 . . . . 0.71 109.349 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.009 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.7 t -123.57 104.48 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.586 0.708 . . . . 0.4 109.155 172.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.1 pt-20 -109.45 160.19 16.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.795 0.807 . . . . 1.09 111.568 -173.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 5' ' ' VAL . 22.6 mm -134.68 104.18 5.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 114.072 -1.422 . . . . 0.54 108.624 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.618 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -110.04 139.26 45.35 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.533 0.682 . . . . 0.64 111.904 -174.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.477 HD13 ' HA ' ' A' ' 26' ' ' LEU . 3.9 mm? -116.84 139.99 26.35 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 114.985 -1.007 . . . . 0.85 108.955 171.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 85.1 Cg_endo -79.06 8.77 3.64 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 C-N-CA 122.824 2.349 . . . . 0.35 111.893 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.651 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 7.9 t 66.22 -63.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.03 0.831 . . . . 0.91 110.291 -173.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.406 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.1 m-80 60.81 65.42 2.05 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.059 -1.089 . . . . 1.39 108.059 -172.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -48.66 112.86 0.69 Allowed 'Trans proline' 0 CA--C 1.517 -0.353 0 C-N-CA 123.875 3.05 . . . . 0.83 113.57 -165.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.545 HG23 ' CE2' ' A' ' 89' ' ' TYR . 38.7 p -80.7 -73.98 0.34 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.167 -1.378 . . . . 1.83 112.176 -174.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.445 ' H ' ' H ' ' A' ' 33' ' ' GLY . 6.3 t -171.19 -12.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.473 -0.785 . . . . 2.36 110.359 -174.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' H ' ' H ' ' A' ' 32' ' ' THR . . . 176.44 -33.93 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.39 -0.684 . . . . 1.3 111.39 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.556 ' HA ' ' C ' ' A' ' 90' ' ' MET . 45.7 m-85 -52.5 139.72 24.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.559 -0.32 . . . . 2.22 111.284 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.608 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -137.72 151.44 48.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.661 -0.866 . . . . 0.44 108.661 171.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.651 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 95.9 m95 -79.87 109.79 14.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.328 0.585 . . . . 0.43 111.415 -174.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 51.2 m-85 -114.67 177.53 4.61 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 108.395 -0.965 . . . . 2.78 108.395 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.776 ' HA ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -70.02 -73.94 0.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.01 0.823 . . . . 0.43 109.466 169.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -110.43 -11.86 14.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.709 -0.678 . . . . 2.39 110.179 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.31 108.1 2.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.564 -0.827 . . . . 0.73 112.099 -179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.06 -16.92 7.94 Favored Glycine 0 CA--C 1.516 0.145 0 C-N-CA 120.987 -0.625 . . . . 0.7 112.648 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 m -128.97 142.09 51.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.886 -0.413 . . . . 1.13 109.886 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -139.91 141.56 36.51 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.522 -0.548 . . . . 2.52 109.522 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -137.45 164.35 28.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.607 0.718 . . . . 2.3 112.625 -172.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.851 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 15.9 p -135.23 128.41 18.39 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.315 -0.857 . . . . 1.61 108.996 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.9 150.36 86.49 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.635 2.223 . . . . 1.88 112.138 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.471 ' HB2' HG21 ' A' ' 77' ' ' VAL . 94.6 m-20 66.35 42.78 2.88 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.573 0.546 . . . . 2.43 110.574 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.581 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -88.72 31.15 0.86 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.539 -0.755 . . . . 3.26 111.304 -173.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -88.09 12.11 14.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.392 -0.367 . . . . 2.06 111.266 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.442 ' HG3' ' HD1' ' A' ' 51' ' ' PHE . 20.5 ptt? -175.27 -32.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.418 0.627 . . . . 1.25 110.461 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.754 ' HB3' ' O ' ' A' ' 76' ' ' THR . 9.4 m-85 -122.5 162.87 20.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.121 -0.945 . . . . 0.74 109.297 -176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.6 t -159.65 167.88 27.37 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.342 0.592 . . . . 1.46 112.278 -164.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 45' ' ' SER . 7.5 p -103.09 139.34 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 115.311 -0.859 . . . . 1.31 111.401 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.702 ' HG3' ' HB2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -112.43 142.93 44.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.194 -0.669 . . . . 2.45 109.194 172.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.407 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . 3.7 p-10 -111.16 161.32 16.08 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.959 -0.296 . . . . 1.93 111.229 -176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.786 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -165.14 111.76 0.96 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.881 -0.785 . . . . 1.42 108.881 171.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 5.7 m-85 -111.18 112.83 24.9 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.173 -0.611 . . . . 1.66 111.916 -173.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.707 ' C ' ' HD3' ' A' ' 60' ' ' PRO . 90.5 m-85 -113.72 109.03 50.8 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.219 -0.9 . . . . 2.14 109.417 172.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' N ' ' HD3' ' A' ' 60' ' ' PRO . 19.0 Cg_endo -104.46 55.21 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.22 0 C-N-CA 123.381 2.72 . . . . 1.92 116.042 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 1.027 ' HA ' ' HB3' ' A' ' 65' ' ' LEU . 18.6 Cg_endo -94.99 172.03 1.38 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 123.251 2.634 . . . . 2.64 111.501 168.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.514 ' CB ' ' HB2' ' A' ' 65' ' ' LEU . 19.9 t70 -132.41 -74.58 0.51 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.024 -0.535 . . . . 5.8 110.927 -167.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.788 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 33.9 p -173.65 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.215 -0.902 . . . . 7.43 111.538 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' HG2' ' H ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.48 -69.26 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.495 0.188 . . . . 8.71 110.931 -177.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.649 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 71.3 mt -57.89 -65.66 0.6 Allowed 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.939 0.876 . . . . 8.1 109.111 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.027 ' HB3' ' HA ' ' A' ' 60' ' ' PRO . 3.1 mm? -85.91 143.02 28.43 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.06 -2.2 . . . . 4.74 105.06 167.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.67 37.78 3.32 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 118.752 -1.69 . . . . 3.02 114.496 -156.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.788 ' HB2' ' HA ' ' A' ' 62' ' ' SER . . . 64.38 142.1 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.793 0.837 . . . . 4.02 112.195 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.8 25.26 3.13 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 119.388 -1.386 . . . . 2.84 112.206 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.918 ' HA2' ' HD2' ' A' ' 60' ' ' PRO . . . -55.79 108.36 1.06 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.419 -0.895 . . . . 1.49 111.805 -177.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 69' ' ' GLY . 2.7 p -156.24 86.96 1.03 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.64 0.733 . . . . 0.97 112.349 -173.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.718 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 39.9 mt-10 -103.98 103.56 13.41 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 107.936 -1.135 . . . . 0.81 107.936 174.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.786 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 11.0 m-70 -105.03 150.59 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.719 0.771 . . . . 0.53 111.863 -171.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HE2' ' HB2' ' A' ' 43' ' ' LYS . 32.6 m-85 -125.2 104.5 8.54 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.912 -1.494 . . . . 1.13 108.679 172.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.702 ' HB2' ' HG3' ' A' ' 54' ' ' GLU . 23.3 m170 -102.52 104.27 14.68 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 110.159 -0.312 . . . . 0.5 110.159 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -101.9 114.57 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 CA-C-O 122.609 1.195 . . . . 0.87 109.479 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.754 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 27.7 m -101.61 104.72 15.6 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.248 -1.342 . . . . 0.46 107.904 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.565 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 6.1 p -149.04 148.31 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 O-C-N 124.206 0.941 . . . . 1.04 110.043 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -130.99 102.77 6.18 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.845 0.831 . . . . 1.54 108.854 164.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -166.21 160.94 16.54 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.271 -0.877 . . . . 0.67 110.063 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.25 95.99 10.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.994 0.426 . . . . 0.44 111.151 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.14 165.84 34.95 Favored Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.308 -0.717 . . . . 0.29 111.308 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -102.44 131.73 48.92 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 122.062 -0.669 . . . . 0.4 109.846 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.692 ' ND1' HG22 ' A' ' 85' ' ' VAL . 2.8 t-80 -104.13 104.46 14.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.728 -0.669 . . . . 0.4 110.041 -173.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.89 109.69 21.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.319 -0.993 . . . . 0.35 108.319 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.1 t -103.96 104.26 16.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-N 116.063 -0.517 . . . . 0.59 111.191 -170.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -113.4 103.29 11.14 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.687 0.756 . . . . 1.53 110.121 -179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 38' ' ' PHE . 90.8 mt -105.89 129.62 54.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.761 -1.109 . . . . 0.24 110.137 -175.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.741 HG22 ' HG3' ' A' ' 90' ' ' MET . 5.9 m -101.31 118.93 37.96 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.588 0.709 . . . . 0.29 110.747 -171.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.683 ' HB3' ' HB3' ' A' ' 101' ' ' GLU . 1.6 t80 -87.84 83.42 7.12 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.568 -1.197 . . . . 1.11 109.467 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.741 ' HG3' HG22 ' A' ' 88' ' ' THR . 30.2 mtm -117.26 158.32 24.54 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 120.858 0.361 . . . . 0.65 111.833 -171.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -70.09 105.94 1.41 Allowed Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.158 -1.053 . . . . 2.59 108.158 166.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.7 Cg_endo -50.71 -26.79 18.19 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.49 2.793 . . . . 1.04 114.564 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.472 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.2 p90 -92.25 -4.5 53.97 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.196 0.443 . . . . 1.17 112.196 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.616 HG23 ' H ' ' A' ' 95' ' ' GLY . 5.2 t -161.89 -62.72 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 122.365 -0.209 . . . . 1.09 111.076 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.616 ' H ' HG23 ' A' ' 94' ' ' THR . . . 53.18 66.64 2.59 Favored Glycine 0 C--N 1.335 0.481 0 CA-C-O 119.962 -0.355 . . . . 1.16 112.967 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -50.5 128.7 24.22 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.671 2.247 . . . . 1.2 112.269 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.8 t -57.79 138.9 55.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.752 -0.658 . . . . 2.64 109.687 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.1 m80 77.96 -8.11 1.72 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.805 0.69 . . . . 4.09 111.574 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -99.41 -25.66 14.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.83 0.824 . . . . 1.67 108.925 175.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.465 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 6.2 p -81.26 163.33 23.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.72 -1.127 . . . . 1.39 110.9 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 10.8 tp10 -103.09 172.35 6.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.727 -0.842 . . . . 1.91 108.727 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 48.8 ttt180 -156.04 139.9 16.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.797 0.808 . . . . 0.62 110.909 174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.709 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -103.75 156.53 17.74 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.228 -1.351 . . . . 0.86 109.052 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.83 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 93.5 m -160.22 103.5 1.45 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.788 -0.365 . . . . 0.31 111.105 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.846 HG11 HG21 ' A' ' 5' ' ' VAL . 11.1 p -103.72 137.47 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 120.308 -0.557 . . . . 0.88 110.31 170.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 13' ' ' THR . 96.5 m-85 -105.29 107.87 19.08 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.503 -0.772 . . . . 0.7 109.127 175.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.623 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 2.6 pp -130.69 146.13 52.1 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.443 -0.577 . . . . 2.12 109.443 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.692 ' O ' HG22 ' A' ' 16' ' ' VAL . 11.8 tttp -103.76 114.72 29.19 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.583 -0.447 . . . . 1.89 110.722 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.532 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.53 132.2 46.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.306 -0.406 . . . . 0.53 110.382 -168.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.648 ' C ' HG22 ' A' ' 18' ' ' VAL . 7.7 p30 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.26 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.968 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 108.403 -0.962 . . . . 0.59 108.403 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.49 134.55 25.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.033 0.444 . . . . 2.36 111.364 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.944 HG21 HG11 ' A' ' 105' ' ' VAL . 2.0 t -106.44 156.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.227 -0.442 . . . . 0.49 110.786 173.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -146.85 170.82 16.25 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.195 0.998 . . . . 0.51 108.621 -172.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 23.2 tptp -48.17 -39.53 21.12 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.257 0.836 . . . . 0.83 113.257 -173.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.1 -35.64 77.55 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.688 0.756 . . . . 0.33 110.856 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.779 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.7 m80 -64.4 -3.9 3.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.203 -0.908 . . . . 2.12 111.205 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.71 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 17.7 t-20 -48.03 -21.44 0.45 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.378 0.671 . . . . 1.41 110.548 171.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.06 54.6 0.65 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.22 -0.752 . . . . 0.3 111.22 177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.843 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -117.05 160.58 20.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.961 0.726 . . . . 0.32 112.961 -174.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 27.4 m -151.76 117.03 5.28 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.231 -0.895 . . . . 0.95 109.467 174.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.6 pp -164.29 168.29 18.91 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.534 0.207 . . . . 3.0 111.367 -173.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.0 m -102.97 145.9 29.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.885 0.374 . . . . 1.73 111.077 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.817 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -123.5 162.26 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.74 -0.664 . . . . 0.78 110.15 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.448 ' HA ' ' OXT' ' A' ' 110' ' ' ASN . . . -115.16 117.01 29.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.733 -0.84 . . . . 0.76 108.733 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 22' ' ' VAL . 25.2 m -93.85 178.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.481 . . . . 1.23 111.956 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.52 -52.86 0.76 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.454 -0.793 . . . . 0.71 111.556 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -78.06 -72.52 0.36 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.558 -0.534 . . . . 2.35 109.558 174.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.4 tp -168.07 128.49 1.33 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.753 -0.658 . . . . 0.71 110.931 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.968 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.9 t -104.41 114.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.703 0.763 . . . . 0.4 109.725 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -103.6 145.07 30.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.464 -0.789 . . . . 1.09 111.854 -171.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.562 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 38.5 mm -128.6 102.98 8.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 107.873 -1.158 . . . . 0.54 107.873 169.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.535 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -114.91 138.48 50.76 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 120.304 -0.559 . . . . 0.64 111.859 -173.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.2 mm? -116.42 144.2 32.65 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.517 -0.765 . . . . 0.85 109.178 174.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.546 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 42.6 Cg_endo -85.73 13.26 2.8 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 C-N-CA 122.992 2.462 . . . . 0.35 111.858 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.549 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . 12.2 t 69.34 -65.6 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.9 0.75 . . . . 0.91 111.225 -178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' ND2' ' HE3' ' A' ' 7' ' ' LYS . 2.8 m-80 58.95 77.09 0.41 Allowed Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.285 0.634 . . . . 1.39 109.832 -175.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.746 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 79.4 Cg_exo -52.91 105.03 0.11 Allowed 'Trans proline' 0 CA--C 1.517 -0.333 0 C-N-CA 123.495 2.797 . . . . 0.83 113.741 -166.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.413 HG23 ' CE2' ' A' ' 89' ' ' TYR . 70.2 p -83.4 -53.49 5.68 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.816 -1.083 . . . . 1.83 109.667 175.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.0 t -179.52 -136.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.686 -1.227 . . . . 2.36 107.686 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.48 -25.61 65.35 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.078 -0.582 . . . . 1.3 113.176 176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.591 ' HA ' ' O ' ' A' ' 90' ' ' MET . 3.6 m-30 -53.3 150.32 6.4 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.123 0.487 . . . . 2.22 112.027 176.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -150.01 163.97 36.73 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.226 -0.897 . . . . 0.44 109.093 172.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.549 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.5 m95 -83.6 123.44 29.79 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.216 0.532 . . . . 0.43 111.505 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.881 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -158.32 147.58 19.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.459 -0.791 . . . . 2.78 109.296 173.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.6 m-85 -45.31 -68.9 0.16 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.232 0.456 . . . . 0.43 112.232 -173.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' ' OG1' ' A' ' 42' ' ' THR . 7.1 pt-20 -130.34 18.84 5.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.082 0.468 . . . . 2.39 110.79 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 100.27 91.64 2.08 Favored Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.561 -0.828 . . . . 0.73 113.128 174.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.89 -3.35 80.22 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.804 -0.712 . . . . 0.7 112.388 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.635 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -128.3 142.76 51.04 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 120.91 0.386 . . . . 1.13 111.663 -177.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.778 ' H ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -144.22 133.9 23.62 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.237 -0.892 . . . . 2.52 111.097 173.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.71 160.25 33.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.353 -0.385 . . . . 2.3 110.086 172.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.926 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 31.0 t -125.73 138.54 32.16 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.323 -0.621 . . . . 1.61 109.323 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.544 ' HD2' ' CD2' ' A' ' 83' ' ' HIS . 32.1 Cg_exo -58.72 129.42 32.19 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.396 2.064 . . . . 1.88 111.006 176.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 46' ' ' PRO . 92.0 m-20 72.37 42.87 0.52 Allowed 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.05 0.844 . . . . 2.43 110.629 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -83.73 33.67 0.48 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.859 -0.609 . . . . 3.26 111.602 -179.119 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.1 m -67.67 -64.11 0.92 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.264 0.554 . . . . 2.06 110.176 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.668 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -107.36 -33.43 7.38 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.583 -0.735 . . . . 1.25 110.594 -177.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.739 ' HB3' ' O ' ' A' ' 76' ' ' THR . 5.0 m-85 -104.83 165.24 11.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.049 -0.978 . . . . 0.74 108.729 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 t -159.35 170.29 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.066 -0.654 . . . . 1.46 112.309 -166.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.926 ' HB ' ' HB2' ' A' ' 45' ' ' SER . 2.5 p -99.86 126.21 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.522 -0.763 . . . . 1.31 110.319 -176.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -111.26 125.06 53.42 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.131 -0.94 . . . . 2.45 108.867 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.77 152.94 21.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.299 0.571 . . . . 1.93 111.463 -172.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.82 ' HD2' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -164.9 114.48 1.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.222 -0.899 . . . . 1.42 109.333 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 1.1 m-85 -120.88 156.37 32.15 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.168 -0.613 . . . . 1.66 110.127 -175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -147.16 100.65 3.87 Favored Pre-proline 0 N--CA 1.433 -1.308 0 CA-C-N 115.837 -0.62 . . . . 2.14 110.8 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -66.99 154.08 75.8 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.735 2.29 . . . . 1.92 110.301 170.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -35.2 111.56 0.07 OUTLIER 'Trans proline' 0 CA--C 1.511 -0.639 0 C-N-CA 124.456 3.437 . . . . 2.64 114.998 -176.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 62' ' ' SER . 5.2 p-10 -84.07 -80.15 0.2 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.334 -1.757 . . . . 5.8 110.784 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.567 ' H ' ' CG ' ' A' ' 61' ' ' ASP . 33.4 t -179.95 -39.39 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.13 -0.941 . . . . 7.43 110.681 -176.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -125.08 -27.62 3.52 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.184 0.809 . . . . 8.71 113.184 -171.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.603 ' N ' ' HD3' ' A' ' 63' ' ' LYS . 4.5 tt -61.23 -51.06 70.54 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 107.713 -1.217 . . . . 8.1 107.713 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.531 HD22 HD22 ' A' ' 64' ' ' LEU . 1.7 pt? -156.54 -51.91 0.08 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.599 -0.728 . . . . 4.74 111.507 163.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.1 -35.55 1.28 Allowed Glycine 0 C--N 1.317 -0.52 0 C-N-CA 121.084 -0.579 . . . . 3.02 112.228 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 65' ' ' LEU . . . -52.89 -57.98 8.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.297 0.57 . . . . 4.02 111.126 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.746 ' HA2' ' HD3' ' A' ' 30' ' ' PRO . . . -116.56 -49.52 0.43 Allowed Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.466 -0.788 . . . . 2.84 112.34 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.526 ' H ' HD11 ' A' ' 65' ' ' LEU . . . 116.53 -167.69 12.58 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.291 -0.957 . . . . 1.49 110.829 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.64 84.82 0.62 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.406 0.521 . . . . 0.97 112.406 -172.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 35.4 mt-10 -104.15 109.44 21.25 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.285 -0.635 . . . . 0.81 109.285 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.82 ' HB2' ' HD2' ' A' ' 56' ' ' LYS . 2.1 m170 -110.89 148.92 31.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.674 0.749 . . . . 0.53 111.899 -171.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.881 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 27.0 m-85 -118.82 109.12 15.67 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.284 -1.325 . . . . 1.13 108.864 171.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -103.53 107.33 18.13 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.893 -0.41 . . . . 0.5 109.893 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.599 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 2.4 m -103.31 118.82 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 122.453 1.12 . . . . 0.87 109.19 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.739 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 20.8 m -102.75 104.26 14.55 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 107.807 -1.182 . . . . 0.46 107.807 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.552 ' HA ' ' HB3' ' A' ' 51' ' ' PHE . 3.3 p -146.59 140.37 20.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 1.04 110.262 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HA ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.23 102.22 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.821 0.82 . . . . 1.54 109.868 171.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.83 167.27 17.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.93 -1.032 . . . . 0.67 108.58 -177.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.797 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -99.69 89.61 4.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.184 0.516 . . . . 0.44 110.506 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -153.1 168.1 31.86 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.123 -0.791 . . . . 0.29 111.123 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.2 m -101.89 134.17 45.5 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.594 0.697 . . . . 0.4 109.609 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 85' ' ' VAL . 30.1 t-80 -104.4 104.64 14.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.668 -0.696 . . . . 0.4 109.684 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.76 109.7 21.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.562 -0.533 . . . . 0.35 109.562 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 83' ' ' HIS . 1.1 t -105.55 104.61 17.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.827 -0.624 . . . . 0.59 111.235 -170.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.502 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.28 103.51 12.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.084 -0.71 . . . . 1.53 109.084 174.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.61 128.44 52.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.269 -0.641 . . . . 0.24 109.269 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 102' ' ' ARG . 9.0 m -102.6 137.09 41.28 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.673 0.749 . . . . 0.29 110.922 -170.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.413 ' CE2' HG23 ' A' ' 31' ' ' THR . 0.8 OUTLIER -103.78 90.05 3.51 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.919 -1.037 . . . . 1.11 109.6 -175.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.591 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 5.0 mtm -132.62 173.46 11.31 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 110.024 -0.361 . . . . 0.65 110.024 -175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 18.9 mtt180 -82.07 114.01 47.63 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 2.59 109.444 170.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.88 -35.15 39.26 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 123.537 2.825 . . . . 1.04 114.133 -172.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -85.14 2.02 45.37 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.738 0.273 . . . . 1.17 111.738 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 95' ' ' GLY . 3.1 t -170.88 -74.38 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.583 -0.28 . . . . 1.09 111.24 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.777 ' H ' HG23 ' A' ' 94' ' ' THR . . . 80.83 108.08 0.31 Allowed Glycine 0 C--N 1.333 0.398 0 N-CA-C 110.431 -1.068 . . . . 1.16 110.431 -175.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.809 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 10.3 Cg_exo -73.51 40.82 0.56 Allowed 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.741 2.961 . . . . 1.2 113.558 -172.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.7 t 44.22 -85.52 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.393 1.077 . . . . 2.64 112.625 176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.7 -21.39 66.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.263 -0.426 . . . . 4.09 110.748 -177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.809 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 21.7 t0 -92.62 3.92 54.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.542 0.687 . . . . 1.67 110.211 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 7.1 m -95.52 144.92 25.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.483 -0.78 . . . . 1.39 110.626 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.91 178.19 5.03 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.7 -0.852 . . . . 1.91 108.7 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 56.3 ttt180 -161.12 144.51 12.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.524 0.678 . . . . 0.62 110.625 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.731 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -104.45 156.29 18.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.709 -1.132 . . . . 0.86 109.198 179.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.665 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 99.4 m -157.66 103.47 1.92 Allowed 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.625 -0.43 . . . . 0.31 111.375 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.944 HG11 HG21 ' A' ' 5' ' ' VAL . 11.7 p -108.63 136.84 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 119.617 -0.833 . . . . 0.88 109.993 168.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 13' ' ' THR . 97.6 m-85 -106.2 103.34 12.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.295 -0.866 . . . . 0.7 108.732 173.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.696 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -126.19 150.89 48.01 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.198 -0.667 . . . . 2.12 109.198 177.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.817 ' O ' HG22 ' A' ' 16' ' ' VAL . 48.4 tttm -102.78 119.77 39.43 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.376 -0.601 . . . . 1.89 109.376 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -99.94 115.68 30.24 Favored 'General case' 0 CA--C 1.509 -0.607 0 O-C-N 123.928 0.768 . . . . 0.53 109.725 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.797 ' HB3' ' HA ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-N 114.718 -1.128 . . . . 1.78 110.569 -171.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.929 ' HB3' HG22 ' A' ' 22' ' ' VAL . 17.1 t60 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.408 -0.96 . . . . 0.59 108.408 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 58.5 pttt -135.67 151.47 50.23 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.884 0.373 . . . . 2.36 111.021 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.839 HG21 HG11 ' A' ' 105' ' ' VAL . 2.1 t -122.43 155.22 27.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.114 0.483 . . . . 0.49 111.046 175.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 7.2 p -143.67 170.55 15.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.922 -1.036 . . . . 0.51 108.67 -173.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 24.9 tptp -48.28 -38.16 18.12 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.573 0.582 . . . . 0.83 112.573 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.31 79.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.883 0.849 . . . . 0.33 111.073 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.77 ' HB2' HG13 ' A' ' 5' ' ' VAL . 32.9 m80 -63.9 -2.93 2.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.951 -1.022 . . . . 2.12 111.346 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.733 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 15.5 t-20 -49.93 -19.6 0.73 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.257 0.623 . . . . 1.41 110.685 172.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.87 48.61 0.92 Allowed Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.296 -0.722 . . . . 0.3 111.296 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.92 ' HB3' HG23 ' A' ' 105' ' ' VAL . . . -112.54 154.92 25.2 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.875 0.694 . . . . 0.32 112.875 -173.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 41.3 m -147.9 104.38 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.271 -0.877 . . . . 0.95 109.062 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.571 HD11 ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -141.81 167.93 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.141 0.496 . . . . 3.0 111.618 -171.254 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.9 m -101.59 139.03 37.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.599 -0.728 . . . . 1.73 109.897 174.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 108' ' ' LYS . 2.5 m -127.46 162.87 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.252 0.549 . . . . 0.78 112.137 -175.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.19 120.64 38.9 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.452 -0.944 . . . . 0.76 108.452 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.795 HG12 ' H ' ' A' ' 19' ' ' GLY . 2.2 t -105.73 -156.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.166 -0.679 . . . . 1.23 109.166 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.795 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 108.67 -49.04 0.88 Allowed Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.667 -0.973 . . . . 0.71 110.667 -175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -79.62 -73.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.086 -0.709 . . . . 2.35 109.086 171.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.8 tp -166.88 145.14 5.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.346 -0.843 . . . . 0.71 109.367 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.929 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.8 t -122.63 111.71 31.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.568 0.699 . . . . 0.4 109.641 171.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.676 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -104.83 139.73 39.16 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.55 0.69 . . . . 1.09 110.918 -173.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 85' ' ' VAL . 47.1 mm -117.34 101.48 12.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.932 -1.136 . . . . 0.54 107.932 172.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.507 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.61 142.95 34.46 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.243 0.544 . . . . 0.64 111.211 -172.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' N ' ' HG2' ' A' ' 25' ' ' GLN . 3.7 mt -128.44 138.15 32.44 Favored Pre-proline 0 N--CA 1.425 -1.69 0 CA-C-O 121.546 0.689 . . . . 0.85 111.079 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.521 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 85.3 Cg_endo -78.78 8.66 3.61 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 123.035 2.49 . . . . 0.35 112.068 -175.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.653 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 13.7 t 69.37 -57.81 0.52 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 123.712 0.632 . . . . 0.91 110.165 -174.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' OD1' ' HG2' ' A' ' 27' ' ' PRO . 1.2 m-80 52.54 63.46 8.79 Favored Pre-proline 0 C--N 1.317 -0.813 0 N-CA-C 108.051 -1.092 . . . . 1.39 108.051 -172.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.806 ' HB3' ' HA ' ' A' ' 62' ' ' SER . 48.3 Cg_exo -44.94 125.67 6.87 Favored 'Trans proline' 0 CA--C 1.515 -0.456 0 C-N-CA 124.136 3.224 . . . . 0.83 114.486 -165.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.444 HG23 ' CE2' ' A' ' 89' ' ' TYR . 4.1 t -157.6 96.8 1.55 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.605 -1.179 . . . . 1.83 110.433 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 33' ' ' GLY . 16.3 m 73.22 176.25 0.26 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.746 -0.661 . . . . 2.36 110.102 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.554 ' H ' HG22 ' A' ' 32' ' ' THR . . . -59.05 -8.71 6.39 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.539 -0.362 . . . . 1.3 113.926 178.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.629 ' HA ' ' C ' ' A' ' 90' ' ' MET . 6.3 m-85 -55.06 154.68 5.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 2.22 111.779 176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 89' ' ' TYR . . . -154.83 154.21 32.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.489 -0.56 . . . . 0.44 109.489 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.653 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 97.7 m95 -76.52 111.28 11.83 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.9 0.381 . . . . 0.43 110.944 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.853 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 10.1 p90 -149.25 146.26 27.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 2.78 109.575 170.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 42' ' ' THR . 1.7 m-85 -44.86 -78.28 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.947 1.092 . . . . 0.43 113.947 -169.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -118.22 -10.57 10.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.3 -0.56 . . . . 2.39 111.621 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.782 ' HA2' ' CE1' ' A' ' 37' ' ' TYR . . . 138.87 92.37 0.25 Allowed Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 119.937 -1.125 . . . . 0.73 113.039 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.07 15.51 65.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.843 -0.694 . . . . 0.7 111.865 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.593 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -138.63 144.16 39.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-N 115.462 -0.369 . . . . 1.13 111.502 -176.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -140.28 131.34 26.3 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.55 -0.75 . . . . 2.52 111.285 171.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -141.16 160.49 40.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.715 -0.675 . . . . 2.3 110.324 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.643 ' HB2' HG23 ' A' ' 53' ' ' VAL . 13.3 t -104.54 134.89 19.44 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.48 -0.933 . . . . 1.61 108.48 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -68.53 41.59 0.26 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.433 2.755 . . . . 1.88 113.262 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 177.33 41.14 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.84 -1.17 . . . . 2.43 107.84 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -80.58 45.07 0.75 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.603 -0.726 . . . . 3.26 111.714 -173.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.0 m -74.9 -41.06 60.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.013 0.435 . . . . 2.06 111.003 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.661 ' HG2' ' HD1' ' A' ' 51' ' ' PHE . 0.0 OUTLIER -134.86 -21.3 1.69 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.329 0.585 . . . . 1.25 110.668 -177.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 76' ' ' THR . 3.7 m-85 -124.24 162.47 23.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.223 -0.898 . . . . 0.74 109.662 -175.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.4 t -152.69 170.6 19.86 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.786 0.661 . . . . 1.46 112.786 -160.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.643 HG23 ' HB2' ' A' ' 45' ' ' SER . 46.5 t -99.84 123.85 52.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.542 -0.753 . . . . 1.31 111.175 -176.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.21 117.82 34.98 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.281 -0.872 . . . . 2.45 108.71 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -104.2 150.19 24.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.852 0.358 . . . . 1.93 111.438 -171.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.581 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -156.19 116.0 3.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.945 -0.57 . . . . 1.42 109.837 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.797 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 9.6 m-85 -113.79 136.05 53.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.479 -0.328 . . . . 1.66 111.258 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -130.64 101.29 17.21 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.32 -0.4 . . . . 2.14 109.969 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.494 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 3.8 Cg_exo -82.18 136.88 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 123.199 2.599 . . . . 1.92 111.641 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.669 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 92.5 Cg_endo -91.08 -16.38 1.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.912 2.408 . . . . 2.64 113.06 -177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -176.39 -41.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.025 0.44 . . . . 5.8 110.483 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.806 ' HA ' ' HB3' ' A' ' 30' ' ' PRO . 16.2 m 74.86 -50.83 0.67 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.918 -1.037 . . . . 7.43 112.63 174.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.41 5.68 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.798 -0.361 . . . . 8.71 111.588 178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.411 ' HB3' ' H ' ' A' ' 65' ' ' LEU . 3.7 tt -166.52 -88.52 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.263 0 N-CA-C 109.854 -0.425 . . . . 8.1 109.854 175.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.709 HD12 ' HD2' ' A' ' 30' ' ' PRO . 0.2 OUTLIER -179.95 140.02 0.13 Allowed 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.473 -0.565 . . . . 4.74 109.473 -179.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.669 ' HA3' ' HB2' ' A' ' 60' ' ' PRO . . . -104.67 -18.22 13.24 Favored Glycine 0 C--O 1.234 0.11 0 C-N-CA 120.901 -0.666 . . . . 3.02 111.656 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 174.45 -42.67 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 4.02 107.694 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.86 -57.56 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.233 -1.349 . . . . 2.84 110.8 173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.32 155.35 10.16 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.987 -0.845 . . . . 1.49 110.987 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.74 80.44 1.22 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.556 0.693 . . . . 0.97 112.58 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.797 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 34.9 mt-10 -105.45 103.59 13.14 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.458 -0.942 . . . . 0.81 108.458 175.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.581 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -108.59 159.19 16.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.814 0.816 . . . . 0.53 111.499 -171.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.853 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 28.4 m-85 -122.47 108.54 13.29 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 113.909 -1.496 . . . . 1.13 109.018 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.676 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 31.9 m170 -102.31 110.74 22.78 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.515 -0.55 . . . . 0.5 109.515 -176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.636 HG12 HG22 ' A' ' 53' ' ' VAL . 3.3 m -102.18 120.06 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.58 1.181 . . . . 0.87 109.219 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.737 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 13.9 m -103.09 103.61 13.7 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 107.318 -1.364 . . . . 0.46 107.318 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.579 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.1 p -160.4 118.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.396 0.435 . . . . 1.04 111.259 -177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -116.45 104.0 11.0 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.174 0.988 . . . . 1.54 109.869 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.65 143.26 5.74 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.653 -1.158 . . . . 0.67 109.737 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.84 96.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.274 0.559 . . . . 0.44 111.107 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -165.32 166.16 38.19 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.175 -1.17 . . . . 0.29 110.175 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 1.6 m -101.62 132.7 47.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 117.808 0.804 . . . . 0.4 109.382 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.688 ' HD1' HG22 ' A' ' 85' ' ' VAL . 44.8 t-80 -103.84 104.95 15.02 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.494 -0.775 . . . . 0.4 109.786 -173.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.23 113.76 27.1 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.374 0.607 . . . . 0.35 109.623 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 104' ' ' THR . 2.3 t -105.96 103.93 16.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.666 -0.697 . . . . 0.59 111.2 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -105.45 103.71 13.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.289 -0.634 . . . . 1.53 109.289 173.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' HG ' HG12 ' A' ' 85' ' ' VAL . 78.0 mt -107.01 123.82 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.51 -0.552 . . . . 0.24 109.51 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.513 HG22 ' CG ' ' A' ' 90' ' ' MET . 3.3 m -105.86 119.96 40.51 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.24 0.543 . . . . 0.29 112.002 -169.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.662 ' HA ' ' O ' ' A' ' 35' ' ' ALA . 28.0 t80 -88.05 85.31 6.95 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.496 -0.774 . . . . 1.11 109.38 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.665 ' HE2' ' HE1' ' A' ' 37' ' ' TYR . 20.7 mtm -124.34 167.13 14.77 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 116.443 -0.344 . . . . 0.65 110.299 -178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.455 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.4 ttt180 -78.65 108.67 8.47 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.792 -0.818 . . . . 2.59 108.792 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.584 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 5.8 Cg_endo -46.93 -32.24 12.42 Favored 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.546 2.831 . . . . 1.04 115.459 -167.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.584 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 41.3 p90 -96.92 11.73 34.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.684 0.624 . . . . 1.17 112.684 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.412 HG23 ' HD3' ' A' ' 96' ' ' PRO . 5.3 t -168.63 -50.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.87 0.322 . . . . 1.09 111.87 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 51.48 80.56 0.06 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 O-C-N 123.303 0.377 . . . . 1.16 112.361 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.878 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 92.4 Cg_exo -40.31 105.83 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.148 2.565 . . . . 1.2 111.218 174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.1 m -54.91 125.31 19.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.831 -0.622 . . . . 2.64 111.117 -174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 77.03 -2.27 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.406 -0.815 . . . . 4.09 111.216 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.878 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 26.4 t0 -97.13 -27.34 14.61 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.941 0.877 . . . . 1.67 108.668 177.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.512 ' CB ' ' HG2' ' A' ' 90' ' ' MET . 12.4 m -68.24 157.08 36.29 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.071 -1.422 . . . . 1.39 110.846 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 7.1 tp10 -96.51 161.13 14.04 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.559 -0.904 . . . . 1.91 108.559 176.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.421 ' HG3' ' HA ' ' A' ' 88' ' ' THR . 31.5 ttt180 -148.83 139.96 23.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.432 0.634 . . . . 0.62 110.315 177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.774 ' CZ ' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -104.22 155.86 18.38 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.86 109.208 -179.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 70.5 m -157.15 102.76 1.97 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.73 -0.388 . . . . 0.31 111.161 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.92 HG23 ' HB3' ' A' ' 12' ' ' ALA . 10.7 p -105.63 136.2 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.639 -0.824 . . . . 0.88 110.014 168.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' THR . 88.4 m-85 -104.71 104.64 14.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.443 -0.799 . . . . 0.7 109.047 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.663 ' HG ' ' HB3' ' A' ' 83' ' ' HIS . 2.0 pp -123.01 147.68 46.38 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.374 -0.602 . . . . 2.12 109.374 -178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 16' ' ' VAL . 38.5 tttt -103.27 115.3 30.29 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.377 -0.529 . . . . 1.89 110.557 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.405 ' HA ' ' CG2' ' A' ' 16' ' ' VAL . . . -101.19 153.56 19.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.952 -0.567 . . . . 0.53 110.775 -169.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.557 ' H ' HG23 ' A' ' 18' ' ' VAL . 4.7 p30 . . . . . 0 C--O 1.244 0.785 0 CA-C-N 115.242 -0.89 . . . . 1.78 108.891 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.954 ' HB3' HG22 ' A' ' 22' ' ' VAL . 6.8 t60 . . . . . 0 N--CA 1.446 -0.643 0 N-CA-C 109.222 -0.659 . . . . 0.59 109.222 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -141.82 130.05 22.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.283 0.364 . . . . 2.36 111.286 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.752 HG11 ' CZ ' ' A' ' 103' ' ' PHE . 2.0 t -104.72 157.7 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.873 0.368 . . . . 0.49 110.462 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 9' ' ' HIS . 1.0 OUTLIER -144.81 170.2 16.58 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.171 0.989 . . . . 0.51 108.904 -173.186 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.428 ' HB2' ' CD ' ' A' ' 27' ' ' PRO . 16.5 tptm -46.9 -43.85 19.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.031 0.752 . . . . 0.83 113.031 -175.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.2 70.98 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.941 0.877 . . . . 0.33 110.974 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.75 ' HB2' HG13 ' A' ' 5' ' ' VAL . 24.4 m80 -62.57 -4.02 1.76 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.928 . . . . 2.12 111.438 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.688 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 2.7 t-20 -45.84 -22.29 0.18 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 1.41 110.422 172.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -135.65 54.95 0.73 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.904 -0.665 . . . . 0.3 111.726 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.577 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . . . -117.38 146.26 43.54 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.157 0.799 . . . . 0.32 113.157 -175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 36.9 m -141.24 111.19 6.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.433 -0.803 . . . . 0.95 109.779 171.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.669 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 4.0 pp -166.64 171.66 11.41 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.148 0.179 . . . . 3.0 110.937 -173.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.7 m -99.17 143.65 29.2 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.106 0.479 . . . . 1.73 111.674 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 108' ' ' LYS . 4.0 m -119.08 160.24 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.668 -0.697 . . . . 0.78 111.624 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.49 135.99 44.88 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.213 -0.662 . . . . 0.76 109.213 172.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 77' ' ' VAL . 24.3 m -121.5 -166.56 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.962 0.411 . . . . 1.23 111.773 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.718 ' HA2' ' HB3' ' A' ' 78' ' ' LYS . . . 108.95 -56.65 0.46 Allowed Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 111.29 -0.724 . . . . 0.71 111.29 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -75.42 -71.99 0.33 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.955 -0.757 . . . . 2.35 108.955 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -166.95 141.3 3.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.593 -0.73 . . . . 0.71 110.184 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.954 HG22 ' HB3' ' A' ' 3' ' ' HIS . 1.4 t -120.57 116.7 50.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.526 -0.546 . . . . 0.4 109.526 173.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.733 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 7.1 pt-20 -114.78 149.23 37.28 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.663 -0.815 . . . . 1.09 112.225 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.532 HD13 ' HB ' ' A' ' 5' ' ' VAL . 44.3 mm -124.13 102.51 11.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.69 -1.141 . . . . 0.54 108.681 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -105.96 141.82 36.7 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 121.561 -0.712 . . . . 0.64 112.46 -172.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 36' ' ' TRP . 4.1 mm? -116.73 147.48 39.99 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.25 -0.886 . . . . 0.85 109.403 171.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.428 ' CD ' ' HB2' ' A' ' 7' ' ' LYS . 43.1 Cg_endo -85.98 11.62 3.27 Favored 'Trans proline' 0 CA--C 1.515 -0.467 0 C-N-CA 122.883 2.389 . . . . 0.35 111.52 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' ' HG3' ' A' ' 71' ' ' GLU . 30.4 t 70.84 -51.45 0.68 Allowed 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.399 -0.818 . . . . 0.91 111.118 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.4 67.36 2.18 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.008 -0.738 . . . . 1.39 109.008 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.18 97.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.439 2.759 . . . . 0.83 112.618 -168.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.426 HG22 ' CE2' ' A' ' 89' ' ' TYR . 1.3 t -105.11 -39.44 6.21 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.29 -0.868 . . . . 1.83 111.353 -176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 34' ' ' PHE . 9.0 t -178.21 -150.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.951 -0.759 . . . . 2.36 108.951 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.76 -23.36 55.66 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 121.71 -0.281 . . . . 1.3 113.349 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.571 ' HA ' ' C ' ' A' ' 90' ' ' MET . 14.3 m-30 -46.01 137.19 6.02 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.212 0.529 . . . . 2.22 112.123 172.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.501 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -141.96 149.94 40.77 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.34 -0.985 . . . . 0.44 108.34 171.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.594 ' HD1' ' HA ' ' A' ' 28' ' ' SER . 95.2 m95 -77.04 117.81 18.98 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.568 0.699 . . . . 0.43 111.141 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 47.0 m-85 -126.03 -179.59 4.77 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.186 -1.042 . . . . 2.78 108.186 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 42' ' ' THR . 2.8 m-85 -73.2 -82.07 0.05 Allowed 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.818 -0.753 . . . . 0.43 109.505 167.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -109.76 10.09 24.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.052 0.453 . . . . 2.39 110.144 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 98.26 105.76 2.51 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.835 -0.698 . . . . 0.73 112.225 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.0 3.3 59.98 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.892 -0.671 . . . . 0.7 111.966 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -129.98 142.61 50.61 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.454 -0.373 . . . . 1.13 111.566 -177.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' HA ' ' CD2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -142.61 129.15 20.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.938 -0.573 . . . . 2.52 110.835 166.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.35 137.41 34.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.726 -0.67 . . . . 2.3 110.14 177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.883 ' HB2' HG23 ' A' ' 52' ' ' THR . 15.4 m -104.4 138.7 19.59 Favored Pre-proline 0 N--CA 1.445 -0.691 0 CA-C-O 121.24 0.543 . . . . 1.61 110.714 171.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 9.8 Cg_endo -93.66 170.05 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.719 3.613 . . . . 1.88 113.493 -168.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.561 ' ND2' ' HA3' ' A' ' 81' ' ' GLY . 59.7 t30 74.67 -36.27 0.32 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.991 0.916 . . . . 2.43 111.107 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.73 ' OE1' ' HG2' ' A' ' 50' ' ' MET . 4.9 mm-40 -109.99 148.34 31.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 122.201 1.001 . . . . 3.26 113.561 -170.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 27.4 t -130.01 -11.85 4.21 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 113.624 -1.626 . . . . 2.06 109.089 173.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.73 ' HG2' ' OE1' ' A' ' 48' ' ' GLU . 19.0 ptt? -97.89 -37.24 9.89 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 120.494 -0.483 . . . . 1.25 110.652 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 76' ' ' THR . 0.2 OUTLIER -147.4 97.01 2.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 118.519 -0.753 . . . . 0.74 110.474 -174.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.883 HG23 ' HB2' ' A' ' 45' ' ' SER . 11.0 t 177.78 93.88 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.627 0.649 . . . . 1.46 111.446 160.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -174.73 142.83 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 122.953 0.501 . . . . 1.31 111.235 162.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 7.9 tp10 -168.76 154.31 6.42 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.959 -0.756 . . . . 2.45 108.959 167.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.7 139.68 25.37 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.171 0.51 . . . . 1.93 111.858 178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.689 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -163.02 103.87 1.0 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.581 -0.736 . . . . 1.42 110.474 175.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.749 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 0.2 OUTLIER -124.81 125.11 43.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.699 -0.682 . . . . 1.66 111.495 -177.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.661 ' HB3' HD21 ' A' ' 64' ' ' LEU . 86.9 m-85 -134.04 113.39 12.54 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.414 -0.812 . . . . 2.14 111.078 -176.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.7 167.62 13.23 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.211 2.607 . . . . 1.92 112.39 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.512 ' HG3' ' C ' ' A' ' 68' ' ' GLY . 83.0 Cg_exo -49.92 173.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.859 3.04 . . . . 2.64 115.549 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -162.01 -94.84 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 113.416 -1.72 . . . . 5.8 108.117 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 74.9 m -165.81 -51.36 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.868 -1.06 . . . . 7.43 108.155 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.736 ' HD2' ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -90.69 -27.63 18.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.84 -0.618 . . . . 8.71 110.686 177.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.736 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 41.1 tp -64.08 -55.53 21.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.371 0.605 . . . . 8.1 109.668 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.823 HD12 ' H ' ' A' ' 68' ' ' GLY . 0.3 OUTLIER -151.05 -54.59 0.14 Allowed 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.459 -0.941 . . . . 4.74 108.459 174.789 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.64 -59.77 4.64 Favored Glycine 0 C--N 1.322 -0.236 0 CA-C-N 114.678 -1.146 . . . . 3.02 112.677 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.91 -64.56 0.82 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.728 0.775 . . . . 4.02 109.981 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.823 ' H ' HD12 ' A' ' 65' ' ' LEU . . . -121.24 -159.36 10.69 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.942 -1.263 . . . . 2.84 109.942 173.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.78 -159.85 22.76 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.411 -0.899 . . . . 1.49 111.111 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.25 80.64 0.83 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.436 0.636 . . . . 0.97 111.265 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.749 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 40.4 mt-10 -104.44 103.23 12.9 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.457 -0.792 . . . . 0.81 109.01 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.689 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -108.26 145.71 33.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 119.685 -0.806 . . . . 0.53 110.973 -174.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 37' ' ' TYR . 6.5 m-85 -117.47 109.64 17.01 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.619 -1.173 . . . . 1.13 109.736 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.733 ' CD2' ' HB2' ' A' ' 23' ' ' GLU . 18.1 m170 -103.54 149.92 24.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.715 -0.476 . . . . 0.5 109.715 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.563 HG22 HG12 ' A' ' 22' ' ' VAL . 3.5 m -132.95 126.93 54.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-O 121.882 0.848 . . . . 0.87 108.902 173.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.665 HG22 ' CE2' ' A' ' 51' ' ' PHE . 3.7 m -102.39 101.36 11.58 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.452 -0.944 . . . . 0.46 108.452 -175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 3.8 p -144.14 145.88 21.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.503 -0.479 . . . . 1.04 112.074 -167.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.718 ' HB3' ' HA2' ' A' ' 19' ' ' GLY . 0.5 OUTLIER -138.91 103.48 4.81 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.55 -0.907 . . . . 1.54 108.55 163.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 110' ' ' ASN . . . -165.31 164.92 19.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.462 -0.79 . . . . 0.67 109.597 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.58 86.95 2.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.44 109.998 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.561 ' HA3' ' ND2' ' A' ' 47' ' ' ASN . . . -158.05 167.92 34.44 Favored Glycine 0 CA--C 1.502 -0.762 0 CA-C-N 115.42 -0.809 . . . . 0.29 111.184 -175.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 108' ' ' LYS . 6.1 m -100.23 132.6 45.51 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 119.817 -0.753 . . . . 0.4 109.908 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.667 ' ND1' HG22 ' A' ' 85' ' ' VAL . 48.2 t-80 -103.5 103.82 13.82 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.753 -0.658 . . . . 0.4 109.586 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.17 110.97 23.06 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.957 -0.757 . . . . 0.35 108.957 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.726 HG23 HG12 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -107.44 103.72 15.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.682 -0.69 . . . . 0.59 110.292 -171.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.511 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -108.22 103.6 12.82 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.917 -0.771 . . . . 1.53 108.917 176.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 38' ' ' PHE . 63.7 mt -107.35 123.99 49.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.641 -0.709 . . . . 0.24 109.666 -177.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.48 HG22 ' CG ' ' A' ' 90' ' ' MET . 4.4 m -102.15 119.8 39.4 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.871 0.844 . . . . 0.29 110.688 -173.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.501 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 7.4 t80 -89.3 88.37 7.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.503 -1.226 . . . . 1.11 109.676 -175.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.571 ' C ' ' HA ' ' A' ' 34' ' ' PHE . 14.1 mtm -129.22 166.43 19.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.245 0.545 . . . . 0.65 111.051 -172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.433 ' N ' ' HD1' ' A' ' 34' ' ' PHE . 2.3 mtm180 -70.04 107.39 2.31 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.859 -1.064 . . . . 2.59 108.786 168.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HG2' ' CE3' ' A' ' 93' ' ' TRP . 9.5 Cg_endo -51.63 -27.0 24.38 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.335 2.69 . . . . 1.04 114.655 -169.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.456 ' CE3' ' HG2' ' A' ' 92' ' ' PRO . 45.7 p90 -93.46 3.89 54.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.0 0.37 . . . . 1.17 112.0 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 95' ' ' GLY . 2.3 t -164.06 -66.99 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.834 -0.166 . . . . 1.09 111.14 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.681 ' H ' HG23 ' A' ' 94' ' ' THR . . . 67.53 94.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 112.012 -0.435 . . . . 1.16 112.012 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.975 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 15.8 Cg_exo -64.92 130.03 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.607 2.205 . . . . 1.2 111.11 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.8 t -43.75 -50.32 7.73 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.955 0.902 . . . . 2.64 113.018 -170.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -121.65 20.79 10.99 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.522 -0.471 . . . . 4.09 111.029 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.975 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 28.7 t0 -103.99 -22.18 13.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.412 -0.958 . . . . 1.67 108.412 175.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB3' ' HG2' ' A' ' 90' ' ' MET . 16.3 m -80.0 148.22 31.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.614 -1.175 . . . . 1.39 110.561 178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.84 172.87 7.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.096 -1.076 . . . . 1.91 108.096 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 86' ' ' ASN . 26.6 ttt180 -158.48 139.01 12.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.407 0.623 . . . . 0.62 110.361 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.773 ' CZ ' ' HB ' ' A' ' 105' ' ' VAL . 0.8 OUTLIER -103.76 155.88 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.875 -1.057 . . . . 0.86 109.069 -178.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 24.3 m -157.36 104.56 2.04 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 120.881 0.372 . . . . 0.31 110.972 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.773 ' HB ' ' CZ ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -103.81 132.5 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 119.769 -0.772 . . . . 0.88 109.592 168.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.689 ' O ' HD12 ' A' ' 107' ' ' LEU . 73.1 m-85 -108.06 97.42 7.12 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.628 -1.249 . . . . 0.7 107.628 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 106' ' ' TYR . 8.9 mp -134.21 144.78 48.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.288 -0.634 . . . . 2.12 109.288 -173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 16' ' ' VAL . 35.5 ttpt -102.81 130.98 49.98 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.129 -0.628 . . . . 1.89 110.946 -166.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.588 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.06 132.37 45.46 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.609 -0.723 . . . . 0.53 109.566 -171.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.598 ' C ' HG22 ' A' ' 18' ' ' VAL . 6.2 p30 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.469 -0.777 . . . . 1.78 110.386 -176.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 1.015 ' HB3' HG22 ' A' ' 22' ' ' VAL . 33.3 t60 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.385 -0.598 . . . . 0.59 109.385 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -138.91 134.15 32.84 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.266 -0.642 . . . . 2.36 109.266 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -107.49 125.81 63.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 119.5 -0.88 . . . . 0.49 110.685 178.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.474 ' C ' ' ND1' ' A' ' 9' ' ' HIS . 0.7 OUTLIER -120.99 152.09 38.97 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 112.122 0.416 . . . . 0.51 112.122 -176.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HB2' ' HG3' ' A' ' 27' ' ' PRO . 27.0 tptp -31.17 -45.65 0.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.252 1.945 . . . . 0.83 116.252 -153.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -43.61 -34.98 1.57 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.311 1.053 . . . . 0.33 111.731 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.935 ' ND1' HG13 ' A' ' 5' ' ' VAL . 2.4 p-80 -55.19 -9.36 0.4 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.126 -1.397 . . . . 2.12 113.159 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -58.14 -15.32 9.24 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 107.633 -1.247 . . . . 1.41 107.633 -174.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -133.91 58.63 0.69 Allowed Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.091 -1.413 . . . . 0.3 110.169 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.891 ' HB2' ' HA ' ' A' ' 9' ' ' HIS . . . -116.09 151.91 34.65 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.752 0.649 . . . . 0.32 112.752 -173.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 23.6 m -149.43 108.45 3.9 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.772 -0.649 . . . . 0.95 109.941 173.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.766 ' O ' ' HA ' ' A' ' 107' ' ' LEU . 2.1 pt? -150.67 166.85 29.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.758 0.313 . . . . 3.0 111.25 -171.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -103.11 144.63 31.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.638 -0.256 . . . . 1.73 110.424 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 108' ' ' LYS . 3.1 m -128.41 156.27 40.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.159 0.504 . . . . 0.78 111.493 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.2 137.73 42.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.338 -0.986 . . . . 0.76 108.338 170.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 HG21 ' A' ' 22' ' ' VAL . 29.5 m -115.74 -178.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 120.664 -0.414 . . . . 1.23 111.424 -177.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.4 -60.59 0.66 Allowed Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 111.272 -0.731 . . . . 0.71 111.272 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -75.2 -72.08 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.339 0.59 . . . . 2.35 109.725 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.4 tp -165.69 133.36 2.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.036 -0.984 . . . . 0.71 110.45 -176.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.015 HG22 ' HB3' ' A' ' 3' ' ' HIS . 2.2 t -119.95 113.0 39.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.368 -0.604 . . . . 0.4 109.368 174.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' CD2' ' A' ' 74' ' ' HIS . 5.2 pt-20 -111.48 157.32 20.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 122.509 1.147 . . . . 1.09 112.985 -173.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.426 HG21 HG11 ' A' ' 85' ' ' VAL . 40.6 mm -126.62 102.69 10.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 CA-C-N 112.889 -1.959 . . . . 0.54 107.405 175.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' HG3' ' CE1' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -114.59 135.17 54.43 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.04 0.924 . . . . 0.64 111.91 -173.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 26' ' ' LEU . 4.4 mm? -112.33 145.32 32.63 Favored Pre-proline 0 N--CA 1.437 -1.078 0 CA-C-N 114.735 -1.12 . . . . 0.85 108.855 174.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 71.4 Cg_endo -82.12 7.08 5.3 Favored 'Trans proline' 0 C--N 1.326 -0.625 0 C-N-CA 122.648 2.232 . . . . 0.35 111.345 178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.627 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 14.9 t 67.77 -64.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.91 109.658 -172.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 61.71 67.98 1.23 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.285 -1.006 . . . . 1.39 108.285 -171.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.717 ' HB3' ' HA ' ' A' ' 62' ' ' SER . 73.1 Cg_exo -53.82 108.83 0.31 Allowed 'Trans proline' 0 CA--C 1.52 -0.177 0 C-N-CA 123.378 2.719 . . . . 0.83 112.813 -169.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -91.87 -37.25 13.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.363 -0.835 . . . . 1.83 111.482 -176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 t -178.22 -44.7 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 111.748 0.277 . . . . 2.36 111.748 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.98 -32.97 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.533 0 N-CA-C 111.436 -0.665 . . . . 1.3 111.436 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.602 ' HE1' ' HD2' ' A' ' 96' ' ' PRO . 31.2 m-85 -43.26 141.49 1.26 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.222 -0.489 . . . . 2.22 111.778 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 89' ' ' TYR . . . -140.17 150.22 43.93 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.847 -1.07 . . . . 0.44 108.438 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 28' ' ' SER . 94.4 m95 -78.83 118.37 20.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.969 0.414 . . . . 0.43 111.01 -177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.822 ' HA ' ' HZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -150.37 145.68 26.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.939 -0.573 . . . . 2.78 109.789 172.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' HB2' ' HA ' ' A' ' 43' ' ' LYS . 1.1 m-85 -46.37 -76.19 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.879 0.696 . . . . 0.43 112.879 -172.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.23 -8.84 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.232 -0.44 . . . . 2.39 110.936 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.686 ' HA2' ' CD1' ' A' ' 37' ' ' TYR . . . 116.75 86.64 1.24 Allowed Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 119.72 -1.228 . . . . 0.73 112.193 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.6 -4.34 74.15 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.149 -0.78 . . . . 0.7 111.149 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.39 137.84 52.07 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.836 -0.431 . . . . 1.13 109.836 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -141.52 139.59 33.28 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.534 -0.543 . . . . 2.52 109.534 178.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -140.3 165.37 27.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.23 0.538 . . . . 2.3 111.487 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.49 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 2.6 p -114.26 140.05 24.56 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.603 -0.726 . . . . 1.61 109.247 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 45' ' ' SER . 2.6 Cg_exo -76.16 -5.59 16.42 Favored 'Trans proline' 0 CA--C 1.529 0.244 0 C-N-CA 122.954 2.436 . . . . 1.88 113.128 -170.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.546 HD22 ' HB3' ' A' ' 79' ' ' ALA . 9.4 p-10 -151.17 67.64 0.92 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.496 0.665 . . . . 2.43 110.663 -177.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -109.45 -147.49 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.271 -0.877 . . . . 3.26 111.518 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m 71.43 36.14 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.431 0.634 . . . . 2.06 110.894 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.8 ptt? 175.94 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.57 -1.195 . . . . 1.25 107.879 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 76' ' ' THR . 11.6 m-85 -130.13 162.9 27.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 113.336 -1.756 . . . . 0.74 106.291 173.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.1 t -152.46 166.13 32.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 119.48 1.036 . . . . 1.46 112.953 -165.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 5.3 p -103.01 133.08 47.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.14 -0.936 . . . . 1.31 110.966 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 74' ' ' HIS . 28.9 tt0 -104.18 153.98 20.3 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.99 -1.004 . . . . 2.45 108.779 173.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 54' ' ' GLU . 21.4 p-10 -133.47 122.73 24.09 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.094 -0.503 . . . . 1.93 109.966 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.807 ' HD3' ' HB2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -137.73 113.27 9.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.617 0.722 . . . . 1.42 110.07 176.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.82 ' HA ' ' HA ' ' A' ' 71' ' ' GLU . 3.4 m-85 -106.83 124.04 49.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.333 -0.848 . . . . 1.66 110.49 -176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.477 ' HE2' ' HG3' ' A' ' 56' ' ' LYS . 96.7 m-85 -119.91 101.05 48.16 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-O 121.284 0.564 . . . . 2.14 110.586 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.501 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 1.8 Cg_endo -90.64 131.95 1.65 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.073 3.182 . . . . 1.92 111.628 173.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.851 ' HB3' ' HA3' ' A' ' 66' ' ' GLY . 39.0 Cg_exo -64.39 -58.39 0.24 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 123.368 2.712 . . . . 2.64 112.548 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.614 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 8.6 m-20 -147.66 -47.71 0.17 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.555 -0.748 . . . . 5.8 110.312 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.717 ' HA ' ' HB3' ' A' ' 30' ' ' PRO . 21.0 t 82.99 -21.91 0.27 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 114.414 -1.266 . . . . 7.43 110.765 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -74.69 -18.6 60.5 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.85 -1.166 . . . . 8.71 107.85 165.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.827 ' HG ' ' H ' ' A' ' 65' ' ' LEU . 14.5 tp -165.12 -156.88 0.32 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 113.802 -1.544 . . . . 8.1 108.005 177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.827 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -109.5 164.68 12.29 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.035 -0.53 . . . . 4.74 109.8 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.851 ' HA3' ' HB3' ' A' ' 60' ' ' PRO . . . -136.82 27.81 2.9 Favored Glycine 0 C--N 1.314 -0.644 0 CA-C-N 115.084 -0.962 . . . . 3.02 110.993 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 67.15 -66.24 0.2 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.632 0.773 . . . . 4.02 110.992 -171.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.27 60.65 4.73 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.922 -0.581 . . . . 2.84 113.321 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 27' ' ' PRO . . . -78.98 122.72 5.91 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.85 -1.7 . . . . 1.49 108.85 168.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.49 92.62 1.51 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.418 0.896 . . . . 0.97 113.418 -168.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.82 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . 36.8 mt-10 -104.44 106.82 17.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.741 -0.837 . . . . 0.81 108.741 174.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.807 ' HB2' ' HD3' ' A' ' 56' ' ' LYS . 3.6 m170 -107.4 152.78 23.73 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.413 0.625 . . . . 0.53 111.825 -172.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.822 ' HZ ' ' HA ' ' A' ' 37' ' ' TYR . 30.8 m-85 -123.44 108.29 12.53 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.301 -1.318 . . . . 1.13 108.6 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.615 ' CE1' ' HE2' ' A' ' 56' ' ' LYS . 21.0 m170 -103.6 107.65 18.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.194 -0.457 . . . . 0.5 110.377 -173.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 3.3 m -101.93 113.99 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-O 122.986 1.374 . . . . 0.87 108.463 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.741 ' O ' ' HB3' ' A' ' 51' ' ' PHE . 16.9 m -101.52 103.23 14.08 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.723 -1.584 . . . . 0.46 106.723 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.568 ' HA ' ' CB ' ' A' ' 51' ' ' PHE . 3.2 p -153.97 146.82 14.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 O-C-N 124.167 0.917 . . . . 1.04 111.179 -173.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' HA ' ' CG2' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -128.59 102.5 6.63 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.561 0.696 . . . . 1.54 109.533 166.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' HD22 ' A' ' 47' ' ' ASN . . . -165.83 140.29 4.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.69 -0.687 . . . . 0.67 110.043 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HA ' ' HB3' ' A' ' 110' ' ' ASN . . . -73.89 95.89 2.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.383 0.611 . . . . 0.44 111.213 -177.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.79 166.75 34.03 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.201 -0.909 . . . . 0.29 110.993 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.0 m -102.97 134.84 45.74 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.895 -0.78 . . . . 0.4 108.895 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.905 ' HD1' HG22 ' A' ' 85' ' ' VAL . 31.0 t-80 -102.96 105.35 15.67 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.36 -0.607 . . . . 0.4 109.36 -174.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -101.11 106.63 17.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.808 -0.812 . . . . 0.35 108.808 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.905 HG22 ' HD1' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -104.88 110.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.588 -0.733 . . . . 0.59 110.773 -170.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -114.39 104.28 11.89 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.962 0.789 . . . . 1.53 109.164 174.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.652 ' H ' ' HD1' ' A' ' 103' ' ' PHE . 76.6 mt -105.55 130.48 53.59 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 109.166 -0.679 . . . . 0.24 109.166 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.517 HG22 ' CG ' ' A' ' 90' ' ' MET . 6.7 m -102.42 122.08 43.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.343 0.592 . . . . 0.29 110.354 -172.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.478 ' HE1' ' HA ' ' A' ' 35' ' ' ALA . 1.2 t80 -91.18 85.54 5.91 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.308 -0.86 . . . . 1.11 109.486 -175.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.604 ' HB3' ' CA ' ' A' ' 95' ' ' GLY . 7.9 mtm -128.94 172.35 11.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.177 0.513 . . . . 0.65 110.943 -175.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.536 ' H ' ' HA2' ' A' ' 95' ' ' GLY . 5.4 mtm180 -84.23 109.84 22.19 Favored Pre-proline 0 C--N 1.313 -0.989 0 CA-C-N 115.485 -0.779 . . . . 2.59 109.477 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 91' ' ' ARG . 2.0 Cg_endo -41.63 -34.7 2.28 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 124.724 3.616 . . . . 1.04 115.51 -168.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -87.03 3.53 45.65 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.504 0.557 . . . . 1.17 112.504 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.472 HG23 ' N ' ' A' ' 95' ' ' GLY . 6.2 t -169.22 -58.88 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.409 -0.182 . . . . 1.09 111.401 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.604 ' CA ' ' HB3' ' A' ' 90' ' ' MET . . . 66.12 78.74 0.22 Allowed Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 121.137 -0.554 . . . . 1.16 111.784 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 1.061 ' HB2' ' HB3' ' A' ' 99' ' ' ASP . 71.6 Cg_exo -47.82 121.51 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.296 2.664 . . . . 1.2 111.958 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -50.08 -39.52 42.7 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 114.969 -1.014 . . . . 2.64 113.25 -169.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -112.79 17.53 18.95 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.32 -0.552 . . . . 4.09 110.925 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 1.061 ' HB3' ' HB2' ' A' ' 96' ' ' PRO . 25.3 t0 -121.53 -0.29 9.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.737 0.78 . . . . 1.67 109.57 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.4 p -97.9 156.22 16.71 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.104 -0.953 . . . . 1.39 110.96 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 89' ' ' TYR . 40.6 tt0 -108.26 175.81 5.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.453 -0.943 . . . . 1.91 108.453 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 87' ' ' LEU . 47.8 ttt180 -158.7 142.81 15.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.685 0.755 . . . . 0.62 110.483 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.757 ' HZ ' HG12 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -104.16 162.81 12.86 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.428 -1.26 . . . . 0.86 109.796 -177.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 38.2 m -164.67 104.82 0.82 Allowed 'General case' 0 N--CA 1.441 -0.917 0 O-C-N 123.407 0.442 . . . . 0.31 110.39 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.969 HG21 HG21 ' A' ' 5' ' ' VAL . 13.4 p -110.87 136.67 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 C-N-CA 119.408 -0.917 . . . . 0.88 109.153 166.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 13' ' ' THR . 98.0 m-85 -103.5 103.44 13.41 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.409 -0.96 . . . . 0.7 108.409 174.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.766 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -127.26 147.24 50.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.653 -0.499 . . . . 2.12 109.653 178.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.688 ' O ' HG22 ' A' ' 16' ' ' VAL . 20.1 tttm -102.38 117.02 33.82 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.78 -0.368 . . . . 1.89 110.346 -173.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.495 ' HB1' HG11 ' A' ' 18' ' ' VAL . . . -100.62 120.4 39.99 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 123.614 0.571 . . . . 0.53 110.176 -170.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.527 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.516 -0.754 . . . . 1.78 110.422 -174.562 . . . . . . . . 2 2 . 1 stop_ save_